
Inclusion NCT03928964 0 9 O
criteria NCT03928964 10 18 O
: NCT03928964 19 20 O

1 NCT03928964 24 25 O
. NCT03928964 25 26 O
Patients NCT03928964 28 36 O
with NCT03928964 37 41 O
locally NCT03928964 42 49 B-Modifier
advanced NCT03928964 50 58 I-Modifier
or NCT03928964 59 61 B-Or
metastatic NCT03928964 62 72 B-Modifier
renal NCT03928964 73 78 I-Modifier
cell NCT03928964 79 83 I-Modifier
carcinoma NCT03928964 84 93 B-Condition

2 NCT03928964 96 97 O
. NCT03928964 97 98 O
Whose NCT03928964 100 105 O
first NCT03928964 106 111 B-Procedure
- NCT03928964 112 113 I-Procedure
line NCT03928964 114 118 I-Procedure
treatment NCT03928964 119 128 I-Procedure
included NCT03928964 129 137 O
at NCT03928964 138 140 B-Eq_Comparison
least NCT03928964 141 146 I-Eq_Comparison
one NCT03928964 147 150 I-Eq_Comparison
anti NCT03928964 151 155 B-Drug
- NCT03928964 156 157 I-Drug
angiogenic NCT03928964 158 168 I-Drug
agent NCT03928964 169 174 I-Drug
( NCT03928964 175 176 O
tyrosine NCT03928964 177 185 B-Drug
kinase NCT03928964 186 192 I-Drug
inhibitor NCT03928964 193 202 I-Drug
or NCT03928964 203 205 O
monoclonal NCT03928964 206 216 B-Drug
antibodies NCT03928964 217 227 I-Drug
) NCT03928964 228 229 O
and NCT03928964 230 233 B-Or
/ NCT03928964 234 235 I-Or
or NCT03928964 236 238 I-Or
an NCT03928964 239 241 O
mTOR NCT03928964 242 246 B-Drug
inhibitor NCT03928964 247 256 I-Drug
; NCT03928964 256 257 O

3 NCT03928964 260 261 O
. NCT03928964 261 262 O
Whatever NCT03928964 264 272 O
was NCT03928964 273 276 O
the NCT03928964 277 280 O
overall NCT03928964 281 288 O
ECOG NCT03928964 289 293 B-Observation
- NCT03928964 294 295 I-Observation
PS NCT03928964 296 298 I-Observation
score NCT03928964 299 304 O
( NCT03928964 305 306 O
Eastern NCT03928964 307 314 B-Observation
Cooperative NCT03928964 315 326 I-Observation
Oncology NCT03928964 327 335 I-Observation
Group NCT03928964 336 341 I-Observation
Performance NCT03928964 342 353 I-Observation
Status NCT03928964 354 360 I-Observation
) NCT03928964 361 362 O
at NCT03928964 363 365 B-Temporal_Connection___Temporal_Connection_Type_Value:during
treatment NCT03928964 366 375 B-Procedure
initiation NCT03928964 376 386 B-Eq_Comparison
time NCT03928964 387 391 O

4 NCT03928964 394 395 O
. NCT03928964 395 396 O
With NCT03928964 398 402 O
first NCT03928964 403 408 B-Procedure
- NCT03928964 409 410 I-Procedure
line NCT03928964 411 415 I-Procedure
treatment NCT03928964 416 425 I-Procedure
carried NCT03928964 426 433 B-Eq_Comparison
out NCT03928964 434 437 I-Eq_Comparison
between NCT03928964 438 445 B-Eq_Comparison
2007 NCT03928964 446 450 I-Eq_Comparison
and NCT03928964 451 454 I-Eq_Comparison
June NCT03928964 455 459 I-Eq_Comparison
2016 NCT03928964 460 464 I-Eq_Comparison
. NCT03928964 464 465 O

Exclusion NCT03928964 467 476 O
criteria NCT03928964 477 485 O
: NCT03928964 486 487 O

1 NCT03928964 491 492 O
. NCT03928964 492 493 O
Patient NCT03928964 495 502 O
previously NCT03928964 503 513 B-Eq_Comparison
treated NCT03928964 514 521 B-Procedure
with NCT03928964 522 526 O
only NCT03928964 527 531 O
one NCT03928964 532 535 B-Eq_Comparison
cytokine NCT03928964 536 544 B-Drug
( NCT03928964 545 546 O
Interferon NCT03928964 547 557 B-Drug
Î± NCT03928964 558 559 I-Drug
2 NCT03928964 560 561 I-Drug
a NCT03928964 562 563 I-Drug
, NCT03928964 564 565 O
high NCT03928964 566 570 O
- NCT03928964 571 572 O
dose NCT03928964 573 577 O
interleukin NCT03928964 578 589 B-Drug
- NCT03928964 590 591 I-Drug
2 NCT03928964 592 593 I-Drug
) NCT03928964 594 595 O

2 NCT03928964 599 600 O
. NCT03928964 600 601 O
Refusal NCT03928964 603 610 O
of NCT03928964 611 613 O
processing NCT03928964 614 624 O
of NCT03928964 625 627 O
personal NCT03928964 628 636 O
data NCT03928964 637 641 O

Inclusion NCT03922828 0 9 O
Criteria NCT03922828 10 18 O
: NCT03922828 19 20 O

- NCT03922828 24 25 O
The NCT03922828 27 30 O
subject NCT03922828 31 38 O
must NCT03922828 39 43 O
meet NCT03922828 44 48 O
all NCT03922828 49 52 O
of NCT03922828 53 55 O
the NCT03922828 56 59 O
following NCT03922828 60 69 O
inclusion NCT03922828 70 79 O
criteria NCT03922828 80 88 O
to NCT03922828 89 91 O
participate NCT03922828 92 103 O
in NCT03922828 104 106 O
this NCT03922828 107 111 O
study NCT03922828 112 117 O
. NCT03922828 118 119 O

1 NCT03922828 128 129 O
. NCT03922828 129 130 O
Evidence NCT03922828 132 140 O
of NCT03922828 141 143 O
lung NCT03922828 144 148 B-Condition
nodule NCT03922828 149 155 I-Condition
on NCT03922828 156 158 O
chest NCT03922828 159 164 B-Procedure
radiograph NCT03922828 165 175 I-Procedure
or NCT03922828 176 178 B-Or
Computed NCT03922828 179 187 B-Procedure
Tomography NCT03922828 188 198 I-Procedure
regardless NCT03922828 199 209 O
of NCT03922828 210 212 O
underlying NCT03922828 213 223 O
aetiology NCT03922828 224 233 O

2 NCT03922828 241 242 O
. NCT03922828 242 243 O
Age NCT03922828 245 248 B-Age
> NCT03922828 249 250 B-Eq_Comparison
21 NCT03922828 251 253 I-Eq_Comparison
years NCT03922828 254 259 I-Eq_Comparison
old NCT03922828 260 263 O

3 NCT03922828 271 272 O
. NCT03922828 272 273 O
Ability NCT03922828 275 282 O
to NCT03922828 283 285 O
provide NCT03922828 286 293 O
informed NCT03922828 294 302 O
consent NCT03922828 303 310 O

Exclusion NCT03922828 311 320 O
Criteria NCT03922828 321 329 O
: NCT03922828 330 331 O

- NCT03922828 335 336 O
Subjects NCT03922828 338 346 O
who NCT03922828 347 350 O
no NCT03922828 351 353 B-Negation
radiographic NCT03922828 354 366 B-Procedure
evidence NCT03922828 367 375 O
of NCT03922828 376 378 O
lung NCT03922828 379 383 B-Condition
nodules NCT03922828 384 391 I-Condition
or NCT03922828 392 394 O
who NCT03922828 395 398 O
are NCT03922828 399 402 O
unwilling NCT03922828 403 412 O
/ NCT03922828 413 414 O
unable NCT03922828 415 421 O
to NCT03922828 422 424 O
provide NCT03922828 425 432 O
informed NCT03922828 433 441 O
consent NCT03922828 442 449 O

Inclusion NCT03928834 0 9 O
Criteria NCT03928834 10 18 O
: NCT03928834 19 20 O

1 NCT03928834 24 25 O
. NCT03928834 25 26 O
HIV NCT03928834 28 31 B-Condition
- NCT03928834 32 33 O
positive NCT03928834 34 42 O
adolescents NCT03928834 43 54 O
aged NCT03928834 55 59 B-Age
10 NCT03928834 60 62 B-Eq_Comparison
- NCT03928834 63 64 I-Eq_Comparison
19 NCT03928834 65 67 I-Eq_Comparison
years NCT03928834 68 73 I-Eq_Comparison
who NCT03928834 74 77 O
know NCT03928834 78 82 O
their NCT03928834 83 88 O
status NCT03928834 89 95 O

2 NCT03928834 98 99 O
. NCT03928834 99 100 O
On NCT03928834 102 104 B-Eq_Comparison
ART NCT03928834 105 108 B-Procedure
for NCT03928834 109 112 O
at NCT03928834 113 115 B-Eq_Comparison
least NCT03928834 116 121 I-Eq_Comparison
6 NCT03928834 122 123 I-Eq_Comparison
months NCT03928834 124 130 I-Eq_Comparison
as NCT03928834 131 133 O
per NCT03928834 134 137 O
clinic NCT03928834 138 144 O
records NCT03928834 145 152 O
: NCT03928834 153 154 O
the NCT03928834 155 158 O
patient NCT03928834 159 166 O
will NCT03928834 167 171 O
have NCT03928834 172 176 O
attended NCT03928834 177 185 B-Encounter
the NCT03928834 186 189 O
clinic NCT03928834 190 196 O
as NCT03928834 197 199 O
shown NCT03928834 200 205 O
in NCT03928834 206 208 O
clinic NCT03928834 209 215 O
records NCT03928834 216 223 O
at NCT03928834 224 226 B-Eq_Comparison
least NCT03928834 227 232 I-Eq_Comparison
once NCT03928834 233 237 I-Eq_Comparison
since NCT03928834 238 243 B-Temporal_Connection___Temporal_Connection_Type_Value:after
initiation NCT03928834 244 254 B-Eq_Comparison
AND NCT03928834 255 258 B-And
will NCT03928834 259 263 O
have NCT03928834 264 268 O
re NCT03928834 269 271 O
- NCT03928834 272 273 O
filled NCT03928834 274 280 O
their NCT03928834 281 286 O
ART NCT03928834 287 290 B-Procedure
at NCT03928834 291 293 B-Eq_Comparison
least NCT03928834 294 299 I-Eq_Comparison
once NCT03928834 300 304 I-Eq_Comparison
since NCT03928834 305 310 O
initiation NCT03928834 311 321 O
as NCT03928834 322 324 O
shown NCT03928834 325 330 O
in NCT03928834 331 333 O
clinic NCT03928834 334 340 O
records NCT03928834 341 348 O
. NCT03928834 349 350 O
. NCT03928834 351 352 O

3 NCT03928834 356 357 O
. NCT03928834 357 358 O
Planning NCT03928834 360 368 B-Assertion___Assertion_Type_Value:intention
to NCT03928834 369 371 O
stay NCT03928834 372 376 O
in NCT03928834 377 379 O
care NCT03928834 380 384 B-Encounter
at NCT03928834 385 387 O
that NCT03928834 388 392 O
facility NCT03928834 393 401 O
for NCT03928834 402 405 O
at NCT03928834 406 408 B-Eq_Comparison
least NCT03928834 409 414 I-Eq_Comparison
12 NCT03928834 415 417 I-Eq_Comparison
months NCT03928834 418 424 I-Eq_Comparison

Exclusion NCT03928834 425 434 O
Criteria NCT03928834 435 443 O
: NCT03928834 444 445 O

1 NCT03928834 449 450 O
. NCT03928834 450 451 O
Participant NCT03928834 453 464 O
and NCT03928834 465 468 O
/ NCT03928834 469 470 O
or NCT03928834 471 473 O
caregiver NCT03928834 474 483 O
unable NCT03928834 484 490 O
to NCT03928834 491 493 O
give NCT03928834 494 498 O
consent NCT03928834 499 506 O
and NCT03928834 507 510 O
assent NCT03928834 511 517 O

2 NCT03928834 520 521 O
. NCT03928834 521 522 O
Those NCT03928834 524 529 O
participants NCT03928834 530 542 O
who NCT03928834 543 546 O
the NCT03928834 547 550 O
healthcare NCT03928834 551 561 O
worker NCT03928834 562 568 O
considers NCT03928834 569 578 O
to NCT03928834 579 581 O
be NCT03928834 582 584 O
too NCT03928834 585 588 O
ill NCT03928834 589 592 O
to NCT03928834 593 595 O
participate NCT03928834 596 607 O

Inclusion NCT03922685 0 9 O
Criteria NCT03922685 10 18 O
: NCT03922685 19 20 O

- NCT03922685 24 25 O
postmenopausal NCT03922685 27 41 B-Condition

- NCT03922685 44 45 O
normal NCT03922685 47 53 O
blood NCT03922685 54 59 B-Observation
glucose NCT03922685 60 67 I-Observation

- NCT03922685 70 71 O
no NCT03922685 73 75 B-Negation
cholesterol NCT03922685 76 87 B-Condition
medication NCT03922685 88 98 B-Drug

- NCT03922685 101 102 O
age NCT03922685 104 107 B-Age
between NCT03922685 108 115 B-Eq_Comparison
50 NCT03922685 116 118 I-Eq_Comparison
an NCT03922685 119 121 I-Eq_Comparison
65 NCT03922685 122 124 I-Eq_Comparison
years NCT03922685 125 130 I-Eq_Comparison

- NCT03922685 133 134 O
overweight NCT03922685 136 146 B-Condition
but NCT03922685 147 150 B-And
not NCT03922685 151 154 B-Negation
obese NCT03922685 155 160 B-Condition

- NCT03922685 163 164 O
BMI NCT03922685 166 169 B-Observation
between NCT03922685 170 177 B-Eq_Comparison
25 NCT03922685 178 180 I-Eq_Comparison
and NCT03922685 181 184 I-Eq_Comparison
30 NCT03922685 185 187 I-Eq_Comparison
kg NCT03922685 188 190 I-Eq_Comparison
/ NCT03922685 191 192 I-Eq_Comparison
m NCT03922685 193 194 I-Eq_Comparison
2 NCT03922685 195 196 I-Eq_Comparison

- NCT03922685 199 200 O
weight NCT03922685 202 208 B-Observation
- NCT03922685 209 210 O
stable NCT03922685 211 217 O
during NCT03922685 218 224 B-Temporal_Connection___Temporal_Connection_Type_Value:during
past NCT03922685 225 229 B-Eq_Comparison
6 NCT03922685 230 231 I-Eq_Comparison
months NCT03922685 232 238 I-Eq_Comparison

- NCT03922685 241 242 O
exercise NCT03922685 244 252 B-Observation
less NCT03922685 253 257 B-Eq_Comparison
than NCT03922685 258 262 I-Eq_Comparison
20 NCT03922685 263 265 I-Eq_Comparison
minutes NCT03922685 266 273 I-Eq_Comparison
three NCT03922685 274 279 B-Eq_Comparison
times NCT03922685 280 285 I-Eq_Comparison
a NCT03922685 286 287 I-Eq_Comparison
week NCT03922685 288 292 I-Eq_Comparison

Exclusion NCT03922685 293 302 O
Criteria NCT03922685 303 311 O
: NCT03922685 312 313 O

- NCT03922685 317 318 O
metabolic NCT03922685 320 329 B-Condition
disease NCT03922685 330 337 I-Condition
other NCT03922685 338 343 B-Exception
than NCT03922685 344 348 I-Exception
hormonally NCT03922685 349 359 B-Modifier
- NCT03922685 360 361 I-Modifier
corrected NCT03922685 362 371 I-Modifier
hypothyroidism NCT03922685 372 386 B-Condition

- NCT03922685 389 390 O
musculo NCT03922685 392 399 B-Condition
- NCT03922685 400 401 I-Condition
skeletal NCT03922685 402 410 I-Condition
disability NCT03922685 411 421 I-Condition
that NCT03922685 422 426 O
would NCT03922685 427 432 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03922685 433 441 B-Negation
exercise NCT03922685 442 450 B-Observation

- NCT03922685 453 454 O
smoker NCT03922685 456 462 B-Condition

- NCT03922685 465 466 O
do NCT03922685 468 470 O
not NCT03922685 471 474 O
meet NCT03922685 475 479 O
inclusion NCT03922685 480 489 O
criteria NCT03922685 490 498 O

Inclusion NCT03928418 0 9 O
Criteria NCT03928418 10 18 O
: NCT03928418 19 20 O

- NCT03928418 24 25 O
Age NCT03928418 27 30 B-Age
18 NCT03928418 31 33 B-Eq_Comparison
years NCT03928418 34 39 I-Eq_Comparison
and NCT03928418 40 43 I-Eq_Comparison
older NCT03928418 44 49 I-Eq_Comparison
; NCT03928418 49 50 O

- NCT03928418 53 54 O
HIV NCT03928418 56 59 B-Condition
positive NCT03928418 60 68 O
; NCT03928418 68 69 O

- NCT03928418 72 73 O
On NCT03928418 75 77 B-Eq_Comparison
ART NCT03928418 78 81 B-Procedure
for NCT03928418 82 85 O
at NCT03928418 86 88 B-Eq_Comparison
least NCT03928418 89 94 I-Eq_Comparison
six NCT03928418 95 98 I-Eq_Comparison
months NCT03928418 99 105 I-Eq_Comparison
; NCT03928418 105 106 O

- NCT03928418 109 110 O
Reported NCT03928418 112 120 O
alcohol NCT03928418 121 128 B-Drug
use NCT03928418 129 132 O
in NCT03928418 133 135 O
the NCT03928418 136 139 O
prior NCT03928418 140 145 B-Eq_Comparison
year NCT03928418 146 150 I-Eq_Comparison
at NCT03928418 151 153 O
clinic NCT03928418 154 160 O
entry NCT03928418 161 166 O
; NCT03928418 166 167 O

- NCT03928418 170 171 O
Fluency NCT03928418 173 180 O
in NCT03928418 181 183 O
Runyakole NCT03928418 184 193 O
; NCT03928418 193 194 O

- NCT03928418 197 198 O
Living NCT03928418 200 206 O
within NCT03928418 207 213 B-Eq_Comparison
two NCT03928418 214 217 I-Eq_Comparison
hours NCT03928418 218 223 I-Eq_Comparison
travel NCT03928418 224 230 B-Observation
time NCT03928418 231 235 I-Observation
from NCT03928418 236 240 O
the NCT03928418 241 244 O
clinic NCT03928418 245 251 O
; NCT03928418 251 252 O

- NCT03928418 255 256 O
Owning NCT03928418 258 264 O
or NCT03928418 265 267 O
having NCT03928418 268 274 O
daily NCT03928418 275 280 O
access NCT03928418 281 287 O
to NCT03928418 288 290 O
a NCT03928418 291 292 O
cell NCT03928418 293 297 O
phone NCT03928418 298 303 O
; NCT03928418 303 304 O

- NCT03928418 307 308 O
Screening NCT03928418 310 319 O
positive NCT03928418 320 328 O
on NCT03928418 329 331 O
the NCT03928418 332 335 O
AUDIT NCT03928418 336 341 B-Observation
- NCT03928418 342 343 I-Observation
C NCT03928418 344 345 I-Observation

Exclusion NCT03928418 346 355 O
Criteria NCT03928418 356 364 O
: NCT03928418 365 366 O

- NCT03928418 370 371 O
Plans NCT03928418 373 378 B-Assertion___Assertion_Type_Value:intention
to NCT03928418 379 381 O
move NCT03928418 382 386 B-Observation
out NCT03928418 387 390 I-Observation
of NCT03928418 391 393 O
the NCT03928418 394 397 O
catchment NCT03928418 398 407 O
area NCT03928418 408 412 O
within NCT03928418 413 419 B-Eq_Comparison
6 NCT03928418 420 421 I-Eq_Comparison
months NCT03928418 422 428 I-Eq_Comparison
; NCT03928418 428 429 O

- NCT03928418 432 433 O
Unable NCT03928418 435 441 O
to NCT03928418 442 444 O
provide NCT03928418 445 452 O
informed NCT03928418 453 461 O
consent NCT03928418 462 469 O
. NCT03928418 470 471 O

- NCT03928418 475 476 O
Participation NCT03928418 478 491 O
in NCT03928418 492 494 O
another NCT03928418 495 502 B-Other
research NCT03928418 503 511 O
study NCT03928418 512 517 B-Study
. NCT03928418 518 519 O

Inclusion NCT03930134 0 9 O
Criteria NCT03930134 10 18 O
: NCT03930134 19 20 O

- NCT03930134 24 25 O
singleton NCT03930134 27 36 B-Modifier
pregnancy NCT03930134 37 46 B-Condition

- NCT03930134 49 50 O
Cicatricial NCT03930134 52 63 B-Condition
uterus NCT03930134 64 70 I-Condition
with NCT03930134 71 75 B-And
contraindication NCT03930134 76 92 B-Contraindication
to NCT03930134 93 95 O
vaginal NCT03930134 96 103 B-Procedure
delivery NCT03930134 104 112 I-Procedure
( NCT03930134 113 114 O
uterus NCT03930134 115 121 B-Condition
bi NCT03930134 122 124 B-Modifier
or NCT03930134 125 127 B-Or
multi NCT03930134 128 133 B-Modifier
- NCT03930134 134 135 I-Modifier
cicatricial NCT03930134 136 147 I-Modifier
, NCT03930134 148 149 O
corporal NCT03930134 150 158 B-Condition
uterine NCT03930134 159 166 I-Condition
scar NCT03930134 167 171 I-Condition
, NCT03930134 172 173 O
intra NCT03930134 174 179 B-Procedure
- NCT03930134 180 181 I-Procedure
mural NCT03930134 182 187 I-Procedure
myomectomy NCT03930134 188 198 I-Procedure
, NCT03930134 199 200 O
dystocic NCT03930134 201 209 B-Condition
presentation NCT03930134 210 222 I-Condition
) NCT03930134 223 224 O

- NCT03930134 228 229 O
Fetal NCT03930134 231 236 B-Condition
macrosomia NCT03930134 237 247 I-Condition
with NCT03930134 248 252 B-And
a NCT03930134 253 254 O
weight NCT03930134 255 261 B-Observation
greater NCT03930134 262 269 B-Eq_Comparison
than NCT03930134 270 274 I-Eq_Comparison
4 NCT03930134 275 276 I-Eq_Comparison
Kg NCT03930134 277 279 I-Eq_Comparison

- NCT03930134 282 283 O
Placenta NCT03930134 285 293 B-Condition
previa NCT03930134 294 300 I-Condition

Exclusion NCT03930134 301 310 O
Criteria NCT03930134 311 319 O
: NCT03930134 320 321 O

- NCT03930134 325 326 O
Patients NCT03930134 328 336 O
who NCT03930134 337 340 O
refuse NCT03930134 341 347 O
to NCT03930134 348 350 O
participate NCT03930134 351 362 O
in NCT03930134 363 365 O
the NCT03930134 366 369 O
study NCT03930134 370 375 B-Study

- NCT03930134 378 379 O
prenatally NCT03930134 381 391 O
diagnosed NCT03930134 392 401 O
fetal NCT03930134 402 407 B-Condition
pathology NCT03930134 408 417 I-Condition
( NCT03930134 418 419 O
intrauterine NCT03930134 420 432 B-Condition
growth NCT03930134 433 439 I-Condition
restriction NCT03930134 440 451 I-Condition
, NCT03930134 452 453 O
malformation NCT03930134 454 466 B-Condition
, NCT03930134 467 468 O
genetics NCT03930134 469 477 B-Condition
disorders NCT03930134 478 487 I-Condition
) NCT03930134 488 489 O

- NCT03930134 493 494 O
adherent NCT03930134 496 504 B-Condition
placenta NCT03930134 505 513 I-Condition
, NCT03930134 514 515 O
an NCT03930134 516 518 O
adnexal NCT03930134 519 526 B-Condition
mass NCT03930134 527 531 I-Condition
or NCT03930134 532 534 B-Or
a NCT03930134 535 536 O
myoma NCT03930134 537 542 B-Condition
at NCT03930134 543 545 I-Condition
the NCT03930134 546 549 I-Condition
lower NCT03930134 550 555 I-Condition
uterine NCT03930134 556 563 I-Condition
segment NCT03930134 564 571 I-Condition

- NCT03930134 574 575 O
Cesarean NCT03930134 577 585 B-Procedure
section NCT03930134 586 593 I-Procedure
in NCT03930134 594 596 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03930134 597 598 I-Temporal_Connection___Temporal_Connection_Type_Value:during
context NCT03930134 599 606 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03930134 607 609 O
medical NCT03930134 610 617 B-Modifier
or NCT03930134 618 620 B-Or
obstetrical NCT03930134 621 632 B-Modifier
emergency NCT03930134 633 642 B-Encounter

- NCT03930134 645 646 O
Caesarean NCT03930134 648 657 B-Procedure
section NCT03930134 658 665 I-Procedure
with NCT03930134 666 670 B-And
a NCT03930134 671 672 O
high NCT03930134 673 677 O
risk NCT03930134 678 682 B-Risk
of NCT03930134 683 685 O
bleeding NCT03930134 686 694 B-Condition

Inclusion NCT03926104 0 9 O
Criteria NCT03926104 10 18 O
: NCT03926104 19 20 O

- NCT03926104 24 25 O
Ability NCT03926104 27 34 O
to NCT03926104 35 37 O
provide NCT03926104 38 45 O
an NCT03926104 46 48 O
informed NCT03926104 49 57 O
consent NCT03926104 58 65 O

- NCT03926104 68 69 O
Age NCT03926104 71 74 B-Age
> NCT03926104 75 76 B-Eq_Comparison
18 NCT03926104 77 79 I-Eq_Comparison
years NCT03926104 80 85 I-Eq_Comparison
old NCT03926104 86 89 O

- NCT03926104 92 93 O
Elective NCT03926104 95 103 O
abdominal NCT03926104 104 113 B-Condition
aortic NCT03926104 114 120 I-Condition
aneurysm NCT03926104 121 129 I-Condition
surgery NCT03926104 130 137 B-Procedure

Exclusion NCT03926104 138 147 O
Criteria NCT03926104 148 156 O
: NCT03926104 157 158 O

- NCT03926104 162 163 O
Emergency NCT03926104 165 174 B-Modifier
surgery NCT03926104 175 182 B-Procedure

- NCT03926104 185 186 O
Age NCT03926104 188 191 B-Age
< NCT03926104 192 193 B-Eq_Comparison
18 NCT03926104 194 196 I-Eq_Comparison
years NCT03926104 197 202 I-Eq_Comparison
old NCT03926104 203 206 O

- NCT03926104 209 210 O
Creatinine NCT03926104 212 222 B-Observation
> NCT03926104 223 224 B-Eq_Comparison
2 NCT03926104 225 226 I-Eq_Comparison
mg NCT03926104 227 229 I-Eq_Comparison
/ NCT03926104 230 231 I-Eq_Comparison
dl NCT03926104 232 234 I-Eq_Comparison

- NCT03926104 237 238 O
Diseases NCT03926104 240 248 B-Condition
of NCT03926104 249 251 O
ascending NCT03926104 252 261 B-Modifier
aorta NCT03926104 262 267 I-Modifier
, NCT03926104 268 269 O
aortic NCT03926104 270 276 B-Modifier
arch NCT03926104 277 281 I-Modifier
or NCT03926104 282 284 B-Or
thoracic NCT03926104 285 293 B-Modifier
aorta NCT03926104 294 299 I-Modifier

- NCT03926104 302 303 O
Chronic NCT03926104 305 312 O
atrial NCT03926104 313 319 B-Condition
fibrillation NCT03926104 320 332 I-Condition

- NCT03926104 335 336 O
Patient NCT03926104 338 345 O
refusal NCT03926104 346 353 O
to NCT03926104 354 356 O
provide NCT03926104 357 364 O
informed NCT03926104 365 373 O
consent NCT03926104 374 381 O

Inclusion NCT03863496 0 9 O
Criteria NCT03863496 10 18 O
: NCT03863496 19 20 O

- NCT03863496 24 25 O
Signed NCT03863496 27 33 O
and NCT03863496 34 37 O
dated NCT03863496 38 43 O
informed NCT03863496 44 52 O
consent NCT03863496 53 60 O
for NCT03863496 61 64 O
participation NCT03863496 65 78 O
in NCT03863496 79 81 O
the NCT03863496 82 85 O
study NCT03863496 86 91 O
( NCT03863496 92 93 O
separate NCT03863496 94 102 O
informed NCT03863496 103 111 O
consents NCT03863496 112 120 O
for NCT03863496 121 124 O
child NCT03863496 125 130 B-Family_Member___Family_Member_Type:child
and NCT03863496 131 134 B-Or
parents NCT03863496 135 142 B-Family_Member___Family_Member_Type:parent
/ NCT03863496 143 144 O
caregivers NCT03863496 145 155 O
) NCT03863496 156 157 O
, NCT03863496 158 159 O
obtained NCT03863496 160 168 O
before NCT03863496 169 175 B-Temporal_Connection___Temporal_Connection_Type_Value:before
conducting NCT03863496 176 186 O
any NCT03863496 187 190 O
study NCT03863496 191 196 B-Study
procedures NCT03863496 197 207 B-Procedure

- NCT03863496 210 211 O
Verified NCT03863496 213 221 O
and NCT03863496 222 225 O
documented NCT03863496 226 236 O
diagnosis NCT03863496 237 246 O
( NCT03863496 247 248 O
neuromuscular NCT03863496 249 262 B-Condition
desease NCT03863496 263 270 I-Condition
, NCT03863496 271 272 O
NMD NCT03863496 273 276 B-Condition
) NCT03863496 277 278 O
with NCT03863496 279 283 O
the NCT03863496 284 287 O
results NCT03863496 288 295 O
of NCT03863496 296 298 O
neurologic NCT03863496 299 309 B-Procedure
examination NCT03863496 310 321 I-Procedure

- NCT03863496 324 325 O
Deformity NCT03863496 327 336 B-Condition
of NCT03863496 337 339 O
thoracic NCT03863496 340 348 B-Modifier
and NCT03863496 349 352 B-Or
/ NCT03863496 353 354 I-Or
or NCT03863496 355 357 I-Or
lumbar NCT03863496 358 364 B-Modifier
spine NCT03863496 365 370 I-Modifier
associated NCT03863496 371 381 O
with NCT03863496 382 386 O
NMD NCT03863496 387 390 B-Condition
, NCT03863496 391 392 O
which NCT03863496 393 398 O
requires NCT03863496 399 407 B-Assertion___Assertion_Type_Value:hypothetical
surgical NCT03863496 408 416 B-Procedure
intervention NCT03863496 417 429 I-Procedure

Exclusion NCT03863496 430 439 O
Criteria NCT03863496 440 448 O
: NCT03863496 449 450 O

- NCT03863496 454 455 O
Patient NCT03863496 457 464 O
unwillingness NCT03863496 465 478 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03863496 479 481 B-Or
inability NCT03863496 482 491 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03863496 492 494 O
follow NCT03863496 495 501 O
study NCT03863496 502 507 B-Study
procedures NCT03863496 508 518 B-Procedure

- NCT03863496 521 522 O
Absence NCT03863496 524 531 O
of NCT03863496 532 534 O
signed NCT03863496 535 541 O
and NCT03863496 542 545 O
dated NCT03863496 546 551 O
informed NCT03863496 552 560 O
consent NCT03863496 561 568 O
for NCT03863496 569 572 O
participation NCT03863496 573 586 O
in NCT03863496 587 589 O
the NCT03863496 590 593 O
study NCT03863496 594 599 O
( NCT03863496 600 601 O
as NCT03863496 602 604 O
for NCT03863496 605 608 O
child NCT03863496 609 614 B-Family_Member___Family_Member_Type:child
and NCT03863496 615 618 B-Or
for NCT03863496 619 622 O
parents NCT03863496 623 630 B-Family_Member___Family_Member_Type:parent
/ NCT03863496 631 632 O
caregivers NCT03863496 633 643 O
) NCT03863496 644 645 O

- NCT03863496 649 650 O
Patient NCT03863496 652 659 O
participation NCT03863496 660 673 O
in NCT03863496 674 676 O
another NCT03863496 677 684 B-Other
clinical NCT03863496 685 693 O
study NCT03863496 694 699 B-Study
, NCT03863496 700 701 O
which NCT03863496 702 707 O
can NCT03863496 708 711 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03863496 712 721 O
the NCT03863496 722 725 O
results NCT03863496 726 733 O
of NCT03863496 734 736 O
this NCT03863496 737 741 O
study NCT03863496 742 747 B-Study

- NCT03863496 750 751 O
Left NCT03863496 753 757 B-Observation
ventricle NCT03863496 758 767 I-Observation
ejection NCT03863496 768 776 I-Observation
fraction NCT03863496 777 785 I-Observation
less NCT03863496 786 790 B-Eq_Comparison
than NCT03863496 791 795 I-Eq_Comparison
40 NCT03863496 796 798 I-Eq_Comparison
% NCT03863496 799 800 I-Eq_Comparison
by NCT03863496 801 803 O
echocardiography NCT03863496 804 820 B-Procedure

- NCT03863496 823 824 O
FEV NCT03863496 826 829 B-Observation
> NCT03863496 830 831 B-Eq_Comparison
20 NCT03863496 832 834 I-Eq_Comparison

- NCT03863496 838 839 O
Life NCT03863496 841 845 B-Observation
expectancy NCT03863496 846 856 I-Observation
< NCT03863496 857 858 B-Eq_Comparison
12 NCT03863496 859 861 I-Eq_Comparison
months NCT03863496 862 868 I-Eq_Comparison

- NCT03863496 871 872 O
Liver NCT03863496 874 879 B-Condition
insufficiency NCT03863496 880 893 I-Condition
: NCT03863496 894 895 O
ALT NCT03863496 896 899 B-Observation
, NCT03863496 900 901 O
AST NCT03863496 902 905 B-Observation
and NCT03863496 906 909 B-Or
total NCT03863496 910 915 B-Observation
bilirubin NCT03863496 916 925 I-Observation
twice NCT03863496 926 931 B-Eq_Comparison
higher NCT03863496 932 938 I-Eq_Comparison
than NCT03863496 939 943 I-Eq_Comparison
normal NCT03863496 944 950 I-Eq_Comparison

- NCT03863496 953 954 O
Kidney NCT03863496 956 962 B-Condition
insufficiency NCT03863496 963 976 I-Condition
( NCT03863496 977 978 O
creatinine NCT03863496 979 989 B-Observation
clearance NCT03863496 990 999 I-Observation
< NCT03863496 1000 1001 B-Eq_Comparison
60 NCT03863496 1002 1004 I-Eq_Comparison
ml NCT03863496 1005 1007 I-Eq_Comparison
/ NCT03863496 1008 1009 I-Eq_Comparison
min NCT03863496 1010 1013 I-Eq_Comparison
) NCT03863496 1014 1015 O

- NCT03863496 1019 1020 O
Concomitant NCT03863496 1022 1033 B-Modifier
diseases NCT03863496 1034 1042 B-Condition
, NCT03863496 1043 1044 O
which NCT03863496 1045 1050 O
preclude NCT03863496 1051 1059 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
patient NCT03863496 1060 1067 O
participation NCT03863496 1068 1081 O
in NCT03863496 1082 1084 O
this NCT03863496 1085 1089 O
study NCT03863496 1090 1095 B-Study
according NCT03863496 1096 1105 O
to NCT03863496 1106 1108 O
doctor NCT03863496 1109 1115 O
's NCT03863496 1115 1117 O
opinion NCT03863496 1118 1125 O

Inclusion NCT03865823 0 9 O
Criteria NCT03865823 10 18 O
: NCT03865823 19 20 O

- NCT03865823 24 25 O
Patient NCT03865823 27 34 O
over NCT03865823 35 39 B-Eq_Comparison
the NCT03865823 40 43 I-Eq_Comparison
age NCT03865823 44 47 I-Eq_Comparison
of NCT03865823 48 50 I-Eq_Comparison
18 NCT03865823 51 53 I-Eq_Comparison
, NCT03865823 54 55 O
patient NCT03865823 56 63 O
with NCT03865823 64 68 O
an NCT03865823 69 71 O
anus NCT03865823 72 76 B-Modifier
fistula NCT03865823 77 84 B-Condition
with NCT03865823 85 89 B-And
indication NCT03865823 90 100 B-Indication
for NCT03865823 101 104 O
surgical NCT03865823 105 113 B-Procedure
treatment NCT03865823 114 123 I-Procedure

Exclusion NCT03865823 124 133 O
Criteria NCT03865823 134 142 O
: NCT03865823 143 144 O

- NCT03865823 148 149 O
Cutaneous NCT03865823 151 160 B-Condition
Suppuration NCT03865823 161 172 I-Condition
, NCT03865823 173 174 O
without NCT03865823 175 182 B-Negation
fistula NCT03865823 183 190 B-Condition
( NCT03865823 191 192 O
e NCT03865823 193 194 O
. NCT03865823 195 196 O
g NCT03865823 197 198 O
. NCT03865823 199 200 O
, NCT03865823 201 202 O
Verneuil NCT03865823 203 211 B-Condition
disease NCT03865823 212 219 I-Condition
, NCT03865823 220 221 O
boil NCT03865823 222 226 B-Condition
) NCT03865823 227 228 O

Inclusion NCT03922503 0 9 O
Criteria NCT03922503 10 18 O
: NCT03922503 19 20 O

- NCT03922503 24 25 O
Stage NCT03922503 27 32 B-Eq_Comparison
III NCT03922503 33 36 I-Eq_Comparison
periodontitis NCT03922503 37 50 B-Condition
patient NCT03922503 51 58 O
having NCT03922503 59 65 B-And
at NCT03922503 66 68 B-Eq_Comparison
least NCT03922503 69 74 I-Eq_Comparison
one NCT03922503 75 78 I-Eq_Comparison
tooth NCT03922503 79 84 B-Observation
with NCT03922503 85 89 B-And
one NCT03922503 90 93 B-Modifier
wall NCT03922503 94 98 I-Modifier
or NCT03922503 99 101 B-Or
combined NCT03922503 102 110 B-Modifier
1 NCT03922503 111 112 I-Modifier
- NCT03922503 113 114 I-Modifier
to NCT03922503 115 117 I-Modifier
2 NCT03922503 118 119 I-Modifier
- NCT03922503 120 121 I-Modifier
wall NCT03922503 122 126 I-Modifier
intraosseous NCT03922503 127 139 B-Observation
defect NCT03922503 140 146 I-Observation
â¥ NCT03922503 147 148 B-Eq_Comparison
3 NCT03922503 149 150 I-Eq_Comparison
mm NCT03922503 151 153 I-Eq_Comparison
deep NCT03922503 154 158 O
( NCT03922503 159 160 O
assessed NCT03922503 161 169 O
by NCT03922503 170 172 O
trans NCT03922503 173 178 B-Procedure
- NCT03922503 179 180 I-Procedure
gingival NCT03922503 181 189 I-Procedure
probing NCT03922503 190 197 I-Procedure
, NCT03922503 198 199 O
radiographic NCT03922503 200 212 B-Procedure
examination NCT03922503 213 224 I-Procedure
) NCT03922503 225 226 O
with NCT03922503 227 231 O
clinical NCT03922503 232 240 B-Observation
attachment NCT03922503 241 251 I-Observation
level NCT03922503 252 257 I-Observation
( NCT03922503 258 259 O
CAL NCT03922503 260 263 B-Observation
) NCT03922503 264 265 O
â¥ NCT03922503 266 267 B-Eq_Comparison
5 NCT03922503 268 269 I-Eq_Comparison
mm NCT03922503 270 272 I-Eq_Comparison
and NCT03922503 273 276 O
pocket NCT03922503 277 283 B-Observation
depth NCT03922503 284 289 I-Observation
( NCT03922503 290 291 O
PD NCT03922503 292 294 B-Observation
) NCT03922503 295 296 O
â¥ NCT03922503 297 298 B-Eq_Comparison
6 NCT03922503 299 300 I-Eq_Comparison
mm NCT03922503 301 303 I-Eq_Comparison
. NCT03922503 304 305 O

- NCT03922503 309 310 O
Defect NCT03922503 312 318 B-Condition
not NCT03922503 319 322 B-Negation
extending NCT03922503 323 332 O
to NCT03922503 333 335 O
a NCT03922503 336 337 O
root NCT03922503 338 342 B-Modifier
furcation NCT03922503 343 352 I-Modifier
area NCT03922503 353 357 I-Modifier

- NCT03922503 360 361 O
Vital NCT03922503 363 368 B-Condition
teeth NCT03922503 369 374 I-Condition

- NCT03922503 377 378 O
Non NCT03922503 380 383 B-Negation
- NCT03922503 384 385 O
smokers NCT03922503 386 393 B-Condition
. NCT03922503 394 395 O

- NCT03922503 399 400 O
No NCT03922503 402 404 B-Negation
history NCT03922503 405 412 B-Eq_Comparison
of NCT03922503 413 415 O
intake NCT03922503 416 422 O
of NCT03922503 423 425 O
antibiotics NCT03922503 426 437 B-Drug
or NCT03922503 438 440 B-Or
other NCT03922503 441 446 B-Other
medications NCT03922503 447 458 B-Drug
affecting NCT03922503 459 468 O
the NCT03922503 469 472 O
periodontium NCT03922503 473 485 B-Condition
in NCT03922503 486 488 O
the NCT03922503 489 492 O
previous NCT03922503 493 501 B-Eq_Comparison
6 NCT03922503 502 503 I-Eq_Comparison
months NCT03922503 504 510 I-Eq_Comparison
. NCT03922503 511 512 O

- NCT03922503 516 517 O
No NCT03922503 519 521 B-Negation
periodontal NCT03922503 522 533 B-Procedure
therapy NCT03922503 534 541 I-Procedure
carried NCT03922503 542 549 O
out NCT03922503 550 553 O
in NCT03922503 554 556 O
the NCT03922503 557 560 O
past NCT03922503 561 565 B-Eq_Comparison
6 NCT03922503 566 567 I-Eq_Comparison
months NCT03922503 568 574 I-Eq_Comparison
. NCT03922503 575 576 O

- NCT03922503 580 581 O
Able NCT03922503 583 587 O
to NCT03922503 588 590 O
sign NCT03922503 591 595 O
an NCT03922503 596 598 O
informed NCT03922503 599 607 O
consent NCT03922503 608 615 O
form NCT03922503 616 620 O
. NCT03922503 621 622 O

- NCT03922503 626 627 O
Patients NCT03922503 629 637 O
age NCT03922503 638 641 B-Age
between NCT03922503 642 649 B-Eq_Comparison
25 NCT03922503 650 652 I-Eq_Comparison
and NCT03922503 653 656 I-Eq_Comparison
50 NCT03922503 657 659 I-Eq_Comparison
years NCT03922503 660 665 I-Eq_Comparison
old NCT03922503 666 669 O
. NCT03922503 670 671 O

- NCT03922503 675 676 O
Patients NCT03922503 678 686 O
who NCT03922503 687 690 O
are NCT03922503 691 694 O
cooperative NCT03922503 695 706 O
, NCT03922503 707 708 O
motivated NCT03922503 709 718 O
, NCT03922503 719 720 O
and NCT03922503 721 724 O
hygiene NCT03922503 725 732 O
conscious NCT03922503 733 742 O
. NCT03922503 743 744 O

- NCT03922503 748 749 O
Systemically NCT03922503 751 763 B-Condition
free NCT03922503 764 768 I-Condition
according NCT03922503 769 778 O
to NCT03922503 779 781 O
Cornell NCT03922503 782 789 O
Medical NCT03922503 790 797 O
Index NCT03922503 798 803 O

Exclusion NCT03922503 804 813 O
Criteria NCT03922503 814 822 O
: NCT03922503 823 824 O

- NCT03922503 828 829 O
Pregnancy NCT03922503 831 840 B-Condition
or NCT03922503 841 843 B-Or
breast NCT03922503 844 850 B-Condition
feeding NCT03922503 851 858 I-Condition

- NCT03922503 861 862 O
The NCT03922503 864 867 O
presence NCT03922503 868 876 O
of NCT03922503 877 879 O
an NCT03922503 880 882 O
orthodontic NCT03922503 883 894 B-Procedure
appliance NCT03922503 895 904 I-Procedure

- NCT03922503 907 908 O
Teeth NCT03922503 910 915 B-Observation
mobility NCT03922503 916 924 I-Observation
greater NCT03922503 925 932 B-Eq_Comparison
than NCT03922503 933 937 I-Eq_Comparison
grade NCT03922503 938 943 I-Eq_Comparison
I NCT03922503 944 945 I-Eq_Comparison

Inclusion NCT03923309 0 9 O
Criteria NCT03923309 10 18 O
: NCT03923309 19 20 O

- NCT03923309 24 25 O
biopsy NCT03923309 27 33 B-Procedure
proven NCT03923309 34 40 O
rectal NCT03923309 41 47 B-Modifier
cancer NCT03923309 48 54 B-Condition
( NCT03923309 55 56 O
anal NCT03923309 57 61 B-Observation
verge NCT03923309 62 67 I-Observation
â¤ NCT03923309 68 69 B-Eq_Comparison
10 NCT03923309 70 72 I-Eq_Comparison
cm NCT03923309 73 75 I-Eq_Comparison
) NCT03923309 76 77 O

- NCT03923309 81 82 O
neoadjuvant NCT03923309 84 95 B-Modifier
radiotherapy NCT03923309 96 108 B-Procedure
or NCT03923309 109 111 B-Or
chemoradiotherapy NCT03923309 112 129 B-Procedure

- NCT03923309 132 133 O
no NCT03923309 135 137 B-Negation
radical NCT03923309 138 145 B-Modifier
surgery NCT03923309 146 153 B-Procedure
after NCT03923309 154 159 B-Temporal_Connection___Temporal_Connection_Type_Value:after
neoadjuvant NCT03923309 160 171 B-Procedure
therapy NCT03923309 172 179 I-Procedure

Exclusion NCT03923309 180 189 O
Criteria NCT03923309 190 198 O
: NCT03923309 199 200 O

- NCT03923309 204 205 O
other NCT03923309 207 212 B-Other
malignant NCT03923309 213 222 B-Condition
disease NCT03923309 223 230 I-Condition

- NCT03923309 233 234 O
other NCT03923309 236 241 B-Other
fatel NCT03923309 242 247 B-Condition
disease NCT03923309 248 255 I-Condition

- NCT03923309 258 259 O
incompletion NCT03923309 261 273 B-Negation
of NCT03923309 274 276 O
half NCT03923309 277 281 O
of NCT03923309 282 284 O
radiotherapy NCT03923309 285 297 B-Procedure
course NCT03923309 298 304 O

- NCT03923309 307 308 O
metastasis NCT03923309 310 320 B-Condition
on NCT03923309 321 323 B-Temporal_Connection___Temporal_Connection_Type_Value:during
initial NCT03923309 324 331 B-Eq_Comparison
presentation NCT03923309 332 344 B-Condition

Inclusion NCT03923647 0 9 O
Criteria NCT03923647 10 18 O
: NCT03923647 19 20 O

- NCT03923647 24 25 O
stable NCT03923647 27 33 O
patients NCT03923647 34 42 O
with NCT03923647 43 47 O
definite NCT03923647 48 56 O
occurrence NCT03923647 57 67 O
of NCT03923647 68 70 O
intra NCT03923647 71 76 B-Modifier
- NCT03923647 77 78 I-Modifier
abdominal NCT03923647 79 88 I-Modifier
injury NCT03923647 89 95 B-Condition

- NCT03923647 98 99 O
patients NCT03923647 101 109 O
with NCT03923647 110 114 O
equivocal NCT03923647 115 124 O
result NCT03923647 125 131 O
by NCT03923647 132 134 O
clinical NCT03923647 135 143 O
and NCT03923647 144 147 O
radiological NCT03923647 148 160 B-Procedure
evaluation NCT03923647 161 171 I-Procedure

Exclusion NCT03923647 172 181 O
Criteria NCT03923647 182 190 O
: NCT03923647 191 192 O

- NCT03923647 196 197 O
patients NCT03923647 199 207 O
with NCT03923647 208 212 O
penetrating NCT03923647 213 224 B-Modifier
abdominal NCT03923647 225 234 I-Modifier
trauma NCT03923647 235 241 B-Condition

- NCT03923647 244 245 O
stable NCT03923647 247 253 O
patients NCT03923647 254 262 O
not NCT03923647 263 266 B-Negation
in NCT03923647 267 269 O
need NCT03923647 270 274 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03923647 275 278 I-Assertion___Assertion_Type_Value:hypothetical
any NCT03923647 279 282 O
intervention NCT03923647 283 295 B-Procedure
for NCT03923647 296 299 O
conservative NCT03923647 300 312 B-Procedure
management NCT03923647 313 323 I-Procedure

- NCT03923647 326 327 O
patients NCT03923647 329 337 O
with NCT03923647 338 342 O
marked NCT03923647 343 349 O
haemodynamic NCT03923647 350 362 B-Condition
instability NCT03923647 363 374 I-Condition

- NCT03923647 377 378 O
polyt NCT03923647 380 385 B-Condition
- NCT03923647 386 387 I-Condition
traumatized NCT03923647 388 399 I-Condition
Patients NCT03923647 400 408 O

Inclusion NCT03920592 0 9 O
Criteria NCT03920592 10 18 O
: NCT03920592 19 20 O

- NCT03920592 24 25 O
All NCT03920592 27 30 O
pupils NCT03920592 31 37 O
assisting NCT03920592 38 47 O
5 NCT03920592 48 49 O
th NCT03920592 50 52 O
and NCT03920592 53 56 O
6 NCT03920592 57 58 O
th NCT03920592 59 61 O
grade NCT03920592 62 67 O
of NCT03920592 68 70 O
primary NCT03920592 71 78 O
school NCT03920592 79 85 O
( NCT03920592 86 87 O
Spain NCT03920592 88 93 O
education NCT03920592 94 103 O
system NCT03920592 104 110 O
) NCT03920592 111 112 O
of NCT03920592 113 115 O
the NCT03920592 116 119 O
" NCT03920592 120 121 O
Escola NCT03920592 121 127 O
Parc NCT03920592 128 132 O
del NCT03920592 133 136 O
GuinardÃ³ NCT03920592 137 145 O
" NCT03920592 145 146 O
school NCT03920592 147 153 O

- NCT03920592 156 157 O
Pupils NCT03920592 159 165 O
who NCT03920592 166 169 O
s NCT03920592 169 170 O
parents NCT03920592 171 178 B-Family_Member___Family_Member_Type:parent
have NCT03920592 179 183 O
read NCT03920592 184 188 O
, NCT03920592 189 190 O
understand NCT03920592 191 201 O
and NCT03920592 202 205 O
approved NCT03920592 206 214 O
the NCT03920592 215 218 O
informed NCT03920592 219 227 O
consent NCT03920592 228 235 O
of NCT03920592 236 238 O
the NCT03920592 239 242 O
study NCT03920592 243 248 O
. NCT03920592 249 250 O

Exclusion NCT03920592 252 261 O
Criteria NCT03920592 262 270 O
: NCT03920592 271 272 O

- NCT03920592 276 277 O
Pupils NCT03920592 279 285 O
whose NCT03920592 286 291 O
parents NCT03920592 292 299 B-Family_Member___Family_Member_Type:parent
have NCT03920592 300 304 O
not NCT03920592 305 308 O
approved NCT03920592 309 317 O
their NCT03920592 318 323 O
inclusion NCT03920592 324 333 O
in NCT03920592 334 336 O
the NCT03920592 337 340 O
study NCT03920592 341 346 O
. NCT03920592 347 348 O

Inclusion NCT03926546 0 9 O
Criteria NCT03926546 10 18 O
: NCT03926546 19 20 O

- NCT03926546 24 25 O
Participants NCT03926546 27 39 O
must NCT03926546 40 44 O
be NCT03926546 45 47 O
adults NCT03926546 48 54 O
18 NCT03926546 55 57 B-Eq_Comparison
years NCT03926546 58 63 I-Eq_Comparison
or NCT03926546 64 66 I-Eq_Comparison
older NCT03926546 67 72 I-Eq_Comparison
. NCT03926546 73 74 O

- NCT03926546 78 79 O
Participants NCT03926546 81 93 O
must NCT03926546 94 98 O
have NCT03926546 99 103 O
the NCT03926546 104 107 O
capacity NCT03926546 108 116 O
and NCT03926546 117 120 O
ability NCT03926546 121 128 O
to NCT03926546 129 131 O
give NCT03926546 132 136 O
informed NCT03926546 137 145 O
consent NCT03926546 146 153 O
. NCT03926546 154 155 O

- NCT03926546 159 160 O
Participants NCT03926546 162 174 O
have NCT03926546 175 179 O
been NCT03926546 180 184 O
given NCT03926546 185 190 B-Eq_Comparison
an NCT03926546 191 193 O
assessment NCT03926546 194 204 B-Procedure
and NCT03926546 205 208 B-And
received NCT03926546 209 217 B-Eq_Comparison
a NCT03926546 218 219 O
diagnosis NCT03926546 220 229 O
of NCT03926546 230 232 O
OCD NCT03926546 233 236 B-Condition
. NCT03926546 237 238 O

- NCT03926546 242 243 O
Participants NCT03926546 245 257 O
must NCT03926546 258 262 O
speak NCT03926546 263 268 O
English NCT03926546 269 276 O
. NCT03926546 277 278 O

- NCT03926546 282 283 O
Participants NCT03926546 285 297 O
must NCT03926546 298 302 O
be NCT03926546 303 305 O
able NCT03926546 306 310 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926546 311 313 I-Assertion___Assertion_Type_Value:hypothetical
physically NCT03926546 314 324 O
attend NCT03926546 325 331 O
treatment NCT03926546 332 341 B-Procedure
. NCT03926546 342 343 O

Exclusion NCT03926546 345 354 O
Criteria NCT03926546 355 363 O
: NCT03926546 364 365 O

- NCT03926546 369 370 O
Prisoners NCT03926546 372 381 B-Observation
or NCT03926546 382 384 B-Or
any NCT03926546 385 388 O
other NCT03926546 389 394 B-Other
high NCT03926546 395 399 O
- NCT03926546 400 401 O
risk NCT03926546 402 406 B-Risk
population NCT03926546 407 417 O
group NCT03926546 418 423 O
. NCT03926546 424 425 O

- NCT03926546 429 430 O
experiencing NCT03926546 432 444 O
active NCT03926546 445 451 B-Eq_Comparison
psychosis NCT03926546 452 461 B-Condition

- NCT03926546 464 465 O
experiencing NCT03926546 467 479 O
active NCT03926546 480 486 B-Eq_Comparison
substance NCT03926546 487 496 B-Condition
abuse NCT03926546 497 502 I-Condition
disorder NCT03926546 503 511 I-Condition

- NCT03926546 514 515 O
experiencing NCT03926546 517 529 O
active NCT03926546 530 536 B-Eq_Comparison
suicidality NCT03926546 537 548 B-Condition

Inclusion NCT03927690 0 9 O
Criteria NCT03927690 10 18 O

1 NCT03927690 21 22 O
. NCT03927690 22 23 O
Written NCT03927690 25 32 O
informed NCT03927690 33 41 O
consent NCT03927690 42 49 O
must NCT03927690 50 54 O
be NCT03927690 55 57 O
obtained NCT03927690 58 66 O
before NCT03927690 67 73 O
any NCT03927690 74 77 O
assessment NCT03927690 78 88 O
is NCT03927690 89 91 O
performed NCT03927690 92 101 O
. NCT03927690 102 103 O

2 NCT03927690 107 108 O
. NCT03927690 108 109 O
Male NCT03927690 111 115 O
and NCT03927690 116 119 B-Or
female NCT03927690 120 126 O
patients NCT03927690 127 135 O
age NCT03927690 136 139 B-Age
18 NCT03927690 140 142 B-Eq_Comparison
to NCT03927690 143 145 I-Eq_Comparison
85 NCT03927690 146 148 I-Eq_Comparison
years NCT03927690 149 154 I-Eq_Comparison
of NCT03927690 155 157 O
age NCT03927690 158 161 O
inclusive NCT03927690 162 171 O
at NCT03927690 172 174 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03927690 175 184 B-Study

3 NCT03927690 187 188 O
. NCT03927690 188 189 O
Presence NCT03927690 191 199 O
of NCT03927690 200 202 O
type NCT03927690 203 207 B-Modifier
I NCT03927690 208 209 I-Modifier
or NCT03927690 210 212 B-Or
type NCT03927690 213 217 B-Modifier
II NCT03927690 218 220 I-Modifier
diabetes NCT03927690 221 229 B-Condition
mellitus NCT03927690 230 238 I-Condition

4 NCT03927690 241 242 O
. NCT03927690 242 243 O
The NCT03927690 245 248 O
ETDRS NCT03927690 249 254 B-Observation
letter NCT03927690 255 261 I-Observation
score NCT03927690 262 267 I-Observation
in NCT03927690 268 270 O
the NCT03927690 271 274 O
study NCT03927690 275 280 O
eye NCT03927690 281 284 B-Modifier
must NCT03927690 285 289 O
be NCT03927690 290 292 O
between NCT03927690 293 300 B-Eq_Comparison
24 NCT03927690 301 303 I-Eq_Comparison
and NCT03927690 304 307 I-Eq_Comparison
70 NCT03927690 308 310 I-Eq_Comparison
letters NCT03927690 311 318 I-Eq_Comparison
( NCT03927690 319 320 O
approximate NCT03927690 321 332 O
Snellen NCT03927690 333 340 B-Observation
equivalent NCT03927690 341 351 O
of NCT03927690 352 354 O
20 NCT03927690 355 357 O
/ NCT03927690 358 359 O
40 NCT03927690 360 362 O
- NCT03927690 363 364 B-Eq_Comparison
20 NCT03927690 365 367 I-Eq_Comparison
/ NCT03927690 368 369 O
320 NCT03927690 370 373 O
) NCT03927690 374 375 O
. NCT03927690 376 377 O
The NCT03927690 379 382 O
non NCT03927690 383 386 O
- NCT03927690 387 388 O
study NCT03927690 389 394 O
eye NCT03927690 395 398 O
( NCT03927690 399 400 O
fellow NCT03927690 401 407 O
eye NCT03927690 408 411 O
) NCT03927690 412 413 O
should NCT03927690 414 420 O
be NCT03927690 421 423 O
â¥ NCT03927690 424 425 B-Eq_Comparison
34 NCT03927690 426 428 I-Eq_Comparison
letters NCT03927690 429 436 I-Eq_Comparison
or NCT03927690 437 439 I-Eq_Comparison
better NCT03927690 440 446 I-Eq_Comparison
( NCT03927690 447 448 O
approximate NCT03927690 449 460 O
Snellen NCT03927690 461 468 B-Observation
equivalent NCT03927690 469 479 O
of NCT03927690 480 482 O
20 NCT03927690 483 485 B-Eq_Comparison
/ NCT03927690 486 487 I-Eq_Comparison
200 NCT03927690 488 491 I-Eq_Comparison
) NCT03927690 492 493 O
at NCT03927690 494 496 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03927690 497 506 B-Study

5 NCT03927690 509 510 O
. NCT03927690 510 511 O
Presence NCT03927690 513 521 O
of NCT03927690 522 524 O
DME NCT03927690 525 528 B-Condition
in NCT03927690 529 531 O
the NCT03927690 532 535 O
study NCT03927690 536 541 O
eye NCT03927690 542 545 B-Modifier
, NCT03927690 546 547 O
with NCT03927690 548 552 B-And
decrease NCT03927690 553 561 O
in NCT03927690 562 564 O
vision NCT03927690 565 571 B-Condition
due NCT03927690 572 575 O
to NCT03927690 576 578 O
foveal NCT03927690 579 585 B-Condition
thickening NCT03927690 586 596 I-Condition
of NCT03927690 597 599 O
central NCT03927690 600 607 B-Observation
macular NCT03927690 608 615 I-Observation
thickness NCT03927690 616 625 I-Observation
â¥ NCT03927690 626 627 B-Eq_Comparison
320 NCT03927690 628 631 I-Eq_Comparison
Âµm NCT03927690 632 634 I-Eq_Comparison
in NCT03927690 635 637 O
the NCT03927690 638 641 O
central NCT03927690 642 649 B-Modifier
subfield NCT03927690 650 658 I-Modifier
, NCT03927690 659 660 O
as NCT03927690 661 663 O
assessed NCT03927690 664 672 O
on NCT03927690 673 675 O
SD NCT03927690 676 678 B-Procedure
- NCT03927690 679 680 I-Procedure
OCT NCT03927690 681 684 I-Procedure
and NCT03927690 685 688 O
confirmed NCT03927690 689 698 O
by NCT03927690 699 701 O
the NCT03927690 702 705 O
central NCT03927690 706 713 O
reading NCT03927690 714 721 O
center NCT03927690 722 728 O
at NCT03927690 729 731 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03927690 732 741 B-Study

Other NCT03927690 742 747 O
protocol NCT03927690 748 756 O
specified NCT03927690 757 766 O
inclusion NCT03927690 767 776 O
/ NCT03927690 777 778 O
exclusion NCT03927690 779 788 O
criteria NCT03927690 789 797 O
apply NCT03927690 798 803 O
. NCT03927690 804 805 O

Inclusion NCT03924024 0 9 O
Criteria NCT03924024 10 18 O
: NCT03924024 19 20 O

- NCT03924024 24 25 O
Male NCT03924024 27 31 O
or NCT03924024 32 34 B-Or
female NCT03924024 35 41 O
, NCT03924024 42 43 O
18 NCT03924024 44 46 B-Eq_Comparison
to NCT03924024 47 49 I-Eq_Comparison
65 NCT03924024 50 52 I-Eq_Comparison
years NCT03924024 53 58 I-Eq_Comparison
of NCT03924024 59 61 O
age NCT03924024 62 65 B-Age
. NCT03924024 66 67 O

- NCT03924024 71 72 O
Able NCT03924024 74 78 O
to NCT03924024 79 81 O
provide NCT03924024 82 89 O
informed NCT03924024 90 98 O
consent NCT03924024 99 106 O
. NCT03924024 107 108 O

- NCT03924024 112 113 O
Present NCT03924024 115 122 B-Encounter
to NCT03924024 123 125 O
Stanford NCT03924024 126 134 O
Emergency NCT03924024 135 144 O
Department NCT03924024 145 155 O
as NCT03924024 156 158 O
a NCT03924024 159 160 O
trauma NCT03924024 161 167 B-Condition
with NCT03924024 168 172 B-And
a NCT03924024 173 174 O
major NCT03924024 175 180 B-Modifier
operative NCT03924024 181 190 I-Modifier
lower NCT03924024 191 196 I-Modifier
extremity NCT03924024 197 206 I-Modifier
injury NCT03924024 207 213 B-Condition

- NCT03924024 216 217 O
Glasgow NCT03924024 219 226 B-Observation
coma NCT03924024 227 231 I-Observation
scale NCT03924024 232 237 I-Observation
of NCT03924024 238 240 O
15 NCT03924024 241 243 B-Eq_Comparison
within NCT03924024 244 250 B-Eq_Comparison
24 NCT03924024 251 253 I-Eq_Comparison
hours NCT03924024 254 259 I-Eq_Comparison
after NCT03924024 260 265 B-Temporal_Connection___Temporal_Connection_Type_Value:after
admission NCT03924024 266 275 B-Encounter
or NCT03924024 276 278 B-Or
extubation NCT03924024 279 289 B-Procedure

- NCT03924024 292 293 O
Negative NCT03924024 295 303 O
urinary NCT03924024 304 311 B-Observation
toxicology NCT03924024 312 322 I-Observation
screen NCT03924024 323 329 B-Modifier
for NCT03924024 330 333 I-Modifier
illicit NCT03924024 334 341 I-Modifier
substances NCT03924024 342 352 I-Modifier
; NCT03924024 352 353 O

- NCT03924024 356 357 O
Negative NCT03924024 359 367 O
pregnancy NCT03924024 368 377 B-Condition
test NCT03924024 378 382 O
if NCT03924024 383 385 O
female NCT03924024 386 392 O
and NCT03924024 393 396 B-And
less NCT03924024 397 401 B-Eq_Comparison
then NCT03924024 402 406 I-Eq_Comparison
60 NCT03924024 407 409 I-Eq_Comparison
y NCT03924024 410 411 I-Eq_Comparison
/ NCT03924024 412 413 I-Eq_Comparison
o NCT03924024 414 415 I-Eq_Comparison
; NCT03924024 415 416 O

- NCT03924024 419 420 O
No NCT03924024 422 424 B-Negation
suspicion NCT03924024 425 434 B-Assertion___Assertion_Type_Value:possible
for NCT03924024 435 438 O
a NCT03924024 439 440 O
head NCT03924024 441 445 B-Modifier
injury NCT03924024 446 452 B-Condition
and NCT03924024 453 456 B-Or
/ NCT03924024 457 458 I-Or
or NCT03924024 459 461 I-Or
negative NCT03924024 462 470 O
head NCT03924024 471 475 B-Modifier
CT NCT03924024 476 478 B-Procedure
scan NCT03924024 479 483 I-Procedure
for NCT03924024 484 487 O
intracranial NCT03924024 488 500 B-Condition
hemorrhage NCT03924024 501 511 I-Condition
or NCT03924024 512 514 B-Or
injury NCT03924024 515 521 B-Condition
based NCT03924024 522 527 O
on NCT03924024 528 530 O
standard NCT03924024 531 539 O
of NCT03924024 540 542 O
care NCT03924024 543 547 O

- NCT03924024 550 551 O
No NCT03924024 553 555 B-Negation
history NCT03924024 556 563 B-Eq_Comparison
of NCT03924024 564 566 O
seizure NCT03924024 567 574 B-Condition
disorder NCT03924024 575 583 I-Condition
or NCT03924024 584 586 B-Or
other NCT03924024 587 592 B-Other
neurological NCT03924024 593 605 B-Condition
disorders NCT03924024 606 615 I-Condition
. NCT03924024 616 617 O

- NCT03924024 621 622 O
All NCT03924024 624 627 O
patients NCT03924024 628 636 O
included NCT03924024 637 645 O
must NCT03924024 646 650 O
screen NCT03924024 651 657 O
positive NCT03924024 658 666 O
for NCT03924024 667 670 O
PHQ NCT03924024 671 674 B-Observation
- NCT03924024 675 676 I-Observation
9 NCT03924024 677 678 I-Observation
score NCT03924024 679 684 B-Eq_Comparison
> NCT03924024 685 686 I-Eq_Comparison
4 NCT03924024 687 688 I-Eq_Comparison
( NCT03924024 689 690 O
positive NCT03924024 691 699 O
symptoms NCT03924024 700 708 B-Assertion___Assertion_Type_Value:possible
of NCT03924024 709 711 O
depression NCT03924024 712 722 B-Condition
) NCT03924024 723 724 O
and NCT03924024 725 728 B-And
CES NCT03924024 729 732 B-Observation
- NCT03924024 733 734 I-Observation
T NCT03924024 735 736 I-Observation
score NCT03924024 737 742 B-Eq_Comparison
< NCT03924024 743 744 I-Eq_Comparison
36 NCT03924024 745 747 I-Eq_Comparison
( NCT03924024 748 749 O
poor NCT03924024 750 754 B-Condition
coping NCT03924024 755 761 I-Condition
self NCT03924024 762 766 I-Condition
- NCT03924024 767 768 I-Condition
efficacy NCT03924024 769 777 I-Condition
) NCT03924024 778 779 O
. NCT03924024 780 781 O

Exclusion NCT03924024 783 792 O
Criteria NCT03924024 793 801 O
: NCT03924024 802 803 O

- NCT03924024 807 808 O
Incarceration NCT03924024 810 823 B-Observation
, NCT03924024 824 825 O

- NCT03924024 829 830 O
Pregnant NCT03924024 832 840 B-Condition
females NCT03924024 841 848 O
, NCT03924024 849 850 O

- NCT03924024 854 855 O
Prior NCT03924024 857 862 B-Eq_Comparison
psychotic NCT03924024 863 872 B-Condition
disorder NCT03924024 873 881 I-Condition
, NCT03924024 882 883 O

- NCT03924024 887 888 O
Current NCT03924024 890 897 B-Eq_Comparison
use NCT03924024 898 901 I-Eq_Comparison
of NCT03924024 902 904 O
anti NCT03924024 905 909 B-Drug
- NCT03924024 910 911 I-Drug
depressant NCT03924024 912 922 I-Drug
or NCT03924024 923 925 B-Or
anti NCT03924024 926 930 B-Drug
- NCT03924024 931 932 I-Drug
psychotic NCT03924024 933 942 I-Drug
medications NCT03924024 943 954 I-Drug
, NCT03924024 955 956 O

- NCT03924024 960 961 O
Prior NCT03924024 963 968 B-Eq_Comparison
- NCT03924024 969 970 O
admission NCT03924024 971 980 B-Encounter
opioid NCT03924024 981 987 B-Condition
use NCT03924024 988 991 I-Condition
within NCT03924024 992 998 B-Eq_Comparison
30 NCT03924024 999 1001 I-Eq_Comparison
days NCT03924024 1002 1006 I-Eq_Comparison
( NCT03924024 1007 1008 O
patients NCT03924024 1009 1017 O
will NCT03924024 1018 1022 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03924024 1023 1025 I-Assertion___Assertion_Type_Value:hypothetical
screened NCT03924024 1026 1034 O
for NCT03924024 1035 1038 O
recent NCT03924024 1039 1045 B-Eq_Comparison
prescription NCT03924024 1046 1058 O
opioid NCT03924024 1059 1065 B-Drug
use NCT03924024 1066 1069 O
using NCT03924024 1070 1075 O
the NCT03924024 1076 1079 O
CURES NCT03924024 1080 1085 B-Observation
report NCT03924024 1086 1092 O
) NCT03924024 1093 1094 O
, NCT03924024 1095 1096 O

- NCT03924024 1100 1101 O
Heavy NCT03924024 1103 1108 O
alcohol NCT03924024 1109 1116 B-Condition
use NCT03924024 1117 1120 I-Condition
, NCT03924024 1121 1122 O

- NCT03924024 1126 1127 O
Lesional NCT03924024 1129 1137 B-Modifier
neurological NCT03924024 1138 1150 B-Condition
disorder NCT03924024 1151 1159 I-Condition
or NCT03924024 1160 1162 B-Or
brain NCT03924024 1163 1168 B-Modifier
implant NCT03924024 1169 1176 B-Procedure
or NCT03924024 1177 1179 B-Or
intracranial NCT03924024 1180 1192 B-Condition
ferromagnetic NCT03924024 1193 1206 I-Condition
material NCT03924024 1207 1215 I-Condition
, NCT03924024 1216 1217 O

- NCT03924024 1221 1222 O
Seizure NCT03924024 1224 1231 B-Condition
disorder NCT03924024 1232 1240 I-Condition

Inclusion NCT03929536 0 9 O
Criteria NCT03929536 10 18 O
: NCT03929536 19 20 O

- NCT03929536 24 25 O
surgical NCT03929536 27 35 B-Procedure
treatment NCT03929536 36 45 I-Procedure
of NCT03929536 46 48 O
acetabular NCT03929536 49 59 B-Modifier
fracture NCT03929536 60 68 B-Condition
between NCT03929536 69 76 B-Eq_Comparison
2009 NCT03929536 77 81 I-Eq_Comparison
and NCT03929536 82 85 I-Eq_Comparison
2018 NCT03929536 86 90 I-Eq_Comparison

Exclusion NCT03929536 92 101 O
Criteria NCT03929536 102 110 O
: NCT03929536 111 112 O

- NCT03929536 116 117 O
pathological NCT03929536 119 131 B-Modifier
fractures NCT03929536 132 141 B-Condition
due NCT03929536 142 145 O
to NCT03929536 146 148 O
neoplasm NCT03929536 149 157 B-Condition
or NCT03929536 158 160 B-Or
metastasis NCT03929536 161 171 B-Condition

- NCT03929536 174 175 O
status NCT03929536 177 183 O
after NCT03929536 184 189 B-Temporal_Connection___Temporal_Connection_Type_Value:after
implantation NCT03929536 190 202 B-Procedure
of NCT03929536 203 205 I-Procedure
an NCT03929536 206 208 I-Procedure
endoprosthesis NCT03929536 209 223 I-Procedure

Inclusion NCT03920020 0 9 O
Criteria NCT03920020 10 18 O
: NCT03920020 19 20 O

- NCT03920020 24 25 O
Diagnosis NCT03920020 27 36 O
of NCT03920020 37 39 O
primary NCT03920020 40 47 B-Modifier
knee NCT03920020 48 52 I-Modifier
osteoarthritis NCT03920020 53 67 B-Condition
according NCT03920020 68 77 O
to NCT03920020 78 80 O
American NCT03920020 81 89 O
College NCT03920020 90 97 O
of NCT03920020 98 100 O
Radiology NCT03920020 101 110 O

- NCT03920020 113 114 O
Being NCT03920020 116 121 O
radiographically NCT03920020 122 138 B-Condition
K NCT03920020 139 140 B-Eq_Comparison
- NCT03920020 141 142 I-Eq_Comparison
L NCT03920020 143 144 I-Eq_Comparison
grade NCT03920020 145 150 I-Eq_Comparison
2 NCT03920020 151 152 I-Eq_Comparison
- NCT03920020 153 154 I-Eq_Comparison
3 NCT03920020 155 156 I-Eq_Comparison

- NCT03920020 160 161 O
Presence NCT03920020 163 171 O
of NCT03920020 172 174 O
symptoms NCT03920020 175 183 B-Assertion___Assertion_Type_Value:possible
for NCT03920020 184 187 O
at NCT03920020 188 190 B-Eq_Comparison
least NCT03920020 191 196 I-Eq_Comparison
3 NCT03920020 197 198 I-Eq_Comparison
months NCT03920020 199 205 I-Eq_Comparison

- NCT03920020 208 209 O
Patients NCT03920020 211 219 O
who NCT03920020 220 223 O
have NCT03920020 224 228 O
been NCT03920020 229 233 O
planned NCT03920020 234 241 B-Eq_Comparison
a NCT03920020 242 243 O
conventional NCT03920020 244 256 O
physiotherapy NCT03920020 257 270 B-Procedure
programme NCT03920020 271 280 O
because NCT03920020 281 288 O
of NCT03920020 289 291 O
knee NCT03920020 292 296 B-Modifier
osteoarthritis NCT03920020 297 311 B-Condition

- NCT03920020 314 315 O
Presence NCT03920020 317 325 O
of NCT03920020 326 328 O
functional NCT03920020 329 339 O
capacity NCT03920020 340 348 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03920020 349 352 I-Assertion___Assertion_Type_Value:hypothetical
outpatient NCT03920020 353 363 B-Procedure
physical NCT03920020 364 372 I-Procedure
therapy NCT03920020 373 380 I-Procedure

Exclusion NCT03920020 381 390 O
Criteria NCT03920020 391 399 O
: NCT03920020 400 401 O

- NCT03920020 405 406 O
Patients NCT03920020 408 416 O
with NCT03920020 417 421 O
seconder NCT03920020 422 430 B-Modifier
knee NCT03920020 431 435 I-Modifier
osteoarthritis NCT03920020 436 450 B-Condition

- NCT03920020 453 454 O
History NCT03920020 456 463 B-Eq_Comparison
of NCT03920020 464 466 O
lower NCT03920020 467 472 B-Modifier
extremity NCT03920020 473 482 I-Modifier
or NCT03920020 483 485 B-Or
spine NCT03920020 486 491 B-Modifier
surgery NCT03920020 492 499 B-Procedure

- NCT03920020 502 503 O
History NCT03920020 505 512 B-Eq_Comparison
of NCT03920020 513 515 O
intraarticular NCT03920020 516 530 B-Procedure
injection NCT03920020 531 540 I-Procedure
in NCT03920020 541 543 O
last NCT03920020 544 548 B-Eq_Comparison
1 NCT03920020 549 550 I-Eq_Comparison
month NCT03920020 551 556 I-Eq_Comparison

- NCT03920020 559 560 O
Patients NCT03920020 562 570 O
with NCT03920020 571 575 O
neurological NCT03920020 576 588 B-Condition
disease NCT03920020 589 596 I-Condition
that NCT03920020 597 601 O
will NCT03920020 602 606 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03920020 607 613 O
muscle NCT03920020 614 620 B-Condition
strength NCT03920020 621 629 I-Condition
, NCT03920020 630 631 O
balance NCT03920020 632 639 B-Condition
and NCT03920020 640 643 B-Or
coordination NCT03920020 644 656 B-Condition

Inclusion NCT03868111 0 9 O
Criteria NCT03868111 10 18 O
: NCT03868111 19 20 O

- NCT03868111 24 25 O
Patients NCT03868111 27 35 O
aged NCT03868111 36 40 B-Age
between NCT03868111 41 48 B-Eq_Comparison
19 NCT03868111 49 51 I-Eq_Comparison
and NCT03868111 52 55 I-Eq_Comparison
65 NCT03868111 56 58 I-Eq_Comparison
years NCT03868111 59 64 I-Eq_Comparison

- NCT03868111 67 68 O
Patients NCT03868111 70 78 O
with NCT03868111 79 83 O
American NCT03868111 84 92 B-Observation
Society NCT03868111 93 100 I-Observation
of NCT03868111 101 103 I-Observation
Anesthesiologists NCT03868111 104 121 I-Observation
physical NCT03868111 122 130 O
status NCT03868111 131 137 O
I NCT03868111 138 139 B-Eq_Comparison
or NCT03868111 140 142 I-Eq_Comparison
II NCT03868111 143 145 I-Eq_Comparison

- NCT03868111 148 149 O
Patients NCT03868111 151 159 O
scheduled NCT03868111 160 169 B-Eq_Comparison
for NCT03868111 170 173 O
elective NCT03868111 174 182 B-Modifier
laparoscopic NCT03868111 183 195 B-Procedure
cholecystectomy NCT03868111 196 211 I-Procedure
under NCT03868111 212 217 O
balanced NCT03868111 218 226 O
general NCT03868111 227 234 B-Procedure
anesthesia NCT03868111 235 245 I-Procedure
for NCT03868111 246 249 O
benign NCT03868111 250 256 B-Condition
cholecystic NCT03868111 257 268 I-Condition
diseases NCT03868111 269 277 I-Condition

- NCT03868111 280 281 O
Patients NCT03868111 283 291 O
obtaining NCT03868111 292 301 O
written NCT03868111 302 309 O
informed NCT03868111 310 318 O
consent NCT03868111 319 326 O

Exclusion NCT03868111 327 336 O
Criteria NCT03868111 337 345 O
: NCT03868111 346 347 O

- NCT03868111 351 352 O
Patients NCT03868111 354 362 O
with NCT03868111 363 367 O
asthma NCT03868111 368 374 B-Condition
or NCT03868111 375 377 B-Or
hypertension NCT03868111 378 390 B-Condition

- NCT03868111 393 394 O
Patients NCT03868111 396 404 O
with NCT03868111 405 409 O
an NCT03868111 410 412 O
inability NCT03868111 413 422 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03868111 423 425 O
express NCT03868111 426 433 O
their NCT03868111 434 439 O
pain NCT03868111 440 444 B-Condition
accurately NCT03868111 445 455 O

- NCT03868111 458 459 O
Patients NCT03868111 461 469 O
with NCT03868111 470 474 O
an NCT03868111 475 477 O
inability NCT03868111 478 487 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868111 488 490 I-Assertion___Assertion_Type_Value:hypothetical
understand NCT03868111 491 501 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03868111 502 505 O
pain NCT03868111 506 510 B-Observation
scale NCT03868111 511 516 I-Observation

- NCT03868111 519 520 O
Patients NCT03868111 522 530 O
with NCT03868111 531 535 O
chronic NCT03868111 536 543 O
abdominal NCT03868111 544 553 B-Modifier
pain NCT03868111 554 558 B-Condition
or NCT03868111 559 561 B-Or
chronic NCT03868111 562 569 O
pain NCT03868111 570 574 B-Condition
syndrome NCT03868111 575 583 I-Condition

- NCT03868111 586 587 O
Patients NCT03868111 589 597 O
who NCT03868111 598 601 O
required NCT03868111 602 610 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868111 611 613 I-Assertion___Assertion_Type_Value:hypothetical
convert NCT03868111 614 621 O
to NCT03868111 622 624 O
laparotomy NCT03868111 625 635 B-Procedure
from NCT03868111 636 640 O
laparoscopic NCT03868111 641 653 B-Procedure
surgery NCT03868111 654 661 I-Procedure

- NCT03868111 664 665 O
Patients NCT03868111 667 675 O
who NCT03868111 676 679 O
required NCT03868111 680 688 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868111 689 691 I-Assertion___Assertion_Type_Value:hypothetical
receive NCT03868111 692 699 O
incidental NCT03868111 700 710 B-Modifier
lower NCT03868111 711 716 I-Modifier
abdominal NCT03868111 717 726 B-Procedure
procedures NCT03868111 727 737 I-Procedure
owing NCT03868111 738 743 O
to NCT03868111 744 746 O
adhesion NCT03868111 747 755 B-Condition
, NCT03868111 756 757 O
injury NCT03868111 758 764 B-Condition
, NCT03868111 765 766 O
or NCT03868111 767 769 B-Or
other NCT03868111 770 775 B-Other
incidental NCT03868111 776 786 B-Condition
findings NCT03868111 787 795 I-Condition
at NCT03868111 796 798 O
the NCT03868111 799 802 O
lower NCT03868111 803 808 B-Modifier
abdominal NCT03868111 809 818 I-Modifier
cavity NCT03868111 819 825 I-Modifier

- NCT03868111 828 829 O
Patients NCT03868111 831 839 O
with NCT03868111 840 844 O
a NCT03868111 845 846 O
history NCT03868111 847 854 B-Eq_Comparison
of NCT03868111 855 857 O
drug NCT03868111 858 862 B-Modifier
or NCT03868111 863 865 B-Or
alcohol NCT03868111 866 873 B-Modifier
abuse NCT03868111 874 879 B-Condition

- NCT03868111 882 883 O
Pregnant NCT03868111 885 893 B-Condition
women NCT03868111 894 899 O

Inclusion NCT03927924 0 9 O
Criteria NCT03927924 10 18 O
: NCT03927924 19 20 O

- NCT03927924 24 25 O
Visible NCT03927924 27 34 B-Condition
index NCT03927924 35 40 I-Condition
lesion NCT03927924 41 47 I-Condition
( NCT03927924 48 49 O
s NCT03927924 50 51 O
) NCT03927924 52 53 O
on NCT03927924 54 56 O
MRI NCT03927924 57 60 B-Procedure

- NCT03927924 63 64 O
Index NCT03927924 66 71 B-Observation
lesion NCT03927924 72 78 I-Observation
( NCT03927924 79 80 O
s NCT03927924 81 82 O
) NCT03927924 83 84 O
greater NCT03927924 85 92 B-Eq_Comparison
than NCT03927924 93 97 I-Eq_Comparison
0.5 NCT03927924 98 101 I-Eq_Comparison
cm NCT03927924 102 104 I-Eq_Comparison
3 NCT03927924 105 106 I-Eq_Comparison

- NCT03927924 109 110 O
Found NCT03927924 112 117 O
to NCT03927924 118 120 O
have NCT03927924 121 125 O
localized NCT03927924 126 135 B-Modifier
low NCT03927924 136 139 O
- NCT03927924 140 141 O
risk NCT03927924 142 146 B-Risk
or NCT03927924 147 149 B-Or
intermediate NCT03927924 150 162 O
- NCT03927924 163 164 O
risk NCT03927924 165 169 B-Risk
prostate NCT03927924 170 178 B-Condition
cancer NCT03927924 179 185 I-Condition
after NCT03927924 186 191 B-Temporal_Connection___Temporal_Connection_Type_Value:after
MRI NCT03927924 192 195 B-Procedure
- NCT03927924 196 197 I-Procedure
USG NCT03927924 198 201 I-Procedure
fusion NCT03927924 202 208 I-Procedure
targeted NCT03927924 209 217 I-Procedure
biopsy NCT03927924 218 224 I-Procedure
and NCT03927924 225 228 B-Or
saturation NCT03927924 229 239 B-Procedure
biopsy NCT03927924 240 246 I-Procedure
: NCT03927924 247 248 O

1 NCT03927924 257 258 O
. NCT03927924 258 259 O
Clinical NCT03927924 261 269 O
tumour NCT03927924 270 276 B-Condition
stage NCT03927924 277 282 B-Eq_Comparison
T NCT03927924 283 284 I-Eq_Comparison
2 NCT03927924 285 286 I-Eq_Comparison
, NCT03927924 287 288 O
or NCT03927924 289 291 B-Or

2 NCT03927924 299 300 O
. NCT03927924 300 301 O
Gleason NCT03927924 303 310 B-Observation
score NCT03927924 311 316 I-Observation
7 NCT03927924 317 318 B-Eq_Comparison
, NCT03927924 319 320 O
or NCT03927924 321 323 B-Or

3 NCT03927924 331 332 O
. NCT03927924 332 333 O
PSA NCT03927924 335 338 B-Observation
20 NCT03927924 339 341 B-Eq_Comparison
ng NCT03927924 342 344 I-Eq_Comparison
/ NCT03927924 345 346 I-Eq_Comparison
ml NCT03927924 347 349 I-Eq_Comparison

Exclusion NCT03927924 350 359 O
Criteria NCT03927924 360 368 O
: NCT03927924 369 370 O

- NCT03927924 374 375 O
Prostate NCT03927924 377 385 B-Observation
size NCT03927924 386 390 I-Observation
larger NCT03927924 391 397 B-Eq_Comparison
than NCT03927924 398 402 I-Eq_Comparison
50 NCT03927924 403 405 I-Eq_Comparison
ml NCT03927924 406 408 I-Eq_Comparison

- NCT03927924 411 412 O
Patients NCT03927924 414 422 O
unfit NCT03927924 423 428 B-Contraindication
for NCT03927924 429 432 O
contrast NCT03927924 433 441 B-Procedure
MRI NCT03927924 442 445 I-Procedure
exam NCT03927924 446 450 O

- NCT03927924 453 454 O
Patients NCT03927924 456 464 O
with NCT03927924 465 469 O
previous NCT03927924 470 478 B-Eq_Comparison
treatment NCT03927924 479 488 B-Procedure
of NCT03927924 489 491 O
prostate NCT03927924 492 500 B-Modifier
cancer NCT03927924 501 507 B-Condition

- NCT03927924 510 511 O
Patients NCT03927924 513 521 O
with NCT03927924 522 526 O
previous NCT03927924 527 535 B-Eq_Comparison
surgery NCT03927924 536 543 B-Procedure
on NCT03927924 544 546 O
the NCT03927924 547 550 O
prostate NCT03927924 551 559 B-Modifier

- NCT03927924 562 563 O
Patients NCT03927924 565 573 O
with NCT03927924 574 578 O
active NCT03927924 579 585 B-Eq_Comparison
urinary NCT03927924 586 593 B-Modifier
tract NCT03927924 594 599 I-Modifier
infection NCT03927924 600 609 B-Condition

- NCT03927924 612 613 O
Patients NCT03927924 615 623 O
with NCT03927924 624 628 O
bladder NCT03927924 629 636 B-Condition
pathology NCT03927924 637 646 I-Condition
including NCT03927924 647 656 O
bladder NCT03927924 657 664 B-Condition
stone NCT03927924 665 670 I-Condition
and NCT03927924 671 674 B-Or
bladder NCT03927924 675 682 B-Modifier
cancer NCT03927924 683 689 B-Condition

- NCT03927924 692 693 O
Patients NCT03927924 695 703 O
with NCT03927924 704 708 O
urethral NCT03927924 709 717 B-Condition
stricture NCT03927924 718 727 I-Condition

- NCT03927924 730 731 O
Patients NCT03927924 733 741 O
with NCT03927924 742 746 O
neurogenic NCT03927924 747 757 B-Condition
bladder NCT03927924 758 765 I-Condition
and NCT03927924 766 769 B-Or
/ NCT03927924 770 771 I-Or
or NCT03927924 772 774 I-Or
sphincter NCT03927924 775 784 B-Condition
abnormalities NCT03927924 785 798 I-Condition

- NCT03927924 801 802 O
Fail NCT03927924 804 808 O
to NCT03927924 809 811 O
give NCT03927924 812 816 O
informed NCT03927924 817 825 O
consent NCT03927924 826 833 O

Inclusion NCT03923803 0 9 O
Criteria NCT03923803 10 18 O
: NCT03923803 19 20 O

- NCT03923803 23 24 O
Patients NCT03923803 25 33 O
admitted NCT03923803 34 42 B-Encounter
to NCT03923803 43 45 O
the NCT03923803 46 49 O
hospital NCT03923803 50 58 O

Exclusion NCT03923803 59 68 O
Criteria NCT03923803 69 77 O
: NCT03923803 78 79 O

- NCT03923803 83 84 O
patients NCT03923803 86 94 O
with NCT03923803 95 99 O
malignancies NCT03923803 100 112 B-Condition

- NCT03923803 115 116 O
patients NCT03923803 118 126 O
with NCT03923803 127 131 O
other NCT03923803 132 137 B-Other
systemic NCT03923803 138 146 B-Modifier
infection NCT03923803 147 156 B-Condition

Inclusion NCT03931148 0 9 O
Criteria NCT03931148 10 18 O
: NCT03931148 19 20 O

- NCT03931148 24 25 O
French NCT03931148 27 33 O
speaker NCT03931148 34 41 O

- NCT03931148 44 45 O
Recent NCT03931148 47 53 B-Eq_Comparison
diagnosis NCT03931148 54 63 O
of NCT03931148 64 66 O
neurocognitive NCT03931148 67 81 B-Condition
disorder NCT03931148 82 90 I-Condition

- NCT03931148 93 94 O
Agreed NCT03931148 96 102 O
with NCT03931148 103 107 O
the NCT03931148 108 111 O
study NCT03931148 112 117 O

Exclusion NCT03931148 118 127 O
Criteria NCT03931148 128 136 O
: NCT03931148 137 138 O

- NCT03931148 142 143 O
Delirium NCT03931148 145 153 B-Condition

- NCT03931148 156 157 O
Major NCT03931148 159 164 O
depressive NCT03931148 165 175 B-Condition
symptoms NCT03931148 176 184 B-Assertion___Assertion_Type_Value:possible

- NCT03931148 187 188 O
MRI NCT03931148 190 193 B-Procedure
contraindication NCT03931148 194 210 B-Contraindication

Inclusion NCT03925571 0 9 O
Criteria NCT03925571 10 18 O
: NCT03925571 19 20 O

- NCT03925571 24 25 O
Majors NCT03925571 27 33 O
aged NCT03925571 34 38 B-Age
between NCT03925571 39 46 B-Eq_Comparison
18 NCT03925571 47 49 I-Eq_Comparison
and NCT03925571 50 53 I-Eq_Comparison
55 NCT03925571 54 56 I-Eq_Comparison
years NCT03925571 57 62 I-Eq_Comparison
, NCT03925571 63 64 O
with NCT03925571 65 69 O
an NCT03925571 70 72 O
appropriate NCT03925571 73 84 O
hearing NCT03925571 85 92 O
and NCT03925571 93 96 O
able NCT03925571 97 101 O
to NCT03925571 102 104 O
use NCT03925571 105 108 O
Music NCT03925571 109 114 O
- NCT03925571 115 116 O
Care NCT03925571 117 121 O
Â© NCT03925571 121 122 O
( NCT03925571 123 124 O
selection NCT03925571 125 134 O
of NCT03925571 135 137 O
the NCT03925571 138 141 O
playlist NCT03925571 142 150 O
via NCT03925571 151 154 O
internet NCT03925571 155 163 O
access NCT03925571 164 170 O
) NCT03925571 171 172 O
, NCT03925571 173 174 O

- NCT03925571 178 179 O
Needing NCT03925571 181 188 B-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03925571 189 198 B-Procedure
in NCT03925571 199 201 O
odontology NCT03925571 202 212 B-Modifier
- NCT03925571 213 214 O
periodontal NCT03925571 215 226 B-Modifier
surgery NCT03925571 227 234 B-Procedure
( NCT03925571 235 236 O
coronary NCT03925571 237 245 B-Procedure
elongation NCT03925571 246 256 I-Procedure
or NCT03925571 257 259 B-Or
sanitation NCT03925571 260 270 B-Procedure
surgery NCT03925571 271 278 I-Procedure
or NCT03925571 279 281 B-Or
muco NCT03925571 282 286 B-Procedure
- NCT03925571 287 288 I-Procedure
gingival NCT03925571 289 297 I-Procedure
surgery NCT03925571 298 305 I-Procedure
) NCT03925571 306 307 O
or NCT03925571 308 310 B-Or
implantary NCT03925571 311 321 B-Procedure
surgery NCT03925571 322 329 I-Procedure
( NCT03925571 330 331 O
placement NCT03925571 332 341 B-Procedure
of NCT03925571 342 344 I-Procedure
an NCT03925571 345 347 I-Procedure
unit NCT03925571 348 352 I-Procedure
implant NCT03925571 353 360 B-Modifier
or NCT03925571 361 363 B-Or
two NCT03925571 364 367 B-Modifier
implant NCT03925571 368 375 I-Modifier
in NCT03925571 376 378 I-Modifier
the NCT03925571 379 382 I-Modifier
same NCT03925571 383 387 I-Modifier
localization NCT03925571 388 400 I-Modifier
) NCT03925571 401 402 O
, NCT03925571 403 404 O

- NCT03925571 408 409 O
Oral NCT03925571 411 415 O
and NCT03925571 416 419 O
dated NCT03925571 420 425 O
consent NCT03925571 426 433 O
, NCT03925571 434 435 O

- NCT03925571 439 440 O
Agreeing NCT03925571 442 450 O
to NCT03925571 451 453 O
be NCT03925571 454 456 O
contacted NCT03925571 457 466 O
via NCT03925571 467 470 O
phone NCT03925571 471 476 O
at NCT03925571 477 479 O
J NCT03925571 480 481 O
+ NCT03925571 482 483 O
1 NCT03925571 484 485 O
and NCT03925571 486 489 O
to NCT03925571 490 492 O
fill NCT03925571 493 497 O
follow NCT03925571 498 504 O
- NCT03925571 505 506 O
up NCT03925571 507 509 O
study NCT03925571 510 515 O
documents NCT03925571 516 525 O
, NCT03925571 526 527 O

- NCT03925571 531 532 O
Profiting NCT03925571 534 543 O
of NCT03925571 544 546 O
social NCT03925571 547 553 O
security NCT03925571 554 562 O
or NCT03925571 563 565 O
CMU NCT03925571 566 569 O
. NCT03925571 570 571 O

Exclusion NCT03925571 573 582 O
Criteria NCT03925571 583 591 O
: NCT03925571 592 593 O

- NCT03925571 597 598 O
Patients NCT03925571 600 608 O
with NCT03925571 609 613 O
a NCT03925571 614 615 O
long NCT03925571 616 620 O
- NCT03925571 621 622 O
term NCT03925571 623 627 O
taking NCT03925571 628 634 B-Eq_Comparison
of NCT03925571 635 637 O
anxiolytic NCT03925571 638 648 B-Drug
or NCT03925571 649 651 B-Or
analgesic NCT03925571 652 661 B-Drug
, NCT03925571 662 663 O

- NCT03925571 667 668 O
Regular NCT03925571 670 677 O
consumer NCT03925571 678 686 O
of NCT03925571 687 689 O
soft NCT03925571 690 694 B-Drug
drug NCT03925571 695 699 I-Drug
( NCT03925571 700 701 O
cannabis NCT03925571 702 710 B-Drug
) NCT03925571 711 712 O
or NCT03925571 713 715 B-Or
hard NCT03925571 716 720 B-Drug
drug NCT03925571 721 725 I-Drug
( NCT03925571 726 727 O
opioid NCT03925571 728 734 B-Drug
) NCT03925571 735 736 O
, NCT03925571 737 738 O

- NCT03925571 742 743 O
Patient NCT03925571 745 752 O
with NCT03925571 753 757 O
medical NCT03925571 758 765 O
history NCT03925571 766 773 B-Eq_Comparison
of NCT03925571 774 776 O
psychiatry NCT03925571 777 787 B-Procedure
( NCT03925571 788 789 O
mental NCT03925571 790 796 B-Condition
harm NCT03925571 797 801 I-Condition
) NCT03925571 802 803 O
, NCT03925571 804 805 O
hearing NCT03925571 806 813 B-Condition
problem NCT03925571 814 821 I-Condition
, NCT03925571 822 823 O
cognitive NCT03925571 824 833 B-Modifier
and NCT03925571 834 837 B-Or
behavioural NCT03925571 838 849 B-Modifier
impairment NCT03925571 850 860 B-Condition
( NCT03925571 861 862 O
claustrophobia NCT03925571 863 877 B-Condition
) NCT03925571 878 879 O
, NCT03925571 880 881 O
sensory NCT03925571 882 889 B-Condition
disabilities NCT03925571 890 902 I-Condition
, NCT03925571 903 904 O

- NCT03925571 908 909 O
Patient NCT03925571 911 918 O
with NCT03925571 919 923 O
problems NCT03925571 924 932 O
of NCT03925571 933 935 O
hemostasis NCT03925571 936 946 B-Procedure
, NCT03925571 947 948 O

- NCT03925571 952 953 O
Majors NCT03925571 955 961 O
under NCT03925571 962 967 O
trusteeship NCT03925571 968 979 O
or NCT03925571 980 982 O
guardianship NCT03925571 983 995 O
, NCT03925571 996 997 O

- NCT03925571 1001 1002 O
Pregnant NCT03925571 1004 1012 B-Condition
women NCT03925571 1013 1018 O
or NCT03925571 1019 1021 B-Or
lactating NCT03925571 1022 1031 B-Condition
, NCT03925571 1032 1033 O

- NCT03925571 1037 1038 O
Minors NCT03925571 1040 1046 O
, NCT03925571 1047 1048 O

- NCT03925571 1052 1053 O
Protected NCT03925571 1055 1064 B-Observation
person NCT03925571 1065 1071 I-Observation
, NCT03925571 1072 1073 O
deprived NCT03925571 1074 1082 O
of NCT03925571 1083 1085 O
freedom NCT03925571 1086 1093 O
or NCT03925571 1094 1096 O
under NCT03925571 1097 1102 O
justice NCT03925571 1103 1110 O
safeguard NCT03925571 1111 1120 O
, NCT03925571 1121 1122 O

- NCT03925571 1126 1127 O
Profiting NCT03925571 1129 1138 O
of NCT03925571 1139 1141 O
a NCT03925571 1142 1143 O
medical NCT03925571 1144 1151 O
help NCT03925571 1152 1156 O
from NCT03925571 1157 1161 O
government NCT03925571 1162 1172 O
( NCT03925571 1173 1174 O
AME NCT03925571 1175 1178 O
) NCT03925571 1179 1180 O
, NCT03925571 1181 1182 O

- NCT03925571 1186 1187 O
Not NCT03925571 1189 1192 O
contactable NCT03925571 1193 1204 O
after NCT03925571 1205 1210 O
care NCT03925571 1211 1215 O
, NCT03925571 1216 1217 O

- NCT03925571 1221 1222 O
Patient NCT03925571 1224 1231 O
with NCT03925571 1232 1236 O
hepatic NCT03925571 1237 1244 B-Condition
impairment NCT03925571 1245 1255 I-Condition
, NCT03925571 1256 1257 O

- NCT03925571 1261 1262 O
Patient NCT03925571 1264 1271 O
with NCT03925571 1272 1276 O
dry NCT03925571 1277 1280 B-Condition
mouth NCT03925571 1281 1286 I-Condition
, NCT03925571 1287 1288 O

- NCT03925571 1292 1293 O
Patient NCT03925571 1295 1302 O
relevant NCT03925571 1303 1311 O
a NCT03925571 1312 1313 O
suboptimal NCT03925571 1314 1324 B-Condition
hearing NCT03925571 1325 1332 I-Condition
incompatible NCT03925571 1333 1345 O
with NCT03925571 1346 1350 O
musicotherapy NCT03925571 1351 1364 O
or NCT03925571 1365 1367 O
inability NCT03925571 1368 1377 O
to NCT03925571 1378 1380 O
use NCT03925571 1381 1384 O
Music NCT03925571 1385 1390 O
- NCT03925571 1391 1392 O
care NCT03925571 1393 1397 O
Â® NCT03925571 1397 1398 O
. NCT03925571 1399 1400 O

Inclusion NCT03861208 0 9 O
Criteria NCT03861208 10 18 O
: NCT03861208 19 20 O

- NCT03861208 24 25 O
healthy NCT03861208 27 34 B-Condition
children NCT03861208 35 43 O

Exclusion NCT03861208 44 53 O
Criteria NCT03861208 54 62 O
: NCT03861208 63 64 O

- NCT03861208 68 69 O
no NCT03861208 71 73 B-Negation
food NCT03861208 74 78 O
allergies NCT03861208 79 88 B-Allergy

- NCT03861208 91 92 O
no NCT03861208 94 96 B-Negation
medications NCT03861208 97 108 B-Drug
that NCT03861208 109 113 O
affect NCT03861208 114 120 B-Assertion___Assertion_Type_Value:hypothetical
behavior NCT03861208 121 129 B-Condition
/ NCT03861208 130 131 B-Or
learning NCT03861208 132 140 B-Condition
/ NCT03861208 141 142 B-Or
appetite NCT03861208 143 151 B-Condition

Inclusion NCT03867955 0 9 O
Criteria NCT03867955 10 18 O
: NCT03867955 19 20 O

- NCT03867955 24 25 O
Majors NCT03867955 27 33 O
patients NCT03867955 34 42 O

- NCT03867955 45 46 O
Score NCT03867955 48 53 O
American NCT03867955 54 62 B-Observation
Society NCT03867955 63 70 I-Observation
of NCT03867955 71 73 I-Observation
Anesthesiologists NCT03867955 74 91 I-Observation
( NCT03867955 92 93 O
ASA NCT03867955 94 97 B-Observation
) NCT03867955 98 99 O
1 NCT03867955 100 101 B-Eq_Comparison
or NCT03867955 102 104 I-Eq_Comparison
2 NCT03867955 105 106 I-Eq_Comparison

- NCT03867955 110 111 O
Managed NCT03867955 113 120 B-Encounter
in NCT03867955 121 123 O
the NCT03867955 124 127 O
operating NCT03867955 128 137 O
theater NCT03867955 138 145 O
of NCT03867955 146 148 O
the NCT03867955 149 152 O
University NCT03867955 153 163 O
Hospital NCT03867955 164 172 O
of NCT03867955 173 175 O
Saint NCT03867955 176 181 O
- NCT03867955 182 183 O
Etienne NCT03867955 184 191 O
for NCT03867955 192 195 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03867955 196 197 O
neurosurgical NCT03867955 198 211 B-Procedure
intervention NCT03867955 212 224 I-Procedure
. NCT03867955 225 226 O

Exclusion NCT03867955 228 237 O
Criteria NCT03867955 238 246 O
: NCT03867955 247 248 O

- NCT03867955 252 253 O
Single NCT03867955 255 261 B-Modifier
or NCT03867955 262 264 B-Or
bilateral NCT03867955 265 274 B-Modifier
eye NCT03867955 275 278 B-Procedure
surgery NCT03867955 279 286 I-Procedure
modifying NCT03867955 287 296 O
the NCT03867955 297 300 O
possibilities NCT03867955 301 314 O
of NCT03867955 315 317 O
variation NCT03867955 318 327 O
of NCT03867955 328 330 O
the NCT03867955 331 334 O
pupillary NCT03867955 335 344 O
diameter NCT03867955 345 353 O

- NCT03867955 356 357 O
Having NCT03867955 359 365 O
been NCT03867955 366 370 O
asleep NCT03867955 371 377 O
under NCT03867955 378 383 O
general NCT03867955 384 391 B-Procedure
anesthesia NCT03867955 392 402 I-Procedure
in NCT03867955 403 405 O
the NCT03867955 406 409 O
7 NCT03867955 410 411 B-Eq_Comparison
days NCT03867955 412 416 I-Eq_Comparison
prior NCT03867955 417 422 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867955 423 425 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03867955 426 429 O
current NCT03867955 430 437 B-Eq_Comparison
surgery NCT03867955 438 445 B-Procedure

- NCT03867955 448 449 O
History NCT03867955 451 458 B-Eq_Comparison
of NCT03867955 459 461 O
Parkinson NCT03867955 462 471 B-Condition
's NCT03867955 471 473 I-Condition
disease NCT03867955 474 481 I-Condition
, NCT03867955 482 483 O
insulin NCT03867955 484 491 B-Modifier
- NCT03867955 492 493 I-Modifier
dependent NCT03867955 494 503 I-Modifier
or NCT03867955 504 506 B-Or
non NCT03867955 507 510 B-Negation
- NCT03867955 511 512 O
insulin NCT03867955 513 520 B-Modifier
- NCT03867955 521 522 I-Modifier
dependent NCT03867955 523 532 I-Modifier
diabetes NCT03867955 533 541 B-Condition
at NCT03867955 542 544 O
a NCT03867955 545 546 O
dysautonomic NCT03867955 547 559 B-Modifier
stage NCT03867955 560 565 I-Modifier
or NCT03867955 566 568 B-Or
chronic NCT03867955 569 576 O
alcoholism NCT03867955 577 587 B-Condition
at NCT03867955 588 590 O
a NCT03867955 591 592 O
dysautonomous NCT03867955 593 606 B-Modifier
stage NCT03867955 607 612 I-Modifier

Subjects NCT03860181 0 8 O
will NCT03860181 9 13 O
be NCT03860181 14 16 O
included NCT03860181 17 25 O
if NCT03860181 26 28 O
: NCT03860181 29 30 O

- NCT03860181 34 35 O
They NCT03860181 37 41 O
are NCT03860181 42 45 O
18 NCT03860181 46 48 B-Eq_Comparison
years NCT03860181 49 54 I-Eq_Comparison
or NCT03860181 55 57 I-Eq_Comparison
older NCT03860181 58 63 I-Eq_Comparison
; NCT03860181 63 64 O

- NCT03860181 67 68 O
They NCT03860181 70 74 O
are NCT03860181 75 78 O
undergoing NCT03860181 79 89 B-Eq_Comparison
primary NCT03860181 90 97 B-Modifier
total NCT03860181 98 103 B-Procedure
shoulder NCT03860181 104 112 I-Procedure
arthroplasty NCT03860181 113 125 I-Procedure
by NCT03860181 126 128 O
the NCT03860181 129 132 O
principal NCT03860181 133 142 O
and NCT03860181 143 146 O
co NCT03860181 147 149 O
- NCT03860181 150 151 O
investigator NCT03860181 152 164 O
. NCT03860181 165 166 O

- NCT03860181 170 171 O
They NCT03860181 173 177 O
are NCT03860181 178 181 O
willing NCT03860181 182 189 O
and NCT03860181 190 193 O
have NCT03860181 194 198 O
the NCT03860181 199 202 O
capacity NCT03860181 203 211 O
to NCT03860181 212 214 O
provide NCT03860181 215 222 O
informed NCT03860181 223 231 O
consent NCT03860181 232 239 O
; NCT03860181 239 240 O

- NCT03860181 243 244 O
They NCT03860181 246 250 O
expect NCT03860181 251 257 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860181 258 260 I-Assertion___Assertion_Type_Value:hypothetical
continue NCT03860181 261 269 O
their NCT03860181 270 275 O
post NCT03860181 276 280 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03860181 281 282 O
operative NCT03860181 283 292 B-Procedure
follow NCT03860181 293 299 B-Encounter
up NCT03860181 300 302 I-Encounter
care NCT03860181 303 307 I-Encounter
with NCT03860181 308 312 O
their NCT03860181 313 318 O
operating NCT03860181 319 328 O
surgeons NCT03860181 329 337 O
at NCT03860181 338 340 O
Medical NCT03860181 341 348 O
University NCT03860181 349 359 O
of NCT03860181 360 362 O
South NCT03860181 363 368 O
Carolina NCT03860181 369 377 O
( NCT03860181 378 379 O
MUSC NCT03860181 380 384 O
) NCT03860181 385 386 O
. NCT03860181 387 388 O

Subjects NCT03860181 390 398 O
will NCT03860181 399 403 O
be NCT03860181 404 406 O
excluded NCT03860181 407 415 O
if NCT03860181 416 418 O
: NCT03860181 419 420 O

- NCT03860181 424 425 O
They NCT03860181 427 431 O
have NCT03860181 432 436 O
a NCT03860181 437 438 O
unique NCT03860181 439 445 O
, NCT03860181 446 447 O
identifying NCT03860181 448 459 O
tattoo NCT03860181 460 466 B-Condition
or NCT03860181 467 469 B-Or
skin NCT03860181 470 474 B-Condition
marking NCT03860181 475 482 I-Condition
within NCT03860181 483 489 B-Eq_Comparison
2 NCT03860181 490 491 I-Eq_Comparison
inches NCT03860181 492 498 I-Eq_Comparison
of NCT03860181 499 501 O
intended NCT03860181 502 510 B-Modifier
site NCT03860181 511 515 I-Modifier
of NCT03860181 516 518 O
surgical NCT03860181 519 527 B-Procedure
incision NCT03860181 528 536 I-Procedure

- NCT03860181 539 540 O
They NCT03860181 542 546 O
self NCT03860181 547 551 O
- NCT03860181 552 553 O
report NCT03860181 554 560 O
a NCT03860181 561 562 O
known NCT03860181 563 568 O
hypersensitivity NCT03860181 569 585 B-Condition
to NCT03860181 586 588 O
cyanoacrylate NCT03860181 589 602 B-Drug
, NCT03860181 603 604 O
formaldehyde NCT03860181 605 617 B-Drug
, NCT03860181 618 619 O
benzalkonium NCT03860181 620 632 B-Drug
chloride NCT03860181 633 641 I-Drug
, NCT03860181 642 643 O
or NCT03860181 644 646 B-Or
pressure NCT03860181 647 655 B-Condition
sensitive NCT03860181 656 665 I-Condition
adhesive NCT03860181 666 674 I-Condition
; NCT03860181 674 675 O

- NCT03860181 678 679 O
They NCT03860181 681 685 O
self NCT03860181 686 690 O
- NCT03860181 691 692 O
report NCT03860181 693 699 O
or NCT03860181 700 702 O
have NCT03860181 703 707 O
a NCT03860181 708 709 O
documented NCT03860181 710 720 O
prior NCT03860181 721 726 B-Eq_Comparison
ipsilateral NCT03860181 727 738 B-Modifier
shoulder NCT03860181 739 747 B-Procedure
arthroplasty NCT03860181 748 760 I-Procedure
or NCT03860181 761 763 B-Or
other NCT03860181 764 769 B-Other
open NCT03860181 770 774 B-Modifier
ispilateral NCT03860181 775 786 I-Modifier
shoulder NCT03860181 787 795 B-Procedure
surgery NCT03860181 796 803 I-Procedure
utilizing NCT03860181 804 813 O
the NCT03860181 814 817 O
delto NCT03860181 818 823 B-Modifier
- NCT03860181 824 825 I-Modifier
pectoral NCT03860181 826 834 I-Modifier
approach NCT03860181 835 843 I-Modifier
; NCT03860181 843 844 O

- NCT03860181 847 848 O
Their NCT03860181 850 855 O
medical NCT03860181 856 863 O
record NCT03860181 864 870 O
shows NCT03860181 871 876 O
that NCT03860181 877 881 O
they NCT03860181 882 886 O
are NCT03860181 887 890 O
HIV NCT03860181 891 894 B-Condition
positive NCT03860181 895 903 O
or NCT03860181 904 906 B-Or
otherwise NCT03860181 907 916 O
immunocompromised NCT03860181 917 934 B-Condition
; NCT03860181 934 935 O

- NCT03860181 938 939 O
Their NCT03860181 941 946 O
medical NCT03860181 947 954 O
record NCT03860181 955 961 O
shows NCT03860181 962 967 O
a NCT03860181 968 969 O
skin NCT03860181 970 974 B-Modifier
abnormality NCT03860181 975 986 B-Condition
or NCT03860181 987 989 B-Or
dermatological NCT03860181 990 1004 B-Condition
condition NCT03860181 1005 1014 I-Condition
which NCT03860181 1015 1020 O
affects NCT03860181 1021 1028 B-Assertion___Assertion_Type_Value:hypothetical
skin NCT03860181 1029 1033 B-Condition
healing NCT03860181 1034 1041 I-Condition
; NCT03860181 1041 1042 O

- NCT03860181 1045 1046 O
They NCT03860181 1048 1052 O
report NCT03860181 1053 1059 O
a NCT03860181 1060 1061 O
personal NCT03860181 1062 1070 B-Family_Member___Family_Member_Type:patient
or NCT03860181 1071 1073 B-Or
family NCT03860181 1074 1080 B-Family_Member
history NCT03860181 1081 1088 I-Family_Member
of NCT03860181 1089 1091 O
significant NCT03860181 1092 1103 O
keloid NCT03860181 1104 1110 B-Modifier
or NCT03860181 1111 1113 B-Or
significant NCT03860181 1114 1125 O
hypertrophic NCT03860181 1126 1138 B-Condition
scar NCT03860181 1139 1143 I-Condition
formations NCT03860181 1144 1154 I-Condition
, NCT03860181 1155 1156 O
or NCT03860181 1157 1159 B-Or
other NCT03860181 1160 1165 B-Other
problems NCT03860181 1166 1174 B-Condition
with NCT03860181 1175 1179 I-Condition
wound NCT03860181 1180 1185 I-Condition
healing NCT03860181 1186 1193 I-Condition
. NCT03860181 1194 1195 O

Inclusion NCT03927456 0 9 O
Criteria NCT03927456 10 18 O
: NCT03927456 19 20 O

1 NCT03927456 24 25 O
. NCT03927456 25 26 O
Has NCT03927456 28 31 O
the NCT03927456 32 35 O
pathologically NCT03927456 36 50 B-Procedure
- NCT03927456 51 52 O
confirmed NCT03927456 53 62 O
diagnosis NCT03927456 63 72 O
of NCT03927456 73 75 O
locally NCT03927456 76 83 B-Modifier
recurrent NCT03927456 84 93 I-Modifier
or NCT03927456 94 96 B-Or
metastatic NCT03927456 97 107 B-Modifier
, NCT03927456 108 109 O
hormone NCT03927456 110 117 B-Modifier
- NCT03927456 118 119 I-Modifier
receptor NCT03927456 120 128 I-Modifier
positive NCT03927456 129 137 I-Modifier
, NCT03927456 138 139 O
HER NCT03927456 140 143 B-Modifier
2 NCT03927456 144 145 I-Modifier
negative NCT03927456 146 154 I-Modifier
Breast NCT03927456 155 161 I-Modifier
Cancer NCT03927456 162 168 B-Condition
. NCT03927456 169 170 O

2 NCT03927456 174 175 O
. NCT03927456 175 176 O
Age NCT03927456 178 181 B-Age
: NCT03927456 182 183 O
18 NCT03927456 184 186 B-Eq_Comparison
- NCT03927456 187 188 I-Eq_Comparison
75 NCT03927456 189 191 I-Eq_Comparison
years NCT03927456 192 197 I-Eq_Comparison
old NCT03927456 198 201 O
, NCT03927456 202 203 O
postmenopausal NCT03927456 204 218 B-Condition
women NCT03927456 219 224 O
or NCT03927456 225 227 B-Or
prepostmenopausal NCT03927456 228 245 B-Condition
women NCT03927456 246 251 O

3 NCT03927456 254 255 O
. NCT03927456 255 256 O
Received NCT03927456 258 266 B-Eq_Comparison
prior NCT03927456 267 272 I-Eq_Comparison
endocrine NCT03927456 273 282 B-Procedure
therapy NCT03927456 283 290 I-Procedure

4 NCT03927456 293 294 O
. NCT03927456 294 295 O
One NCT03927456 297 300 B-Eq_Comparison
previous NCT03927456 301 309 B-Eq_Comparison
line NCT03927456 310 314 O
of NCT03927456 315 317 O
chemotherapy NCT03927456 318 330 B-Procedure
for NCT03927456 331 334 O
advanced NCT03927456 335 343 B-Modifier
/ NCT03927456 344 345 B-Or
metastatic NCT03927456 346 356 B-Modifier
disease NCT03927456 357 364 B-Condition
is NCT03927456 365 367 O
allowed NCT03927456 368 375 O
in NCT03927456 376 378 B-And
addition NCT03927456 379 387 I-And
to NCT03927456 388 390 O
endocrine NCT03927456 391 400 B-Procedure
therapy NCT03927456 401 408 I-Procedure
. NCT03927456 409 410 O

5 NCT03927456 414 415 O
. NCT03927456 415 416 O
Eastern NCT03927456 418 425 B-Observation
Cooperative NCT03927456 426 437 I-Observation
Oncology NCT03927456 438 446 I-Observation
Group NCT03927456 447 452 I-Observation
[ NCT03927456 453 454 O
ECOG NCT03927456 455 459 B-Observation
] NCT03927456 460 461 O
0 NCT03927456 462 463 B-Eq_Comparison
- NCT03927456 464 465 I-Eq_Comparison
1 NCT03927456 466 467 I-Eq_Comparison

Exclusion NCT03927456 469 478 O
Criteria NCT03927456 479 487 O
: NCT03927456 488 489 O

1 NCT03927456 493 494 O
. NCT03927456 494 495 O
Patients NCT03927456 497 505 O
who NCT03927456 506 509 O
received NCT03927456 510 518 B-Eq_Comparison
prior NCT03927456 519 524 I-Eq_Comparison
treatment NCT03927456 525 534 B-Procedure
with NCT03927456 535 539 O
any NCT03927456 540 543 O
CDK NCT03927456 544 547 B-Drug
4 NCT03927456 548 549 I-Drug
/ NCT03927456 550 551 I-Drug
6 NCT03927456 552 553 I-Drug
inhibitor NCT03927456 554 563 I-Drug
, NCT03927456 564 565 O
everolimus NCT03927456 566 576 B-Drug
or NCT03927456 577 579 B-Or
fulvestant NCT03927456 580 590 B-Drug
. NCT03927456 591 592 O

2 NCT03927456 596 597 O
. NCT03927456 597 598 O
Clinically NCT03927456 600 610 O
significant NCT03927456 611 622 O
cardiovascular NCT03927456 623 637 B-Modifier
and NCT03927456 638 641 B-Or
cerebrovascular NCT03927456 642 657 B-Modifier
diseases NCT03927456 658 666 B-Condition
, NCT03927456 667 668 O
including NCT03927456 669 678 O
but NCT03927456 679 682 O
not NCT03927456 683 686 O
limited NCT03927456 687 694 O
to NCT03927456 695 697 O
severe NCT03927456 698 704 O
acute NCT03927456 705 710 B-Condition
myocardial NCT03927456 711 721 I-Condition
infarction NCT03927456 722 732 I-Condition
within NCT03927456 733 739 B-Eq_Comparison
6 NCT03927456 740 741 I-Eq_Comparison
months NCT03927456 742 748 I-Eq_Comparison
before NCT03927456 749 755 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03927456 756 766 B-Study
, NCT03927456 767 768 O
unstable NCT03927456 769 777 O
or NCT03927456 778 780 B-Or
severe NCT03927456 781 787 O
angina NCT03927456 788 794 B-Condition
, NCT03927456 795 796 O
Congestive NCT03927456 797 807 B-Condition
heart NCT03927456 808 813 I-Condition
failure NCT03927456 814 821 I-Condition
( NCT03927456 822 823 O
New NCT03927456 824 827 B-Observation
York NCT03927456 828 832 I-Observation
heart NCT03927456 833 838 I-Observation
association NCT03927456 839 850 I-Observation
( NCT03927456 851 852 O
NYHA NCT03927456 853 857 B-Observation
) NCT03927456 858 859 O
class NCT03927456 860 865 B-Eq_Comparison
> NCT03927456 866 867 I-Eq_Comparison
2 NCT03927456 868 869 I-Eq_Comparison
) NCT03927456 870 871 O
, NCT03927456 872 873 O
or NCT03927456 874 876 B-Or
ventricular NCT03927456 877 888 B-Condition
arrhythmia NCT03927456 889 899 I-Condition
which NCT03927456 900 905 O
need NCT03927456 906 910 B-Assertion___Assertion_Type_Value:hypothetical
medical NCT03927456 911 918 O
intervention NCT03927456 919 931 B-Procedure
. NCT03927456 932 933 O

Inclusion NCT03866642 0 9 O
Criteria NCT03866642 10 18 O
: NCT03866642 19 20 O

- NCT03866642 24 25 O
Ankle NCT03866642 27 32 B-Modifier
arthritis NCT03866642 33 42 B-Condition
treated NCT03866642 43 50 O
with NCT03866642 51 55 O
Cadence NCT03866642 56 63 B-Modifier
Total NCT03866642 64 69 B-Procedure
Ankle NCT03866642 70 75 I-Procedure
Replacement NCT03866642 76 87 I-Procedure
system NCT03866642 88 94 I-Procedure

Exclusion NCT03866642 95 104 O
Criteria NCT03866642 105 113 O
: NCT03866642 114 115 O

- NCT03866642 119 120 O
Under NCT03866642 122 127 B-Eq_Comparison
18 NCT03866642 128 130 I-Eq_Comparison
years NCT03866642 131 136 I-Eq_Comparison
of NCT03866642 137 139 O
age NCT03866642 140 143 B-Age

Inclusion NCT03869502 0 9 O
Criteria NCT03869502 10 18 O
: NCT03869502 19 20 O

- NCT03869502 24 25 O
Age NCT03869502 27 30 B-Age
> NCT03869502 31 32 B-Eq_Comparison
18 NCT03869502 33 35 I-Eq_Comparison
years NCT03869502 36 41 I-Eq_Comparison

- NCT03869502 44 45 O
Diagnosis NCT03869502 47 56 O
of NCT03869502 57 59 O
BCRâABL NCT03869502 60 67 B-Condition
positive NCT03869502 68 76 O
CML NCT03869502 77 80 B-Modifier
blast NCT03869502 81 86 I-Modifier
crisis NCT03869502 87 93 I-Modifier
according NCT03869502 94 103 O
to NCT03869502 104 106 O
the NCT03869502 107 110 O
WHO NCT03869502 111 114 O
criteria NCT03869502 115 123 O
: NCT03869502 124 125 O

- NCT03869502 134 135 O
Blasts NCT03869502 137 143 B-Observation
20 NCT03869502 144 146 B-Eq_Comparison
% NCT03869502 147 148 I-Eq_Comparison
or NCT03869502 149 151 I-Eq_Comparison
more NCT03869502 152 156 I-Eq_Comparison
of NCT03869502 157 159 O
peripheral NCT03869502 160 170 B-Modifier
blood NCT03869502 171 176 I-Modifier
white NCT03869502 177 182 I-Modifier
cells NCT03869502 183 188 I-Modifier
or NCT03869502 189 191 B-Or
bone NCT03869502 192 196 B-Modifier
marrow NCT03869502 197 203 I-Modifier
cells NCT03869502 204 209 I-Modifier
or NCT03869502 210 212 B-Or

- NCT03869502 220 221 O
Extramedullary NCT03869502 223 237 B-Modifier
blast NCT03869502 238 243 B-Condition
proliferation NCT03869502 244 257 I-Condition
or NCT03869502 258 260 B-Or

- NCT03869502 268 269 O
Large NCT03869502 271 276 B-Modifier
foci NCT03869502 277 281 I-Modifier
or NCT03869502 282 284 B-Or
clusters NCT03869502 285 293 B-Modifier
of NCT03869502 294 296 O
blasts NCT03869502 297 303 B-Condition
in NCT03869502 304 306 O
bone NCT03869502 307 311 B-Procedure
marrow NCT03869502 312 318 I-Procedure
biopsy NCT03869502 319 325 I-Procedure

Exclusion NCT03869502 326 335 O
Criteria NCT03869502 336 344 O
: NCT03869502 345 346 O

- NCT03869502 350 351 O
Lack NCT03869502 353 357 O
of NCT03869502 358 360 O
informed NCT03869502 361 369 O
consent NCT03869502 370 377 O

Inclusion NCT03864315 0 9 O
Criteria NCT03864315 10 18 O
: NCT03864315 19 20 O

1 NCT03864315 24 25 O
. NCT03864315 25 26 O
20 NCT03864315 28 30 B-Eq_Comparison
- NCT03864315 31 32 I-Eq_Comparison
75 NCT03864315 33 35 I-Eq_Comparison
years NCT03864315 36 41 I-Eq_Comparison
old NCT03864315 42 45 B-Age

2 NCT03864315 48 49 O
. NCT03864315 49 50 O
With NCT03864315 52 56 O
skin NCT03864315 57 61 B-Condition
type NCT03864315 62 66 I-Condition
â¢ NCT03864315 67 68 B-Eq_Comparison
or NCT03864315 69 71 I-Eq_Comparison
â£ NCT03864315 72 73 I-Eq_Comparison

3 NCT03864315 76 77 O
. NCT03864315 77 78 O
With NCT03864315 80 84 O
Vitiligo NCT03864315 85 93 B-Condition

4 NCT03864315 96 97 O
. NCT03864315 97 98 O
Can NCT03864315 100 103 O
read NCT03864315 104 108 O
the NCT03864315 109 112 O
informed NCT03864315 113 121 O
consent NCT03864315 122 129 O
form NCT03864315 130 134 O

5 NCT03864315 137 138 O
. NCT03864315 138 139 O
Can NCT03864315 141 144 O
continue NCT03864315 145 153 O
the NCT03864315 154 157 O
original NCT03864315 158 166 O
treatments NCT03864315 167 177 O

Exclusion NCT03864315 178 187 O
Criteria NCT03864315 188 196 O
: NCT03864315 197 198 O

1 NCT03864315 202 203 O
. NCT03864315 203 204 O
With NCT03864315 206 210 O
segmental NCT03864315 211 220 B-Modifier
vitiligo NCT03864315 221 229 B-Condition
. NCT03864315 230 231 O

2 NCT03864315 235 236 O
. NCT03864315 236 237 O
Have NCT03864315 239 243 O
joined NCT03864315 244 250 O
other NCT03864315 251 256 B-Other
clinical NCT03864315 257 265 B-Study
trials NCT03864315 266 272 I-Study

Inclusion NCT03929822 0 9 O
Criteria NCT03929822 10 18 O
: NCT03929822 19 20 O

- NCT03929822 24 25 O
Women NCT03929822 27 32 O
called NCT03929822 33 39 O
back NCT03929822 40 44 O
from NCT03929822 45 49 O
a NCT03929822 50 51 O
screening NCT03929822 52 61 B-Procedure
mammography NCT03929822 62 73 I-Procedure
by NCT03929822 74 76 O
either NCT03929822 77 83 O
FFDM NCT03929822 84 88 B-Procedure
or NCT03929822 89 91 B-Or
tomosynthesis NCT03929822 92 105 B-Procedure
with NCT03929822 106 110 B-And
soft NCT03929822 111 115 B-Condition
tissue NCT03929822 116 122 I-Condition
abnormalities NCT03929822 123 136 I-Condition
including NCT03929822 137 146 O
masses NCT03929822 147 153 B-Condition
, NCT03929822 154 155 O
asymmetries NCT03929822 156 167 B-Condition
, NCT03929822 168 169 O
focal NCT03929822 170 175 B-Condition
asymmetries NCT03929822 176 187 I-Condition
or NCT03929822 188 190 B-Or
architectural NCT03929822 191 204 B-Condition
distortion NCT03929822 205 215 I-Condition
with NCT03929822 216 220 B-Modifier
or NCT03929822 221 223 B-Or
without NCT03929822 224 231 B-Negation
calcifications NCT03929822 232 246 B-Condition
. NCT03929822 247 248 O
Patients NCT03929822 250 258 O
will NCT03929822 259 263 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03929822 264 266 I-Assertion___Assertion_Type_Value:hypothetical
questioned NCT03929822 267 277 I-Assertion___Assertion_Type_Value:hypothetical
regarding NCT03929822 278 287 O
the NCT03929822 288 291 O
possibility NCT03929822 292 303 O
of NCT03929822 304 306 O
pregnancy NCT03929822 307 316 B-Condition
and NCT03929822 317 320 B-And
will NCT03929822 321 325 B-Assertion___Assertion_Type_Value:hypothetical
need NCT03929822 326 330 I-Assertion___Assertion_Type_Value:hypothetical
a NCT03929822 331 332 O
negative NCT03929822 333 341 O
pregnancy NCT03929822 342 351 B-Observation
test NCT03929822 352 356 I-Observation
prior NCT03929822 357 362 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03929822 363 366 O
study NCT03929822 367 372 B-Study
intervention NCT03929822 373 385 O
. NCT03929822 386 387 O

Exclusion NCT03929822 389 398 O
Criteria NCT03929822 399 407 O
: NCT03929822 408 409 O

- NCT03929822 413 414 O
Age NCT03929822 416 419 B-Age
< NCT03929822 420 421 B-Eq_Comparison
30 NCT03929822 422 424 I-Eq_Comparison
years NCT03929822 425 430 I-Eq_Comparison
old NCT03929822 431 434 O

- NCT03929822 437 438 O
Screening NCT03929822 440 449 B-Procedure
mammography NCT03929822 450 461 I-Procedure
with NCT03929822 462 466 O
only NCT03929822 467 471 O
calcifications NCT03929822 472 486 B-Condition
abnormalities NCT03929822 487 500 I-Condition

- NCT03929822 503 504 O
Male NCT03929822 506 510 O
patients NCT03929822 511 519 O

- NCT03929822 522 523 O
Pregnant NCT03929822 525 533 B-Condition
or NCT03929822 534 536 B-Or
lactating NCT03929822 537 546 B-Condition
patients NCT03929822 547 555 O

- NCT03929822 558 559 O
Patients NCT03929822 561 569 O
with NCT03929822 570 574 O
any NCT03929822 575 578 O
allergy NCT03929822 579 586 B-Allergy
to NCT03929822 587 589 O
iodinated NCT03929822 590 599 O
contrast NCT03929822 600 608 O

- NCT03929822 611 612 O
Patients NCT03929822 614 622 O
with NCT03929822 623 627 O
eGFR NCT03929822 628 632 B-Observation
< NCT03929822 633 634 B-Eq_Comparison
45 NCT03929822 635 637 I-Eq_Comparison

- NCT03929822 641 642 O
Patients NCT03929822 644 652 O
that NCT03929822 653 657 O
may NCT03929822 658 661 B-Assertion___Assertion_Type_Value:possible
be NCT03929822 662 664 O
treated NCT03929822 665 672 B-Procedure
with NCT03929822 673 677 O
radioactive NCT03929822 678 689 B-Procedure
iodine NCT03929822 690 696 I-Procedure

Inclusion NCT03924128 0 9 O
Criteria NCT03924128 10 18 O
: NCT03924128 19 20 O

- NCT03924128 24 25 O
Selected NCT03924128 27 35 O
will NCT03924128 36 40 O
be NCT03924128 41 43 O
subjects NCT03924128 44 52 O
to NCT03924128 53 55 O
meeting NCT03924128 56 63 O
the NCT03924128 64 67 O
following NCT03924128 68 77 O
criteria NCT03924128 78 86 O
: NCT03924128 87 88 O
male NCT03924128 89 93 O
and NCT03924128 94 97 B-Or
female NCT03924128 98 104 O
subjects NCT03924128 105 113 O
age NCT03924128 114 117 B-Age
â¥ NCT03924128 118 119 B-Eq_Comparison
20 NCT03924128 120 122 I-Eq_Comparison
years NCT03924128 123 128 I-Eq_Comparison
old NCT03924128 129 132 O
, NCT03924128 133 134 O
diagnosed NCT03924128 135 144 O
with NCT03924128 145 149 O
Osteoarthritis NCT03924128 150 164 B-Condition
stages NCT03924128 165 171 B-Eq_Comparison
III NCT03924128 172 175 I-Eq_Comparison
and NCT03924128 176 179 I-Eq_Comparison
IV NCT03924128 180 182 I-Eq_Comparison
according NCT03924128 183 192 O
to NCT03924128 193 195 O
the NCT03924128 196 199 O
American NCT03924128 200 208 O
College NCT03924128 209 216 O
of NCT03924128 217 219 O
Rheumatology NCT03924128 220 232 O
, NCT03924128 233 234 O
manifesting NCT03924128 235 246 O
pain NCT03924128 247 251 B-Condition
, NCT03924128 252 253 O
functional NCT03924128 254 264 B-Condition
impairment NCT03924128 265 275 I-Condition
for NCT03924128 276 279 O
more NCT03924128 280 284 B-Eq_Comparison
than NCT03924128 285 289 I-Eq_Comparison
3 NCT03924128 290 291 I-Eq_Comparison
months NCT03924128 292 298 I-Eq_Comparison
, NCT03924128 299 300 O
able NCT03924128 301 305 B-Condition
to NCT03924128 306 308 I-Condition
wander NCT03924128 309 315 I-Condition
with NCT03924128 316 320 B-Modifier
or NCT03924128 321 323 B-Or
without NCT03924128 324 331 B-Negation
canes NCT03924128 332 337 B-Modifier
. NCT03924128 338 339 O

Exclusion NCT03924128 341 350 O
Criteria NCT03924128 351 359 O
: NCT03924128 360 361 O

- NCT03924128 365 366 O
Will NCT03924128 368 372 O
be NCT03924128 373 375 O
excluded NCT03924128 376 384 B-Negation
from NCT03924128 385 389 O
study NCT03924128 390 395 B-Study
subjects NCT03924128 396 404 O
with NCT03924128 405 409 O
history NCT03924128 410 417 B-Eq_Comparison
of NCT03924128 418 420 O
cancer NCT03924128 421 427 B-Condition
, NCT03924128 428 429 O
unstable NCT03924128 430 438 O
cardiovascular NCT03924128 439 453 B-Condition
disease NCT03924128 454 461 I-Condition
, NCT03924128 462 463 O
uncontrolled NCT03924128 464 476 B-Modifier
hypertension NCT03924128 477 489 B-Condition
, NCT03924128 490 491 O
morbid NCT03924128 492 498 B-Condition
obesity NCT03924128 499 506 I-Condition
, NCT03924128 507 508 O
that NCT03924128 509 513 O
is NCT03924128 514 516 O
, NCT03924128 517 518 O
BMI NCT03924128 519 522 B-Observation
â¥ NCT03924128 523 524 B-Eq_Comparison
40 NCT03924128 525 527 I-Eq_Comparison
, NCT03924128 528 529 O
terminal NCT03924128 530 538 B-Condition
illness NCT03924128 539 546 I-Condition
, NCT03924128 547 548 O
cerebrovascular NCT03924128 549 564 B-Condition
disease NCT03924128 565 572 I-Condition
, NCT03924128 573 574 O
dementia NCT03924128 575 583 B-Condition
, NCT03924128 584 585 O
heart NCT03924128 586 591 B-Procedure
pacemaker NCT03924128 592 601 I-Procedure
, NCT03924128 602 603 O
superior NCT03924128 604 612 B-Modifier
or NCT03924128 613 615 B-Or
inferior NCT03924128 616 624 B-Modifier
limb NCT03924128 625 629 I-Modifier
fractures NCT03924128 630 639 B-Condition
. NCT03924128 640 641 O

Inclusion NCT03928093 0 9 O
Criteria NCT03928093 10 18 O
: NCT03928093 19 20 O

- NCT03928093 24 25 O
Age NCT03928093 27 30 B-Age
: NCT03928093 31 32 O
> NCT03928093 33 34 B-Eq_Comparison
8 NCT03928093 35 36 I-Eq_Comparison
- NCT03928093 37 38 I-Eq_Comparison
40 NCT03928093 39 41 I-Eq_Comparison
years NCT03928093 42 47 I-Eq_Comparison
( NCT03928093 48 49 O
we NCT03928093 50 52 O
selected NCT03928093 53 61 O
this NCT03928093 62 66 O
range NCT03928093 67 72 O
due NCT03928093 73 76 O
to NCT03928093 77 79 O
lack NCT03928093 80 84 O
of NCT03928093 85 87 O
data NCT03928093 88 92 O
in NCT03928093 93 95 O
younger NCT03928093 96 103 O
population NCT03928093 104 114 O
and NCT03928093 115 118 O
the NCT03928093 119 122 O
difficulty NCT03928093 123 133 O
in NCT03928093 134 136 O
getting NCT03928093 137 144 O
patient NCT03928093 145 152 O
reported NCT03928093 153 161 O
outcomes NCT03928093 162 170 O
in NCT03928093 171 173 O
younger NCT03928093 174 181 O
patients NCT03928093 182 190 O
) NCT03928093 191 192 O

- NCT03928093 196 197 O
Diagnosis NCT03928093 199 208 O
of NCT03928093 209 211 O
RDEB NCT03928093 212 216 B-Condition
( NCT03928093 217 218 O
by NCT03928093 219 221 O
a NCT03928093 222 223 O
dermatologist NCT03928093 224 237 B-Provider
and NCT03928093 238 241 B-Or
/ NCT03928093 242 243 I-Or
or NCT03928093 244 246 I-Or
EB NCT03928093 247 249 B-Provider
specialist NCT03928093 250 260 I-Provider
and NCT03928093 261 264 B-Or
/ NCT03928093 265 266 I-Or
or NCT03928093 267 269 I-Or
genetic NCT03928093 270 277 B-Procedure
confirmation NCT03928093 278 290 I-Procedure
) NCT03928093 291 292 O

- NCT03928093 296 297 O
Evidence NCT03928093 299 307 O
of NCT03928093 308 310 O
neuropathy NCT03928093 311 321 B-Condition
defined NCT03928093 322 329 O
by NCT03928093 330 332 O
: NCT03928093 333 334 O
thermal NCT03928093 335 342 B-Condition
sensory NCT03928093 343 350 I-Condition
loss NCT03928093 351 355 I-Condition
( NCT03928093 356 357 O
determined NCT03928093 358 368 O
by NCT03928093 369 371 O
a NCT03928093 372 373 O
thermal NCT03928093 374 381 B-Procedure
roller NCT03928093 382 388 I-Procedure
, NCT03928093 389 390 O
ROLLTEMP NCT03928093 391 399 O
2 NCT03928093 400 401 O
, NCT03928093 402 403 O
Sometic NCT03928093 404 411 O
, NCT03928093 412 413 O
Sweden NCT03928093 414 420 O
) NCT03928093 421 422 O
14 NCT03928093 423 425 O
and NCT03928093 426 429 O
> NCT03928093 430 431 B-Eq_Comparison
4 NCT03928093 432 433 I-Eq_Comparison
/ NCT03928093 434 435 I-Eq_Comparison
10 NCT03928093 436 438 I-Eq_Comparison
score NCT03928093 439 444 O
using NCT03928093 445 450 O
a NCT03928093 451 452 O
screening NCT03928093 453 462 O
tool NCT03928093 463 467 O
for NCT03928093 468 471 O
neuropathic NCT03928093 472 483 B-Observation
pain NCT03928093 484 488 I-Observation
, NCT03928093 489 490 O
the NCT03928093 491 494 O
DN NCT03928093 495 497 O
4 NCT03928093 498 499 O
questionnaire NCT03928093 500 513 O
15 NCT03928093 514 516 O

- NCT03928093 520 521 O
Pain NCT03928093 523 527 B-Observation
intensity NCT03928093 528 537 I-Observation
of NCT03928093 538 540 O
> NCT03928093 541 542 B-Eq_Comparison
4 NCT03928093 543 544 I-Eq_Comparison
/ NCT03928093 545 546 I-Eq_Comparison
10 NCT03928093 547 549 I-Eq_Comparison
on NCT03928093 550 552 O
a NCT03928093 553 554 O
0 NCT03928093 555 556 O
- NCT03928093 557 558 O
10 NCT03928093 559 561 O
VAS NCT03928093 562 565 O
scale NCT03928093 566 571 O
measured NCT03928093 572 580 O
daily NCT03928093 581 586 B-Eq_Comparison
( NCT03928093 587 588 O
reduced NCT03928093 589 596 O
frequency NCT03928093 597 606 O
is NCT03928093 607 609 O
also NCT03928093 610 614 O
acceptable NCT03928093 615 625 O
) NCT03928093 626 627 O
at NCT03928093 628 630 O
night NCT03928093 631 636 O
over NCT03928093 637 641 B-Eq_Comparison
2 NCT03928093 642 643 I-Eq_Comparison
weeks NCT03928093 644 649 I-Eq_Comparison

- NCT03928093 652 653 O
Itch NCT03928093 655 659 B-Observation
intensity NCT03928093 660 669 I-Observation
of NCT03928093 670 672 O
> NCT03928093 673 674 B-Eq_Comparison
4 NCT03928093 675 676 I-Eq_Comparison
/ NCT03928093 677 678 I-Eq_Comparison
10 NCT03928093 679 681 I-Eq_Comparison
on NCT03928093 682 684 O
a NCT03928093 685 686 O
0 NCT03928093 687 688 O
- NCT03928093 689 690 O
10 NCT03928093 691 693 O
VAS NCT03928093 694 697 O
scale NCT03928093 698 703 O
measures NCT03928093 704 712 O
daily NCT03928093 713 718 B-Eq_Comparison
( NCT03928093 719 720 O
reduced NCT03928093 721 728 O
frequency NCT03928093 729 738 O
is NCT03928093 739 741 O
also NCT03928093 742 746 O
acceptable NCT03928093 747 757 O
) NCT03928093 758 759 O
at NCT03928093 760 762 O
night NCT03928093 763 768 O
over NCT03928093 769 773 B-Eq_Comparison
2 NCT03928093 774 775 I-Eq_Comparison
weeks NCT03928093 776 781 I-Eq_Comparison

- NCT03928093 784 785 O
Consent NCT03928093 787 794 O
to NCT03928093 795 797 O
follow NCT03928093 798 804 O
with NCT03928093 805 809 O
study NCT03928093 810 815 O
procedures NCT03928093 816 826 O

Exclusion NCT03928093 827 836 O
Criteria NCT03928093 837 845 O
: NCT03928093 846 847 O

- NCT03928093 851 852 O
Intolerance NCT03928093 854 865 B-Condition
and NCT03928093 866 869 B-Or
/ NCT03928093 870 871 I-Or
or NCT03928093 872 874 I-Or
allergy NCT03928093 875 882 B-Allergy
to NCT03928093 883 885 O
Pregabalin NCT03928093 886 896 B-Drug
or NCT03928093 897 899 B-Or
gabapentin NCT03928093 900 910 B-Drug

- NCT03928093 913 914 O
Lactose NCT03928093 916 923 B-Condition
intolerance NCT03928093 924 935 I-Condition
( NCT03928093 936 937 O
placebo NCT03928093 938 945 O
capsules NCT03928093 946 954 O
contain NCT03928093 955 962 O
lactose NCT03928093 963 970 O
) NCT03928093 971 972 O

- NCT03928093 976 977 O
Pregabalin NCT03928093 979 989 B-Drug
use NCT03928093 990 993 O
within NCT03928093 994 1000 B-Eq_Comparison
2 NCT03928093 1001 1002 I-Eq_Comparison
weeks NCT03928093 1003 1008 I-Eq_Comparison
before NCT03928093 1009 1015 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03928093 1016 1021 B-Study
enrolment NCT03928093 1022 1031 O

- NCT03928093 1034 1035 O
Ongoing NCT03928093 1037 1044 B-Eq_Comparison
treatment NCT03928093 1045 1054 B-Procedure
with NCT03928093 1055 1059 O
gabapentin NCT03928093 1060 1070 B-Drug
, NCT03928093 1071 1072 O
amitriptyline NCT03928093 1073 1086 B-Drug
, NCT03928093 1087 1088 O
duloxetine NCT03928093 1089 1099 B-Drug
, NCT03928093 1100 1101 O
nortriptyline NCT03928093 1102 1115 B-Drug
, NCT03928093 1116 1117 O
other NCT03928093 1118 1123 B-Other
tricyclics NCT03928093 1124 1134 B-Drug
or NCT03928093 1135 1137 B-Or
SNRIs NCT03928093 1138 1143 B-Drug

- NCT03928093 1146 1147 O
Medical NCT03928093 1149 1156 B-Condition
conditions NCT03928093 1157 1167 I-Condition
that NCT03928093 1168 1172 O
would NCT03928093 1173 1178 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03928093 1179 1181 O
considered NCT03928093 1182 1192 O
as NCT03928093 1193 1195 O
contraindications NCT03928093 1196 1213 B-Contraindication
for NCT03928093 1214 1217 O
pregabalin NCT03928093 1218 1228 B-Drug
treatment NCT03928093 1229 1238 O
( NCT03928093 1239 1240 O
ischemic NCT03928093 1241 1249 B-Condition
heart NCT03928093 1250 1255 I-Condition
disease NCT03928093 1256 1263 I-Condition
, NCT03928093 1264 1265 O
cardiac NCT03928093 1266 1273 B-Condition
dysrhythmia NCT03928093 1274 1285 I-Condition
, NCT03928093 1286 1287 O
glaucoma NCT03928093 1288 1296 B-Condition
, NCT03928093 1297 1298 O
history NCT03928093 1299 1306 B-Eq_Comparison
of NCT03928093 1307 1309 O
urinary NCT03928093 1310 1317 B-Condition
retention NCT03928093 1318 1327 I-Condition
) NCT03928093 1328 1329 O

- NCT03928093 1333 1334 O
Pregnancy NCT03928093 1336 1345 B-Condition

- NCT03928093 1348 1349 O
History NCT03928093 1351 1358 B-Eq_Comparison
of NCT03928093 1359 1361 O
use NCT03928093 1362 1365 O
of NCT03928093 1366 1368 O
restrictive NCT03928093 1369 1380 B-Condition
substances NCT03928093 1381 1391 I-Condition
or NCT03928093 1392 1394 B-Or
alcohol NCT03928093 1395 1402 B-Condition
abuse NCT03928093 1403 1408 I-Condition

- NCT03928093 1411 1412 O
Allergy NCT03928093 1414 1421 B-Allergy
to NCT03928093 1422 1424 O
gelatin NCT03928093 1425 1432 O

Inclusion NCT03924999 0 9 O
Criteria NCT03924999 10 18 O
: NCT03924999 19 20 O

- NCT03924999 24 25 O
Subject NCT03924999 27 34 O
diagnosed NCT03924999 35 44 O
with NCT03924999 45 49 O
lipedema NCT03924999 50 58 B-Condition
according NCT03924999 59 68 O
to NCT03924999 69 71 O
the NCT03924999 72 75 O
criteria NCT03924999 76 84 O
of NCT03924999 85 87 O
revised NCT03924999 88 95 O
Wold NCT03924999 96 100 O
. NCT03924999 101 102 O

- NCT03924999 106 107 O
Subject NCT03924999 109 116 O
did NCT03924999 117 120 O
not NCT03924999 121 124 B-Negation
participate NCT03924999 125 136 O
in NCT03924999 137 139 O
any NCT03924999 140 143 O
exercise NCT03924999 144 152 B-Procedure
program NCT03924999 153 160 I-Procedure
within NCT03924999 161 167 B-Eq_Comparison
the NCT03924999 168 171 I-Eq_Comparison
last NCT03924999 172 176 I-Eq_Comparison
three NCT03924999 177 182 I-Eq_Comparison
months NCT03924999 183 189 I-Eq_Comparison
. NCT03924999 190 191 O

- NCT03924999 195 196 O
No NCT03924999 198 200 B-Negation
pregnancy NCT03924999 201 210 B-Condition
/ NCT03924999 211 212 B-Or
breastfeeding NCT03924999 213 226 B-Condition

Exclusion NCT03924999 227 236 O
Criteria NCT03924999 237 245 O
: NCT03924999 246 247 O

- NCT03924999 251 252 O
History NCT03924999 254 261 B-Eq_Comparison
of NCT03924999 262 264 O
acute NCT03924999 265 270 O
infection NCT03924999 271 280 B-Condition
, NCT03924999 281 282 O
cancer NCT03924999 283 289 B-Condition
, NCT03924999 290 291 O
inflammatory NCT03924999 292 304 B-Modifier
rheumatic NCT03924999 305 314 I-Modifier
/ NCT03924999 315 316 B-Or
connective NCT03924999 317 327 B-Modifier
tissue NCT03924999 328 334 I-Modifier
diseases NCT03924999 335 343 B-Condition

- NCT03924999 346 347 O
History NCT03924999 349 356 B-Eq_Comparison
of NCT03924999 357 359 O
cardiovascular NCT03924999 360 374 B-Modifier
or NCT03924999 375 377 B-Or
musculoskeletal NCT03924999 378 393 B-Modifier
problems NCT03924999 394 402 B-Condition
that NCT03924999 403 407 O
may NCT03924999 408 411 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03924999 412 419 B-Negation
them NCT03924999 420 424 O
from NCT03924999 425 429 O
participating NCT03924999 430 443 O
in NCT03924999 444 446 O
the NCT03924999 447 450 O
exercise NCT03924999 451 459 B-Procedure
program NCT03924999 460 467 I-Procedure

Inclusion NCT03921905 0 9 O
Criteria NCT03921905 10 18 O
: NCT03921905 19 20 O

- NCT03921905 24 25 O
Patients NCT03921905 27 35 O
of NCT03921905 36 38 O
both NCT03921905 39 43 O
sexes NCT03921905 44 49 O
with NCT03921905 50 54 O
a NCT03921905 55 56 O
diagnosis NCT03921905 57 66 O
of NCT03921905 67 69 O
stable NCT03921905 70 76 O
CAD NCT03921905 77 80 B-Condition
as NCT03921905 81 83 O
follows NCT03921905 84 91 O
: NCT03921905 92 93 O
acute NCT03921905 94 99 B-Condition
myocardial NCT03921905 100 110 I-Condition
infarction NCT03921905 111 121 I-Condition
or NCT03921905 122 124 B-Or
percutaneous NCT03921905 125 137 B-Procedure
coronary NCT03921905 138 146 I-Procedure
revascularization NCT03921905 147 164 I-Procedure
or NCT03921905 165 167 B-Or
coronary NCT03921905 168 176 B-Procedure
artery NCT03921905 177 183 I-Procedure
bypass NCT03921905 184 190 I-Procedure
graft NCT03921905 191 196 I-Procedure
surgery NCT03921905 197 204 I-Procedure
occured NCT03921905 205 212 O
at NCT03921905 213 215 B-Eq_Comparison
least NCT03921905 216 221 I-Eq_Comparison
12 NCT03921905 222 224 I-Eq_Comparison
months NCT03921905 225 231 I-Eq_Comparison
before NCT03921905 232 238 B-Temporal_Connection___Temporal_Connection_Type_Value:before
entering NCT03921905 239 247 O
the NCT03921905 248 251 O
study NCT03921905 252 257 B-Study
or NCT03921905 258 260 B-Or
chronic NCT03921905 261 268 O
stable NCT03921905 269 275 O
angina NCT03921905 276 282 B-Condition
. NCT03921905 283 284 O

Exclusion NCT03921905 286 295 O
Criteria NCT03921905 296 304 O
: NCT03921905 305 306 O

- NCT03921905 310 311 O
Mental NCT03921905 313 319 B-Condition
illness NCT03921905 320 327 I-Condition
limiting NCT03921905 328 336 O
the NCT03921905 337 340 O
capacity NCT03921905 341 349 O
of NCT03921905 350 352 O
self NCT03921905 353 357 B-Procedure
- NCT03921905 358 359 I-Procedure
care NCT03921905 360 364 I-Procedure
or NCT03921905 365 367 B-Or
any NCT03921905 368 371 O
condition NCT03921905 372 381 B-Condition
limiting NCT03921905 382 390 O
seriously NCT03921905 391 400 O
the NCT03921905 401 404 O
life NCT03921905 405 409 B-Observation
expectancy NCT03921905 410 420 I-Observation
less NCT03921905 421 425 B-Eq_Comparison
than NCT03921905 426 430 I-Eq_Comparison
12 NCT03921905 431 433 I-Eq_Comparison
months NCT03921905 434 440 I-Eq_Comparison
. NCT03921905 441 442 O

Inclusion NCT03929562 0 9 O
Criteria NCT03929562 10 18 O
: NCT03929562 19 20 O

- NCT03929562 24 25 O
Referred NCT03929562 27 35 B-Encounter
for NCT03929562 36 39 O
elective NCT03929562 40 48 O
or NCT03929562 49 51 O
semi NCT03929562 52 56 O
- NCT03929562 57 58 O
elective NCT03929562 59 67 O
surgery NCT03929562 68 75 B-Procedure
or NCT03929562 76 78 B-Or
pre NCT03929562 79 82 B-Observation
- NCT03929562 83 84 I-Observation
operative NCT03929562 85 94 I-Observation
assessment NCT03929562 95 105 I-Observation
in NCT03929562 106 108 O
the NCT03929562 109 112 O
next NCT03929562 113 117 B-Eq_Comparison
120 NCT03929562 118 121 I-Eq_Comparison
days NCT03929562 122 126 I-Eq_Comparison

- NCT03929562 129 130 O
Meet NCT03929562 132 136 O
criteria NCT03929562 137 145 O
for NCT03929562 146 149 O
" NCT03929562 150 151 O
risky NCT03929562 151 156 B-Condition
drinking NCT03929562 157 165 I-Condition
" NCT03929562 165 166 O
as NCT03929562 167 169 O
defined NCT03929562 170 177 O
by NCT03929562 178 180 O
study NCT03929562 181 186 O
staff NCT03929562 187 192 O

Exclusion NCT03929562 193 202 O
Criteria NCT03929562 203 211 O
: NCT03929562 212 213 O

- NCT03929562 217 218 O
Displays NCT03929562 220 228 O
or NCT03929562 229 231 O
shows NCT03929562 232 237 O
evidence NCT03929562 238 246 O
of NCT03929562 247 249 O
psychotic NCT03929562 250 259 B-Condition
symptoms NCT03929562 260 268 B-Assertion___Assertion_Type_Value:possible

- NCT03929562 271 272 O
Undergoing NCT03929562 274 284 B-Eq_Comparison
surgeries NCT03929562 285 294 B-Procedure
that NCT03929562 295 299 O
commonly NCT03929562 300 308 O
require NCT03929562 309 316 O
local NCT03929562 317 322 B-Procedure
anesthesia NCT03929562 323 333 I-Procedure
only NCT03929562 334 338 O


Inclusion NCT03868306 0 9 O
Criteria NCT03868306 10 18 O
: NCT03868306 19 20 O

- NCT03868306 24 25 O
All NCT03868306 27 30 O
patients NCT03868306 31 39 O
with NCT03868306 40 44 O
microcytic NCT03868306 45 55 B-Condition
hypochromic NCT03868306 56 67 I-Condition
anemia NCT03868306 68 74 I-Condition
( NCT03868306 75 76 O
according NCT03868306 77 86 O
to NCT03868306 87 89 O
WHO NCT03868306 90 93 O
, NCT03868306 94 95 O
MCV NCT03868306 96 99 B-Observation
less NCT03868306 100 104 B-Eq_Comparison
than NCT03868306 105 109 I-Eq_Comparison
80 NCT03868306 110 112 I-Eq_Comparison
fl NCT03868306 113 115 I-Eq_Comparison
and NCT03868306 116 119 B-And
HB NCT03868306 120 122 B-Observation
level NCT03868306 123 128 O
below NCT03868306 129 134 B-Eq_Comparison
the NCT03868306 135 138 I-Eq_Comparison
lower NCT03868306 139 144 I-Eq_Comparison
limit NCT03868306 145 150 I-Eq_Comparison
of NCT03868306 151 153 I-Eq_Comparison
normal NCT03868306 154 160 I-Eq_Comparison
value NCT03868306 161 166 I-Eq_Comparison
specified NCT03868306 167 176 O
by NCT03868306 177 179 O
age NCT03868306 180 183 O
and NCT03868306 184 187 O
gender NCT03868306 188 194 O
. NCT03868306 195 196 O

Exclusion NCT03868306 198 207 O
Criteria NCT03868306 208 216 O
: NCT03868306 217 218 O

- NCT03868306 222 223 O
Beta NCT03868306 225 229 B-Condition
thalassemia NCT03868306 230 241 I-Condition
major NCT03868306 242 247 I-Condition
patients NCT03868306 248 256 O
. NCT03868306 257 258 O

- NCT03868306 262 263 O
Chronic NCT03868306 265 272 O
diseases NCT03868306 273 281 B-Condition
or NCT03868306 282 284 B-Or
infections NCT03868306 285 295 B-Condition
. NCT03868306 296 297 O

- NCT03868306 301 302 O
Lead NCT03868306 304 308 B-Condition
poisoning NCT03868306 309 318 I-Condition
. NCT03868306 319 320 O

- NCT03868306 324 325 O
Sideroblastic NCT03868306 327 340 B-Condition
anaemia NCT03868306 341 348 I-Condition
. NCT03868306 349 350 O

Inclusion NCT03869970 0 9 O
Criteria NCT03869970 10 18 O
: NCT03869970 19 20 O

- NCT03869970 24 25 O
Diagnosis NCT03869970 27 36 O
of NCT03869970 37 39 O
mTBI NCT03869970 40 44 B-Condition
in NCT03869970 45 47 O
the NCT03869970 48 51 O
past NCT03869970 52 56 B-Eq_Comparison
48 NCT03869970 57 59 I-Eq_Comparison
hours NCT03869970 60 65 I-Eq_Comparison

Exclusion NCT03869970 66 75 O
Criteria NCT03869970 76 84 O
: NCT03869970 85 86 O

- NCT03869970 90 91 O
Patients NCT03869970 93 101 O
having NCT03869970 102 108 O
conditions NCT03869970 109 119 B-Condition
otherwise NCT03869970 120 129 O
which NCT03869970 130 135 O
limit NCT03869970 136 141 O
physical NCT03869970 142 150 B-Observation
activity NCT03869970 151 159 I-Observation
or NCT03869970 160 162 B-Or
neurocognitive NCT03869970 163 177 B-Modifier
assessment NCT03869970 178 188 B-Procedure

- NCT03869970 191 192 O
Do NCT03869970 194 196 O
not NCT03869970 197 200 O
have NCT03869970 201 205 O
a NCT03869970 206 207 O
smart NCT03869970 208 213 O
phone NCT03869970 214 219 O

- NCT03869970 222 223 O
History NCT03869970 225 232 B-Eq_Comparison
of NCT03869970 233 235 I-Eq_Comparison
past NCT03869970 236 240 I-Eq_Comparison
moderate NCT03869970 241 249 O
/ NCT03869970 250 251 B-Or
severe NCT03869970 252 258 O
TBI NCT03869970 259 262 B-Condition
, NCT03869970 263 264 O

- NCT03869970 268 269 O
Substance NCT03869970 271 280 B-Condition
abuse NCT03869970 281 286 I-Condition
, NCT03869970 287 288 O

- NCT03869970 292 293 O
Major NCT03869970 295 300 O
psychiatric NCT03869970 301 312 B-Condition
condition NCT03869970 313 322 I-Condition
, NCT03869970 323 324 O

- NCT03869970 328 329 O
Vestibular NCT03869970 331 341 B-Condition
disorder NCT03869970 342 350 I-Condition
, NCT03869970 351 352 O

- NCT03869970 356 357 O
Cardiac NCT03869970 359 366 B-Condition
condition NCT03869970 367 376 I-Condition
, NCT03869970 377 378 O

- NCT03869970 382 383 O
Unable NCT03869970 385 391 O
to NCT03869970 392 394 O
provide NCT03869970 395 402 O
consent NCT03869970 403 410 O
/ NCT03869970 411 412 O
assent NCT03869970 413 419 O

Inclusion NCT03862820 0 9 O
Criteria NCT03862820 10 18 O
: NCT03862820 19 20 O

Pregnant NCT03862820 22 30 B-Condition
women NCT03862820 31 36 O
in NCT03862820 37 39 O
third NCT03862820 40 45 B-Condition
trimester NCT03862820 46 55 I-Condition
planned NCT03862820 56 63 B-Eq_Comparison
to NCT03862820 64 66 O
undergo NCT03862820 67 74 O
elective NCT03862820 75 83 B-Modifier
cesarean NCT03862820 84 92 B-Procedure
section NCT03862820 93 100 I-Procedure

Exclusion NCT03862820 101 110 O
Criteria NCT03862820 111 119 O
: NCT03862820 120 121 O

Primary NCT03862820 123 130 B-Modifier
elective NCT03862820 131 139 I-Modifier
cesarean NCT03862820 140 148 B-Procedure
section NCT03862820 149 156 I-Procedure
. NCT03862820 157 158 O

Inclusion NCT03924583 0 9 O
Criteria NCT03924583 10 18 O
: NCT03924583 19 20 O

- NCT03924583 24 25 O
central NCT03924583 27 34 B-Procedure
venous NCT03924583 35 41 I-Procedure
catheter NCT03924583 42 50 I-Procedure
more NCT03924583 51 55 B-Eq_Comparison
than NCT03924583 56 60 I-Eq_Comparison
48 NCT03924583 61 63 I-Eq_Comparison
hours NCT03924583 64 69 I-Eq_Comparison
in NCT03924583 70 72 B-Modifier
situ NCT03924583 73 77 I-Modifier

- NCT03924583 80 81 O
consent NCT03924583 83 90 O
of NCT03924583 91 93 O
a NCT03924583 94 95 O
patient NCT03924583 96 103 O

Exclusion NCT03924583 104 113 O
Criteria NCT03924583 114 122 O
: NCT03924583 123 124 O

- NCT03924583 128 129 O
technical NCT03924583 131 140 B-Assertion___Assertion_Type_Value:hypothetical
difficulties NCT03924583 141 153 I-Assertion___Assertion_Type_Value:hypothetical
of NCT03924583 154 156 O
ultrasound NCT03924583 157 167 B-Procedure
machine NCT03924583 168 175 I-Procedure

- NCT03924583 178 179 O
unfavorable NCT03924583 181 192 O
local NCT03924583 193 198 O
findings NCT03924583 199 207 B-Condition
- NCT03924583 208 209 O
inflammation NCT03924583 210 222 B-Condition
of NCT03924583 223 225 I-Condition
skin NCT03924583 226 230 I-Condition
, NCT03924583 231 232 O
excoriation NCT03924583 233 244 B-Condition
etc NCT03924583 245 248 O
. NCT03924583 249 250 O

Inclusion NCT03861533 0 9 O
Criteria NCT03861533 10 18 O
: NCT03861533 19 20 O

1 NCT03861533 24 25 O
. NCT03861533 25 26 O
Adults NCT03861533 28 34 O
â¥ NCT03861533 35 36 B-Eq_Comparison
18 NCT03861533 37 39 I-Eq_Comparison
years NCT03861533 40 45 I-Eq_Comparison
old NCT03861533 46 49 B-Age

2 NCT03861533 52 53 O
. NCT03861533 53 54 O
High NCT03861533 56 60 O
risk NCT03861533 61 65 B-Risk
for NCT03861533 66 69 O
cardiovascular NCT03861533 70 84 B-Condition
morbidity NCT03861533 85 94 I-Condition
and NCT03861533 95 98 B-Or
mortality NCT03861533 99 108 B-Death
such NCT03861533 109 113 O
as NCT03861533 114 116 O
prior NCT03861533 117 122 B-Eq_Comparison
history NCT03861533 123 130 I-Eq_Comparison
of NCT03861533 131 133 O
clinical NCT03861533 134 142 B-Modifier
cardiovascular NCT03861533 143 157 B-Condition
disease NCT03861533 158 165 I-Condition
and NCT03861533 166 169 B-Or
/ NCT03861533 170 171 I-Or
or NCT03861533 172 174 I-Or
history NCT03861533 175 182 B-Eq_Comparison
of NCT03861533 183 185 O
familial NCT03861533 186 194 B-Modifier
hypercholesterolemia NCT03861533 195 215 B-Condition

3 NCT03861533 218 219 O
. NCT03861533 219 220 O
LDL NCT03861533 222 225 B-Observation
- NCT03861533 226 227 I-Observation
C NCT03861533 228 229 I-Observation
within NCT03861533 230 236 B-Eq_Comparison
the NCT03861533 237 240 I-Eq_Comparison
past NCT03861533 241 245 I-Eq_Comparison
6 NCT03861533 246 247 I-Eq_Comparison
months NCT03861533 248 254 I-Eq_Comparison
above NCT03861533 255 260 B-Eq_Comparison
recommended NCT03861533 261 272 I-Eq_Comparison
level NCT03861533 273 278 I-Eq_Comparison
despite NCT03861533 279 286 B-And
maximal NCT03861533 287 294 B-Modifier
tolerated NCT03861533 295 304 I-Modifier
statin NCT03861533 305 311 B-Procedure
therapy NCT03861533 312 319 I-Procedure
Â± NCT03861533 320 321 O
ezetimibe NCT03861533 322 331 B-Drug
for NCT03861533 332 335 O
the NCT03861533 336 339 B-Eq_Comparison
past NCT03861533 340 344 I-Eq_Comparison
3 NCT03861533 345 346 I-Eq_Comparison
months NCT03861533 347 353 I-Eq_Comparison
. NCT03861533 354 355 O

Exclusion NCT03861533 357 366 O
Criteria NCT03861533 367 375 O
: NCT03861533 376 377 O

1 NCT03861533 381 382 O
. NCT03861533 382 383 O
Current NCT03861533 385 392 B-Eq_Comparison
treatment NCT03861533 393 402 B-Procedure
with NCT03861533 403 407 O
PCSK NCT03861533 408 412 B-Drug
9 NCT03861533 413 414 I-Drug
inhibitor NCT03861533 415 424 I-Drug

2 NCT03861533 427 428 O
. NCT03861533 428 429 O
Current NCT03861533 431 438 B-Eq_Comparison
participation NCT03861533 439 452 O
in NCT03861533 453 455 O
investigational NCT03861533 456 471 O
study NCT03861533 472 477 B-Study

3 NCT03861533 480 481 O
. NCT03861533 481 482 O
Prior NCT03861533 484 489 O
participation NCT03861533 490 503 O
in NCT03861533 504 506 O
the NCT03861533 507 510 O
GOAL NCT03861533 511 515 O
program NCT03861533 516 523 O

Inclusion NCT03866733 0 9 O
Criteria NCT03866733 10 18 O
: NCT03866733 19 20 O

- NCT03866733 24 25 O
elective NCT03866733 27 35 B-Modifier
cardiac NCT03866733 36 43 B-Procedure
surgery NCT03866733 44 51 I-Procedure
. NCT03866733 52 53 O

- NCT03866733 57 58 O
age NCT03866733 60 63 B-Age
18 NCT03866733 64 66 B-Eq_Comparison
- NCT03866733 67 68 I-Eq_Comparison
65 NCT03866733 69 71 I-Eq_Comparison
years NCT03866733 72 77 I-Eq_Comparison
. NCT03866733 78 79 O

- NCT03866733 83 84 O
patients NCT03866733 86 94 O
with NCT03866733 95 99 O
median NCT03866733 100 106 B-Procedure
sternotomy NCT03866733 107 117 I-Procedure
. NCT03866733 118 119 O

- NCT03866733 123 124 O
body NCT03866733 126 130 B-Observation
mass NCT03866733 131 135 I-Observation
index NCT03866733 136 141 I-Observation
< NCT03866733 142 143 B-Eq_Comparison
30 NCT03866733 144 146 I-Eq_Comparison
kg NCT03866733 147 149 I-Eq_Comparison
. NCT03866733 150 151 I-Eq_Comparison
m NCT03866733 152 153 I-Eq_Comparison
2 NCT03866733 154 155 I-Eq_Comparison
. NCT03866733 155 156 O

- NCT03866733 160 161 O
left NCT03866733 163 167 B-Observation
ventricular NCT03866733 168 179 I-Observation
ejection NCT03866733 180 188 I-Observation
fraction NCT03866733 189 197 I-Observation
> NCT03866733 198 199 B-Eq_Comparison
50 NCT03866733 200 202 I-Eq_Comparison
% NCT03866733 203 204 I-Eq_Comparison
. NCT03866733 205 206 O

Exclusion NCT03866733 208 217 O
Criteria NCT03866733 218 226 O
: NCT03866733 227 228 O

- NCT03866733 232 233 O
signiï¬cant NCT03866733 235 245 O
aortic NCT03866733 246 252 B-Condition
stenosis NCT03866733 253 261 I-Condition
. NCT03866733 262 263 O

- NCT03866733 267 268 O
left NCT03866733 270 274 B-Modifier
main NCT03866733 275 279 I-Modifier
coronary NCT03866733 280 288 B-Condition
artery NCT03866733 289 295 I-Condition
disease NCT03866733 296 303 I-Condition
. NCT03866733 304 305 O

- NCT03866733 309 310 O
patient NCT03866733 312 319 O
on NCT03866733 320 322 B-Eq_Comparison
anti NCT03866733 323 327 B-Drug
- NCT03866733 328 329 I-Drug
coagulants NCT03866733 330 340 I-Drug
0 NCT03866733 341 342 I-Drug

- NCT03866733 345 346 O
pre NCT03866733 348 351 B-Eq_Comparison
- NCT03866733 352 353 I-Eq_Comparison
existing NCT03866733 354 362 I-Eq_Comparison
respiratory NCT03866733 363 374 B-Modifier
, NCT03866733 375 376 O
neurological NCT03866733 377 389 B-Modifier
, NCT03866733 390 391 O
or NCT03866733 392 394 B-Or
renal NCT03866733 395 400 B-Modifier
disease NCT03866733 401 408 B-Condition
. NCT03866733 409 410 O

- NCT03866733 414 415 O
CSF NCT03866733 417 420 B-Procedure
or NCT03866733 421 423 B-Or
blood NCT03866733 424 429 B-Procedure
tap NCT03866733 430 433 I-Procedure
during NCT03866733 434 440 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866733 441 444 O
procedure NCT03866733 445 454 O
. NCT03866733 455 456 O

- NCT03866733 460 461 O
failure NCT03866733 463 470 B-Modifier
to NCT03866733 471 473 I-Modifier
thread NCT03866733 474 480 I-Modifier
the NCT03866733 481 484 O
catheter NCT03866733 485 493 B-Procedure
. NCT03866733 494 495 O

- NCT03866733 499 500 O
anomalies NCT03866733 502 511 B-Condition
of NCT03866733 512 514 O
vertebral NCT03866733 515 524 B-Modifier
column NCT03866733 525 531 I-Modifier
. NCT03866733 532 533 O

Inclusion NCT03921892 0 9 O
Criteria NCT03921892 10 18 O
: NCT03921892 19 20 O

- NCT03921892 24 25 O
age NCT03921892 27 30 B-Age
15 NCT03921892 31 33 B-Eq_Comparison
to NCT03921892 34 36 I-Eq_Comparison
21 NCT03921892 37 39 I-Eq_Comparison
, NCT03921892 40 41 O

- NCT03921892 45 46 O
be NCT03921892 48 50 O
able NCT03921892 51 55 O
to NCT03921892 56 58 O
read NCT03921892 59 63 O
and NCT03921892 64 67 O
understand NCT03921892 68 78 O
English NCT03921892 79 86 O
( NCT03921892 87 88 O
as NCT03921892 89 91 O
determined NCT03921892 92 102 O
by NCT03921892 103 105 O
having NCT03921892 106 112 O
the NCT03921892 113 116 O
individual NCT03921892 117 127 O
read NCT03921892 128 132 O
a NCT03921892 133 134 O
brief NCT03921892 135 140 O
, NCT03921892 141 142 O
eighth NCT03921892 143 149 O
grade NCT03921892 150 155 O
reading NCT03921892 156 163 O
level NCT03921892 164 169 O
paragraph NCT03921892 170 179 O
) NCT03921892 180 181 O
, NCT03921892 182 183 O

- NCT03921892 187 188 O
able NCT03921892 190 194 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921892 195 197 I-Assertion___Assertion_Type_Value:hypothetical
begin NCT03921892 198 203 O
the NCT03921892 204 207 O
intervention NCT03921892 208 220 B-Study
within NCT03921892 221 227 B-Eq_Comparison
six NCT03921892 228 231 I-Eq_Comparison
weeks NCT03921892 232 237 I-Eq_Comparison
of NCT03921892 238 240 B-Temporal_Connection___Temporal_Connection_Type_Value:after
their NCT03921892 241 246 O
infant NCT03921892 247 253 B-Family_Member___Family_Member_Type:child
's NCT03921892 253 255 I-Family_Member___Family_Member_Type:child
birth NCT03921892 256 261 B-Birth
, NCT03921892 262 263 O

- NCT03921892 267 268 O
be NCT03921892 270 272 O
able NCT03921892 273 277 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921892 278 280 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03921892 281 292 O
in NCT03921892 293 295 O
an NCT03921892 296 298 O
intervention NCT03921892 299 311 B-Study
over NCT03921892 312 316 B-Eq_Comparison
two NCT03921892 317 320 I-Eq_Comparison
weeks NCT03921892 321 326 I-Eq_Comparison
, NCT03921892 327 328 O
requiring NCT03921892 329 338 O
approximately NCT03921892 339 352 O
a NCT03921892 353 354 O
12 NCT03921892 355 357 O
- NCT03921892 358 359 O
hour NCT03921892 360 364 O
time NCT03921892 365 369 O
commitment NCT03921892 370 380 O
: NCT03921892 381 382 O
either NCT03921892 383 389 O
in NCT03921892 390 392 O
- NCT03921892 393 394 O
person NCT03921892 395 401 O
on NCT03921892 402 404 O
two NCT03921892 405 408 O
Saturdays NCT03921892 409 418 O
for NCT03921892 419 422 O
six NCT03921892 423 426 O
hours NCT03921892 427 432 O
each NCT03921892 433 437 O
, NCT03921892 438 439 O
or NCT03921892 440 442 O
a NCT03921892 443 444 O
self NCT03921892 445 449 O
- NCT03921892 450 451 O
paced NCT03921892 452 457 O
content NCT03921892 458 465 O
of NCT03921892 466 468 O
videos NCT03921892 469 475 O
and NCT03921892 476 479 O
resource NCT03921892 480 488 O
materials NCT03921892 489 498 O
over NCT03921892 499 503 O
two NCT03921892 504 507 O
weeks NCT03921892 508 513 O
, NCT03921892 514 515 O

- NCT03921892 519 520 O
own NCT03921892 522 525 O
or NCT03921892 526 528 O
have NCT03921892 529 533 O
access NCT03921892 534 540 O
to NCT03921892 541 543 O
a NCT03921892 544 545 O
device NCT03921892 546 552 O
with NCT03921892 553 557 O
internet NCT03921892 558 566 O
access NCT03921892 567 573 O
and NCT03921892 574 577 O

- NCT03921892 580 581 O
have NCT03921892 583 587 O
a NCT03921892 588 589 O
working NCT03921892 590 597 O
e NCT03921892 598 599 O
- NCT03921892 600 601 O
mail NCT03921892 602 606 O
address NCT03921892 607 614 O
. NCT03921892 615 616 O

Exclusion NCT03921892 618 627 O
Criteria NCT03921892 628 636 O
: NCT03921892 637 638 O

- NCT03921892 642 643 O
Any NCT03921892 645 648 O
condition NCT03921892 649 658 B-Condition
that NCT03921892 659 663 O
might NCT03921892 664 669 B-Assertion___Assertion_Type_Value:possible
prevent NCT03921892 670 677 B-Negation
the NCT03921892 678 681 O
father NCT03921892 682 688 B-Family_Member___Family_Member_Type:father
's NCT03921892 688 690 I-Family_Member___Family_Member_Type:father
infant NCT03921892 691 697 B-Family_Member___Family_Member_Type:child
from NCT03921892 698 702 O
reaching NCT03921892 703 711 O
normal NCT03921892 712 718 O
developmental NCT03921892 719 732 B-Observation
milestones NCT03921892 733 743 I-Observation
will NCT03921892 744 748 O
participation NCT03921892 749 762 O
, NCT03921892 763 764 O
including NCT03921892 765 774 O
congenital NCT03921892 775 785 B-Condition
malformations NCT03921892 786 799 I-Condition
or NCT03921892 800 802 B-Or
prematurity NCT03921892 803 814 B-Condition
requiring NCT03921892 815 824 B-Assertion___Assertion_Type_Value:hypothetical
prolonged NCT03921892 825 834 O
/ NCT03921892 835 836 O
ongoing NCT03921892 837 844 B-Eq_Comparison
infant NCT03921892 845 851 B-Family_Member___Family_Member_Type:child
hospitalization NCT03921892 852 867 B-Encounter
. NCT03921892 868 869 O


Inclusion NCT03867734 0 9 O
Criteria NCT03867734 10 18 O
: NCT03867734 19 20 O

- NCT03867734 24 25 O
Persons NCT03867734 27 34 O
diagnosed NCT03867734 35 44 O
with NCT03867734 45 49 O
pharyngeal NCT03867734 50 60 B-Modifier
gonorrhea NCT03867734 61 70 B-Condition
or NCT03867734 71 73 B-Or
gonococcal NCT03867734 74 84 B-Modifier
urethritis NCT03867734 85 95 B-Condition
who NCT03867734 96 99 B-And
are NCT03867734 100 103 O
undergoing NCT03867734 104 114 B-Eq_Comparison
pharyngeal NCT03867734 115 125 B-Procedure
gonorrhea NCT03867734 126 135 I-Procedure
testing NCT03867734 136 143 I-Procedure
, NCT03867734 144 145 O
who NCT03867734 146 149 B-And
are NCT03867734 150 153 O
not NCT03867734 154 157 B-Negation
yet NCT03867734 158 161 O
treated NCT03867734 162 169 B-Procedure
. NCT03867734 170 171 O

Exclusion NCT03867734 173 182 O
Criteria NCT03867734 183 191 O
: NCT03867734 192 193 O

- NCT03867734 197 198 O
Age NCT03867734 200 203 B-Age
less NCT03867734 204 208 B-Eq_Comparison
than NCT03867734 209 213 I-Eq_Comparison
16 NCT03867734 214 216 I-Eq_Comparison
years NCT03867734 217 222 I-Eq_Comparison

- NCT03867734 225 226 O
Receipt NCT03867734 228 235 O
of NCT03867734 236 238 O
antibiotics NCT03867734 239 250 B-Drug
in NCT03867734 251 253 O
â¤ NCT03867734 254 255 B-Eq_Comparison
30 NCT03867734 256 258 I-Eq_Comparison
days NCT03867734 259 263 I-Eq_Comparison

- NCT03867734 266 267 O
Known NCT03867734 269 274 O
allergy NCT03867734 275 282 B-Allergy
to NCT03867734 283 285 O
aztreonam NCT03867734 286 295 B-Drug

- NCT03867734 298 299 O
History NCT03867734 301 308 B-Eq_Comparison
of NCT03867734 309 311 O
renal NCT03867734 312 317 B-Condition
disease NCT03867734 318 325 I-Condition
( NCT03867734 326 327 O
including NCT03867734 328 337 O
diagnosis NCT03867734 338 347 O
of NCT03867734 348 350 O
solitary NCT03867734 351 359 B-Condition
kidney NCT03867734 360 366 I-Condition
, NCT03867734 367 368 O
chronic NCT03867734 369 376 O
renal NCT03867734 377 382 B-Condition
insufficiency NCT03867734 383 396 I-Condition
, NCT03867734 397 398 O
renal NCT03867734 399 404 B-Condition
cell NCT03867734 405 409 I-Condition
carcinoma NCT03867734 410 419 I-Condition
etc NCT03867734 420 423 O
. NCT03867734 424 425 O
) NCT03867734 426 427 O

- NCT03867734 431 432 O
Concurrent NCT03867734 434 444 B-Modifier
infection NCT03867734 445 454 B-Condition
with NCT03867734 455 459 O
syphilis NCT03867734 460 468 B-Condition
or NCT03867734 469 471 B-Or
chlamydia NCT03867734 472 481 B-Condition

- NCT03867734 484 485 O
Pregnancy NCT03867734 487 496 B-Condition
and NCT03867734 497 500 B-Or
/ NCT03867734 501 502 I-Or
or NCT03867734 503 505 I-Or
nursing NCT03867734 506 513 B-Condition

- NCT03867734 516 517 O
Unable NCT03867734 519 525 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03867734 526 528 O
return NCT03867734 529 535 O
for NCT03867734 536 539 O
a NCT03867734 540 541 O
follow NCT03867734 542 548 B-Encounter
- NCT03867734 549 550 I-Encounter
up NCT03867734 551 553 I-Encounter
visit NCT03867734 554 559 I-Encounter
4 NCT03867734 560 561 B-Eq_Comparison
- NCT03867734 562 563 I-Eq_Comparison
7 NCT03867734 564 565 I-Eq_Comparison
days NCT03867734 566 570 I-Eq_Comparison
( NCT03867734 571 572 O
+ NCT03867734 573 574 B-Eq_Comparison
/ NCT03867734 575 576 I-Eq_Comparison
- NCT03867734 577 578 I-Eq_Comparison
1 NCT03867734 579 580 I-Eq_Comparison
day NCT03867734 581 584 I-Eq_Comparison
) NCT03867734 585 586 O
. NCT03867734 587 588 O

- NCT03867734 592 593 O
Study NCT03867734 595 600 O
team NCT03867734 601 605 O
's NCT03867734 605 607 O
discretion NCT03867734 608 618 O

Inclusion NCT03928561 0 9 O
Criteria NCT03928561 10 18 O
: NCT03928561 19 20 O

- NCT03928561 24 25 O
Controlled NCT03928561 27 37 B-Modifier
intermittent NCT03928561 38 50 I-Modifier
asthma NCT03928561 51 57 B-Condition
( NCT03928561 58 59 O
step NCT03928561 60 64 O
1 NCT03928561 65 66 O
treatment NCT03928561 67 76 O
, NCT03928561 77 78 O
according NCT03928561 79 88 O
to NCT03928561 89 91 O
GINA NCT03928561 92 96 O
Guideline NCT03928561 97 106 O
2016 NCT03928561 107 111 O
) NCT03928561 112 113 O
with NCT03928561 114 118 B-And
or NCT03928561 119 121 O
without NCT03928561 122 129 O
association NCT03928561 130 141 O
with NCT03928561 142 146 O
cat NCT03928561 147 150 O
allergy NCT03928561 151 158 B-Allergy
related NCT03928561 159 166 O
rhino NCT03928561 167 172 B-Modifier
- NCT03928561 173 174 O
conjunctivitis NCT03928561 175 189 B-Condition
; NCT03928561 189 190 O

- NCT03928561 193 194 O
Sensitization NCT03928561 196 209 B-Allergy
to NCT03928561 210 212 O
cat NCT03928561 213 216 O
allergen NCT03928561 217 225 O
extract NCT03928561 226 233 O
as NCT03928561 234 236 O
defined NCT03928561 237 244 O
by NCT03928561 245 247 O
skin NCT03928561 248 252 B-Observation
prick NCT03928561 253 258 I-Observation
test NCT03928561 259 263 I-Observation
for NCT03928561 264 267 O
cat NCT03928561 268 271 B-Modifier
extract NCT03928561 272 279 I-Modifier
with NCT03928561 280 284 O
a NCT03928561 285 286 O
wheal NCT03928561 287 292 O
diameter NCT03928561 293 301 O
of NCT03928561 302 304 O
â¥ NCT03928561 305 306 B-Eq_Comparison
3 NCT03928561 307 308 I-Eq_Comparison
mm NCT03928561 309 311 I-Eq_Comparison
greater NCT03928561 312 319 I-Eq_Comparison
than NCT03928561 320 324 I-Eq_Comparison
negative NCT03928561 325 333 I-Eq_Comparison
control NCT03928561 334 341 I-Eq_Comparison
( NCT03928561 342 343 O
ALK NCT03928561 344 347 O
, NCT03928561 348 349 O
HÃrsholm NCT03928561 350 358 O
, NCT03928561 359 360 O
Denmark NCT03928561 361 368 O
) NCT03928561 369 370 O
and NCT03928561 371 374 O
specific NCT03928561 375 383 O
IgE NCT03928561 384 387 B-Observation
anti NCT03928561 388 392 I-Observation
Fel NCT03928561 393 396 I-Observation
d NCT03928561 397 398 I-Observation
1 NCT03928561 399 400 B-Eq_Comparison
â¥ NCT03928561 401 402 I-Eq_Comparison
0.7 NCT03928561 403 406 I-Eq_Comparison
kU NCT03928561 407 409 I-Eq_Comparison
/ NCT03928561 410 411 I-Eq_Comparison
L NCT03928561 412 413 I-Eq_Comparison
( NCT03928561 414 415 O
ImmunoCAP NCT03928561 416 425 O
, NCT03928561 426 427 O
Thermofisher NCT03928561 428 440 O
, NCT03928561 441 442 O
Uppsala NCT03928561 443 450 O
, NCT03928561 451 452 O
Sweden NCT03928561 453 459 O
) NCT03928561 460 461 O
; NCT03928561 462 463 O

- NCT03928561 466 467 O
FEV NCT03928561 469 472 B-Observation
1 NCT03928561 473 474 I-Observation
â¥ NCT03928561 475 476 B-Eq_Comparison
70 NCT03928561 477 479 I-Eq_Comparison
% NCT03928561 480 481 I-Eq_Comparison
of NCT03928561 482 484 O
the NCT03928561 485 488 O
predicted NCT03928561 489 498 O
value NCT03928561 499 504 O
; NCT03928561 504 505 O

- NCT03928561 508 509 O
No NCT03928561 511 513 B-Negation
cat NCT03928561 514 517 B-Condition
exposure NCT03928561 518 526 I-Condition
at NCT03928561 527 529 O
home NCT03928561 530 534 O
or NCT03928561 535 537 B-Or
outside NCT03928561 538 545 B-Negation
of NCT03928561 546 548 O
the NCT03928561 549 552 O
home NCT03928561 553 557 O
during NCT03928561 558 564 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928561 565 568 O
study NCT03928561 569 574 B-Study
; NCT03928561 574 575 O

- NCT03928561 578 579 O
Positive NCT03928561 581 589 O
methacholine NCT03928561 590 602 B-Observation
challenge NCT03928561 603 612 I-Observation
test NCT03928561 613 617 I-Observation
performed NCT03928561 618 627 B-Eq_Comparison
using NCT03928561 628 633 O
an NCT03928561 634 636 O
AeroDoseur NCT03928561 637 647 B-Modifier
DTF NCT03928561 648 651 I-Modifier
- NCT03928561 652 653 I-Modifier
Atomisor NCT03928561 654 662 I-Modifier
ATO NCT03928561 663 666 I-Modifier
- NCT03928561 667 668 I-Modifier
AD NCT03928561 669 671 I-Modifier
12 NCT03928561 672 674 O
( NCT03928561 675 676 O
Saint NCT03928561 677 682 O
- NCT03928561 683 684 O
Etienne NCT03928561 685 692 O
, NCT03928561 693 694 O
France NCT03928561 695 701 O
) NCT03928561 702 703 O
; NCT03928561 704 705 O

- NCT03928561 713 714 O
Early NCT03928561 716 721 B-Modifier
asthmatic NCT03928561 722 731 B-Condition
response NCT03928561 732 740 O
during NCT03928561 741 747 O
baseline NCT03928561 748 756 O
cat NCT03928561 757 760 B-Condition
allergen NCT03928561 761 769 I-Condition
exposure NCT03928561 770 778 I-Condition
. NCT03928561 779 780 O

Exclusion NCT03928561 782 791 O
Criteria NCT03928561 792 800 O
: NCT03928561 801 802 O

- NCT03928561 806 807 O
Uncontrolled NCT03928561 809 821 B-Modifier
asthma NCT03928561 822 828 B-Condition
, NCT03928561 829 830 O
asthma NCT03928561 831 837 B-Observation
control NCT03928561 838 845 I-Observation
test NCT03928561 846 850 I-Observation
inferior NCT03928561 851 859 B-Eq_Comparison
to NCT03928561 860 862 I-Eq_Comparison
20 NCT03928561 863 865 I-Eq_Comparison
within NCT03928561 866 872 B-Eq_Comparison
the NCT03928561 873 876 I-Eq_Comparison
4 NCT03928561 877 878 I-Eq_Comparison
weeks NCT03928561 879 884 I-Eq_Comparison
preceding NCT03928561 885 894 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03928561 895 898 O
study NCT03928561 899 904 B-Study
. NCT03928561 905 906 O

- NCT03928561 910 911 O
Uncontrolled NCT03928561 913 925 B-Modifier
asthma NCT03928561 926 932 B-Condition
2 NCT03928561 933 934 B-Eq_Comparison
weeks NCT03928561 935 940 I-Eq_Comparison
after NCT03928561 941 946 B-Temporal_Connection___Temporal_Connection_Type_Value:after
stopping NCT03928561 947 955 O
LABA NCT03928561 956 960 B-Drug
treatment NCT03928561 961 970 B-Procedure
. NCT03928561 971 972 O

- NCT03928561 976 977 O
LABA NCT03928561 979 983 B-Drug
treatment NCT03928561 984 993 B-Procedure
within NCT03928561 994 1000 B-Eq_Comparison
the NCT03928561 1001 1004 I-Eq_Comparison
2 NCT03928561 1005 1006 I-Eq_Comparison
weeks NCT03928561 1007 1012 I-Eq_Comparison
preceding NCT03928561 1013 1022 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03928561 1023 1026 O
study NCT03928561 1027 1032 B-Study
. NCT03928561 1033 1034 O

- NCT03928561 1038 1039 O
Severe NCT03928561 1041 1047 O
asthma NCT03928561 1048 1054 B-Condition
( NCT03928561 1055 1056 O
> NCT03928561 1057 1058 B-Eq_Comparison
GINA NCT03928561 1059 1063 B-Observation
2 NCT03928561 1064 1065 O
) NCT03928561 1066 1067 O

- NCT03928561 1071 1072 O
Subject NCT03928561 1074 1081 O
lives NCT03928561 1082 1087 O
with NCT03928561 1088 1092 O
a NCT03928561 1093 1094 O
cat NCT03928561 1095 1098 O

- NCT03928561 1101 1102 O
Cat NCT03928561 1104 1107 B-Condition
desensibilisation NCT03928561 1108 1125 I-Condition
within NCT03928561 1126 1132 B-Eq_Comparison
the NCT03928561 1133 1136 I-Eq_Comparison
6 NCT03928561 1137 1138 I-Eq_Comparison
previous NCT03928561 1139 1147 I-Eq_Comparison
months NCT03928561 1148 1154 I-Eq_Comparison
. NCT03928561 1155 1156 O

- NCT03928561 1160 1161 O
Active NCT03928561 1163 1169 B-Eq_Comparison
smoker NCT03928561 1170 1176 B-Condition


Inclusion NCT03926767 0 9 O
Criteria NCT03926767 10 18 O
: NCT03926767 19 20 O

- NCT03926767 24 25 O
A NCT03926767 27 28 O
diagnosis NCT03926767 29 38 O
of NCT03926767 39 41 O
painful NCT03926767 42 49 B-Modifier
TMD NCT03926767 50 53 B-Condition
Research NCT03926767 54 62 O
Diagnostic NCT03926767 63 73 O
Criteria NCT03926767 74 82 O
for NCT03926767 83 86 O
TMD NCT03926767 87 90 O
( NCT03926767 91 92 O
RDC NCT03926767 93 96 O
/ NCT03926767 97 98 O
TMD NCT03926767 99 102 O
) NCT03926767 103 104 O

- NCT03926767 108 109 O
A NCT03926767 111 112 O
history NCT03926767 113 120 B-Eq_Comparison
of NCT03926767 121 123 O
orofacial NCT03926767 124 133 B-Modifier
pain NCT03926767 134 138 B-Condition
at NCT03926767 139 141 B-Eq_Comparison
least NCT03926767 142 147 I-Eq_Comparison
three NCT03926767 148 153 I-Eq_Comparison
months NCT03926767 154 160 I-Eq_Comparison
prior NCT03926767 161 166 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926767 167 169 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03926767 170 173 O
study NCT03926767 174 179 B-Study
( NCT03926767 180 181 O
TREEDE NCT03926767 182 188 O
et NCT03926767 189 191 O
al NCT03926767 192 194 O
, NCT03926767 195 196 O
2015 NCT03926767 197 201 O
) NCT03926767 202 203 O

- NCT03926767 211 212 O
age NCT03926767 214 217 B-Age
ranging NCT03926767 218 225 O
between NCT03926767 226 233 O
18 NCT03926767 234 236 B-Eq_Comparison
to NCT03926767 237 239 I-Eq_Comparison
55 NCT03926767 240 242 I-Eq_Comparison
years NCT03926767 243 248 I-Eq_Comparison
, NCT03926767 249 250 O
considering NCT03926767 251 262 O
the NCT03926767 263 266 O
greater NCT03926767 267 274 O
prevalence NCT03926767 275 285 O
of NCT03926767 286 288 O
TMD NCT03926767 289 292 O
associated NCT03926767 293 303 O
with NCT03926767 304 308 O
this NCT03926767 309 313 O
age NCT03926767 314 317 O
period NCT03926767 318 324 O
. NCT03926767 325 326 O

Exclusion NCT03926767 328 337 O
Criteria NCT03926767 338 346 O
: NCT03926767 347 348 O

- NCT03926767 352 353 O
Patients NCT03926767 355 363 O
with NCT03926767 364 368 O
illiteracy NCT03926767 369 379 B-Condition
, NCT03926767 380 381 O
severe NCT03926767 382 388 O
depression NCT03926767 389 399 B-Condition
( NCT03926767 400 401 O
medical NCT03926767 402 409 O
diagnoses NCT03926767 410 419 O
) NCT03926767 420 421 O
, NCT03926767 422 423 O
clinical NCT03926767 424 432 O
history NCT03926767 433 440 B-Eq_Comparison
of NCT03926767 441 443 O
tumors NCT03926767 444 450 B-Condition
in NCT03926767 451 453 O
the NCT03926767 454 457 O
craniofacial NCT03926767 458 470 B-Modifier
region NCT03926767 471 477 I-Modifier
, NCT03926767 478 479 O
patients NCT03926767 480 488 O
in NCT03926767 489 491 O
the NCT03926767 492 495 O
post NCT03926767 496 500 B-Temporal_Connection___Temporal_Connection_Type_Value:after
dental NCT03926767 501 507 B-Procedure
surgery NCT03926767 508 515 I-Procedure
period NCT03926767 516 522 O
or NCT03926767 523 525 B-Or
submitted NCT03926767 526 535 O
to NCT03926767 536 538 O
previous NCT03926767 539 547 B-Eq_Comparison
physical NCT03926767 548 556 B-Procedure
therapy NCT03926767 557 564 I-Procedure
in NCT03926767 565 567 O
the NCT03926767 568 571 O
past NCT03926767 572 576 B-Eq_Comparison
year NCT03926767 577 581 I-Eq_Comparison
or NCT03926767 582 584 B-Or
to NCT03926767 585 587 O
any NCT03926767 588 591 O
health NCT03926767 592 598 B-Modifier
/ NCT03926767 599 600 B-Or
pain NCT03926767 601 605 B-Modifier
education NCT03926767 606 615 B-Procedure
strategy NCT03926767 616 624 I-Procedure
, NCT03926767 625 626 O
pregnant NCT03926767 627 635 B-Condition
women NCT03926767 636 641 O
, NCT03926767 642 643 O
infections NCT03926767 644 654 B-Condition
, NCT03926767 655 656 O
whiplash NCT03926767 657 665 B-Condition
- NCT03926767 666 667 O
associated NCT03926767 668 678 O
disorders NCT03926767 679 688 B-Condition
and NCT03926767 689 692 B-Or
with NCT03926767 693 697 O
chronic NCT03926767 698 705 O
degenerative NCT03926767 706 718 B-Modifier
inflammatory NCT03926767 719 731 I-Modifier
or NCT03926767 732 734 B-Or
neurologic NCT03926767 735 745 B-Modifier
disorders NCT03926767 746 755 B-Condition
were NCT03926767 756 760 O
excluded NCT03926767 761 769 B-Negation
from NCT03926767 770 774 O
this NCT03926767 775 779 O
study NCT03926767 780 785 B-Study
. NCT03926767 786 787 O
Patients NCT03926767 789 797 O
will NCT03926767 798 802 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03926767 803 805 I-Assertion___Assertion_Type_Value:hypothetical
instructed NCT03926767 806 816 O
to NCT03926767 817 819 O
not NCT03926767 820 823 B-Negation
use NCT03926767 824 827 O
pain NCT03926767 828 832 B-Condition
relief NCT03926767 833 839 O
medications NCT03926767 840 851 B-Drug
during NCT03926767 852 858 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03926767 859 862 O
intervention NCT03926767 863 875 B-Study
period NCT03926767 876 882 O
of NCT03926767 883 885 O
this NCT03926767 886 890 O
trial NCT03926767 891 896 O
and NCT03926767 897 900 O
if NCT03926767 901 903 O
any NCT03926767 904 907 O
medication NCT03926767 908 918 O
be NCT03926767 919 921 O
used NCT03926767 922 926 O
, NCT03926767 927 928 O
participants NCT03926767 929 941 O
will NCT03926767 942 946 O
be NCT03926767 947 949 O
encouraged NCT03926767 950 960 O
to NCT03926767 961 963 O
report NCT03926767 964 970 O
. NCT03926767 971 972 O


Inclusion NCT03869073 0 9 O
Criteria NCT03869073 10 18 O
: NCT03869073 19 20 O

- NCT03869073 24 25 O
Signed NCT03869073 27 33 O
informed NCT03869073 34 42 O
consent NCT03869073 43 50 O

- NCT03869073 53 54 O
At NCT03869073 56 58 B-Eq_Comparison
least NCT03869073 59 64 I-Eq_Comparison
19 NCT03869073 65 67 I-Eq_Comparison
years NCT03869073 68 73 I-Eq_Comparison
of NCT03869073 74 76 O
age NCT03869073 77 80 B-Age

- NCT03869073 83 84 O
Known NCT03869073 86 91 B-Modifier
or NCT03869073 92 94 B-Or
suspected NCT03869073 95 104 B-Assertion___Assertion_Type_Value:possible
infection NCT03869073 105 114 B-Condition

- NCT03869073 117 118 O
AND NCT03869073 120 123 B-And
one NCT03869073 124 127 B-Eq_Comparison
or NCT03869073 128 130 I-Eq_Comparison
more NCT03869073 131 135 I-Eq_Comparison
of NCT03869073 136 138 O
the NCT03869073 139 142 B-Criteria_Count
following NCT03869073 143 152 I-Criteria_Count
organ NCT03869073 153 158 B-Condition
dysfunctions NCT03869073 159 171 I-Condition
judged NCT03869073 172 178 O
due NCT03869073 179 182 O
to NCT03869073 183 185 O
sepsis NCT03869073 186 192 B-Condition
: NCT03869073 193 194 O

1 NCT03869073 203 204 O
. NCT03869073 204 205 O
Cardiovascular NCT03869073 207 221 B-Modifier
- NCT03869073 222 223 I-Modifier
refractory NCT03869073 224 234 I-Modifier
hypotension NCT03869073 235 246 B-Condition
( NCT03869073 247 248 O
a NCT03869073 249 250 O
systolic NCT03869073 251 259 B-Observation
blood NCT03869073 260 265 I-Observation
pressure NCT03869073 266 274 I-Observation
( NCT03869073 275 276 O
SBP NCT03869073 277 280 B-Observation
) NCT03869073 281 282 O
< NCT03869073 283 284 B-Eq_Comparison
90 NCT03869073 285 287 I-Eq_Comparison
mm NCT03869073 288 290 I-Eq_Comparison
Hg NCT03869073 291 293 I-Eq_Comparison
or NCT03869073 294 296 B-Or
mean NCT03869073 297 301 B-Observation
arterial NCT03869073 302 310 I-Observation
pressure NCT03869073 311 319 I-Observation
( NCT03869073 320 321 O
MAP NCT03869073 322 325 B-Observation
) NCT03869073 326 327 O
< NCT03869073 328 329 B-Eq_Comparison
60 NCT03869073 330 332 I-Eq_Comparison
mm NCT03869073 333 335 I-Eq_Comparison
Hg NCT03869073 336 338 I-Eq_Comparison
despite NCT03869073 339 346 B-And
an NCT03869073 347 349 O
IV NCT03869073 350 352 B-Observation
fluid NCT03869073 353 358 I-Observation
challenge NCT03869073 359 368 I-Observation
of NCT03869073 369 371 O
at NCT03869073 372 374 B-Eq_Comparison
least NCT03869073 375 380 I-Eq_Comparison
30 NCT03869073 381 383 I-Eq_Comparison
ml NCT03869073 384 386 I-Eq_Comparison
/ NCT03869073 387 388 I-Eq_Comparison
kg NCT03869073 389 391 I-Eq_Comparison
fluids NCT03869073 392 398 B-Modifier
) NCT03869073 399 400 O
, NCT03869073 401 402 O
or NCT03869073 403 405 B-Or
use NCT03869073 406 409 O
of NCT03869073 410 412 O
vasopressor NCT03869073 413 424 B-Procedure
( NCT03869073 425 426 I-Procedure
s NCT03869073 427 428 I-Procedure
) NCT03869073 429 430 O
to NCT03869073 431 433 B-Assertion___Assertion_Type_Value:hypothetical
maintain NCT03869073 434 442 I-Assertion___Assertion_Type_Value:hypothetical
SAP NCT03869073 443 446 B-Observation
> NCT03869073 447 448 B-Eq_Comparison
90 NCT03869073 449 451 I-Eq_Comparison
mm NCT03869073 452 454 I-Eq_Comparison
Hg NCT03869073 455 457 I-Eq_Comparison
or NCT03869073 458 460 B-Or
MAP NCT03869073 461 464 B-Observation
> NCT03869073 465 466 B-Eq_Comparison
60 NCT03869073 467 469 I-Eq_Comparison
mm NCT03869073 470 472 I-Eq_Comparison
Hg NCT03869073 473 475 I-Eq_Comparison
, NCT03869073 476 477 O
or NCT03869073 478 480 B-Or
; NCT03869073 480 481 O

2 NCT03869073 489 490 O
. NCT03869073 490 491 O
Respiratory NCT03869073 493 504 B-Condition
: NCT03869073 505 506 O
PaO NCT03869073 507 510 B-Observation
2 NCT03869073 511 512 I-Observation
/ NCT03869073 513 514 B-Or
FiO NCT03869073 515 518 B-Observation
2 NCT03869073 519 520 I-Observation
< NCT03869073 521 522 B-Eq_Comparison
300 NCT03869073 523 526 I-Eq_Comparison
or NCT03869073 527 529 B-Or
PaO NCT03869073 530 533 B-Observation
2 NCT03869073 534 535 I-Observation
/ NCT03869073 536 537 B-Or
FiO NCT03869073 538 541 B-Observation
2 NCT03869073 542 543 I-Observation
< NCT03869073 544 545 B-Eq_Comparison
200 NCT03869073 546 549 I-Eq_Comparison
if NCT03869073 550 552 O
lung NCT03869073 553 557 B-Modifier
is NCT03869073 558 560 O
the NCT03869073 561 564 O
only NCT03869073 565 569 B-Modifier
organ NCT03869073 570 575 I-Modifier
dysfunction NCT03869073 576 587 B-Condition
or NCT03869073 588 590 B-Or
SaO NCT03869073 591 594 B-Observation
2 NCT03869073 595 596 I-Observation
: NCT03869073 597 598 B-Or
FiO NCT03869073 599 602 B-Observation
2 NCT03869073 603 604 I-Observation
150 NCT03869073 605 608 B-Eq_Comparison

Exclusion NCT03869073 610 619 O
Criteria NCT03869073 620 628 O
: NCT03869073 629 630 O

- NCT03869073 634 635 O
Known NCT03869073 637 642 O
pregnancy NCT03869073 643 652 B-Condition

- NCT03869073 655 656 O
Underlying NCT03869073 658 668 O
severe NCT03869073 669 675 O
congestive NCT03869073 676 686 B-Condition
heart NCT03869073 687 692 I-Condition
failure NCT03869073 693 700 I-Condition
( NCT03869073 701 702 O
New NCT03869073 703 706 B-Observation
York NCT03869073 707 711 I-Observation
Heart NCT03869073 712 717 I-Observation
Association NCT03869073 718 729 I-Observation
( NCT03869073 730 731 O
NYHA NCT03869073 732 736 B-Observation
) NCT03869073 737 738 O
IV NCT03869073 739 741 B-Eq_Comparison
) NCT03869073 742 743 O
, NCT03869073 744 745 O
severe NCT03869073 746 752 O
COPD NCT03869073 753 757 B-Condition
( NCT03869073 758 759 O
need NCT03869073 760 764 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03869073 765 768 I-Assertion___Assertion_Type_Value:hypothetical
chronic NCT03869073 769 776 B-Procedure
oxygen NCT03869073 777 783 I-Procedure
or NCT03869073 784 786 B-Or
mechanical NCT03869073 787 797 B-Procedure
ventilation NCT03869073 798 809 I-Procedure
) NCT03869073 810 811 O
, NCT03869073 812 813 O
severe NCT03869073 814 820 O
liver NCT03869073 821 826 B-Condition
disease NCT03869073 827 834 I-Condition
( NCT03869073 835 836 O
Child NCT03869073 837 842 B-Condition
- NCT03869073 843 844 I-Condition
Pugh NCT03869073 845 849 I-Condition
Class NCT03869073 850 855 B-Eq_Comparison
C NCT03869073 856 857 I-Eq_Comparison
) NCT03869073 858 859 O
, NCT03869073 860 861 O
cancer NCT03869073 862 868 B-Condition
requiring NCT03869073 869 878 B-Assertion___Assertion_Type_Value:hypothetical
chemotherapy NCT03869073 879 891 B-Procedure
, NCT03869073 892 893 O
or NCT03869073 894 896 B-Or
transplantation NCT03869073 897 912 B-Procedure
( NCT03869073 913 914 O
bone NCT03869073 915 919 B-Modifier
marrow NCT03869073 920 926 I-Modifier
, NCT03869073 927 928 O
heart NCT03869073 929 934 B-Modifier
, NCT03869073 935 936 O
lung NCT03869073 937 941 B-Modifier
, NCT03869073 942 943 O
liver NCT03869073 944 949 B-Modifier
, NCT03869073 950 951 O
pancreas NCT03869073 952 960 B-Modifier
, NCT03869073 961 962 O
or NCT03869073 963 965 B-Or
small NCT03869073 966 971 B-Modifier
bowel NCT03869073 972 977 I-Modifier
) NCT03869073 978 979 O
in NCT03869073 980 982 O
the NCT03869073 983 986 O
past NCT03869073 987 991 B-Eq_Comparison
6 NCT03869073 992 993 I-Eq_Comparison
months NCT03869073 994 1000 I-Eq_Comparison
or NCT03869073 1001 1003 B-Or
likely NCT03869073 1004 1010 B-Assertion___Assertion_Type_Value:possible
within NCT03869073 1011 1017 B-Eq_Comparison
the NCT03869073 1018 1021 I-Eq_Comparison
next NCT03869073 1022 1026 I-Eq_Comparison
6 NCT03869073 1027 1028 I-Eq_Comparison
months NCT03869073 1029 1035 I-Eq_Comparison

- NCT03869073 1038 1039 O
Previous NCT03869073 1041 1049 B-Eq_Comparison
episode NCT03869073 1050 1057 O
of NCT03869073 1058 1060 O
sepsis NCT03869073 1061 1067 B-Condition
during NCT03869073 1068 1074 B-Temporal_Connection___Temporal_Connection_Type_Value:during
that NCT03869073 1075 1079 O
hospital NCT03869073 1080 1088 O
admission NCT03869073 1089 1098 B-Encounter

- NCT03869073 1101 1102 O
Absolute NCT03869073 1104 1112 B-Observation
Neutrophil NCT03869073 1113 1123 I-Observation
Count NCT03869073 1124 1129 I-Observation
< NCT03869073 1130 1131 B-Eq_Comparison
500 NCT03869073 1132 1135 I-Eq_Comparison
/ NCT03869073 1136 1137 I-Eq_Comparison
mmÂ³ NCT03869073 1138 1141 I-Eq_Comparison

- NCT03869073 1144 1145 O
CD NCT03869073 1147 1149 B-Observation
4 NCT03869073 1150 1151 I-Observation
count NCT03869073 1152 1157 I-Observation
< NCT03869073 1158 1159 B-Eq_Comparison
50 NCT03869073 1160 1162 I-Eq_Comparison
/ NCT03869073 1163 1164 I-Eq_Comparison
mmÂ³ NCT03869073 1165 1168 I-Eq_Comparison

- NCT03869073 1171 1172 O
Treating NCT03869073 1174 1182 O
physician NCT03869073 1183 1192 O
deems NCT03869073 1193 1198 O
aggressive NCT03869073 1199 1209 O
care NCT03869073 1210 1214 B-Procedure
unsuitable NCT03869073 1215 1225 B-Contraindication
( NCT03869073 1226 1227 O
i NCT03869073 1228 1229 O
. NCT03869073 1230 1231 O
e NCT03869073 1232 1233 O
. NCT03869073 1234 1235 O
no NCT03869073 1237 1239 B-Negation
commitment NCT03869073 1240 1250 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869073 1251 1253 I-Assertion___Assertion_Type_Value:hypothetical
active NCT03869073 1254 1260 B-Eq_Comparison
care NCT03869073 1261 1265 B-Procedure
) NCT03869073 1266 1267 O

- NCT03869073 1271 1272 O
Participation NCT03869073 1274 1287 O
in NCT03869073 1288 1290 O
another NCT03869073 1291 1298 B-Other
interventional NCT03869073 1299 1313 O
drug NCT03869073 1314 1318 B-Drug
study NCT03869073 1319 1324 B-Study
within NCT03869073 1325 1331 B-Eq_Comparison
previous NCT03869073 1332 1340 I-Eq_Comparison
1 NCT03869073 1341 1342 I-Eq_Comparison
month NCT03869073 1343 1348 I-Eq_Comparison

- NCT03869073 1351 1352 O
Allergic NCT03869073 1354 1362 B-Allergy
to NCT03869073 1363 1365 O
the NCT03869073 1366 1369 O
study NCT03869073 1370 1375 B-Study
drug NCT03869073 1376 1380 B-Drug
or NCT03869073 1381 1383 B-Or
any NCT03869073 1384 1387 O
of NCT03869073 1388 1390 O
its NCT03869073 1391 1394 O
components NCT03869073 1395 1405 O

- NCT03869073 1408 1409 O
Lactation NCT03869073 1411 1420 B-Condition

- NCT03869073 1423 1424 O
Have NCT03869073 1426 1430 O
signed NCT03869073 1431 1437 B-Eq_Comparison
a NCT03869073 1438 1439 O
Do NCT03869073 1440 1442 B-Observation
No NCT03869073 1443 1445 I-Observation
Resuscitate NCT03869073 1446 1457 I-Observation
( NCT03869073 1458 1459 O
DNR NCT03869073 1460 1463 B-Observation
) NCT03869073 1464 1465 O
Form NCT03869073 1466 1470 O

Inclusion NCT03929770 0 9 O
Criteria NCT03929770 10 18 O
: NCT03929770 19 20 O

- NCT03929770 24 25 O
The NCT03929770 27 30 O
patients NCT03929770 31 39 O
who NCT03929770 40 43 O
need NCT03929770 44 48 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929770 49 51 I-Assertion___Assertion_Type_Value:hypothetical
Swan NCT03929770 52 56 B-Procedure
- NCT03929770 57 58 I-Procedure
Ganz NCT03929770 59 63 I-Procedure
catheterization NCT03929770 64 79 I-Procedure
for NCT03929770 80 83 O
heart NCT03929770 84 89 B-Procedure
surgeries NCT03929770 90 99 I-Procedure

Exclusion NCT03929770 100 109 O
Criteria NCT03929770 110 118 O
: NCT03929770 119 120 O

- NCT03929770 124 125 O
Who NCT03929770 127 130 O
does NCT03929770 131 135 O
n't NCT03929770 135 138 O
agree NCT03929770 139 144 O
to NCT03929770 145 147 O
enroll NCT03929770 148 154 O

- NCT03929770 157 158 O
Who NCT03929770 160 163 O
has NCT03929770 164 167 O
thrombus NCT03929770 168 176 B-Condition
in NCT03929770 177 179 I-Condition
the NCT03929770 180 183 I-Condition
heart NCT03929770 184 189 B-Modifier
or NCT03929770 190 192 B-Or
the NCT03929770 193 196 O
vena NCT03929770 197 201 B-Modifier
cavas NCT03929770 202 207 I-Modifier
. NCT03929770 208 209 O

Inclusion NCT03860350 0 9 O
Criteria NCT03860350 10 18 O
: NCT03860350 19 20 O

- NCT03860350 24 25 O
CAC NCT03860350 27 30 B-Observation
score NCT03860350 31 36 I-Observation
> NCT03860350 37 38 B-Eq_Comparison
10 NCT03860350 39 41 I-Eq_Comparison

- NCT03860350 45 46 O
Framingham NCT03860350 48 58 B-Observation
risk NCT03860350 59 63 I-Observation
score NCT03860350 64 69 I-Observation
( NCT03860350 70 71 O
10 NCT03860350 72 74 B-Eq_Comparison
% NCT03860350 75 76 I-Eq_Comparison
or NCT03860350 77 79 I-Eq_Comparison
above NCT03860350 80 85 I-Eq_Comparison
) NCT03860350 86 87 O

- NCT03860350 91 92 O
Subjects NCT03860350 94 102 O
are NCT03860350 103 106 O
required NCT03860350 107 115 O
to NCT03860350 116 118 O
be NCT03860350 119 121 O
on NCT03860350 122 124 O
stable NCT03860350 125 131 O
concomitant NCT03860350 132 143 B-Modifier
medications NCT03860350 144 155 B-Drug
for NCT03860350 156 159 O
at NCT03860350 160 162 B-Eq_Comparison
least NCT03860350 163 168 I-Eq_Comparison
12 NCT03860350 169 171 I-Eq_Comparison
weeks NCT03860350 172 177 I-Eq_Comparison
prior NCT03860350 178 183 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03860350 184 186 I-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03860350 187 200 B-Study

- NCT03860350 203 204 O
Subjects NCT03860350 206 214 O
with NCT03860350 215 219 O
diabetic NCT03860350 220 228 B-Condition
must NCT03860350 229 233 O
have NCT03860350 234 238 O
HbA NCT03860350 239 242 B-Observation
1C NCT03860350 243 245 I-Observation
< NCT03860350 246 247 B-Eq_Comparison
8.0 NCT03860350 248 251 I-Eq_Comparison
, NCT03860350 252 253 O
and NCT03860350 254 257 B-And
stable NCT03860350 258 264 O
HbA NCT03860350 265 268 B-Observation
1C NCT03860350 269 271 I-Observation
level NCT03860350 272 277 O
variation NCT03860350 278 287 B-Modifier
range NCT03860350 288 293 I-Modifier
within NCT03860350 294 300 B-Eq_Comparison
0.5 NCT03860350 301 304 I-Eq_Comparison
% NCT03860350 305 306 I-Eq_Comparison
for NCT03860350 307 310 O
three NCT03860350 311 316 B-Eq_Comparison
months NCT03860350 317 323 I-Eq_Comparison
. NCT03860350 324 325 O

Exclusion NCT03860350 327 336 O
Criteria NCT03860350 337 345 O
: NCT03860350 346 347 O

- NCT03860350 351 352 O
Hypersensitivity NCT03860350 354 370 B-Condition
to NCT03860350 371 373 O
AGE NCT03860350 374 377 B-Procedure
therapy NCT03860350 378 385 I-Procedure
, NCT03860350 386 387 O

- NCT03860350 391 392 O
Unstable NCT03860350 394 402 O
medical NCT03860350 403 410 B-Modifier
, NCT03860350 411 412 O
psychiatric NCT03860350 413 424 B-Modifier
, NCT03860350 425 426 O
or NCT03860350 427 429 B-Or
substance NCT03860350 430 439 B-Modifier
abuse NCT03860350 440 445 I-Modifier
disorder NCT03860350 446 454 B-Condition
that NCT03860350 455 459 O
may NCT03860350 460 463 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03860350 464 473 O
with NCT03860350 474 478 O
continuation NCT03860350 479 491 O
in NCT03860350 492 494 O
the NCT03860350 495 498 O
study NCT03860350 499 504 B-Study
, NCT03860350 505 506 O

- NCT03860350 510 511 O
Weight NCT03860350 513 519 B-Observation
â¥ NCT03860350 520 521 B-Eq_Comparison
325 NCT03860350 522 525 I-Eq_Comparison
pounds NCT03860350 526 532 I-Eq_Comparison
, NCT03860350 533 534 O

- NCT03860350 538 539 O
Bleeding NCT03860350 541 549 B-Condition
disorder NCT03860350 550 558 I-Condition
, NCT03860350 559 560 O

- NCT03860350 564 565 O
History NCT03860350 567 574 B-Eq_Comparison
of NCT03860350 575 577 O
myocardial NCT03860350 578 588 B-Condition
infarction NCT03860350 589 599 I-Condition
, NCT03860350 600 601 O

- NCT03860350 605 606 O
Stroke NCT03860350 608 614 B-Condition

- NCT03860350 617 618 O
Life NCT03860350 620 624 B-Death|B-Risk
- NCT03860350 625 626 I-Death|I-Risk
threatening NCT03860350 627 638 I-Death|I-Risk
arrhythmia NCT03860350 639 649 B-Condition
within NCT03860350 650 656 B-Eq_Comparison
prior NCT03860350 657 662 I-Eq_Comparison
6 NCT03860350 663 664 I-Eq_Comparison
months NCT03860350 665 671 I-Eq_Comparison
, NCT03860350 672 673 O

- NCT03860350 677 678 O
Resting NCT03860350 680 687 B-Modifier
hypotension NCT03860350 688 699 B-Condition
( NCT03860350 700 701 O
systolic NCT03860350 702 710 B-Observation
< NCT03860350 711 712 B-Eq_Comparison
90 NCT03860350 713 715 I-Eq_Comparison
mmHg NCT03860350 716 720 I-Eq_Comparison
) NCT03860350 721 722 O
or NCT03860350 723 725 B-Or
hypertension NCT03860350 726 738 B-Condition
( NCT03860350 739 740 O
resting NCT03860350 741 748 B-Modifier
blood NCT03860350 749 754 B-Observation
pressure NCT03860350 755 763 I-Observation
> NCT03860350 764 765 B-Eq_Comparison
170 NCT03860350 766 769 I-Eq_Comparison
/ NCT03860350 770 771 I-Eq_Comparison
110 NCT03860350 772 775 I-Eq_Comparison
) NCT03860350 776 777 O

- NCT03860350 781 782 O
Heart NCT03860350 784 789 B-Condition
failure NCT03860350 790 797 I-Condition
NYHA NCT03860350 798 802 B-Observation
class NCT03860350 803 808 O
III NCT03860350 809 812 B-Eq_Comparison
or NCT03860350 813 815 I-Eq_Comparison
IV NCT03860350 816 818 I-Eq_Comparison
, NCT03860350 819 820 O

- NCT03860350 824 825 O
History NCT03860350 827 834 B-Eq_Comparison
of NCT03860350 835 837 O
malignancy NCT03860350 838 848 B-Condition
within NCT03860350 849 855 B-Eq_Comparison
the NCT03860350 856 859 I-Eq_Comparison
last NCT03860350 860 864 I-Eq_Comparison
5 NCT03860350 865 866 I-Eq_Comparison
years NCT03860350 867 872 I-Eq_Comparison
( NCT03860350 873 874 O
other NCT03860350 875 880 B-Exception
than NCT03860350 881 885 I-Exception
skin NCT03860350 886 890 B-Modifier
cancer NCT03860350 891 897 B-Condition
) NCT03860350 898 899 O
or NCT03860350 900 902 B-Or
evidence NCT03860350 903 911 O
of NCT03860350 912 914 O
active NCT03860350 915 921 B-Eq_Comparison
cancer NCT03860350 922 928 B-Condition
which NCT03860350 929 934 O
would NCT03860350 935 940 B-Assertion___Assertion_Type_Value:hypothetical
require NCT03860350 941 948 I-Assertion___Assertion_Type_Value:hypothetical
concomitant NCT03860350 949 960 B-Modifier
cancer NCT03860350 961 967 B-Procedure
chemotherapy NCT03860350 968 980 I-Procedure

- NCT03860350 983 984 O
Serum NCT03860350 986 991 B-Observation
creatinine NCT03860350 992 1002 I-Observation
> NCT03860350 1003 1004 B-Eq_Comparison
1.4 NCT03860350 1005 1008 I-Eq_Comparison
mg NCT03860350 1009 1011 I-Eq_Comparison
/ NCT03860350 1012 1013 I-Eq_Comparison
dl NCT03860350 1014 1016 I-Eq_Comparison

- NCT03860350 1019 1020 O
Triglycerides NCT03860350 1022 1035 B-Observation
> NCT03860350 1036 1037 B-Eq_Comparison
400 NCT03860350 1038 1041 I-Eq_Comparison
at NCT03860350 1042 1044 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03860350 1045 1053 B-Study
visit NCT03860350 1054 1059 O

- NCT03860350 1062 1063 O
Diabetic NCT03860350 1065 1073 B-Condition
subjects NCT03860350 1074 1082 O
with NCT03860350 1083 1087 O
HbA NCT03860350 1088 1091 B-Observation
1C NCT03860350 1092 1094 I-Observation
> NCT03860350 1095 1096 B-Eq_Comparison
8 NCT03860350 1097 1098 I-Eq_Comparison
% NCT03860350 1099 1100 I-Eq_Comparison
, NCT03860350 1101 1102 O

- NCT03860350 1106 1107 O
Drug NCT03860350 1109 1113 B-Modifier
or NCT03860350 1114 1116 B-Or
alcohol NCT03860350 1117 1124 B-Modifier
abuse NCT03860350 1125 1130 B-Condition

- NCT03860350 1133 1134 O
Conditions NCT03860350 1136 1146 B-Condition
interfering NCT03860350 1147 1158 O
with NCT03860350 1159 1163 O
accurate NCT03860350 1164 1172 O
assessment NCT03860350 1173 1183 O
of NCT03860350 1184 1186 O
coronary NCT03860350 1187 1195 B-Condition
calcification NCT03860350 1196 1209 I-Condition
( NCT03860350 1210 1211 O
metal NCT03860350 1212 1217 B-Condition
clips NCT03860350 1218 1223 I-Condition
, NCT03860350 1224 1225 O
bypass NCT03860350 1226 1232 B-Procedure
patients NCT03860350 1233 1241 O
, NCT03860350 1242 1243 O
intracoronary NCT03860350 1244 1257 B-Procedure
stents NCT03860350 1258 1264 I-Procedure
) NCT03860350 1265 1266 O
and NCT03860350 1267 1270 B-Or
drug NCT03860350 1271 1275 B-Condition
absorption NCT03860350 1276 1286 I-Condition
( NCT03860350 1287 1288 O
partial NCT03860350 1289 1296 B-Procedure
ileal NCT03860350 1297 1302 I-Procedure
bypass NCT03860350 1303 1309 I-Procedure
or NCT03860350 1310 1312 B-Or
malabsorption NCT03860350 1313 1326 B-Condition
syndrome NCT03860350 1327 1335 I-Condition
) NCT03860350 1336 1337 O
. NCT03860350 1338 1339 O

- NCT03860350 1343 1344 O
Current NCT03860350 1346 1353 B-Eq_Comparison
use NCT03860350 1354 1357 O
of NCT03860350 1358 1360 O
anticoagulants NCT03860350 1361 1375 B-Drug
( NCT03860350 1376 1377 O
except NCT03860350 1378 1384 B-Exception
for NCT03860350 1385 1388 I-Exception
antiplatelet NCT03860350 1389 1401 B-Drug
agents NCT03860350 1402 1408 I-Drug
) NCT03860350 1409 1410 O

- NCT03860350 1414 1415 O
Chronic NCT03860350 1417 1424 O
renal NCT03860350 1425 1430 B-Condition
failure NCT03860350 1431 1438 I-Condition

- NCT03860350 1441 1442 O
Liver NCT03860350 1444 1449 B-Condition
failure NCT03860350 1450 1457 I-Condition

- NCT03860350 1460 1461 O
Hematological NCT03860350 1463 1476 B-Modifier
or NCT03860350 1477 1479 B-Or
biochemical NCT03860350 1480 1491 B-Modifier
values NCT03860350 1492 1498 B-Observation
at NCT03860350 1499 1501 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03860350 1502 1510 B-Study
visit NCT03860350 1511 1516 O
outside NCT03860350 1517 1524 O
the NCT03860350 1525 1528 O
reference NCT03860350 1529 1538 O
ranges NCT03860350 1539 1545 O
considered NCT03860350 1546 1556 O
as NCT03860350 1557 1559 O
clinically NCT03860350 1560 1570 O
significant NCT03860350 1571 1582 O
. NCT03860350 1583 1584 O

Inclusion NCT03926325 0 9 O
Criteria NCT03926325 10 18 O
: NCT03926325 19 20 O

1 NCT03926325 24 25 O
. NCT03926325 25 26 O
OHCA NCT03926325 28 32 O
: NCT03926325 33 34 O
Every NCT03926325 35 40 O
patient NCT03926325 41 48 O
who NCT03926325 49 52 O
suffered NCT03926325 53 61 O
a NCT03926325 62 63 O
cardiac NCT03926325 64 71 B-Condition
arrest NCT03926325 72 78 I-Condition
that NCT03926325 79 83 O
occurred NCT03926325 84 92 O
in NCT03926325 93 95 O
any NCT03926325 96 99 O
location NCT03926325 100 108 O
other NCT03926325 109 114 B-Exception
than NCT03926325 115 119 I-Exception
a NCT03926325 120 121 O
hospital NCT03926325 122 130 O
, NCT03926325 131 132 O
and NCT03926325 133 136 B-And
was NCT03926325 137 140 O
attended NCT03926325 141 149 B-Encounter
and NCT03926325 150 153 O
/ NCT03926325 154 155 O
or NCT03926325 156 158 O
treated NCT03926325 159 166 O
by NCT03926325 167 169 O
an NCT03926325 170 172 O
EMS NCT03926325 173 176 B-Provider
. NCT03926325 177 178 O

2 NCT03926325 182 183 O
. NCT03926325 183 184 O
IHCA NCT03926325 186 190 O
: NCT03926325 191 192 O
Every NCT03926325 193 198 O
patient NCT03926325 199 206 O
who NCT03926325 207 210 O
suffered NCT03926325 211 219 O
a NCT03926325 220 221 O
cardiac NCT03926325 222 229 B-Condition
arrest NCT03926325 230 236 I-Condition
in NCT03926325 237 239 O
hospital NCT03926325 240 248 O
. NCT03926325 249 250 O

3 NCT03926325 254 255 O
. NCT03926325 255 256 O
the NCT03926325 258 261 O
representative NCT03926325 262 276 O
population NCT03926325 277 287 O
- NCT03926325 288 289 O
based NCT03926325 290 295 O
survey NCT03926325 296 302 O
: NCT03926325 303 304 O
Every NCT03926325 305 310 O
patient NCT03926325 311 318 O
who NCT03926325 319 322 O
suffered NCT03926325 323 331 O
a NCT03926325 332 333 O
cardiac NCT03926325 334 341 B-Condition
arrest NCT03926325 342 348 I-Condition
in NCT03926325 349 351 O
the NCT03926325 352 355 O
selected NCT03926325 356 364 O
cities NCT03926325 365 371 O
or NCT03926325 372 374 O
suburbs NCT03926325 375 382 O
. NCT03926325 383 384 O

Exclusion NCT03926325 386 395 O
Criteria NCT03926325 396 404 O
: NCT03926325 405 406 O

1 NCT03926325 410 411 O
. NCT03926325 411 412 O
OHCA NCT03926325 414 418 O
: NCT03926325 419 420 O
1 NCT03926325 421 422 O
) NCT03926325 423 424 O
The NCT03926325 425 428 O
out NCT03926325 429 432 B-Negation
- NCT03926325 433 434 I-Negation
of NCT03926325 435 437 I-Negation
- NCT03926325 438 439 O
hospital NCT03926325 440 448 O
cardiac NCT03926325 449 456 B-Condition
arrest NCT03926325 457 463 I-Condition
patients NCT03926325 464 472 O
who NCT03926325 473 476 O
were NCT03926325 477 481 O
taken NCT03926325 482 487 O
to NCT03926325 488 490 O
the NCT03926325 491 494 O
hospital NCT03926325 495 503 O
by NCT03926325 504 506 O
their NCT03926325 507 512 O
family NCT03926325 513 519 O
members NCT03926325 520 527 O
; NCT03926325 527 528 O
2 NCT03926325 529 530 O
) NCT03926325 531 532 O
Bystanders NCT03926325 533 543 O
suspected NCT03926325 544 553 B-Assertion___Assertion_Type_Value:possible
cardiac NCT03926325 554 561 B-Condition
arrest NCT03926325 562 568 I-Condition
, NCT03926325 569 570 O
but NCT03926325 571 574 O
the NCT03926325 575 578 O
ROSC NCT03926325 579 583 O
was NCT03926325 584 587 O
achieved NCT03926325 588 596 O
without NCT03926325 597 604 B-Negation
defibrillation NCT03926325 605 619 B-Procedure
or NCT03926325 620 622 B-Or
resuscitation NCT03926325 623 636 B-Procedure
by NCT03926325 637 639 O
EMS NCT03926325 640 643 B-Provider
. NCT03926325 644 645 O

2 NCT03926325 649 650 O
. NCT03926325 650 651 O
IHCA NCT03926325 653 657 O
: NCT03926325 658 659 O
The NCT03926325 660 663 O
patient NCT03926325 664 671 O
who NCT03926325 672 675 O
suffered NCT03926325 676 684 O
a NCT03926325 685 686 O
cardiac NCT03926325 687 694 B-Condition
arrest NCT03926325 695 701 I-Condition
that NCT03926325 702 706 O
occurred NCT03926325 707 715 O
out NCT03926325 716 719 B-Negation
- NCT03926325 720 721 I-Negation
of NCT03926325 722 724 I-Negation
- NCT03926325 725 726 O
hospital NCT03926325 727 735 O
and NCT03926325 736 739 O
then NCT03926325 740 744 B-Temporal_Connection___Temporal_Connection_Type_Value:before
transferred NCT03926325 745 756 B-Encounter
to NCT03926325 757 759 O
the NCT03926325 760 763 O
hospital NCT03926325 764 772 O
. NCT03926325 773 774 O

Inclusion NCT03924622 0 9 O
Criteria NCT03924622 10 18 O
: NCT03924622 19 20 O

- NCT03924622 24 25 O
Men NCT03924622 27 30 O
and NCT03924622 31 34 B-Or
women NCT03924622 35 40 O

- NCT03924622 43 44 O
Age NCT03924622 46 49 B-Age
18 NCT03924622 50 52 B-Eq_Comparison
to NCT03924622 53 55 I-Eq_Comparison
55 NCT03924622 56 58 I-Eq_Comparison

- NCT03924622 62 63 O
Meet NCT03924622 65 69 O
the NCT03924622 70 73 O
physical NCT03924622 74 82 O
standards NCT03924622 83 92 O
for NCT03924622 93 96 O
military NCT03924622 97 105 O
personnel NCT03924622 106 115 O

- NCT03924622 118 119 O
Weigh NCT03924622 121 126 B-Observation
less NCT03924622 127 131 B-Eq_Comparison
than NCT03924622 132 136 I-Eq_Comparison
250 NCT03924622 137 140 I-Eq_Comparison
pounds NCT03924622 141 147 I-Eq_Comparison

- NCT03924622 150 151 O
Be NCT03924622 153 155 O
able NCT03924622 156 160 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924622 161 163 I-Assertion___Assertion_Type_Value:hypothetical
remain NCT03924622 164 170 O
in NCT03924622 171 173 O
the NCT03924622 174 177 O
study NCT03924622 178 183 B-Study
position NCT03924622 184 192 B-Observation
for NCT03924622 193 196 O
the NCT03924622 197 200 O
duration NCT03924622 201 209 B-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03924622 210 212 O
the NCT03924622 213 216 O
study NCT03924622 217 222 B-Study
. NCT03924622 223 224 O

Exclusion NCT03924622 226 235 O
Criteria NCT03924622 236 244 O

- NCT03924622 247 248 O
Previous NCT03924622 250 258 B-Eq_Comparison
injuries NCT03924622 259 267 B-Condition
to NCT03924622 268 270 O
sacrum NCT03924622 271 277 B-Modifier
/ NCT03924622 278 279 B-Or
buttocks NCT03924622 280 288 B-Modifier
with NCT03924622 289 293 B-Modifier
scarring NCT03924622 294 302 I-Modifier

- NCT03924622 305 306 O
History NCT03924622 308 315 B-Eq_Comparison
of NCT03924622 316 318 O
pressure NCT03924622 319 327 B-Modifier
injuries NCT03924622 328 336 B-Condition

- NCT03924622 339 340 O
Cardiovascular NCT03924622 342 356 B-Condition
disease NCT03924622 357 364 I-Condition

- NCT03924622 367 368 O
Neurological NCT03924622 370 382 B-Condition
disease NCT03924622 383 390 I-Condition
that NCT03924622 391 395 O
would NCT03924622 396 401 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03924622 402 408 O
vascular NCT03924622 409 417 B-Modifier
response NCT03924622 418 426 B-Condition

- NCT03924622 429 430 O
Diabetes NCT03924622 432 440 B-Condition

- NCT03924622 443 444 O
History NCT03924622 446 453 B-Eq_Comparison
of NCT03924622 454 456 O
malignancy NCT03924622 457 467 B-Condition

- NCT03924622 470 471 O
Current NCT03924622 473 480 B-Eq_Comparison
skin NCT03924622 481 485 B-Condition
condition NCT03924622 486 495 I-Condition
( NCT03924622 496 497 O
e NCT03924622 498 499 O
. NCT03924622 500 501 O
g NCT03924622 502 503 O
. NCT03924622 504 505 O
, NCT03924622 506 507 O
eczema NCT03924622 508 514 B-Condition
or NCT03924622 515 517 B-Or
psoriasis NCT03924622 518 527 B-Condition
) NCT03924622 528 529 O

- NCT03924622 533 534 O
Current NCT03924622 536 543 B-Eq_Comparison
neck NCT03924622 544 548 B-Modifier
/ NCT03924622 549 550 B-Or
back NCT03924622 551 555 B-Modifier
pain NCT03924622 556 560 B-Condition
or NCT03924622 561 563 B-Or
history NCT03924622 564 571 B-Eq_Comparison
of NCT03924622 572 574 O
chronic NCT03924622 575 582 O
neck NCT03924622 583 587 B-Modifier
/ NCT03924622 588 589 B-Or
back NCT03924622 590 594 B-Modifier
pain NCT03924622 595 599 B-Condition

- NCT03924622 602 603 O
Known NCT03924622 605 610 O
vertebral NCT03924622 611 620 B-Modifier
/ NCT03924622 621 622 B-Or
spinal NCT03924622 623 629 B-Modifier
cord NCT03924622 630 634 I-Modifier
disease NCT03924622 635 642 B-Condition
/ NCT03924622 643 644 B-Or
injury NCT03924622 645 651 B-Condition
( NCT03924622 652 653 O
scoliosis NCT03924622 654 663 B-Condition
, NCT03924622 664 665 O
kyphosis NCT03924622 666 674 B-Condition
, NCT03924622 675 676 O
or NCT03924622 677 679 B-Or
lordosis NCT03924622 680 688 B-Condition
) NCT03924622 689 690 O

- NCT03924622 694 695 O
Self NCT03924622 697 701 O
- NCT03924622 702 703 O
reported NCT03924622 704 712 O
pregnancy NCT03924622 713 722 B-Condition

- NCT03924622 725 726 O
Concern NCT03924622 728 735 O
about NCT03924622 736 741 O
ability NCT03924622 742 749 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924622 750 752 I-Assertion___Assertion_Type_Value:hypothetical
remain NCT03924622 753 759 B-Observation
in NCT03924622 760 762 O
the NCT03924622 763 766 O
vacuum NCT03924622 767 773 B-Modifier
spine NCT03924622 774 779 I-Modifier
board NCT03924622 780 785 I-Modifier
for NCT03924622 786 789 O
120 NCT03924622 790 793 B-Eq_Comparison
minutes NCT03924622 794 801 I-Eq_Comparison

Inclusion NCT03860103 0 9 O
Criteria NCT03860103 10 18 O
: NCT03860103 19 20 O

- NCT03860103 24 25 O
Patient NCT03860103 27 34 O
who NCT03860103 35 38 O
accepted NCT03860103 39 47 O
to NCT03860103 48 50 O
participate NCT03860103 51 62 O
in NCT03860103 63 65 O
the NCT03860103 66 69 O
study NCT03860103 70 75 O

- NCT03860103 78 79 O
Woman NCT03860103 81 86 O
over NCT03860103 87 91 B-Eq_Comparison
18 NCT03860103 92 94 I-Eq_Comparison
years NCT03860103 95 100 I-Eq_Comparison
old NCT03860103 101 104 B-Age

- NCT03860103 107 108 O
Affiliated NCT03860103 110 120 O
to NCT03860103 121 123 O
a NCT03860103 124 125 O
social NCT03860103 126 132 O
security NCT03860103 133 141 O
scheme NCT03860103 142 148 O

- NCT03860103 151 152 O
Mono NCT03860103 154 158 B-Modifier
- NCT03860103 159 160 I-Modifier
fetal NCT03860103 161 166 I-Modifier
pregnancy NCT03860103 167 176 B-Condition

- NCT03860103 179 180 O
Patients NCT03860103 182 190 O
with NCT03860103 191 195 O
normal NCT03860103 196 202 O
pregnancy NCT03860103 203 212 B-Condition
between NCT03860103 213 220 B-Eq_Comparison
11 NCT03860103 221 223 I-Eq_Comparison
and NCT03860103 224 227 I-Eq_Comparison
42 NCT03860103 228 230 I-Eq_Comparison
weeks NCT03860103 231 236 I-Eq_Comparison
of NCT03860103 237 239 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03860103 240 250 B-Condition

- NCT03860103 253 254 O
Patients NCT03860103 256 264 O
hospitalized NCT03860103 265 277 B-Encounter
for NCT03860103 278 281 O
preeclampsia NCT03860103 282 294 B-Condition
and NCT03860103 295 298 B-Or
/ NCT03860103 299 300 I-Or
or NCT03860103 301 303 I-Or
intrauterine NCT03860103 304 316 B-Condition
growth NCT03860103 317 323 I-Condition
retardation NCT03860103 324 335 I-Condition
, NCT03860103 336 337 O
beyond NCT03860103 338 344 B-Eq_Comparison
20 NCT03860103 345 347 I-Eq_Comparison
weeks NCT03860103 348 353 I-Eq_Comparison
of NCT03860103 354 356 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03860103 357 367 B-Condition

Exclusion NCT03860103 368 377 O
Criteria NCT03860103 378 386 O
: NCT03860103 387 388 O

- NCT03860103 392 393 O
Minors NCT03860103 395 401 O
, NCT03860103 402 403 O
adults NCT03860103 404 410 O
under NCT03860103 411 416 B-Observation
guardianship NCT03860103 417 429 I-Observation
, NCT03860103 430 431 O
protected NCT03860103 432 441 B-Observation
persons NCT03860103 442 449 I-Observation

- NCT03860103 452 453 O
Not NCT03860103 455 458 O
affiliated NCT03860103 459 469 O
to NCT03860103 470 472 O
a NCT03860103 473 474 O
social NCT03860103 475 481 O
security NCT03860103 482 490 O
scheme NCT03860103 491 497 O

- NCT03860103 500 501 O
Multiple NCT03860103 503 511 B-Eq_Comparison
pregnancy NCT03860103 512 521 B-Condition

Inclusion NCT03867968 0 9 O
Criteria NCT03867968 10 18 O
: NCT03867968 19 20 O

- NCT03867968 24 25 O
Adult NCT03867968 27 32 O
18 NCT03867968 33 35 B-Eq_Comparison
years NCT03867968 36 41 I-Eq_Comparison
old NCT03867968 42 45 I-Eq_Comparison
or NCT03867968 46 48 I-Eq_Comparison
older NCT03867968 49 54 I-Eq_Comparison

- NCT03867968 57 58 O
Have NCT03867968 60 64 O
a NCT03867968 65 66 O
child NCT03867968 67 72 B-Family_Member___Family_Member_Type:child
age NCT03867968 73 76 B-Age
3 NCT03867968 77 78 B-Eq_Comparison
- NCT03867968 79 80 I-Eq_Comparison
18 NCT03867968 81 83 I-Eq_Comparison
that NCT03867968 84 88 B-And
was NCT03867968 89 92 O
hospitalized NCT03867968 93 105 B-Encounter
overnight NCT03867968 106 115 O
with NCT03867968 116 120 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03867968 121 122 O
traumatic NCT03867968 123 132 B-Condition
brain NCT03867968 133 138 I-Condition
injury NCT03867968 139 145 I-Condition
( NCT03867968 146 147 O
TBI NCT03867968 148 151 B-Condition
) NCT03867968 152 153 O
. NCT03867968 154 155 O

- NCT03867968 159 160 O
Involved NCT03867968 162 170 O
in NCT03867968 171 173 O
the NCT03867968 174 177 O
care NCT03867968 178 182 O
and NCT03867968 183 186 O
support NCT03867968 187 194 O
of NCT03867968 195 197 O
the NCT03867968 198 201 O
child NCT03867968 202 207 B-Family_Member___Family_Member_Type:child
with NCT03867968 208 212 O
the NCT03867968 213 216 O
TBI NCT03867968 217 220 B-Condition
. NCT03867968 221 222 O

- NCT03867968 226 227 O
Live NCT03867968 229 233 O
in NCT03867968 234 236 O
the NCT03867968 237 240 O
same NCT03867968 241 245 O
household NCT03867968 246 255 O
as NCT03867968 256 258 O
child NCT03867968 259 264 B-Family_Member___Family_Member_Type:child
with NCT03867968 265 269 O
a NCT03867968 270 271 O
TBI NCT03867968 272 275 B-Condition
. NCT03867968 276 277 O

- NCT03867968 281 282 O
The NCT03867968 284 287 O
child NCT03867968 288 293 B-Family_Member___Family_Member_Type:child
with NCT03867968 294 298 O
the NCT03867968 299 302 O
TBI NCT03867968 303 306 B-Condition
is NCT03867968 307 309 O
able NCT03867968 310 314 O
to NCT03867968 315 317 O
follow NCT03867968 318 324 O
simple NCT03867968 325 331 O
instructions NCT03867968 332 344 O
such NCT03867968 345 349 O
as NCT03867968 350 352 O
" NCT03867968 353 354 O
please NCT03867968 354 360 O
eat NCT03867968 361 364 O
your NCT03867968 365 369 O
toast NCT03867968 370 375 O
. NCT03867968 376 377 O
" NCT03867968 378 379 O

Exclusion NCT03867968 380 389 O
Criteria NCT03867968 390 398 O
: NCT03867968 399 400 O

- NCT03867968 404 405 O
Does NCT03867968 407 411 O
not NCT03867968 412 415 B-Negation
speak NCT03867968 416 421 O
and NCT03867968 422 425 O
read NCT03867968 426 430 O
English NCT03867968 431 438 O
. NCT03867968 439 440 O

- NCT03867968 444 445 O
Does NCT03867968 447 451 O
not NCT03867968 452 455 O
have NCT03867968 456 460 O
high NCT03867968 461 465 O
speed NCT03867968 466 471 O
Internet NCT03867968 472 480 O
access NCT03867968 481 487 O
. NCT03867968 488 489 O

- NCT03867968 493 494 O
Not NCT03867968 496 499 B-Negation
US NCT03867968 500 502 O
resident NCT03867968 503 511 O

Inclusion NCT03929419 0 9 O
Criteria NCT03929419 10 18 O
: NCT03929419 19 20 O

- NCT03929419 24 25 O
female NCT03929419 27 33 O
volunteer NCT03929419 34 43 O
adults NCT03929419 44 50 O

- NCT03929419 53 54 O
HbA NCT03929419 56 59 B-Observation
1c NCT03929419 60 62 I-Observation
< NCT03929419 63 64 B-Eq_Comparison
6.0 NCT03929419 65 68 I-Eq_Comparison
% NCT03929419 69 70 I-Eq_Comparison

- NCT03929419 74 75 O
Age NCT03929419 77 80 B-Age
between NCT03929419 81 88 B-Eq_Comparison
18 NCT03929419 89 91 I-Eq_Comparison
and NCT03929419 92 95 I-Eq_Comparison
30 NCT03929419 96 98 I-Eq_Comparison
years NCT03929419 99 104 I-Eq_Comparison

- NCT03929419 107 108 O
Standard NCT03929419 110 118 O
routine NCT03929419 119 126 B-Modifier
laboratory NCT03929419 127 137 B-Observation

- NCT03929419 140 141 O
No NCT03929419 143 145 B-Negation
underlying NCT03929419 146 156 O
diseases NCT03929419 157 165 B-Condition

- NCT03929419 168 169 O
No NCT03929419 171 173 B-Negation
medication NCT03929419 174 184 B-Drug

- NCT03929419 187 188 O
No NCT03929419 190 192 B-Negation
hormonal NCT03929419 193 201 B-Procedure
contraception NCT03929419 202 215 I-Procedure

- NCT03929419 218 219 O
Understanding NCT03929419 221 234 O
of NCT03929419 235 237 O
the NCT03929419 238 241 O
explanations NCT03929419 242 254 O
of NCT03929419 255 257 O
the NCT03929419 258 261 O
study NCT03929419 262 267 O
and NCT03929419 268 271 O
the NCT03929419 272 275 O
instructions NCT03929419 276 288 O

Exclusion NCT03929419 289 298 O
Criteria NCT03929419 299 307 O
: NCT03929419 308 309 O

- NCT03929419 313 314 O
Persons NCT03929419 316 323 O
with NCT03929419 324 328 O
limited NCT03929419 329 336 O
temperature NCT03929419 337 348 B-Condition
perception NCT03929419 349 359 I-Condition
and NCT03929419 360 363 B-Or
/ NCT03929419 364 365 I-Or
or NCT03929419 366 368 I-Or
increased NCT03929419 369 378 O
temperature NCT03929419 379 390 B-Condition
Sensitivity NCT03929419 391 402 I-Condition
to NCT03929419 403 405 O
warming NCT03929419 406 413 B-Modifier
of NCT03929419 414 416 I-Modifier
the NCT03929419 417 420 I-Modifier
body NCT03929419 421 425 I-Modifier

- NCT03929419 428 429 O
Cardiovascular NCT03929419 431 445 B-Condition
disease NCT03929419 446 453 I-Condition
, NCT03929419 454 455 O
such NCT03929419 456 460 O
as NCT03929419 461 463 O
manifest NCT03929419 464 472 O
coronary NCT03929419 473 481 B-Condition
Heart NCT03929419 482 487 I-Condition
disease NCT03929419 488 495 I-Condition
, NCT03929419 496 497 O
heart NCT03929419 498 503 B-Condition
failure NCT03929419 504 511 I-Condition
greater NCT03929419 512 519 B-Eq_Comparison
than NCT03929419 520 524 I-Eq_Comparison
NYHA NCT03929419 525 529 B-Observation
2 NCT03929419 530 531 O
, NCT03929419 532 533 O
recent NCT03929419 534 540 B-Eq_Comparison
myocardial NCT03929419 541 551 B-Condition
infarction NCT03929419 552 562 I-Condition

- NCT03929419 565 566 O
People NCT03929419 568 574 O
with NCT03929419 575 579 O
a NCT03929419 580 581 O
hearing NCT03929419 582 589 B-Condition
disorder NCT03929419 590 598 I-Condition
or NCT03929419 599 601 B-Or
increased NCT03929419 602 611 O
sensitivity NCT03929419 612 623 B-Condition
to NCT03929419 624 626 I-Condition
loud NCT03929419 627 631 I-Condition
Sounds NCT03929419 632 638 I-Condition

- NCT03929419 641 642 O
persons NCT03929419 644 651 O
with NCT03929419 652 656 O
claustrophobia NCT03929419 657 671 B-Condition

- NCT03929419 674 675 O
Minors NCT03929419 677 683 O
or NCT03929419 684 686 O
non NCT03929419 687 690 O
- NCT03929419 691 692 O
consenting NCT03929419 693 703 O
subjects NCT03929419 704 712 O
are NCT03929419 713 716 O
also NCT03929419 717 721 O
excluded NCT03929419 722 730 B-Negation

- NCT03929419 733 734 O
Pregnancy NCT03929419 736 745 B-Condition
or NCT03929419 746 748 B-Or
breastfeeding NCT03929419 749 762 B-Condition
women NCT03929419 763 768 O

- NCT03929419 771 772 O
Surgery NCT03929419 774 781 B-Procedure
less NCT03929419 782 786 B-Eq_Comparison
than NCT03929419 787 791 I-Eq_Comparison
3 NCT03929419 792 793 I-Eq_Comparison
months NCT03929419 794 800 I-Eq_Comparison
ago NCT03929419 801 804 I-Eq_Comparison

- NCT03929419 807 808 O
Simultaneous NCT03929419 810 822 O
participation NCT03929419 823 836 O
in NCT03929419 837 839 O
other NCT03929419 840 845 B-Other
interventional NCT03929419 846 860 O
studies NCT03929419 861 868 B-Study

- NCT03929419 871 872 O
Acute NCT03929419 874 879 O
illness NCT03929419 880 887 B-Condition
or NCT03929419 888 890 B-Or
infection NCT03929419 891 900 B-Condition
within NCT03929419 901 907 B-Eq_Comparison
the NCT03929419 908 911 I-Eq_Comparison
last NCT03929419 912 916 I-Eq_Comparison
4 NCT03929419 917 918 I-Eq_Comparison
weeks NCT03929419 919 924 I-Eq_Comparison

- NCT03929419 927 928 O
Neurological NCT03929419 930 942 B-Modifier
and NCT03929419 943 946 B-Or
psychiatric NCT03929419 947 958 B-Modifier
disorders NCT03929419 959 968 B-Condition

- NCT03929419 971 972 O
Subjects NCT03929419 974 982 O
with NCT03929419 983 987 O
hemoglobin NCT03929419 988 998 B-Observation
Hb NCT03929419 999 1001 I-Observation
< NCT03929419 1002 1003 B-Eq_Comparison
12 NCT03929419 1004 1006 I-Eq_Comparison
g NCT03929419 1007 1008 I-Eq_Comparison
/ NCT03929419 1009 1010 I-Eq_Comparison
dl NCT03929419 1011 1013 I-Eq_Comparison
( NCT03929419 1014 1015 O
at NCT03929419 1016 1018 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03929419 1019 1028 B-Study
) NCT03929419 1029 1030 O

- NCT03929419 1034 1035 O
Allergic NCT03929419 1037 1045 B-Allergy
diseases NCT03929419 1046 1054 B-Condition

- NCT03929419 1057 1058 O
Individuals NCT03929419 1060 1071 O
with NCT03929419 1072 1076 O
a NCT03929419 1077 1078 O
history NCT03929419 1079 1086 B-Eq_Comparison
of NCT03929419 1087 1089 O
heparin NCT03929419 1090 1097 B-Drug
- NCT03929419 1098 1099 O
induced NCT03929419 1100 1107 B-Modifier
thrombocytopenia NCT03929419 1108 1124 B-Condition
( NCT03929419 1125 1126 O
HIT NCT03929419 1127 1130 B-Condition
) NCT03929419 1131 1132 O

Inclusion NCT03925064 0 9 O
Criteria NCT03925064 10 18 O
: NCT03925064 19 20 O

- NCT03925064 24 25 O
18 NCT03925064 27 29 B-Eq_Comparison
- NCT03925064 30 31 I-Eq_Comparison
40 NCT03925064 32 34 I-Eq_Comparison
years NCT03925064 35 40 I-Eq_Comparison
old NCT03925064 41 44 B-Age
pregnant NCT03925064 45 53 B-Condition
women NCT03925064 54 59 O

Exclusion NCT03925064 60 69 O
Criteria NCT03925064 70 78 O
: NCT03925064 79 80 O

- NCT03925064 84 85 O
fetal NCT03925064 87 92 B-Condition
cardiac NCT03925064 93 100 I-Condition
anomalies NCT03925064 101 110 I-Condition

- NCT03925064 113 114 O
multiple NCT03925064 116 124 B-Condition
gestations NCT03925064 125 135 I-Condition

Inclusion NCT03861585 0 9 O
Criteria NCT03861585 10 18 O
: NCT03861585 19 20 O

- NCT03861585 24 25 O
Children NCT03861585 27 35 O
between NCT03861585 36 43 B-Eq_Comparison
7 NCT03861585 44 45 I-Eq_Comparison
and NCT03861585 46 49 I-Eq_Comparison
12 NCT03861585 50 52 I-Eq_Comparison
years NCT03861585 53 58 I-Eq_Comparison
old NCT03861585 59 62 B-Age
â¦ NCT03861585 62 63 O
â¦â¦ NCT03861585 63 65 O
â¦â¦ NCT03861585 65 67 O
â¦â¦ NCT03861585 67 69 O
â¦â¦ NCT03861585 69 71 O
â¦â¦ NCT03861585 71 73 O
. NCT03861585 74 75 O

- NCT03861585 79 80 O
Normal NCT03861585 82 88 O
or NCT03861585 89 91 B-Or
corrected NCT03861585 92 101 B-Modifier
visual NCT03861585 102 108 B-Condition
acuity NCT03861585 109 115 I-Condition
â¦ NCT03861585 116 117 O
â¦ NCT03861585 117 118 O
â¦ NCT03861585 118 119 O
â¦ NCT03861585 119 120 O
â¦â¦ NCT03861585 120 122 O
â¦â¦ NCT03861585 122 124 O
â¦â¦ NCT03861585 124 126 O
â¦â¦ NCT03861585 126 128 O
. NCT03861585 129 130 O

- NCT03861585 134 135 O
ADHD NCT03861585 137 141 B-Condition
diagnostic NCT03861585 142 152 O
given NCT03861585 153 158 O
by NCT03861585 159 161 O
a NCT03861585 162 163 O
doctor NCT03861585 164 170 O
according NCT03861585 171 180 O
to NCT03861585 181 183 O
DSM NCT03861585 184 187 O
5 NCT03861585 188 189 O
criteria NCT03861585 190 198 O
( NCT03861585 199 200 O
Diagnostic NCT03861585 201 211 O
and NCT03861585 212 215 O
Statistical NCT03861585 216 227 O
Manual NCT03861585 228 234 O
of NCT03861585 235 237 O
Mental NCT03861585 238 244 O
Disorders NCT03861585 245 254 O
) NCT03861585 255 256 O

- NCT03861585 260 261 O
Free NCT03861585 263 267 B-Negation
from NCT03861585 268 272 I-Negation
drug NCT03861585 273 277 B-Drug
treatment NCT03861585 278 287 B-Procedure
until NCT03861585 288 293 B-Eq_Comparison
24 NCT03861585 294 296 I-Eq_Comparison
hours NCT03861585 297 302 I-Eq_Comparison
before NCT03861585 303 309 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03861585 310 313 O
experiment NCT03861585 314 324 B-Study
session NCT03861585 325 332 O
â¦ NCT03861585 332 333 O
â¦â¦ NCT03861585 333 335 O
â¦â¦ NCT03861585 335 337 O
â¦â¦ NCT03861585 337 339 O
â¦â¦ NCT03861585 339 341 O
. NCT03861585 342 343 O

- NCT03861585 347 348 O
Affiliation NCT03861585 350 361 O
to NCT03861585 362 364 O
a NCT03861585 365 366 O
social NCT03861585 367 373 O
security NCT03861585 374 382 O
system NCT03861585 383 389 O
â¦â¦ NCT03861585 389 391 O
â¦â¦ NCT03861585 391 393 O
â¦â¦ NCT03861585 393 395 O
â¦â¦ NCT03861585 395 397 O
. NCT03861585 398 399 O

- NCT03861585 403 404 O
Signature NCT03861585 406 415 O
of NCT03861585 416 418 O
the NCT03861585 419 422 O
authorization NCT03861585 423 436 O
documents NCT03861585 437 446 O
from NCT03861585 447 451 O
one NCT03861585 452 455 O
parent NCT03861585 456 462 O
or NCT03861585 463 465 O
the NCT03861585 466 469 O
holder NCT03861585 470 476 O
of NCT03861585 477 479 O
parental NCT03861585 480 488 O
authority NCT03861585 489 498 O

Exclusion NCT03861585 499 508 O
Criteria NCT03861585 509 517 O
: NCT03861585 518 519 O

- NCT03861585 522 523 O
History NCT03861585 524 531 B-Eq_Comparison
of NCT03861585 532 534 O
neurological NCT03861585 535 547 B-Condition
troubles NCT03861585 548 556 I-Condition
, NCT03861585 557 558 O
dysphasia NCT03861585 559 568 B-Condition
, NCT03861585 569 570 O
autistic NCT03861585 571 579 B-Condition
spectrum NCT03861585 580 588 I-Condition
disorder NCT03861585 589 597 I-Condition
, NCT03861585 598 599 O
intellectual NCT03861585 600 612 B-Condition
disabilities NCT03861585 613 625 I-Condition


Inclusion NCT03924076 0 9 O
Criteria NCT03924076 10 18 O
: NCT03924076 19 20 O

- NCT03924076 24 25 O
children NCT03924076 27 35 O
at NCT03924076 36 38 B-And
age NCT03924076 39 42 B-Age
of NCT03924076 43 45 O
7 NCT03924076 46 47 B-Eq_Comparison
- NCT03924076 48 49 I-Eq_Comparison
9 NCT03924076 50 51 I-Eq_Comparison
years NCT03924076 52 57 I-Eq_Comparison

- NCT03924076 60 61 O
have NCT03924076 63 67 O
normal NCT03924076 68 74 O
body NCT03924076 75 79 B-Observation
mass NCT03924076 80 84 I-Observation
index NCT03924076 85 90 I-Observation
( NCT03924076 91 92 O
BMI NCT03924076 93 96 B-Observation
) NCT03924076 97 98 O
i NCT03924076 99 100 O
. NCT03924076 101 102 O
e NCT03924076 103 104 O
. NCT03924076 105 106 O
- NCT03924076 108 109 B-Eq_Comparison
2 NCT03924076 110 111 I-Eq_Comparison
â¤ NCT03924076 112 113 I-Eq_Comparison
z NCT03924076 114 115 I-Eq_Comparison
- NCT03924076 116 117 I-Eq_Comparison
score NCT03924076 118 123 I-Eq_Comparison
< NCT03924076 124 125 I-Eq_Comparison
+ NCT03924076 126 127 I-Eq_Comparison
1 NCT03924076 128 129 I-Eq_Comparison
, NCT03924076 130 131 O
slightly NCT03924076 132 140 O
overweight NCT03924076 141 151 B-Observation
z NCT03924076 152 153 B-Eq_Comparison
- NCT03924076 154 155 I-Eq_Comparison
score NCT03924076 156 161 I-Eq_Comparison
< NCT03924076 162 163 I-Eq_Comparison
+ NCT03924076 164 165 I-Eq_Comparison
1.5 NCT03924076 166 169 I-Eq_Comparison
, NCT03924076 170 171 O
and NCT03924076 172 175 B-Or
slightly NCT03924076 176 184 O
underweight NCT03924076 185 196 B-Observation
z NCT03924076 197 198 B-Eq_Comparison
- NCT03924076 199 200 I-Eq_Comparison
score NCT03924076 201 206 I-Eq_Comparison
> NCT03924076 207 208 I-Eq_Comparison
- NCT03924076 209 210 I-Eq_Comparison
3 NCT03924076 211 212 I-Eq_Comparison
. NCT03924076 212 213 O

Exclusion NCT03924076 215 224 O
Criteria NCT03924076 225 233 O
: NCT03924076 234 235 O

- NCT03924076 239 240 O
allergic NCT03924076 242 250 B-Allergy
to NCT03924076 251 253 O
milk NCT03924076 254 258 O

- NCT03924076 261 262 O
consuming NCT03924076 264 273 B-Eq_Comparison
other NCT03924076 274 279 B-Other
probiotic NCT03924076 280 289 B-Drug
product NCT03924076 290 297 I-Drug

- NCT03924076 300 301 O
he NCT03924076 303 305 O
/ NCT03924076 306 307 O
she NCT03924076 308 311 O
do NCT03924076 312 314 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03924076 315 318 I-Assertion___Assertion_Type_Value:hypothetical
want NCT03924076 319 323 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03924076 324 326 O
stop NCT03924076 327 331 O
consumption NCT03924076 332 343 O
& NCT03924076 344 345 B-And
doing NCT03924076 346 351 O
washout NCT03924076 352 359 B-Procedure
for NCT03924076 360 363 O
2 NCT03924076 364 365 B-Eq_Comparison
weeks NCT03924076 366 371 I-Eq_Comparison
. NCT03924076 372 373 O

Inclusion NCT03867877 0 9 O
Criteria NCT03867877 10 18 O
: NCT03867877 19 20 O

- NCT03867877 24 25 O
Hoehn NCT03867877 27 32 B-Condition
& NCT03867877 33 34 I-Condition
Yahr NCT03867877 35 39 I-Condition
Classification NCT03867877 40 54 I-Condition
of NCT03867877 55 57 I-Condition
Disability NCT03867877 58 68 I-Condition
, NCT03867877 69 70 O
stage NCT03867877 71 76 B-Eq_Comparison
1 NCT03867877 77 78 I-Eq_Comparison
- NCT03867877 79 80 I-Eq_Comparison
3 NCT03867877 81 82 I-Eq_Comparison

- NCT03867877 86 87 O
can NCT03867877 89 92 B-Condition
ambulate NCT03867877 93 101 I-Condition
with NCT03867877 102 106 B-And
or NCT03867877 107 109 B-Or
without NCT03867877 110 117 B-Negation
an NCT03867877 118 120 O
assistive NCT03867877 121 130 B-Procedure
device NCT03867877 131 137 I-Procedure
for NCT03867877 138 141 O
at NCT03867877 142 144 B-Eq_Comparison
least NCT03867877 145 150 I-Eq_Comparison
50 NCT03867877 151 153 I-Eq_Comparison
feet NCT03867877 154 158 I-Eq_Comparison

- NCT03867877 161 162 O
able NCT03867877 164 168 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867877 169 171 I-Assertion___Assertion_Type_Value:hypothetical
get NCT03867877 172 175 B-Observation
up NCT03867877 176 178 I-Observation
and NCT03867877 179 182 I-Observation
down NCT03867877 183 187 I-Observation
from NCT03867877 188 192 I-Observation
the NCT03867877 193 196 I-Observation
floor NCT03867877 197 202 I-Observation
with NCT03867877 203 207 O
minimal NCT03867877 208 215 B-Modifier
assistance NCT03867877 216 226 I-Modifier

- NCT03867877 229 230 O
has NCT03867877 232 235 O
a NCT03867877 236 237 O
score NCT03867877 238 243 O
of NCT03867877 244 246 O
24 NCT03867877 247 249 B-Eq_Comparison
or NCT03867877 250 252 I-Eq_Comparison
above NCT03867877 253 258 I-Eq_Comparison
on NCT03867877 259 261 O
the NCT03867877 262 265 O
Folstein NCT03867877 266 274 B-Observation
Mini NCT03867877 275 279 I-Observation
- NCT03867877 280 281 I-Observation
Mental NCT03867877 282 288 I-Observation
State NCT03867877 289 294 I-Observation
Exam NCT03867877 295 299 I-Observation

Exclusion NCT03867877 300 309 O
Criteria NCT03867877 310 318 O
: NCT03867877 319 320 O

- NCT03867877 324 325 O
Greater NCT03867877 327 334 B-Eq_Comparison
than NCT03867877 335 339 I-Eq_Comparison
Stage NCT03867877 340 345 I-Eq_Comparison
3 NCT03867877 346 347 I-Eq_Comparison
on NCT03867877 348 350 O
the NCT03867877 351 354 O
Hoehn NCT03867877 355 360 B-Condition
& NCT03867877 361 362 I-Condition
Yahr NCT03867877 363 367 I-Condition
Classification NCT03867877 368 382 I-Condition
of NCT03867877 383 385 I-Condition
Disability NCT03867877 386 396 I-Condition

- NCT03867877 399 400 O
decline NCT03867877 402 409 O
in NCT03867877 410 412 O
immune NCT03867877 413 419 B-Condition
function NCT03867877 420 428 I-Condition
such NCT03867877 429 433 O
as NCT03867877 434 436 O
pneumonia NCT03867877 437 446 B-Condition
or NCT03867877 447 449 B-Or
systemic NCT03867877 450 458 B-Modifier
infection NCT03867877 459 468 B-Condition

- NCT03867877 471 472 O
progressive NCT03867877 474 485 B-Condition
degenerative NCT03867877 486 498 I-Condition
disease NCT03867877 499 506 I-Condition
besides NCT03867877 507 514 B-Exception
PD NCT03867877 515 517 B-Condition

- NCT03867877 520 521 O
spinal NCT03867877 523 529 B-Procedure
fusion NCT03867877 530 536 I-Procedure
or NCT03867877 537 539 B-Or
other NCT03867877 540 545 B-Other
orthopedic NCT03867877 546 556 B-Procedure
surgery NCT03867877 557 564 I-Procedure
in NCT03867877 565 567 O
the NCT03867877 568 571 O
past NCT03867877 572 576 B-Eq_Comparison
six NCT03867877 577 580 I-Eq_Comparison
months NCT03867877 581 587 I-Eq_Comparison

- NCT03867877 590 591 O
mental NCT03867877 593 599 B-Condition
disease NCT03867877 600 607 I-Condition
/ NCT03867877 608 609 B-Or
psychosis NCT03867877 610 619 B-Condition
such NCT03867877 620 624 O
as NCT03867877 625 627 O
dementia NCT03867877 628 636 B-Condition

- NCT03867877 639 640 O
greater NCT03867877 642 649 B-Eq_Comparison
than NCT03867877 650 654 I-Eq_Comparison
minimal NCT03867877 655 662 B-Observation
assistance NCT03867877 663 673 I-Observation
required NCT03867877 674 682 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03867877 683 686 O
gait NCT03867877 687 691 B-Modifier
and NCT03867877 692 695 B-And
transfers NCT03867877 696 705 B-Modifier

- NCT03867877 708 709 O
inability NCT03867877 711 720 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03867877 721 723 O
make NCT03867877 724 728 O
regular NCT03867877 729 736 O
time NCT03867877 737 741 O
commitments NCT03867877 742 753 O
to NCT03867877 754 756 O
the NCT03867877 757 760 O
scheduled NCT03867877 761 770 B-Eq_Comparison
training NCT03867877 771 779 B-Procedure
sessions NCT03867877 780 788 I-Procedure

- NCT03867877 791 792 O
participation NCT03867877 794 807 O
in NCT03867877 808 810 O
resistance NCT03867877 811 821 B-Observation
training NCT03867877 822 830 I-Observation
on NCT03867877 831 833 O
a NCT03867877 834 835 O
regular NCT03867877 836 843 O
basis NCT03867877 844 849 O
within NCT03867877 850 856 B-Eq_Comparison
the NCT03867877 857 860 I-Eq_Comparison
past NCT03867877 861 865 I-Eq_Comparison
six NCT03867877 866 869 I-Eq_Comparison
months NCT03867877 870 876 I-Eq_Comparison

- NCT03867877 879 880 O
inability NCT03867877 882 891 O
to NCT03867877 892 894 O
provide NCT03867877 895 902 O
consent NCT03867877 903 910 O

- NCT03867877 913 914 O
pregnancy NCT03867877 916 925 B-Condition

- NCT03867877 928 929 O
a NCT03867877 931 932 O
prisoner NCT03867877 933 941 B-Observation

Inclusion NCT03868163 0 9 O
Criteria NCT03868163 10 18 O
: NCT03868163 19 20 O

- NCT03868163 24 25 O
Treatment NCT03868163 27 36 B-Procedure
- NCT03868163 37 38 O
naÃ¯ve NCT03868163 39 44 B-Negation
or NCT03868163 45 47 B-Or
- NCT03868163 48 49 O
pegIFN NCT03868163 50 56 B-Drug
( NCT03868163 57 58 O
or NCT03868163 59 61 B-Or
IFN NCT03868163 62 65 B-Drug
) NCT03868163 66 67 O
, NCT03868163 68 69 O
and NCT03868163 70 73 B-Or
/ NCT03868163 74 75 I-Or
or NCT03868163 76 78 I-Or
Ribavirin NCT03868163 79 88 B-Drug
( NCT03868163 89 90 O
RBV NCT03868163 91 94 B-Drug
) NCT03868163 95 96 O
and NCT03868163 97 100 B-Or
/ NCT03868163 101 102 I-Or
or NCT03868163 103 105 I-Or
sofosbuvir NCT03868163 106 116 B-Drug
( NCT03868163 117 118 O
PRS NCT03868163 119 122 B-Drug
) NCT03868163 123 124 O
experienced NCT03868163 125 136 B-Eq_Comparison
with NCT03868163 137 141 B-And
confirmed NCT03868163 142 151 O
CHC NCT03868163 152 155 B-Condition
, NCT03868163 156 157 O
genotypes NCT03868163 158 167 B-Modifier
1 NCT03868163 168 169 B-Modifier
, NCT03868163 170 171 O
2 NCT03868163 172 173 B-Modifier
, NCT03868163 174 175 O
3 NCT03868163 176 177 B-Modifier
, NCT03868163 178 179 O
4 NCT03868163 180 181 B-Modifier
, NCT03868163 182 183 O
5 NCT03868163 184 185 B-Modifier
, NCT03868163 186 187 O
or NCT03868163 188 190 B-Or
6 NCT03868163 191 192 B-Modifier
, NCT03868163 193 194 O
with NCT03868163 195 199 B-And
or NCT03868163 200 202 B-Or
without NCT03868163 203 210 B-Negation
compensated NCT03868163 211 222 B-Modifier
cirrhosis NCT03868163 223 232 B-Condition
, NCT03868163 233 234 O
receiving NCT03868163 235 244 B-Eq_Comparison
combination NCT03868163 245 256 B-Procedure
therapy NCT03868163 257 264 I-Procedure
with NCT03868163 265 269 O
the NCT03868163 270 273 O
all NCT03868163 274 277 O
oral NCT03868163 278 282 B-Drug
GLE NCT03868163 283 286 I-Drug
/ NCT03868163 287 288 B-Or
PIB NCT03868163 289 292 B-Drug
regimen NCT03868163 293 300 O
according NCT03868163 301 310 O
to NCT03868163 311 313 O
standard NCT03868163 314 322 O
of NCT03868163 323 325 O
care NCT03868163 326 330 O
, NCT03868163 331 332 O
international NCT03868163 333 346 O
guidelines NCT03868163 347 357 O
and NCT03868163 358 361 O
in NCT03868163 362 364 O
line NCT03868163 365 369 O
with NCT03868163 370 374 O
the NCT03868163 375 378 O
current NCT03868163 379 386 O
local NCT03868163 387 392 O
label NCT03868163 393 398 O
. NCT03868163 399 400 O

- NCT03868163 404 405 O
May NCT03868163 407 410 O
be NCT03868163 411 413 O
enrolled NCT03868163 414 422 O
up NCT03868163 423 425 B-Eq_Comparison
to NCT03868163 426 428 I-Eq_Comparison
4 NCT03868163 429 430 I-Eq_Comparison
weeks NCT03868163 431 436 I-Eq_Comparison
after NCT03868163 437 442 B-Temporal_Connection___Temporal_Connection_Type_Value:after
treatment NCT03868163 443 452 B-Procedure
initiation NCT03868163 453 463 B-Eq_Comparison
. NCT03868163 464 465 O

- NCT03868163 469 470 O
Patients NCT03868163 472 480 O
must NCT03868163 481 485 O
voluntarily NCT03868163 486 497 O
sign NCT03868163 498 502 O
and NCT03868163 503 506 O
date NCT03868163 507 511 O
Informed NCT03868163 512 520 O
Consent NCT03868163 521 528 O
Form NCT03868163 529 533 O
prior NCT03868163 534 539 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03868163 540 542 O
inclusion NCT03868163 543 552 O
into NCT03868163 553 557 O
the NCT03868163 558 561 O
study NCT03868163 562 567 B-Study
. NCT03868163 568 569 O

- NCT03868163 573 574 O
Patient NCT03868163 576 583 O
must NCT03868163 584 588 O
not NCT03868163 589 592 B-Negation
be NCT03868163 593 595 O
participating NCT03868163 596 609 O
or NCT03868163 610 612 O
intending NCT03868163 613 622 O
to NCT03868163 623 625 O
participate NCT03868163 626 637 O
in NCT03868163 638 640 O
a NCT03868163 641 642 O
concurrent NCT03868163 643 653 O
interventional NCT03868163 654 668 O
therapeutic NCT03868163 669 680 B-Procedure
trial NCT03868163 681 686 B-Study
. NCT03868163 687 688 O

Exclusion NCT03868163 690 699 O
Criteria NCT03868163 700 708 O
: NCT03868163 709 710 O

- NCT03868163 714 715 O
None NCT03868163 717 721 O
. NCT03868163 722 723 O

Inclusion NCT03866876 0 9 O
Criteria NCT03866876 10 18 O
: NCT03866876 19 20 O

- NCT03866876 24 25 O
All NCT03866876 27 30 O
birth NCT03866876 31 36 B-Birth
more NCT03866876 37 41 B-Eq_Comparison
than NCT03866876 42 46 I-Eq_Comparison
37 NCT03866876 47 49 I-Eq_Comparison
weeks NCT03866876 50 55 I-Eq_Comparison
of NCT03866876 56 58 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03866876 59 69 B-Condition
at NCT03866876 70 72 O
the NCT03866876 73 76 O
maternity NCT03866876 77 86 O
ward NCT03866876 87 91 O
of NCT03866876 92 94 O
the NCT03866876 95 98 O
hospital NCT03866876 99 107 O
Femme NCT03866876 108 113 O
- NCT03866876 114 115 O
MÃ¨re NCT03866876 116 120 O
- NCT03866876 121 122 O
Enfant NCT03866876 123 129 O

- NCT03866876 132 133 O
from NCT03866876 135 139 O
1 NCT03866876 140 141 B-Eq_Comparison
st NCT03866876 142 144 I-Eq_Comparison
of NCT03866876 145 147 I-Eq_Comparison
january NCT03866876 148 155 I-Eq_Comparison
2000 NCT03866876 156 160 I-Eq_Comparison
to NCT03866876 161 163 I-Eq_Comparison
31 NCT03866876 164 166 I-Eq_Comparison
december NCT03866876 167 175 I-Eq_Comparison
2016 NCT03866876 176 180 I-Eq_Comparison

Exclusion NCT03866876 182 191 O
Criteria NCT03866876 192 200 O
: NCT03866876 201 202 O

- NCT03866876 206 207 O
Infants NCT03866876 209 216 O
born NCT03866876 217 221 B-Birth
out NCT03866876 222 225 B-Negation
of NCT03866876 226 228 I-Negation
the NCT03866876 229 232 O
hospital NCT03866876 233 241 O
and NCT03866876 242 245 B-And
secondarily NCT03866876 246 257 B-Encounter
hospitalized NCT03866876 258 270 I-Encounter
in NCT03866876 271 273 O
the NCT03866876 274 277 O
hospital NCT03866876 278 286 O
Femme NCT03866876 287 292 O
- NCT03866876 293 294 O
MÃ¨re NCT03866876 295 299 O
- NCT03866876 300 301 O
Enfant NCT03866876 302 308 O

- NCT03866876 311 312 O
Children NCT03866876 314 322 O
with NCT03866876 323 327 B-And
congenital NCT03866876 328 338 B-Condition
anomalies NCT03866876 339 348 I-Condition
or NCT03866876 349 351 B-Or
without NCT03866876 352 359 B-Negation
valid NCT03866876 360 365 O
arterial NCT03866876 366 374 B-Modifier
and NCT03866876 375 378 B-Or
venous NCT03866876 379 385 B-Modifier
umbilical NCT03866876 386 395 B-Observation
cord NCT03866876 396 400 I-Observation
samples NCT03866876 401 408 I-Observation

Inclusion NCT03929549 0 9 O
Criteria NCT03929549 10 18 O
: NCT03929549 19 20 O

- NCT03929549 24 25 O
Moderate NCT03929549 27 35 O
to NCT03929549 36 38 B-Or
severe NCT03929549 39 45 O
OSA NCT03929549 46 49 B-Condition
( NCT03929549 50 51 O
AHI NCT03929549 52 55 B-Observation
> NCT03929549 56 57 B-Eq_Comparison
15 NCT03929549 58 60 I-Eq_Comparison
) NCT03929549 61 62 O

- NCT03929549 66 67 O
Age NCT03929549 69 72 B-Age
18 NCT03929549 73 75 B-Eq_Comparison
years NCT03929549 76 81 I-Eq_Comparison
or NCT03929549 82 84 I-Eq_Comparison
older NCT03929549 85 90 I-Eq_Comparison

- NCT03929549 93 94 O
BMI NCT03929549 96 99 B-Observation
< NCT03929549 100 101 B-Eq_Comparison
40 NCT03929549 102 104 I-Eq_Comparison
, NCT03929549 105 106 O

- NCT03929549 110 111 O
Baseline NCT03929549 113 121 O
polysomnogram NCT03929549 122 135 B-Procedure
completed NCT03929549 136 145 O
within NCT03929549 146 152 B-Eq_Comparison
the NCT03929549 153 156 I-Eq_Comparison
last NCT03929549 157 161 I-Eq_Comparison
12 NCT03929549 162 164 I-Eq_Comparison
months NCT03929549 165 171 I-Eq_Comparison
with NCT03929549 172 176 B-And
no NCT03929549 177 179 O
significant NCT03929549 180 191 O
weight NCT03929549 192 198 B-Observation
changes NCT03929549 199 206 O
( NCT03929549 207 208 O
< NCT03929549 209 210 B-Eq_Comparison
10 NCT03929549 211 213 I-Eq_Comparison
lbs NCT03929549 214 217 I-Eq_Comparison
. NCT03929549 218 219 O
weight NCT03929549 221 227 O
fluctuation NCT03929549 228 239 O
) NCT03929549 240 241 O
. NCT03929549 242 243 O

- NCT03929549 247 248 O
The NCT03929549 250 253 O
baseline NCT03929549 254 262 O
sleep NCT03929549 263 268 O
study NCT03929549 269 274 O
must NCT03929549 275 279 O
be NCT03929549 280 282 O
diagnostic NCT03929549 283 293 O
with NCT03929549 294 298 O
adequate NCT03929549 299 307 O
sample NCT03929549 308 314 O

Exclusion NCT03929549 315 324 O
Criteria NCT03929549 325 333 O
: NCT03929549 334 335 O

- NCT03929549 339 340 O
BMI NCT03929549 342 345 B-Observation
â¥ NCT03929549 346 347 B-Eq_Comparison
40 NCT03929549 348 350 I-Eq_Comparison

- NCT03929549 354 355 O
pregnancy NCT03929549 357 366 B-Condition

- NCT03929549 369 370 O
Central NCT03929549 372 379 B-Condition
sleep NCT03929549 380 385 I-Condition
apnea NCT03929549 386 391 I-Condition
( NCT03929549 392 393 O
CSA NCT03929549 394 397 B-Condition
) NCT03929549 398 399 O
- NCT03929549 400 401 O
5 NCT03929549 402 403 B-Eq_Comparison
or NCT03929549 404 406 I-Eq_Comparison
more NCT03929549 407 411 I-Eq_Comparison
central NCT03929549 412 419 I-Eq_Comparison|B-Observation
apneas NCT03929549 420 426 I-Eq_Comparison
per NCT03929549 427 430 I-Eq_Comparison
hour NCT03929549 431 435 I-Eq_Comparison

- NCT03929549 438 439 O
Psychoactive NCT03929549 441 453 B-Drug
medications NCT03929549 454 465 I-Drug
that NCT03929549 466 470 O
influence NCT03929549 471 480 O
sleep NCT03929549 481 486 B-Condition

- NCT03929549 489 490 O
Chronic NCT03929549 492 499 O
opioid NCT03929549 500 506 B-Drug
use NCT03929549 507 510 O

- NCT03929549 513 514 O
Other NCT03929549 516 521 B-Other
sleep NCT03929549 522 527 B-Condition
disorders NCT03929549 528 537 I-Condition

- NCT03929549 540 541 O
Active NCT03929549 543 549 B-Eq_Comparison
temporomandibular NCT03929549 550 567 B-Modifier
joint NCT03929549 568 573 I-Modifier
( NCT03929549 574 575 O
TMJ NCT03929549 576 579 B-Modifier
) NCT03929549 580 581 O
Disorders NCT03929549 582 591 B-Condition

- NCT03929549 594 595 O
Fibromyalgia NCT03929549 597 609 B-Condition
with NCT03929549 610 614 B-And
significant NCT03929549 615 626 O
facial NCT03929549 627 633 B-Modifier
pain NCT03929549 634 638 B-Condition

- NCT03929549 641 642 O
Inability NCT03929549 644 653 B-Negation
to NCT03929549 654 656 O
protrude NCT03929549 657 665 B-Observation
the NCT03929549 666 669 I-Observation
mandible NCT03929549 670 678 I-Observation
beyond NCT03929549 679 685 B-Eq_Comparison
5 NCT03929549 686 687 I-Eq_Comparison
mm NCT03929549 688 690 I-Eq_Comparison

- NCT03929549 693 694 O
Inability NCT03929549 696 705 B-Negation
to NCT03929549 706 708 O
follow NCT03929549 709 715 B-Encounter
- NCT03929549 716 717 I-Encounter
up NCT03929549 718 720 I-Encounter
after NCT03929549 721 726 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03929549 727 734 B-Procedure

- NCT03929549 737 738 O
Uncontrolled NCT03929549 740 752 B-Modifier
psychiatric NCT03929549 753 764 B-Condition
disorders NCT03929549 765 774 I-Condition

- NCT03929549 777 778 O
Dental NCT03929549 780 786 B-Condition
disorders NCT03929549 787 796 I-Condition
including NCT03929549 797 806 O
loose NCT03929549 807 812 B-Condition
teeth NCT03929549 813 818 I-Condition
and NCT03929549 819 822 B-Or
periodontal NCT03929549 823 834 B-Condition
disease NCT03929549 835 842 I-Condition

Inclusion NCT03863210 0 9 O
Criteria NCT03863210 10 18 O
: NCT03863210 19 20 O

- NCT03863210 24 25 O
female NCT03863210 27 33 O
sex NCT03863210 34 37 O

- NCT03863210 40 41 O
age NCT03863210 43 46 B-Age
45 NCT03863210 47 49 B-Eq_Comparison
to NCT03863210 50 52 I-Eq_Comparison
60 NCT03863210 53 55 I-Eq_Comparison
years NCT03863210 56 61 I-Eq_Comparison

- NCT03863210 64 65 O
one NCT03863210 67 70 B-Eq_Comparison
or NCT03863210 71 73 I-Eq_Comparison
more NCT03863210 74 78 I-Eq_Comparison
CV NCT03863210 79 81 B-Condition
risk NCT03863210 82 86 B-Risk
factors NCT03863210 87 94 I-Risk
[ NCT03863210 95 96 O
overweight NCT03863210 97 107 B-Condition
or NCT03863210 108 110 B-Or
obesity NCT03863210 111 118 B-Condition
, NCT03863210 119 120 O
i NCT03863210 121 122 O
. NCT03863210 123 124 O
e NCT03863210 126 127 O
. NCT03863210 128 129 O
body NCT03863210 131 135 B-Observation
mass NCT03863210 136 140 I-Observation
index NCT03863210 141 146 I-Observation
( NCT03863210 147 148 O
BMI NCT03863210 149 152 B-Observation
) NCT03863210 153 154 O
â¥ NCT03863210 155 156 B-Eq_Comparison
25 NCT03863210 157 159 I-Eq_Comparison
kg NCT03863210 160 162 I-Eq_Comparison
/ NCT03863210 163 164 I-Eq_Comparison
m NCT03863210 165 166 I-Eq_Comparison
2 NCT03863210 167 168 I-Eq_Comparison
, NCT03863210 169 170 O
and NCT03863210 171 174 B-Or
/ NCT03863210 175 176 I-Or
or NCT03863210 177 179 I-Or
central NCT03863210 180 187 B-Modifier
obesity NCT03863210 188 195 B-Condition
- NCT03863210 196 197 O
waist NCT03863210 198 203 B-Observation
circumference NCT03863210 204 217 I-Observation
â¥ NCT03863210 218 219 B-Eq_Comparison
88 NCT03863210 220 222 I-Eq_Comparison
cm NCT03863210 223 225 I-Eq_Comparison
, NCT03863210 226 227 O
high NCT03863210 228 232 O
blood NCT03863210 233 238 B-Observation
pressure NCT03863210 239 247 I-Observation
( NCT03863210 248 249 O
systolic NCT03863210 250 258 B-Observation
blood NCT03863210 259 264 I-Observation
pressure NCT03863210 265 273 I-Observation
â¥ NCT03863210 274 275 B-Eq_Comparison
140 NCT03863210 276 279 I-Eq_Comparison
mm NCT03863210 280 282 I-Eq_Comparison
Hg NCT03863210 283 285 I-Eq_Comparison
and NCT03863210 286 289 B-Or
/ NCT03863210 290 291 I-Or
or NCT03863210 292 294 I-Or
diastolic NCT03863210 295 304 B-Observation
blood NCT03863210 305 310 I-Observation
pressure NCT03863210 311 319 I-Observation
â¥ NCT03863210 320 321 B-Eq_Comparison
90 NCT03863210 322 324 I-Eq_Comparison
mm NCT03863210 325 327 I-Eq_Comparison
Hg NCT03863210 328 330 I-Eq_Comparison
) NCT03863210 331 332 O
, NCT03863210 333 334 O
high NCT03863210 335 339 O
blood NCT03863210 340 345 B-Observation
cholesterol NCT03863210 346 357 I-Observation
( NCT03863210 358 359 O
â¥ NCT03863210 360 361 B-Eq_Comparison
5.2 NCT03863210 362 365 I-Eq_Comparison
mmol NCT03863210 366 370 I-Eq_Comparison
/ NCT03863210 371 372 I-Eq_Comparison
L NCT03863210 373 374 I-Eq_Comparison
) NCT03863210 375 376 O
and NCT03863210 377 380 B-And
active NCT03863210 381 387 B-Eq_Comparison
smoking NCT03863210 388 395 B-Condition
] NCT03863210 396 397 O

- NCT03863210 401 402 O
participants NCT03863210 404 416 O
on NCT03863210 417 419 B-Eq_Comparison
antihypertensive NCT03863210 420 436 B-Procedure
therapy NCT03863210 437 444 I-Procedure
were NCT03863210 445 449 O
also NCT03863210 450 454 O
included NCT03863210 455 463 O
in NCT03863210 464 466 O
the NCT03863210 467 470 O
study NCT03863210 471 476 B-Study

Exclusion NCT03863210 477 486 O
Criteria NCT03863210 487 495 O
: NCT03863210 496 497 O

- NCT03863210 501 502 O
current NCT03863210 504 511 B-Eq_Comparison
cardiovascular NCT03863210 512 526 B-Condition
disease NCT03863210 527 534 I-Condition
( NCT03863210 535 536 O
CVD NCT03863210 537 540 B-Condition
) NCT03863210 541 542 O
( NCT03863210 543 544 O
ischemic NCT03863210 545 553 B-Condition
heart NCT03863210 554 559 I-Condition
disease NCT03863210 560 567 I-Condition
, NCT03863210 568 569 O
peripheral NCT03863210 570 580 B-Condition
artery NCT03863210 581 587 I-Condition
disease NCT03863210 588 595 I-Condition
, NCT03863210 596 597 O
and NCT03863210 598 601 B-Or
stroke NCT03863210 602 608 B-Condition
) NCT03863210 609 610 O

- NCT03863210 614 615 O
malignant NCT03863210 617 626 B-Condition
diseases NCT03863210 627 635 I-Condition

- NCT03863210 638 639 O
serious NCT03863210 641 648 O
systemic NCT03863210 649 657 B-Modifier
or NCT03863210 658 660 B-Or
mental NCT03863210 661 667 B-Modifier
diseases NCT03863210 668 676 B-Condition

Inclusion NCT03869164 0 9 O
Criteria NCT03869164 10 18 O
: NCT03869164 19 20 O

1 NCT03869164 24 25 O
. NCT03869164 25 26 O
age NCT03869164 28 31 B-Age
older NCT03869164 32 37 B-Eq_Comparison
than NCT03869164 38 42 I-Eq_Comparison
60 NCT03869164 43 45 I-Eq_Comparison
years NCT03869164 46 51 I-Eq_Comparison
; NCT03869164 51 52 O

2 NCT03869164 55 56 O
. NCT03869164 56 57 O
moderate NCT03869164 59 67 B-Eq_Comparison
to NCT03869164 68 70 I-Eq_Comparison
severe NCT03869164 71 77 I-Eq_Comparison
or NCT03869164 78 80 B-Or
severe NCT03869164 81 87 O
mitral NCT03869164 88 94 B-Condition
regurgitation NCT03869164 95 108 I-Condition
; NCT03869164 108 109 O

3 NCT03869164 112 113 O
. NCT03869164 113 114 O
symptoms NCT03869164 116 124 B-Assertion___Assertion_Type_Value:possible
( NCT03869164 125 126 O
New NCT03869164 127 130 B-Observation
York NCT03869164 131 135 I-Observation
Heart NCT03869164 136 141 I-Observation
Association NCT03869164 142 153 I-Observation
[ NCT03869164 154 155 O
NYHA NCT03869164 156 160 B-Observation
] NCT03869164 161 162 O
cardiac NCT03869164 163 170 O
function NCT03869164 171 179 O
class NCT03869164 180 185 O
â¥ NCT03869164 186 187 B-Eq_Comparison
2 NCT03869164 188 189 I-Eq_Comparison
) NCT03869164 190 191 O
related NCT03869164 192 199 O
to NCT03869164 200 202 O
MR NCT03869164 203 205 B-Condition
; NCT03869164 205 206 O

4 NCT03869164 209 210 O
. NCT03869164 210 211 O
the NCT03869164 213 216 O
primary NCT03869164 217 224 B-Modifier
regurgitant NCT03869164 225 236 I-Modifier
jet NCT03869164 237 240 I-Modifier
originated NCT03869164 241 251 I-Modifier
from NCT03869164 252 256 O
malcoaptation NCT03869164 257 270 B-Condition
of NCT03869164 271 273 O
the NCT03869164 274 277 O
A NCT03869164 278 279 B-Modifier
2 NCT03869164 280 281 I-Modifier
and NCT03869164 282 285 B-Or
P NCT03869164 286 287 B-Modifier
2 NCT03869164 288 289 I-Modifier
scallops NCT03869164 290 298 I-Modifier
of NCT03869164 299 301 I-Modifier
the NCT03869164 302 305 I-Modifier
mitral NCT03869164 306 312 I-Modifier
valve NCT03869164 313 318 I-Modifier
; NCT03869164 318 319 O

5 NCT03869164 322 323 O
. NCT03869164 323 324 O
high NCT03869164 326 330 O
risk NCT03869164 331 335 B-Risk
for NCT03869164 336 339 O
surgery NCT03869164 340 347 B-Procedure
according NCT03869164 348 357 O
the NCT03869164 358 361 O
MVARC NCT03869164 362 367 O
criteria NCT03869164 368 376 O
; NCT03869164 376 377 O

6 NCT03869164 380 381 O
. NCT03869164 381 382 O
providing NCT03869164 384 393 O
signed NCT03869164 394 400 O
informed NCT03869164 401 409 O
consent NCT03869164 410 417 O
. NCT03869164 418 419 O

Exclusion NCT03869164 421 430 O
Criteria NCT03869164 431 439 O
: NCT03869164 440 441 O

1 NCT03869164 445 446 O
. NCT03869164 446 447 O
acute NCT03869164 449 454 O
myocardial NCT03869164 455 465 B-Condition
infarction NCT03869164 466 476 I-Condition
in NCT03869164 477 479 O
the NCT03869164 480 483 O
prior NCT03869164 484 489 B-Eq_Comparison
4 NCT03869164 490 491 I-Eq_Comparison
weeks NCT03869164 492 497 I-Eq_Comparison
of NCT03869164 498 500 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03869164 501 504 O
intended NCT03869164 505 513 O
treatment NCT03869164 514 523 B-Procedure
; NCT03869164 523 524 O

2 NCT03869164 527 528 O
. NCT03869164 528 529 O
any NCT03869164 531 534 O
interventional NCT03869164 535 549 B-Modifier
or NCT03869164 550 552 B-Or
surgical NCT03869164 553 561 B-Modifier
cardiac NCT03869164 562 569 B-Procedure
procedure NCT03869164 570 579 I-Procedure
performed NCT03869164 580 589 O
within NCT03869164 590 596 B-Eq_Comparison
30 NCT03869164 597 599 I-Eq_Comparison
days NCT03869164 600 604 I-Eq_Comparison
prior NCT03869164 605 610 I-Eq_Comparison
; NCT03869164 610 611 O

3 NCT03869164 614 615 O
. NCT03869164 615 616 O
the NCT03869164 618 621 O
need NCT03869164 622 626 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03869164 627 630 I-Assertion___Assertion_Type_Value:hypothetical
any NCT03869164 631 634 O
other NCT03869164 635 640 B-Other
cardiac NCT03869164 641 648 B-Procedure
surgery NCT03869164 649 656 I-Procedure
; NCT03869164 656 657 O

4 NCT03869164 660 661 O
. NCT03869164 661 662 O
echocardiographic NCT03869164 664 681 B-Procedure
evidence NCT03869164 682 690 O
of NCT03869164 691 693 O
intracardiac NCT03869164 694 706 B-Condition
mass NCT03869164 707 711 B-Modifier
, NCT03869164 712 713 O
thrombus NCT03869164 714 722 B-Modifier
, NCT03869164 723 724 O
or NCT03869164 725 727 B-Or
vegetation NCT03869164 728 738 B-Modifier
; NCT03869164 738 739 O

5 NCT03869164 742 743 O
. NCT03869164 743 744 O
life NCT03869164 746 750 B-Observation
expectancy NCT03869164 751 761 I-Observation
within NCT03869164 762 768 B-Eq_Comparison
12 NCT03869164 769 771 I-Eq_Comparison
months NCT03869164 772 778 I-Eq_Comparison
; NCT03869164 778 779 O

6 NCT03869164 782 783 O
. NCT03869164 783 784 O
moderate NCT03869164 786 794 O
or NCT03869164 795 797 B-Or
severe NCT03869164 798 804 O
aortic NCT03869164 805 811 B-Condition
stenosis NCT03869164 812 820 B-Modifier
or NCT03869164 821 823 B-Or
regurgitation NCT03869164 824 837 B-Modifier
; NCT03869164 837 838 O

7 NCT03869164 841 842 O
. NCT03869164 842 843 O
mitral NCT03869164 845 851 B-Observation
valve NCT03869164 852 857 I-Observation
orifice NCT03869164 858 865 I-Observation
area NCT03869164 866 870 I-Observation
< NCT03869164 871 872 B-Eq_Comparison
3.5 NCT03869164 873 876 I-Eq_Comparison
cm NCT03869164 877 879 I-Eq_Comparison
2 NCT03869164 880 881 I-Eq_Comparison
; NCT03869164 881 882 O

8 NCT03869164 885 886 O
. NCT03869164 886 887 O
untreated NCT03869164 889 898 B-Negation|B-Procedure
significant NCT03869164 899 910 O
coronary NCT03869164 911 919 B-Condition
stenosis NCT03869164 920 928 I-Condition
; NCT03869164 928 929 O

9 NCT03869164 932 933 O
. NCT03869164 933 934 O
history NCT03869164 936 943 B-Eq_Comparison
of NCT03869164 944 946 O
mitral NCT03869164 947 953 B-Condition
valvuloplasty NCT03869164 954 967 I-Condition
; NCT03869164 967 968 O

10 NCT03869164 970 972 O
. NCT03869164 972 973 O
Infective NCT03869164 975 984 B-Condition
endocarditis NCT03869164 985 997 I-Condition
and NCT03869164 998 1001 B-Or
rheumatic NCT03869164 1002 1011 B-Condition
heart NCT03869164 1012 1017 I-Condition
disease NCT03869164 1018 1025 I-Condition
; NCT03869164 1025 1026 O

11 NCT03869164 1028 1030 O
. NCT03869164 1030 1031 O
untreated NCT03869164 1033 1042 B-Negation|B-Procedure
cardiogenic NCT03869164 1043 1054 B-Condition
shock NCT03869164 1055 1060 I-Condition
, NCT03869164 1061 1062 O
acute NCT03869164 1063 1068 O
pulmonary NCT03869164 1069 1078 B-Condition
congestion NCT03869164 1079 1089 I-Condition
; NCT03869164 1089 1090 O

12 NCT03869164 1092 1094 O
. NCT03869164 1094 1095 O
unfavored NCT03869164 1097 1106 B-Modifier
mitral NCT03869164 1107 1113 B-Condition
valve NCT03869164 1114 1119 I-Condition
anatomy NCT03869164 1120 1127 I-Condition
that NCT03869164 1128 1132 O
may NCT03869164 1133 1136 O
preclude NCT03869164 1137 1145 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
device NCT03869164 1146 1152 B-Procedure
implantation NCT03869164 1153 1165 I-Procedure
including NCT03869164 1166 1175 O
: NCT03869164 1176 1177 O

calcification NCT03869164 1184 1197 B-Modifier
or NCT03869164 1198 1200 B-Or
significant NCT03869164 1201 1212 O
cleft NCT03869164 1213 1218 B-Condition
in NCT03869164 1219 1221 O
area NCT03869164 1222 1226 B-Modifier
of NCT03869164 1227 1229 I-Modifier
the NCT03869164 1230 1233 I-Modifier
A NCT03869164 1234 1235 I-Modifier
2 NCT03869164 1236 1237 I-Modifier
and NCT03869164 1238 1241 B-Or
/ NCT03869164 1242 1243 I-Or
or NCT03869164 1244 1246 I-Or
P NCT03869164 1247 1248 B-Modifier
2 NCT03869164 1249 1250 I-Modifier
scallops NCT03869164 1251 1259 I-Modifier
, NCT03869164 1260 1261 O
significant NCT03869164 1262 1273 O
regurgitation NCT03869164 1274 1287 B-Condition
beyond NCT03869164 1288 1294 B-Negation
A NCT03869164 1295 1296 B-Modifier
2 NCT03869164 1297 1298 I-Modifier
or NCT03869164 1299 1301 B-Or
P NCT03869164 1302 1303 B-Modifier
2 NCT03869164 1304 1305 I-Modifier
scallops NCT03869164 1306 1314 I-Modifier
and NCT03869164 1315 1318 B-Or
short NCT03869164 1319 1324 B-Observation
posterior NCT03869164 1325 1334 I-Observation
leaflet NCT03869164 1335 1342 I-Observation
( NCT03869164 1343 1344 O
< NCT03869164 1345 1346 B-Eq_Comparison
10 NCT03869164 1347 1349 I-Eq_Comparison
mm NCT03869164 1350 1352 I-Eq_Comparison
) NCT03869164 1353 1354 O
. NCT03869164 1355 1356 O

13 NCT03869164 1359 1361 O
. NCT03869164 1361 1362 O
Other NCT03869164 1364 1369 B-Other
clinical NCT03869164 1370 1378 B-Study
trials NCT03869164 1379 1385 I-Study
that NCT03869164 1386 1390 O
the NCT03869164 1391 1394 O
subjects NCT03869164 1395 1403 O
participated NCT03869164 1404 1416 O
in NCT03869164 1417 1419 O
have NCT03869164 1420 1424 O
not NCT03869164 1425 1428 O
reached NCT03869164 1429 1436 O
the NCT03869164 1437 1440 O
end NCT03869164 1441 1444 O
point NCT03869164 1445 1450 O
. NCT03869164 1451 1452 O

Inclusion NCT03924817 0 9 O
Criteria NCT03924817 10 18 O
: NCT03924817 19 20 O

- NCT03924817 24 25 O
Prescription NCT03924817 27 39 O
of NCT03924817 40 42 O
a NCT03924817 43 44 O
Narval NCT03924817 45 51 B-Procedure
CC NCT03924817 52 54 I-Procedure
mandibular NCT03924817 55 65 I-Procedure
advancement NCT03924817 66 77 I-Procedure
device NCT03924817 78 84 I-Procedure

- NCT03924817 87 88 O
Age NCT03924817 90 93 B-Age
â¥ NCT03924817 94 95 B-Eq_Comparison
18 NCT03924817 96 98 I-Eq_Comparison
years NCT03924817 99 104 I-Eq_Comparison

- NCT03924817 107 108 O
Ability NCT03924817 110 117 O
to NCT03924817 118 120 O
understand NCT03924817 121 131 O
the NCT03924817 132 135 O
study NCT03924817 136 141 O
information NCT03924817 142 153 O
and NCT03924817 154 157 O
information NCT03924817 158 169 O
on NCT03924817 170 172 O
usage NCT03924817 173 178 O
of NCT03924817 179 181 O
personal NCT03924817 182 190 O
data NCT03924817 191 195 O

- NCT03924817 198 199 O
Signed NCT03924817 201 207 O
and NCT03924817 208 211 O
dated NCT03924817 212 217 O
informed NCT03924817 218 226 O
consent NCT03924817 227 234 O

Exclusion NCT03924817 235 244 O
Criteria NCT03924817 245 253 O
: NCT03924817 254 255 O

- NCT03924817 259 260 O
Patients NCT03924817 262 270 O
with NCT03924817 271 275 O
central NCT03924817 276 283 B-Condition
sleep NCT03924817 284 289 I-Condition
apnea NCT03924817 290 295 I-Condition
( NCT03924817 296 297 O
central NCT03924817 298 305 B-Observation
AI NCT03924817 306 308 I-Observation
> NCT03924817 309 310 B-Eq_Comparison
5 NCT03924817 311 312 I-Eq_Comparison
/ NCT03924817 313 314 I-Eq_Comparison
hour NCT03924817 315 319 I-Eq_Comparison
) NCT03924817 320 321 O

- NCT03924817 325 326 O
Patients NCT03924817 328 336 O
with NCT03924817 337 341 O
loose NCT03924817 342 347 B-Condition
teeth NCT03924817 348 353 I-Condition
and NCT03924817 354 357 B-Or
severe NCT03924817 358 364 O
parodontitis NCT03924817 365 377 B-Condition

- NCT03924817 380 381 O
Patients NCT03924817 383 391 O
with NCT03924817 392 396 O
completely NCT03924817 397 407 O
missing NCT03924817 408 415 B-Condition
teeth NCT03924817 416 421 I-Condition
or NCT03924817 422 424 B-Or
removable NCT03924817 425 434 B-Procedure
tooth NCT03924817 435 440 I-Procedure
replacement NCT03924817 441 452 I-Procedure
, NCT03924817 453 454 O
or NCT03924817 455 457 O
with NCT03924817 458 462 O
a NCT03924817 463 464 O
teeth NCT03924817 465 470 B-Condition
health NCT03924817 471 477 I-Condition
insufficient NCT03924817 478 490 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03924817 491 493 O
retain NCT03924817 494 500 O
an NCT03924817 501 503 O
MAD NCT03924817 504 507 B-Procedure
Patients NCT03924817 508 516 O
with NCT03924817 517 521 O
missing NCT03924817 522 529 B-Condition
molars NCT03924817 530 536 I-Condition
Patients NCT03924817 537 545 O
with NCT03924817 546 550 O
maximum NCT03924817 551 558 B-Observation
protrusion NCT03924817 559 569 I-Observation
of NCT03924817 570 572 O
less NCT03924817 573 577 B-Eq_Comparison
than NCT03924817 578 582 I-Eq_Comparison
5 NCT03924817 583 584 I-Eq_Comparison
mm NCT03924817 585 587 I-Eq_Comparison

Inclusion NCT03866161 0 9 O
Criteria NCT03866161 10 18 O
: NCT03866161 19 20 O

- NCT03866161 24 25 O
Newly NCT03866161 27 32 B-Eq_Comparison
diagnosed NCT03866161 33 42 O
obstructive NCT03866161 43 54 B-Condition
sleep NCT03866161 55 60 I-Condition
apnea NCT03866161 61 66 I-Condition
indicated NCT03866161 67 76 B-Indication
for NCT03866161 77 80 O
positive NCT03866161 81 89 O
airway NCT03866161 90 96 B-Procedure
pressure NCT03866161 97 105 I-Procedure
therapy NCT03866161 106 113 I-Procedure
, NCT03866161 114 115 O
i NCT03866161 116 117 O
. NCT03866161 118 119 O
e NCT03866161 120 121 O
. NCT03866161 122 123 O
Apnea NCT03866161 125 130 B-Observation
- NCT03866161 131 132 I-Observation
Hypopnea NCT03866161 133 141 I-Observation
index NCT03866161 142 147 I-Observation
AHI NCT03866161 148 151 B-Observation
> NCT03866161 152 153 B-Eq_Comparison
15 NCT03866161 154 156 I-Eq_Comparison

Exclusion NCT03866161 158 167 O
Criteria NCT03866161 168 176 O
: NCT03866161 177 178 O

- NCT03866161 182 183 O
Psychiatric NCT03866161 185 196 B-Procedure
treatment NCT03866161 197 206 I-Procedure

- NCT03866161 209 210 O
Treatment NCT03866161 212 221 B-Procedure
with NCT03866161 222 226 O
psychoactive NCT03866161 227 239 B-Drug
drugs NCT03866161 240 245 I-Drug

Inclusion NCT03868020 0 9 O
Criteria NCT03868020 10 18 O
: NCT03868020 19 20 O

- NCT03868020 24 25 O
Adults NCT03868020 27 33 O
with NCT03868020 34 38 B-And
biopsy NCT03868020 39 45 B-Procedure
proven NCT03868020 46 52 O
metastatic NCT03868020 53 63 B-Modifier
cervical NCT03868020 64 72 I-Modifier
nodal NCT03868020 73 78 I-Modifier
squamous NCT03868020 79 87 I-Modifier
cell NCT03868020 88 92 I-Modifier
carcinoma NCT03868020 93 102 B-Condition

- NCT03868020 105 106 O
CT NCT03868020 108 110 B-Procedure
of NCT03868020 111 113 O
the NCT03868020 114 117 O
neck NCT03868020 118 122 B-Modifier
with NCT03868020 123 127 B-And
contrast NCT03868020 128 136 B-Modifier
that NCT03868020 137 141 O
does NCT03868020 142 146 O
not NCT03868020 147 150 B-Negation
confidently NCT03868020 151 162 O
identify NCT03868020 163 171 O
a NCT03868020 172 173 O
primary NCT03868020 174 181 B-Modifier
oropharyngeal NCT03868020 182 195 I-Modifier
site NCT03868020 196 200 I-Modifier
of NCT03868020 201 203 O
disease NCT03868020 204 211 O

- NCT03868020 214 215 O
Planned NCT03868020 217 224 B-Eq_Comparison
standard NCT03868020 225 233 O
of NCT03868020 234 236 O
care NCT03868020 237 241 O
18 NCT03868020 242 244 B-Modifier
F NCT03868020 245 246 I-Modifier
- NCT03868020 247 248 I-Modifier
FDG NCT03868020 249 252 I-Modifier
PET NCT03868020 253 256 B-Procedure
CT NCT03868020 257 259 I-Procedure
examination NCT03868020 260 271 I-Procedure

- NCT03868020 274 275 O
Planned NCT03868020 277 284 B-Eq_Comparison
standard NCT03868020 285 293 O
of NCT03868020 294 296 O
care NCT03868020 297 301 B-Procedure
exam NCT03868020 302 306 I-Procedure
under NCT03868020 307 312 O
anesthesia NCT03868020 313 323 B-Procedure
with NCT03868020 324 328 B-And
oropharyngeal NCT03868020 329 342 B-Procedure
surgical NCT03868020 343 351 I-Procedure
biopsy NCT03868020 352 358 I-Procedure

Exclusion NCT03868020 359 368 O
Criteria NCT03868020 369 377 O
: NCT03868020 378 379 O

- NCT03868020 383 384 O
Pregnant NCT03868020 386 394 B-Condition
women NCT03868020 395 400 O

- NCT03868020 403 404 O
Known NCT03868020 406 411 O
allergy NCT03868020 412 419 B-Allergy
to NCT03868020 420 422 O
FDG NCT03868020 423 426 B-Drug
, NCT03868020 427 428 O
fluciclovine NCT03868020 429 441 B-Drug
, NCT03868020 442 443 O
or NCT03868020 444 446 B-Or
iodine NCT03868020 447 453 B-Modifier
- NCT03868020 454 455 I-Modifier
based NCT03868020 456 461 I-Modifier
contrast NCT03868020 462 470 B-Drug
agents NCT03868020 471 477 I-Drug

- NCT03868020 480 481 O
Severe NCT03868020 483 489 O
renal NCT03868020 490 495 B-Condition
dysfunction NCT03868020 496 507 I-Condition
( NCT03868020 508 509 O
glomerular NCT03868020 510 520 B-Observation
filtrate NCT03868020 521 529 I-Observation
rate NCT03868020 530 534 I-Observation
[ NCT03868020 535 536 O
within NCT03868020 537 543 B-Eq_Comparison
30 NCT03868020 544 546 I-Eq_Comparison
days NCT03868020 547 551 I-Eq_Comparison
] NCT03868020 552 553 O
less NCT03868020 554 558 B-Eq_Comparison
than NCT03868020 559 563 I-Eq_Comparison
30 NCT03868020 564 566 I-Eq_Comparison
) NCT03868020 567 568 O

- NCT03868020 572 573 O
Inability NCT03868020 575 584 B-Condition
to NCT03868020 585 587 I-Condition
tolerate NCT03868020 588 596 I-Condition
lying NCT03868020 597 602 I-Condition
supine NCT03868020 603 609 I-Condition
, NCT03868020 610 611 O
relatively NCT03868020 612 622 B-Modifier
motionless NCT03868020 623 633 I-Modifier
for NCT03868020 634 637 O
up NCT03868020 638 640 B-Eq_Comparison
to NCT03868020 641 643 I-Eq_Comparison
1 NCT03868020 644 645 I-Eq_Comparison
hour NCT03868020 646 650 I-Eq_Comparison

Inclusion NCT03920904 0 9 O
Criteria NCT03920904 10 18 O
: NCT03920904 19 20 O

- NCT03920904 24 25 O
ASA NCT03920904 27 30 B-Observation
l NCT03920904 31 32 B-Eq_Comparison
- NCT03920904 33 34 I-Eq_Comparison
lll NCT03920904 35 38 I-Eq_Comparison

- NCT03920904 41 42 O
Undergoing NCT03920904 44 54 B-Eq_Comparison
sternotomy NCT03920904 55 65 B-Procedure
for NCT03920904 66 69 O
cardiac NCT03920904 70 77 B-Procedure
surgery NCT03920904 78 85 I-Procedure
under NCT03920904 86 91 O
a NCT03920904 92 93 O
PIFB NCT03920904 94 98 B-Procedure
and NCT03920904 99 102 B-And
general NCT03920904 103 110 B-Procedure
anesthesia NCT03920904 111 121 I-Procedure

Exclusion NCT03920904 122 131 O
Criteria NCT03920904 132 140 O
: NCT03920904 141 142 O

- NCT03920904 146 147 O
Patient NCT03920904 149 156 O
's NCT03920904 156 158 O
refusal NCT03920904 159 166 O
or NCT03920904 167 169 O
inability NCT03920904 170 179 O
to NCT03920904 180 182 O
consent NCT03920904 183 190 O

- NCT03920904 193 194 O
Allergy NCT03920904 196 203 B-Allergy
, NCT03920904 204 205 O
hypersensibility NCT03920904 206 222 B-Condition
or NCT03920904 223 225 B-Or
resistance NCT03920904 226 236 B-Condition
to NCT03920904 237 239 O
local NCT03920904 240 245 B-Procedure
anesthetic NCT03920904 246 256 I-Procedure

- NCT03920904 259 260 O
Contraindication NCT03920904 262 278 B-Contraindication
to NCT03920904 279 281 O
regional NCT03920904 282 290 B-Procedure
anesthesia NCT03920904 291 301 I-Procedure
: NCT03920904 302 303 O
infection NCT03920904 304 313 B-Condition
in NCT03920904 314 316 O
the NCT03920904 317 320 O
designated NCT03920904 321 331 O
area NCT03920904 332 336 O
, NCT03920904 337 338 O
severe NCT03920904 339 345 O
congenital NCT03920904 346 356 B-Modifier
coagulopathy NCT03920904 357 369 B-Condition
or NCT03920904 370 372 O
inadequate NCT03920904 373 383 B-Negation
hemostasis NCT03920904 384 394 B-Procedure
before NCT03920904 395 401 B-Temporal_Connection___Temporal_Connection_Type_Value:before
PIFB NCT03920904 402 406 B-Procedure

- NCT03920904 409 410 O
Severe NCT03920904 412 418 O
hepatic NCT03920904 419 426 B-Modifier
( NCT03920904 427 428 O
Child NCT03920904 429 434 O
B NCT03920904 435 436 B-Modifier
and NCT03920904 437 440 B-Or
C NCT03920904 441 442 B-Modifier
) NCT03920904 443 444 O
or NCT03920904 445 447 B-Or
renal NCT03920904 448 453 B-Modifier
insufficiency NCT03920904 454 467 B-Condition
( NCT03920904 468 469 O
GFR NCT03920904 470 473 B-Observation
< NCT03920904 474 475 B-Eq_Comparison
30 NCT03920904 476 478 I-Eq_Comparison
mL NCT03920904 479 481 I-Eq_Comparison
/ NCT03920904 482 483 I-Eq_Comparison
min NCT03920904 484 487 I-Eq_Comparison
) NCT03920904 488 489 O

Inclusion NCT03922815 0 9 O
Criteria NCT03922815 10 18 O
: NCT03922815 19 20 O

- NCT03922815 24 25 O
written NCT03922815 27 34 O
consent NCT03922815 35 42 O
to NCT03922815 43 45 O
participate NCT03922815 46 57 O
in NCT03922815 58 60 O
the NCT03922815 61 64 O
study NCT03922815 65 70 O

- NCT03922815 73 74 O
written NCT03922815 76 83 O
consent NCT03922815 84 91 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03922815 92 94 I-Assertion___Assertion_Type_Value:hypothetical
undergo NCT03922815 95 102 B-Eq_Comparison
deep NCT03922815 103 107 B-Procedure
sedation NCT03922815 108 116 I-Procedure
for NCT03922815 117 120 O
colonoscopic NCT03922815 121 133 B-Procedure
procedure NCT03922815 134 143 I-Procedure

- NCT03922815 146 147 O
general NCT03922815 149 156 O
heath NCT03922815 157 162 O
condition NCT03922815 163 172 O
I NCT03922815 173 174 B-Eq_Comparison
- NCT03922815 175 176 I-Eq_Comparison
III NCT03922815 177 180 I-Eq_Comparison
of NCT03922815 181 183 O
American NCT03922815 184 192 B-Observation
Society NCT03922815 193 200 I-Observation
of NCT03922815 201 203 I-Observation
Anaesthesiology NCT03922815 204 219 I-Observation

Exclusion NCT03922815 220 229 O
Criteria NCT03922815 230 238 O
: NCT03922815 239 240 O

- NCT03922815 244 245 O
necessity NCT03922815 247 256 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03922815 257 259 O
administration NCT03922815 260 274 O
of NCT03922815 275 277 O
vasoactive NCT03922815 278 288 B-Drug
drugs NCT03922815 289 294 I-Drug
influencing NCT03922815 295 306 O
SPI NCT03922815 307 310 B-Procedure
monitoring NCT03922815 311 321 I-Procedure

- NCT03922815 324 325 O
pregnancy NCT03922815 327 336 B-Condition

- NCT03922815 339 340 O
anatomical NCT03922815 342 352 B-Condition
malformation NCT03922815 353 365 I-Condition
that NCT03922815 366 370 O
make NCT03922815 371 375 O
monitoring NCT03922815 376 386 B-Procedure
using NCT03922815 387 392 I-Procedure
SE NCT03922815 393 395 I-Procedure
sensor NCT03922815 396 402 I-Procedure
impossible NCT03922815 403 413 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation

- NCT03922815 416 417 O
general NCT03922815 419 426 B-Condition
atherosclerosis NCT03922815 427 442 I-Condition
, NCT03922815 443 444 O
heart NCT03922815 445 450 B-Condition
rhythm NCT03922815 451 457 I-Condition
disturbances NCT03922815 458 470 I-Condition
impairing NCT03922815 471 480 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
SPI NCT03922815 481 484 B-Procedure
monitoring NCT03922815 485 495 I-Procedure

- NCT03922815 498 499 O
chronic NCT03922815 501 508 O
medication NCT03922815 509 519 O
using NCT03922815 520 525 B-Eq_Comparison
opioid NCT03922815 526 532 B-Drug
drugs NCT03922815 533 538 I-Drug
leading NCT03922815 539 546 O
to NCT03922815 547 549 O
resistancy NCT03922815 550 560 B-Condition
to NCT03922815 561 563 I-Condition
opioids NCT03922815 564 571 I-Condition
. NCT03922815 572 573 O

Inclusion NCT03863795 0 9 O
Criteria NCT03863795 10 18 O
: NCT03863795 19 20 O

- NCT03863795 24 25 O
United NCT03863795 27 33 O
States NCT03863795 34 40 O
( NCT03863795 41 42 O
US NCT03863795 43 45 O
) NCT03863795 46 47 O
adult NCT03863795 48 53 O
smokers NCT03863795 54 61 B-Condition
. NCT03863795 62 63 O

Smokers NCT03863795 65 72 B-Condition
recruited NCT03863795 73 82 O
through NCT03863795 83 90 O
Amazon NCT03863795 91 97 O
Mechanical NCT03863795 98 108 O
Turk NCT03863795 109 113 O

Inclusion NCT03863730 0 9 O
Criteria NCT03863730 10 18 O
: NCT03863730 19 20 O

- NCT03863730 24 25 O
Prior NCT03863730 27 32 B-Eq_Comparison
or NCT03863730 33 35 B-Or
ongoing NCT03863730 36 43 B-Eq_Comparison
harmful NCT03863730 44 51 O
alcohol NCT03863730 52 59 B-Drug
intake NCT03863730 60 66 O
defined NCT03863730 67 74 O
as NCT03863730 75 77 O
an NCT03863730 78 80 O
average NCT03863730 81 88 O
of NCT03863730 89 91 O
â¥ NCT03863730 92 93 B-Eq_Comparison
24 NCT03863730 94 96 I-Eq_Comparison
g NCT03863730 97 98 I-Eq_Comparison
alcohol NCT03863730 99 106 I-Eq_Comparison
/ NCT03863730 107 108 I-Eq_Comparison
day NCT03863730 109 112 I-Eq_Comparison
for NCT03863730 113 116 O
women NCT03863730 117 122 O
and NCT03863730 123 126 O
â¥ NCT03863730 127 128 B-Eq_Comparison
36 NCT03863730 129 131 I-Eq_Comparison
g NCT03863730 132 133 I-Eq_Comparison
/ NCT03863730 134 135 I-Eq_Comparison
d NCT03863730 136 137 I-Eq_Comparison
for NCT03863730 138 141 O
men NCT03863730 142 145 O
for NCT03863730 146 149 O
â¥ NCT03863730 150 151 B-Eq_Comparison
5 NCT03863730 152 153 I-Eq_Comparison
year NCT03863730 154 158 I-Eq_Comparison
. NCT03863730 159 160 O

- NCT03863730 169 170 O
Outpatients NCT03863730 172 183 B-Encounter
with NCT03863730 184 188 B-And
compensated NCT03863730 189 200 B-Modifier
advanced NCT03863730 201 209 I-Modifier
chronic NCT03863730 210 217 I-Modifier
alcohol NCT03863730 218 225 B-Drug
- NCT03863730 226 227 O
related NCT03863730 228 235 O
liver NCT03863730 236 241 B-Condition
disease NCT03863730 242 249 I-Condition
, NCT03863730 250 251 O
defined NCT03863730 252 259 O
as NCT03863730 260 262 O
stable NCT03863730 263 269 O
patients NCT03863730 270 278 O
with NCT03863730 279 283 O
: NCT03863730 284 285 O

1 NCT03863730 299 300 O
. NCT03863730 300 301 O
liver NCT03863730 303 308 B-Condition
stiffness NCT03863730 309 318 I-Condition
â¥ NCT03863730 319 320 B-Eq_Comparison
15 NCT03863730 321 323 I-Eq_Comparison
kPa NCT03863730 324 327 B-Observation
and NCT03863730 328 331 B-And
asymptomatic NCT03863730 332 344 B-Condition
and NCT03863730 345 348 B-Or
/ NCT03863730 349 350 I-Or
or NCT03863730 351 353 I-Or

2 NCT03863730 366 367 O
. NCT03863730 367 368 O
New NCT03863730 370 373 B-Eq_Comparison
liver NCT03863730 374 379 B-Procedure
biopsy NCT03863730 380 386 I-Procedure
( NCT03863730 387 388 O
< NCT03863730 389 390 B-Eq_Comparison
6 NCT03863730 391 392 I-Eq_Comparison
months NCT03863730 393 399 I-Eq_Comparison
) NCT03863730 400 401 O
with NCT03863730 402 406 B-And
at NCT03863730 407 409 B-Eq_Comparison
least NCT03863730 410 415 I-Eq_Comparison
F NCT03863730 416 417 I-Eq_Comparison
3 NCT03863730 418 419 I-Eq_Comparison
fibrosis NCT03863730 420 428 B-Condition
( NCT03863730 429 430 O
kleiner NCT03863730 431 438 B-Modifier
) NCT03863730 439 440 O
and NCT03863730 441 444 B-Or
/ NCT03863730 445 446 I-Or
or NCT03863730 447 449 I-Or

3 NCT03863730 462 463 O
. NCT03863730 463 464 O
Liver NCT03863730 466 471 B-Procedure
biopsy NCT03863730 472 478 I-Procedure
older NCT03863730 479 484 B-Eq_Comparison
that NCT03863730 485 489 I-Eq_Comparison
6 NCT03863730 490 491 I-Eq_Comparison
months NCT03863730 492 498 I-Eq_Comparison
with NCT03863730 499 503 B-And
liver NCT03863730 504 509 B-Condition
stiffness NCT03863730 510 519 I-Condition
â¥ NCT03863730 520 521 B-Eq_Comparison
10 NCT03863730 522 524 I-Eq_Comparison
kPa NCT03863730 525 528 B-Observation

- NCT03863730 536 537 O
Understand NCT03863730 539 549 O
and NCT03863730 550 553 O
speak NCT03863730 554 559 O
Danish NCT03863730 560 566 O
written NCT03863730 567 574 O
and NCT03863730 575 578 O
orally NCT03863730 579 585 O

- NCT03863730 593 594 O
Informed NCT03863730 596 604 O
consent NCT03863730 605 612 O

Exclusion NCT03863730 613 622 O
Criteria NCT03863730 623 631 O
: NCT03863730 632 633 O

- NCT03863730 637 638 O
Hospitalised NCT03863730 640 652 B-Encounter

- NCT03863730 655 656 O
Moderete NCT03863730 658 666 O
or NCT03863730 667 669 B-Or
severe NCT03863730 670 676 O
Ascites NCT03863730 677 684 B-Condition
, NCT03863730 685 686 O
determined NCT03863730 687 697 O
from NCT03863730 698 702 O
imaging NCT03863730 703 710 B-Procedure
diagnostics NCT03863730 711 722 I-Procedure

- NCT03863730 725 726 O
High NCT03863730 728 732 O
- NCT03863730 733 734 O
risk NCT03863730 735 739 B-Risk
varices NCT03863730 740 747 B-Condition
needing NCT03863730 748 755 B-Assertion___Assertion_Type_Value:hypothetical
interventional NCT03863730 756 770 B-Procedure
treatment NCT03863730 771 780 I-Procedure
( NCT03863730 781 782 O
endoscopy NCT03863730 783 792 B-Procedure
, NCT03863730 793 794 O
TIPS NCT03863730 795 799 B-Procedure
) NCT03863730 800 801 O

- NCT03863730 805 806 O
Child NCT03863730 808 813 B-Observation
- NCT03863730 814 815 I-Observation
Pugh NCT03863730 816 820 I-Observation
C NCT03863730 821 822 B-Eq_Comparison
score NCT03863730 823 828 I-Eq_Comparison

- NCT03863730 831 832 O
MELD NCT03863730 834 838 B-Observation
- NCT03863730 839 840 I-Observation
Na NCT03863730 841 843 I-Observation
â¥ NCT03863730 844 845 B-Eq_Comparison
15 NCT03863730 846 848 I-Eq_Comparison

- NCT03863730 852 853 O
Lactose NCT03863730 855 862 B-Condition
intolerance NCT03863730 863 874 I-Condition

- NCT03863730 877 878 O
Coeliac NCT03863730 880 887 B-Condition
disease NCT03863730 888 895 I-Condition

- NCT03863730 898 899 O
Irritable NCT03863730 901 910 B-Condition
bowel NCT03863730 911 916 I-Condition
syndrome NCT03863730 917 925 I-Condition
defined NCT03863730 926 933 O
by NCT03863730 934 936 O
ROME NCT03863730 937 941 O
III NCT03863730 942 945 O
criteria NCT03863730 946 954 O

- NCT03863730 957 958 O
Antibiotic NCT03863730 960 970 B-Drug
treatment NCT03863730 971 980 B-Procedure
the NCT03863730 981 984 O
prior NCT03863730 985 990 B-Eq_Comparison
3 NCT03863730 991 992 I-Eq_Comparison
months NCT03863730 993 999 I-Eq_Comparison

- NCT03863730 1002 1003 O
Treatment NCT03863730 1005 1014 B-Procedure
with NCT03863730 1015 1019 O
nutritional NCT03863730 1020 1031 B-Drug
drinks NCT03863730 1032 1038 I-Drug
, NCT03863730 1039 1040 O
probiotics NCT03863730 1041 1051 B-Drug
or NCT03863730 1052 1054 B-Or
prebiotics NCT03863730 1055 1065 B-Drug
within NCT03863730 1066 1072 B-Eq_Comparison
the NCT03863730 1073 1076 I-Eq_Comparison
last NCT03863730 1077 1081 I-Eq_Comparison
3 NCT03863730 1082 1083 I-Eq_Comparison
months NCT03863730 1084 1090 I-Eq_Comparison

- NCT03863730 1093 1094 O
The NCT03863730 1096 1099 O
investigator NCT03863730 1100 1112 O
judge NCT03863730 1113 1118 O
that NCT03863730 1119 1123 O
the NCT03863730 1124 1127 O
patient NCT03863730 1128 1135 O
would NCT03863730 1136 1141 O
not NCT03863730 1142 1145 O
be NCT03863730 1146 1148 O
compliant NCT03863730 1149 1158 O
with NCT03863730 1159 1163 O
trial NCT03863730 1164 1169 O
medicine NCT03863730 1170 1178 O

- NCT03863730 1181 1182 O
Pregnancy NCT03863730 1184 1193 B-Condition

- NCT03863730 1196 1197 O
Known NCT03863730 1199 1204 O
liver NCT03863730 1205 1210 B-Condition
disease NCT03863730 1211 1218 I-Condition
other NCT03863730 1219 1224 B-Exception
than NCT03863730 1225 1229 O
alcoholic NCT03863730 1230 1239 B-Condition
, NCT03863730 1240 1241 O
of NCT03863730 1242 1244 O
any NCT03863730 1245 1248 O
aetiology NCT03863730 1249 1258 O

- NCT03863730 1261 1262 O
Severe NCT03863730 1264 1270 O
malnutrition NCT03863730 1271 1283 B-Condition

- NCT03863730 1286 1287 O
Malignancy NCT03863730 1289 1299 B-Condition
- NCT03863730 1300 1301 O
except NCT03863730 1302 1308 B-Exception
spino NCT03863730 1309 1314 B-Condition
- NCT03863730 1315 1316 I-Condition
or NCT03863730 1317 1319 I-Condition
basocellular NCT03863730 1320 1332 I-Condition
skin NCT03863730 1333 1337 I-Condition
cancer NCT03863730 1338 1344 I-Condition
. NCT03863730 1345 1346 O
Patients NCT03863730 1348 1356 O
with NCT03863730 1357 1361 O
prior NCT03863730 1362 1367 B-Eq_Comparison
malignant NCT03863730 1368 1377 B-Condition
disease NCT03863730 1378 1385 I-Condition
are NCT03863730 1386 1389 O
allowed NCT03863730 1390 1397 O
if NCT03863730 1398 1400 O
cancer NCT03863730 1401 1407 B-Condition
- NCT03863730 1408 1409 O
free NCT03863730 1410 1414 B-Negation
for NCT03863730 1415 1418 O
at NCT03863730 1419 1421 B-Eq_Comparison
least NCT03863730 1422 1427 I-Eq_Comparison
one NCT03863730 1428 1431 I-Eq_Comparison
year NCT03863730 1432 1436 I-Eq_Comparison

- NCT03863730 1439 1440 O
Recent NCT03863730 1442 1448 B-Eq_Comparison
infectious NCT03863730 1449 1459 B-Modifier
gastroenteritis NCT03863730 1460 1475 B-Condition
( NCT03863730 1476 1477 O
for NCT03863730 1478 1481 O
the NCT03863730 1482 1485 O
last NCT03863730 1486 1490 B-Eq_Comparison
6 NCT03863730 1491 1492 I-Eq_Comparison
weeks NCT03863730 1493 1498 I-Eq_Comparison
) NCT03863730 1499 1500 O

Inclusion NCT03865537 0 9 O
Criteria NCT03865537 10 18 O
: NCT03865537 19 20 O

- NCT03865537 24 25 O
Any NCT03865537 27 30 O
patient NCT03865537 31 38 O
â¥ NCT03865537 39 40 B-Eq_Comparison
18 NCT03865537 41 43 I-Eq_Comparison
who NCT03865537 44 47 B-And
presents NCT03865537 48 56 B-Eq_Comparison
for NCT03865537 57 60 I-Eq_Comparison
a NCT03865537 61 62 O
colonoscopy NCT03865537 63 74 B-Procedure
and NCT03865537 75 78 B-And
who NCT03865537 79 82 O
does NCT03865537 83 87 O
not NCT03865537 88 91 B-Negation
have NCT03865537 92 96 O
criteria NCT03865537 97 105 B-Condition
for NCT03865537 106 109 O
exclusion NCT03865537 110 119 B-Negation

- NCT03865537 122 123 O
Patients NCT03865537 125 133 O
with NCT03865537 134 138 O
a NCT03865537 139 140 O
â¥ NCT03865537 141 142 B-Eq_Comparison
20 NCT03865537 143 145 I-Eq_Comparison
mm NCT03865537 146 148 I-Eq_Comparison
non NCT03865537 149 152 B-Negation
- NCT03865537 153 154 O
pedunculated NCT03865537 155 167 B-Modifier
colorectal NCT03865537 168 178 B-Modifier
polyp NCT03865537 179 184 B-Observation

Exclusion NCT03865537 185 194 O
Criteria NCT03865537 195 203 O
: NCT03865537 204 205 O

- NCT03865537 209 210 O
Pedunculated NCT03865537 212 224 B-Modifier
polyps NCT03865537 225 231 B-Condition
( NCT03865537 232 233 O
as NCT03865537 234 236 O
defined NCT03865537 237 244 O
by NCT03865537 245 247 O
Paris NCT03865537 248 253 O
Classification NCT03865537 254 268 O
type NCT03865537 269 273 O
Ip NCT03865537 274 276 O
) NCT03865537 277 278 O

- NCT03865537 282 283 O
Suspected NCT03865537 285 294 B-Assertion___Assertion_Type_Value:possible
adenocarcinoma NCT03865537 295 309 B-Condition
with NCT03865537 310 314 O
deep NCT03865537 315 319 B-Modifier
submucosal NCT03865537 320 330 I-Modifier
invasion NCT03865537 331 339 I-Modifier

- NCT03865537 342 343 O
Patients NCT03865537 345 353 O
with NCT03865537 354 358 O
ulcerated NCT03865537 359 368 B-Modifier
depressed NCT03865537 369 378 I-Modifier
lesions NCT03865537 379 386 B-Condition
( NCT03865537 387 388 O
as NCT03865537 389 391 O
defined NCT03865537 392 399 O
by NCT03865537 400 402 O
Paris NCT03865537 403 408 O
Classification NCT03865537 409 423 O
type NCT03865537 424 428 O
III NCT03865537 429 432 O
) NCT03865537 433 434 O
or NCT03865537 435 437 B-Or
confirmed NCT03865537 438 447 O
adenocarcinoma NCT03865537 448 462 B-Condition

- NCT03865537 465 466 O
Patients NCT03865537 468 476 O
with NCT03865537 477 481 O
inflammatory NCT03865537 482 494 B-Condition
bowel NCT03865537 495 500 I-Condition
disease NCT03865537 501 508 I-Condition

- NCT03865537 511 512 O
Patients NCT03865537 514 522 O
who NCT03865537 523 526 O
are NCT03865537 527 530 O
receiving NCT03865537 531 540 B-Eq_Comparison
an NCT03865537 541 543 O
emergency NCT03865537 544 553 B-Modifier
colonoscopy NCT03865537 554 565 B-Procedure

- NCT03865537 568 569 O
Poor NCT03865537 571 575 B-Condition
general NCT03865537 576 583 I-Condition
health NCT03865537 584 590 I-Condition
( NCT03865537 591 592 O
ASA NCT03865537 593 596 B-Observation
class NCT03865537 597 602 O
> NCT03865537 603 604 B-Eq_Comparison
3 NCT03865537 605 606 I-Eq_Comparison
) NCT03865537 607 608 O

- NCT03865537 612 613 O
Patients NCT03865537 615 623 O
with NCT03865537 624 628 O
coagulopathy NCT03865537 629 641 B-Condition
with NCT03865537 642 646 B-And
an NCT03865537 647 649 O
elevated NCT03865537 650 658 O
INR NCT03865537 659 662 B-Observation
â¥ NCT03865537 663 664 B-Eq_Comparison
1.5 NCT03865537 665 668 I-Eq_Comparison
, NCT03865537 669 670 O
or NCT03865537 671 673 B-Or
platelets NCT03865537 674 683 B-Observation
< NCT03865537 684 685 B-Eq_Comparison
50 NCT03865537 686 688 I-Eq_Comparison

- NCT03865537 692 693 O
Inadequate NCT03865537 695 705 B-Condition
bowel NCT03865537 706 711 I-Condition
preparation NCT03865537 712 723 I-Condition
( NCT03865537 724 725 O
Boston NCT03865537 726 732 B-Observation
Bowel NCT03865537 733 738 I-Observation
Prep NCT03865537 739 743 I-Observation
Scale NCT03865537 744 749 I-Observation
, NCT03865537 750 751 O
total NCT03865537 752 757 O
score NCT03865537 758 763 O
â¤ NCT03865537 764 765 B-Eq_Comparison
2 NCT03865537 766 767 I-Eq_Comparison
) NCT03865537 768 769 O

- NCT03865537 773 774 O
Pregnancy NCT03865537 776 785 B-Condition


Inclusion NCT03862495 0 9 O
Criteria NCT03862495 10 18 O
: NCT03862495 19 20 O

1 NCT03862495 24 25 O
. NCT03862495 25 26 O
pregnant NCT03862495 28 36 B-Condition
women NCT03862495 37 42 O
on NCT03862495 43 45 O
their NCT03862495 46 51 O
first NCT03862495 52 57 B-Eq_Comparison
visit NCT03862495 58 63 B-Encounter
to NCT03862495 64 66 O
the NCT03862495 67 70 O
hospital NCT03862495 71 79 O
( NCT03862495 80 81 O
regardless NCT03862495 82 92 O
of NCT03862495 93 95 O
gestational NCT03862495 96 107 B-Observation
age NCT03862495 108 111 I-Observation
) NCT03862495 112 113 O
; NCT03862495 114 115 O

2 NCT03862495 118 119 O
. NCT03862495 119 120 O
aged NCT03862495 122 126 B-Age
18 NCT03862495 127 129 B-Eq_Comparison
or NCT03862495 130 132 I-Eq_Comparison
above NCT03862495 133 138 I-Eq_Comparison
; NCT03862495 138 139 O

3 NCT03862495 142 143 O
. NCT03862495 143 144 O
agree NCT03862495 146 151 O
to NCT03862495 152 154 O
participate NCT03862495 155 166 O
and NCT03862495 167 170 O
sign NCT03862495 171 175 O
an NCT03862495 176 178 O
informed NCT03862495 179 187 O
consent NCT03862495 188 195 O
. NCT03862495 196 197 O

Exclusion NCT03862495 199 208 O
Criteria NCT03862495 209 217 O
: NCT03862495 218 219 O

1 NCT03862495 223 224 O
. NCT03862495 224 225 O
systemic NCT03862495 227 235 B-Modifier
or NCT03862495 236 238 B-Or
topical NCT03862495 239 246 B-Modifier
vaginal NCT03862495 247 254 I-Modifier
antibiotics NCT03862495 255 266 B-Drug
use NCT03862495 267 270 O
within NCT03862495 271 277 B-Eq_Comparison
2 NCT03862495 278 279 I-Eq_Comparison
weeks NCT03862495 280 285 I-Eq_Comparison
prior NCT03862495 286 291 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862495 292 294 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03862495 295 298 O
first NCT03862495 299 304 B-Eq_Comparison
perinatal NCT03862495 305 314 B-Modifier
visit NCT03862495 315 320 B-Encounter
; NCT03862495 320 321 O

2 NCT03862495 324 325 O
. NCT03862495 325 326 O
comorbidities NCT03862495 328 341 B-Condition
that NCT03862495 342 346 O
are NCT03862495 347 350 O
known NCT03862495 351 356 O
to NCT03862495 357 359 O
be NCT03862495 360 362 O
related NCT03862495 363 370 O
to NCT03862495 371 373 O
adverse NCT03862495 374 381 B-Condition
pregnancy NCT03862495 382 391 I-Condition
outcomes NCT03862495 392 400 I-Condition
( NCT03862495 401 402 O
e NCT03862495 403 404 O
. NCT03862495 405 406 O
g NCT03862495 407 408 O
. NCT03862495 409 410 O
, NCT03862495 411 412 O
diabetes NCT03862495 413 421 B-Condition
and NCT03862495 422 425 B-Or
hypertension NCT03862495 426 438 B-Condition
) NCT03862495 439 440 O
; NCT03862495 441 442 O

3 NCT03862495 445 446 O
. NCT03862495 446 447 O
diagnosed NCT03862495 449 458 O
adverse NCT03862495 459 466 B-Condition
pregnancy NCT03862495 467 476 I-Condition
outcomes NCT03862495 477 485 I-Condition
at NCT03862495 486 488 B-Temporal_Connection___Temporal_Connection_Type_Value:during
recruitment NCT03862495 489 500 B-Study
( NCT03862495 501 502 O
e NCT03862495 503 504 O
. NCT03862495 505 506 O
g NCT03862495 507 508 O
. NCT03862495 509 510 O
, NCT03862495 511 512 O
stillbirth NCT03862495 513 523 B-Condition
) NCT03862495 524 525 O
; NCT03862495 526 527 O
Women NCT03862495 528 533 O
with NCT03862495 534 538 B-And
a NCT03862495 539 540 O
previous NCT03862495 541 549 B-Eq_Comparison
history NCT03862495 550 557 I-Eq_Comparison
of NCT03862495 558 560 O
CT NCT03862495 561 563 B-Procedure
or NCT03862495 564 566 B-Or
NG NCT03862495 567 569 B-Procedure
and NCT03862495 570 573 B-Or
women NCT03862495 574 579 O
with NCT03862495 580 584 B-And
a NCT03862495 585 586 O
prior NCT03862495 587 592 B-Eq_Comparison
adverse NCT03862495 593 600 B-Condition
outcome NCT03862495 601 608 I-Condition
will NCT03862495 609 613 O
not NCT03862495 614 617 O
be NCT03862495 618 620 O
excluded NCT03862495 621 629 O
. NCT03862495 630 631 O
Instead NCT03862495 633 640 O
, NCT03862495 641 642 O
the NCT03862495 643 646 O
investigators NCT03862495 647 660 O
will NCT03862495 661 665 O
conduct NCT03862495 666 673 O
sub NCT03862495 674 677 O
- NCT03862495 678 679 O
analysis NCT03862495 680 688 O
and NCT03862495 689 692 O
check NCT03862495 693 698 O
whether NCT03862495 699 706 O
the NCT03862495 707 710 O
intervention NCT03862495 711 723 O
has NCT03862495 724 727 O
different NCT03862495 728 737 O
effects NCT03862495 738 745 O
on NCT03862495 746 748 O
different NCT03862495 749 758 O
groups NCT03862495 759 765 O
of NCT03862495 766 768 O
pregnant NCT03862495 769 777 O
women NCT03862495 778 783 O
. NCT03862495 784 785 O

Inclusion NCT03863613 0 9 O
Criteria NCT03863613 10 18 O
: NCT03863613 19 20 O

- NCT03863613 24 25 O
Women NCT03863613 27 32 O
with NCT03863613 33 37 B-And
a NCT03863613 38 39 O
twin NCT03863613 40 44 B-Modifier
pregnancy NCT03863613 45 54 B-Condition
( NCT03863613 55 56 O
mono NCT03863613 57 61 B-Modifier
- NCT03863613 62 63 I-Modifier
and NCT03863613 64 67 B-Or
di NCT03863613 68 70 B-Modifier
- NCT03863613 71 72 I-Modifier
chorionic NCT03863613 73 82 I-Modifier
) NCT03863613 83 84 O

- NCT03863613 88 89 O
16 NCT03863613 91 93 B-Eq_Comparison
0 NCT03863613 94 95 I-Eq_Comparison
/ NCT03863613 96 97 I-Eq_Comparison
7 NCT03863613 98 99 I-Eq_Comparison
to NCT03863613 100 102 I-Eq_Comparison
22 NCT03863613 103 105 I-Eq_Comparison
0 NCT03863613 106 107 I-Eq_Comparison
/ NCT03863613 108 109 I-Eq_Comparison
7 NCT03863613 110 111 I-Eq_Comparison
weeks NCT03863613 112 117 I-Eq_Comparison
of NCT03863613 118 120 O
gestation NCT03863613 121 130 B-Observation

- NCT03863613 133 134 O
Maternal NCT03863613 136 144 O
age NCT03863613 145 148 B-Age
â¥ NCT03863613 149 150 B-Eq_Comparison
18 NCT03863613 151 153 I-Eq_Comparison
yrs NCT03863613 154 157 I-Eq_Comparison

- NCT03863613 160 161 O
Cervical NCT03863613 163 171 B-Observation
length NCT03863613 172 178 I-Observation
â¤ NCT03863613 179 180 B-Eq_Comparison
28 NCT03863613 181 183 I-Eq_Comparison
mm NCT03863613 184 186 I-Eq_Comparison

- NCT03863613 189 190 O
Informed NCT03863613 192 200 O
consent NCT03863613 201 208 O

- NCT03863613 211 212 O
Not NCT03863613 214 217 B-Negation
participating NCT03863613 218 231 O
in NCT03863613 232 234 O
another NCT03863613 235 242 B-Other
preterm NCT03863613 243 250 B-Modifier
birth NCT03863613 251 256 B-Birth
study NCT03863613 257 262 B-Study
at NCT03863613 263 265 O
the NCT03863613 266 269 O
same NCT03863613 270 274 O
time NCT03863613 275 279 O

Exclusion NCT03863613 280 289 O
Criteria NCT03863613 290 298 O
: NCT03863613 299 300 O

- NCT03863613 304 305 O
Uterine NCT03863613 307 314 B-Condition
anomalies NCT03863613 315 324 I-Condition

- NCT03863613 327 328 O
Cervical NCT03863613 330 338 B-Condition
dilation NCT03863613 339 347 I-Condition
with NCT03863613 348 352 B-And
visible NCT03863613 353 360 O
amniotic NCT03863613 361 369 B-Condition
membranes NCT03863613 370 379 I-Condition
or NCT03863613 380 382 B-Or
amniotic NCT03863613 383 391 B-Condition
membranes NCT03863613 392 401 I-Condition
prolapsed NCT03863613 402 411 I-Condition
into NCT03863613 412 416 B-Modifier
the NCT03863613 417 420 I-Modifier
vagina NCT03863613 421 427 I-Modifier

- NCT03863613 430 431 O
Twin NCT03863613 433 437 B-Modifier
- NCT03863613 438 439 I-Modifier
to NCT03863613 440 442 I-Modifier
- NCT03863613 443 444 I-Modifier
twin NCT03863613 445 449 I-Modifier
transfusion NCT03863613 450 461 B-Condition
syndrome NCT03863613 462 470 I-Condition

- NCT03863613 473 474 O
Stillbirth NCT03863613 476 486 B-Condition
or NCT03863613 487 489 B-Or
major NCT03863613 490 495 O
congenital NCT03863613 496 506 B-Condition
abnormalities NCT03863613 507 520 I-Condition
in NCT03863613 521 523 O
any NCT03863613 524 527 O
of NCT03863613 528 530 O
the NCT03863613 531 534 O
fetus NCT03863613 535 540 B-Modifier

- NCT03863613 543 544 O
Severe NCT03863613 546 552 O
vaginal NCT03863613 553 560 B-Condition
discharge NCT03863613 561 570 I-Condition

- NCT03863613 573 574 O
Acute NCT03863613 576 581 O
vaginitis NCT03863613 582 591 B-Condition
or NCT03863613 592 594 B-Or
cervicitis NCT03863613 595 605 B-Condition

- NCT03863613 608 609 O
Vaginal NCT03863613 611 618 B-Modifier
bleeding NCT03863613 619 627 B-Condition

- NCT03863613 630 631 O
Placental NCT03863613 633 642 B-Condition
preavia NCT03863613 643 650 I-Condition

- NCT03863613 653 654 O
Vasa NCT03863613 656 660 B-Condition
preavia NCT03863613 661 668 I-Condition

- NCT03863613 671 672 O
Premature NCT03863613 674 683 B-Modifier
rupture NCT03863613 684 691 B-Condition
of NCT03863613 692 694 I-Condition
membranes NCT03863613 695 704 I-Condition

- NCT03863613 707 708 O
Premature NCT03863613 710 719 B-Modifier
labor NCT03863613 720 725 B-Condition
with NCT03863613 726 730 B-And
/ NCT03863613 731 732 B-Or
without NCT03863613 733 740 B-Negation
ruptured NCT03863613 741 749 B-Condition
membrane NCT03863613 750 758 I-Condition

- NCT03863613 761 762 O
Suspicion NCT03863613 764 773 B-Assertion___Assertion_Type_Value:possible
of NCT03863613 774 776 O
chorioamnionitis NCT03863613 777 793 B-Condition

- NCT03863613 796 797 O
Cerclage NCT03863613 799 807 B-Condition
in NCT03863613 808 810 I-Condition
place NCT03863613 811 816 I-Condition
or NCT03863613 817 819 B-Or
unable NCT03863613 820 826 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03863613 827 829 O
undergo NCT03863613 830 837 O
cervical NCT03863613 838 846 B-Procedure
cerclage NCT03863613 847 855 B-Modifier
or NCT03863613 856 858 B-Or
pessary NCT03863613 859 866 B-Modifier

Inclusion NCT03929926 0 9 O
Criteria NCT03929926 10 18 O
: NCT03929926 19 20 O

- NCT03929926 24 25 O
Had NCT03929926 27 30 O
a NCT03929926 31 32 O
recent NCT03929926 33 39 B-Eq_Comparison
office NCT03929926 40 46 B-Encounter
visit NCT03929926 47 52 I-Encounter
with NCT03929926 53 57 O
a NCT03929926 58 59 O
primary NCT03929926 60 67 B-Provider
care NCT03929926 68 72 I-Provider
physician NCT03929926 73 82 I-Provider
in NCT03929926 83 85 O
one NCT03929926 86 89 O
of NCT03929926 90 92 O
the NCT03929926 93 96 O
study NCT03929926 97 102 O
practices NCT03929926 103 112 O
. NCT03929926 113 114 O

- NCT03929926 118 119 O
History NCT03929926 121 128 B-Eq_Comparison
of NCT03929926 129 131 O
smoking NCT03929926 132 139 B-Condition
( NCT03929926 140 141 O
current NCT03929926 142 149 B-Eq_Comparison
or NCT03929926 150 152 B-Or
former NCT03929926 153 159 B-Eq_Comparison
) NCT03929926 160 161 O
in NCT03929926 162 164 O
the NCT03929926 165 168 O
electronic NCT03929926 169 179 O
health NCT03929926 180 186 O
record NCT03929926 187 193 O
( NCT03929926 194 195 O
EHR NCT03929926 196 199 O
) NCT03929926 200 201 O
. NCT03929926 202 203 O

Exclusion NCT03929926 205 214 O
Criteria NCT03929926 215 223 O
: NCT03929926 224 225 O

- NCT03929926 229 230 O
LDCT NCT03929926 232 236 B-Procedure
performed NCT03929926 237 246 O
in NCT03929926 247 249 O
the NCT03929926 250 253 O
12 NCT03929926 254 256 B-Eq_Comparison
months NCT03929926 257 263 I-Eq_Comparison
prior NCT03929926 264 269 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03929926 270 272 I-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03929926 273 278 B-Study
initiation NCT03929926 279 289 O
according NCT03929926 290 299 O
to NCT03929926 300 302 O
EHR NCT03929926 303 306 O
. NCT03929926 307 308 O

- NCT03929926 312 313 O
Diagnosis NCT03929926 315 324 O
of NCT03929926 325 327 O
lung NCT03929926 328 332 B-Modifier
cancer NCT03929926 333 339 B-Condition
indicated NCT03929926 340 349 O
in NCT03929926 350 352 O
problem NCT03929926 353 360 O
list NCT03929926 361 365 O
in NCT03929926 366 368 O
the NCT03929926 369 372 O
EHR NCT03929926 373 376 O
. NCT03929926 377 378 O

Inclusion NCT03929341 0 9 O
Criteria NCT03929341 10 18 O
: NCT03929341 19 20 O

- NCT03929341 24 25 O
Men NCT03929341 27 30 O
and NCT03929341 31 34 B-Or
women NCT03929341 35 40 O
age NCT03929341 41 44 B-Age
â¥ NCT03929341 45 46 B-Eq_Comparison
40 NCT03929341 47 49 I-Eq_Comparison
years NCT03929341 50 55 I-Eq_Comparison
of NCT03929341 56 58 O
age NCT03929341 59 62 O

- NCT03929341 65 66 O
Stable NCT03929341 68 74 O
chest NCT03929341 75 80 B-Modifier
pain NCT03929341 81 85 B-Condition
or NCT03929341 86 88 B-Or
equivalent NCT03929341 89 99 B-Modifier
symptoms NCT03929341 100 108 B-Assertion___Assertion_Type_Value:possible

- NCT03929341 111 112 O
Planned NCT03929341 114 121 B-Eq_Comparison
non NCT03929341 122 125 B-Negation
- NCT03929341 126 127 O
urgent NCT03929341 128 134 B-Modifier
, NCT03929341 135 136 O
non NCT03929341 137 140 B-Negation
- NCT03929341 141 142 O
invasive NCT03929341 143 151 B-Modifier
testing NCT03929341 152 159 B-Procedure
for NCT03929341 160 163 O
diagnosis NCT03929341 164 173 O
of NCT03929341 174 176 O
chest NCT03929341 177 182 B-Modifier
pain NCT03929341 183 187 B-Condition
or NCT03929341 188 190 B-Or
equivalent NCT03929341 191 201 B-Modifier
symptoms NCT03929341 202 210 B-Assertion___Assertion_Type_Value:possible

Exclusion NCT03929341 211 220 O
Criteria NCT03929341 221 229 O
: NCT03929341 230 231 O

- NCT03929341 235 236 O
Acute NCT03929341 238 243 O
coronary NCT03929341 244 252 B-Condition
syndrome NCT03929341 253 261 I-Condition
, NCT03929341 262 263 O
including NCT03929341 264 273 O
acute NCT03929341 274 279 O
myocardial NCT03929341 280 290 B-Condition
infarction NCT03929341 291 301 I-Condition
or NCT03929341 302 304 B-Or
unstable NCT03929341 305 313 O
angina NCT03929341 314 320 B-Condition
, NCT03929341 321 322 O
known NCT03929341 323 328 O
non NCT03929341 329 332 B-Negation
- NCT03929341 333 334 O
ischemic NCT03929341 335 343 B-Modifier
cardiomyopathy NCT03929341 344 358 B-Condition
or NCT03929341 359 361 B-Or
other NCT03929341 362 367 B-Other
cardiac NCT03929341 368 375 B-Condition
disease NCT03929341 376 383 I-Condition
( NCT03929341 384 385 O
e NCT03929341 386 387 O
. NCT03929341 388 389 O
g NCT03929341 390 391 O
. NCT03929341 392 393 O
mitral NCT03929341 395 401 B-Condition
valve NCT03929341 402 407 I-Condition
prolapse NCT03929341 408 416 I-Condition
, NCT03929341 417 418 O
etc NCT03929341 419 422 O
. NCT03929341 423 424 O
) NCT03929341 425 426 O
which NCT03929341 427 432 O
would NCT03929341 433 438 B-Assertion___Assertion_Type_Value:hypothetical
require NCT03929341 439 446 O
urgent NCT03929341 447 453 B-Modifier
cardiac NCT03929341 454 461 B-Procedure
evaluation NCT03929341 462 472 I-Procedure

- NCT03929341 475 476 O
Known NCT03929341 478 483 O
CAD NCT03929341 484 487 B-Condition

- NCT03929341 490 491 O
Prior NCT03929341 493 498 B-Eq_Comparison
cardiac NCT03929341 499 506 B-Procedure
evaluation NCT03929341 507 517 I-Procedure
for NCT03929341 518 521 O
current NCT03929341 522 529 B-Eq_Comparison
episode NCT03929341 530 537 O
of NCT03929341 538 540 O
symptoms NCT03929341 541 549 B-Condition

- NCT03929341 552 553 O
Previously NCT03929341 555 565 B-Eq_Comparison
investigated NCT03929341 566 578 B-Procedure
for NCT03929341 579 582 O
CAD NCT03929341 583 586 B-Condition
in NCT03929341 587 589 O
the NCT03929341 590 593 O
last NCT03929341 594 598 B-Eq_Comparison
12 NCT03929341 599 601 I-Eq_Comparison
months NCT03929341 602 608 I-Eq_Comparison

- NCT03929341 611 612 O
Severe NCT03929341 614 620 O
allergic NCT03929341 621 629 B-Allergy
reaction NCT03929341 630 638 O
to NCT03929341 639 641 O
iodinated NCT03929341 642 651 O
contrast NCT03929341 652 660 O
( NCT03929341 661 662 O
mild NCT03929341 663 667 O
reactions NCT03929341 668 677 O
such NCT03929341 678 682 O
as NCT03929341 683 685 O
urticaria NCT03929341 686 695 B-Condition
that NCT03929341 696 700 O
can NCT03929341 701 704 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03929341 705 707 O
controlled NCT03929341 708 718 O
by NCT03929341 719 721 O
premedication NCT03929341 722 735 B-Procedure
with NCT03929341 736 740 O
Benadryl NCT03929341 741 749 B-Drug
& NCT03929341 750 751 B-Or
Prednisone NCT03929341 752 762 B-Drug
may NCT03929341 763 766 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03929341 767 769 O
included NCT03929341 770 778 O
in NCT03929341 779 781 O
the NCT03929341 782 785 O
study NCT03929341 786 791 B-Study
) NCT03929341 792 793 O

- NCT03929341 797 798 O
Renal NCT03929341 800 805 B-Condition
failure NCT03929341 806 813 I-Condition
or NCT03929341 814 816 B-Or
dysfunction NCT03929341 817 828 B-Condition
( NCT03929341 829 830 O
estimated NCT03929341 831 840 B-Observation
Glomerular NCT03929341 841 851 I-Observation
Filtration NCT03929341 852 862 I-Observation
Rate NCT03929341 863 867 I-Observation
< NCT03929341 868 869 B-Eq_Comparison
30 NCT03929341 870 872 I-Eq_Comparison
ml NCT03929341 873 875 I-Eq_Comparison
/ NCT03929341 876 877 I-Eq_Comparison
min NCT03929341 878 881 I-Eq_Comparison
/ NCT03929341 882 883 I-Eq_Comparison
m NCT03929341 884 885 I-Eq_Comparison
2 NCT03929341 886 887 I-Eq_Comparison
within NCT03929341 888 894 B-Eq_Comparison
the NCT03929341 895 898 I-Eq_Comparison
past NCT03929341 899 903 I-Eq_Comparison
3 NCT03929341 904 905 I-Eq_Comparison
months NCT03929341 906 912 I-Eq_Comparison
) NCT03929341 913 914 O

- NCT03929341 918 919 O
Pregnancy NCT03929341 921 930 B-Condition
( NCT03929341 931 932 O
status NCT03929341 933 939 O
will NCT03929341 940 944 O
be NCT03929341 945 947 O
confirmed NCT03929341 948 957 O
verbally NCT03929341 958 966 O
. NCT03929341 967 968 O
For NCT03929341 970 973 O
premenopausal NCT03929341 974 987 B-Condition
patients NCT03929341 988 996 O
who NCT03929341 997 1000 O
are NCT03929341 1001 1004 O
unsure NCT03929341 1005 1011 O
, NCT03929341 1012 1013 O
status NCT03929341 1014 1020 O
will NCT03929341 1021 1025 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03929341 1026 1028 I-Assertion___Assertion_Type_Value:hypothetical
confirmed NCT03929341 1029 1038 O
by NCT03929341 1039 1041 O
completing NCT03929341 1042 1052 O
a NCT03929341 1053 1054 O
pregnancy NCT03929341 1055 1064 B-Observation
strip NCT03929341 1065 1070 I-Observation
test NCT03929341 1071 1075 I-Observation
) NCT03929341 1076 1077 O
. NCT03929341 1078 1079 O

Inclusion NCT03929731 0 9 O
Criteria NCT03929731 10 18 O
: NCT03929731 19 20 O

- NCT03929731 24 25 O
Participants NCT03929731 27 39 O
will NCT03929731 40 44 O
have NCT03929731 45 49 O
completed NCT03929731 50 59 O
the NCT03929731 60 63 O
previous NCT03929731 64 72 B-Eq_Comparison
PCV NCT03929731 73 76 B-Procedure
RCTs NCT03929731 77 81 O
: NCT03929731 82 83 O
EVEREST NCT03929731 84 91 O
II NCT03929731 92 94 O
, NCT03929731 95 96 O
PLANET NCT03929731 97 103 O
and NCT03929731 104 107 O
PCV NCT03929731 108 111 B-Procedure
T&amp;E NCT03929731 112 119 O
studies NCT03929731 120 127 O

- NCT03929731 130 131 O
Are NCT03929731 133 136 O
able NCT03929731 137 141 O
to NCT03929731 142 144 O
give NCT03929731 145 149 O
consent NCT03929731 150 157 O
for NCT03929731 158 161 O
this NCT03929731 162 166 O
follow NCT03929731 167 173 O
up NCT03929731 174 176 O
study NCT03929731 177 182 O

Exclusion NCT03929731 183 192 O
Criteria NCT03929731 193 201 O
: NCT03929731 202 203 O

- NCT03929731 207 208 O
No NCT03929731 210 212 O
exclusion NCT03929731 213 222 O
criteria NCT03929731 223 231 O
unless NCT03929731 232 238 O
they NCT03929731 239 243 O
do NCT03929731 244 246 O
not NCT03929731 247 250 O
meet NCT03929731 251 255 O
the NCT03929731 256 259 O
inclusion NCT03929731 260 269 O
criteria NCT03929731 270 278 O

Inclusion NCT03861182 0 9 O
Criteria NCT03861182 10 18 O
: NCT03861182 19 20 O

Adult NCT03861182 22 27 O
Healthy NCT03861182 28 35 B-Condition
Volunteers NCT03861182 36 46 O
: NCT03861182 47 48 O

- NCT03861182 51 52 O
Over NCT03861182 53 57 B-Eq_Comparison
18 NCT03861182 58 60 I-Eq_Comparison
years NCT03861182 61 66 I-Eq_Comparison
of NCT03861182 67 69 O
age NCT03861182 70 73 B-Age

Neonates NCT03861182 74 82 B-Condition
: NCT03861182 83 84 O

- NCT03861182 88 89 O
Aged NCT03861182 91 95 B-Age
between NCT03861182 96 103 B-Eq_Comparison
1 NCT03861182 104 105 I-Eq_Comparison
h NCT03861182 106 107 I-Eq_Comparison
of NCT03861182 108 110 I-Eq_Comparison
life NCT03861182 111 115 I-Eq_Comparison
and NCT03861182 116 119 I-Eq_Comparison
28 NCT03861182 120 122 I-Eq_Comparison
days NCT03861182 123 127 I-Eq_Comparison
of NCT03861182 128 130 O
life NCT03861182 131 135 O

- NCT03861182 138 139 O
Born NCT03861182 141 145 B-Birth
beyond NCT03861182 146 152 B-Eq_Comparison
33 NCT03861182 153 155 I-Eq_Comparison
Week NCT03861182 156 160 I-Eq_Comparison
of NCT03861182 161 163 B-Temporal_Connection___Temporal_Connection_Type_Value:after
Amenorrhea NCT03861182 164 174 B-Condition
+ NCT03861182 175 176 B-Temporal_Connection___Temporal_Connection_Type_Value:after
1 NCT03861182 177 178 B-Eq_Comparison
day NCT03861182 179 182 I-Eq_Comparison
and NCT03861182 183 186 B-And
2 NCT03861182 187 188 B-Eq_Comparison
kg NCT03861182 189 191 I-Eq_Comparison
of NCT03861182 192 194 O
birth NCT03861182 195 200 B-Observation
weight NCT03861182 201 207 I-Observation

- NCT03861182 210 211 O
Hospitalized NCT03861182 213 225 B-Encounter
in NCT03861182 226 228 O
the NCT03861182 229 232 O
medical NCT03861182 233 240 O
- NCT03861182 241 242 O
surgical NCT03861182 243 251 O
centre NCT03861182 252 258 O
of NCT03861182 259 261 O
Pediatrics NCT03861182 262 272 O
of NCT03861182 273 275 O
the NCT03861182 276 279 O
hospital NCT03861182 280 288 O
of NCT03861182 289 291 O
Strasbourg NCT03861182 292 302 O

- NCT03861182 305 306 O
For NCT03861182 308 311 O
whom NCT03861182 312 316 O
a NCT03861182 317 318 O
blood NCT03861182 319 324 B-Observation
sample NCT03861182 325 331 I-Observation
was NCT03861182 332 335 O
prescribed NCT03861182 336 346 O
as NCT03861182 347 349 O
part NCT03861182 350 354 O
of NCT03861182 355 357 O
their NCT03861182 358 363 O
routine NCT03861182 364 371 O
care NCT03861182 372 376 O

Exclusion NCT03861182 377 386 O
Criteria NCT03861182 387 395 O
: NCT03861182 396 397 O

Adult NCT03861182 399 404 O
Healthy NCT03861182 405 412 B-Condition
Volunteers NCT03861182 413 423 O
: NCT03861182 424 425 O

- NCT03861182 429 430 O
Systemic NCT03861182 432 440 B-Modifier
inflammatory NCT03861182 441 453 B-Condition
disease NCT03861182 454 461 I-Condition

- NCT03861182 464 465 O
Transient NCT03861182 467 476 B-Condition
inflammatory NCT03861182 477 489 I-Condition
state NCT03861182 490 495 I-Condition

- NCT03861182 498 499 O
Any NCT03861182 501 504 O
drug NCT03861182 505 509 B-Drug
that NCT03861182 510 514 O
modifies NCT03861182 515 523 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03861182 524 527 O
coagulation NCT03861182 528 539 B-Condition
cascade NCT03861182 540 547 I-Condition
during NCT03861182 548 554 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861182 555 558 O
48 NCT03861182 559 561 B-Eq_Comparison
h NCT03861182 562 563 I-Eq_Comparison
preceding NCT03861182 564 573 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03861182 574 577 O
sampling NCT03861182 578 586 B-Study

Neonates NCT03861182 587 595 O
: NCT03861182 596 597 O

- NCT03861182 601 602 O
Risk NCT03861182 604 608 B-Risk
of NCT03861182 609 611 O
anemia NCT03861182 612 618 B-Condition
< NCT03861182 619 620 B-Eq_Comparison
7 NCT03861182 621 622 I-Eq_Comparison
g NCT03861182 623 624 I-Eq_Comparison
/ NCT03861182 625 626 I-Eq_Comparison
DL NCT03861182 627 629 I-Eq_Comparison

- NCT03861182 632 633 O
Current NCT03861182 635 642 B-Eq_Comparison
anticoagulant NCT03861182 643 656 B-Drug
treatment NCT03861182 657 666 B-Procedure

Inclusion NCT03865381 0 9 O
Criteria NCT03865381 10 18 O
: NCT03865381 19 20 O

- NCT03865381 24 25 O
Male NCT03865381 27 31 O
and NCT03865381 32 35 B-Or
Female NCT03865381 36 42 O
; NCT03865381 42 43 O
18 NCT03865381 44 46 B-Eq_Comparison
years NCT03865381 47 52 I-Eq_Comparison
of NCT03865381 53 55 I-Eq_Comparison
age NCT03865381 56 59 I-Eq_Comparison
or NCT03865381 60 62 I-Eq_Comparison
older NCT03865381 63 68 I-Eq_Comparison

- NCT03865381 71 72 O
Confirmed NCT03865381 74 83 O
diagnosis NCT03865381 84 93 O
of NCT03865381 94 96 O
Type NCT03865381 97 101 B-Modifier
2 NCT03865381 102 103 I-Modifier
diabetes NCT03865381 104 112 B-Condition
mellitus NCT03865381 113 121 I-Condition

- NCT03865381 124 125 O
Willing NCT03865381 127 134 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865381 135 137 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03865381 138 141 O
CGM NCT03865381 142 145 B-Procedure
and NCT03865381 146 149 B-Or
BGM NCT03865381 150 153 B-Procedure

- NCT03865381 156 157 O
A NCT03865381 159 160 B-Observation
1c NCT03865381 161 163 I-Observation
result NCT03865381 164 170 O
â¥ NCT03865381 171 172 B-Eq_Comparison
8.0 NCT03865381 173 176 I-Eq_Comparison
% NCT03865381 177 178 I-Eq_Comparison
and NCT03865381 179 182 B-And
â¤ NCT03865381 183 184 B-Eq_Comparison
12.0 NCT03865381 185 189 I-Eq_Comparison
% NCT03865381 190 191 I-Eq_Comparison

- NCT03865381 195 196 O
Receive NCT03865381 198 205 B-Eq_Comparison
their NCT03865381 206 211 O
diabetes NCT03865381 212 220 B-Condition
care NCT03865381 221 225 B-Procedure
from NCT03865381 226 230 O
Premier NCT03865381 231 238 O
Medical NCT03865381 239 246 O
Associates NCT03865381 247 257 O
or NCT03865381 258 260 B-Or
the NCT03865381 261 264 O
Palo NCT03865381 265 269 O
Alto NCT03865381 270 274 O
Medical NCT03865381 275 282 O
Foundation NCT03865381 283 293 O

- NCT03865381 296 297 O
Own NCT03865381 299 302 O
a NCT03865381 303 304 O
Smartphone NCT03865381 305 315 O
with NCT03865381 316 320 O
a NCT03865381 321 322 O
data NCT03865381 323 327 O
plan NCT03865381 328 332 O
and NCT03865381 333 336 O
be NCT03865381 337 339 O
the NCT03865381 340 343 O
primary NCT03865381 344 351 O
user NCT03865381 352 356 O
of NCT03865381 357 359 O
that NCT03865381 360 364 O
smartphone NCT03865381 365 375 O

- NCT03865381 378 379 O
Smartphone NCT03865381 381 391 O
must NCT03865381 392 396 O
use NCT03865381 397 400 O
a NCT03865381 401 402 O
supported NCT03865381 403 412 O
Android NCT03865381 413 420 O
OS NCT03865381 421 423 O
or NCT03865381 424 426 O
iOS NCT03865381 427 430 O

Exclusion NCT03865381 431 440 O
Criteria NCT03865381 441 449 O
: NCT03865381 450 451 O

- NCT03865381 455 456 O
Pregnant NCT03865381 458 466 B-Condition
or NCT03865381 467 469 B-Or
breastfeeding NCT03865381 470 483 B-Condition

- NCT03865381 486 487 O
Use NCT03865381 489 492 O
of NCT03865381 493 495 O
an NCT03865381 496 498 O
insulin NCT03865381 499 506 B-Procedure
pump NCT03865381 507 511 I-Procedure

- NCT03865381 514 515 O
Any NCT03865381 517 520 O
condition NCT03865381 521 530 B-Condition
or NCT03865381 531 533 B-Or
situation NCT03865381 534 543 B-Condition
that NCT03865381 544 548 O
the NCT03865381 549 552 O
Sponsor NCT03865381 553 560 O
or NCT03865381 561 563 O
Investigator NCT03865381 564 576 O
determines NCT03865381 577 587 O
as NCT03865381 588 590 O
inappropriate NCT03865381 591 604 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
for NCT03865381 605 608 O
study NCT03865381 609 614 B-Study
inclusion NCT03865381 615 624 O

Inclusion NCT03928769 0 9 O
Criteria NCT03928769 10 18 O
: NCT03928769 19 20 O

- NCT03928769 24 25 O
Male NCT03928769 27 31 O
or NCT03928769 32 34 B-Or
female NCT03928769 35 41 O
â¥ NCT03928769 42 43 B-Eq_Comparison
18 NCT03928769 44 46 I-Eq_Comparison
years NCT03928769 47 52 I-Eq_Comparison

- NCT03928769 55 56 O
Patient NCT03928769 58 65 O
for NCT03928769 66 69 O
whom NCT03928769 70 74 O
a NCT03928769 75 76 O
vascular NCT03928769 77 85 B-Modifier
surgery NCT03928769 86 93 B-Procedure
is NCT03928769 94 96 O
programmed NCT03928769 97 107 B-Eq_Comparison
, NCT03928769 108 109 O
and NCT03928769 110 113 B-And
whose NCT03928769 114 119 O
nature NCT03928769 120 126 O
allows NCT03928769 127 133 B-Assertion___Assertion_Type_Value:hypothetical
obtaining NCT03928769 134 143 O
of NCT03928769 144 146 O
arterial NCT03928769 147 155 B-Condition
segment NCT03928769 156 163 I-Condition
without NCT03928769 164 171 B-Negation
any NCT03928769 172 175 O
harm NCT03928769 176 180 O
for NCT03928769 181 184 O
the NCT03928769 185 188 O
health NCT03928769 189 195 B-Condition
of NCT03928769 196 198 O
the NCT03928769 199 202 O
patient NCT03928769 203 210 O

- NCT03928769 213 214 O
Patient NCT03928769 216 223 O
for NCT03928769 224 227 O
whom NCT03928769 228 232 O
a NCT03928769 233 234 O
blood NCT03928769 235 240 B-Observation
sample NCT03928769 241 247 I-Observation
is NCT03928769 248 250 O
planned NCT03928769 251 258 B-Eq_Comparison
on NCT03928769 259 261 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928769 262 265 I-Temporal_Connection___Temporal_Connection_Type_Value:during
day NCT03928769 266 269 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03928769 270 272 O
the NCT03928769 273 276 O
procedure NCT03928769 277 286 B-Procedure

- NCT03928769 289 290 O
Person NCT03928769 292 298 O
who NCT03928769 299 302 O
has NCT03928769 303 306 O
received NCT03928769 307 315 O
complete NCT03928769 316 324 O
information NCT03928769 325 336 O
on NCT03928769 337 339 O
the NCT03928769 340 343 O
organization NCT03928769 344 356 O
of NCT03928769 357 359 O
the NCT03928769 360 363 O
research NCT03928769 364 372 O
and NCT03928769 373 376 O
who NCT03928769 377 380 O
has NCT03928769 381 384 O
not NCT03928769 385 388 O
objected NCT03928769 389 397 O
to NCT03928769 398 400 O
his NCT03928769 401 404 O
participation NCT03928769 405 418 O
and NCT03928769 419 422 O
the NCT03928769 423 426 O
exploitation NCT03928769 427 439 O
of NCT03928769 440 442 O
his NCT03928769 443 446 O
data NCT03928769 447 451 O

- NCT03928769 454 455 O
Compulsory NCT03928769 457 467 O
affiliation NCT03928769 468 479 O
to NCT03928769 480 482 O
social NCT03928769 483 489 O
security NCT03928769 490 498 O

Exclusion NCT03928769 499 508 O
Criteria NCT03928769 509 517 O
: NCT03928769 518 519 O

- NCT03928769 523 524 O
Patient NCT03928769 526 533 O
who NCT03928769 534 537 O
has NCT03928769 538 541 O
previously NCT03928769 542 552 B-Eq_Comparison
undergone NCT03928769 553 562 I-Eq_Comparison
radiotherapy NCT03928769 563 575 B-Procedure
at NCT03928769 576 578 O
the NCT03928769 579 582 O
sampling NCT03928769 583 591 B-Modifier
site NCT03928769 592 596 I-Modifier

- NCT03928769 599 600 O
Patient NCT03928769 602 609 O
with NCT03928769 610 614 O
cancer NCT03928769 615 621 B-Condition
at NCT03928769 622 624 O
the NCT03928769 625 628 O
sampling NCT03928769 629 637 B-Modifier
site NCT03928769 638 642 I-Modifier

Inclusion NCT03929887 0 9 O
Criteria NCT03929887 10 18 O
: NCT03929887 19 20 O

- NCT03929887 24 25 O
Diagnosis NCT03929887 27 36 O
of NCT03929887 37 39 O
glomerulonephritis NCT03929887 40 58 B-Condition
( NCT03929887 59 60 O
MCD NCT03929887 61 64 B-Condition
, NCT03929887 65 66 O
FSGS NCT03929887 67 71 B-Condition
, NCT03929887 72 73 O
MN NCT03929887 74 76 B-Condition
, NCT03929887 77 78 O
IgAN NCT03929887 79 83 B-Condition
, NCT03929887 84 85 O
RPGN NCT03929887 86 90 B-Condition
, NCT03929887 91 92 O
lupus NCT03929887 93 98 B-Condition
nephritis NCT03929887 99 108 I-Condition
and NCT03929887 109 112 O
etc NCT03929887 113 116 O
. NCT03929887 117 118 O
) NCT03929887 119 120 O
on NCT03929887 121 123 O
first NCT03929887 124 129 B-Eq_Comparison
diagnostic NCT03929887 130 140 O
kidney NCT03929887 141 147 B-Modifier
biopsy NCT03929887 148 154 B-Procedure
, NCT03929887 155 156 O
as NCT03929887 157 159 O
per NCT03929887 160 163 O
specified NCT03929887 164 173 O
pathology NCT03929887 174 183 O
definitions NCT03929887 184 195 O

- NCT03929887 198 199 O
First NCT03929887 201 206 B-Eq_Comparison
diagnostic NCT03929887 207 217 O
kidney NCT03929887 218 224 B-Modifier
biopsy NCT03929887 225 231 B-Procedure
since NCT03929887 232 237 B-Eq_Comparison
2010 NCT03929887 238 242 I-Eq_Comparison

- NCT03929887 246 247 O
Willingness NCT03929887 249 260 O
to NCT03929887 261 263 O
comply NCT03929887 264 270 O
with NCT03929887 271 275 O
study NCT03929887 276 281 O
requirements NCT03929887 282 294 O
, NCT03929887 295 296 O
including NCT03929887 297 306 O
intention NCT03929887 307 316 O
to NCT03929887 317 319 O
fully NCT03929887 320 325 O
participate NCT03929887 326 337 O
in NCT03929887 338 340 O
protocol NCT03929887 341 349 O
- NCT03929887 350 351 O
specified NCT03929887 352 361 O
follow NCT03929887 362 368 O
- NCT03929887 369 370 O
up NCT03929887 371 373 O
at NCT03929887 374 376 O
a NCT03929887 377 378 O
clinical NCT03929887 379 387 O
study NCT03929887 388 393 O
site NCT03929887 394 398 O

- NCT03929887 401 402 O
Informed NCT03929887 404 412 O
consent NCT03929887 413 420 O
and NCT03929887 421 424 O
, NCT03929887 425 426 O
where NCT03929887 427 432 O
age NCT03929887 433 436 O
appropriate NCT03929887 437 448 O
, NCT03929887 449 450 O
informed NCT03929887 451 459 O
assent NCT03929887 460 466 O
( NCT03929887 467 468 O
clinical NCT03929887 469 477 O
data NCT03929887 478 482 O
, NCT03929887 483 484 O
human NCT03929887 485 490 O
derived NCT03929887 491 498 O
materials NCT03929887 499 508 O
including NCT03929887 509 518 O
genomic NCT03929887 519 526 O
data NCT03929887 527 531 O
) NCT03929887 532 533 O

Exclusion NCT03929887 535 544 O
Criteria NCT03929887 545 553 O
: NCT03929887 554 555 O

- NCT03929887 559 560 O
Unwillingness NCT03929887 562 575 O
to NCT03929887 576 578 O
give NCT03929887 579 583 O
informed NCT03929887 584 592 O
consent NCT03929887 593 600 O

- NCT03929887 603 604 O
Not NCT03929887 606 609 B-Negation
enough NCT03929887 610 616 B-Assertion___Assertion_Type_Value:hypothetical
kidney NCT03929887 617 623 B-Observation
tissue NCT03929887 624 630 I-Observation
to NCT03929887 631 633 O
confirm NCT03929887 634 641 O
a NCT03929887 642 643 O
diagnosis NCT03929887 644 653 O
( NCT03929887 654 655 O
adequate NCT03929887 656 664 O
tissue NCT03929887 665 671 O
: NCT03929887 672 673 O
more NCT03929887 674 678 B-Eq_Comparison
than NCT03929887 679 683 I-Eq_Comparison
2 NCT03929887 684 685 I-Eq_Comparison
cores NCT03929887 686 691 I-Eq_Comparison
of NCT03929887 692 694 O
kidney NCT03929887 695 701 B-Observation
tissues NCT03929887 702 709 I-Observation
( NCT03929887 710 711 O
10 NCT03929887 712 714 B-Eq_Comparison
x NCT03929887 715 716 I-Eq_Comparison
1.2 NCT03929887 717 720 I-Eq_Comparison
mm NCT03929887 721 723 I-Eq_Comparison
) NCT03929887 724 725 O
including NCT03929887 726 735 O
over NCT03929887 736 740 B-Eq_Comparison
10 NCT03929887 741 743 I-Eq_Comparison
- NCT03929887 744 745 I-Eq_Comparison
15 NCT03929887 746 748 I-Eq_Comparison
glomerulus NCT03929887 749 759 I-Eq_Comparison
each NCT03929887 760 764 O
) NCT03929887 765 766 O

Inclusion NCT03920306 0 9 O
Criteria NCT03920306 10 18 O
: NCT03920306 19 20 O

- NCT03920306 24 25 O
Eligible NCT03920306 27 35 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03920306 36 39 I-Assertion___Assertion_Type_Value:hypothetical
gastrostomy NCT03920306 40 51 B-Procedure
tube NCT03920306 52 56 I-Procedure
removal NCT03920306 57 64 I-Procedure

Exclusion NCT03920306 65 74 O
Criteria NCT03920306 75 83 O
: NCT03920306 84 85 O

- NCT03920306 89 90 O
Recurrent NCT03920306 92 101 O
gastrocutaneous NCT03920306 102 117 B-Condition
fistula NCT03920306 118 125 I-Condition

- NCT03920306 128 129 O
Non NCT03920306 131 134 O
- NCT03920306 135 136 O
consenting NCT03920306 137 147 O

- NCT03920306 150 151 O
Unable NCT03920306 153 159 O
to NCT03920306 160 162 O
comply NCT03920306 163 169 O
with NCT03920306 170 174 O
follow NCT03920306 175 181 O
up NCT03920306 182 184 O
assessments NCT03920306 185 196 O

- NCT03920306 199 200 O
Known NCT03920306 202 207 O
allergic NCT03920306 208 216 B-Allergy
reaction NCT03920306 217 225 O
to NCT03920306 226 228 O
study NCT03920306 229 234 B-Study
products NCT03920306 235 243 B-Drug

Inclusion NCT03866356 0 9 O
Criteria NCT03866356 10 18 O
: NCT03866356 19 20 O

- NCT03866356 24 25 O
The NCT03866356 27 30 O
inclusion NCT03866356 31 40 O
criteria NCT03866356 41 49 O
were NCT03866356 50 54 O
being NCT03866356 55 60 O
female NCT03866356 61 67 O
, NCT03866356 68 69 O
â¥ NCT03866356 70 71 B-Eq_Comparison
18 NCT03866356 72 74 I-Eq_Comparison
years NCT03866356 75 80 I-Eq_Comparison
, NCT03866356 81 82 O
having NCT03866356 83 89 B-And
an NCT03866356 90 92 O
initial NCT03866356 93 100 B-Eq_Comparison
diagnosis NCT03866356 101 110 O
of NCT03866356 111 113 O
SI NCT03866356 114 116 B-Condition
, NCT03866356 117 118 O
being NCT03866356 119 124 O
literate NCT03866356 125 133 B-Condition
, NCT03866356 134 135 O
having NCT03866356 136 142 O
no NCT03866356 143 145 B-Negation
sensory NCT03866356 146 153 B-Condition
disorder NCT03866356 154 162 I-Condition
affecting NCT03866356 163 172 O
communication NCT03866356 173 186 B-Condition
, NCT03866356 187 188 O
and NCT03866356 189 192 O
agreeing NCT03866356 193 201 O
to NCT03866356 202 204 O
participate NCT03866356 205 216 O
in NCT03866356 217 219 O
the NCT03866356 220 223 O
research NCT03866356 224 232 O

Exclusion NCT03866356 233 242 O
Criteria NCT03866356 243 251 O
: NCT03866356 252 253 O

- NCT03866356 257 258 O
The NCT03866356 260 263 O
exclusion NCT03866356 264 273 O
criteria NCT03866356 274 282 O
were NCT03866356 283 287 O
pregnancy NCT03866356 288 297 B-Condition
, NCT03866356 298 299 O
presence NCT03866356 300 308 O
of NCT03866356 309 311 O
a NCT03866356 312 313 O
urinary NCT03866356 314 321 B-Condition
tract NCT03866356 322 327 I-Condition
infection NCT03866356 328 337 I-Condition
and NCT03866356 338 341 B-Or
previous NCT03866356 342 350 B-Eq_Comparison
treatment NCT03866356 351 360 B-Procedure
for NCT03866356 361 364 O
SI NCT03866356 365 367 B-Condition
. NCT03866356 368 369 O
The NCT03866356 371 374 O
removal NCT03866356 375 382 O
criteria NCT03866356 383 391 O
were NCT03866356 392 396 O
patient NCT03866356 397 404 O
non NCT03866356 405 408 O
- NCT03866356 409 410 O
compliance NCT03866356 411 421 O
with NCT03866356 422 426 O
the NCT03866356 427 430 O
protocol NCT03866356 431 439 O
, NCT03866356 440 441 O
failure NCT03866356 442 449 O
in NCT03866356 450 452 O
contacting NCT03866356 453 463 O
the NCT03866356 464 467 O
patient NCT03866356 468 475 O
and NCT03866356 476 479 O
the NCT03866356 480 483 O
patient NCT03866356 484 491 O
's NCT03866356 491 493 O
wish NCT03866356 494 498 O
to NCT03866356 499 501 O
withdraw NCT03866356 502 510 O
from NCT03866356 511 515 O
the NCT03866356 516 519 O
study NCT03866356 520 525 O
. NCT03866356 526 527 O

Inclusion NCT03925207 0 9 O
Criteria NCT03925207 10 18 O
: NCT03925207 19 20 O

- NCT03925207 24 25 O
Patients NCT03925207 27 35 O
were NCT03925207 36 40 O
included NCT03925207 41 49 O
if NCT03925207 50 52 O
they NCT03925207 53 57 O
underwent NCT03925207 58 67 B-Eq_Comparison
orbital NCT03925207 68 75 B-Procedure
ball NCT03925207 76 80 I-Procedure
implants NCT03925207 81 89 I-Procedure
after NCT03925207 90 95 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enucleation NCT03925207 96 107 B-Procedure
surgery NCT03925207 108 115 I-Procedure
by NCT03925207 116 118 O
one NCT03925207 119 122 O
ophthalmologist NCT03925207 123 138 B-Provider
surgeon NCT03925207 139 146 I-Provider
specializing NCT03925207 147 159 O
in NCT03925207 160 162 O
oculoplastic NCT03925207 163 175 B-Modifier
and NCT03925207 176 179 B-And
orbital NCT03925207 180 187 B-Modifier
surgery NCT03925207 188 195 I-Modifier
at NCT03925207 196 198 O
our NCT03925207 199 202 O
centre NCT03925207 203 209 O
. NCT03925207 210 211 O

Exclusion NCT03925207 213 222 O
Criteria NCT03925207 223 231 O
: NCT03925207 232 233 O

- NCT03925207 237 238 O
Patients NCT03925207 240 248 O
were NCT03925207 249 253 O
excluded NCT03925207 254 262 B-Negation
if NCT03925207 263 265 O
they NCT03925207 266 270 O
underwent NCT03925207 271 280 B-Eq_Comparison
other NCT03925207 281 286 B-Other
concurrent NCT03925207 287 297 O
surgical NCT03925207 298 306 B-Procedure
procedures NCT03925207 307 317 I-Procedure
, NCT03925207 318 319 O
or NCT03925207 320 322 B-Or
were NCT03925207 323 327 O
under NCT03925207 328 333 B-Eq_Comparison
18 NCT03925207 334 336 I-Eq_Comparison
yr NCT03925207 337 339 I-Eq_Comparison
of NCT03925207 340 342 O
age NCT03925207 343 346 B-Age
. NCT03925207 347 348 O

Inclusion NCT03863353 0 9 O
Criteria NCT03863353 10 18 O
: NCT03863353 19 20 O

- NCT03863353 24 25 O
Undergoing NCT03863353 27 37 B-Eq_Comparison
an NCT03863353 38 40 O
elective NCT03863353 41 49 B-Modifier
surgical NCT03863353 50 58 B-Procedure
procedure NCT03863353 59 68 I-Procedure
for NCT03863353 69 72 O
which NCT03863353 73 78 O
it NCT03863353 79 81 O
is NCT03863353 82 84 O
expected NCT03863353 85 93 B-Assertion___Assertion_Type_Value:hypothetical
they NCT03863353 94 98 I-Assertion___Assertion_Type_Value:hypothetical
will NCT03863353 99 103 O
receive NCT03863353 104 111 O
a NCT03863353 112 113 O
prescription NCT03863353 114 126 B-Modifier
pain NCT03863353 127 131 B-Condition
medicine NCT03863353 132 140 B-Drug
for NCT03863353 141 144 O
management NCT03863353 145 155 O
of NCT03863353 156 158 O
pain NCT03863353 159 163 B-Condition
during NCT03863353 164 170 B-Temporal_Connection___Temporal_Connection_Type_Value:during
recovery NCT03863353 171 179 B-Observation
at NCT03863353 180 182 O
home NCT03863353 183 187 O
. NCT03863353 188 189 O

Exclusion NCT03863353 191 200 O
Criteria NCT03863353 201 209 O
: NCT03863353 210 211 O

- NCT03863353 215 216 O
Undergoing NCT03863353 218 228 B-Eq_Comparison
non NCT03863353 229 232 B-Negation
- NCT03863353 233 234 O
elective NCT03863353 235 243 B-Modifier
procedure NCT03863353 244 253 B-Procedure

- NCT03863353 256 257 O
Cognitive NCT03863353 259 268 B-Condition
impairment NCT03863353 269 279 I-Condition
precluding NCT03863353 280 290 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
self NCT03863353 291 295 O
- NCT03863353 296 297 O
reporting NCT03863353 298 307 O
of NCT03863353 308 310 O
pain NCT03863353 311 315 B-Condition

- NCT03863353 318 319 O
Hematologic NCT03863353 321 332 B-Modifier
/ NCT03863353 333 334 B-Or
oncologic NCT03863353 335 344 B-Modifier
condition NCT03863353 345 354 B-Condition

- NCT03863353 357 358 O
Liver NCT03863353 360 365 B-Modifier
of NCT03863353 366 368 I-Modifier
kidney NCT03863353 369 375 I-Modifier
conditions NCT03863353 376 386 B-Condition
precluding NCT03863353 387 397 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
usual NCT03863353 398 403 O
analgesic NCT03863353 404 413 B-Drug
prescription NCT03863353 414 426 I-Drug
patters NCT03863353 427 434 I-Drug
( NCT03863353 435 436 O
opioid NCT03863353 437 443 B-Drug
plus NCT03863353 444 448 B-And
a NCT03863353 449 450 O
non NCT03863353 451 454 O
- NCT03863353 455 456 O
opioid NCT03863353 457 463 B-Drug
) NCT03863353 464 465 O

- NCT03863353 469 470 O
Use NCT03863353 472 475 B-Eq_Comparison
of NCT03863353 476 478 O
opioids NCT03863353 479 486 B-Drug
for NCT03863353 487 490 O
prolonged NCT03863353 491 500 B-Modifier
pain NCT03863353 501 505 B-Condition
pre NCT03863353 506 509 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03863353 510 511 O
operatively NCT03863353 512 523 B-Procedure
( NCT03863353 524 525 O
< NCT03863353 526 527 B-Eq_Comparison
2 NCT03863353 528 529 I-Eq_Comparison
weeks NCT03863353 530 535 I-Eq_Comparison
) NCT03863353 536 537 O

Inclusion NCT03923699 0 9 O
Criteria NCT03923699 10 18 O
: NCT03923699 19 20 O

- NCT03923699 24 25 O
All NCT03923699 27 30 O
patients NCT03923699 31 39 O
18 NCT03923699 40 42 B-Eq_Comparison
years NCT03923699 43 48 I-Eq_Comparison
or NCT03923699 49 51 I-Eq_Comparison
older NCT03923699 52 57 I-Eq_Comparison
undergoing NCT03923699 58 68 B-Eq_Comparison
surgery NCT03923699 69 76 B-Procedure
at NCT03923699 77 79 O
Barnes NCT03923699 80 86 O
Jewish NCT03923699 87 93 O
Hospital NCT03923699 94 102 O
in NCT03923699 103 105 O
St NCT03923699 106 108 O
. NCT03923699 109 110 O
Louis NCT03923699 112 117 O
, NCT03923699 118 119 O
MO NCT03923699 120 122 O

Exclusion NCT03923699 123 132 O
Criteria NCT03923699 133 141 O
: NCT03923699 142 143 O

- NCT03923699 146 147 O

Inclusion NCT03929367 0 9 O
Criteria NCT03929367 10 18 O
: NCT03929367 19 20 O

- NCT03929367 24 25 O
Male NCT03929367 27 31 O
or NCT03929367 32 34 B-Or
female NCT03929367 35 41 O
> NCT03929367 42 43 B-Eq_Comparison
18 NCT03929367 44 46 I-Eq_Comparison
and NCT03929367 47 50 B-And
< NCT03929367 51 52 B-Eq_Comparison
60 NCT03929367 53 55 I-Eq_Comparison
years NCT03929367 56 61 I-Eq_Comparison
of NCT03929367 62 64 O
age NCT03929367 65 68 B-Age
, NCT03929367 69 70 O
Body NCT03929367 71 75 B-Observation
Mass NCT03929367 76 80 I-Observation
Index NCT03929367 81 86 I-Observation
( NCT03929367 87 88 O
BMI NCT03929367 89 92 B-Observation
) NCT03929367 93 94 O
< NCT03929367 95 96 B-Eq_Comparison
40 NCT03929367 97 99 I-Eq_Comparison
. NCT03929367 99 100 O

- NCT03929367 104 105 O
Generally NCT03929367 107 116 O
in NCT03929367 117 119 O
good NCT03929367 120 124 B-Condition
health NCT03929367 125 131 I-Condition
as NCT03929367 132 134 O
determined NCT03929367 135 145 O
by NCT03929367 146 148 O
the NCT03929367 149 152 O
Principal NCT03929367 153 162 O
Investigator NCT03929367 163 175 O
based NCT03929367 176 181 O
on NCT03929367 182 184 O
prior NCT03929367 185 190 O
medical NCT03929367 191 198 O
history NCT03929367 199 206 O
, NCT03929367 207 208 O
American NCT03929367 209 217 B-Observation
Society NCT03929367 218 225 I-Observation
of NCT03929367 226 228 I-Observation
Anesthesiologists NCT03929367 229 246 I-Observation
physical NCT03929367 247 255 O
status NCT03929367 256 262 B-Eq_Comparison
I NCT03929367 263 264 I-Eq_Comparison
or NCT03929367 265 267 I-Eq_Comparison
II NCT03929367 268 270 I-Eq_Comparison

- NCT03929367 273 274 O
Normal NCT03929367 276 282 O
blood NCT03929367 283 288 B-Observation
pressure NCT03929367 289 297 I-Observation
( NCT03929367 298 299 O
systolic NCT03929367 300 308 B-Observation
90 NCT03929367 309 311 B-Eq_Comparison
- NCT03929367 312 313 I-Eq_Comparison
140 NCT03929367 314 317 I-Eq_Comparison
mmHg NCT03929367 318 322 I-Eq_Comparison
; NCT03929367 322 323 O
diastolic NCT03929367 324 333 B-Observation
50 NCT03929367 334 336 B-Eq_Comparison
- NCT03929367 337 338 I-Eq_Comparison
90 NCT03929367 339 341 I-Eq_Comparison
mmHg NCT03929367 342 346 I-Eq_Comparison
) NCT03929367 347 348 O
resting NCT03929367 349 356 B-Observation
heart NCT03929367 357 362 I-Observation
rate NCT03929367 363 367 I-Observation

45 NCT03929367 373 375 B-Eq_Comparison
- NCT03929367 376 377 I-Eq_Comparison
100 NCT03929367 378 381 I-Eq_Comparison
beats NCT03929367 382 387 I-Eq_Comparison
per NCT03929367 388 391 I-Eq_Comparison
minute NCT03929367 392 398 I-Eq_Comparison
) NCT03929367 399 400 O
without NCT03929367 401 408 B-Negation
medication NCT03929367 409 419 B-Drug

- NCT03929367 422 423 O
Female NCT03929367 425 431 O
subjects NCT03929367 432 440 O
of NCT03929367 441 443 O
child NCT03929367 444 449 B-Condition
- NCT03929367 450 451 I-Condition
bearing NCT03929367 452 459 I-Condition
potential NCT03929367 460 469 I-Condition
and NCT03929367 470 473 B-And
those NCT03929367 474 479 O
< NCT03929367 480 481 B-Eq_Comparison
1 NCT03929367 482 483 I-Eq_Comparison
year NCT03929367 484 488 I-Eq_Comparison
post NCT03929367 489 493 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03929367 494 495 O
menopausal NCT03929367 496 506 B-Condition
, NCT03929367 507 508 O
must NCT03929367 509 513 O
be NCT03929367 514 516 O
practicing NCT03929367 517 527 B-Eq_Comparison
highly NCT03929367 528 534 O
effective NCT03929367 535 544 O
methods NCT03929367 545 552 O
of NCT03929367 553 555 O
birth NCT03929367 556 561 B-Procedure
control NCT03929367 562 569 I-Procedure
such NCT03929367 570 574 O
as NCT03929367 575 577 O
hormonal NCT03929367 578 586 B-Procedure
methods NCT03929367 587 594 I-Procedure

Exclusion NCT03929367 595 604 O
Criteria NCT03929367 605 613 O
: NCT03929367 614 615 O

- NCT03929367 619 620 O
Hypersensitivity NCT03929367 622 638 B-Condition
, NCT03929367 639 640 O
allergy NCT03929367 641 648 B-Allergy
, NCT03929367 649 650 O
or NCT03929367 651 653 B-Or
significant NCT03929367 654 665 O
reaction NCT03929367 666 674 B-Condition
to NCT03929367 675 677 O
any NCT03929367 678 681 O
ingredient NCT03929367 682 692 O
of NCT03929367 693 695 O
Pitocin NCT03929367 696 703 B-Drug
Â® NCT03929367 703 704 O

- NCT03929367 707 708 O
Any NCT03929367 710 713 O
disease NCT03929367 714 721 B-Condition
, NCT03929367 722 723 O
diagnosis NCT03929367 724 733 B-Condition
, NCT03929367 734 735 O
or NCT03929367 736 738 B-Or
condition NCT03929367 739 748 B-Condition
( NCT03929367 749 750 O
medical NCT03929367 751 758 B-Modifier
or NCT03929367 759 761 B-Or
surgical NCT03929367 762 770 B-Modifier
) NCT03929367 771 772 O
that NCT03929367 773 777 O
, NCT03929367 778 779 O
in NCT03929367 780 782 O
the NCT03929367 783 786 O
opinion NCT03929367 787 794 O
of NCT03929367 795 797 O
the NCT03929367 798 801 O
Principal NCT03929367 802 811 O
Investigator NCT03929367 812 824 O
, NCT03929367 825 826 O
would NCT03929367 827 832 O
place NCT03929367 833 838 O
the NCT03929367 839 842 O
subject NCT03929367 843 850 O
at NCT03929367 851 853 O
increased NCT03929367 854 863 O
risk NCT03929367 864 868 B-Risk
( NCT03929367 869 870 O
active NCT03929367 871 877 B-Eq_Comparison
gynecologic NCT03929367 878 889 B-Condition
disease NCT03929367 890 897 I-Condition
in NCT03929367 898 900 O
which NCT03929367 901 906 O
increased NCT03929367 907 916 O
tone NCT03929367 917 921 O
would NCT03929367 922 927 O
be NCT03929367 928 930 O
detrimental NCT03929367 931 942 O
e NCT03929367 943 944 O
. NCT03929367 945 946 O
g NCT03929367 947 948 O
. NCT03929367 949 950 O
, NCT03929367 951 952 O
uterine NCT03929367 953 960 B-Condition
fibroids NCT03929367 961 969 I-Condition
with NCT03929367 970 974 B-And
ongoing NCT03929367 975 982 O
bleeding NCT03929367 983 991 B-Condition
) NCT03929367 992 993 O
, NCT03929367 994 995 O
compromise NCT03929367 996 1006 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03929367 1007 1010 O
subject NCT03929367 1011 1018 O
's NCT03929367 1018 1020 O
compliance NCT03929367 1021 1031 O
with NCT03929367 1032 1036 O
study NCT03929367 1037 1042 B-Study
procedures NCT03929367 1043 1053 O
, NCT03929367 1054 1055 O
or NCT03929367 1056 1058 O
compromise NCT03929367 1059 1069 O
the NCT03929367 1070 1073 O
quality NCT03929367 1074 1081 O
of NCT03929367 1082 1084 O
the NCT03929367 1085 1088 O
data NCT03929367 1089 1093 O

- NCT03929367 1096 1097 O
Women NCT03929367 1099 1104 O
who NCT03929367 1105 1108 B-And
are NCT03929367 1109 1112 O
pregnant NCT03929367 1113 1121 B-Condition
( NCT03929367 1122 1123 O
positive NCT03929367 1124 1132 O
result NCT03929367 1133 1139 O
for NCT03929367 1140 1143 O
serum NCT03929367 1144 1149 B-Observation
pregnancy NCT03929367 1150 1159 I-Observation
test NCT03929367 1160 1164 I-Observation
at NCT03929367 1165 1167 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03929367 1168 1177 B-Study
visit NCT03929367 1178 1183 O
) NCT03929367 1184 1185 O
, NCT03929367 1186 1187 O
women NCT03929367 1188 1193 O
who NCT03929367 1194 1197 B-And
are NCT03929367 1198 1201 I-And
currently NCT03929367 1202 1211 B-Eq_Comparison
nursing NCT03929367 1212 1219 B-Condition
or NCT03929367 1220 1222 B-Or
lactating NCT03929367 1223 1232 B-Condition
, NCT03929367 1233 1234 O
women NCT03929367 1235 1240 O
that NCT03929367 1241 1245 B-And
have NCT03929367 1246 1250 B-Eq_Comparison
been NCT03929367 1251 1255 I-Eq_Comparison
pregnant NCT03929367 1256 1264 B-Condition
within NCT03929367 1265 1271 B-Eq_Comparison
2 NCT03929367 1272 1273 I-Eq_Comparison
years NCT03929367 1274 1279 I-Eq_Comparison

- NCT03929367 1282 1283 O
Subjects NCT03929367 1285 1293 O
with NCT03929367 1294 1298 O
neuropathy NCT03929367 1299 1309 B-Condition
, NCT03929367 1310 1311 O
chronic NCT03929367 1312 1319 O
pain NCT03929367 1320 1324 B-Condition
, NCT03929367 1325 1326 O
diabetes NCT03929367 1327 1335 B-Condition
mellitus NCT03929367 1336 1344 I-Condition
, NCT03929367 1345 1346 O
or NCT03929367 1347 1349 B-Or
taking NCT03929367 1350 1356 B-Eq_Comparison
benzodiazepines NCT03929367 1357 1372 B-Drug
or NCT03929367 1373 1375 B-Or
pain NCT03929367 1376 1380 B-Drug
medications NCT03929367 1381 1392 I-Drug
on NCT03929367 1393 1395 O
a NCT03929367 1396 1397 O
daily NCT03929367 1398 1403 B-Eq_Comparison
basis NCT03929367 1404 1409 O
. NCT03929367 1410 1411 O

Inclusion NCT03927014 0 9 O
Criteria NCT03927014 10 18 O
: NCT03927014 19 20 O

- NCT03927014 24 25 O
preeclampsia NCT03927014 27 39 B-Condition

- NCT03927014 42 43 O
healthy NCT03927014 45 52 B-Condition
pregnancy NCT03927014 53 62 B-Condition

Exclusion NCT03927014 63 72 O
Criteria NCT03927014 73 81 O
: NCT03927014 82 83 O

- NCT03927014 87 88 O
pregnant NCT03927014 90 98 B-Condition
women NCT03927014 99 104 O
with NCT03927014 105 109 O
any NCT03927014 110 113 O
systemic NCT03927014 114 122 B-Modifier
condition NCT03927014 123 132 B-Condition
( NCT03927014 133 134 O
such NCT03927014 135 139 O
as NCT03927014 140 142 O
chronic NCT03927014 143 150 B-Condition
hypertension NCT03927014 151 163 I-Condition
, NCT03927014 164 165 O
diabetes NCT03927014 166 174 B-Condition
mellitus NCT03927014 175 183 I-Condition
, NCT03927014 184 185 O
thyroid NCT03927014 186 193 B-Condition
diseases NCT03927014 194 202 I-Condition
, NCT03927014 203 204 O
liver NCT03927014 205 210 B-Modifier
and NCT03927014 211 214 B-Or
kidney NCT03927014 215 221 B-Modifier
diseases NCT03927014 222 230 B-Condition
) NCT03927014 231 232 O

- NCT03927014 236 237 O
women NCT03927014 239 244 O
with NCT03927014 245 249 B-And
a NCT03927014 250 251 O
history NCT03927014 252 259 B-Eq_Comparison
of NCT03927014 260 262 O
drug NCT03927014 263 267 B-Condition
use NCT03927014 268 271 I-Condition
throughout NCT03927014 272 282 B-Temporal_Connection___Temporal_Connection_Type_Value:during
pregnancy NCT03927014 283 292 B-Condition

- NCT03927014 295 296 O
history NCT03927014 298 305 B-Eq_Comparison
of NCT03927014 306 308 O
medication NCT03927014 309 319 B-Drug
for NCT03927014 320 323 O
PE NCT03927014 324 326 B-Condition
treatment NCT03927014 327 336 O
at NCT03927014 337 339 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03927014 340 343 O
time NCT03927014 344 348 O
of NCT03927014 349 351 O
first NCT03927014 352 357 B-Eq_Comparison
admission NCT03927014 358 367 B-Encounter

- NCT03927014 370 371 O
patients NCT03927014 373 381 O
who NCT03927014 382 385 O
had NCT03927014 386 389 O
fetal NCT03927014 390 395 B-Condition
congenital NCT03927014 396 406 I-Condition
abnormalities NCT03927014 407 420 I-Condition
or NCT03927014 421 423 B-Or
genetic NCT03927014 424 431 B-Condition
syndromes NCT03927014 432 441 I-Condition

- NCT03927014 444 445 O
multiple NCT03927014 447 455 B-Condition
gestation NCT03927014 456 465 I-Condition

- NCT03927014 468 469 O
active NCT03927014 471 477 B-Eq_Comparison
labor NCT03927014 478 483 B-Condition

Inclusion NCT03861962 0 9 O
Criteria NCT03861962 10 18 O
: NCT03861962 19 20 O

- NCT03861962 24 25 O
patients NCT03861962 27 35 O
( NCT03861962 36 37 O
adults NCT03861962 38 44 O
and NCT03861962 45 48 B-Or
children NCT03861962 49 57 O
) NCT03861962 58 59 O

- NCT03861962 63 64 O
patients NCT03861962 66 74 O
recipients NCT03861962 75 85 O
in NCT03861962 86 88 O
France NCT03861962 89 95 O
from NCT03861962 96 100 O
2008 NCT03861962 101 105 B-Eq_Comparison
to NCT03861962 106 108 I-Eq_Comparison
2015 NCT03861962 109 113 I-Eq_Comparison
of NCT03861962 114 116 O
a NCT03861962 117 118 O
first NCT03861962 119 124 B-Eq_Comparison
kidney NCT03861962 125 131 B-Modifier
transplant NCT03861962 132 142 B-Procedure
/ NCT03861962 143 144 B-Or
heart NCT03861962 145 150 B-Modifier
/ NCT03861962 151 152 B-Or
lung NCT03861962 153 157 B-Modifier
/ NCT03861962 158 159 B-Or
liver NCT03861962 160 165 B-Modifier
donor NCT03861962 166 171 I-Modifier
living NCT03861962 172 178 B-Death|B-Negation
or NCT03861962 179 181 B-Or
deceased NCT03861962 182 190 B-Death
, NCT03861962 191 192 O
non NCT03861962 193 196 B-Negation
- NCT03861962 197 198 O
immunized NCT03861962 199 208 B-Immunization
anti NCT03861962 209 213 O
- NCT03861962 214 215 O
HLA NCT03861962 216 219 B-Condition
before NCT03861962 220 226 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03861962 227 230 O
transplant NCT03861962 231 241 O

- NCT03861962 244 245 O
patients NCT03861962 247 255 O
having NCT03861962 256 262 O
preserved NCT03861962 263 272 O
their NCT03861962 273 278 O
graft NCT03861962 279 284 B-Procedure
> NCT03861962 285 286 B-Eq_Comparison
2 NCT03861962 287 288 I-Eq_Comparison
years NCT03861962 289 294 I-Eq_Comparison

- NCT03861962 297 298 O
having NCT03861962 300 306 O
agreed NCT03861962 307 313 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861962 314 316 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03861962 317 320 O
use NCT03861962 321 324 O
for NCT03861962 325 328 O
research NCT03861962 329 337 O
purposes NCT03861962 338 346 O
in NCT03861962 347 349 O
transplantation NCT03861962 350 365 B-Procedure
of NCT03861962 366 368 O
the NCT03861962 369 372 O
remains NCT03861962 373 380 O
of NCT03861962 381 383 O
the NCT03861962 384 387 O
DNA NCT03861962 388 391 B-Observation
and NCT03861962 392 395 B-And
serum NCT03861962 396 401 B-Observation
samples NCT03861962 402 409 I-Observation
taken NCT03861962 410 415 O
as NCT03861962 416 418 O
part NCT03861962 419 423 O
of NCT03861962 424 426 O
the NCT03861962 427 430 O
care NCT03861962 431 435 O
of NCT03861962 436 438 O
which NCT03861962 439 444 O
the NCT03861962 445 448 O
remains NCT03861962 449 456 O
are NCT03861962 457 460 O
available NCT03861962 461 470 O

Exclusion NCT03861962 471 480 O
Criteria NCT03861962 481 489 O
: NCT03861962 490 491 O

- NCT03861962 495 496 O
no NCT03861962 498 500 O
inclusion NCT03861962 501 510 O
if NCT03861962 511 513 O
one NCT03861962 514 517 O
of NCT03861962 518 520 O
the NCT03861962 521 524 O
inclusion NCT03861962 525 534 O
criteria NCT03861962 535 543 O
is NCT03861962 544 546 O
not NCT03861962 547 550 O
met NCT03861962 551 554 O

Inclusion NCT03866681 0 9 O
Criteria NCT03866681 10 18 O
: NCT03866681 19 20 O

- NCT03866681 24 25 O
age NCT03866681 27 30 B-Age
18 NCT03866681 31 33 B-Eq_Comparison
- NCT03866681 34 35 I-Eq_Comparison
70 NCT03866681 36 38 I-Eq_Comparison
years NCT03866681 39 44 I-Eq_Comparison

- NCT03866681 47 48 O
diagnosed NCT03866681 50 59 O
with NCT03866681 60 64 O
PNH NCT03866681 65 68 B-Condition
and NCT03866681 69 72 B-And
no NCT03866681 73 75 B-Negation
thrombosis NCT03866681 76 86 B-Condition

- NCT03866681 89 90 O
ineffective NCT03866681 92 103 B-Modifier
, NCT03866681 104 105 O
relapsed NCT03866681 106 114 B-Modifier
or NCT03866681 115 117 B-Or
intolerant NCT03866681 118 128 B-Condition
to NCT03866681 129 131 O
conventional NCT03866681 132 144 B-Procedure
treatment NCT03866681 145 154 I-Procedure
( NCT03866681 155 156 O
eg NCT03866681 157 159 O
glucocorticoids NCT03866681 160 175 B-Drug
, NCT03866681 176 177 O
â¢ NCT03866681 178 179 O
â¢ NCT03866681 180 181 O
iron NCT03866681 182 186 B-Drug
, NCT03866681 187 188 O
folic NCT03866681 189 194 B-Drug
acid NCT03866681 195 199 I-Drug
, NCT03866681 200 201 O
androgen NCT03866681 202 210 B-Drug
, NCT03866681 211 212 O
etc NCT03866681 213 216 O
. NCT03866681 217 218 O
) NCT03866681 219 220 O

- NCT03866681 224 225 O
not NCT03866681 227 230 B-Negation
available NCT03866681 231 240 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03866681 241 244 O
hematopoietic NCT03866681 245 258 B-Procedure
stem NCT03866681 259 263 I-Procedure
cell NCT03866681 264 268 I-Procedure
transplantation NCT03866681 269 284 I-Procedure

- NCT03866681 287 288 O
ECOG NCT03866681 290 294 B-Observation
â¤ NCT03866681 295 296 B-Eq_Comparison
2 NCT03866681 297 298 I-Eq_Comparison

- NCT03866681 302 303 O
agreed NCT03866681 305 311 O
to NCT03866681 312 314 O
sign NCT03866681 315 319 O
the NCT03866681 320 323 O
consent NCT03866681 324 331 O
forms NCT03866681 332 337 O

Exclusion NCT03866681 338 347 O
Criteria NCT03866681 348 356 O
: NCT03866681 357 358 O

- NCT03866681 362 363 O
severe NCT03866681 365 371 O
heart NCT03866681 372 377 B-Modifier
, NCT03866681 378 379 O
liver NCT03866681 380 385 B-Modifier
and NCT03866681 386 389 B-Or
kidney NCT03866681 390 396 B-Modifier
dysfunction NCT03866681 397 408 B-Condition

- NCT03866681 411 412 O
combined NCT03866681 414 422 O
with NCT03866681 423 427 O
thrombotic NCT03866681 428 438 B-Modifier
complications NCT03866681 439 452 B-Condition

- NCT03866681 455 456 O
people NCT03866681 458 464 O
who NCT03866681 465 468 O
are NCT03866681 469 472 O
pregnant NCT03866681 473 481 B-Condition
and NCT03866681 482 485 B-Or
breastfeeding NCT03866681 486 499 B-Condition

- NCT03866681 502 503 O
history NCT03866681 505 512 B-Eq_Comparison
of NCT03866681 513 515 O
other NCT03866681 516 521 B-Other
immunosuppressive NCT03866681 522 539 B-Drug
agents NCT03866681 540 546 I-Drug
in NCT03866681 547 549 O
recent NCT03866681 550 556 B-Eq_Comparison
3 NCT03866681 557 558 I-Eq_Comparison
months NCT03866681 559 565 I-Eq_Comparison

- NCT03866681 568 569 O
Patients NCT03866681 571 579 O
who NCT03866681 580 583 O
are NCT03866681 584 587 O
not NCT03866681 588 591 B-Negation
eligible NCT03866681 592 600 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03866681 601 603 O
participate NCT03866681 604 615 O
in NCT03866681 616 618 O
this NCT03866681 619 623 O
trial NCT03866681 624 629 O
due NCT03866681 630 633 O
to NCT03866681 634 636 O
any NCT03866681 637 640 O
reason NCT03866681 641 647 O
based NCT03866681 648 653 O
â¢ NCT03866681 654 655 O
â¢ NCT03866681 656 657 O
â¢ NCT03866681 658 659 O
on NCT03866681 660 662 O
the NCT03866681 663 666 O
consideration NCT03866681 667 680 O
of NCT03866681 681 683 O
investigator NCT03866681 684 696 O

Inclusions NCT03864536 0 10 O
: NCT03864536 11 12 O

- NCT03864536 16 17 O
Must NCT03864536 19 23 O
be NCT03864536 24 26 O
African NCT03864536 27 34 O
American NCT03864536 35 43 O

- NCT03864536 46 47 O
Must NCT03864536 49 53 O
be NCT03864536 54 56 O
age NCT03864536 57 60 B-Age
50 NCT03864536 61 63 B-Eq_Comparison
to NCT03864536 64 66 I-Eq_Comparison
65 NCT03864536 67 69 I-Eq_Comparison

- NCT03864536 73 74 O
Must NCT03864536 76 80 O
have NCT03864536 81 85 O
a NCT03864536 86 87 O
working NCT03864536 88 95 O
cell NCT03864536 96 100 O
phone NCT03864536 101 106 O
with NCT03864536 107 111 O
unlimited NCT03864536 112 121 O
texting NCT03864536 122 129 O

- NCT03864536 132 133 O
Must NCT03864536 135 139 O
be NCT03864536 140 142 O
ambulatory NCT03864536 143 153 B-Condition

Exclusions NCT03864536 154 164 O
: NCT03864536 165 166 O

- NCT03864536 170 171 O
No NCT03864536 173 175 B-Negation
neurological NCT03864536 176 188 B-Modifier
( NCT03864536 189 190 O
including NCT03864536 191 200 O
dementia NCT03864536 201 209 B-Condition
diagnosis NCT03864536 210 219 O
) NCT03864536 220 221 O
or NCT03864536 222 224 B-Or
severe NCT03864536 225 231 O
psychiatric NCT03864536 232 243 B-Modifier
( NCT03864536 244 245 O
e NCT03864536 246 247 O
. NCT03864536 248 249 O
g NCT03864536 250 251 O
. NCT03864536 252 253 O
, NCT03864536 254 255 O
schizophrenia NCT03864536 256 269 B-Condition
or NCT03864536 270 272 B-Or
bipolar NCT03864536 273 280 B-Condition
disorder NCT03864536 281 289 I-Condition
) NCT03864536 290 291 O
disorders NCT03864536 292 301 B-Condition

- NCT03864536 304 305 O
No NCT03864536 307 309 B-Negation
insomnia NCT03864536 310 318 B-Condition

- NCT03864536 321 322 O
Telephone NCT03864536 324 333 B-Observation
Interview NCT03864536 334 343 I-Observation
for NCT03864536 344 347 I-Observation
Cognitive NCT03864536 348 357 I-Observation
Status NCT03864536 358 364 I-Observation
( NCT03864536 365 366 O
TICS NCT03864536 367 371 B-Observation
) NCT03864536 372 373 O
score NCT03864536 374 379 O
â¤ NCT03864536 380 381 B-Eq_Comparison
20 NCT03864536 382 384 I-Eq_Comparison

Inclusion NCT03867292 0 9 O
Criteria NCT03867292 10 18 O
: NCT03867292 19 20 O

- NCT03867292 24 25 O
Padel NCT03867292 27 32 B-Observation
players NCT03867292 33 40 I-Observation

- NCT03867292 43 44 O
With NCT03867292 46 50 O
federal NCT03867292 51 58 O
sheet NCT03867292 59 64 O

- NCT03867292 67 68 O
Male NCT03867292 70 74 O

- NCT03867292 77 78 O
Over NCT03867292 80 84 B-Eq_Comparison
18 NCT03867292 85 87 I-Eq_Comparison
years NCT03867292 88 93 I-Eq_Comparison

- NCT03867292 96 97 O
Currently NCT03867292 99 108 O
participate NCT03867292 109 120 O
in NCT03867292 121 123 O
regional NCT03867292 124 132 O
and NCT03867292 133 136 O
/ NCT03867292 137 138 O
or NCT03867292 139 141 O
national NCT03867292 142 150 O
competitions NCT03867292 151 163 O

Exclusion NCT03867292 164 173 O
Criteria NCT03867292 174 182 O
: NCT03867292 183 184 O

- NCT03867292 188 189 O
Present NCT03867292 191 198 O
a NCT03867292 199 200 O
medical NCT03867292 201 208 O
diagnosis NCT03867292 209 218 O
of NCT03867292 219 221 O
musculoskeletal NCT03867292 222 237 B-Modifier
pathology NCT03867292 238 247 B-Condition

- NCT03867292 250 251 O
Not NCT03867292 253 256 O
signed NCT03867292 257 263 O
the NCT03867292 264 267 O
informed NCT03867292 268 276 O
consent NCT03867292 277 284 O
document NCT03867292 285 293 O
. NCT03867292 294 295 O

Inclusion NCT03924843 0 9 O
Criteria NCT03924843 10 18 O
: NCT03924843 19 20 O

- NCT03924843 24 25 O
Men NCT03924843 27 30 O
/ NCT03924843 31 32 B-Or
Women NCT03924843 33 38 O
age NCT03924843 39 42 B-Age
> NCT03924843 43 44 B-Eq_Comparison
40 NCT03924843 45 47 I-Eq_Comparison
years NCT03924843 48 53 I-Eq_Comparison
. NCT03924843 54 55 O

- NCT03924843 59 60 O
Diagnoses NCT03924843 62 71 O
of NCT03924843 72 74 O
COPD NCT03924843 75 79 B-Condition
according NCT03924843 80 89 O
to NCT03924843 90 92 O
criteria NCT03924843 93 101 O
of NCT03924843 102 104 O
the NCT03924843 105 108 O
American NCT03924843 109 117 O
Thoracic NCT03924843 118 126 O
Society NCT03924843 127 134 O
( NCT03924843 135 136 O
ATS NCT03924843 137 140 O
) NCT03924843 141 142 O
, NCT03924843 143 144 O
a NCT03924843 145 146 O
disease NCT03924843 147 154 O
state NCT03924843 155 160 O
characterized NCT03924843 161 174 O
by NCT03924843 175 177 O
the NCT03924843 178 181 O
presence NCT03924843 182 190 O
of NCT03924843 191 193 O
chronic NCT03924843 194 201 O
airway NCT03924843 202 208 B-Condition
obstruction NCT03924843 209 220 I-Condition
due NCT03924843 221 224 O
to NCT03924843 225 227 O
chronic NCT03924843 228 235 O
bronchitis NCT03924843 236 246 B-Condition
( NCT03924843 247 248 O
cough NCT03924843 249 254 B-Condition
/ NCT03924843 255 256 B-Or
sputum NCT03924843 257 263 B-Condition
on NCT03924843 264 266 O
most NCT03924843 267 271 O
days NCT03924843 272 276 B-Eq_Comparison
a NCT03924843 277 278 I-Eq_Comparison
week NCT03924843 279 283 I-Eq_Comparison
for NCT03924843 284 287 O
3 NCT03924843 288 289 B-Eq_Comparison
months NCT03924843 290 296 I-Eq_Comparison
in NCT03924843 297 299 I-Eq_Comparison
a NCT03924843 300 301 I-Eq_Comparison
year NCT03924843 302 306 I-Eq_Comparison
for NCT03924843 307 310 O
at NCT03924843 311 313 B-Eq_Comparison
least NCT03924843 314 319 I-Eq_Comparison
two NCT03924843 320 323 I-Eq_Comparison
successive NCT03924843 324 334 I-Eq_Comparison
years NCT03924843 335 340 I-Eq_Comparison
) NCT03924843 341 342 O
and NCT03924843 343 346 B-Or
/ NCT03924843 347 348 I-Or
or NCT03924843 349 351 I-Or
emphysema NCT03924843 352 361 B-Condition

- NCT03924843 364 365 O
Diagnosis NCT03924843 367 376 O
of NCT03924843 377 379 O
moderate NCT03924843 380 388 B-Eq_Comparison
or NCT03924843 389 391 I-Eq_Comparison
severe NCT03924843 392 398 I-Eq_Comparison
COPD NCT03924843 399 403 B-Condition
exacerbation NCT03924843 404 416 I-Condition
( NCT03924843 417 418 O
see NCT03924843 419 422 O
" NCT03924843 423 424 O
Definitions NCT03924843 424 435 O
" NCT03924843 435 436 O
) NCT03924843 437 438 O

- NCT03924843 442 443 O
FEV NCT03924843 445 448 B-Observation
1 NCT03924843 449 450 I-Observation
> NCT03924843 451 452 B-Eq_Comparison
0.8 NCT03924843 453 456 I-Eq_Comparison
L NCT03924843 457 458 I-Eq_Comparison
and NCT03924843 459 462 B-And
ability NCT03924843 463 470 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924843 471 473 I-Assertion___Assertion_Type_Value:hypothetical
produce NCT03924843 474 481 B-Condition
sputum NCT03924843 482 488 I-Condition
after NCT03924843 489 494 B-Temporal_Connection___Temporal_Connection_Type_Value:after
hypertonic NCT03924843 495 505 B-Drug
saline NCT03924843 506 512 I-Drug
production NCT03924843 513 523 I-Drug

- NCT03924843 526 527 O
Post NCT03924843 529 533 B-Temporal_Connection___Temporal_Connection_Type_Value:after
bronchodilator NCT03924843 534 548 B-Procedure
FEV NCT03924843 549 552 B-Observation
1 NCT03924843 553 554 I-Observation
/ NCT03924843 555 556 B-Or
Forced NCT03924843 557 563 B-Observation
Vital NCT03924843 564 569 I-Observation
Capacity NCT03924843 570 578 I-Observation
( NCT03924843 579 580 O
FVC NCT03924843 581 584 B-Observation
) NCT03924843 585 586 O
ratio NCT03924843 587 592 O
< NCT03924843 593 594 B-Eq_Comparison
70 NCT03924843 595 597 I-Eq_Comparison
% NCT03924843 598 599 I-Eq_Comparison
and NCT03924843 600 603 B-And
post NCT03924843 604 608 B-Temporal_Connection___Temporal_Connection_Type_Value:after
bronchodilator NCT03924843 609 623 B-Procedure
FEV NCT03924843 624 627 B-Observation
1 NCT03924843 628 629 I-Observation
< NCT03924843 630 631 B-Eq_Comparison
80 NCT03924843 632 634 I-Eq_Comparison
% NCT03924843 635 636 I-Eq_Comparison
pred NCT03924843 637 641 O
. NCT03924843 642 643 O

- NCT03924843 647 648 O
A NCT03924843 650 651 O
smoking NCT03924843 652 659 B-Observation
history NCT03924843 660 667 B-Eq_Comparison
of NCT03924843 668 670 O
> NCT03924843 671 672 B-Eq_Comparison
10 NCT03924843 673 675 I-Eq_Comparison
pack NCT03924843 676 680 I-Eq_Comparison
years NCT03924843 681 686 I-Eq_Comparison

Exclusion NCT03924843 687 696 O
Criteria NCT03924843 697 705 O
: NCT03924843 706 707 O

- NCT03924843 711 712 O
Pneumonia NCT03924843 714 723 B-Condition
as NCT03924843 724 726 O
determined NCT03924843 727 737 O
by NCT03924843 738 740 O
X NCT03924843 741 742 B-Procedure
- NCT03924843 743 744 I-Procedure
ray NCT03924843 745 748 I-Procedure

- NCT03924843 751 752 O
> NCT03924843 754 755 B-Eq_Comparison
48 NCT03924843 756 758 I-Eq_Comparison
h NCT03924843 759 760 I-Eq_Comparison
intake NCT03924843 761 767 O
of NCT03924843 768 770 O
prednisolon NCT03924843 771 782 B-Drug
/ NCT03924843 783 784 B-Or
antibiotics NCT03924843 785 796 B-Drug

- NCT03924843 799 800 O
Need NCT03924843 802 806 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03924843 807 810 I-Assertion___Assertion_Type_Value:hypothetical
mechanical NCT03924843 811 821 B-Procedure
ventilation NCT03924843 822 833 I-Procedure
( NCT03924843 834 835 O
either NCT03924843 836 842 O
invasive NCT03924843 843 851 B-Modifier
or NCT03924843 852 854 B-Or
non NCT03924843 855 858 B-Modifier
- NCT03924843 859 860 I-Modifier
invasive NCT03924843 861 869 I-Modifier
) NCT03924843 870 871 O

- NCT03924843 875 876 O
Treatment NCT03924843 878 887 B-Procedure
with NCT03924843 888 892 O
immune NCT03924843 893 899 B-Drug
- NCT03924843 900 901 I-Drug
modulating NCT03924843 902 912 I-Drug
agents NCT03924843 913 919 I-Drug
for NCT03924843 920 923 O
any NCT03924843 924 927 O
disease NCT03924843 928 935 B-Condition

- NCT03924843 938 939 O
Experimental NCT03924843 941 953 O
interventions NCT03924843 954 967 B-Procedure
for NCT03924843 968 971 O
COPD NCT03924843 972 976 B-Condition
last NCT03924843 977 981 B-Eq_Comparison
half NCT03924843 982 986 I-Eq_Comparison
year NCT03924843 987 991 I-Eq_Comparison

- NCT03924843 994 995 O
Former NCT03924843 997 1003 B-Eq_Comparison
/ NCT03924843 1004 1005 B-Or
concomitant NCT03924843 1006 1017 B-Modifier
diagnosis NCT03924843 1018 1027 O
of NCT03924843 1028 1030 O
asthma NCT03924843 1031 1037 B-Condition

- NCT03924843 1040 1041 O
Any NCT03924843 1043 1046 O
significant NCT03924843 1047 1058 O
other NCT03924843 1059 1064 B-Other
pulmonary NCT03924843 1065 1074 B-Modifier
disease NCT03924843 1075 1082 B-Condition
or NCT03924843 1083 1085 B-Or
disorder NCT03924843 1086 1094 B-Condition

- NCT03924843 1097 1098 O
Other NCT03924843 1100 1105 O
significant NCT03924843 1106 1117 O
disease NCT03924843 1118 1125 B-Condition
or NCT03924843 1126 1128 B-Or
disorder NCT03924843 1129 1137 B-Condition
( NCT03924843 1138 1139 O
like NCT03924843 1140 1144 O
alpha NCT03924843 1145 1150 B-Condition
- NCT03924843 1151 1152 I-Condition
1 NCT03924843 1153 1154 I-Condition
- NCT03924843 1155 1156 I-Condition
antitrypsine NCT03924843 1157 1169 I-Condition
deficiency NCT03924843 1170 1180 I-Condition
, NCT03924843 1181 1182 O
significant NCT03924843 1183 1194 O
bronchiectasis NCT03924843 1195 1209 B-Condition
, NCT03924843 1210 1211 O
cardiovascular NCT03924843 1212 1226 B-Modifier
, NCT03924843 1227 1228 O
gastrointestinal NCT03924843 1229 1245 B-Modifier
, NCT03924843 1246 1247 O
liver NCT03924843 1248 1253 B-Modifier
, NCT03924843 1254 1255 O
renal NCT03924843 1256 1261 B-Modifier
, NCT03924843 1262 1263 O
neurological NCT03924843 1264 1276 B-Modifier
, NCT03924843 1277 1278 O
musculoskeletal NCT03924843 1279 1294 B-Modifier
, NCT03924843 1295 1296 O
endocrine NCT03924843 1297 1306 B-Modifier
, NCT03924843 1307 1308 O
metabolic NCT03924843 1309 1318 B-Modifier
( NCT03924843 1319 1320 O
including NCT03924843 1321 1330 O
diagnosed NCT03924843 1331 1340 O
diabetes NCT03924843 1341 1349 B-Condition
) NCT03924843 1350 1351 O
, NCT03924843 1352 1353 O
malignant NCT03924843 1354 1363 B-Modifier
, NCT03924843 1364 1365 O
psychiatric NCT03924843 1366 1377 B-Modifier
, NCT03924843 1378 1379 O
major NCT03924843 1380 1385 B-Modifier
physical NCT03924843 1386 1394 I-Modifier
impairment NCT03924843 1395 1405 B-Condition
) NCT03924843 1406 1407 O
, NCT03924843 1408 1409 O
which NCT03924843 1410 1415 O
, NCT03924843 1416 1417 O
in NCT03924843 1418 1420 O
the NCT03924843 1421 1424 O
opinion NCT03924843 1425 1432 O
of NCT03924843 1433 1435 O
the NCT03924843 1436 1439 O
investigators NCT03924843 1440 1453 O
may NCT03924843 1454 1457 B-Assertion___Assertion_Type_Value:hypothetical
either NCT03924843 1458 1464 O
put NCT03924843 1465 1468 O
the NCT03924843 1469 1472 O
patient NCT03924843 1473 1480 O
at NCT03924843 1481 1483 O
risk NCT03924843 1484 1488 B-Risk
because NCT03924843 1489 1496 O
of NCT03924843 1497 1499 O
participation NCT03924843 1500 1513 O
in NCT03924843 1514 1516 O
the NCT03924843 1517 1520 O
study NCT03924843 1521 1526 O
, NCT03924843 1527 1528 O
or NCT03924843 1529 1531 B-Or
may NCT03924843 1532 1535 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03924843 1536 1545 O
the NCT03924843 1546 1549 O
results NCT03924843 1550 1557 O
of NCT03924843 1558 1560 O
the NCT03924843 1561 1564 O
study NCT03924843 1565 1570 B-Study
, NCT03924843 1571 1572 O
or NCT03924843 1573 1575 O
the NCT03924843 1576 1579 O
patient NCT03924843 1580 1587 O
's NCT03924843 1587 1589 O
ability NCT03924843 1590 1597 O
to NCT03924843 1598 1600 O
participate NCT03924843 1601 1612 O
in NCT03924843 1613 1615 O
the NCT03924843 1616 1619 O
study NCT03924843 1620 1625 O
. NCT03924843 1626 1627 O

- NCT03924843 1631 1632 O
Existing NCT03924843 1634 1642 B-Eq_Comparison
pregnancy NCT03924843 1643 1652 B-Condition
/ NCT03924843 1653 1654 B-Or
current NCT03924843 1655 1662 B-Eq_Comparison
willingness NCT03924843 1663 1674 B-Assertion___Assertion_Type_Value:intention
for NCT03924843 1675 1678 I-Assertion___Assertion_Type_Value:intention
becoming NCT03924843 1679 1687 I-Assertion___Assertion_Type_Value:intention
pregnant NCT03924843 1688 1696 B-Condition

Inclusion NCT03929510 0 9 O
Criteria NCT03929510 10 18 O
: NCT03929510 19 20 O

- NCT03929510 24 25 O
Male NCT03929510 27 31 O
participants NCT03929510 32 44 O
who NCT03929510 45 48 B-And
are NCT03929510 49 52 O
healthy NCT03929510 53 60 B-Condition
as NCT03929510 61 63 O
determined NCT03929510 64 74 O
by NCT03929510 75 77 O
medical NCT03929510 78 85 B-Procedure
evaluation NCT03929510 86 96 I-Procedure
including NCT03929510 97 106 O
a NCT03929510 107 108 O
detailed NCT03929510 109 117 O
medical NCT03929510 118 125 O
history NCT03929510 126 133 O
, NCT03929510 134 135 O
full NCT03929510 136 140 B-Modifier
physical NCT03929510 141 149 B-Procedure
examination NCT03929510 150 161 I-Procedure
, NCT03929510 162 163 O
including NCT03929510 164 173 O
blood NCT03929510 174 179 B-Observation
pressure NCT03929510 180 188 I-Observation
( NCT03929510 189 190 O
BP NCT03929510 191 193 B-Observation
) NCT03929510 194 195 O
and NCT03929510 196 199 B-And
pulse NCT03929510 200 205 B-Observation
rate NCT03929510 206 210 I-Observation
( NCT03929510 211 212 O
PR NCT03929510 213 215 B-Observation
) NCT03929510 216 217 O
measurement NCT03929510 218 229 O
, NCT03929510 230 231 O
12 NCT03929510 232 234 B-Procedure
lead NCT03929510 235 239 I-Procedure
ECG NCT03929510 240 243 I-Procedure
, NCT03929510 244 245 O
and NCT03929510 246 249 O
clinical NCT03929510 250 258 O
laboratory NCT03929510 259 269 B-Observation
tests NCT03929510 270 275 I-Observation
. NCT03929510 276 277 O

- NCT03929510 281 282 O
Body NCT03929510 284 288 B-Observation
mass NCT03929510 289 293 I-Observation
index NCT03929510 294 299 I-Observation
( NCT03929510 300 301 O
BMI NCT03929510 302 305 B-Observation
) NCT03929510 306 307 O
of NCT03929510 308 310 O
17.5 NCT03929510 311 315 B-Eq_Comparison
to NCT03929510 316 318 I-Eq_Comparison
30.5 NCT03929510 319 323 I-Eq_Comparison
kg NCT03929510 324 326 I-Eq_Comparison
/ NCT03929510 327 328 I-Eq_Comparison
m NCT03929510 329 330 I-Eq_Comparison
2 NCT03929510 331 332 I-Eq_Comparison
; NCT03929510 332 333 O
and NCT03929510 334 337 O
a NCT03929510 338 339 O
total NCT03929510 340 345 O
body NCT03929510 346 350 B-Observation
weight NCT03929510 351 357 I-Observation
> NCT03929510 358 359 B-Eq_Comparison
50 NCT03929510 360 362 I-Eq_Comparison
kg NCT03929510 363 365 I-Eq_Comparison
( NCT03929510 366 367 O
110 NCT03929510 368 371 B-Eq_Comparison
lb NCT03929510 372 374 I-Eq_Comparison
) NCT03929510 375 376 O
. NCT03929510 377 378 O

Exclusion NCT03929510 380 389 O
Criteria NCT03929510 390 398 O
: NCT03929510 399 400 O

- NCT03929510 404 405 O
Known NCT03929510 407 412 O
immunodeficiency NCT03929510 413 429 B-Condition
disorder NCT03929510 430 438 I-Condition
, NCT03929510 439 440 O
including NCT03929510 441 450 O
positive NCT03929510 451 459 O
serology NCT03929510 460 468 O
for NCT03929510 469 472 O
human NCT03929510 473 478 B-Condition
immunodeficiency NCT03929510 479 495 I-Condition
virus NCT03929510 496 501 I-Condition
( NCT03929510 502 503 O
HIV NCT03929510 504 507 B-Condition
) NCT03929510 508 509 O
at NCT03929510 510 512 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03929510 513 522 B-Study
, NCT03929510 523 524 O
or NCT03929510 525 527 B-Or
a NCT03929510 528 529 O
first NCT03929510 530 535 B-Modifier
degree NCT03929510 536 542 I-Modifier
relative NCT03929510 543 551 B-Family_Member
with NCT03929510 552 556 O
a NCT03929510 557 558 O
hereditary NCT03929510 559 569 B-Modifier
immunodeficiency NCT03929510 570 586 B-Condition
. NCT03929510 587 588 O

- NCT03929510 592 593 O
Infection NCT03929510 595 604 B-Condition
with NCT03929510 605 609 I-Condition
hepatitis NCT03929510 610 619 I-Condition
B NCT03929510 620 621 I-Condition
or NCT03929510 622 624 B-Or
hepatitis NCT03929510 625 634 B-Condition
C NCT03929510 635 636 I-Condition
viruses NCT03929510 637 644 I-Condition
. NCT03929510 645 646 O

- NCT03929510 650 651 O
Participants NCT03929510 653 665 O
with NCT03929510 666 670 O
selected NCT03929510 671 679 O
acute NCT03929510 680 685 O
or NCT03929510 686 688 O
chronic NCT03929510 689 696 B-Condition
infections NCT03929510 697 707 I-Condition
or NCT03929510 708 710 B-Or
infection NCT03929510 711 720 B-Condition
history NCT03929510 721 728 B-Eq_Comparison
. NCT03929510 729 730 O

- NCT03929510 734 735 O
Participants NCT03929510 737 749 O
have NCT03929510 750 754 O
a NCT03929510 755 756 O
known NCT03929510 757 762 O
present NCT03929510 763 770 B-Eq_Comparison
or NCT03929510 771 773 B-Or
a NCT03929510 774 775 O
history NCT03929510 776 783 B-Eq_Comparison
of NCT03929510 784 786 O
malignancy NCT03929510 787 797 B-Condition
other NCT03929510 798 803 B-Exception
than NCT03929510 804 808 I-Exception
a NCT03929510 809 810 O
successfully NCT03929510 811 823 O
treated NCT03929510 824 831 B-Procedure
or NCT03929510 832 834 B-Or
excised NCT03929510 835 842 B-Procedure
non NCT03929510 843 846 B-Modifier
metastatic NCT03929510 847 857 I-Modifier
basal NCT03929510 858 863 I-Modifier
cell NCT03929510 864 868 I-Modifier
or NCT03929510 869 871 B-Or
squamous NCT03929510 872 880 B-Modifier
cell NCT03929510 881 885 I-Modifier
cancer NCT03929510 886 892 B-Condition
of NCT03929510 893 895 O
the NCT03929510 896 899 O
skin NCT03929510 900 904 B-Modifier
. NCT03929510 905 906 O

- NCT03929510 910 911 O
History NCT03929510 913 920 B-Eq_Comparison
of NCT03929510 921 923 O
alcohol NCT03929510 924 931 B-Condition
abuse NCT03929510 932 937 I-Condition
or NCT03929510 938 940 B-Or
binge NCT03929510 941 946 B-Condition
drinking NCT03929510 947 955 I-Condition
and NCT03929510 956 959 B-Or
/ NCT03929510 960 961 I-Or
or NCT03929510 962 964 I-Or
any NCT03929510 965 968 O
other NCT03929510 969 974 B-Other
illicit NCT03929510 975 982 B-Condition
drug NCT03929510 983 987 I-Condition
use NCT03929510 988 991 I-Condition
or NCT03929510 992 994 B-Or
dependence NCT03929510 995 1005 B-Condition
within NCT03929510 1006 1012 B-Eq_Comparison
6 NCT03929510 1013 1014 I-Eq_Comparison
months NCT03929510 1015 1021 I-Eq_Comparison
of NCT03929510 1022 1024 B-Temporal_Connection___Temporal_Connection_Type_Value:before
Screening NCT03929510 1025 1034 B-Study
. NCT03929510 1035 1036 O

- NCT03929510 1040 1041 O
Use NCT03929510 1043 1046 O
of NCT03929510 1047 1049 O
tobacco NCT03929510 1050 1057 B-Drug
/ NCT03929510 1058 1059 B-Or
nicotine NCT03929510 1060 1068 B-Drug
containing NCT03929510 1069 1079 O
products NCT03929510 1080 1088 O
within NCT03929510 1089 1095 B-Eq_Comparison
3 NCT03929510 1096 1097 I-Eq_Comparison
months NCT03929510 1098 1104 I-Eq_Comparison
prior NCT03929510 1105 1110 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03929510 1111 1113 O
dosing NCT03929510 1114 1120 O
or NCT03929510 1121 1123 O
positive NCT03929510 1124 1132 O
urine NCT03929510 1133 1138 B-Observation
cotinine NCT03929510 1139 1147 I-Observation
test NCT03929510 1148 1152 I-Observation
. NCT03929510 1153 1154 O

Inclusion NCT03863886 0 9 O
Criteria NCT03863886 10 18 O
: NCT03863886 19 20 O

- NCT03863886 24 25 O
Adults NCT03863886 27 33 O
patients NCT03863886 34 42 O
â¥ NCT03863886 43 44 B-Eq_Comparison
18 NCT03863886 45 47 I-Eq_Comparison
years NCT03863886 48 53 I-Eq_Comparison
of NCT03863886 54 56 O
age NCT03863886 57 60 B-Age
with NCT03863886 61 65 B-And
CD NCT03863886 66 68 B-Condition
with NCT03863886 69 73 B-And
at NCT03863886 74 76 O
least NCT03863886 77 82 O
colonic NCT03863886 83 90 B-Condition
involvement NCT03863886 91 102 I-Condition
, NCT03863886 103 104 O
UC NCT03863886 105 107 B-Condition
, NCT03863886 108 109 O
or NCT03863886 110 112 B-Or
non NCT03863886 113 116 B-Negation
- NCT03863886 117 118 O
IBD NCT03863886 119 122 B-Condition
controls NCT03863886 123 131 O
who NCT03863886 132 135 B-And
have NCT03863886 136 140 O
been NCT03863886 141 145 O
referred NCT03863886 146 154 B-Eq_Comparison
for NCT03863886 155 158 I-Eq_Comparison
colonoscopy NCT03863886 159 170 B-Procedure
for NCT03863886 171 174 O
clinical NCT03863886 175 183 B-Observation
reasons NCT03863886 184 191 I-Observation
. NCT03863886 192 193 O
The NCT03863886 195 198 O
clinical NCT03863886 199 207 B-Observation
reasons NCT03863886 208 215 I-Observation
may NCT03863886 216 219 O
include NCT03863886 220 227 O
colorectal NCT03863886 228 238 B-Procedure
cancer NCT03863886 239 245 I-Procedure
screening NCT03863886 246 255 I-Procedure
, NCT03863886 256 257 O
surveillance NCT03863886 258 270 B-Observation
, NCT03863886 271 272 O
diagnostic NCT03863886 273 283 O
for NCT03863886 284 287 O
CD NCT03863886 288 290 B-Condition
or NCT03863886 291 293 B-Or
UC NCT03863886 294 296 B-Condition
flare NCT03863886 297 302 O
, NCT03863886 303 304 O
or NCT03863886 305 307 B-Or
gastrointestinal NCT03863886 308 324 B-Condition
symptoms NCT03863886 325 333 B-Assertion___Assertion_Type_Value:possible
. NCT03863886 334 335 O

Exclusion NCT03863886 337 346 O
Criteria NCT03863886 347 355 O
: NCT03863886 356 357 O

- NCT03863886 361 362 O
Pregnant NCT03863886 364 372 B-Condition
patients NCT03863886 373 381 O
. NCT03863886 382 383 O

- NCT03863886 387 388 O
Patients NCT03863886 390 398 O
with NCT03863886 399 403 O
known NCT03863886 404 409 O
current NCT03863886 410 417 B-Eq_Comparison
colorectal NCT03863886 418 428 B-Modifier
cancer NCT03863886 429 435 B-Condition
, NCT03863886 436 437 O
infectious NCT03863886 438 448 B-Condition
colitis NCT03863886 449 456 I-Condition
, NCT03863886 457 458 O
diverticulitis NCT03863886 459 473 B-Condition
, NCT03863886 474 475 O
or NCT03863886 476 478 B-Or
microscopic NCT03863886 479 490 B-Condition
colitis NCT03863886 491 498 I-Condition
. NCT03863886 499 500 O

- NCT03863886 504 505 O
Patients NCT03863886 507 515 O
who NCT03863886 516 519 O
have NCT03863886 520 524 O
undergone NCT03863886 525 534 B-Eq_Comparison
surgery NCT03863886 535 542 B-Procedure
involving NCT03863886 543 552 O
the NCT03863886 553 556 O
cecum NCT03863886 557 562 B-Modifier
or NCT03863886 563 565 B-Or
rectum NCT03863886 566 572 B-Modifier
. NCT03863886 573 574 O

Inclusion NCT03861637 0 9 O
Criteria NCT03861637 10 18 O
: NCT03861637 19 20 O

- NCT03861637 24 25 O
Patients NCT03861637 27 35 O
who NCT03861637 36 39 O
fulfilled NCT03861637 40 49 O
the NCT03861637 50 53 O
following NCT03861637 54 63 O
criteria NCT03861637 64 72 O
were NCT03861637 73 77 O
included NCT03861637 78 86 O
in NCT03861637 87 89 O
the NCT03861637 90 93 O
study NCT03861637 94 99 O
: NCT03861637 100 101 O

- NCT03861637 105 106 O
Adult NCT03861637 108 113 O
renal NCT03861637 114 119 B-Procedure
transplant NCT03861637 120 130 I-Procedure
patients NCT03861637 131 139 O
( NCT03861637 140 141 O
â¥ NCT03861637 142 143 B-Eq_Comparison
21 NCT03861637 144 146 I-Eq_Comparison
years NCT03861637 147 152 I-Eq_Comparison
) NCT03861637 153 154 O
, NCT03861637 155 156 O

- NCT03861637 160 161 O
Informed NCT03861637 163 171 O
consent NCT03861637 172 179 O
, NCT03861637 180 181 O

- NCT03861637 185 186 O
Stable NCT03861637 188 194 O
maintenance NCT03861637 195 206 O
subcutaneous NCT03861637 207 219 B-Modifier
ESA NCT03861637 220 223 B-Procedure
therapy NCT03861637 224 231 I-Procedure
with NCT03861637 232 236 O
constant NCT03861637 237 245 O
dose NCT03861637 246 250 O
interval NCT03861637 251 259 O
during NCT03861637 260 266 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861637 267 270 O
last NCT03861637 271 275 B-Eq_Comparison
2 NCT03861637 276 277 I-Eq_Comparison
months NCT03861637 278 284 I-Eq_Comparison
, NCT03861637 285 286 O

- NCT03861637 290 291 O
Haemoglobin NCT03861637 293 304 B-Observation
( NCT03861637 305 306 O
Hb NCT03861637 307 309 B-Observation
) NCT03861637 310 311 O
â¥ NCT03861637 312 313 B-Eq_Comparison
10 NCT03861637 314 316 I-Eq_Comparison
mg NCT03861637 317 319 I-Eq_Comparison
/ NCT03861637 320 321 I-Eq_Comparison
dL NCT03861637 322 324 I-Eq_Comparison
( NCT03861637 325 326 O
Hct NCT03861637 327 330 B-Observation
32 NCT03861637 331 333 B-Eq_Comparison
% NCT03861637 334 335 I-Eq_Comparison
) NCT03861637 336 337 O
, NCT03861637 338 339 O

- NCT03861637 343 344 O
Transferrin NCT03861637 346 357 B-Observation
saturation NCT03861637 358 368 I-Observation
( NCT03861637 369 370 O
TSAT NCT03861637 371 375 B-Observation
) NCT03861637 376 377 O
â¥ NCT03861637 378 379 B-Eq_Comparison
20 NCT03861637 380 382 I-Eq_Comparison
% NCT03861637 383 384 I-Eq_Comparison
( NCT03861637 385 386 O
during NCT03861637 387 393 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861637 394 397 O
screening NCT03861637 398 407 B-Study
phase NCT03861637 408 413 O
) NCT03861637 414 415 O
, NCT03861637 416 417 O

- NCT03861637 421 422 O
and NCT03861637 424 427 B-And
serum NCT03861637 428 433 B-Observation
ferritin NCT03861637 434 442 I-Observation
â¥ NCT03861637 443 444 B-Eq_Comparison
100 NCT03861637 445 448 I-Eq_Comparison
ng NCT03861637 449 451 I-Eq_Comparison
/ NCT03861637 452 453 I-Eq_Comparison
mL NCT03861637 454 456 I-Eq_Comparison

Exclusion NCT03861637 457 466 O
Criteria NCT03861637 467 475 O
: NCT03861637 476 477 O

We NCT03861637 479 481 O
excluded NCT03861637 482 490 O
patients NCT03861637 491 499 O
with NCT03861637 500 504 O
the NCT03861637 505 508 O
following NCT03861637 509 518 O
criteria NCT03861637 519 527 O
: NCT03861637 528 529 O

- NCT03861637 533 534 O
Acute NCT03861637 536 541 O
or NCT03861637 542 544 B-Or
chronic NCT03861637 545 552 O
bleeding NCT03861637 553 561 B-Condition
, NCT03861637 562 563 O
or NCT03861637 564 566 B-Or
erythrocyte NCT03861637 567 578 B-Procedure
transfusion NCT03861637 579 590 I-Procedure
, NCT03861637 591 592 O
within NCT03861637 593 599 B-Eq_Comparison
the NCT03861637 600 603 I-Eq_Comparison
preceding NCT03861637 604 613 I-Eq_Comparison
8 NCT03861637 614 615 I-Eq_Comparison
weeks NCT03861637 616 621 I-Eq_Comparison
. NCT03861637 622 623 O
change NCT03861637 625 631 O
in NCT03861637 632 634 O
Hb NCT03861637 635 637 B-Observation
level NCT03861637 638 643 O
â¥ NCT03861637 644 645 B-Eq_Comparison
2 NCT03861637 646 647 I-Eq_Comparison
g NCT03861637 648 649 I-Eq_Comparison
/ NCT03861637 650 651 I-Eq_Comparison
dL NCT03861637 652 654 I-Eq_Comparison
during NCT03861637 655 661 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03861637 662 671 B-Study
phase NCT03861637 672 677 O
, NCT03861637 678 679 O

- NCT03861637 683 684 O
Hemolytic NCT03861637 686 695 B-Condition
anemia NCT03861637 696 702 I-Condition
, NCT03861637 703 704 O

- NCT03861637 708 709 O
Recent NCT03861637 711 717 B-Eq_Comparison
infection NCT03861637 718 727 B-Condition
or NCT03861637 728 730 B-Or
rejection NCT03861637 731 740 B-Condition
, NCT03861637 741 742 O

- NCT03861637 746 747 O
Diastolic NCT03861637 749 758 B-Observation
blood NCT03861637 759 764 I-Observation
pressure NCT03861637 765 773 I-Observation
> NCT03861637 774 775 O
100 NCT03861637 776 779 B-Eq_Comparison
mmHg NCT03861637 780 784 I-Eq_Comparison
or NCT03861637 785 787 B-Or
discontinuation NCT03861637 788 803 B-Negation
of NCT03861637 804 806 O
ESA NCT03861637 807 810 B-Procedure
due NCT03861637 811 814 O
to NCT03861637 815 817 O
hypertension NCT03861637 818 830 B-Condition
in NCT03861637 831 833 O
the NCT03861637 834 837 O
6 NCT03861637 838 839 B-Eq_Comparison
months NCT03861637 840 846 I-Eq_Comparison
prior NCT03861637 847 852 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03861637 853 855 I-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03861637 856 861 B-Study
, NCT03861637 862 863 O

- NCT03861637 867 868 O
Vitamin NCT03861637 870 877 B-Modifier
B NCT03861637 878 879 I-Modifier
12 NCT03861637 880 882 I-Modifier
or NCT03861637 883 885 B-Or
folic NCT03861637 886 891 B-Modifier
acid NCT03861637 892 896 I-Modifier
deficiency NCT03861637 897 907 B-Condition
, NCT03861637 908 909 O

- NCT03861637 913 914 O
Uncontrolled NCT03861637 916 928 B-Modifier
or NCT03861637 929 931 B-Or
secondary NCT03861637 932 941 B-Modifier
hyperparathyroidism NCT03861637 942 961 B-Condition
, NCT03861637 962 963 O

- NCT03861637 967 968 O
Acute NCT03861637 970 975 O
or NCT03861637 976 978 B-Or
chronic NCT03861637 979 986 O
systemic NCT03861637 987 995 B-Condition
inflammatory NCT03861637 996 1008 I-Condition
disease NCT03861637 1009 1016 I-Condition
and NCT03861637 1017 1020 B-Or
/ NCT03861637 1021 1022 I-Or
or NCT03861637 1023 1025 I-Or
C NCT03861637 1026 1027 B-Observation
- NCT03861637 1028 1029 I-Observation
reactive NCT03861637 1030 1038 I-Observation
protein NCT03861637 1039 1046 I-Observation
( NCT03861637 1047 1048 O
CRP NCT03861637 1049 1052 B-Observation
) NCT03861637 1053 1054 O
> NCT03861637 1055 1056 B-Eq_Comparison
30 NCT03861637 1057 1059 I-Eq_Comparison
mg NCT03861637 1060 1062 I-Eq_Comparison
/ NCT03861637 1063 1064 I-Eq_Comparison
L NCT03861637 1065 1066 I-Eq_Comparison
, NCT03861637 1067 1068 O

- NCT03861637 1072 1073 O
Hemodialysis NCT03861637 1075 1087 B-Procedure
due NCT03861637 1088 1091 O
to NCT03861637 1092 1094 O
failure NCT03861637 1095 1102 B-Modifier
of NCT03861637 1103 1105 O
a NCT03861637 1106 1107 O
kidney NCT03861637 1108 1114 B-Procedure
transplant NCT03861637 1115 1125 I-Procedure
, NCT03861637 1126 1127 O

- NCT03861637 1131 1132 O
and NCT03861637 1134 1137 B-Or
malignancy NCT03861637 1138 1148 B-Condition


Inclusion NCT03920774 0 9 O
Criteria NCT03920774 10 18 O
: NCT03920774 19 20 O

- NCT03920774 24 25 O
Patients NCT03920774 27 35 O
of NCT03920774 36 38 O
any NCT03920774 39 42 O
age NCT03920774 43 46 O
with NCT03920774 47 51 O
a NCT03920774 52 53 O
diagnosis NCT03920774 54 63 O
of NCT03920774 64 66 O
familial NCT03920774 67 75 B-Condition
dysautonomia NCT03920774 76 88 I-Condition
( NCT03920774 89 90 O
FD NCT03920774 91 93 B-Condition
) NCT03920774 94 95 O
with NCT03920774 96 100 B-And
molecular NCT03920774 101 110 O
confirmation NCT03920774 111 123 O
of NCT03920774 124 126 O
the NCT03920774 127 130 O
IKBKAP NCT03920774 131 137 B-Condition
mutation NCT03920774 138 146 I-Condition
. NCT03920774 147 148 O

- NCT03920774 152 153 O
Ability NCT03920774 155 162 O
to NCT03920774 163 165 O
provide NCT03920774 166 173 O
informed NCT03920774 174 182 O
consent NCT03920774 183 190 O
( NCT03920774 191 192 O
or NCT03920774 193 195 O
assent NCT03920774 196 202 O
) NCT03920774 203 204 O
and NCT03920774 205 208 O
comply NCT03920774 209 215 O
with NCT03920774 216 220 O
the NCT03920774 221 224 O
study NCT03920774 225 230 O
protocol NCT03920774 231 239 O

Exclusion NCT03920774 240 249 O
Criteria NCT03920774 250 258 O
: NCT03920774 259 260 O

- NCT03920774 264 265 O
Subjects NCT03920774 267 275 O
that NCT03920774 276 280 O
do NCT03920774 281 283 O
not NCT03920774 284 287 O
wish NCT03920774 288 292 O
to NCT03920774 293 295 O
be NCT03920774 296 298 O
a NCT03920774 299 300 O
part NCT03920774 301 305 O
of NCT03920774 306 308 O
the NCT03920774 309 312 O
study NCT03920774 313 318 O
. NCT03920774 319 320 O

Inclusion NCT03928912 0 9 O
Criteria NCT03928912 10 18 O
: NCT03928912 19 20 O

- NCT03928912 24 25 O
The NCT03928912 27 30 O
tibial NCT03928912 31 37 B-Modifier
shaft NCT03928912 38 43 I-Modifier
fracture NCT03928912 44 52 B-Condition
was NCT03928912 53 56 O
caused NCT03928912 57 63 O
by NCT03928912 64 66 O
trauma NCT03928912 67 73 B-Condition
. NCT03928912 74 75 O

Exclusion NCT03928912 77 86 O
Criteria NCT03928912 87 95 O
: NCT03928912 96 97 O

- NCT03928912 101 102 O
The NCT03928912 104 107 O
tibial NCT03928912 108 114 B-Modifier
shaft NCT03928912 115 120 I-Modifier
fracture NCT03928912 121 129 B-Condition
was NCT03928912 130 133 O
caused NCT03928912 134 140 O
by NCT03928912 141 143 O
tumor NCT03928912 144 149 B-Condition
, NCT03928912 150 151 O
infection NCT03928912 152 161 B-Condition
and NCT03928912 162 165 O
other NCT03928912 166 171 O
reasons NCT03928912 172 179 O
. NCT03928912 180 181 O

Inclusion NCT03861442 0 9 O
Criteria NCT03861442 10 18 O
: NCT03861442 19 20 O

- NCT03861442 24 25 O
A NCT03861442 27 28 O
minimum NCT03861442 29 36 B-Eq_Comparison
of NCT03861442 37 39 I-Eq_Comparison
18 NCT03861442 40 42 I-Eq_Comparison
years NCT03861442 43 48 I-Eq_Comparison
old NCT03861442 49 52 B-Age

- NCT03861442 55 56 O
Experienced NCT03861442 58 69 O
user NCT03861442 70 74 O
( NCT03861442 75 76 O
â¥ NCT03861442 77 78 B-Eq_Comparison
6 NCT03861442 79 80 I-Eq_Comparison
months NCT03861442 81 87 I-Eq_Comparison
) NCT03861442 88 89 O
of NCT03861442 90 92 O
a NCT03861442 93 94 O
MED NCT03861442 95 98 B-Procedure
- NCT03861442 99 100 I-Procedure
EL NCT03861442 101 103 I-Procedure
cochlear NCT03861442 104 112 I-Procedure
implant NCT03861442 113 120 I-Procedure
( NCT03861442 121 122 O
CI NCT03861442 123 125 B-Modifier
; NCT03861442 125 126 O
C NCT03861442 127 128 B-Modifier
40 NCT03861442 129 131 I-Modifier
+ NCT03861442 132 133 I-Modifier
and NCT03861442 134 137 O
later NCT03861442 138 143 O
model NCT03861442 144 149 O
) NCT03861442 150 151 O

- NCT03861442 155 156 O
Experienced NCT03861442 158 169 O
user NCT03861442 170 174 O
of NCT03861442 175 177 O
a NCT03861442 178 179 O
MED NCT03861442 180 183 B-Procedure
- NCT03861442 184 185 I-Procedure
EL NCT03861442 186 188 I-Procedure
SONNET NCT03861442 189 195 I-Procedure
audio NCT03861442 196 201 I-Procedure
processor NCT03861442 202 211 I-Procedure
( NCT03861442 212 213 O
â¥ NCT03861442 214 215 B-Eq_Comparison
6 NCT03861442 216 217 I-Eq_Comparison
months NCT03861442 218 224 I-Eq_Comparison
) NCT03861442 225 226 O

- NCT03861442 230 231 O
Post NCT03861442 233 237 B-Modifier
- NCT03861442 238 239 I-Modifier
lingual NCT03861442 240 247 I-Modifier
onset NCT03861442 248 253 B-Eq_Comparison
of NCT03861442 254 256 O
bilateral NCT03861442 257 266 B-Modifier
severe NCT03861442 267 273 B-Eq_Comparison
to NCT03861442 274 276 I-Eq_Comparison
profound NCT03861442 277 285 I-Eq_Comparison
sensory NCT03861442 286 293 B-Condition
- NCT03861442 294 295 I-Condition
neural NCT03861442 296 302 I-Condition
hearing NCT03861442 303 310 I-Condition
loss NCT03861442 311 315 I-Condition

- NCT03861442 318 319 O
Unilateral NCT03861442 321 331 B-Procedure
CI NCT03861442 332 334 I-Procedure
user NCT03861442 335 339 O

- NCT03861442 342 343 O
A NCT03861442 345 346 O
minimum NCT03861442 347 354 B-Eq_Comparison
of NCT03861442 355 357 I-Eq_Comparison
10 NCT03861442 358 360 I-Eq_Comparison
active NCT03861442 361 367 B-Eq_Comparison
electrodes NCT03861442 368 378 B-Procedure

- NCT03861442 381 382 O
A NCT03861442 384 385 O
minimum NCT03861442 386 393 B-Eq_Comparison
of NCT03861442 394 396 I-Eq_Comparison
40 NCT03861442 397 399 I-Eq_Comparison
% NCT03861442 400 401 I-Eq_Comparison
speech NCT03861442 402 408 B-Modifier
recognition NCT03861442 409 420 I-Modifier
in NCT03861442 421 423 O
the NCT03861442 424 427 O
Freiburg NCT03861442 428 436 B-Observation
Monosyllables NCT03861442 437 450 I-Observation
test NCT03861442 451 455 I-Observation
in NCT03861442 456 458 O
quiet NCT03861442 459 464 B-Modifier
at NCT03861442 465 467 I-Modifier
65 NCT03861442 468 470 I-Modifier
dB NCT03861442 471 473 I-Modifier
sound NCT03861442 474 479 I-Modifier
pressure NCT03861442 480 488 I-Modifier
level NCT03861442 489 494 I-Modifier
( NCT03861442 495 496 O
SPL NCT03861442 497 500 B-Modifier
; NCT03861442 500 501 O
at NCT03861442 502 504 O
the NCT03861442 505 508 O
last NCT03861442 509 513 B-Eq_Comparison
time NCT03861442 514 518 I-Eq_Comparison
tested NCT03861442 519 525 O
) NCT03861442 526 527 O

- NCT03861442 531 532 O
Fluent NCT03861442 534 540 O
in NCT03861442 541 543 O
German NCT03861442 544 550 O
( NCT03861442 551 552 O
the NCT03861442 553 556 O
language NCT03861442 557 565 O
of NCT03861442 566 568 O
the NCT03861442 569 572 O
test NCT03861442 573 577 O
centre NCT03861442 578 584 O
) NCT03861442 585 586 O

- NCT03861442 590 591 O
Signed NCT03861442 593 599 O
and NCT03861442 600 603 O
dated NCT03861442 604 609 O
Informed NCT03861442 610 618 O
Consent NCT03861442 619 626 O
Form NCT03861442 627 631 O
before NCT03861442 632 638 O
the NCT03861442 639 642 O
start NCT03861442 643 648 O
of NCT03861442 649 651 O
any NCT03861442 652 655 O
study NCT03861442 656 661 O
- NCT03861442 662 663 O
specific NCT03861442 664 672 O
procedure NCT03861442 673 682 O
. NCT03861442 683 684 O

Exclusion NCT03861442 686 695 O
Criteria NCT03861442 696 704 O
: NCT03861442 705 706 O

- NCT03861442 710 711 O
Lack NCT03861442 713 717 O
of NCT03861442 718 720 O
compliance NCT03861442 721 731 O
with NCT03861442 732 736 O
any NCT03861442 737 740 O
inclusion NCT03861442 741 750 O
criteria NCT03861442 751 759 O

- NCT03861442 762 763 O
CI NCT03861442 765 767 B-Procedure
user NCT03861442 768 772 O
with NCT03861442 773 777 B-And
contralateral NCT03861442 778 791 B-Condition
hearing NCT03861442 792 799 I-Condition
equal NCT03861442 800 805 B-Eq_Comparison
to NCT03861442 806 808 I-Eq_Comparison
or NCT03861442 809 811 I-Eq_Comparison
better NCT03861442 812 818 I-Eq_Comparison
than NCT03861442 819 823 I-Eq_Comparison
60 NCT03861442 824 826 I-Eq_Comparison
dB NCT03861442 827 829 I-Eq_Comparison
( NCT03861442 830 831 O
PTA NCT03861442 832 835 B-Observation
measured NCT03861442 836 844 O
at NCT03861442 845 847 O
500 NCT03861442 848 851 B-Eq_Comparison
, NCT03861442 852 853 I-Eq_Comparison
1000 NCT03861442 854 858 I-Eq_Comparison
, NCT03861442 859 860 I-Eq_Comparison
and NCT03861442 861 864 I-Eq_Comparison
2000 NCT03861442 865 869 I-Eq_Comparison
Hz NCT03861442 870 872 I-Eq_Comparison
) NCT03861442 873 874 O

- NCT03861442 881 882 O
User NCT03861442 884 888 O
with NCT03861442 889 893 O
electric NCT03861442 894 902 B-Procedure
- NCT03861442 903 904 I-Procedure
acoustic NCT03861442 905 913 I-Procedure
stimulation NCT03861442 914 925 I-Procedure
( NCT03861442 926 927 O
EAS NCT03861442 928 931 B-Procedure
; NCT03861442 931 932 O
user NCT03861442 933 937 O
of NCT03861442 938 940 O
an NCT03861442 941 943 O
EAS NCT03861442 944 947 B-Procedure
audio NCT03861442 948 953 I-Procedure
processor NCT03861442 954 963 I-Procedure
) NCT03861442 964 965 O

- NCT03861442 969 970 O
Implanted NCT03861442 972 981 B-Procedure
with NCT03861442 982 986 O
C NCT03861442 987 988 B-Modifier
40 NCT03861442 989 991 I-Modifier
X NCT03861442 992 993 I-Modifier
and NCT03861442 994 997 B-Or
C NCT03861442 998 999 B-Modifier
40 NCT03861442 1000 1002 I-Modifier
C NCT03861442 1003 1004 I-Modifier

- NCT03861442 1007 1008 O
Implanted NCT03861442 1010 1019 B-Procedure
with NCT03861442 1020 1024 O
an NCT03861442 1025 1027 O
Auditory NCT03861442 1028 1036 B-Modifier
Brainstem NCT03861442 1037 1046 I-Modifier
Implant NCT03861442 1047 1054 I-Modifier
or NCT03861442 1055 1057 B-Or
Split NCT03861442 1058 1063 B-Modifier
electrode NCT03861442 1064 1073 I-Modifier
array NCT03861442 1074 1079 I-Modifier

- NCT03861442 1082 1083 O
Known NCT03861442 1085 1090 O
allergic NCT03861442 1091 1099 B-Allergy
reactions NCT03861442 1100 1109 O
to NCT03861442 1110 1112 O
components NCT03861442 1113 1123 O
of NCT03861442 1124 1126 O
the NCT03861442 1127 1130 O
investigational NCT03861442 1131 1146 B-Study
medical NCT03861442 1147 1154 B-Procedure
device NCT03861442 1155 1161 I-Procedure

- NCT03861442 1164 1165 O
Unstable NCT03861442 1167 1175 O
psychological NCT03861442 1176 1189 B-Condition
status NCT03861442 1190 1196 I-Condition

- NCT03861442 1199 1200 O
Anything NCT03861442 1202 1210 O
that NCT03861442 1211 1215 O
, NCT03861442 1216 1217 O
in NCT03861442 1218 1220 O
the NCT03861442 1221 1224 O
opinion NCT03861442 1225 1232 O
of NCT03861442 1233 1235 O
the NCT03861442 1236 1239 O
Investigator NCT03861442 1240 1252 O
, NCT03861442 1253 1254 O
would NCT03861442 1255 1260 B-Assertion___Assertion_Type_Value:hypothetical
place NCT03861442 1261 1266 O
the NCT03861442 1267 1270 O
subject NCT03861442 1271 1278 O
at NCT03861442 1279 1281 O
increased NCT03861442 1282 1291 O
risk NCT03861442 1292 1296 B-Risk
or NCT03861442 1297 1299 B-Or
preclude NCT03861442 1300 1308 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
the NCT03861442 1309 1312 O
subject NCT03861442 1313 1320 O
's NCT03861442 1320 1322 O
full NCT03861442 1323 1327 O
compliance NCT03861442 1328 1338 O
with NCT03861442 1339 1343 O
or NCT03861442 1344 1346 O
completion NCT03861442 1347 1357 O
of NCT03861442 1358 1360 O
the NCT03861442 1361 1364 O
study NCT03861442 1365 1370 B-Study


Inclusion NCT03923413 0 9 O
Criteria NCT03923413 10 18 O
: NCT03923413 19 20 O

- NCT03923413 24 25 O
Inclusion NCT03923413 27 36 O
Criteria NCT03923413 37 45 O
: NCT03923413 46 47 O
chronic NCT03923413 48 55 B-Condition
heart NCT03923413 56 61 I-Condition
failure NCT03923413 62 69 I-Condition
INTERMASC NCT03923413 70 79 B-Observation
5 NCT03923413 80 81 B-Eq_Comparison
- NCT03923413 82 83 I-Eq_Comparison
7 NCT03923413 84 85 I-Eq_Comparison
or NCT03923413 86 88 B-Or

- NCT03923413 91 92 O
Patients NCT03923413 94 102 O
on NCT03923413 103 105 B-Eq_Comparison
LVAD NCT03923413 106 110 B-Procedure
support NCT03923413 111 118 I-Procedure

Exclusion NCT03923413 119 128 O
Criteria NCT03923413 129 137 O
: NCT03923413 138 139 O

- NCT03923413 143 144 O
current NCT03923413 146 153 B-Eq_Comparison
thrombembolic NCT03923413 154 167 B-Modifier
or NCT03923413 168 170 B-Or
bleeding NCT03923413 171 179 B-Modifier
event NCT03923413 180 185 B-Condition

Inclusion NCT03925831 0 9 O
Criteria NCT03925831 10 18 O
: NCT03925831 19 20 O

Individuals NCT03925831 22 33 O
died NCT03925831 34 38 B-Death
from NCT03925831 39 43 O
cancer NCT03925831 44 50 B-Condition
between NCT03925831 51 58 B-Eq_Comparison
2008 NCT03925831 59 63 I-Eq_Comparison
and NCT03925831 64 67 I-Eq_Comparison
2017 NCT03925831 68 72 I-Eq_Comparison
. NCT03925831 72 73 O

Exclusion NCT03925831 75 84 O
Criteria NCT03925831 85 93 O
: NCT03925831 94 95 O

- NCT03925831 98 99 O

Inclusion NCT03921086 0 9 O
Criteria NCT03921086 10 18 O
: NCT03921086 19 20 O

- NCT03921086 24 25 O
Adult NCT03921086 27 32 O
( NCT03921086 33 34 O
older NCT03921086 35 40 B-Eq_Comparison
than NCT03921086 41 45 I-Eq_Comparison
18 NCT03921086 46 48 I-Eq_Comparison
years NCT03921086 49 54 I-Eq_Comparison
) NCT03921086 55 56 O

- NCT03921086 60 61 O
Elective NCT03921086 63 71 B-Modifier
surgery NCT03921086 72 79 B-Procedure
at NCT03921086 80 82 B-Temporal_Connection___Temporal_Connection_Type_Value:during
pre NCT03921086 83 86 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03921086 87 96 B-Procedure
in NCT03921086 97 99 B-Encounter
- NCT03921086 100 101 I-Encounter
hospital NCT03921086 102 110 I-Encounter
visit NCT03921086 111 116 I-Encounter

- NCT03921086 119 120 O
All NCT03921086 122 125 O
stage NCT03921086 126 131 O
1 NCT03921086 132 133 B-Eq_Comparison
and NCT03921086 134 137 I-Eq_Comparison
stage NCT03921086 138 143 I-Eq_Comparison
2 NCT03921086 144 145 I-Eq_Comparison
hypertensive NCT03921086 146 158 B-Condition
patients NCT03921086 159 167 O
as NCT03921086 168 170 O
defined NCT03921086 171 178 O
by NCT03921086 179 181 O
the NCT03921086 182 185 O
South NCT03921086 186 191 O
African NCT03921086 192 199 O
Hypertension NCT03921086 200 212 O
Practice NCT03921086 213 221 O
Guideline NCT03921086 222 231 O
2014 NCT03921086 232 236 O

Exclusion NCT03921086 238 247 O
Criteria NCT03921086 248 256 O
: NCT03921086 257 258 O

- NCT03921086 262 263 O
Patient NCT03921086 265 272 O
refusal NCT03921086 273 280 O

- NCT03921086 283 284 O
Day NCT03921086 286 289 B-Modifier
case NCT03921086 290 294 I-Modifier
surgery NCT03921086 295 302 B-Procedure

- NCT03921086 305 306 O
Obstetric NCT03921086 308 317 B-Modifier
and NCT03921086 318 321 B-Or
cardiac NCT03921086 322 329 B-Modifier
surgery NCT03921086 330 337 B-Procedure

- NCT03921086 340 341 O
Patients NCT03921086 343 351 O
with NCT03921086 352 356 O
severe NCT03921086 357 363 O
hypertension NCT03921086 364 376 B-Condition
( NCT03921086 377 378 O
> NCT03921086 379 380 B-Eq_Comparison
180 NCT03921086 381 384 I-Eq_Comparison
/ NCT03921086 385 386 I-Eq_Comparison
110 NCT03921086 387 390 I-Eq_Comparison
mmHg NCT03921086 391 395 I-Eq_Comparison
) NCT03921086 396 397 O
as NCT03921086 398 400 O
defined NCT03921086 401 408 O
by NCT03921086 409 411 O
the NCT03921086 412 415 O
South NCT03921086 416 421 O
African NCT03921086 422 429 O
Hypertension NCT03921086 430 442 O
Practice NCT03921086 443 451 O
Guideline NCT03921086 452 461 O
2014 NCT03921086 462 466 O

Inclusion NCT03865251 0 9 O
Criteria NCT03865251 10 18 O
: NCT03865251 19 20 O

- NCT03865251 24 25 O
Undertake NCT03865251 27 36 B-Eq_Comparison
regular NCT03865251 37 44 B-Modifier
exercise NCT03865251 45 53 B-Observation
at NCT03865251 54 56 B-Eq_Comparison
least NCT03865251 57 62 I-Eq_Comparison
3 NCT03865251 63 64 I-Eq_Comparison
times NCT03865251 65 70 I-Eq_Comparison
a NCT03865251 71 72 I-Eq_Comparison
week NCT03865251 73 77 I-Eq_Comparison
with NCT03865251 78 82 O
accumulation NCT03865251 83 95 O
of NCT03865251 96 98 O
150 NCT03865251 99 102 B-Eq_Comparison
min NCT03865251 103 106 I-Eq_Comparison
per NCT03865251 107 110 I-Eq_Comparison
week NCT03865251 111 115 I-Eq_Comparison

- NCT03865251 118 119 O
Age NCT03865251 121 124 B-Age
between NCT03865251 125 132 B-Eq_Comparison
20 NCT03865251 133 135 I-Eq_Comparison
and NCT03865251 136 139 I-Eq_Comparison
30 NCT03865251 140 142 I-Eq_Comparison
years NCT03865251 143 148 I-Eq_Comparison
old NCT03865251 149 152 O

Exclusion NCT03865251 153 162 O
Criteria NCT03865251 163 171 O
: NCT03865251 172 173 O

- NCT03865251 177 178 O
History NCT03865251 180 187 B-Eq_Comparison
of NCT03865251 188 190 O
severe NCT03865251 191 197 O
neuromuscular NCT03865251 198 211 B-Modifier
injury NCT03865251 212 218 B-Condition

- NCT03865251 221 222 O
Current NCT03865251 224 231 B-Eq_Comparison
lower NCT03865251 232 237 B-Modifier
extremity NCT03865251 238 247 I-Modifier
injury NCT03865251 248 254 B-Condition

- NCT03865251 257 258 O
Current NCT03865251 260 267 B-Eq_Comparison
neurological NCT03865251 268 280 B-Condition
diseases NCT03865251 281 289 I-Condition

Inclution NCT03921775 0 9 O
Criteria NCT03921775 10 18 O
: NCT03921775 19 20 O

1 NCT03921775 24 25 O
. NCT03921775 25 26 O
18 NCT03921775 28 30 B-Eq_Comparison
~ NCT03921775 31 32 I-Eq_Comparison
60 NCT03921775 33 35 I-Eq_Comparison
years NCT03921775 36 41 I-Eq_Comparison
, NCT03921775 42 43 O
female NCT03921775 44 50 O
or NCT03921775 51 53 B-Or
male NCT03921775 54 58 O

2 NCT03921775 61 62 O
. NCT03921775 62 63 O
Patients NCT03921775 65 73 O
scheduled NCT03921775 74 83 B-Eq_Comparison
for NCT03921775 84 87 O
an NCT03921775 88 90 O
elective NCT03921775 91 99 B-Procedure
surgical NCT03921775 100 108 I-Procedure
procedure NCT03921775 109 118 I-Procedure
( NCT03921775 119 120 O
mechanical NCT03921775 121 131 B-Procedure
ventilation NCT03921775 132 143 I-Procedure
via NCT03921775 144 147 O
endotracheal NCT03921775 148 160 B-Procedure
tube NCT03921775 161 165 I-Procedure
) NCT03921775 166 167 O

3 NCT03921775 171 172 O
. NCT03921775 172 173 O
BMI NCT03921775 175 178 B-Observation
: NCT03921775 179 180 O
18 NCT03921775 181 183 B-Eq_Comparison
~ NCT03921775 184 185 I-Eq_Comparison
30 NCT03921775 186 188 I-Eq_Comparison
kg NCT03921775 189 191 I-Eq_Comparison
/ NCT03921775 192 193 I-Eq_Comparison
m NCT03921775 194 195 I-Eq_Comparison
2 NCT03921775 196 197 I-Eq_Comparison

4 NCT03921775 200 201 O
. NCT03921775 201 202 O
Patients NCT03921775 204 212 O
understand NCT03921775 213 223 O
clearly NCT03921775 224 231 O
and NCT03921775 232 235 O
participate NCT03921775 236 247 O
in NCT03921775 248 250 O
the NCT03921775 251 254 O
study NCT03921775 255 260 O
voluntarily NCT03921775 261 272 O
, NCT03921775 273 274 O
and NCT03921775 275 278 O
sign NCT03921775 279 283 O
the NCT03921775 284 287 O
informed NCT03921775 288 296 O
consent NCT03921775 297 304 O

Exclusion NCT03921775 305 314 O
criteria NCT03921775 315 323 O
: NCT03921775 324 325 O

1 NCT03921775 329 330 O
. NCT03921775 330 331 O
Patients NCT03921775 333 341 O
scheduled NCT03921775 342 351 B-Eq_Comparison
for NCT03921775 352 355 O
emergency NCT03921775 356 365 B-Procedure
surgery NCT03921775 366 373 I-Procedure

2 NCT03921775 376 377 O
. NCT03921775 377 378 O
Patients NCT03921775 380 388 O
with NCT03921775 389 393 O
a NCT03921775 394 395 O
history NCT03921775 396 403 B-Eq_Comparison
of NCT03921775 404 406 O
drug NCT03921775 407 411 B-Condition
abuse NCT03921775 412 417 I-Condition
and NCT03921775 418 421 B-Or
/ NCT03921775 422 423 I-Or
or NCT03921775 424 426 I-Or
alcohol NCT03921775 427 434 B-Condition
abuse NCT03921775 435 440 I-Condition
2 NCT03921775 441 442 B-Eq_Comparison
years NCT03921775 443 448 I-Eq_Comparison
prior NCT03921775 449 454 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03921775 455 457 O
the NCT03921775 458 461 O
screening NCT03921775 462 471 B-Study
period NCT03921775 472 478 O

3 NCT03921775 481 482 O
. NCT03921775 482 483 O
One NCT03921775 485 488 O
or NCT03921775 489 491 O
more NCT03921775 492 496 O
of NCT03921775 497 499 O
the NCT03921775 500 503 O
laboratory NCT03921775 504 514 B-Observation
findings NCT03921775 515 523 I-Observation
fall NCT03921775 524 528 O
out NCT03921775 529 532 O
of NCT03921775 533 535 O
the NCT03921775 536 539 O
limitations NCT03921775 540 551 O
for NCT03921775 552 555 O
this NCT03921775 556 560 O
study NCT03921775 561 566 O
( NCT03921775 567 568 O
platelet NCT03921775 569 577 B-Observation
, NCT03921775 578 579 O
hemoglobin NCT03921775 580 590 B-Observation
, NCT03921775 591 592 O
aspartate NCT03921775 593 602 B-Observation
aminotransferase NCT03921775 603 619 I-Observation
, NCT03921775 620 621 O
etc NCT03921775 622 625 O
. NCT03921775 626 627 O
) NCT03921775 628 629 O

4 NCT03921775 633 634 O
. NCT03921775 634 635 O
Pregnant NCT03921775 637 645 B-Condition
women NCT03921775 646 651 O
or NCT03921775 652 654 B-Or
those NCT03921775 655 660 O
in NCT03921775 661 663 O
lactation NCT03921775 664 673 B-Condition
period NCT03921775 674 680 O

5 NCT03921775 683 684 O
. NCT03921775 684 685 O
Allergic NCT03921775 687 695 B-Allergy
to NCT03921775 696 698 O
drugs NCT03921775 699 704 B-Drug
used NCT03921775 705 709 O
in NCT03921775 710 712 O
the NCT03921775 713 716 O
study NCT03921775 717 722 B-Study

6 NCT03921775 725 726 O
. NCT03921775 726 727 O
Patients NCT03921775 729 737 O
with NCT03921775 738 742 O
respiratory NCT03921775 743 754 B-Condition
management NCT03921775 755 765 I-Condition
difficulties NCT03921775 766 778 I-Condition
( NCT03921775 779 780 O
Modified NCT03921775 781 789 B-Condition
Mallampati NCT03921775 790 800 I-Condition
grade NCT03921775 801 806 B-Eq_Comparison
IV NCT03921775 807 809 I-Eq_Comparison
) NCT03921775 810 811 O

7 NCT03921775 815 816 O
. NCT03921775 816 817 O
Patients NCT03921775 819 827 O
have NCT03921775 828 832 O
participated NCT03921775 833 845 O
in NCT03921775 846 848 O
other NCT03921775 849 854 B-Other
clinical NCT03921775 855 863 B-Study
trial NCT03921775 864 869 I-Study
within NCT03921775 870 876 B-Eq_Comparison
the NCT03921775 877 880 I-Eq_Comparison
3 NCT03921775 881 882 I-Eq_Comparison
months NCT03921775 883 889 I-Eq_Comparison
prior NCT03921775 890 895 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03921775 896 898 O
randomization NCT03921775 899 912 B-Study

8 NCT03921775 915 916 O
. NCT03921775 916 917 O
Any NCT03921775 919 922 O
patient NCT03921775 923 930 O
judged NCT03921775 931 937 O
by NCT03921775 938 940 O
the NCT03921775 941 944 O
Principal NCT03921775 945 954 O
Investigator NCT03921775 955 967 O
( NCT03921775 968 969 O
PI NCT03921775 970 972 O
) NCT03921775 973 974 O
or NCT03921775 975 977 O
Sub NCT03921775 978 981 O
- NCT03921775 982 983 O
Investigator NCT03921775 984 996 O
to NCT03921775 997 999 O
be NCT03921775 1000 1002 O
inappropriate NCT03921775 1003 1016 O
for NCT03921775 1017 1020 O
the NCT03921775 1021 1024 O
subject NCT03921775 1025 1032 O
for NCT03921775 1033 1036 O
any NCT03921775 1037 1040 O
other NCT03921775 1041 1046 O
reason NCT03921775 1047 1053 O

Inclusion NCT03869125 0 9 O
Criteria NCT03869125 10 18 O
: NCT03869125 19 20 O

- NCT03869125 24 25 O
Obstructive NCT03869125 27 38 B-Condition
sleep NCT03869125 39 44 I-Condition
apnoea NCT03869125 45 51 I-Condition
syndrome NCT03869125 52 60 I-Condition

Exclusion NCT03869125 61 70 O
Criteria NCT03869125 71 79 O
: NCT03869125 80 81 O

- NCT03869125 85 86 O
Non NCT03869125 88 91 B-Assertion___Assertion_Type_Value:hypothetical
- NCT03869125 92 93 I-Assertion___Assertion_Type_Value:hypothetical
compliance NCT03869125 94 104 I-Assertion___Assertion_Type_Value:hypothetical
of NCT03869125 105 107 O
patients NCT03869125 108 116 O
with NCT03869125 117 121 O
blood NCT03869125 122 127 B-Procedure
pressure NCT03869125 128 136 I-Procedure
monitoring NCT03869125 137 147 I-Procedure

Inclusion NCT03861598 0 9 O
Criteria NCT03861598 10 18 O
: NCT03861598 19 20 O

- NCT03861598 24 25 O
Grade NCT03861598 27 32 B-Eq_Comparison
IV NCT03861598 33 35 I-Eq_Comparison
Glioblastoma NCT03861598 36 48 B-Condition
, NCT03861598 49 50 O
receiving NCT03861598 51 60 B-Eq_Comparison
chemotherapy NCT03861598 61 73 B-Procedure
with NCT03861598 74 78 O
or NCT03861598 79 81 B-Or
without NCT03861598 82 89 B-Negation
TTfields NCT03861598 90 98 B-Drug
. NCT03861598 99 100 O

- NCT03861598 104 105 O
Progressive NCT03861598 107 118 B-Modifier
or NCT03861598 119 121 B-Or
recurrent NCT03861598 122 131 B-Modifier
disease NCT03861598 132 139 B-Condition
requiring NCT03861598 140 149 B-Assertion___Assertion_Type_Value:hypothetical
second NCT03861598 150 156 B-Procedure
line NCT03861598 157 161 I-Procedure
treatment NCT03861598 162 171 I-Procedure

- NCT03861598 174 175 O
evidence NCT03861598 177 185 O
of NCT03861598 186 188 O
progression NCT03861598 189 200 B-Condition
of NCT03861598 201 203 I-Condition
disease NCT03861598 204 211 I-Condition
by NCT03861598 212 214 O
brain NCT03861598 215 220 B-Procedure
MRI NCT03861598 221 224 I-Procedure
and NCT03861598 225 228 B-And
are NCT03861598 229 232 O
planned NCT03861598 233 240 B-Eq_Comparison
to NCT03861598 241 243 O
receive NCT03861598 244 251 O
chemotherapy NCT03861598 252 264 B-Procedure

Exclusion NCT03861598 265 274 O
Criteria NCT03861598 275 283 O
: NCT03861598 284 285 O

- NCT03861598 289 290 O
Current NCT03861598 292 299 B-Eq_Comparison
use NCT03861598 300 303 O
of NCT03861598 304 306 O
another NCT03861598 307 314 B-Other
beta NCT03861598 315 319 B-Drug
blocker NCT03861598 320 327 I-Drug
that NCT03861598 328 332 O
can NCT03861598 333 336 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
not NCT03861598 336 339 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
be NCT03861598 340 342 O
switched NCT03861598 343 351 O
to NCT03861598 352 354 O
carvedilol NCT03861598 355 365 B-Drug
at NCT03861598 366 368 O
the NCT03861598 369 372 O
onset NCT03861598 373 378 B-Eq_Comparison
of NCT03861598 379 381 O
the NCT03861598 382 385 O
trial NCT03861598 386 391 B-Study
. NCT03861598 392 393 O

- NCT03861598 397 398 O
Systolic NCT03861598 400 408 B-Observation
blood NCT03861598 409 414 I-Observation
pressure NCT03861598 415 423 I-Observation
< NCT03861598 424 425 B-Eq_Comparison
90 NCT03861598 426 428 I-Eq_Comparison
mmHg NCT03861598 429 433 I-Eq_Comparison
and NCT03861598 434 437 B-Or
/ NCT03861598 438 439 I-Or
or NCT03861598 440 442 I-Or
heart NCT03861598 443 448 B-Observation
rate NCT03861598 449 453 I-Observation
< NCT03861598 454 455 B-Eq_Comparison
60 NCT03861598 456 458 I-Eq_Comparison
bpm NCT03861598 459 462 I-Eq_Comparison
without NCT03861598 463 470 B-Negation
hypertensive NCT03861598 471 483 B-Condition
medications NCT03861598 484 495 B-Drug

- NCT03861598 498 499 O
Allergy NCT03861598 501 508 B-Allergy
to NCT03861598 509 511 O
beta NCT03861598 512 516 B-Drug
blockers NCT03861598 517 525 I-Drug

- NCT03861598 528 529 O
Severe NCT03861598 531 537 O
or NCT03861598 538 540 B-Or
uncontrolled NCT03861598 541 553 B-Modifier
asthma NCT03861598 554 560 B-Condition
or NCT03861598 561 563 B-Or
COPD NCT03861598 564 568 B-Condition
( NCT03861598 569 570 O
chronic NCT03861598 571 578 B-Condition
obstructive NCT03861598 579 590 I-Condition
pulmonary NCT03861598 591 600 I-Condition
disease NCT03861598 601 608 I-Condition
) NCT03861598 609 610 O

Inclusion NCT03866291 0 9 O
Criteria NCT03866291 10 18 O
: NCT03866291 19 20 O

- NCT03866291 24 25 O
Travellers NCT03866291 27 37 B-Modifier
diarrhoea NCT03866291 38 47 B-Condition

- NCT03866291 50 51 O
foreign NCT03866291 53 60 O
traveller NCT03866291 61 70 O

Exclusion NCT03866291 71 80 O
Criteria NCT03866291 81 89 O
: NCT03866291 90 91 O

- NCT03866291 95 96 O
foreign NCT03866291 98 105 O
traveller NCT03866291 106 115 O
but NCT03866291 116 119 B-And
no NCT03866291 120 122 B-Negation
symptoms NCT03866291 123 131 O

Inclusion NCT03868475 0 9 O
Criteria NCT03868475 10 18 O
: NCT03868475 19 20 O

- NCT03868475 24 25 O
Women NCT03868475 27 32 O
over NCT03868475 33 37 B-Eq_Comparison
age NCT03868475 38 41 I-Eq_Comparison
18 NCT03868475 42 44 I-Eq_Comparison
with NCT03868475 45 49 B-And
a NCT03868475 50 51 O
core NCT03868475 52 56 B-Modifier
biopsy NCT03868475 57 63 B-Procedure
proven NCT03868475 64 70 O
borderline NCT03868475 71 81 B-Modifier
or NCT03868475 82 84 B-Or
high NCT03868475 85 89 O
- NCT03868475 90 91 O
risk NCT03868475 92 96 B-Risk
breast NCT03868475 97 103 B-Modifier
lesion NCT03868475 104 110 B-Condition
that NCT03868475 111 115 O
requires NCT03868475 116 124 B-Assertion___Assertion_Type_Value:hypothetical
further NCT03868475 125 132 O
excision NCT03868475 133 141 B-Procedure
for NCT03868475 142 145 O
management NCT03868475 146 156 O
based NCT03868475 157 162 O
on NCT03868475 163 165 O
the NCT03868475 166 169 O
surgeon NCT03868475 170 177 B-Provider
's NCT03868475 177 179 O
assessment NCT03868475 180 190 O

- NCT03868475 193 194 O
Informed NCT03868475 196 204 O
consent NCT03868475 205 212 O
must NCT03868475 213 217 O
be NCT03868475 218 220 O
obtained NCT03868475 221 229 O
. NCT03868475 230 231 O

Exclusion NCT03868475 233 242 O
Criteria NCT03868475 243 251 O
: NCT03868475 252 253 O

- NCT03868475 257 258 O
Women NCT03868475 260 265 O
who NCT03868475 266 269 B-And
are NCT03868475 270 273 O
considered NCT03868475 274 284 O
high NCT03868475 285 289 O
- NCT03868475 290 291 O
risk NCT03868475 292 296 B-Risk
based NCT03868475 297 302 O
on NCT03868475 303 305 O
a NCT03868475 306 307 O
greater NCT03868475 308 315 B-Eq_Comparison
than NCT03868475 316 320 I-Eq_Comparison
25 NCT03868475 321 323 I-Eq_Comparison
% NCT03868475 324 325 I-Eq_Comparison
lifetime NCT03868475 326 334 O
risk NCT03868475 335 339 B-Risk
of NCT03868475 340 342 O
breast NCT03868475 343 349 B-Modifier
cancer NCT03868475 350 356 B-Condition
as NCT03868475 357 359 O
per NCT03868475 360 363 O
the NCT03868475 364 367 O
IBIS NCT03868475 368 372 O
( NCT03868475 373 374 O
International NCT03868475 375 388 O
Breast NCT03868475 389 395 O
Cancer NCT03868475 396 402 O
Intervention NCT03868475 403 415 O
Study NCT03868475 416 421 O
) NCT03868475 422 423 O
Breast NCT03868475 424 430 B-Observation
Cancer NCT03868475 431 437 I-Observation
Risk NCT03868475 438 442 I-Observation
Evaluation NCT03868475 443 453 I-Observation
Tool NCT03868475 454 458 I-Observation

- NCT03868475 461 462 O
Pathology NCT03868475 464 473 B-Condition
that NCT03868475 474 478 O
is NCT03868475 479 481 O
felt NCT03868475 482 486 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868475 487 489 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03868475 490 492 O
discordant NCT03868475 493 503 B-Modifier
with NCT03868475 504 508 O
imaging NCT03868475 509 516 B-Procedure

- NCT03868475 519 520 O
Extensive NCT03868475 522 531 O
calcifications NCT03868475 532 546 B-Observation
extending NCT03868475 547 556 O
more NCT03868475 557 561 B-Eq_Comparison
than NCT03868475 562 566 I-Eq_Comparison
20 NCT03868475 567 569 I-Eq_Comparison
mm NCT03868475 570 572 I-Eq_Comparison
and NCT03868475 573 576 B-Or
/ NCT03868475 577 578 I-Or
or NCT03868475 579 581 I-Or
masses NCT03868475 582 588 B-Observation
greater NCT03868475 589 596 B-Eq_Comparison
than NCT03868475 597 601 I-Eq_Comparison
30 NCT03868475 602 604 I-Eq_Comparison
mm NCT03868475 605 607 I-Eq_Comparison

- NCT03868475 610 611 O
The NCT03868475 613 616 O
following NCT03868475 617 626 O
lesions NCT03868475 627 634 B-Condition
will NCT03868475 635 639 O
be NCT03868475 640 642 O
excluded NCT03868475 643 651 B-Negation
based NCT03868475 652 657 O
on NCT03868475 658 660 O
their NCT03868475 661 666 O
increased NCT03868475 667 676 O
risk NCT03868475 677 681 B-Risk
of NCT03868475 682 684 O
upstaging NCT03868475 685 694 B-Condition
; NCT03868475 694 695 O
lesions NCT03868475 696 703 B-Condition
( NCT03868475 704 705 O
other NCT03868475 706 711 B-Exception
than NCT03868475 712 716 I-Exception
fibroadenomas NCT03868475 717 730 B-Condition
, NCT03868475 731 732 O
phyllodes NCT03868475 733 742 B-Condition
and NCT03868475 743 746 B-Or
papillomas NCT03868475 747 757 B-Condition
) NCT03868475 758 759 O
that NCT03868475 760 764 O
are NCT03868475 765 768 O
associated NCT03868475 769 779 O
with NCT03868475 780 784 O
a NCT03868475 785 786 O
palpable NCT03868475 787 795 B-Condition
mass NCT03868475 796 800 I-Condition
, NCT03868475 801 802 O
ADH NCT03868475 803 806 B-Condition
( NCT03868475 807 808 O
atypical NCT03868475 809 817 B-Condition
ductal NCT03868475 818 824 I-Condition
hyperplasia NCT03868475 825 836 I-Condition
) NCT03868475 837 838 O
with NCT03868475 839 843 B-And
high NCT03868475 844 848 O
- NCT03868475 849 850 O
risk NCT03868475 851 855 B-Risk
features NCT03868475 856 864 B-Condition
( NCT03868475 865 866 O
ADH NCT03868475 867 870 B-Condition
with NCT03868475 871 875 B-And
zonal NCT03868475 876 881 B-Condition
necrosis NCT03868475 882 890 I-Condition
, NCT03868475 891 892 O
significant NCT03868475 893 904 O
cytological NCT03868475 905 916 B-Condition
atypia NCT03868475 917 923 I-Condition
or NCT03868475 924 926 B-Or
more NCT03868475 927 931 B-Eq_Comparison
than NCT03868475 932 936 I-Eq_Comparison
2 NCT03868475 937 938 I-Eq_Comparison
foci NCT03868475 939 943 B-Condition
) NCT03868475 944 945 O
, NCT03868475 946 947 O
LCIS NCT03868475 948 952 B-Condition
( NCT03868475 953 954 O
lobular NCT03868475 955 962 B-Modifier
carcinoma NCT03868475 963 972 B-Condition
in NCT03868475 973 975 B-Modifier
situ NCT03868475 976 980 I-Modifier
) NCT03868475 981 982 O
with NCT03868475 983 987 B-And
high NCT03868475 988 992 O
- NCT03868475 993 994 O
risk NCT03868475 995 999 B-Risk
features NCT03868475 1000 1008 B-Condition
( NCT03868475 1009 1010 O
associated NCT03868475 1011 1021 O
with NCT03868475 1022 1026 O
ADH NCT03868475 1027 1030 B-Condition
, NCT03868475 1031 1032 O
pleomorphic NCT03868475 1033 1044 B-Condition
LCIS NCT03868475 1045 1049 I-Condition
, NCT03868475 1050 1051 O
zonal NCT03868475 1052 1057 B-Condition
necrosis NCT03868475 1058 1066 I-Condition
and NCT03868475 1067 1070 B-Or
> NCT03868475 1071 1072 B-Eq_Comparison
4 NCT03868475 1073 1074 I-Eq_Comparison
foci NCT03868475 1075 1079 B-Condition
) NCT03868475 1080 1081 O
or NCT03868475 1082 1084 B-Or
discordant NCT03868475 1085 1095 B-Modifier
with NCT03868475 1096 1100 O
imaging NCT03868475 1101 1108 B-Procedure
, NCT03868475 1109 1110 O
papilloma NCT03868475 1111 1120 B-Condition
with NCT03868475 1121 1125 O
atypia NCT03868475 1126 1132 B-Modifier
, NCT03868475 1133 1134 O
and NCT03868475 1135 1138 B-Or
spindle NCT03868475 1139 1146 B-Modifier
cell NCT03868475 1147 1151 I-Modifier
lesion NCT03868475 1152 1158 B-Condition
( NCT03868475 1159 1160 O
especially NCT03868475 1161 1171 O
if NCT03868475 1172 1174 O
there NCT03868475 1175 1180 O
is NCT03868475 1181 1183 O
atypia NCT03868475 1184 1190 B-Modifier
) NCT03868475 1191 1192 O
. NCT03868475 1193 1194 O

- NCT03868475 1198 1199 O
Lesions NCT03868475 1201 1208 B-Condition
that NCT03868475 1209 1213 O
are NCT03868475 1214 1217 O
suspicious NCT03868475 1218 1228 B-Assertion___Assertion_Type_Value:possible
for NCT03868475 1229 1232 O
borderline NCT03868475 1233 1243 B-Modifier
or NCT03868475 1244 1246 B-Or
malignant NCT03868475 1247 1256 B-Modifier
Phyllodes NCT03868475 1257 1266 B-Condition
, NCT03868475 1267 1268 O
DCIS NCT03868475 1269 1273 B-Condition
( NCT03868475 1274 1275 O
ductal NCT03868475 1276 1282 B-Condition
carcinoma NCT03868475 1283 1292 I-Condition
in NCT03868475 1293 1295 B-Modifier
situ NCT03868475 1296 1300 I-Modifier
) NCT03868475 1301 1302 O
, NCT03868475 1303 1304 O
invasive NCT03868475 1305 1313 B-Modifier
mammary NCT03868475 1314 1321 I-Modifier
carcinoma NCT03868475 1322 1331 B-Condition
, NCT03868475 1332 1333 O
or NCT03868475 1334 1336 B-Or
encapsulated NCT03868475 1337 1349 B-Modifier
papillary NCT03868475 1350 1359 I-Modifier
carcinoma NCT03868475 1360 1369 B-Condition

- NCT03868475 1372 1373 O
Any NCT03868475 1375 1378 O
lesion NCT03868475 1379 1385 B-Condition
that NCT03868475 1386 1390 O
either NCT03868475 1391 1397 O
the NCT03868475 1398 1401 O
radiologist NCT03868475 1402 1413 B-Provider
, NCT03868475 1414 1415 O
pathologist NCT03868475 1416 1427 B-Provider
or NCT03868475 1428 1430 B-Or
surgeon NCT03868475 1431 1438 B-Provider
feels NCT03868475 1439 1444 O
is NCT03868475 1445 1447 O
not NCT03868475 1448 1451 B-Negation
amenable NCT03868475 1452 1460 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868475 1461 1463 O
VAPE NCT03868475 1464 1468 B-Procedure
or NCT03868475 1469 1471 B-Or
surgical NCT03868475 1472 1480 B-Procedure
excision NCT03868475 1481 1489 I-Procedure

Inclusion NCT03869996 0 9 O
Criteria NCT03869996 10 18 O
: NCT03869996 19 20 O

- NCT03869996 24 25 O
patients NCT03869996 27 35 O
affected NCT03869996 36 44 O
by NCT03869996 45 47 O
knee NCT03869996 48 52 B-Modifier
osteoarthritis NCT03869996 53 67 B-Condition
, NCT03869996 68 69 O
eligible NCT03869996 70 78 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03869996 79 82 I-Assertion___Assertion_Type_Value:hypothetical
primary NCT03869996 83 90 B-Modifier
total NCT03869996 91 96 B-Procedure
knee NCT03869996 97 101 I-Procedure
arthroplasty NCT03869996 102 114 I-Procedure

- NCT03869996 117 118 O
BMI NCT03869996 120 123 B-Observation
< NCT03869996 124 125 B-Eq_Comparison
32 NCT03869996 126 128 I-Eq_Comparison

- NCT03869996 132 133 O
Time NCT03869996 135 139 B-Observation
up NCT03869996 140 142 I-Observation
ang NCT03869996 143 146 I-Observation
go NCT03869996 147 149 I-Observation
test NCT03869996 150 154 I-Observation
< NCT03869996 155 156 B-Eq_Comparison
/ NCT03869996 157 158 I-Eq_Comparison
= NCT03869996 159 160 I-Eq_Comparison
12 NCT03869996 161 163 I-Eq_Comparison
seconds NCT03869996 164 171 I-Eq_Comparison

- NCT03869996 174 175 O
American NCT03869996 177 185 B-Observation
Society NCT03869996 186 193 I-Observation
of NCT03869996 194 196 I-Observation
Anesthesiologists NCT03869996 197 214 I-Observation
physical NCT03869996 215 223 O
status NCT03869996 224 230 O
classification NCT03869996 231 245 O
system NCT03869996 246 252 O
( NCT03869996 253 254 O
ASA NCT03869996 255 258 B-Observation
) NCT03869996 259 260 O
< NCT03869996 261 262 B-Eq_Comparison
/ NCT03869996 263 264 I-Eq_Comparison
= NCT03869996 265 266 I-Eq_Comparison
2 NCT03869996 267 268 I-Eq_Comparison

- NCT03869996 272 273 O
pre NCT03869996 275 278 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03869996 279 288 B-Procedure
hemoglobin NCT03869996 289 299 B-Observation
( NCT03869996 300 301 O
HB NCT03869996 302 304 B-Observation
) NCT03869996 305 306 O
> NCT03869996 307 308 B-Eq_Comparison
13 NCT03869996 309 311 I-Eq_Comparison
g NCT03869996 312 313 I-Eq_Comparison
/ NCT03869996 314 315 I-Eq_Comparison
dl NCT03869996 316 318 I-Eq_Comparison

- NCT03869996 321 322 O
patients NCT03869996 324 332 O
eligible NCT03869996 333 341 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03869996 342 345 I-Assertion___Assertion_Type_Value:hypothetical
spinal NCT03869996 346 352 B-Procedure
anesthesia NCT03869996 353 363 I-Procedure

- NCT03869996 366 367 O
presence NCT03869996 369 377 O
of NCT03869996 378 380 O
a NCT03869996 381 382 O
care NCT03869996 383 387 O
- NCT03869996 388 389 O
giver NCT03869996 390 395 O

Exclusion NCT03869996 396 405 O
Criteria NCT03869996 406 414 O
: NCT03869996 415 416 O

- NCT03869996 420 421 O
psychiatric NCT03869996 423 434 B-Condition
diseases NCT03869996 435 443 I-Condition

- NCT03869996 446 447 O
pre NCT03869996 449 452 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03869996 453 462 B-Procedure
use NCT03869996 463 466 O
of NCT03869996 467 469 O
crutches NCT03869996 470 478 B-Procedure

- NCT03869996 481 482 O
ASA NCT03869996 484 487 B-Observation
> NCT03869996 488 489 B-Eq_Comparison
3 NCT03869996 490 491 I-Eq_Comparison

- NCT03869996 495 496 O
pre NCT03869996 498 501 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03869996 502 511 B-Procedure
HB NCT03869996 512 514 B-Observation
< NCT03869996 515 516 B-Eq_Comparison
13 NCT03869996 517 519 I-Eq_Comparison
g NCT03869996 520 521 I-Eq_Comparison
/ NCT03869996 522 523 I-Eq_Comparison
dl NCT03869996 524 526 I-Eq_Comparison

Inclusion NCT03929900 0 9 O
Criteria NCT03929900 10 18 O
: NCT03929900 19 20 O

- NCT03929900 24 25 O
Age NCT03929900 27 30 B-Age
45 NCT03929900 31 33 B-Eq_Comparison
- NCT03929900 34 35 I-Eq_Comparison
79 NCT03929900 36 38 I-Eq_Comparison
years NCT03929900 39 44 I-Eq_Comparison

- NCT03929900 47 48 O
Estimated NCT03929900 50 59 B-Observation
glomerular NCT03929900 60 70 I-Observation
filtration NCT03929900 71 81 I-Observation
rate NCT03929900 82 86 I-Observation
20 NCT03929900 87 89 B-Eq_Comparison
- NCT03929900 90 91 I-Eq_Comparison
60 NCT03929900 92 94 I-Eq_Comparison
mL NCT03929900 95 97 I-Eq_Comparison
/ NCT03929900 98 99 I-Eq_Comparison
min NCT03929900 100 103 I-Eq_Comparison
/ NCT03929900 104 105 I-Eq_Comparison
1.73 NCT03929900 106 110 I-Eq_Comparison
m NCT03929900 111 112 I-Eq_Comparison
2 NCT03929900 113 114 I-Eq_Comparison
based NCT03929900 115 120 O
on NCT03929900 121 123 O
CKD NCT03929900 124 127 O
- NCT03929900 128 129 O
EPI NCT03929900 130 133 O
( NCT03929900 134 135 O
Cr NCT03929900 136 138 O
) NCT03929900 139 140 O
equation NCT03929900 141 149 O

- NCT03929900 152 153 O
Non NCT03929900 155 158 B-Condition
- NCT03929900 159 160 I-Condition
dialysis NCT03929900 161 169 I-Condition
dependent NCT03929900 170 179 I-Condition
( NCT03929900 180 181 O
NDD NCT03929900 182 185 B-Condition
) NCT03929900 186 187 O

Exclusion NCT03929900 189 198 O
Criteria NCT03929900 199 207 O
: NCT03929900 208 209 O

- NCT03929900 213 214 O
Autosomal NCT03929900 216 225 B-Condition
dominant NCT03929900 226 234 I-Condition
polycystic NCT03929900 235 245 I-Condition
kidney NCT03929900 246 252 I-Condition
disease NCT03929900 253 260 I-Condition

- NCT03929900 263 264 O
Unable NCT03929900 266 272 O
or NCT03929900 273 275 O
unwilling NCT03929900 276 285 O
to NCT03929900 286 288 O
give NCT03929900 289 293 O
consent NCT03929900 294 301 O

- NCT03929900 304 305 O
Previously NCT03929900 307 317 B-Eq_Comparison
received NCT03929900 318 326 I-Eq_Comparison
chronic NCT03929900 327 334 O
dialysis NCT03929900 335 343 B-Procedure

- NCT03929900 346 347 O
Previous NCT03929900 349 357 B-Eq_Comparison
any NCT03929900 358 361 O
organ NCT03929900 362 367 B-Procedure
transplant NCT03929900 368 378 I-Procedure

- NCT03929900 381 382 O
Patients NCT03929900 384 392 O
who NCT03929900 393 396 O
diagnosed NCT03929900 397 406 O
heart NCT03929900 407 412 B-Condition
failure NCT03929900 413 420 I-Condition
with NCT03929900 421 425 B-And
NYHA NCT03929900 426 430 B-Observation
class NCT03929900 431 436 B-Eq_Comparison
3 NCT03929900 437 438 I-Eq_Comparison
or NCT03929900 439 441 I-Eq_Comparison
4 NCT03929900 442 443 I-Eq_Comparison

- NCT03929900 447 448 O
Known NCT03929900 450 455 O
liver NCT03929900 456 461 B-Condition
cirrhosis NCT03929900 462 471 I-Condition
( NCT03929900 472 473 O
Child NCT03929900 474 479 B-Condition
- NCT03929900 480 481 I-Condition
pugh NCT03929900 482 486 I-Condition
class NCT03929900 487 492 B-Eq_Comparison
2 NCT03929900 493 494 I-Eq_Comparison
or NCT03929900 495 497 I-Eq_Comparison
3 NCT03929900 498 499 I-Eq_Comparison
) NCT03929900 500 501 O

- NCT03929900 505 506 O
Pregnant NCT03929900 508 516 B-Condition
women NCT03929900 517 522 O

- NCT03929900 525 526 O
Single NCT03929900 528 534 B-Condition
kidney NCT03929900 535 541 I-Condition
due NCT03929900 542 545 O
to NCT03929900 546 548 O
trauma NCT03929900 549 555 B-Condition
or NCT03929900 556 558 B-Or
donation NCT03929900 559 567 B-Condition

- NCT03929900 570 571 O
Patients NCT03929900 573 581 O
who NCT03929900 582 585 O
received NCT03929900 586 594 B-Eq_Comparison
immunosuppressive NCT03929900 595 612 B-Drug
agent NCT03929900 613 618 I-Drug
within NCT03929900 619 625 B-Eq_Comparison
the NCT03929900 626 629 I-Eq_Comparison
past NCT03929900 630 634 I-Eq_Comparison
1 NCT03929900 635 636 I-Eq_Comparison
year NCT03929900 637 641 I-Eq_Comparison

- NCT03929900 644 645 O
Patients NCT03929900 647 655 O
who NCT03929900 656 659 O
diagnosed NCT03929900 660 669 O
with NCT03929900 670 674 O
glomerulonephritis NCT03929900 675 693 B-Condition
through NCT03929900 694 701 O
kidney NCT03929900 702 708 B-Modifier
biopsy NCT03929900 709 715 B-Procedure

Inclusion NCT03928496 0 9 O
Criteria NCT03928496 10 18 O
: NCT03928496 19 20 O

- NCT03928496 24 25 O
male NCT03928496 27 31 O
or NCT03928496 32 34 B-Or
female NCT03928496 35 41 O

- NCT03928496 44 45 O
age NCT03928496 47 50 B-Age
18 NCT03928496 51 53 B-Eq_Comparison
- NCT03928496 54 55 I-Eq_Comparison
65 NCT03928496 56 58 I-Eq_Comparison

- NCT03928496 62 63 O
meets NCT03928496 65 70 O
International NCT03928496 71 84 B-Condition
Classification NCT03928496 85 99 I-Condition
Headache NCT03928496 100 108 I-Condition
Disorders NCT03928496 109 118 I-Condition
II NCT03928496 119 121 B-Eq_Comparison
( NCT03928496 122 123 O
ICHD NCT03928496 124 128 B-Condition
- NCT03928496 129 130 O
II NCT03928496 131 133 B-Eq_Comparison
) NCT03928496 134 135 O
criteria NCT03928496 136 144 O
for NCT03928496 145 148 O
post NCT03928496 149 153 B-Condition
- NCT03928496 154 155 I-Condition
traumatic NCT03928496 156 165 I-Condition
headache NCT03928496 166 174 I-Condition

- NCT03928496 177 178 O
average NCT03928496 180 187 O
pain NCT03928496 188 192 B-Observation
score NCT03928496 193 198 I-Observation
of NCT03928496 199 201 O
greater NCT03928496 202 209 B-Eq_Comparison
than NCT03928496 210 214 I-Eq_Comparison
4 NCT03928496 215 216 I-Eq_Comparison
/ NCT03928496 217 218 I-Eq_Comparison
10 NCT03928496 219 221 I-Eq_Comparison
in NCT03928496 222 224 O
severity NCT03928496 225 233 O
on NCT03928496 234 236 O
the NCT03928496 237 240 O
numerical NCT03928496 241 250 O
rating NCT03928496 251 257 O
system NCT03928496 258 264 O

- NCT03928496 267 268 O
Rancho NCT03928496 270 276 B-Observation
Los NCT03928496 277 280 I-Observation
Amigos NCT03928496 281 287 I-Observation
cognitive NCT03928496 288 297 I-Observation
scale NCT03928496 298 303 I-Observation
score NCT03928496 304 309 I-Observation
greater NCT03928496 310 317 B-Eq_Comparison
than NCT03928496 318 322 I-Eq_Comparison
seven NCT03928496 323 328 I-Eq_Comparison
. NCT03928496 329 330 O

Exclusion NCT03928496 332 341 O
Criteria NCT03928496 342 350 O
: NCT03928496 351 352 O

- NCT03928496 356 357 O
Uncontrolled NCT03928496 359 371 B-Modifier
medical NCT03928496 372 379 B-Condition
condition NCT03928496 380 389 I-Condition
other NCT03928496 390 395 B-Exception
than NCT03928496 396 400 I-Exception
PTH NCT03928496 401 404 B-Condition

- NCT03928496 407 408 O
Severe NCT03928496 410 416 O
additional NCT03928496 417 427 O
chronic NCT03928496 428 435 O
pain NCT03928496 436 440 B-Condition
complaint NCT03928496 441 450 O
which NCT03928496 451 456 O
could NCT03928496 457 462 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03928496 463 466 B-Negation
be NCT03928496 467 469 O
distinguished NCT03928496 470 483 O
from NCT03928496 484 488 O
headache NCT03928496 489 497 B-Modifier
pain NCT03928496 498 502 B-Condition

- NCT03928496 505 506 O
pregnancy NCT03928496 508 517 B-Condition
, NCT03928496 518 519 O
breast NCT03928496 520 526 B-Condition
feeding NCT03928496 527 534 I-Condition
, NCT03928496 535 536 O

- NCT03928496 540 541 O
prior NCT03928496 543 548 B-Eq_Comparison
treatment NCT03928496 549 558 B-Procedure
with NCT03928496 559 563 O
botulinum NCT03928496 564 573 B-Drug
toxin NCT03928496 574 579 I-Drug
within NCT03928496 580 586 B-Eq_Comparison
one NCT03928496 587 590 I-Eq_Comparison
year NCT03928496 591 595 I-Eq_Comparison
of NCT03928496 596 598 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03928496 599 609 B-Study

- NCT03928496 612 613 O
current NCT03928496 615 622 B-Eq_Comparison
substance NCT03928496 623 632 B-Condition
abuse NCT03928496 633 638 B-Modifier
/ NCT03928496 639 640 B-Or
dependence NCT03928496 641 651 B-Modifier

- NCT03928496 654 655 O
medical NCT03928496 657 664 B-Condition
condition NCT03928496 665 674 I-Condition
that NCT03928496 675 679 O
would NCT03928496 680 685 B-Assertion___Assertion_Type_Value:hypothetical
increase NCT03928496 686 694 O
risk NCT03928496 695 699 B-Risk
of NCT03928496 700 702 O
neuromuscular NCT03928496 703 716 B-Condition
junction NCT03928496 717 725 I-Condition
blockade NCT03928496 726 734 I-Condition
with NCT03928496 735 739 O
botulinum NCT03928496 740 749 B-Drug
toxin NCT03928496 750 755 I-Drug
( NCT03928496 756 757 O
myasthenia NCT03928496 758 768 B-Condition
gravis NCT03928496 769 775 I-Condition
, NCT03928496 776 777 O
Eaton NCT03928496 778 783 B-Condition
Lambert NCT03928496 784 791 I-Condition
, NCT03928496 792 793 O
amyotrophic NCT03928496 794 805 B-Condition
lateral NCT03928496 806 813 I-Condition
sclerosis NCT03928496 814 823 I-Condition
) NCT03928496 824 825 O

- NCT03928496 829 830 O
poorly NCT03928496 832 838 B-Modifier
controlled NCT03928496 839 849 I-Modifier
psychiatric NCT03928496 850 861 B-Condition

- NCT03928496 864 865 O
initiation NCT03928496 867 877 O
of NCT03928496 878 880 O
a NCT03928496 881 882 O
new NCT03928496 883 886 B-Eq_Comparison
anti NCT03928496 887 891 B-Drug
- NCT03928496 892 893 I-Drug
depressant NCT03928496 894 904 I-Drug
or NCT03928496 905 907 B-Or
anti NCT03928496 908 912 B-Drug
- NCT03928496 913 914 I-Drug
seizure NCT03928496 915 922 I-Drug
medication NCT03928496 923 933 I-Drug
within NCT03928496 934 940 B-Eq_Comparison
three NCT03928496 941 946 I-Eq_Comparison
months NCT03928496 947 953 I-Eq_Comparison
of NCT03928496 954 956 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrolling NCT03928496 957 966 O
in NCT03928496 967 969 O
study NCT03928496 970 975 B-Study

- NCT03928496 978 979 O
ongoing NCT03928496 981 988 B-Eq_Comparison
disability NCT03928496 989 999 B-Condition
or NCT03928496 1000 1002 O
litigation NCT03928496 1003 1013 O
claim NCT03928496 1014 1019 O
. NCT03928496 1020 1021 O

Inclusion NCT03866889 0 9 O
Criteria NCT03866889 10 18 O
: NCT03866889 19 20 O

- NCT03866889 24 25 O
Military NCT03866889 27 35 B-Observation
personnel NCT03866889 36 45 I-Observation
belonging NCT03866889 46 55 O
to NCT03866889 56 58 O
the NCT03866889 59 62 O
Military NCT03866889 63 71 B-Modifier
Emergency NCT03866889 72 81 I-Modifier
Unit NCT03866889 82 86 I-Modifier

- NCT03866889 89 90 O
male NCT03866889 92 96 O

- NCT03866889 99 100 O
With NCT03866889 102 106 O
an NCT03866889 107 109 O
age NCT03866889 110 113 B-Age
of NCT03866889 114 116 O
25 NCT03866889 117 119 B-Eq_Comparison
to NCT03866889 120 122 I-Eq_Comparison
45 NCT03866889 123 125 I-Eq_Comparison
years NCT03866889 126 131 I-Eq_Comparison

- NCT03866889 134 135 O
No NCT03866889 137 139 B-Negation
history NCT03866889 140 147 B-Eq_Comparison
of NCT03866889 148 150 O
musculoskeletal NCT03866889 151 166 B-Modifier
injury NCT03866889 167 173 B-Condition
in NCT03866889 174 176 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866889 177 180 O
3 NCT03866889 181 182 B-Eq_Comparison
months NCT03866889 183 189 I-Eq_Comparison
prior NCT03866889 190 195 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866889 196 198 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03866889 199 202 O
study NCT03866889 203 208 B-Study

Exclusion NCT03866889 209 218 O
Criteria NCT03866889 219 227 O
: NCT03866889 228 229 O

- NCT03866889 233 234 O
Present NCT03866889 236 243 O
a NCT03866889 244 245 O
diagnosis NCT03866889 246 255 O
of NCT03866889 256 258 O
injury NCT03866889 259 265 B-Condition
in NCT03866889 266 268 O
the NCT03866889 269 272 O
period NCT03866889 273 279 O
prior NCT03866889 280 285 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866889 286 288 I-Temporal_Connection___Temporal_Connection_Type_Value:before
or NCT03866889 289 291 B-Or
during NCT03866889 292 298 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866889 299 302 O
study NCT03866889 303 308 B-Study

- NCT03866889 311 312 O
Who NCT03866889 314 317 O
are NCT03866889 318 321 O
receiving NCT03866889 322 331 B-Eq_Comparison
a NCT03866889 332 333 O
physiotherapy NCT03866889 334 347 B-Procedure
intervention NCT03866889 348 360 I-Procedure
at NCT03866889 361 363 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866889 364 367 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03866889 368 372 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03866889 373 375 O
the NCT03866889 376 379 O
study NCT03866889 380 385 B-Study

- NCT03866889 388 389 O
Not NCT03866889 391 394 O
signed NCT03866889 395 401 O
the NCT03866889 402 405 O
informed NCT03866889 406 414 O
consent NCT03866889 415 422 O
document NCT03866889 423 431 O

Inclusion NCT03921736 0 9 O
Criteria NCT03921736 10 18 O
: NCT03921736 19 20 O

- NCT03921736 24 25 O
Treatment NCT03921736 27 36 B-Procedure
- NCT03921736 37 38 O
naive NCT03921736 39 44 B-Negation
postmenopausal NCT03921736 45 59 B-Condition
women NCT03921736 60 65 O

- NCT03921736 68 69 O
Diagnosed NCT03921736 71 80 O
hypertension NCT03921736 81 93 B-Condition
( NCT03921736 94 95 O
grade NCT03921736 96 101 B-Eq_Comparison
1 NCT03921736 102 103 I-Eq_Comparison
or NCT03921736 104 106 I-Eq_Comparison
2 NCT03921736 107 108 I-Eq_Comparison
according NCT03921736 109 118 O
to NCT03921736 119 121 O
ESH NCT03921736 122 125 O
/ NCT03921736 126 127 O
ESC NCT03921736 128 131 O
2013 NCT03921736 132 136 O
guidelines NCT03921736 137 147 O
) NCT03921736 148 149 O

Exclusion NCT03921736 151 160 O
Criteria NCT03921736 161 169 O
: NCT03921736 170 171 O

- NCT03921736 175 176 O
breast NCT03921736 178 184 B-Modifier
cancer NCT03921736 185 191 B-Condition
in NCT03921736 192 194 O
a NCT03921736 195 196 O
first NCT03921736 197 202 B-Family_Member
- NCT03921736 203 204 I-Family_Member
degree NCT03921736 205 211 I-Family_Member
relative NCT03921736 212 220 I-Family_Member

- NCT03921736 223 224 O
hyperplasia NCT03921736 226 237 B-Condition
diagnosed NCT03921736 238 247 O
by NCT03921736 248 250 O
endometrial NCT03921736 251 262 B-Procedure
biopsy NCT03921736 263 269 I-Procedure
, NCT03921736 270 271 O

- NCT03921736 275 276 O
history NCT03921736 278 285 B-Eq_Comparison
of NCT03921736 286 288 O
thromboembolic NCT03921736 289 303 B-Condition
diseases NCT03921736 304 312 I-Condition
, NCT03921736 313 314 O

- NCT03921736 318 319 O
current NCT03921736 321 328 B-Eq_Comparison
or NCT03921736 329 331 B-Or
history NCT03921736 332 339 B-Eq_Comparison
of NCT03921736 340 342 O
use NCT03921736 343 346 O
of NCT03921736 347 349 O
estrogen NCT03921736 350 358 B-Procedure
- NCT03921736 359 360 I-Procedure
progestin NCT03921736 361 370 I-Procedure
therapy NCT03921736 371 378 I-Procedure
or NCT03921736 379 381 B-Or
contraceptives NCT03921736 382 396 B-Procedure

- NCT03921736 399 400 O
diabetes NCT03921736 402 410 B-Condition
, NCT03921736 411 412 O

- NCT03921736 416 417 O
kidney NCT03921736 419 425 B-Condition
failure NCT03921736 426 433 I-Condition
, NCT03921736 434 435 O

- NCT03921736 439 440 O
thyroid NCT03921736 442 449 B-Condition
disease NCT03921736 450 457 I-Condition
, NCT03921736 458 459 O

- NCT03921736 463 464 O
heart NCT03921736 466 471 B-Modifier
and NCT03921736 472 475 B-Or
other NCT03921736 476 481 B-Other
chronic NCT03921736 482 489 O
diseases NCT03921736 490 498 B-Condition
( NCT03921736 499 500 O
secondary NCT03921736 501 510 B-Condition
hypertension NCT03921736 511 523 I-Condition
, NCT03921736 524 525 O
atrial NCT03921736 526 532 B-Condition
fibrillation NCT03921736 533 545 I-Condition
) NCT03921736 546 547 O

Inclusion NCT03929523 0 9 O
Criteria NCT03929523 10 18 O
: NCT03929523 19 20 O

- NCT03929523 24 25 O
Provide NCT03929523 27 34 O
written NCT03929523 35 42 O
informed NCT03929523 43 51 O
consent NCT03929523 52 59 O
prior NCT03929523 60 65 O
to NCT03929523 66 68 O
the NCT03929523 69 72 O
performance NCT03929523 73 84 O
of NCT03929523 85 87 O
any NCT03929523 88 91 O
study NCT03929523 92 97 B-Study
specific NCT03929523 98 106 O
procedure NCT03929523 107 116 B-Procedure

- NCT03929523 119 120 O
Affiliated NCT03929523 122 132 O
to NCT03929523 133 135 O
the NCT03929523 136 139 O
French NCT03929523 140 146 O
social NCT03929523 147 153 O
security NCT03929523 154 162 O
system NCT03929523 163 169 O

- NCT03929523 172 173 O
Recipient NCT03929523 175 184 O
age NCT03929523 185 188 B-Age
â¥ NCT03929523 189 190 B-Eq_Comparison
18 NCT03929523 191 193 I-Eq_Comparison
years NCT03929523 194 199 I-Eq_Comparison

- NCT03929523 202 203 O
Patients NCT03929523 205 213 O
undergoing NCT03929523 214 224 B-Eq_Comparison
primary NCT03929523 225 232 B-Modifier
liver NCT03929523 233 238 B-Procedure
transplantation NCT03929523 239 254 I-Procedure
. NCT03929523 255 256 O

- NCT03929523 260 261 O
Candidate NCT03929523 263 272 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03929523 273 276 O
a NCT03929523 277 278 O
first NCT03929523 279 284 B-Eq_Comparison
elective NCT03929523 285 293 B-Modifier
liver NCT03929523 294 299 B-Procedure
transplantation NCT03929523 300 315 I-Procedure
, NCT03929523 316 317 O
whatever NCT03929523 318 326 O
the NCT03929523 327 330 O
indication NCT03929523 331 341 O
, NCT03929523 342 343 O
with NCT03929523 344 348 B-And
a NCT03929523 349 350 O
liver NCT03929523 351 356 B-Procedure
graft NCT03929523 357 362 I-Procedure
harvested NCT03929523 363 372 O
from NCT03929523 373 377 O
a NCT03929523 378 379 O
brain NCT03929523 380 385 B-Procedure
- NCT03929523 386 387 I-Procedure
dead NCT03929523 388 392 I-Procedure
ECD NCT03929523 393 396 I-Procedure
defined NCT03929523 397 404 O
by NCT03929523 405 407 O
the NCT03929523 408 411 O
presence NCT03929523 412 420 O
of NCT03929523 421 423 O
at NCT03929523 424 426 B-Eq_Comparison
least NCT03929523 427 432 I-Eq_Comparison
one NCT03929523 433 436 I-Eq_Comparison
of NCT03929523 437 439 O
the NCT03929523 440 443 B-Criteria_Count
following NCT03929523 444 453 I-Criteria_Count
criteria NCT03929523 454 462 I-Criteria_Count
: NCT03929523 463 464 O

- NCT03929523 473 474 O
Donor NCT03929523 476 481 B-Modifier
age NCT03929523 482 485 B-Age
> NCT03929523 486 487 B-Eq_Comparison
65 NCT03929523 488 490 I-Eq_Comparison
years NCT03929523 491 496 I-Eq_Comparison

- NCT03929523 504 505 O
Intensive NCT03929523 507 516 O
care NCT03929523 517 521 O
unit NCT03929523 522 526 O
stay NCT03929523 527 531 B-Encounter
> NCT03929523 532 533 B-Eq_Comparison
7 NCT03929523 534 535 I-Eq_Comparison
days NCT03929523 536 540 I-Eq_Comparison

- NCT03929523 548 549 O
BMI NCT03929523 551 554 B-Observation
> NCT03929523 555 556 B-Eq_Comparison
30 NCT03929523 557 559 I-Eq_Comparison

- NCT03929523 568 569 O
Proven NCT03929523 571 577 O
macro NCT03929523 578 583 B-Observation
- NCT03929523 584 585 I-Observation
steatosis NCT03929523 586 595 I-Observation
biopsy NCT03929523 596 602 B-Procedure
â¥ NCT03929523 603 604 B-Eq_Comparison
30 NCT03929523 605 607 I-Eq_Comparison
% NCT03929523 608 609 I-Eq_Comparison

- NCT03929523 618 619 O
Natremia NCT03929523 621 629 B-Observation
> NCT03929523 630 631 B-Eq_Comparison
155 NCT03929523 632 635 I-Eq_Comparison
mmol NCT03929523 636 640 I-Eq_Comparison
/ NCT03929523 641 642 I-Eq_Comparison
L NCT03929523 643 644 I-Eq_Comparison
at NCT03929523 645 647 B-Eq_Comparison
any NCT03929523 648 651 I-Eq_Comparison
time NCT03929523 652 656 I-Eq_Comparison

- NCT03929523 664 665 O
AST NCT03929523 667 670 B-Observation
> NCT03929523 671 672 B-Eq_Comparison
150 NCT03929523 673 676 I-Eq_Comparison
IU NCT03929523 677 679 I-Eq_Comparison
/ NCT03929523 680 681 I-Eq_Comparison
mL NCT03929523 682 684 I-Eq_Comparison
at NCT03929523 685 687 B-Eq_Comparison
any NCT03929523 688 691 I-Eq_Comparison
time NCT03929523 692 696 I-Eq_Comparison

- NCT03929523 704 705 O
ALT NCT03929523 707 710 B-Observation
> NCT03929523 711 712 B-Eq_Comparison
170 NCT03929523 713 716 I-Eq_Comparison
IU NCT03929523 717 719 I-Eq_Comparison
/ NCT03929523 720 721 I-Eq_Comparison
mL NCT03929523 722 724 I-Eq_Comparison
at NCT03929523 725 727 B-Eq_Comparison
any NCT03929523 728 731 I-Eq_Comparison
time NCT03929523 732 736 I-Eq_Comparison
. NCT03929523 737 738 O

Exclusion NCT03929523 740 749 O
Criteria NCT03929523 750 758 O
: NCT03929523 759 760 O

- NCT03929523 764 765 O
Fulminant NCT03929523 767 776 B-Condition
hepatic NCT03929523 777 784 I-Condition
failure NCT03929523 785 792 I-Condition

- NCT03929523 795 796 O
Retransplantation NCT03929523 798 815 B-Procedure

- NCT03929523 818 819 O
Split NCT03929523 821 826 B-Modifier
liver NCT03929523 827 832 B-Procedure
transplantation NCT03929523 833 848 I-Procedure

- NCT03929523 851 852 O
Living NCT03929523 854 860 B-Modifier
donor NCT03929523 861 866 I-Modifier
liver NCT03929523 867 872 B-Procedure
transplantation NCT03929523 873 888 I-Procedure

- NCT03929523 891 892 O
Grafts NCT03929523 894 900 B-Observation
donated NCT03929523 901 908 I-Observation
after NCT03929523 909 914 B-Temporal_Connection___Temporal_Connection_Type_Value:after
cardiac NCT03929523 915 922 B-Condition
arrest NCT03929523 923 929 I-Condition
( NCT03929523 930 931 O
DCD NCT03929523 932 935 B-Observation
grafts NCT03929523 936 942 I-Observation
) NCT03929523 943 944 O

- NCT03929523 948 949 O
Domino NCT03929523 951 957 B-Modifier
transplantation NCT03929523 958 973 B-Procedure

- NCT03929523 976 977 O
Combined NCT03929523 979 987 B-Modifier
liver NCT03929523 988 993 B-Procedure
transplant NCT03929523 994 1004 I-Procedure

- NCT03929523 1007 1008 O
Unexpected NCT03929523 1010 1020 O
medical NCT03929523 1021 1028 O
contraindication NCT03929523 1029 1045 B-Contraindication
to NCT03929523 1046 1048 O
liver NCT03929523 1049 1054 B-Procedure
transplantation NCT03929523 1055 1070 I-Procedure

- NCT03929523 1073 1074 O
Patient NCT03929523 1076 1083 O
participating NCT03929523 1084 1097 B-Eq_Comparison
in NCT03929523 1098 1100 O
other NCT03929523 1101 1106 B-Other
interventional NCT03929523 1107 1121 B-Study
research NCT03929523 1122 1130 I-Study
, NCT03929523 1131 1132 O
excluding NCT03929523 1133 1142 B-Exception
routine NCT03929523 1143 1150 B-Modifier
care NCT03929523 1151 1155 I-Modifier
research NCT03929523 1156 1164 B-Study
( NCT03929523 1165 1166 O
old NCT03929523 1167 1170 B-Modifier
regulation NCT03929523 1171 1181 I-Modifier
) NCT03929523 1182 1183 O
and NCT03929523 1184 1187 B-Or
category NCT03929523 1188 1196 B-Modifier
2 NCT03929523 1197 1198 I-Modifier
research NCT03929523 1199 1207 B-Study
not NCT03929523 1208 1211 B-Negation
interfering NCT03929523 1212 1223 O
with NCT03929523 1224 1228 O
primary NCT03929523 1229 1236 O
endpoint NCT03929523 1237 1245 O
analysis NCT03929523 1246 1254 B-Study

- NCT03929523 1257 1258 O
Patient NCT03929523 1260 1267 O
under NCT03929523 1268 1273 O
legal NCT03929523 1274 1279 B-Observation
protection NCT03929523 1280 1290 I-Observation

- NCT03929523 1293 1294 O
Patient NCT03929523 1296 1303 O
deprived NCT03929523 1304 1312 B-Observation
of NCT03929523 1313 1315 I-Observation
liberty NCT03929523 1316 1323 I-Observation
by NCT03929523 1324 1326 O
a NCT03929523 1327 1328 O
judicial NCT03929523 1329 1337 O
or NCT03929523 1338 1340 O
administrative NCT03929523 1341 1355 O
decision NCT03929523 1356 1364 O

- NCT03929523 1367 1368 O
Patient NCT03929523 1370 1377 O
refusing NCT03929523 1378 1386 O
to NCT03929523 1387 1389 O
participate NCT03929523 1390 1401 O
in NCT03929523 1402 1404 O
the NCT03929523 1405 1408 O
study NCT03929523 1409 1414 O

- NCT03929523 1417 1418 O
Pregnant NCT03929523 1420 1428 B-Condition
or NCT03929523 1429 1431 B-Or
lactating NCT03929523 1432 1441 B-Condition
women NCT03929523 1442 1447 O

- NCT03929523 1450 1451 O
Inability NCT03929523 1453 1462 B-Condition
to NCT03929523 1463 1465 I-Condition
understand NCT03929523 1466 1476 I-Condition
information NCT03929523 1477 1488 O
concerning NCT03929523 1489 1499 O
the NCT03929523 1500 1503 O
protocol NCT03929523 1504 1512 O

Inclusion NCT03861650 0 9 O
Criteria NCT03861650 10 18 O
: NCT03861650 19 20 O

1 NCT03861650 24 25 O
. NCT03861650 25 26 O
Patients NCT03861650 28 36 O
free NCT03861650 37 41 B-Negation
from NCT03861650 42 46 I-Negation
any NCT03861650 47 50 O
disease NCT03861650 51 58 B-Condition
affecting NCT03861650 59 68 O
bone NCT03861650 69 73 B-Condition
formation NCT03861650 74 83 I-Condition
of NCT03861650 84 86 O
both NCT03861650 87 91 O
sexes NCT03861650 92 97 O
was NCT03861650 98 101 O
included NCT03861650 102 110 O
in NCT03861650 111 113 O
the NCT03861650 114 117 O
study NCT03861650 118 123 O
. NCT03861650 124 125 O

2 NCT03861650 129 130 O
. NCT03861650 130 131 O
Patients NCT03861650 133 141 O
younger NCT03861650 142 149 B-Eq_Comparison
than NCT03861650 150 154 I-Eq_Comparison
25 NCT03861650 155 157 I-Eq_Comparison
years NCT03861650 158 163 I-Eq_Comparison
old NCT03861650 164 167 B-Age
. NCT03861650 168 169 O

3 NCT03861650 173 174 O
. NCT03861650 174 175 O
Patients NCT03861650 177 185 O
included NCT03861650 186 194 O
in NCT03861650 195 197 O
the NCT03861650 198 201 O
study NCT03861650 202 207 B-Study
were NCT03861650 208 212 O
post NCT03861650 213 217 B-Condition
traumatic NCT03861650 218 227 I-Condition
patients NCT03861650 228 236 O
, NCT03861650 237 238 O
hemifacial NCT03861650 239 249 B-Condition
microsomia NCT03861650 250 260 I-Condition
, NCT03861650 261 262 O
Treacher NCT03861650 263 271 B-Condition
Collins NCT03861650 272 279 I-Condition
and NCT03861650 280 283 B-Or
post NCT03861650 284 288 B-Condition
ankylotic NCT03861650 289 298 I-Condition
mandibular NCT03861650 299 309 I-Condition
deformity NCT03861650 310 319 I-Condition
. NCT03861650 320 321 O

4 NCT03861650 325 326 O
. NCT03861650 326 327 O
Distraction NCT03861650 329 340 B-Observation
range NCT03861650 341 346 I-Observation
was NCT03861650 347 350 O
between NCT03861650 351 358 B-Eq_Comparison
15 NCT03861650 359 361 I-Eq_Comparison
- NCT03861650 362 363 I-Eq_Comparison
20 NCT03861650 364 366 I-Eq_Comparison
mm NCT03861650 367 369 I-Eq_Comparison
. NCT03861650 370 371 O

Exclusion NCT03861650 373 382 O
Criteria NCT03861650 383 391 O
: NCT03861650 392 393 O

1 NCT03861650 397 398 O
. NCT03861650 398 399 O
The NCT03861650 401 404 O
presence NCT03861650 405 413 O
of NCT03861650 414 416 O
uncontrolled NCT03861650 417 429 B-Modifier
systemic NCT03861650 430 438 I-Modifier
disease NCT03861650 439 446 B-Condition
. NCT03861650 447 448 O

2 NCT03861650 452 453 O
. NCT03861650 453 454 O
Previous NCT03861650 456 464 B-Eq_Comparison
radiotherapy NCT03861650 465 477 B-Procedure
on NCT03861650 478 480 O
head NCT03861650 481 485 B-Modifier
and NCT03861650 486 489 B-Or
neck NCT03861650 490 494 B-Modifier
region NCT03861650 495 501 O
. NCT03861650 502 503 O

3 NCT03861650 507 508 O
. NCT03861650 508 509 O
Chemotherapy NCT03861650 511 523 B-Procedure
within NCT03861650 524 530 B-Eq_Comparison
the NCT03861650 531 534 I-Eq_Comparison
past NCT03861650 535 539 I-Eq_Comparison
12 NCT03861650 540 542 I-Eq_Comparison
- NCT03861650 543 544 I-Eq_Comparison
month NCT03861650 545 550 I-Eq_Comparison
period NCT03861650 551 557 O
. NCT03861650 558 559 O

4 NCT03861650 563 564 O
. NCT03861650 564 565 O
An NCT03861650 567 569 O
active NCT03861650 570 576 B-Eq_Comparison
infection NCT03861650 577 586 B-Condition
at NCT03861650 587 589 O
the NCT03861650 590 593 O
distraction NCT03861650 594 605 B-Modifier
site NCT03861650 606 610 I-Modifier
. NCT03861650 611 612 O

Inclusion NCT03920878 0 9 O
Criteria NCT03920878 10 18 O
: NCT03920878 19 20 O

- NCT03920878 24 25 O
Adults NCT03920878 27 33 O
over NCT03920878 34 38 B-Eq_Comparison
age NCT03920878 39 42 I-Eq_Comparison
18 NCT03920878 43 45 I-Eq_Comparison
with NCT03920878 46 50 B-And
diabetes NCT03920878 51 59 B-Condition
mellitus NCT03920878 60 68 I-Condition
, NCT03920878 69 70 O
diabetic NCT03920878 71 79 B-Condition
macular NCT03920878 80 87 I-Condition
edema NCT03920878 88 93 I-Condition
and NCT03920878 94 97 B-And
visually NCT03920878 98 106 O
significant NCT03920878 107 118 O
cataracts NCT03920878 119 128 B-Condition
planning NCT03920878 129 137 B-Eq_Comparison
to NCT03920878 138 140 O
undergo NCT03920878 141 148 O
cataract NCT03920878 149 157 B-Procedure
surgery NCT03920878 158 165 I-Procedure

Exclusion NCT03920878 166 175 O
Criteria NCT03920878 176 184 O
: NCT03920878 185 186 O

- NCT03920878 190 191 O
Patients NCT03920878 193 201 O
who NCT03920878 202 205 O
have NCT03920878 206 210 O
undergone NCT03920878 211 220 B-Eq_Comparison
panretinal NCT03920878 221 231 B-Procedure
photocoagulation NCT03920878 232 248 I-Procedure
( NCT03920878 249 250 O
PRP NCT03920878 251 254 B-Procedure
) NCT03920878 255 256 O
in NCT03920878 257 259 O
prior NCT03920878 260 265 B-Eq_Comparison
4 NCT03920878 266 267 I-Eq_Comparison
months NCT03920878 268 274 I-Eq_Comparison
or NCT03920878 275 277 B-Or
an NCT03920878 278 280 O
ocular NCT03920878 281 287 B-Condition
condition NCT03920878 288 297 I-Condition
( NCT03920878 298 299 O
other NCT03920878 300 305 B-Exception
than NCT03920878 306 310 I-Exception
cataract NCT03920878 311 319 B-Condition
and NCT03920878 320 323 B-Or
DME NCT03920878 324 327 B-Condition
) NCT03920878 328 329 O
that NCT03920878 330 334 O
might NCT03920878 335 340 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03920878 341 347 O
visual NCT03920878 348 354 B-Condition
acuity NCT03920878 355 361 I-Condition
during NCT03920878 362 368 B-Temporal_Connection___Temporal_Connection_Type_Value:during
course NCT03920878 369 375 O
of NCT03920878 376 378 O
study NCT03920878 379 384 B-Study
. NCT03920878 385 386 O

- NCT03920878 390 391 O
Patients NCT03920878 393 401 O
with NCT03920878 402 406 O
history NCT03920878 407 414 B-Eq_Comparison
of NCT03920878 415 417 O
vitrectomy NCT03920878 418 428 B-Condition
. NCT03920878 429 430 O

- NCT03920878 434 435 O
Patients NCT03920878 437 445 O
with NCT03920878 446 450 O
neovascular NCT03920878 451 462 B-Condition
glaucoma NCT03920878 463 471 I-Condition
. NCT03920878 472 473 O

Inclusion NCT03923478 0 9 O
Criteria NCT03923478 10 18 O
: NCT03923478 19 20 O

- NCT03923478 24 25 O
Established NCT03923478 27 38 O
diagnosis NCT03923478 39 48 O
of NCT03923478 49 51 O
UC NCT03923478 52 54 B-Condition
for NCT03923478 55 58 O
at NCT03923478 59 61 B-Eq_Comparison
least NCT03923478 62 67 I-Eq_Comparison
3 NCT03923478 68 69 I-Eq_Comparison
months NCT03923478 70 76 I-Eq_Comparison
prior NCT03923478 77 82 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03923478 83 85 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03923478 86 95 B-Study
, NCT03923478 96 97 O
with NCT03923478 98 102 B-And
minimum NCT03923478 103 110 B-Observation
disease NCT03923478 111 118 I-Observation
extent NCT03923478 119 125 I-Observation
of NCT03923478 126 128 O
15 NCT03923478 129 131 B-Eq_Comparison
cm NCT03923478 132 134 I-Eq_Comparison
from NCT03923478 135 139 O
the NCT03923478 140 143 O
anal NCT03923478 144 148 B-Modifier
verge NCT03923478 149 154 I-Modifier

- NCT03923478 157 158 O
Mildly NCT03923478 160 166 B-Eq_Comparison
to NCT03923478 167 169 I-Eq_Comparison
moderately NCT03923478 170 180 I-Eq_Comparison
active NCT03923478 181 187 B-Eq_Comparison
UC NCT03923478 188 190 B-Condition

- NCT03923478 193 194 O
Inadequate NCT03923478 196 206 B-Modifier
response NCT03923478 207 215 I-Modifier
to NCT03923478 216 218 O
ongoing NCT03923478 219 226 B-Eq_Comparison
treatment NCT03923478 227 236 B-Procedure
with NCT03923478 237 241 O
oral NCT03923478 242 246 B-Drug
mesalamine NCT03923478 247 257 I-Drug
â¥ NCT03923478 258 259 B-Eq_Comparison
2.4 NCT03923478 260 263 I-Eq_Comparison
g NCT03923478 264 265 I-Eq_Comparison
/ NCT03923478 266 267 I-Eq_Comparison
day NCT03923478 268 271 I-Eq_Comparison
for NCT03923478 272 275 O
â¥ NCT03923478 276 277 B-Eq_Comparison
4 NCT03923478 278 279 I-Eq_Comparison
weeks NCT03923478 280 285 I-Eq_Comparison
from NCT03923478 286 290 B-Temporal_Connection___Temporal_Connection_Type_Value:after
screening NCT03923478 291 300 B-Study
visit NCT03923478 301 306 O

Exclusion NCT03923478 307 316 O
Criteria NCT03923478 317 325 O
: NCT03923478 326 327 O

- NCT03923478 331 332 O
Possible NCT03923478 334 342 B-Assertion___Assertion_Type_Value:possible
or NCT03923478 343 345 O
confirmed NCT03923478 346 355 O
diagnosis NCT03923478 356 365 O
of NCT03923478 366 368 O
Crohn NCT03923478 369 374 B-Condition
's NCT03923478 374 376 I-Condition
Disease NCT03923478 377 384 I-Condition
or NCT03923478 385 387 B-Or
other NCT03923478 388 393 B-Other
forms NCT03923478 394 399 O
of NCT03923478 400 402 O
inflammatory NCT03923478 403 415 B-Modifier
bowel NCT03923478 416 421 B-Condition
disorders NCT03923478 422 431 I-Condition

- NCT03923478 434 435 O
Ongoing NCT03923478 437 444 B-Eq_Comparison
or NCT03923478 445 447 B-Or
failed NCT03923478 448 454 B-Modifier
prior NCT03923478 455 460 B-Eq_Comparison
treatment NCT03923478 461 470 B-Procedure
for NCT03923478 471 474 O
UC NCT03923478 475 477 B-Condition
with NCT03923478 478 482 O
methotrexate NCT03923478 483 495 B-Drug
, NCT03923478 496 497 O
azathioprine NCT03923478 498 510 B-Drug
, NCT03923478 511 512 O

6 NCT03923478 519 520 B-Drug
- NCT03923478 521 522 I-Drug
mercaptopurine NCT03923478 523 537 I-Drug
, NCT03923478 538 539 O
cyclosporine NCT03923478 540 552 B-Drug
, NCT03923478 553 554 O
tofacitinib NCT03923478 555 566 B-Drug
, NCT03923478 567 568 O
mycophenolate NCT03923478 569 582 B-Drug
mofetil NCT03923478 583 590 I-Drug
, NCT03923478 591 592 O
sirolimus NCT03923478 593 602 B-Drug
( NCT03923478 603 604 O
rapamycin NCT03923478 605 614 B-Drug
) NCT03923478 615 616 O
, NCT03923478 617 618 O
thalidomide NCT03923478 619 630 B-Drug
, NCT03923478 631 632 O
tacrolimus NCT03923478 633 643 B-Drug
( NCT03923478 644 645 O
FK NCT03923478 646 648 B-Drug
- NCT03923478 649 650 I-Drug
506 NCT03923478 651 654 I-Drug
) NCT03923478 655 656 O
, NCT03923478 657 658 O
or NCT03923478 659 661 B-Or
biologics NCT03923478 662 671 B-Drug
( NCT03923478 672 673 O
e NCT03923478 674 675 O
. NCT03923478 676 677 O
g NCT03923478 678 679 O
. NCT03923478 680 681 O
, NCT03923478 682 683 O
TNF NCT03923478 684 687 B-Drug
- NCT03923478 688 689 I-Drug
alpha NCT03923478 690 695 I-Drug
- NCT03923478 696 697 I-Drug
antagonists NCT03923478 698 709 I-Drug
, NCT03923478 710 711 O
anti NCT03923478 712 716 B-Drug
- NCT03923478 717 718 I-Drug
integrin NCT03923478 719 727 I-Drug
therapies NCT03923478 728 737 I-Drug
, NCT03923478 738 739 O
or NCT03923478 740 742 B-Or
agents NCT03923478 743 749 B-Drug
targeting NCT03923478 750 759 I-Drug
IL NCT03923478 760 762 B-Modifier
- NCT03923478 763 764 I-Modifier
12 NCT03923478 765 767 I-Modifier
or NCT03923478 768 770 B-Or
IL NCT03923478 771 773 B-Modifier
- NCT03923478 774 775 I-Modifier
23 NCT03923478 776 778 I-Modifier
, NCT03923478 779 780 O
etc NCT03923478 781 784 O
. NCT03923478 785 786 O
) NCT03923478 787 788 O

- NCT03923478 792 793 O
Any NCT03923478 795 798 O
immunosuppressive NCT03923478 799 816 B-Condition
condition NCT03923478 817 826 I-Condition
or NCT03923478 827 829 B-Or
treatment NCT03923478 830 839 B-Procedure
with NCT03923478 840 844 O
immunosuppressive NCT03923478 845 862 B-Drug
medications NCT03923478 863 874 I-Drug

- NCT03923478 877 878 O
History NCT03923478 880 887 B-Eq_Comparison
of NCT03923478 888 890 I-Eq_Comparison
prior NCT03923478 891 896 I-Eq_Comparison
surgical NCT03923478 897 905 B-Procedure
intervention NCT03923478 906 918 I-Procedure
in NCT03923478 919 921 O
any NCT03923478 922 925 O
region NCT03923478 926 932 O
of NCT03923478 933 935 O
the NCT03923478 936 939 O
gastrointestinal NCT03923478 940 956 B-Modifier
tract NCT03923478 957 962 I-Modifier
( NCT03923478 963 964 O
excluding NCT03923478 965 974 B-Exception
minor NCT03923478 975 980 B-Procedure
surgery NCT03923478 981 988 I-Procedure
) NCT03923478 989 990 O

- NCT03923478 994 995 O
Prior NCT03923478 997 1002 B-Eq_Comparison
diagnosis NCT03923478 1003 1012 O
of NCT03923478 1013 1015 O
any NCT03923478 1016 1019 O
cardiovascular NCT03923478 1020 1034 B-Modifier
, NCT03923478 1035 1036 O
renal NCT03923478 1037 1042 B-Modifier
, NCT03923478 1043 1044 O
hepatic NCT03923478 1045 1052 B-Modifier
, NCT03923478 1053 1054 O
endocrine NCT03923478 1055 1064 B-Modifier
, NCT03923478 1065 1066 O
infectious NCT03923478 1067 1077 B-Modifier
, NCT03923478 1078 1079 O
hematological NCT03923478 1080 1093 B-Modifier
, NCT03923478 1094 1095 O
oncologic NCT03923478 1096 1105 B-Modifier
, NCT03923478 1106 1107 O
neuro NCT03923478 1108 1113 B-Modifier
- NCT03923478 1114 1115 I-Modifier
psychiatric NCT03923478 1116 1127 I-Modifier
or NCT03923478 1128 1130 B-Or
immune NCT03923478 1131 1137 B-Modifier
- NCT03923478 1138 1139 I-Modifier
mediated NCT03923478 1140 1148 I-Modifier
disorder NCT03923478 1149 1157 B-Condition
, NCT03923478 1158 1159 O
which NCT03923478 1160 1165 O
in NCT03923478 1166 1168 O
the NCT03923478 1169 1172 O
opinion NCT03923478 1173 1180 O
of NCT03923478 1181 1183 O
the NCT03923478 1184 1187 O
Principal NCT03923478 1188 1197 O
Investigator NCT03923478 1198 1210 O
might NCT03923478 1211 1216 B-Assertion___Assertion_Type_Value:hypothetical
impact NCT03923478 1217 1223 O
the NCT03923478 1224 1227 O
subject NCT03923478 1228 1235 O
's NCT03923478 1235 1237 O
safety NCT03923478 1238 1244 O
or NCT03923478 1245 1247 O
compliance NCT03923478 1248 1258 O
, NCT03923478 1259 1260 O
or NCT03923478 1261 1263 O
the NCT03923478 1264 1267 O
interpretation NCT03923478 1268 1282 O
of NCT03923478 1283 1285 O
results NCT03923478 1286 1293 B-Study

- NCT03923478 1296 1297 O
Treatment NCT03923478 1299 1308 B-Procedure
with NCT03923478 1309 1313 O
any NCT03923478 1314 1317 O
other NCT03923478 1318 1323 B-Other
investigational NCT03923478 1324 1339 B-Study
drugs NCT03923478 1340 1345 B-Drug
â¤ NCT03923478 1346 1347 B-Eq_Comparison
12 NCT03923478 1348 1350 I-Eq_Comparison
weeks NCT03923478 1351 1356 I-Eq_Comparison
prior NCT03923478 1357 1362 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03923478 1363 1365 I-Temporal_Connection___Temporal_Connection_Type_Value:before
baseline NCT03923478 1366 1374 B-Study
visit NCT03923478 1375 1380 O

- NCT03923478 1383 1384 O
The NCT03923478 1386 1389 O
participant NCT03923478 1390 1401 O
has NCT03923478 1402 1405 O
a NCT03923478 1406 1407 O
condition NCT03923478 1408 1417 B-Condition
or NCT03923478 1418 1420 O
is NCT03923478 1421 1423 O
in NCT03923478 1424 1426 O
a NCT03923478 1427 1428 O
situation NCT03923478 1429 1438 O
which NCT03923478 1439 1444 O
, NCT03923478 1445 1446 O
in NCT03923478 1447 1449 O
the NCT03923478 1450 1453 O
Principal NCT03923478 1454 1463 O
Investigator NCT03923478 1464 1476 O
's NCT03923478 1476 1478 O
opinion NCT03923478 1479 1486 O
, NCT03923478 1487 1488 O
may NCT03923478 1489 1492 O
put NCT03923478 1493 1496 O
the NCT03923478 1497 1500 O
participant NCT03923478 1501 1512 O
at NCT03923478 1513 1515 O
significant NCT03923478 1516 1527 O
risk NCT03923478 1528 1532 B-Risk
, NCT03923478 1533 1534 O
may NCT03923478 1535 1538 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03923478 1539 1547 O
the NCT03923478 1548 1551 O
study NCT03923478 1552 1557 B-Study
results NCT03923478 1558 1565 O
, NCT03923478 1566 1567 O
or NCT03923478 1568 1570 B-Or
may NCT03923478 1571 1574 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03923478 1575 1584 O
significantly NCT03923478 1585 1598 O
with NCT03923478 1599 1603 O
the NCT03923478 1604 1607 O
participant NCT03923478 1608 1619 O
's NCT03923478 1619 1621 O
participation NCT03923478 1622 1635 O
in NCT03923478 1636 1638 O
the NCT03923478 1639 1642 O
study NCT03923478 1643 1648 B-Study

Inclusion NCT03922672 0 9 O
Criteria NCT03922672 10 18 O
: NCT03922672 19 20 O

- NCT03922672 24 25 O
Caregiver NCT03922672 27 36 O
: NCT03922672 37 38 O

- NCT03922672 47 48 O
Are NCT03922672 50 53 O
currently NCT03922672 54 63 B-Eq_Comparison
a NCT03922672 64 65 O
primary NCT03922672 66 73 B-Observation
caregiver NCT03922672 74 83 I-Observation
to NCT03922672 84 86 O
an NCT03922672 87 89 O
adult NCT03922672 90 95 O
with NCT03922672 96 100 B-And
PD NCT03922672 101 103 B-Condition

- NCT03922672 111 112 O
Are NCT03922672 114 117 O
between NCT03922672 118 125 O
the NCT03922672 126 129 O
age NCT03922672 130 133 B-Age
of NCT03922672 134 136 O
40 NCT03922672 137 139 B-Eq_Comparison
- NCT03922672 140 141 I-Eq_Comparison
80 NCT03922672 142 144 I-Eq_Comparison
years NCT03922672 145 150 I-Eq_Comparison

- NCT03922672 158 159 O
Have NCT03922672 161 165 O
less NCT03922672 166 170 B-Eq_Comparison
than NCT03922672 171 175 I-Eq_Comparison
5 NCT03922672 176 177 I-Eq_Comparison
years NCT03922672 178 183 I-Eq_Comparison
of NCT03922672 184 186 O
music NCT03922672 187 192 B-Observation
training NCT03922672 193 201 I-Observation

- NCT03922672 209 210 O
Speak NCT03922672 212 217 O
and NCT03922672 218 221 O
read NCT03922672 222 226 O
English NCT03922672 227 234 O
fluently NCT03922672 235 243 O

Adult NCT03922672 244 249 O
with NCT03922672 250 254 B-And
PD NCT03922672 255 257 B-Condition
: NCT03922672 258 259 O

- NCT03922672 263 264 O
Stage NCT03922672 266 271 B-Eq_Comparison
1 NCT03922672 272 273 I-Eq_Comparison
- NCT03922672 274 275 I-Eq_Comparison
3 NCT03922672 276 277 I-Eq_Comparison
Parkinson NCT03922672 278 287 B-Condition
's NCT03922672 287 289 I-Condition
disease NCT03922672 290 297 I-Condition

- NCT03922672 300 301 O
Are NCT03922672 303 306 O
between NCT03922672 307 314 O
the NCT03922672 315 318 O
age NCT03922672 319 322 B-Age
of NCT03922672 323 325 O
40 NCT03922672 326 328 B-Eq_Comparison
- NCT03922672 329 330 I-Eq_Comparison
80 NCT03922672 331 333 I-Eq_Comparison

- NCT03922672 337 338 O
Have NCT03922672 340 344 O
less NCT03922672 345 349 B-Eq_Comparison
than NCT03922672 350 354 I-Eq_Comparison
5 NCT03922672 355 356 I-Eq_Comparison
years NCT03922672 357 362 I-Eq_Comparison
of NCT03922672 363 365 O
music NCT03922672 366 371 B-Observation
training NCT03922672 372 380 I-Observation

- NCT03922672 383 384 O
Speak NCT03922672 386 391 O
and NCT03922672 392 395 O
read NCT03922672 396 400 O
English NCT03922672 401 408 O
fluently NCT03922672 409 417 O

Exclusion NCT03922672 418 427 O
Criteria NCT03922672 428 436 O
: NCT03922672 437 438 O

- NCT03922672 442 443 O
Does NCT03922672 445 449 O
n't NCT03922672 449 452 O
meet NCT03922672 453 457 O
all NCT03922672 458 461 O
the NCT03922672 462 465 O
inclusion NCT03922672 466 475 O
criteria NCT03922672 476 484 O

Inclusion NCT03862638 0 9 O
Criteria NCT03862638 10 18 O
: NCT03862638 19 20 O

- NCT03862638 24 25 O
Meeting NCT03862638 27 34 O
the NCT03862638 35 38 O
diagnostic NCT03862638 39 49 O
criteria NCT03862638 50 58 O
of NCT03862638 59 61 O
CTTH NCT03862638 62 66 B-Condition
in NCT03862638 67 69 O
the NCT03862638 70 73 O
international NCT03862638 74 87 O
classification NCT03862638 88 102 O
of NCT03862638 103 105 O
headache NCT03862638 106 114 O
disorders NCT03862638 115 124 O
, NCT03862638 125 126 O
3 NCT03862638 127 128 O
rd NCT03862638 129 131 O
edition NCT03862638 132 139 O
( NCT03862638 140 141 O
beta NCT03862638 142 146 O
version NCT03862638 147 154 O
) NCT03862638 155 156 O
( NCT03862638 157 158 O
ICHD NCT03862638 159 163 O
- NCT03862638 164 165 O
III NCT03862638 166 169 O
beta NCT03862638 170 174 O
) NCT03862638 175 176 O
; NCT03862638 177 178 O

- NCT03862638 181 182 O
Aged NCT03862638 184 188 B-Age
18 NCT03862638 189 191 B-Eq_Comparison
- NCT03862638 192 193 I-Eq_Comparison
55 NCT03862638 194 196 I-Eq_Comparison
years NCT03862638 197 202 I-Eq_Comparison
; NCT03862638 202 203 O

- NCT03862638 206 207 O
Having NCT03862638 209 215 O
the NCT03862638 216 219 O
ability NCT03862638 220 227 O
of NCT03862638 228 230 O
understanding NCT03862638 231 244 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03862638 245 248 B-And
completing NCT03862638 249 259 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03862638 260 263 O
headache NCT03862638 264 272 B-Observation
dairy NCT03862638 273 278 I-Observation
; NCT03862638 278 279 O

- NCT03862638 282 283 O
Provide NCT03862638 285 292 O
written NCT03862638 293 300 O
informed NCT03862638 301 309 O
consent NCT03862638 310 317 O
. NCT03862638 318 319 O

Exclusion NCT03862638 321 330 O
Criteria NCT03862638 331 339 O
: NCT03862638 340 341 O

- NCT03862638 345 346 O
No NCT03862638 348 350 B-Negation
headache NCT03862638 351 359 B-Condition
during NCT03862638 360 366 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862638 367 370 O
pervious NCT03862638 371 379 B-Eq_Comparison
3 NCT03862638 380 381 I-Eq_Comparison
months NCT03862638 382 388 I-Eq_Comparison
; NCT03862638 388 389 O

- NCT03862638 392 393 O
Taking NCT03862638 395 401 B-Eq_Comparison
any NCT03862638 402 405 O
prophylactic NCT03862638 406 418 B-Drug
medication NCT03862638 419 429 I-Drug
during NCT03862638 430 436 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862638 437 440 O
previous NCT03862638 441 449 B-Eq_Comparison
one NCT03862638 450 453 I-Eq_Comparison
month NCT03862638 454 459 I-Eq_Comparison
; NCT03862638 459 460 O

- NCT03862638 463 464 O
Secondary NCT03862638 466 475 B-Modifier
headache NCT03862638 476 484 B-Condition
or NCT03862638 485 487 B-Or
any NCT03862638 488 491 O
systematic NCT03862638 492 502 B-Modifier
cause NCT03862638 503 508 B-Condition

- NCT03862638 511 512 O
Having NCT03862638 514 520 O
serious NCT03862638 521 528 O
conditions NCT03862638 529 539 B-Condition
of NCT03862638 540 542 O
the NCT03862638 543 546 O
heart NCT03862638 547 552 B-Modifier
, NCT03862638 553 554 O
liver NCT03862638 555 560 B-Modifier
, NCT03862638 561 562 O
kidney NCT03862638 563 569 B-Modifier
or NCT03862638 570 572 B-Or
other NCT03862638 573 578 B-Other
organs NCT03862638 579 585 B-Modifier
; NCT03862638 585 586 O

- NCT03862638 589 590 O
In NCT03862638 592 594 O
pregnancy NCT03862638 595 604 B-Condition
or NCT03862638 605 607 B-Or
lactation NCT03862638 608 617 B-Condition
, NCT03862638 618 619 O
or NCT03862638 620 622 B-Or
planning NCT03862638 623 631 B-Assertion___Assertion_Type_Value:intention
to NCT03862638 632 634 O
be NCT03862638 635 637 O
pregnant NCT03862638 638 646 B-Condition
in NCT03862638 647 649 O
6 NCT03862638 650 651 B-Eq_Comparison
months NCT03862638 652 658 I-Eq_Comparison
; NCT03862638 658 659 O

- NCT03862638 662 663 O
Drug NCT03862638 665 669 B-Modifier
and NCT03862638 670 673 B-Or
Substance NCT03862638 674 683 B-Modifier
abuse NCT03862638 684 689 B-Condition

- NCT03862638 692 693 O
Diagnosed NCT03862638 695 704 O
psychiatric NCT03862638 705 716 B-Condition
condition NCT03862638 717 726 I-Condition

- NCT03862638 729 730 O
Taking NCT03862638 732 738 B-Eq_Comparison
any NCT03862638 739 742 O
other NCT03862638 743 748 B-Other
complementary NCT03862638 749 762 B-Modifier
and NCT03862638 763 766 B-Or
alternative NCT03862638 767 778 B-Modifier
medicines NCT03862638 779 788 B-Drug

- NCT03862638 791 792 O
Practicing NCT03862638 794 804 O
yoga NCT03862638 805 809 B-Observation
of NCT03862638 810 812 O
any NCT03862638 813 816 O
kind NCT03862638 817 821 O
in NCT03862638 822 824 O
last NCT03862638 825 829 B-Eq_Comparison
three NCT03862638 830 835 I-Eq_Comparison
months NCT03862638 836 842 I-Eq_Comparison

Inclusion NCT03866421 0 9 O
Criteria NCT03866421 10 18 O
( NCT03866421 19 20 O
kidney NCT03866421 21 27 B-Procedure
transplanted NCT03866421 28 40 I-Procedure
patients NCT03866421 41 49 O
) NCT03866421 50 51 O
: NCT03866421 52 53 O

- NCT03866421 57 58 O
Outpatient NCT03866421 60 70 B-Encounter
at NCT03866421 71 73 O
the NCT03866421 74 77 O
department NCT03866421 78 88 O
of NCT03866421 89 91 O
nephrology NCT03866421 92 102 O
at NCT03866421 103 105 O
either NCT03866421 106 112 O
Rigshospitalet NCT03866421 113 127 O
or NCT03866421 128 130 B-Or
Herlev NCT03866421 131 137 O
Hospital NCT03866421 138 146 O
scheduled NCT03866421 147 156 B-Eq_Comparison
for NCT03866421 157 160 O
a NCT03866421 161 162 O
kidney NCT03866421 163 169 B-Procedure
transplantation NCT03866421 170 185 I-Procedure
with NCT03866421 186 190 O
a NCT03866421 191 192 O
living NCT03866421 193 199 B-Observation
donor NCT03866421 200 205 I-Observation

- NCT03866421 208 209 O
Impaired NCT03866421 211 219 B-Condition
glucose NCT03866421 220 227 I-Condition
tolerance NCT03866421 228 237 I-Condition
: NCT03866421 238 239 O
fasting NCT03866421 240 247 B-Modifier
glucose NCT03866421 248 255 B-Observation
concentration NCT03866421 256 269 I-Observation
< NCT03866421 270 271 B-Eq_Comparison
7 NCT03866421 272 273 I-Eq_Comparison
, NCT03866421 274 275 I-Eq_Comparison
0 NCT03866421 276 277 I-Eq_Comparison
mmol NCT03866421 278 282 I-Eq_Comparison
/ NCT03866421 283 284 I-Eq_Comparison
l NCT03866421 285 286 I-Eq_Comparison
and NCT03866421 287 290 B-And
a NCT03866421 291 292 O
2 NCT03866421 293 294 B-Observation
- NCT03866421 295 296 I-Observation
hour NCT03866421 297 301 I-Observation
glucose NCT03866421 302 309 I-Observation
load NCT03866421 310 314 I-Observation
â¥ NCT03866421 315 316 B-Eq_Comparison
7 NCT03866421 317 318 I-Eq_Comparison
, NCT03866421 319 320 I-Eq_Comparison
8 NCT03866421 321 322 I-Eq_Comparison
mmol NCT03866421 323 327 I-Eq_Comparison
/ NCT03866421 328 329 I-Eq_Comparison
l NCT03866421 330 331 I-Eq_Comparison
and NCT03866421 332 335 B-And
< NCT03866421 336 337 B-Eq_Comparison
11 NCT03866421 338 340 I-Eq_Comparison
, NCT03866421 341 342 I-Eq_Comparison
1 NCT03866421 343 344 I-Eq_Comparison
mmol NCT03866421 345 349 I-Eq_Comparison
/ NCT03866421 350 351 I-Eq_Comparison
l NCT03866421 352 353 I-Eq_Comparison
OR NCT03866421 354 356 B-Or
Impaired NCT03866421 357 365 B-Condition
fasting NCT03866421 366 373 I-Condition
glycaemia NCT03866421 374 383 I-Condition
: NCT03866421 384 385 O
Fasting NCT03866421 386 393 B-Modifier
blood NCT03866421 394 399 B-Observation
glucose NCT03866421 400 407 I-Observation
â¥ NCT03866421 408 409 B-Eq_Comparison
6 NCT03866421 410 411 I-Eq_Comparison
, NCT03866421 412 413 I-Eq_Comparison
1 NCT03866421 414 415 I-Eq_Comparison
mmol NCT03866421 416 420 I-Eq_Comparison
/ NCT03866421 421 422 I-Eq_Comparison
l NCT03866421 423 424 I-Eq_Comparison
and NCT03866421 425 428 B-And
< NCT03866421 429 430 B-Eq_Comparison
7 NCT03866421 431 432 I-Eq_Comparison
, NCT03866421 433 434 I-Eq_Comparison
0 NCT03866421 435 436 I-Eq_Comparison
mmol NCT03866421 437 441 I-Eq_Comparison
/ NCT03866421 442 443 I-Eq_Comparison
l NCT03866421 444 445 I-Eq_Comparison
and NCT03866421 446 449 B-And
a NCT03866421 450 451 O
2 NCT03866421 452 453 B-Observation
- NCT03866421 454 455 I-Observation
hour NCT03866421 456 460 I-Observation
glucose NCT03866421 461 468 I-Observation
load NCT03866421 469 473 I-Observation
< NCT03866421 474 475 B-Eq_Comparison
7 NCT03866421 476 477 I-Eq_Comparison
, NCT03866421 478 479 I-Eq_Comparison
8 NCT03866421 480 481 I-Eq_Comparison
mmol NCT03866421 482 486 I-Eq_Comparison
/ NCT03866421 487 488 I-Eq_Comparison
l NCT03866421 489 490 I-Eq_Comparison
OR NCT03866421 491 493 B-Or
Normal NCT03866421 494 500 O
glucose NCT03866421 501 508 B-Condition
tolerance NCT03866421 509 518 I-Condition
: NCT03866421 519 520 O
fasting NCT03866421 521 528 B-Modifier
glucose NCT03866421 529 536 B-Observation
concentration NCT03866421 537 550 I-Observation
< NCT03866421 551 552 B-Eq_Comparison
6 NCT03866421 553 554 I-Eq_Comparison
, NCT03866421 555 556 I-Eq_Comparison
1 NCT03866421 557 558 I-Eq_Comparison
mmol NCT03866421 559 563 I-Eq_Comparison
/ NCT03866421 564 565 I-Eq_Comparison
l NCT03866421 566 567 I-Eq_Comparison
and NCT03866421 568 571 B-And
a NCT03866421 572 573 O
2 NCT03866421 574 575 B-Observation
- NCT03866421 576 577 I-Observation
hour NCT03866421 578 582 I-Observation
glucose NCT03866421 583 590 I-Observation
load NCT03866421 591 595 I-Observation
< NCT03866421 596 597 B-Eq_Comparison
7 NCT03866421 598 599 I-Eq_Comparison
, NCT03866421 600 601 I-Eq_Comparison
8 NCT03866421 602 603 I-Eq_Comparison
mmol NCT03866421 604 608 I-Eq_Comparison
/ NCT03866421 609 610 I-Eq_Comparison
l NCT03866421 611 612 I-Eq_Comparison
. NCT03866421 613 614 O

Inclusion NCT03866421 616 625 O
criteria NCT03866421 626 634 O
( NCT03866421 635 636 O
control NCT03866421 637 644 O
group NCT03866421 645 650 O
) NCT03866421 651 652 O
: NCT03866421 653 654 O

- NCT03866421 658 659 O
Normal NCT03866421 661 667 O
kidney NCT03866421 668 674 B-Condition
function NCT03866421 675 683 I-Condition

- NCT03866421 686 687 O
Normal NCT03866421 689 695 O
glucose NCT03866421 696 703 B-Condition
tolerance NCT03866421 704 713 I-Condition

Exclusion NCT03866421 714 723 O
Criteria NCT03866421 724 732 O
: NCT03866421 733 734 O

- NCT03866421 738 739 O
End NCT03866421 741 744 B-Modifier
stage NCT03866421 745 750 I-Modifier
liver NCT03866421 751 756 B-Condition
disease NCT03866421 757 764 I-Condition
as NCT03866421 765 767 O
diagnosed NCT03866421 768 777 O
by NCT03866421 778 780 O
MELD NCT03866421 781 785 O
( NCT03866421 786 787 O
model NCT03866421 788 793 O
for NCT03866421 794 797 O
end NCT03866421 798 801 O
stage NCT03866421 802 807 O
liver NCT03866421 808 813 O
disease NCT03866421 814 821 O
) NCT03866421 822 823 O
criteria NCT03866421 824 832 O
OR NCT03866421 833 835 B-Or

- NCT03866421 838 839 O
At NCT03866421 841 843 O
the NCT03866421 844 847 O
waiting NCT03866421 848 855 B-Assertion___Assertion_Type_Value:hypothetical
list NCT03866421 856 860 I-Assertion___Assertion_Type_Value:hypothetical
for NCT03866421 861 864 O
liver NCT03866421 865 870 B-Procedure
transplantation NCT03866421 871 886 I-Procedure
OR NCT03866421 887 889 B-Or

- NCT03866421 892 893 O
Daily NCT03866421 895 900 B-Eq_Comparison
alcohol NCT03866421 901 908 B-Observation
intake NCT03866421 909 915 I-Observation
above NCT03866421 916 921 B-Eq_Comparison
20 NCT03866421 922 924 I-Eq_Comparison
g NCT03866421 925 926 I-Eq_Comparison
and NCT03866421 927 930 B-And
30 NCT03866421 931 933 B-Eq_Comparison
g NCT03866421 934 935 I-Eq_Comparison
for NCT03866421 936 939 O
women NCT03866421 940 945 O
and NCT03866421 946 949 B-Or
men NCT03866421 950 953 O
respectively NCT03866421 954 966 O
OR NCT03866421 967 969 B-Or

- NCT03866421 972 973 O
Known NCT03866421 975 980 O
hepatitis NCT03866421 981 990 B-Condition
A NCT03866421 991 992 B-Modifier
, NCT03866421 993 994 O
B NCT03866421 995 996 B-Modifier
or NCT03866421 997 999 B-Or
C NCT03866421 1000 1001 B-Modifier
or NCT03866421 1002 1004 B-Or
hepatocellular NCT03866421 1005 1019 B-Modifier
carcinoma NCT03866421 1020 1029 B-Condition
or NCT03866421 1030 1032 B-Or
other NCT03866421 1033 1038 B-Other
known NCT03866421 1039 1044 O
liver NCT03866421 1045 1050 B-Condition
disease NCT03866421 1051 1058 I-Condition
OR NCT03866421 1059 1061 B-Or

- NCT03866421 1064 1065 O
Pregnancy NCT03866421 1067 1076 B-Condition
OR NCT03866421 1077 1079 B-Or

- NCT03866421 1082 1083 O
Weight NCT03866421 1085 1091 B-Observation
> NCT03866421 1092 1093 B-Eq_Comparison
130 NCT03866421 1094 1097 I-Eq_Comparison
kg NCT03866421 1098 1100 I-Eq_Comparison
OR NCT03866421 1101 1103 B-Or

- NCT03866421 1106 1107 O
Implanted NCT03866421 1109 1118 B-Procedure
pacemaker NCT03866421 1119 1128 I-Procedure

Inclusion NCT03921567 0 9 O
Criteria NCT03921567 10 18 O
: NCT03921567 19 20 O

- NCT03921567 24 25 O
Age NCT03921567 27 30 B-Age
of NCT03921567 31 33 O
both NCT03921567 34 38 O
genders NCT03921567 39 46 O
from NCT03921567 47 51 O
18 NCT03921567 52 54 B-Eq_Comparison
to NCT03921567 55 57 I-Eq_Comparison
75 NCT03921567 58 60 I-Eq_Comparison
years NCT03921567 61 66 I-Eq_Comparison

- NCT03921567 69 70 O
ASA NCT03921567 72 75 B-Observation
physiological NCT03921567 76 89 O
status NCT03921567 90 96 O
I NCT03921567 97 98 B-Eq_Comparison
- NCT03921567 99 100 I-Eq_Comparison
III NCT03921567 101 104 I-Eq_Comparison

- NCT03921567 107 108 O
Participation NCT03921567 110 123 O
in NCT03921567 124 126 O
abdominal NCT03921567 127 136 B-Modifier
, NCT03921567 137 138 O
orthopedic NCT03921567 139 149 B-Modifier
, NCT03921567 150 151 O
laparoscopical NCT03921567 152 166 B-Modifier
, NCT03921567 167 168 O
gynecological NCT03921567 169 182 B-Modifier
and NCT03921567 183 186 B-Or
urological NCT03921567 187 197 B-Modifier
interventions NCT03921567 198 211 B-Study
. NCT03921567 212 213 O

Exclusion NCT03921567 215 224 O
Criteria NCT03921567 225 233 O
: NCT03921567 234 235 O

- NCT03921567 239 240 O
Patient NCT03921567 242 249 O
rejection NCT03921567 250 259 O

- NCT03921567 262 263 O
History NCT03921567 265 272 B-Eq_Comparison
of NCT03921567 273 275 O
chronic NCT03921567 276 283 O
opioid NCT03921567 284 290 B-Drug
intake NCT03921567 291 297 O

- NCT03921567 300 301 O
History NCT03921567 303 310 B-Eq_Comparison
of NCT03921567 311 313 O
renal NCT03921567 314 319 B-Modifier
, NCT03921567 320 321 O
hepatic NCT03921567 322 329 B-Modifier
or NCT03921567 330 332 B-Or
psychiatric NCT03921567 333 344 B-Modifier
disorders NCT03921567 345 354 B-Condition

- NCT03921567 357 358 O
Heart NCT03921567 360 365 B-Condition
failure NCT03921567 366 373 I-Condition
, NCT03921567 374 375 O

- NCT03921567 379 380 O
Organ NCT03921567 382 387 B-Procedure
transplant NCT03921567 388 398 I-Procedure
history NCT03921567 399 406 B-Eq_Comparison
, NCT03921567 407 408 O

- NCT03921567 412 413 O
Lidocaine NCT03921567 415 424 B-Drug
allergy NCT03921567 425 432 B-Allergy

- NCT03921567 435 436 O
Family NCT03921567 438 444 B-Family_Member
history NCT03921567 445 452 I-Family_Member
of NCT03921567 453 455 O
malignant NCT03921567 456 465 B-Condition
hyperthermia NCT03921567 466 478 I-Condition

Inclusion NCT03869723 0 9 O
Criteria NCT03869723 10 18 O
: NCT03869723 19 20 O

- NCT03869723 24 25 O
Patients NCT03869723 27 35 O
who NCT03869723 36 39 O
underwent NCT03869723 40 49 B-Eq_Comparison
fibula NCT03869723 50 56 B-Procedure
free NCT03869723 57 61 I-Procedure
flap NCT03869723 62 66 I-Procedure
for NCT03869723 67 70 O
mandibular NCT03869723 71 81 B-Procedure
reconstruction NCT03869723 82 96 I-Procedure

- NCT03869723 99 100 O
Patient NCT03869723 102 109 O
â¥ NCT03869723 110 111 B-Eq_Comparison
18 NCT03869723 112 114 I-Eq_Comparison
years NCT03869723 115 120 I-Eq_Comparison
old NCT03869723 121 124 B-Age

- NCT03869723 127 128 O
patient NCT03869723 130 137 O
alive NCT03869723 138 143 B-Death|B-Negation
6 NCT03869723 144 145 B-Eq_Comparison
months NCT03869723 146 152 I-Eq_Comparison
after NCT03869723 153 158 B-Temporal_Connection___Temporal_Connection_Type_Value:after
completion NCT03869723 159 169 O
of NCT03869723 170 172 O
treatment NCT03869723 173 182 B-Procedure

Exclusion NCT03869723 183 192 O
Criteria NCT03869723 193 201 O
: NCT03869723 202 203 O

- NCT03869723 207 208 O
Patient NCT03869723 210 217 O
without NCT03869723 218 225 B-Negation
post NCT03869723 226 230 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03869723 231 232 O
operative NCT03869723 233 242 B-Procedure
scan NCT03869723 243 247 B-Procedure
evaluation NCT03869723 248 258 I-Procedure

- NCT03869723 261 262 O
Patient NCT03869723 264 271 O
with NCT03869723 272 276 O
a NCT03869723 277 278 O
chirurgical NCT03869723 279 290 B-Procedure
contraindication NCT03869723 291 307 B-Contraindication

- NCT03869723 310 311 O
Pregnant NCT03869723 313 321 B-Condition
or NCT03869723 322 324 B-Or
nursing NCT03869723 325 332 B-Condition
woman NCT03869723 333 338 O

- NCT03869723 341 342 O
Adult NCT03869723 344 349 O
requiring NCT03869723 350 359 B-Observation
protection NCT03869723 360 370 I-Observation
( NCT03869723 371 372 O
guardianship NCT03869723 373 385 B-Observation
, NCT03869723 386 387 O
supervision NCT03869723 388 399 B-Observation
) NCT03869723 400 401 O

Inclusion NCT03924037 0 9 O
Criteria NCT03924037 10 18 O
: NCT03924037 19 20 O

- NCT03924037 24 25 O
American NCT03924037 27 35 O
Indian NCT03924037 36 42 O
youth NCT03924037 43 48 O
aged NCT03924037 49 53 B-Age
13 NCT03924037 54 56 B-Eq_Comparison
- NCT03924037 57 58 I-Eq_Comparison
24 NCT03924037 59 61 I-Eq_Comparison
years NCT03924037 62 67 I-Eq_Comparison
old NCT03924037 68 71 O
who NCT03924037 72 75 O
are NCT03924037 76 79 O
San NCT03924037 80 83 O
Felipe NCT03924037 84 90 O
tribal NCT03924037 91 97 O
members NCT03924037 98 105 O
living NCT03924037 106 112 O
in NCT03924037 113 115 O
the NCT03924037 116 119 O
Pueblo NCT03924037 120 126 O

- NCT03924037 129 130 O
Endorse NCT03924037 132 139 O
suicidal NCT03924037 140 148 B-Condition
ideation NCT03924037 149 157 B-Modifier
or NCT03924037 158 160 B-Or
behaviors NCT03924037 161 170 B-Modifier
on NCT03924037 171 173 O
a NCT03924037 174 175 O
universal NCT03924037 176 185 B-Procedure
screen NCT03924037 186 192 I-Procedure
by NCT03924037 193 195 O
their NCT03924037 196 201 O
primary NCT03924037 202 209 B-Provider
care NCT03924037 210 214 I-Provider
provider NCT03924037 215 223 I-Provider
. NCT03924037 224 225 O

Exclusion NCT03924037 227 236 O
Criteria NCT03924037 237 245 O
: NCT03924037 246 247 O

- NCT03924037 251 252 O
Younger NCT03924037 254 261 B-Eq_Comparison
than NCT03924037 262 266 I-Eq_Comparison
age NCT03924037 267 270 I-Eq_Comparison
of NCT03924037 271 273 I-Eq_Comparison
13 NCT03924037 274 276 I-Eq_Comparison
years NCT03924037 277 282 I-Eq_Comparison
old NCT03924037 283 286 O
or NCT03924037 287 289 B-Or

- NCT03924037 292 293 O
Older NCT03924037 295 300 B-Eq_Comparison
than NCT03924037 301 305 I-Eq_Comparison
the NCT03924037 306 309 I-Eq_Comparison
age NCT03924037 310 313 I-Eq_Comparison
of NCT03924037 314 316 I-Eq_Comparison
24 NCT03924037 317 319 I-Eq_Comparison
, NCT03924037 320 321 O

- NCT03924037 325 326 O
Not NCT03924037 328 331 B-Negation
American NCT03924037 332 340 O
Indian NCT03924037 341 347 O
, NCT03924037 348 349 O

- NCT03924037 353 354 O
Youth NCT03924037 356 361 O
who NCT03924037 362 365 B-And
do NCT03924037 366 368 O
not NCT03924037 369 372 B-Negation
receive NCT03924037 373 380 O
health NCT03924037 381 387 B-Encounter
services NCT03924037 388 396 I-Encounter
at NCT03924037 397 399 O
either NCT03924037 400 406 O
of NCT03924037 407 409 O
the NCT03924037 410 413 O
IHS NCT03924037 414 417 O
clinics NCT03924037 418 425 O
at NCT03924037 426 428 O
the NCT03924037 429 432 O
Pueblo NCT03924037 433 439 O
of NCT03924037 440 442 O
San NCT03924037 443 446 O
Felipe NCT03924037 447 453 O
, NCT03924037 454 455 O

- NCT03924037 459 460 O
Youth NCT03924037 462 467 O
who NCT03924037 468 471 B-And
screen NCT03924037 472 478 O
negative NCT03924037 479 487 O
for NCT03924037 488 491 O
suicidal NCT03924037 492 500 B-Condition
ideation NCT03924037 501 509 B-Modifier
and NCT03924037 510 513 B-Or
/ NCT03924037 514 515 I-Or
or NCT03924037 516 518 I-Or
behavior NCT03924037 519 527 B-Modifier
, NCT03924037 528 529 O

- NCT03924037 533 534 O
Refuse NCT03924037 536 542 O
to NCT03924037 543 545 O
participate NCT03924037 546 557 O
in NCT03924037 558 560 O
the NCT03924037 561 564 O
study NCT03924037 565 570 O
, NCT03924037 571 572 O
and NCT03924037 573 576 O
/ NCT03924037 577 578 O
or NCT03924037 579 581 O

- NCT03924037 584 585 O
Cognitively NCT03924037 587 598 B-Condition
unable NCT03924037 599 605 I-Condition
to NCT03924037 606 608 O
provide NCT03924037 609 616 O
informed NCT03924037 617 625 O
consent NCT03924037 626 633 O
as NCT03924037 634 636 O
demonstrated NCT03924037 637 649 O
by NCT03924037 650 652 O
a NCT03924037 653 654 O
brief NCT03924037 655 660 O
cognitive NCT03924037 661 670 B-Procedure
screen NCT03924037 671 677 I-Procedure
prior NCT03924037 678 683 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924037 684 686 O
completion NCT03924037 687 697 O
of NCT03924037 698 700 O
the NCT03924037 701 704 O
baseline NCT03924037 705 713 B-Study
interview NCT03924037 714 723 O
. NCT03924037 724 725 O

Inclusion NCT03861520 0 9 O
Criteria NCT03861520 10 18 O
: NCT03861520 19 20 O

1 NCT03861520 24 25 O
. NCT03861520 25 26 O
pregnant NCT03861520 28 36 B-Condition
woman NCT03861520 37 42 O
between NCT03861520 43 50 B-Eq_Comparison
( NCT03861520 51 52 I-Eq_Comparison
16 NCT03861520 53 55 I-Eq_Comparison
- NCT03861520 56 57 I-Eq_Comparison
24 NCT03861520 58 60 I-Eq_Comparison
) NCT03861520 61 62 I-Eq_Comparison
weeks NCT03861520 63 68 I-Eq_Comparison
of NCT03861520 69 71 O
gestation NCT03861520 72 81 B-Observation
. NCT03861520 82 83 O

2 NCT03861520 87 88 O
. NCT03861520 88 89 O
singelton NCT03861520 91 100 B-Modifier
pregnancy NCT03861520 101 110 B-Condition
. NCT03861520 111 112 O

Exclusion NCT03861520 114 123 O
Criteria NCT03861520 124 132 O
: NCT03861520 133 134 O

1 NCT03861520 138 139 O
. NCT03861520 139 140 O
Multiple NCT03861520 142 150 B-Eq_Comparison
pregnancies NCT03861520 151 162 B-Condition
. NCT03861520 163 164 O

2 NCT03861520 168 169 O
. NCT03861520 169 170 O
Mental NCT03861520 172 178 B-Condition
condition NCT03861520 179 188 I-Condition
rendering NCT03861520 189 198 O
the NCT03861520 199 202 O
patients NCT03861520 203 211 O
unable NCT03861520 212 218 B-Condition
to NCT03861520 219 221 I-Condition
understand NCT03861520 222 232 I-Condition
the NCT03861520 233 236 O
nature NCT03861520 237 243 O
and NCT03861520 244 247 O
scope NCT03861520 248 253 O
of NCT03861520 254 256 O
the NCT03861520 257 260 O
study NCT03861520 261 266 B-Study
. NCT03861520 267 268 O

Inclusion NCT03865368 0 9 O
Criteria NCT03865368 10 18 O
: NCT03865368 19 20 O

- NCT03865368 24 25 O
Individuals NCT03865368 27 38 O
between NCT03865368 39 46 B-Eq_Comparison
age NCT03865368 47 50 I-Eq_Comparison
18 NCT03865368 51 53 I-Eq_Comparison
- NCT03865368 54 55 I-Eq_Comparison
65 NCT03865368 56 58 I-Eq_Comparison
with NCT03865368 59 63 B-And
Body NCT03865368 64 68 B-Observation
Mass NCT03865368 69 73 I-Observation
Index NCT03865368 74 79 I-Observation
( NCT03865368 80 81 O
BMI NCT03865368 82 85 B-Observation
) NCT03865368 86 87 O
of NCT03865368 88 90 O
> NCT03865368 91 92 B-Eq_Comparison
29.9 NCT03865368 93 97 I-Eq_Comparison
kg NCT03865368 98 100 I-Eq_Comparison
/ NCT03865368 101 102 I-Eq_Comparison
m NCT03865368 103 104 I-Eq_Comparison
2 NCT03865368 105 106 I-Eq_Comparison

Exclusion NCT03865368 107 116 O
Criteria NCT03865368 117 125 O
: NCT03865368 126 127 O

- NCT03865368 131 132 O
Unstable NCT03865368 134 142 O
hypertensive NCT03865368 143 155 B-Condition
patients NCT03865368 156 164 O

- NCT03865368 167 168 O
History NCT03865368 170 177 B-Eq_Comparison
of NCT03865368 178 180 O
cardiovascular NCT03865368 181 195 B-Modifier
, NCT03865368 196 197 O
neurologic NCT03865368 198 208 B-Modifier
, NCT03865368 209 210 O
or NCT03865368 211 213 B-Or
orthopedic NCT03865368 214 224 B-Modifier
diseases NCT03865368 225 233 B-Condition
, NCT03865368 234 235 O

- NCT03865368 239 240 O
Presence NCT03865368 242 250 O
of NCT03865368 251 253 O
knee NCT03865368 254 258 B-Procedure
prosthesis NCT03865368 259 269 I-Procedure
, NCT03865368 270 271 O
hip NCT03865368 272 275 B-Procedure
replacement NCT03865368 276 287 I-Procedure

- NCT03865368 290 291 O
Chronic NCT03865368 293 300 O
inflammatory NCT03865368 301 313 B-Condition
disease NCT03865368 314 321 I-Condition
, NCT03865368 322 323 O

- NCT03865368 327 328 O
Anti NCT03865368 330 334 B-Procedure
- NCT03865368 335 336 I-Procedure
inflammatory NCT03865368 337 349 I-Procedure
treatment NCT03865368 350 359 I-Procedure

- NCT03865368 362 363 O
Cognitive NCT03865368 365 374 B-Condition
impairments NCT03865368 375 386 I-Condition

- NCT03865368 389 390 O
Pregnancy NCT03865368 392 401 B-Condition
. NCT03865368 402 403 O

Inclusion NCT03920046 0 9 O
Criteria NCT03920046 10 18 O
: NCT03920046 19 20 O

- NCT03920046 24 25 O
ASA NCT03920046 27 30 B-Observation
( NCT03920046 31 32 O
American NCT03920046 33 41 B-Observation
Society NCT03920046 42 49 I-Observation
of NCT03920046 50 52 I-Observation
Anesthesiologists NCT03920046 53 70 I-Observation
) NCT03920046 71 72 O
I NCT03920046 73 74 B-Eq_Comparison
- NCT03920046 75 76 I-Eq_Comparison
ASA NCT03920046 77 80 I-Eq_Comparison
II NCT03920046 81 83 I-Eq_Comparison
patients NCT03920046 84 92 O

- NCT03920046 95 96 O
Aged NCT03920046 98 102 B-Age
1 NCT03920046 103 104 B-Eq_Comparison
- NCT03920046 105 106 I-Eq_Comparison
18 NCT03920046 107 109 I-Eq_Comparison
Year NCT03920046 110 114 I-Eq_Comparison
old NCT03920046 115 118 O
patients NCT03920046 119 127 O

Exclusion NCT03920046 128 137 O
Criteria NCT03920046 138 146 O
: NCT03920046 147 148 O

- NCT03920046 152 153 O
Smoker NCT03920046 155 161 B-Condition
patients NCT03920046 162 170 O

Inclusion NCT03860662 0 9 O
Criteria NCT03860662 10 18 O
: NCT03860662 19 20 O

- NCT03860662 24 25 O
Being NCT03860662 27 32 O
between NCT03860662 33 40 B-Eq_Comparison
the NCT03860662 41 44 I-Eq_Comparison
ages NCT03860662 45 49 I-Eq_Comparison
of NCT03860662 50 52 I-Eq_Comparison
18 NCT03860662 53 55 I-Eq_Comparison
- NCT03860662 56 57 I-Eq_Comparison
60 NCT03860662 58 60 I-Eq_Comparison

- NCT03860662 64 65 O
To NCT03860662 67 69 O
accept NCT03860662 70 76 O
voluntary NCT03860662 77 86 O
participation NCT03860662 87 100 O
in NCT03860662 101 103 O
the NCT03860662 104 107 O
study NCT03860662 108 113 O

- NCT03860662 116 117 O
Spastic NCT03860662 119 126 B-Condition
Hemiplegia NCT03860662 127 137 I-Condition
( NCT03860662 138 139 O
Modified NCT03860662 140 148 B-Observation
Ashworth NCT03860662 149 157 I-Observation
Scale NCT03860662 158 163 I-Observation
2 NCT03860662 164 165 B-Eq_Comparison
and NCT03860662 166 169 I-Eq_Comparison
above NCT03860662 170 175 I-Eq_Comparison
) NCT03860662 176 177 O

Exclusion NCT03860662 179 188 O
Criteria NCT03860662 189 197 O
: NCT03860662 198 199 O

- NCT03860662 203 204 O
Pregnant NCT03860662 206 214 B-Condition
women NCT03860662 215 220 O
, NCT03860662 221 222 O
breastfeeding NCT03860662 223 236 B-Condition
and NCT03860662 237 240 B-And
younger NCT03860662 241 248 B-Eq_Comparison
than NCT03860662 249 253 I-Eq_Comparison
18 NCT03860662 254 256 I-Eq_Comparison
years NCT03860662 257 262 I-Eq_Comparison

- NCT03860662 265 266 O
To NCT03860662 268 270 O
have NCT03860662 271 275 O
medication NCT03860662 276 286 B-Drug
and NCT03860662 287 290 B-Or
substance NCT03860662 291 300 B-Condition
use NCT03860662 301 304 I-Condition
causing NCT03860662 305 312 O
neuropathy NCT03860662 313 323 B-Condition
in NCT03860662 324 326 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860662 327 330 O
history NCT03860662 331 338 B-Eq_Comparison
of NCT03860662 339 341 O
the NCT03860662 342 345 O
disease NCT03860662 346 353 B-Condition
and NCT03860662 354 357 B-Or
/ NCT03860662 358 359 I-Or
or NCT03860662 360 362 I-Or
neuropathy NCT03860662 363 373 B-Condition

- NCT03860662 376 377 O
Companies NCT03860662 379 388 O
that NCT03860662 389 393 O
have NCT03860662 394 398 O
received NCT03860662 399 407 B-Eq_Comparison
botulinum NCT03860662 408 417 B-Procedure
toxin NCT03860662 418 423 I-Procedure
injection NCT03860662 424 433 I-Procedure
therapy NCT03860662 434 441 I-Procedure
and NCT03860662 442 445 B-Or
/ NCT03860662 446 447 I-Or
or NCT03860662 448 450 I-Or
oral NCT03860662 451 455 B-Modifier
antispastic NCT03860662 456 467 B-Procedure
therapy NCT03860662 468 475 I-Procedure
within NCT03860662 476 482 B-Eq_Comparison
the NCT03860662 483 486 I-Eq_Comparison
last NCT03860662 487 491 I-Eq_Comparison
6 NCT03860662 492 493 I-Eq_Comparison
months NCT03860662 494 500 I-Eq_Comparison

- NCT03860662 503 504 O
Have NCT03860662 506 510 O
a NCT03860662 511 512 O
history NCT03860662 513 520 B-Eq_Comparison
of NCT03860662 521 523 O
allergies NCT03860662 524 533 B-Allergy
and NCT03860662 534 537 B-Or
hypersensitivity NCT03860662 538 554 B-Condition
to NCT03860662 555 557 O
usability NCT03860662 558 567 B-Modifier
drug NCT03860662 568 572 B-Drug

- NCT03860662 575 576 O
Injection NCT03860662 578 587 B-Procedure
treatment NCT03860662 588 597 I-Procedure
planned NCT03860662 598 605 B-Eq_Comparison
purification NCT03860662 606 618 B-Procedure
hematoma NCT03860662 619 627 I-Procedure
, NCT03860662 628 629 O
cleaning NCT03860662 630 638 B-Modifier
or NCT03860662 639 641 B-Or
skin NCT03860662 642 646 B-Modifier
lesion NCT03860662 647 653 B-Condition
to NCT03860662 654 656 O
be NCT03860662 657 659 O

Inclusion NCT03929406 0 9 O
Criteria NCT03929406 10 18 O
: NCT03929406 19 20 O

- NCT03929406 24 25 O
Eligible NCT03929406 27 35 B-Assertion___Assertion_Type_Value:hypothetical
patients NCT03929406 36 44 O
for NCT03929406 45 48 O
deep NCT03929406 49 53 B-Procedure
brain NCT03929406 54 59 I-Procedure
stimulation NCT03929406 60 71 I-Procedure
surgery NCT03929406 72 79 I-Procedure

- NCT03929406 82 83 O
Patients NCT03929406 85 93 O
affiliated NCT03929406 94 104 O
to NCT03929406 105 107 O
social NCT03929406 108 114 O
security NCT03929406 115 123 O
or NCT03929406 124 126 O
benefiting NCT03929406 127 137 O
of NCT03929406 138 140 O
a NCT03929406 141 142 O
similar NCT03929406 143 150 O
insurance NCT03929406 151 160 O
scheme NCT03929406 161 167 O

- NCT03929406 170 171 O
Patients NCT03929406 173 181 O
having NCT03929406 182 188 O
signed NCT03929406 189 195 O
a NCT03929406 196 197 O
consent NCT03929406 198 205 O
to NCT03929406 206 208 O
participate NCT03929406 209 220 O
to NCT03929406 221 223 O
the NCT03929406 224 227 O
study NCT03929406 228 233 O

Exclusion NCT03929406 234 243 O
Criteria NCT03929406 244 252 O
: NCT03929406 253 254 O

- NCT03929406 258 259 O
Patient NCT03929406 261 268 O
not NCT03929406 269 272 B-Negation
eligible NCT03929406 273 281 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03929406 282 285 O
deep NCT03929406 286 290 B-Procedure
brain NCT03929406 291 296 I-Procedure
stimulation NCT03929406 297 308 I-Procedure
surgery NCT03929406 309 316 I-Procedure

- NCT03929406 319 320 O
Pregnant NCT03929406 322 330 B-Condition
women NCT03929406 331 336 O
or NCT03929406 337 339 B-Or
nursing NCT03929406 340 347 B-Condition
mothers NCT03929406 348 355 O

- NCT03929406 358 359 O
Persons NCT03929406 361 368 O
deprived NCT03929406 369 377 B-Observation
of NCT03929406 378 380 I-Observation
liberty NCT03929406 381 388 I-Observation
by NCT03929406 389 391 O
judicial NCT03929406 392 400 O
or NCT03929406 401 403 O
administrative NCT03929406 404 418 O
decision NCT03929406 419 427 O

- NCT03929406 430 431 O
Persons NCT03929406 433 440 O
unable NCT03929406 441 447 O
to NCT03929406 448 450 O
express NCT03929406 451 458 O
their NCT03929406 459 464 O
consent NCT03929406 465 472 O
or NCT03929406 473 475 O
legally NCT03929406 476 483 B-Observation
protected NCT03929406 484 493 I-Observation

- NCT03929406 496 497 O
Persons NCT03929406 499 506 O
in NCT03929406 507 509 O
period NCT03929406 510 516 O
of NCT03929406 517 519 O
disqualification NCT03929406 520 536 O
for NCT03929406 537 540 O
another NCT03929406 541 548 B-Other
interventional NCT03929406 549 563 B-Study
research NCT03929406 564 572 O

Inclusion NCT03861689 0 9 O
Criteria NCT03861689 10 18 O
: NCT03861689 19 20 O

- NCT03861689 24 25 O
Age NCT03861689 27 30 B-Age
â¥ NCT03861689 31 32 B-Eq_Comparison
18 NCT03861689 33 35 I-Eq_Comparison
years NCT03861689 36 41 I-Eq_Comparison
old NCT03861689 42 45 O

- NCT03861689 48 49 O
Confirmed NCT03861689 51 60 O
diagnosis NCT03861689 61 70 O
of NCT03861689 71 73 O
perianal NCT03861689 74 82 B-Modifier
Crohn NCT03861689 83 88 B-Condition
's NCT03861689 88 90 I-Condition
disease NCT03861689 91 98 I-Condition

- NCT03861689 101 102 O
On NCT03861689 104 106 B-Eq_Comparison
biologics NCT03861689 107 116 B-Drug
or NCT03861689 117 119 B-Or
will NCT03861689 120 124 B-Eq_Comparison
start NCT03861689 125 130 I-Eq_Comparison
biologics NCT03861689 131 140 B-Drug

Exclusion NCT03861689 141 150 O
Criteria NCT03861689 151 159 O
: NCT03861689 160 161 O

- NCT03861689 165 166 O
Patients NCT03861689 168 176 O
who NCT03861689 177 180 O
have NCT03861689 181 185 O
perianal NCT03861689 186 194 B-Condition
fistula NCT03861689 195 202 I-Condition
due NCT03861689 203 206 O
to NCT03861689 207 209 O
causes NCT03861689 210 216 B-Condition
other NCT03861689 217 222 B-Exception
than NCT03861689 223 227 I-Exception
Crohn NCT03861689 228 233 B-Condition
's NCT03861689 233 235 I-Condition
disease NCT03861689 236 243 I-Condition

- NCT03861689 246 247 O
Fistulation NCT03861689 249 260 B-Condition
into NCT03861689 261 265 O
other NCT03861689 266 271 B-Other
organs NCT03861689 272 278 B-Modifier
, NCT03861689 279 280 O
including NCT03861689 281 290 O
bladder NCT03861689 291 298 B-Modifier
and NCT03861689 299 302 B-Or
intestine NCT03861689 303 312 B-Modifier

- NCT03861689 315 316 O
Patients NCT03861689 318 326 O
who NCT03861689 327 330 O
have NCT03861689 331 335 O
allergic NCT03861689 336 344 B-Allergy
reaction NCT03861689 345 353 B-Modifier
/ NCT03861689 354 355 B-Or
contraindications NCT03861689 356 373 B-Contraindication
to NCT03861689 374 376 O
anti NCT03861689 377 381 B-Drug
- NCT03861689 382 383 I-Drug
TNF NCT03861689 384 387 I-Drug

- NCT03861689 390 391 O
Patients NCT03861689 393 401 O
who NCT03861689 402 405 O
have NCT03861689 406 410 O
active NCT03861689 411 417 B-Eq_Comparison
cancer NCT03861689 418 424 B-Condition

- NCT03861689 427 428 O
Patients NCT03861689 430 438 O
who NCT03861689 439 442 O
have NCT03861689 443 447 O
contraindications NCT03861689 448 465 B-Contraindication
for NCT03861689 466 469 O
MRI NCT03861689 470 473 B-Procedure

- NCT03861689 476 477 O
Known NCT03861689 479 484 O
pregnancy NCT03861689 485 494 B-Condition

For NCT03861689 495 498 O
patients NCT03861689 499 507 O
who NCT03861689 508 511 O
refuse NCT03861689 512 518 O
to NCT03861689 519 521 O
participate NCT03861689 522 533 O
in NCT03861689 534 536 O
the NCT03861689 537 540 O
tight NCT03861689 541 546 O
monitoring NCT03861689 547 557 O
arm NCT03861689 558 561 O
, NCT03861689 562 563 O
they NCT03861689 564 568 O
will NCT03861689 569 573 O
be NCT03861689 574 576 O
consented NCT03861689 577 586 O
and NCT03861689 587 590 O
recruited NCT03861689 591 600 O
to NCT03861689 601 603 O
the NCT03861689 604 607 O
control NCT03861689 608 615 B-Procedure
arm NCT03861689 616 619 I-Procedure
for NCT03861689 620 623 O
comparison NCT03861689 624 634 O
. NCT03861689 635 636 O


Inclusion NCT03927326 0 9 O
Criteria NCT03927326 10 18 O
: NCT03927326 19 20 O

- NCT03927326 24 25 O
Patients NCT03927326 27 35 O
scheduled NCT03927326 36 45 B-Eq_Comparison
for NCT03927326 46 49 O
elective NCT03927326 50 58 O
laparoscopic NCT03927326 59 71 B-Procedure
colorectal NCT03927326 72 82 I-Procedure
surgery NCT03927326 83 90 I-Procedure
at NCT03927326 91 93 O
UWMC NCT03927326 94 98 O
requiring NCT03927326 99 108 B-Assertion___Assertion_Type_Value:hypothetical
inpatient NCT03927326 109 118 B-Encounter
stay NCT03927326 119 123 I-Encounter

Exclusion NCT03927326 124 133 O
Criteria NCT03927326 134 142 O
: NCT03927326 143 144 O

- NCT03927326 148 149 O
Patients NCT03927326 151 159 O
on NCT03927326 160 162 B-Eq_Comparison
chronic NCT03927326 163 170 O
pain NCT03927326 171 175 B-Condition
mediations NCT03927326 176 186 B-Drug
equaling NCT03927326 187 195 B-Eq_Comparison
or NCT03927326 196 198 I-Eq_Comparison
exceeding NCT03927326 199 208 I-Eq_Comparison
> NCT03927326 209 210 I-Eq_Comparison
25 NCT03927326 211 213 I-Eq_Comparison
morphine NCT03927326 214 222 I-Eq_Comparison
daily NCT03927326 223 228 I-Eq_Comparison
equivalents NCT03927326 229 240 I-Eq_Comparison

- NCT03927326 243 244 O
Patients NCT03927326 246 254 O
allergic NCT03927326 255 263 B-Allergy
to NCT03927326 264 266 O
bupivacaine NCT03927326 267 278 B-Drug

- NCT03927326 281 282 O
Patients NCT03927326 284 292 O
with NCT03927326 293 297 O
ASA NCT03927326 298 301 B-Observation
status NCT03927326 302 308 O
IV NCT03927326 309 311 B-Eq_Comparison
, NCT03927326 312 313 I-Eq_Comparison
V NCT03927326 314 315 I-Eq_Comparison
, NCT03927326 316 317 I-Eq_Comparison
or NCT03927326 318 320 I-Eq_Comparison
VI NCT03927326 321 323 I-Eq_Comparison

- NCT03927326 326 327 O
Patients NCT03927326 329 337 O
unable NCT03927326 338 344 O
to NCT03927326 345 347 O
consent NCT03927326 348 355 O

- NCT03927326 358 359 O
Patients NCT03927326 361 369 O
that NCT03927326 370 374 O
are NCT03927326 375 378 O
pregnant NCT03927326 379 387 B-Condition

- NCT03927326 390 391 O
Patients NCT03927326 393 401 O
that NCT03927326 402 406 O
are NCT03927326 407 410 O
incarcerated NCT03927326 411 423 B-Observation

- NCT03927326 426 427 O
Patients NCT03927326 429 437 O
receiving NCT03927326 438 447 B-Eq_Comparison
procedures NCT03927326 448 458 B-Procedure
in NCT03927326 459 461 B-Exception
addition NCT03927326 462 470 I-Exception
to NCT03927326 471 473 I-Exception
laparoscopic NCT03927326 474 486 B-Procedure
colorectal NCT03927326 487 497 I-Procedure
procedure NCT03927326 498 507 I-Procedure

- NCT03927326 510 511 O
Patients NCT03927326 513 521 O
on NCT03927326 522 524 B-Eq_Comparison
systemic NCT03927326 525 533 B-Modifier
anticoagulation NCT03927326 534 549 B-Procedure
precluding NCT03927326 550 560 B-Negation
them NCT03927326 561 565 O
from NCT03927326 566 570 O
regional NCT03927326 571 579 B-Procedure
blocks NCT03927326 580 586 I-Procedure

Inclusion NCT03926559 0 9 O
Criteria NCT03926559 10 18 O
: NCT03926559 19 20 O

- NCT03926559 24 25 O
Patients NCT03926559 27 35 O
with NCT03926559 36 40 O
a NCT03926559 41 42 O
second NCT03926559 43 49 B-Modifier
degree NCT03926559 50 56 I-Modifier
, NCT03926559 57 58 O
third NCT03926559 59 64 B-Modifier
degree NCT03926559 65 71 I-Modifier
, NCT03926559 72 73 O
or NCT03926559 74 76 B-Or
fourth NCT03926559 77 83 B-Modifier
degree NCT03926559 84 90 I-Modifier
perineal NCT03926559 91 99 B-Condition
tear NCT03926559 100 104 I-Condition
identified NCT03926559 105 115 O
in NCT03926559 116 118 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03926559 119 122 O
immediate NCT03926559 123 132 O
postpartum NCT03926559 133 143 B-Condition
period NCT03926559 144 150 O
. NCT03926559 151 152 O

- NCT03926559 156 157 O
Pregnant NCT03926559 159 167 B-Condition
patients NCT03926559 168 176 O
who NCT03926559 177 180 B-And
received NCT03926559 181 189 B-Eq_Comparison
neuraxial NCT03926559 190 199 B-Procedure
anesthesia NCT03926559 200 210 I-Procedure
during NCT03926559 211 217 B-Temporal_Connection___Temporal_Connection_Type_Value:during
their NCT03926559 218 223 O
labor NCT03926559 224 229 B-Condition
course NCT03926559 230 236 O

- NCT03926559 239 240 O
Women NCT03926559 242 247 O
> NCT03926559 248 249 B-Eq_Comparison
18 NCT03926559 250 252 I-Eq_Comparison
yo NCT03926559 253 255 B-Age

Exclusion NCT03926559 256 265 O
Criteria NCT03926559 266 274 O
: NCT03926559 275 276 O

- NCT03926559 280 281 O
Unwillingness NCT03926559 283 296 O
to NCT03926559 297 299 O
participate NCT03926559 300 311 O
in NCT03926559 312 314 O
the NCT03926559 315 318 O
study NCT03926559 319 324 B-Study

- NCT03926559 327 328 O
Allergy NCT03926559 330 337 B-Allergy
to NCT03926559 338 340 O
morphine NCT03926559 341 349 B-Drug

- NCT03926559 352 353 O
Women NCT03926559 355 360 O
with NCT03926559 361 365 B-And
history NCT03926559 366 373 B-Eq_Comparison
of NCT03926559 374 376 O
polysubstance NCT03926559 377 390 B-Condition
abuse NCT03926559 391 396 I-Condition
/ NCT03926559 397 398 B-Or
narcotic NCT03926559 399 407 B-Condition
abuse NCT03926559 408 413 I-Condition

- NCT03926559 416 417 O
Women NCT03926559 419 424 O
< NCT03926559 425 426 B-Eq_Comparison
18 NCT03926559 427 429 I-Eq_Comparison
yo NCT03926559 430 432 B-Age

Inclusion NCT03922191 0 9 O
Criteria NCT03922191 10 18 O
: NCT03922191 19 20 O

- NCT03922191 24 25 O
post NCT03922191 27 31 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03922191 32 33 O
cardiac NCT03922191 34 41 B-Procedure
surgery NCT03922191 42 49 I-Procedure
mediastinitis NCT03922191 50 63 B-Condition

- NCT03922191 66 67 O
patients NCT03922191 69 77 O
of NCT03922191 78 80 O
the NCT03922191 81 84 O
CHU NCT03922191 85 88 O
Brugmann NCT03922191 89 97 O
( NCT03922191 98 99 O
adults NCT03922191 100 106 O
) NCT03922191 107 108 O
and NCT03922191 109 112 O
HUDERF NCT03922191 113 119 O
( NCT03922191 120 121 O
pediatric NCT03922191 122 131 O
) NCT03922191 132 133 O
Hospitals NCT03922191 134 143 O

Exclusion NCT03922191 144 153 O
Criteria NCT03922191 154 162 O
: NCT03922191 163 164 O

- NCT03922191 167 168 O
none NCT03922191 169 173 O

Inclusion NCT03920397 0 9 O
Criteria NCT03920397 10 18 O
: NCT03920397 19 20 O

- NCT03920397 24 25 O
Diagnosis NCT03920397 27 36 O
of NCT03920397 37 39 O
Type NCT03920397 40 44 B-Modifier
1 NCT03920397 45 46 I-Modifier
Diabetes NCT03920397 47 55 B-Condition
according NCT03920397 56 65 O
to NCT03920397 66 68 O
the NCT03920397 69 72 O
American NCT03920397 73 81 O
Diabetes NCT03920397 82 90 O
Association NCT03920397 91 102 O
criteria NCT03920397 103 111 O
for NCT03920397 112 115 O
a NCT03920397 116 117 O
period NCT03920397 118 124 O
less NCT03920397 125 129 B-Eq_Comparison
than NCT03920397 130 134 I-Eq_Comparison
four NCT03920397 135 139 I-Eq_Comparison
months NCT03920397 140 146 I-Eq_Comparison
. NCT03920397 147 148 O

- NCT03920397 152 153 O
Pancreatic NCT03920397 155 165 B-Condition
Autoimmunity NCT03920397 166 178 I-Condition
( NCT03920397 179 180 O
positive NCT03920397 181 189 O
anti NCT03920397 190 194 B-Condition
- NCT03920397 195 196 I-Condition
glutamic NCT03920397 197 205 I-Condition
acid NCT03920397 206 210 I-Condition
decarboxylase NCT03920397 211 224 I-Condition
[ NCT03920397 225 226 O
GAD NCT03920397 227 230 B-Condition
] NCT03920397 231 232 O
; NCT03920397 233 234 O
and NCT03920397 235 238 B-Or
/ NCT03920397 239 240 I-Or
or NCT03920397 241 243 I-Or
Islet NCT03920397 244 249 B-Condition
antigen NCT03920397 250 257 I-Condition
2 NCT03920397 258 259 I-Condition
[ NCT03920397 260 261 O
anti NCT03920397 262 266 B-Condition
- NCT03920397 267 268 I-Condition
IA NCT03920397 269 271 I-Condition
2 NCT03920397 272 273 I-Condition
] NCT03920397 274 275 O
) NCT03920397 276 277 O
. NCT03920397 278 279 O

Exclusion NCT03920397 281 290 O
Criteria NCT03920397 291 299 O
: NCT03920397 300 301 O

- NCT03920397 305 306 O
Clinical NCT03920397 308 316 O
evidence NCT03920397 317 325 O
of NCT03920397 326 328 O
malignancy NCT03920397 329 339 B-Condition
or NCT03920397 340 342 O
prior NCT03920397 343 348 B-Eq_Comparison
history NCT03920397 349 356 I-Eq_Comparison
. NCT03920397 357 358 O

- NCT03920397 362 363 O
Pregnancy NCT03920397 365 374 B-Condition
or NCT03920397 375 377 B-Or
desire NCT03920397 378 384 B-Assertion___Assertion_Type_Value:intention
to NCT03920397 385 387 I-Assertion___Assertion_Type_Value:intention
become NCT03920397 388 394 O
pregnant NCT03920397 395 403 B-Condition
within NCT03920397 404 410 B-Eq_Comparison
12 NCT03920397 411 413 I-Eq_Comparison
months NCT03920397 414 420 I-Eq_Comparison
of NCT03920397 421 423 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03920397 424 427 O
study NCT03920397 428 433 B-Study
. NCT03920397 434 435 O

- NCT03920397 439 440 O
Breastfeeding NCT03920397 442 455 B-Condition
. NCT03920397 456 457 O

- NCT03920397 461 462 O
HIV NCT03920397 464 467 B-Condition
( NCT03920397 468 469 O
+ NCT03920397 470 471 O
) NCT03920397 472 473 O
, NCT03920397 474 475 O
Hepatitis NCT03920397 476 485 B-Condition
B NCT03920397 486 487 I-Condition
( NCT03920397 488 489 O
+ NCT03920397 490 491 O
) NCT03920397 492 493 O
, NCT03920397 494 495 O
Hepatitis NCT03920397 496 505 B-Condition
C NCT03920397 506 507 I-Condition
( NCT03920397 508 509 O
+ NCT03920397 510 511 O
) NCT03920397 512 513 O
. NCT03920397 514 515 O

- NCT03920397 519 520 O
Diabetic NCT03920397 522 530 B-Condition
ketoacidosis NCT03920397 531 543 I-Condition
at NCT03920397 544 546 O
diagnosis NCT03920397 547 556 O
. NCT03920397 557 558 O

- NCT03920397 562 563 O
Glomerular NCT03920397 565 575 B-Observation
filtration NCT03920397 576 586 I-Observation
rate NCT03920397 587 591 I-Observation
less NCT03920397 592 596 B-Eq_Comparison
than NCT03920397 597 601 I-Eq_Comparison
60 NCT03920397 602 604 I-Eq_Comparison
ml NCT03920397 605 607 I-Eq_Comparison
/ NCT03920397 608 609 I-Eq_Comparison
min NCT03920397 610 613 I-Eq_Comparison
. NCT03920397 614 615 O

- NCT03920397 619 620 O
Use NCT03920397 622 625 B-Eq_Comparison
of NCT03920397 626 628 O
immunosuppressors NCT03920397 629 646 B-Drug
or NCT03920397 647 649 B-Or
glucocorticoids NCT03920397 650 665 B-Drug
. NCT03920397 666 667 O

Inclusion NCT03923816 0 9 O
Criteria NCT03923816 10 18 O
: NCT03923816 19 20 O

- NCT03923816 24 25 O
patients NCT03923816 27 35 O
> NCT03923816 36 37 B-Eq_Comparison
18 NCT03923816 38 40 I-Eq_Comparison
years NCT03923816 41 46 I-Eq_Comparison
old NCT03923816 47 50 B-Age
, NCT03923816 51 52 O
undergoing NCT03923816 53 63 B-Eq_Comparison
elective NCT03923816 64 72 O
hepatobiliary NCT03923816 73 86 B-Procedure
surgery NCT03923816 87 94 I-Procedure
under NCT03923816 95 100 O
general NCT03923816 101 108 B-Procedure
anesthesia NCT03923816 109 119 I-Procedure
and NCT03923816 120 123 B-And
American NCT03923816 124 132 B-Observation
Society NCT03923816 133 140 I-Observation
of NCT03923816 141 143 I-Observation
Anesthesiologists NCT03923816 144 161 I-Observation
grade NCT03923816 162 167 B-Eq_Comparison
II NCT03923816 168 170 I-Eq_Comparison
. NCT03923816 171 172 O

Exclusion NCT03923816 174 183 O
Criteria NCT03923816 184 192 O
: NCT03923816 193 194 O

- NCT03923816 198 199 O
1 NCT03923816 201 202 O
- NCT03923816 203 204 O
patient NCT03923816 205 212 O
refusal NCT03923816 213 220 O
. NCT03923816 221 222 O
2 NCT03923816 224 225 O
- NCT03923816 226 227 O
psychiatric NCT03923816 228 239 B-Condition
disorders NCT03923816 240 249 I-Condition
. NCT03923816 250 251 O
3 NCT03923816 253 254 O
- NCT03923816 255 256 O
pregnancy NCT03923816 257 266 B-Condition
and NCT03923816 267 270 B-And
lactation NCT03923816 271 280 B-Condition
. NCT03923816 281 282 O
4 NCT03923816 284 285 O
- NCT03923816 286 287 O
preexisting NCT03923816 288 299 B-Eq_Comparison
neurological NCT03923816 300 312 B-Condition
dysfunction NCT03923816 313 324 I-Condition
( NCT03923816 325 326 O
history NCT03923816 327 334 B-Eq_Comparison
of NCT03923816 335 337 O
cerebrovascular NCT03923816 338 353 B-Condition
stroke NCT03923816 354 360 I-Condition
CVS NCT03923816 361 364 B-Condition
) NCT03923816 365 366 O
5 NCT03923816 367 368 O
- NCT03923816 369 370 O
metastatic NCT03923816 371 381 B-Modifier
cancer NCT03923816 382 388 B-Condition
. NCT03923816 389 390 O

6 NCT03923816 397 398 O
- NCT03923816 399 400 O
Inflammatory NCT03923816 401 413 B-Condition
bowel NCT03923816 414 419 I-Condition
disease NCT03923816 420 427 I-Condition
. NCT03923816 428 429 O
7 NCT03923816 431 432 O
- NCT03923816 433 434 O
Diabetes NCT03923816 435 443 B-Condition
mellitus NCT03923816 444 452 I-Condition
. NCT03923816 453 454 O
8 NCT03923816 456 457 O
- NCT03923816 458 459 O
Renal NCT03923816 460 465 B-Condition
insufficiency NCT03923816 466 479 I-Condition
( NCT03923816 480 481 O
serum NCT03923816 482 487 B-Observation
creatinine NCT03923816 488 498 I-Observation
level NCT03923816 499 504 I-Observation
more NCT03923816 505 509 B-Eq_Comparison
than NCT03923816 510 514 I-Eq_Comparison
180 NCT03923816 515 518 I-Eq_Comparison
Î¼mol NCT03923816 519 523 I-Eq_Comparison
/ NCT03923816 524 525 I-Eq_Comparison
l NCT03923816 526 527 I-Eq_Comparison
) NCT03923816 528 529 O
. NCT03923816 530 531 O
9 NCT03923816 533 534 O
- NCT03923816 535 536 O
unexpected NCT03923816 537 547 B-Assertion___Assertion_Type_Value:hypothetical
intraoperative NCT03923816 548 562 B-Condition
findings NCT03923816 563 571 I-Condition
( NCT03923816 572 573 O
inoperable NCT03923816 574 584 O
) NCT03923816 585 586 O
. NCT03923816 587 588 O
10 NCT03923816 590 592 O
- NCT03923816 593 594 O
accidental NCT03923816 595 605 B-Modifier
massive NCT03923816 606 613 I-Modifier
intraoperative NCT03923816 614 628 B-Condition
hemorrhage NCT03923816 629 639 I-Condition
. NCT03923816 640 641 O

Inclusion NCT03867474 0 9 O
Criteria NCT03867474 10 18 O
: NCT03867474 19 20 O

- NCT03867474 24 25 O
Inclusion NCT03867474 27 36 O
criteria NCT03867474 37 45 O
for NCT03867474 46 49 O
study NCT03867474 50 55 O
participants NCT03867474 56 68 O
include NCT03867474 69 76 O
: NCT03867474 77 78 O
( NCT03867474 79 80 O
1 NCT03867474 81 82 O
) NCT03867474 83 84 O
age NCT03867474 85 88 B-Age
â¥ NCT03867474 89 90 B-Eq_Comparison
60 NCT03867474 91 93 I-Eq_Comparison
years NCT03867474 94 99 I-Eq_Comparison
; NCT03867474 99 100 O
( NCT03867474 101 102 O
2 NCT03867474 103 104 O
) NCT03867474 105 106 O
English NCT03867474 107 114 O
fluency NCT03867474 115 122 O
; NCT03867474 122 123 O
( NCT03867474 124 125 O
3 NCT03867474 126 127 O
) NCT03867474 128 129 O
living NCT03867474 130 136 B-Observation
independently NCT03867474 137 150 I-Observation
in NCT03867474 151 153 O
the NCT03867474 154 157 O
community NCT03867474 158 167 O
; NCT03867474 167 168 O
( NCT03867474 169 170 O
4 NCT03867474 171 172 O
) NCT03867474 173 174 O
self NCT03867474 175 179 O
- NCT03867474 180 181 O
reported NCT03867474 182 190 O
demographic NCT03867474 191 202 O
information NCT03867474 203 214 O
that NCT03867474 215 219 O
includes NCT03867474 220 228 O
either NCT03867474 229 235 O
the NCT03867474 236 239 O
label NCT03867474 240 245 O
of NCT03867474 246 248 O
SCD NCT03867474 249 252 B-Condition
or NCT03867474 253 255 B-Or
MCI NCT03867474 256 259 B-Condition

Exclusion NCT03867474 260 269 O
Criteria NCT03867474 270 278 O
: NCT03867474 279 280 O

- NCT03867474 284 285 O
( NCT03867474 287 288 O
1 NCT03867474 289 290 O
) NCT03867474 291 292 O
history NCT03867474 293 300 B-Eq_Comparison
of NCT03867474 301 303 I-Eq_Comparison
prior NCT03867474 304 309 I-Eq_Comparison
participation NCT03867474 310 323 O
in NCT03867474 324 326 O
any NCT03867474 327 330 O
MBSR NCT03867474 331 335 B-Modifier
or NCT03867474 336 338 B-Or
other NCT03867474 339 344 B-Other
mindfulness NCT03867474 345 356 B-Modifier
- NCT03867474 357 358 I-Modifier
based NCT03867474 359 364 I-Modifier
interventions NCT03867474 365 378 B-Procedure
, NCT03867474 379 380 O
or NCT03867474 381 383 B-Or
participation NCT03867474 384 397 O
in NCT03867474 398 400 O
regular NCT03867474 401 408 O
( NCT03867474 409 410 O
weekly NCT03867474 411 417 B-Eq_Comparison
) NCT03867474 418 419 O
mindfulness NCT03867474 420 431 B-Modifier
or NCT03867474 432 434 B-Or
yoga NCT03867474 435 439 B-Modifier
practice NCT03867474 440 448 B-Observation
; NCT03867474 448 449 O
( NCT03867474 450 451 O
2 NCT03867474 452 453 O
) NCT03867474 454 455 O
low NCT03867474 456 459 O
mood NCT03867474 460 464 B-Condition
as NCT03867474 465 467 O
indicated NCT03867474 468 477 O
by NCT03867474 478 480 O
a NCT03867474 481 482 O
5 NCT03867474 483 484 B-Eq_Comparison
or NCT03867474 485 487 I-Eq_Comparison
greater NCT03867474 488 495 I-Eq_Comparison
on NCT03867474 496 498 O
the NCT03867474 499 502 O
Geriatric NCT03867474 503 512 B-Observation
Depression NCT03867474 513 523 I-Observation
Scale NCT03867474 524 529 I-Observation
( NCT03867474 530 531 O
GDS NCT03867474 532 535 B-Observation
) NCT03867474 536 537 O
( NCT03867474 538 539 O
3 NCT03867474 540 541 O
) NCT03867474 542 543 O
alcoholism NCT03867474 544 554 B-Condition
and NCT03867474 555 558 B-Or
/ NCT03867474 559 560 I-Or
or NCT03867474 561 563 I-Or
other NCT03867474 564 569 B-Other
substance NCT03867474 570 579 B-Condition
abuse NCT03867474 580 585 I-Condition
defined NCT03867474 586 593 O
in NCT03867474 594 596 O
the NCT03867474 597 600 O
Diagnostic NCT03867474 601 611 O
and NCT03867474 612 615 O
Statistical NCT03867474 616 627 O
Manual NCT03867474 628 634 O
of NCT03867474 635 637 O
Mental NCT03867474 638 644 O
Disorders NCT03867474 645 654 O
, NCT03867474 655 656 O
Fifth NCT03867474 657 662 O
Edition NCT03867474 663 670 O
( NCT03867474 671 672 O
DSM NCT03867474 673 676 O
- NCT03867474 677 678 O
V NCT03867474 679 680 O
) NCT03867474 681 682 O
( NCT03867474 683 684 O
American NCT03867474 685 693 O
Psychiatric NCT03867474 694 705 O
Association NCT03867474 706 717 O
, NCT03867474 718 719 O
2013 NCT03867474 720 724 O
; NCT03867474 725 726 O
Kiefer NCT03867474 727 733 O
, NCT03867474 734 735 O
Israel NCT03867474 736 742 O
, NCT03867474 743 744 O
& NCT03867474 745 746 O
Martino NCT03867474 747 754 O
, NCT03867474 755 756 O
2016 NCT03867474 757 761 O
) NCT03867474 762 763 O
; NCT03867474 764 765 O
( NCT03867474 766 767 O
4 NCT03867474 768 769 O
) NCT03867474 770 771 O
Montreal NCT03867474 772 780 B-Observation
Cognitive NCT03867474 781 790 I-Observation
Assessment NCT03867474 791 801 I-Observation
( NCT03867474 802 803 O
MoCA NCT03867474 804 808 B-Observation
) NCT03867474 809 810 O
of NCT03867474 811 813 O
23 NCT03867474 814 816 B-Eq_Comparison
( NCT03867474 817 818 I-Eq_Comparison
+ NCT03867474 819 820 I-Eq_Comparison
/ NCT03867474 821 822 I-Eq_Comparison
- NCT03867474 823 824 I-Eq_Comparison
4 NCT03867474 825 826 I-Eq_Comparison
) NCT03867474 827 828 I-Eq_Comparison
( NCT03867474 829 830 O
Clarnette NCT03867474 831 840 O
, NCT03867474 841 842 O
O'Caoimh NCT03867474 843 851 O
, NCT03867474 852 853 O
Antony NCT03867474 854 860 O
, NCT03867474 861 862 O
Svendrovski NCT03867474 863 874 O
, NCT03867474 875 876 O
& NCT03867474 877 878 O
Molloy NCT03867474 879 885 O
, NCT03867474 886 887 O
2017 NCT03867474 888 892 O
; NCT03867474 893 894 O
O'Caoimh NCT03867474 895 903 O
, NCT03867474 904 905 O
Timmons NCT03867474 906 913 O
, NCT03867474 914 915 O
& NCT03867474 916 917 O
Molloy NCT03867474 918 924 O
, NCT03867474 925 926 O
2016 NCT03867474 927 931 O
) NCT03867474 932 933 O
or NCT03867474 934 936 O
under NCT03867474 937 942 O
; NCT03867474 942 943 O
and NCT03867474 944 947 O
( NCT03867474 948 949 O
5 NCT03867474 950 951 O
) NCT03867474 952 953 O
if NCT03867474 954 956 O
participating NCT03867474 957 970 O
in NCT03867474 971 973 O
other NCT03867474 974 979 O
concurrent NCT03867474 980 990 B-Modifier
group NCT03867474 991 996 B-Procedure
( NCT03867474 997 998 O
s NCT03867474 999 1000 O
) NCT03867474 1001 1002 O
e NCT03867474 1003 1004 O
. NCT03867474 1005 1006 O
g NCT03867474 1007 1008 O
. NCT03867474 1009 1010 O
cognitive NCT03867474 1012 1021 B-Procedure
behavioural NCT03867474 1022 1033 I-Procedure
therapy NCT03867474 1034 1041 I-Procedure
( NCT03867474 1042 1043 O
CBT NCT03867474 1044 1047 B-Procedure
) NCT03867474 1048 1049 O
or NCT03867474 1050 1052 B-Or
memory NCT03867474 1053 1059 B-Procedure
training NCT03867474 1060 1068 I-Procedure
programs NCT03867474 1069 1077 I-Procedure
in NCT03867474 1078 1080 O
the NCT03867474 1081 1084 O
community NCT03867474 1085 1094 O
, NCT03867474 1095 1096 O
while NCT03867474 1097 1102 B-Temporal_Connection___Temporal_Connection_Type_Value:during
in NCT03867474 1103 1105 O
the NCT03867474 1106 1109 O
study NCT03867474 1110 1115 B-Study
. NCT03867474 1116 1117 O


Inclusion NCT03924492 0 9 O
Criteria NCT03924492 10 18 O
: NCT03924492 19 20 O

1 NCT03924492 24 25 O
. NCT03924492 25 26 O
Subject NCT03924492 28 35 O
has NCT03924492 36 39 O
signed NCT03924492 40 46 O
an NCT03924492 47 49 O
informed NCT03924492 50 58 O
consent NCT03924492 59 66 O
form NCT03924492 67 71 O
prior NCT03924492 72 77 B-Eq_Comparison
to NCT03924492 78 80 O
any NCT03924492 81 84 O
study NCT03924492 85 90 O
- NCT03924492 91 92 O
specific NCT03924492 93 101 O
procedures NCT03924492 102 112 O
being NCT03924492 113 118 O
performed NCT03924492 119 128 O

2 NCT03924492 131 132 O
. NCT03924492 132 133 O
Subject NCT03924492 135 142 O
is NCT03924492 143 145 O
an NCT03924492 146 148 O
ambulatory NCT03924492 149 159 B-Condition
female NCT03924492 160 166 O
at NCT03924492 167 169 B-Eq_Comparison
least NCT03924492 170 175 I-Eq_Comparison
18 NCT03924492 176 178 I-Eq_Comparison
years NCT03924492 179 184 I-Eq_Comparison
of NCT03924492 185 187 O
age NCT03924492 188 191 B-Age

3 NCT03924492 194 195 O
. NCT03924492 195 196 O
Subject NCT03924492 198 205 O
agrees NCT03924492 206 212 O
to NCT03924492 213 215 O
adhere NCT03924492 216 222 O
to NCT03924492 223 225 O
the NCT03924492 226 229 O
study NCT03924492 230 235 O
requirements NCT03924492 236 248 O

4 NCT03924492 251 252 O
. NCT03924492 252 253 O
Subject NCT03924492 255 262 O
agrees NCT03924492 263 269 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03924492 270 273 O
to NCT03924492 274 276 O
be NCT03924492 277 279 O
the NCT03924492 280 283 O
primary NCT03924492 284 291 B-Observation
caregiver NCT03924492 292 301 I-Observation
of NCT03924492 302 304 O
any NCT03924492 305 308 O
dependents NCT03924492 309 319 O
during NCT03924492 320 326 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03924492 327 330 O
infusion NCT03924492 331 339 B-Procedure

5 NCT03924492 342 343 O
. NCT03924492 343 344 O
Subject NCT03924492 346 353 O
must NCT03924492 354 358 O
have NCT03924492 359 363 O
a NCT03924492 364 365 O
negative NCT03924492 366 374 O
pregnancy NCT03924492 375 384 B-Observation
test NCT03924492 385 389 I-Observation
on NCT03924492 390 392 O
Day NCT03924492 393 396 O
1 NCT03924492 397 398 O
prior NCT03924492 399 404 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924492 405 407 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03924492 408 411 O
start NCT03924492 412 417 O
of NCT03924492 418 420 O
the NCT03924492 421 424 O
ZULRESSO NCT03924492 425 433 B-Procedure
infusion NCT03924492 434 442 I-Procedure

6 NCT03924492 445 446 O
. NCT03924492 446 447 O
Subject NCT03924492 449 456 O
has NCT03924492 457 460 O
a NCT03924492 461 462 O
current NCT03924492 463 470 B-Eq_Comparison
diagnosis NCT03924492 471 480 O
of NCT03924492 481 483 O
PPD NCT03924492 484 487 B-Condition
, NCT03924492 488 489 O
as NCT03924492 490 492 O
assessed NCT03924492 493 501 O
by NCT03924492 502 504 O
the NCT03924492 505 508 O
Investigator NCT03924492 509 521 O

Exclusion NCT03924492 522 531 O
Criteria NCT03924492 532 540 O
: NCT03924492 541 542 O

1 NCT03924492 546 547 O
. NCT03924492 547 548 O
Subject NCT03924492 550 557 O
has NCT03924492 558 561 O
end NCT03924492 562 565 B-Modifier
stage NCT03924492 566 571 I-Modifier
renal NCT03924492 572 577 B-Condition
disease NCT03924492 578 585 I-Condition

2 NCT03924492 588 589 O
. NCT03924492 589 590 O
Subject NCT03924492 592 599 O
has NCT03924492 600 603 O
a NCT03924492 604 605 O
known NCT03924492 606 611 O
allergy NCT03924492 612 619 B-Allergy
to NCT03924492 620 622 O
progesterone NCT03924492 623 635 B-Drug
or NCT03924492 636 638 B-Or
allopregnanolone NCT03924492 639 655 B-Drug

Inclusion NCT03867032 0 9 O
Criteria NCT03867032 10 18 O
: NCT03867032 19 20 O

- NCT03867032 24 25 O
Native NCT03867032 27 33 O
speakers NCT03867032 34 42 O
of NCT03867032 43 45 O
English NCT03867032 46 53 O

- NCT03867032 56 57 O
Cochlear NCT03867032 59 67 B-Procedure
Nucleus NCT03867032 68 75 I-Procedure
cochlear NCT03867032 76 84 I-Procedure
implant NCT03867032 85 92 I-Procedure
users NCT03867032 93 98 O
or NCT03867032 99 101 B-Or
Advanced NCT03867032 102 110 B-Procedure
Bionics NCT03867032 111 118 I-Procedure
users NCT03867032 119 124 O

- NCT03867032 127 128 O
Postlingually NCT03867032 130 143 B-Modifier
deafened NCT03867032 144 152 B-Condition

- NCT03867032 155 156 O
Has NCT03867032 158 161 O
had NCT03867032 162 165 O
device NCT03867032 166 172 B-Procedure
experience NCT03867032 173 183 O
for NCT03867032 184 187 O
at NCT03867032 188 190 B-Eq_Comparison
least NCT03867032 191 196 I-Eq_Comparison
one NCT03867032 197 200 I-Eq_Comparison
year NCT03867032 201 205 I-Eq_Comparison

- NCT03867032 208 209 O
Can NCT03867032 211 214 O
be NCT03867032 215 217 O
child NCT03867032 218 223 O
or NCT03867032 224 226 B-Or
adult NCT03867032 227 232 O
at NCT03867032 233 235 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867032 236 239 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03867032 240 244 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03867032 245 247 O
enrollment NCT03867032 248 258 B-Study

Exclusion NCT03867032 259 268 O
Criteria NCT03867032 269 277 O
: NCT03867032 278 279 O

- NCT03867032 283 284 O
None NCT03867032 286 290 O

Inclusion NCT03863262 0 9 O
Criteria NCT03863262 10 18 O
: NCT03863262 19 20 O

- NCT03863262 24 25 O
Registered NCT03863262 27 37 O
patients NCT03863262 38 46 O
at NCT03863262 47 49 O
Eric NCT03863262 50 54 O
Williams NCT03863262 55 63 O
Medical NCT03863262 64 71 O
Sciences NCT03863262 72 80 O
Complex NCT03863262 81 88 O
in NCT03863262 89 91 O
any NCT03863262 92 95 O
of NCT03863262 96 98 O
the NCT03863262 99 102 O
cardiology NCT03863262 103 113 O
outpatient NCT03863262 114 124 O
clinics NCT03863262 125 132 O
. NCT03863262 133 134 O
This NCT03863262 136 140 O
was NCT03863262 141 144 O
confirmed NCT03863262 145 154 O
by NCT03863262 155 157 O
matching NCT03863262 158 166 O
patients NCT03863262 167 175 O
with NCT03863262 176 180 O
their NCT03863262 181 186 O
registration NCT03863262 187 199 O
numbers NCT03863262 200 207 O
on NCT03863262 208 210 O
the NCT03863262 211 214 O
cardiology NCT03863262 215 225 O
outpatient NCT03863262 226 236 O
clinic NCT03863262 237 243 O
appointment NCT03863262 244 255 O
listings NCT03863262 256 264 O
. NCT03863262 265 266 O
These NCT03863262 268 273 O
lists NCT03863262 274 279 O
are NCT03863262 280 283 O
made NCT03863262 284 288 O
prior NCT03863262 289 294 O
to NCT03863262 295 297 O
each NCT03863262 298 302 O
cardiology NCT03863262 303 313 O
clinic NCT03863262 314 320 O
that NCT03863262 321 325 O
is NCT03863262 326 328 O
scheduled NCT03863262 329 338 O
every NCT03863262 339 344 O
week NCT03863262 345 349 O
on NCT03863262 350 352 O
Mondays NCT03863262 353 360 O
, NCT03863262 361 362 O
Tuesdays NCT03863262 363 371 O
, NCT03863262 372 373 O
Wednesdays NCT03863262 374 384 O
, NCT03863262 385 386 O
Thursdays NCT03863262 387 396 O
and NCT03863262 397 400 O
Fridays NCT03863262 401 408 O
. NCT03863262 409 410 O

- NCT03863262 414 415 O
Patients NCT03863262 417 425 O
who NCT03863262 426 429 O
were NCT03863262 430 434 B-Eq_Comparison
18 NCT03863262 435 437 I-Eq_Comparison
years NCT03863262 438 443 I-Eq_Comparison
old NCT03863262 444 447 B-Age

Exclusion NCT03863262 448 457 O
Criteria NCT03863262 458 466 O
: NCT03863262 467 468 O

- NCT03863262 472 473 O
Patients NCT03863262 475 483 O
less NCT03863262 484 488 B-Eq_Comparison
than NCT03863262 489 493 I-Eq_Comparison
18 NCT03863262 494 496 I-Eq_Comparison
years NCT03863262 497 502 I-Eq_Comparison
old NCT03863262 503 506 B-Age

- NCT03863262 509 510 O
Those NCT03863262 512 517 O
who NCT03863262 518 521 O
did NCT03863262 522 525 O
not NCT03863262 526 529 O
give NCT03863262 530 534 O
informed NCT03863262 535 543 O
consent NCT03863262 544 551 O
to NCT03863262 552 554 O
participate NCT03863262 555 566 O
in NCT03863262 567 569 O
the NCT03863262 570 573 O
study NCT03863262 574 579 O

- NCT03863262 582 583 O
Patients NCT03863262 585 593 O
who NCT03863262 594 597 O
were NCT03863262 598 602 O
not NCT03863262 603 606 B-Negation
registered NCT03863262 607 617 O
patients NCT03863262 618 626 O
of NCT03863262 627 629 O
the NCT03863262 630 633 O
cardiology NCT03863262 634 644 O
outpatient NCT03863262 645 655 O
clinics NCT03863262 656 663 O
at NCT03863262 664 666 O
Eric NCT03863262 667 671 O
Williams NCT03863262 672 680 O
Medical NCT03863262 681 688 O
Sciences NCT03863262 689 697 O
Complex NCT03863262 698 705 O
along NCT03863262 706 711 O

- NCT03863262 714 715 O
Patients NCT03863262 717 725 O
who NCT03863262 726 729 O
were NCT03863262 730 734 O
acutely NCT03863262 735 742 O
unwell NCT03863262 743 749 B-Condition
requiring NCT03863262 750 759 B-Assertion___Assertion_Type_Value:hypothetical
hospital NCT03863262 760 768 O
admission NCT03863262 769 778 B-Encounter

Inclusion NCT03868956 0 9 O
Criteria NCT03868956 10 18 O
: NCT03868956 19 20 O

- NCT03868956 24 25 O
Age NCT03868956 27 30 B-Age
> NCT03868956 31 32 B-Eq_Comparison
= NCT03868956 33 34 I-Eq_Comparison
18 NCT03868956 35 37 I-Eq_Comparison
years NCT03868956 38 43 I-Eq_Comparison

- NCT03868956 46 47 O
Known NCT03868956 49 54 O
history NCT03868956 55 62 B-Eq_Comparison
of NCT03868956 63 65 O
objectively NCT03868956 66 77 O
documented NCT03868956 78 88 O
deep NCT03868956 89 93 B-Condition
vein NCT03868956 94 98 I-Condition
thrombosis NCT03868956 99 109 I-Condition
of NCT03868956 110 112 O
the NCT03868956 113 116 O
lower NCT03868956 117 122 B-Modifier
limb NCT03868956 123 127 I-Modifier
( NCT03868956 128 129 O
with NCT03868956 130 134 B-And
or NCT03868956 135 137 B-Or
without NCT03868956 138 145 B-Negation
pulmonary NCT03868956 146 155 B-Condition
embolism NCT03868956 156 164 I-Condition
) NCT03868956 165 166 O

- NCT03868956 170 171 O
Out NCT03868956 173 176 B-Encounter
- NCT03868956 177 178 I-Encounter
patients NCT03868956 179 187 I-Encounter
referred NCT03868956 188 196 O
for NCT03868956 197 200 O
clinically NCT03868956 201 211 O
suspected NCT03868956 212 221 B-Assertion___Assertion_Type_Value:possible
acute NCT03868956 222 227 O
recurrent NCT03868956 228 237 B-Modifier
ipsilateral NCT03868956 238 249 I-Modifier
DVT NCT03868956 250 253 B-Condition
of NCT03868956 254 256 O
the NCT03868956 257 260 O
lower NCT03868956 261 266 B-Modifier
limb NCT03868956 267 271 I-Modifier
i NCT03868956 272 273 O
. NCT03868956 274 275 O
e NCT03868956 276 277 O
. NCT03868956 278 279 O
the NCT03868956 281 284 O
occurrence NCT03868956 285 295 O
of NCT03868956 296 298 O
new NCT03868956 299 302 B-Eq_Comparison
symptoms NCT03868956 303 311 B-Assertion___Assertion_Type_Value:possible
and NCT03868956 312 315 B-And
signs NCT03868956 316 321 B-Assertion___Assertion_Type_Value:possible
of NCT03868956 322 324 O
DVT NCT03868956 325 328 B-Condition
or NCT03868956 329 331 B-Or
the NCT03868956 332 335 O
increase NCT03868956 336 344 O
of NCT03868956 345 347 O
symptoms NCT03868956 348 356 B-Assertion___Assertion_Type_Value:possible
and NCT03868956 357 360 B-And
signs NCT03868956 361 366 B-Assertion___Assertion_Type_Value:possible
in NCT03868956 367 369 O
patients NCT03868956 370 378 O
with NCT03868956 379 383 O
post NCT03868956 384 388 B-Condition
- NCT03868956 389 390 I-Condition
thrombotic NCT03868956 391 401 I-Condition
syndrome NCT03868956 402 410 I-Condition

- NCT03868956 413 414 O
Patients NCT03868956 416 424 O
covered NCT03868956 425 432 O
by NCT03868956 433 435 O
social NCT03868956 436 442 O
security NCT03868956 443 451 O
or NCT03868956 452 454 O
equivalent NCT03868956 455 465 O
regimen NCT03868956 466 473 O

- NCT03868956 476 477 O
Signed NCT03868956 479 485 O
and NCT03868956 486 489 O
dated NCT03868956 490 495 O
informed NCT03868956 496 504 O
consent NCT03868956 505 512 O

Exclusion NCT03868956 513 522 O
Criteria NCT03868956 523 531 O
: NCT03868956 532 533 O

- NCT03868956 537 538 O
Known NCT03868956 540 545 O
current NCT03868956 546 553 B-Eq_Comparison
pregnancy NCT03868956 554 563 B-Condition

- NCT03868956 566 567 O
Any NCT03868956 569 572 O
condition NCT03868956 573 582 B-Condition
, NCT03868956 583 584 O
which NCT03868956 585 590 O
, NCT03868956 591 592 O
in NCT03868956 593 595 O
the NCT03868956 596 599 O
opinion NCT03868956 600 607 O
of NCT03868956 608 610 O
the NCT03868956 611 614 O
investigator NCT03868956 615 627 O
may NCT03868956 628 631 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03868956 632 639 B-Negation
him NCT03868956 640 643 O
from NCT03868956 644 648 O
performing NCT03868956 649 659 O
the NCT03868956 660 663 O
colour NCT03868956 664 670 B-Procedure
doppler NCT03868956 671 678 I-Procedure
ultrasound NCT03868956 679 689 I-Procedure
test NCT03868956 690 694 I-Procedure
( NCT03868956 695 696 O
plaster NCT03868956 697 704 B-Condition
cast NCT03868956 705 709 I-Condition
, NCT03868956 710 711 O
inaccessible NCT03868956 712 724 B-Modifier
vein NCT03868956 725 729 B-Condition
segment NCT03868956 730 737 I-Condition
after NCT03868956 738 743 B-Temporal_Connection___Temporal_Connection_Type_Value:after
abdominal NCT03868956 744 753 B-Modifier
or NCT03868956 754 756 B-Or
pelvic NCT03868956 757 763 B-Modifier
surgery NCT03868956 764 771 B-Procedure
, NCT03868956 772 773 O
or NCT03868956 774 776 B-Or
other NCT03868956 777 782 B-Other
causes NCT03868956 783 789 B-Condition
that NCT03868956 790 794 O
may NCT03868956 795 798 B-Assertion___Assertion_Type_Value:hypothetical
lead NCT03868956 799 803 O
to NCT03868956 804 806 O
a NCT03868956 807 808 O
technically NCT03868956 809 820 O
inadequate NCT03868956 821 831 O
CDUS NCT03868956 832 836 O
) NCT03868956 837 838 O

- NCT03868956 842 843 O
Delay NCT03868956 845 850 O
from NCT03868956 851 855 O
onset NCT03868956 856 861 B-Eq_Comparison
of NCT03868956 862 864 O
symptoms NCT03868956 865 873 O
to NCT03868956 874 876 B-Temporal_Connection___Temporal_Connection_Type_Value:after
inclusion NCT03868956 877 886 B-Study
of NCT03868956 887 889 O
more NCT03868956 890 894 B-Eq_Comparison
than NCT03868956 895 899 I-Eq_Comparison
10 NCT03868956 900 902 I-Eq_Comparison
days NCT03868956 903 907 I-Eq_Comparison

- NCT03868956 910 911 O
Therapeutic NCT03868956 913 924 B-Procedure
anticoagulation NCT03868956 925 940 I-Procedure
for NCT03868956 941 944 O
more NCT03868956 945 949 B-Eq_Comparison
than NCT03868956 950 954 I-Eq_Comparison
48 NCT03868956 955 957 I-Eq_Comparison
hours NCT03868956 958 963 I-Eq_Comparison
in NCT03868956 964 966 O
the NCT03868956 967 970 O
two NCT03868956 971 974 B-Eq_Comparison
days NCT03868956 975 979 I-Eq_Comparison
prior NCT03868956 980 985 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03868956 986 988 I-Temporal_Connection___Temporal_Connection_Type_Value:before
consent NCT03868956 989 996 O

- NCT03868956 999 1000 O
Prophylactic NCT03868956 1002 1014 B-Procedure
anticoagulation NCT03868956 1015 1030 I-Procedure
for NCT03868956 1031 1034 O
more NCT03868956 1035 1039 B-Eq_Comparison
than NCT03868956 1040 1044 I-Eq_Comparison
48 NCT03868956 1045 1047 I-Eq_Comparison
hours NCT03868956 1048 1053 I-Eq_Comparison
in NCT03868956 1054 1056 O
the NCT03868956 1057 1060 O
two NCT03868956 1061 1064 B-Eq_Comparison
days NCT03868956 1065 1069 I-Eq_Comparison
prior NCT03868956 1070 1075 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03868956 1076 1078 I-Temporal_Connection___Temporal_Connection_Type_Value:before
consent NCT03868956 1079 1086 O

- NCT03868956 1089 1090 O
Clinical NCT03868956 1092 1100 O
symptoms NCT03868956 1101 1109 B-Assertion___Assertion_Type_Value:possible
of NCT03868956 1110 1112 O
pulmonary NCT03868956 1113 1122 B-Condition
embolism NCT03868956 1123 1131 I-Condition

- NCT03868956 1134 1135 O
Life NCT03868956 1137 1141 B-Observation
expectancy NCT03868956 1142 1152 I-Observation
less NCT03868956 1153 1157 B-Eq_Comparison
than NCT03868956 1158 1162 I-Eq_Comparison
3 NCT03868956 1163 1164 I-Eq_Comparison
months NCT03868956 1165 1171 I-Eq_Comparison

- NCT03868956 1174 1175 O
Patient NCT03868956 1177 1184 O
unable NCT03868956 1185 1191 O
to NCT03868956 1192 1194 O
adhere NCT03868956 1195 1201 O
to NCT03868956 1202 1204 O
protocol NCT03868956 1205 1213 O
or NCT03868956 1214 1216 O
follow NCT03868956 1217 1223 O
- NCT03868956 1224 1225 O
up NCT03868956 1226 1228 O
visits NCT03868956 1229 1235 O
and NCT03868956 1236 1239 O
contacts NCT03868956 1240 1248 O

- NCT03868956 1251 1252 O
Participants NCT03868956 1254 1266 O
under NCT03868956 1267 1272 O
legal NCT03868956 1273 1278 B-Observation
guardianship NCT03868956 1279 1291 I-Observation
or NCT03868956 1292 1294 B-Or
incapacitation NCT03868956 1295 1309 B-Condition

- NCT03868956 1312 1313 O
Patient NCT03868956 1315 1322 O
already NCT03868956 1323 1330 B-Eq_Comparison
enrolled NCT03868956 1331 1339 O
in NCT03868956 1340 1342 O
a NCT03868956 1343 1344 O
deep NCT03868956 1345 1349 B-Condition
vein NCT03868956 1350 1354 I-Condition
thrombosis NCT03868956 1355 1365 I-Condition
( NCT03868956 1366 1367 O
DVT NCT03868956 1368 1371 B-Condition
) NCT03868956 1372 1373 O
diagnostic NCT03868956 1374 1384 O
research NCT03868956 1385 1393 B-Study

Inclusion NCT03866915 0 9 O
Criteria NCT03866915 10 18 O
: NCT03866915 19 20 O

- NCT03866915 24 25 O
All NCT03866915 27 30 O
patients NCT03866915 31 39 O
older NCT03866915 40 45 B-Eq_Comparison
than NCT03866915 46 50 I-Eq_Comparison
18 NCT03866915 51 53 I-Eq_Comparison
years NCT03866915 54 59 I-Eq_Comparison
undergoing NCT03866915 60 70 B-Eq_Comparison
elective NCT03866915 71 79 O
surgery NCT03866915 80 87 B-Procedure
that NCT03866915 88 92 B-And
receive NCT03866915 93 100 O
a NCT03866915 101 102 O
pre NCT03866915 103 106 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03866915 107 116 O
visit NCT03866915 117 122 B-Encounter
by NCT03866915 123 125 O
anesthesiologists NCT03866915 126 143 B-Provider
. NCT03866915 144 145 O

Exclusion NCT03866915 147 156 O
Criteria NCT03866915 157 165 O
: NCT03866915 166 167 O

- NCT03866915 171 172 O
Patients NCT03866915 174 182 O
undergoing NCT03866915 183 193 B-Eq_Comparison
emergency NCT03866915 194 203 B-Procedure
surgery NCT03866915 204 211 I-Procedure

- NCT03866915 219 220 O
Patients NCT03866915 222 230 O
under NCT03866915 231 236 B-Eq_Comparison
18 NCT03866915 237 239 I-Eq_Comparison
years NCT03866915 240 245 I-Eq_Comparison
of NCT03866915 246 248 O
age NCT03866915 249 252 B-Age

- NCT03866915 260 261 O
Patients NCT03866915 263 271 O
who NCT03866915 272 275 O
refuse NCT03866915 276 282 O
to NCT03866915 283 285 O
participate NCT03866915 286 297 O

- NCT03866915 305 306 O
Patients NCT03866915 308 316 O
unable NCT03866915 317 323 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03866915 324 326 O
perform NCT03866915 327 334 O
the NCT03866915 335 338 O
6 NCT03866915 339 340 B-Observation
MWT NCT03866915 341 344 I-Observation

- NCT03866915 352 353 O
Claudication NCT03866915 355 367 B-Condition
of NCT03866915 368 370 O
the NCT03866915 371 374 O
lower NCT03866915 375 380 B-Modifier
extremities NCT03866915 381 392 I-Modifier
and NCT03866915 393 396 B-And
inability NCT03866915 397 406 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03866915 407 409 O
maintain NCT03866915 410 418 O
a NCT03866915 419 420 O
constant NCT03866915 421 429 O
pace NCT03866915 430 434 B-Observation
of NCT03866915 435 437 I-Observation
walking NCT03866915 438 445 I-Observation
on NCT03866915 446 448 O
level NCT03866915 449 454 B-Modifier
ground NCT03866915 455 461 I-Modifier

Inclusion NCT03866447 0 9 O
Criteria NCT03866447 10 18 O
: NCT03866447 19 20 O

1 NCT03866447 24 25 O
. NCT03866447 25 26 O
Patients NCT03866447 28 36 O
with NCT03866447 37 41 O
Acne NCT03866447 42 46 B-Condition
of NCT03866447 47 49 O
any NCT03866447 50 53 O
grade NCT03866447 54 59 O
. NCT03866447 60 61 O

2 NCT03866447 65 66 O
. NCT03866447 66 67 O
Patients NCT03866447 69 77 O
between NCT03866447 78 85 B-Eq_Comparison
18 NCT03866447 86 88 I-Eq_Comparison
and NCT03866447 89 92 I-Eq_Comparison
45 NCT03866447 93 95 I-Eq_Comparison
years NCT03866447 96 101 I-Eq_Comparison
old NCT03866447 102 105 B-Age
. NCT03866447 106 107 O

Exclusion NCT03866447 109 118 O
Criteria NCT03866447 119 127 O
: NCT03866447 128 129 O

1 NCT03866447 133 134 O
. NCT03866447 134 135 O
Patients NCT03866447 137 145 O
below NCT03866447 146 151 B-Eq_Comparison
18 NCT03866447 152 154 I-Eq_Comparison
and NCT03866447 155 158 B-Or
above NCT03866447 159 164 B-Eq_Comparison
45 NCT03866447 165 167 I-Eq_Comparison
years NCT03866447 168 173 I-Eq_Comparison
. NCT03866447 174 175 O

2 NCT03866447 179 180 O
. NCT03866447 180 181 O
Patients NCT03866447 183 191 O
with NCT03866447 192 196 O
any NCT03866447 197 200 O
concomitant NCT03866447 201 212 B-Modifier
Dermatologic NCT03866447 213 225 I-Modifier
or NCT03866447 226 228 B-Or
systemic NCT03866447 229 237 B-Modifier
illness NCT03866447 238 245 B-Condition

3 NCT03866447 248 249 O
. NCT03866447 249 250 O
Patients NCT03866447 252 260 O
on NCT03866447 261 263 O
any NCT03866447 264 267 O
topical NCT03866447 268 275 B-Modifier
or NCT03866447 276 278 B-Or
systemic NCT03866447 279 287 B-Modifier
medication NCT03866447 288 298 B-Drug
within NCT03866447 299 305 B-Eq_Comparison
4 NCT03866447 306 307 I-Eq_Comparison
weeks NCT03866447 308 313 I-Eq_Comparison
before NCT03866447 314 320 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03866447 321 331 B-Study
. NCT03866447 332 333 O

4 NCT03866447 337 338 O
. NCT03866447 338 339 O
Pregnancy NCT03866447 341 350 B-Condition
. NCT03866447 351 352 O

Inclusion NCT03924752 0 9 O
Criteria NCT03924752 10 18 O
: NCT03924752 19 20 O

- NCT03924752 24 25 O
Between NCT03924752 27 34 B-Eq_Comparison
18 NCT03924752 35 37 I-Eq_Comparison
- NCT03924752 38 39 I-Eq_Comparison
85 NCT03924752 40 42 I-Eq_Comparison
years NCT03924752 43 48 I-Eq_Comparison
of NCT03924752 49 51 O
age NCT03924752 52 55 B-Age

- NCT03924752 58 59 O
Subjects NCT03924752 61 69 O
should NCT03924752 70 76 O
be NCT03924752 77 79 O
capable NCT03924752 80 87 B-Condition
of NCT03924752 88 90 I-Condition
walking NCT03924752 91 98 B-Modifier
, NCT03924752 99 100 O
ascending NCT03924752 101 110 B-Modifier
/ NCT03924752 111 112 B-Or
descending NCT03924752 113 123 B-Modifier
stairs NCT03924752 124 130 I-Modifier
and NCT03924752 131 134 O
ramps NCT03924752 135 140 O
with NCT03924752 141 145 B-And
full NCT03924752 146 150 B-Modifier
capability NCT03924752 151 161 I-Modifier
in NCT03924752 162 164 O
lower NCT03924752 165 170 B-Modifier
extremity NCT03924752 171 180 I-Modifier
passive NCT03924752 181 188 I-Modifier
range NCT03924752 189 194 B-Condition
of NCT03924752 195 197 I-Condition
motion NCT03924752 198 204 I-Condition
( NCT03924752 205 206 O
knee NCT03924752 207 211 B-Observation
flexion NCT03924752 212 219 I-Observation
contracture NCT03924752 220 231 I-Observation
of NCT03924752 232 234 O
> NCT03924752 235 236 B-Eq_Comparison
10 NCT03924752 237 239 I-Eq_Comparison
degrees NCT03924752 240 247 I-Eq_Comparison
, NCT03924752 248 249 O
knee NCT03924752 250 254 B-Observation
flexion NCT03924752 255 262 I-Observation
ROM NCT03924752 263 266 I-Observation
< NCT03924752 267 268 B-Eq_Comparison
90 NCT03924752 269 271 I-Eq_Comparison
degrees NCT03924752 272 279 I-Eq_Comparison
, NCT03924752 280 281 O
hip NCT03924752 282 285 B-Observation
flexion NCT03924752 286 293 I-Observation
contracture NCT03924752 294 305 I-Observation
< NCT03924752 306 307 B-Eq_Comparison
25 NCT03924752 308 310 I-Eq_Comparison
degrees NCT03924752 311 318 I-Eq_Comparison
, NCT03924752 319 320 O
and NCT03924752 321 324 B-And
ankle NCT03924752 325 330 B-Observation
plantar NCT03924752 331 338 I-Observation
flexion NCT03924752 339 346 I-Observation
contracture NCT03924752 347 358 I-Observation
of NCT03924752 359 361 O
> NCT03924752 362 363 B-Eq_Comparison
15 NCT03924752 364 366 I-Eq_Comparison
degrees NCT03924752 367 374 I-Eq_Comparison
) NCT03924752 375 376 O
. NCT03924752 377 378 O

- NCT03924752 382 383 O
Subjects NCT03924752 385 393 O
must NCT03924752 394 398 O
be NCT03924752 399 401 O
able NCT03924752 402 406 B-Condition
to NCT03924752 407 409 I-Condition
walk NCT03924752 410 414 I-Condition
for NCT03924752 415 418 O
at NCT03924752 419 421 B-Eq_Comparison
least NCT03924752 422 427 I-Eq_Comparison
5 NCT03924752 428 429 I-Eq_Comparison
minutes NCT03924752 430 437 I-Eq_Comparison
and NCT03924752 438 441 B-And
willing NCT03924752 442 449 O
and NCT03924752 450 453 O
able NCT03924752 454 458 B-Condition
to NCT03924752 459 461 I-Condition
participate NCT03924752 462 473 I-Condition
over NCT03924752 474 478 O
a NCT03924752 479 480 O
1 NCT03924752 481 482 B-Eq_Comparison
- NCT03924752 483 484 I-Eq_Comparison
6 NCT03924752 485 486 I-Eq_Comparison
hours NCT03924752 487 492 I-Eq_Comparison
experiment NCT03924752 493 503 O
with NCT03924752 504 508 O
breaks NCT03924752 509 515 O
and NCT03924752 516 519 O
rest NCT03924752 520 524 O
enforced NCT03924752 525 533 O
regularly NCT03924752 534 543 O
and NCT03924752 544 547 O
as NCT03924752 548 550 O
needed NCT03924752 551 557 O
. NCT03924752 558 559 O

- NCT03924752 563 564 O
Subjects NCT03924752 566 574 O
must NCT03924752 575 579 O
be NCT03924752 580 582 O
able NCT03924752 583 587 B-Condition
to NCT03924752 588 590 I-Condition
transfer NCT03924752 591 599 I-Condition
( NCT03924752 600 601 O
sit NCT03924752 602 605 B-Condition
- NCT03924752 606 607 I-Condition
to NCT03924752 608 610 I-Condition
- NCT03924752 611 612 I-Condition
stand NCT03924752 613 618 I-Condition
and NCT03924752 619 622 B-And
stand NCT03924752 623 628 B-Condition
- NCT03924752 629 630 I-Condition
to NCT03924752 631 633 I-Condition
- NCT03924752 634 635 I-Condition
sit NCT03924752 636 639 I-Condition
) NCT03924752 640 641 O
with NCT03924752 642 646 O
no NCT03924752 647 649 O
external NCT03924752 650 658 O
support NCT03924752 659 666 O
( NCT03924752 667 668 O
arm NCT03924752 669 672 O
rests NCT03924752 673 678 O
OK NCT03924752 679 681 O
) NCT03924752 682 683 O
and NCT03924752 684 687 O
to NCT03924752 688 690 O
ambulate NCT03924752 691 699 B-Condition
over NCT03924752 700 704 B-Modifier
small NCT03924752 705 710 I-Modifier
slopes NCT03924752 711 717 I-Modifier
( NCT03924752 718 719 O
3 NCT03924752 720 721 B-Eq_Comparison
degrees NCT03924752 722 729 I-Eq_Comparison
) NCT03924752 730 731 O
and NCT03924752 732 735 B-And
a NCT03924752 736 737 O
few NCT03924752 738 741 O
steps NCT03924752 742 747 B-Modifier
( NCT03924752 748 749 O
6 NCT03924752 750 751 B-Eq_Comparison
steps NCT03924752 752 757 I-Eq_Comparison
) NCT03924752 758 759 O
. NCT03924752 760 761 O

Exclusion NCT03924752 763 772 O
Criteria NCT03924752 773 781 O
: NCT03924752 782 783 O

- NCT03924752 787 788 O
History NCT03924752 790 797 B-Eq_Comparison
of NCT03924752 798 800 O
neurological NCT03924752 801 813 B-Condition
injury NCT03924752 814 820 I-Condition
, NCT03924752 821 822 O
gait NCT03924752 823 827 B-Condition
pathology NCT03924752 828 837 I-Condition
, NCT03924752 838 839 O
or NCT03924752 840 842 B-Or
cardiovascular NCT03924752 843 857 B-Condition
condition NCT03924752 858 867 I-Condition
that NCT03924752 868 872 O
would NCT03924752 873 878 B-Assertion___Assertion_Type_Value:hypothetical
limit NCT03924752 879 884 O
your NCT03924752 885 889 O
ability NCT03924752 890 897 B-Condition
to NCT03924752 898 900 I-Condition
ambulate NCT03924752 901 909 I-Condition
for NCT03924752 910 913 O
multiple NCT03924752 914 922 B-Eq_Comparison
hours NCT03924752 923 928 I-Eq_Comparison
. NCT03924752 929 930 O

Inclusion NCT03864302 0 9 O
Criteria NCT03864302 10 18 O
: NCT03864302 19 20 O

- NCT03864302 24 25 O
Doctors NCT03864302 27 34 B-Provider

- NCT03864302 37 38 O
Informed NCT03864302 40 48 O
written NCT03864302 49 56 O
consent NCT03864302 57 64 O
. NCT03864302 65 66 O

- NCT03864302 70 71 O
Four NCT03864302 73 77 B-Eq_Comparison
video NCT03864302 78 83 O
- NCT03864302 84 85 O
recordings NCT03864302 86 96 O
of NCT03864302 97 99 O
TURBs NCT03864302 100 105 B-Procedure
. NCT03864302 106 107 O

Exclusion NCT03864302 109 118 O
Criteria NCT03864302 119 127 O
: NCT03864302 128 129 O

- NCT03864302 133 134 O
Not NCT03864302 136 139 B-Negation
providing NCT03864302 140 149 O
four NCT03864302 150 154 B-Eq_Comparison
video NCT03864302 155 160 O
recordings NCT03864302 161 171 O
of NCT03864302 172 174 O
TURB NCT03864302 175 179 B-Procedure
procedures NCT03864302 180 190 I-Procedure

- NCT03864302 193 194 O
Simulation NCT03864302 196 206 B-Procedure
- NCT03864302 207 208 I-Procedure
based NCT03864302 209 214 I-Procedure
training NCT03864302 215 223 I-Procedure
course NCT03864302 224 230 O
in NCT03864302 231 233 O
TURB NCT03864302 234 238 B-Procedure
within NCT03864302 239 245 B-Eq_Comparison
6 NCT03864302 246 247 I-Eq_Comparison
months NCT03864302 248 254 I-Eq_Comparison

- NCT03864302 257 258 O
No NCT03864302 260 262 O
consent NCT03864302 263 270 O

Inclusion NCT03922867 0 9 O
Criteria NCT03922867 10 18 O
: NCT03922867 19 20 O

- NCT03922867 24 25 O
Meets NCT03922867 27 32 O
diagnostic NCT03922867 33 43 O
criteria NCT03922867 44 52 O
for NCT03922867 53 56 O
fibromyalgia NCT03922867 57 69 B-Condition

- NCT03922867 72 73 O
Has NCT03922867 75 78 O
insomnia NCT03922867 79 87 B-Condition

- NCT03922867 90 91 O
Have NCT03922867 93 97 O
internet NCT03922867 98 106 O
access NCT03922867 107 113 O
and NCT03922867 114 117 O
a NCT03922867 118 119 O
device NCT03922867 120 126 O
that NCT03922867 127 131 O
can NCT03922867 132 135 O
access NCT03922867 136 142 O
the NCT03922867 143 146 O
web NCT03922867 147 150 O
- NCT03922867 151 152 O
based NCT03922867 153 158 O
program NCT03922867 159 166 O
. NCT03922867 167 168 O

Exclusion NCT03922867 170 179 O
Criteria NCT03922867 180 188 O
: NCT03922867 189 190 O

- NCT03922867 194 195 O
Active NCT03922867 197 203 B-Eq_Comparison
sleep NCT03922867 204 209 B-Condition
disorder NCT03922867 210 218 I-Condition
which NCT03922867 219 224 O
is NCT03922867 225 227 O
not NCT03922867 228 231 B-Negation
treated NCT03922867 232 239 B-Procedure
( NCT03922867 240 241 O
obstructive NCT03922867 242 253 B-Condition
sleep NCT03922867 254 259 I-Condition
apnea NCT03922867 260 265 I-Condition
, NCT03922867 266 267 O
obesity NCT03922867 268 275 B-Condition
hypoventilation NCT03922867 276 291 I-Condition
syndrome NCT03922867 292 300 I-Condition
) NCT03922867 301 302 O

- NCT03922867 306 307 O
Active NCT03922867 309 315 B-Eq_Comparison
psychiatric NCT03922867 316 327 B-Condition
disorder NCT03922867 328 336 I-Condition
( NCT03922867 337 338 O
Bipolar NCT03922867 339 346 B-Condition
affective NCT03922867 347 356 I-Condition
disorder NCT03922867 357 365 I-Condition
, NCT03922867 366 367 O
anxiety NCT03922867 368 375 B-Condition
, NCT03922867 376 377 O
depression NCT03922867 378 388 B-Condition
, NCT03922867 389 390 O
schizophrenia NCT03922867 391 404 B-Condition
) NCT03922867 405 406 O
which NCT03922867 407 412 O
is NCT03922867 413 415 O
not NCT03922867 416 419 O
optimally NCT03922867 420 429 O
managed NCT03922867 430 437 O
. NCT03922867 438 439 O

- NCT03922867 443 444 O
Chronic NCT03922867 446 453 O
fatigue NCT03922867 454 461 B-Condition
syndrome NCT03922867 462 470 I-Condition

- NCT03922867 473 474 O
Morbid NCT03922867 476 482 B-Condition
obesity NCT03922867 483 490 I-Condition

Inclusion NCT03861221 0 9 O
Criteria NCT03861221 10 18 O
: NCT03861221 19 20 O

- NCT03861221 24 25 O
Female NCT03861221 27 33 O
, NCT03861221 34 35 O
older NCT03861221 36 41 B-Eq_Comparison
than NCT03861221 42 46 I-Eq_Comparison
35 NCT03861221 47 49 I-Eq_Comparison
years NCT03861221 50 55 I-Eq_Comparison
. NCT03861221 56 57 O
Already NCT03861221 59 66 B-Eq_Comparison
have NCT03861221 67 71 O
mammography NCT03861221 72 83 B-Procedure
, NCT03861221 84 85 O
or NCT03861221 86 88 B-Or
other NCT03861221 89 94 B-Other
standard NCT03861221 95 103 B-Procedure
exams NCT03861221 104 109 I-Procedure
( NCT03861221 110 111 O
ultrasound NCT03861221 112 122 B-Procedure
, NCT03861221 123 124 O
MRI NCT03861221 125 128 B-Procedure
, NCT03861221 129 130 O
etc NCT03861221 131 134 O
) NCT03861221 135 136 O
. NCT03861221 137 138 O
Could NCT03861221 140 145 B-Assertion___Assertion_Type_Value:hypothetical
participate NCT03861221 146 157 O
this NCT03861221 158 162 O
trial NCT03861221 163 168 B-Study
within NCT03861221 169 175 B-Eq_Comparison
2 NCT03861221 176 177 I-Eq_Comparison
weeks NCT03861221 178 183 I-Eq_Comparison
after NCT03861221 184 189 B-Temporal_Connection___Temporal_Connection_Type_Value:after
mammography NCT03861221 190 201 B-Procedure
. NCT03861221 202 203 O
Have NCT03861221 205 209 O
the NCT03861221 210 213 O
ability NCT03861221 214 221 O
of NCT03861221 222 224 O
consent NCT03861221 225 232 O
inform NCT03861221 233 239 O
. NCT03861221 240 241 O

Exclusion NCT03861221 243 252 O
Criteria NCT03861221 253 261 O
: NCT03861221 262 263 O

- NCT03861221 267 268 O
During NCT03861221 270 276 O
pregnancy NCT03861221 277 286 B-Condition
or NCT03861221 287 289 B-Or
lactation NCT03861221 290 299 B-Condition
period NCT03861221 300 306 O
. NCT03861221 307 308 O
Patients NCT03861221 310 318 O
that NCT03861221 319 323 O
may NCT03861221 324 327 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03861221 328 331 B-Negation
be NCT03861221 332 334 O
capable NCT03861221 335 342 B-Observation
of NCT03861221 343 345 I-Observation
prone NCT03861221 346 351 I-Observation
position NCT03861221 352 360 I-Observation
, NCT03861221 361 362 O
such NCT03861221 363 367 O
as NCT03861221 368 370 O
patients NCT03861221 371 379 O
with NCT03861221 380 384 O
scapulohumeral NCT03861221 385 399 B-Condition
periarthritis NCT03861221 400 413 I-Condition
, NCT03861221 414 415 O
cardiac NCT03861221 416 423 B-Procedure
pacemaker NCT03861221 424 433 I-Procedure
or NCT03861221 434 436 B-Or
have NCT03861221 437 441 O
recent NCT03861221 442 448 B-Eq_Comparison
cardiac NCT03861221 449 456 B-Procedure
surgery NCT03861221 457 464 I-Procedure
. NCT03861221 465 466 O

Lymphoma NCT03861221 468 476 B-Condition
patients NCT03861221 477 485 O
that NCT03861221 486 490 O
under NCT03861221 491 496 B-Eq_Comparison
therapy NCT03861221 497 504 B-Procedure
. NCT03861221 505 506 O
Severe NCT03861221 508 514 O
scoliosis NCT03861221 515 524 B-Condition
. NCT03861221 525 526 O

Inclusion NCT03927638 0 9 O
Criteria NCT03927638 10 18 O
: NCT03927638 19 20 O

- NCT03927638 24 25 O
healthy NCT03927638 27 34 B-Condition
adult NCT03927638 35 40 O

Exclusion NCT03927638 41 50 O
Criteria NCT03927638 51 59 O
: NCT03927638 60 61 O

- NCT03927638 65 66 O
Have NCT03927638 68 72 O
a NCT03927638 73 74 O
history NCT03927638 75 82 B-Eq_Comparison
of NCT03927638 83 85 O
cancer NCT03927638 86 92 B-Condition
, NCT03927638 93 94 O
cardiac NCT03927638 95 102 B-Condition
issues NCT03927638 103 109 I-Condition
, NCT03927638 110 111 O
hypertension NCT03927638 112 124 B-Condition
, NCT03927638 125 126 O
pulmonary NCT03927638 127 136 B-Condition
disease NCT03927638 137 144 I-Condition
, NCT03927638 145 146 O
stroke NCT03927638 147 153 B-Condition
, NCT03927638 154 155 O
neurological NCT03927638 156 168 B-Modifier
or NCT03927638 169 171 B-Or
muscular NCT03927638 172 180 B-Modifier
dystrophy NCT03927638 181 190 B-Condition
, NCT03927638 191 192 O
uncontrolled NCT03927638 193 205 B-Modifier
diabetes NCT03927638 206 214 B-Condition
, NCT03927638 215 216 O
or NCT03927638 217 219 B-Or
any NCT03927638 220 223 O
life NCT03927638 224 228 B-Death|B-Risk
threatening NCT03927638 229 240 I-Death|I-Risk
chronic NCT03927638 241 248 O
conditions NCT03927638 249 259 B-Condition
. NCT03927638 260 261 O

- NCT03927638 265 266 O
Are NCT03927638 268 271 O
currently NCT03927638 272 281 B-Eq_Comparison
being NCT03927638 282 287 O
treated NCT03927638 288 295 B-Procedure
for NCT03927638 296 299 O
infectious NCT03927638 300 310 B-Condition
mononucleosis NCT03927638 311 324 I-Condition
, NCT03927638 325 326 O
hepatitis NCT03927638 327 336 B-Condition
, NCT03927638 337 338 O
pneumonia NCT03927638 339 348 B-Condition
, NCT03927638 349 350 O
or NCT03927638 351 353 B-Or
other NCT03927638 354 359 O
infectious NCT03927638 360 370 B-Condition
diseases NCT03927638 371 379 I-Condition
. NCT03927638 380 381 O

- NCT03927638 385 386 O
Are NCT03927638 388 391 O
unable NCT03927638 392 398 B-Negation
or NCT03927638 399 401 B-Or
unwilling NCT03927638 402 411 B-Negation
to NCT03927638 412 414 O
stand NCT03927638 415 420 B-Observation
in NCT03927638 421 423 I-Observation
one NCT03927638 424 427 I-Observation
position NCT03927638 428 436 I-Observation
continuously NCT03927638 437 449 O
for NCT03927638 450 453 O
15 NCT03927638 454 456 B-Eq_Comparison
- NCT03927638 457 458 I-Eq_Comparison
20 NCT03927638 459 461 I-Eq_Comparison
minutes NCT03927638 462 469 I-Eq_Comparison
at NCT03927638 470 472 O
a NCT03927638 473 474 O
time NCT03927638 475 479 O
. NCT03927638 480 481 O

- NCT03927638 485 486 O
Use NCT03927638 488 491 B-Eq_Comparison
nicotine NCT03927638 492 500 B-Drug
products NCT03927638 501 509 I-Drug
, NCT03927638 510 511 O
or NCT03927638 512 514 B-Or
non NCT03927638 515 518 B-Negation
- NCT03927638 519 520 O
contraceptive NCT03927638 521 534 B-Modifier
hormonal NCT03927638 535 543 B-Procedure
therapy NCT03927638 544 551 I-Procedure
( NCT03927638 552 553 O
birth NCT03927638 554 559 B-Procedure
control NCT03927638 560 567 I-Procedure
is NCT03927638 568 570 O
okay NCT03927638 571 575 B-Exception
) NCT03927638 576 577 O
. NCT03927638 578 579 O

- NCT03927638 583 584 O
Are NCT03927638 586 589 O
pregnant NCT03927638 590 598 B-Condition
or NCT03927638 599 601 B-Or
trying NCT03927638 602 608 B-Assertion___Assertion_Type_Value:intention
to NCT03927638 609 611 I-Assertion___Assertion_Type_Value:intention
become NCT03927638 612 618 O
pregnant NCT03927638 619 627 B-Condition
. NCT03927638 628 629 O

- NCT03927638 633 634 O
Are NCT03927638 636 639 O
not NCT03927638 640 643 B-Negation
between NCT03927638 644 651 B-Eq_Comparison
18 NCT03927638 652 654 I-Eq_Comparison
and NCT03927638 655 658 I-Eq_Comparison
50 NCT03927638 659 661 I-Eq_Comparison
years NCT03927638 662 667 I-Eq_Comparison
of NCT03927638 668 670 O
age NCT03927638 671 674 B-Age
. NCT03927638 675 676 O

Inclusion NCT03862131 0 9 O
Criteria NCT03862131 10 18 O
: NCT03862131 19 20 O

- NCT03862131 24 25 O
Participant NCT03862131 27 38 O
in NCT03862131 39 41 O
the NCT03862131 42 45 O
SURVIVE NCT03862131 46 53 O
registry NCT03862131 54 62 O

- NCT03862131 65 66 O
Signed NCT03862131 68 74 O
informed NCT03862131 75 83 O
consent NCT03862131 84 91 O
form NCT03862131 92 96 O
for NCT03862131 97 100 O
PROACT NCT03862131 101 107 O

- NCT03862131 110 111 O
Histological NCT03862131 113 125 O
diagnosis NCT03862131 126 135 O
of NCT03862131 136 138 O
early NCT03862131 139 144 B-Modifier
or NCT03862131 145 147 B-Or
metastatic NCT03862131 148 158 B-Modifier
breast NCT03862131 159 165 I-Modifier
cancer NCT03862131 166 172 B-Condition
, NCT03862131 173 174 O
lymphoma NCT03862131 175 183 B-Condition
, NCT03862131 184 185 O
sarcoma NCT03862131 186 193 B-Condition
, NCT03862131 194 195 O
leukemia NCT03862131 196 204 B-Condition
, NCT03862131 205 206 O
myeloma NCT03862131 207 214 B-Condition
, NCT03862131 215 216 O
or NCT03862131 217 219 B-Or
lung NCT03862131 220 224 B-Modifier
cancer NCT03862131 225 231 B-Condition
( NCT03862131 232 233 O
patients NCT03862131 234 242 O
with NCT03862131 243 247 O
treated NCT03862131 248 255 B-Procedure
and NCT03862131 256 259 B-And
clinically NCT03862131 260 270 O
stable NCT03862131 271 277 O
brain NCT03862131 278 283 B-Modifier
metastasis NCT03862131 284 294 B-Condition
are NCT03862131 295 298 O
acceptable NCT03862131 299 309 O
) NCT03862131 310 311 O

- NCT03862131 315 316 O
Scheduled NCT03862131 318 327 B-Eq_Comparison
to NCT03862131 328 330 O
receive NCT03862131 331 338 O
anti NCT03862131 339 343 O
- NCT03862131 344 345 O
cancer NCT03862131 346 352 B-Condition
therapy NCT03862131 353 360 B-Procedure
( NCT03862131 361 362 O
radiation NCT03862131 363 372 B-Procedure
therapy NCT03862131 373 380 I-Procedure
is NCT03862131 381 383 O
permitted NCT03862131 384 393 O
) NCT03862131 394 395 O

Exclusion NCT03862131 397 406 O
Criteria NCT03862131 407 415 O
: NCT03862131 416 417 O

- NCT03862131 421 422 O
Contraindication NCT03862131 424 440 B-Contraindication
to NCT03862131 441 443 O
magnetic NCT03862131 444 452 B-Procedure
resonance NCT03862131 453 462 I-Procedure
imaging NCT03862131 463 470 I-Procedure
( NCT03862131 471 472 O
MRI NCT03862131 473 476 B-Procedure
) NCT03862131 477 478 O

- NCT03862131 482 483 O
Unable NCT03862131 485 491 O
to NCT03862131 492 494 O
comply NCT03862131 495 501 O
with NCT03862131 502 506 O
study NCT03862131 507 512 O
investigations NCT03862131 513 527 O
( NCT03862131 528 529 O
in NCT03862131 530 532 O
the NCT03862131 533 536 O
judgment NCT03862131 537 545 O
of NCT03862131 546 548 O
the NCT03862131 549 552 O
investigator NCT03862131 553 565 O
) NCT03862131 566 567 O

- NCT03862131 571 572 O
Life NCT03862131 574 578 B-Observation
expectancy NCT03862131 579 589 I-Observation
less NCT03862131 590 594 B-Eq_Comparison
than NCT03862131 595 599 I-Eq_Comparison
1 NCT03862131 600 601 I-Eq_Comparison
year NCT03862131 602 606 I-Eq_Comparison

Inclusion NCT03923790 0 9 O
Criteria NCT03923790 10 18 O
: NCT03923790 19 20 O

- NCT03923790 24 25 O
Ischemic NCT03923790 27 35 B-Modifier
and NCT03923790 36 39 B-Or
hemorrhagic NCT03923790 40 51 B-Modifier
stroke NCT03923790 52 58 B-Condition
patients NCT03923790 59 67 O

- NCT03923790 70 71 O
Presence NCT03923790 73 81 O
of NCT03923790 82 84 O
at NCT03923790 85 87 B-Eq_Comparison
least NCT03923790 88 93 I-Eq_Comparison
one NCT03923790 94 97 I-Eq_Comparison
of NCT03923790 98 100 O
the NCT03923790 101 104 B-Criteria_Count
following NCT03923790 105 114 I-Criteria_Count
high NCT03923790 115 119 O
risk NCT03923790 120 124 B-Risk
criteria NCT03923790 125 133 O
: NCT03923790 134 135 O
uninsured NCT03923790 136 145 B-Negation
, NCT03923790 146 147 O
Medicaid NCT03923790 148 156 O
payer NCT03923790 157 162 O
status NCT03923790 163 169 O
, NCT03923790 170 171 O
small NCT03923790 172 177 B-Modifier
vessel NCT03923790 178 184 I-Modifier
ischemic NCT03923790 185 193 B-Condition
stroke NCT03923790 194 200 I-Condition
, NCT03923790 201 202 O
hypertensive NCT03923790 203 215 B-Modifier
ICH NCT03923790 216 219 B-Condition
) NCT03923790 220 221 O

- NCT03923790 225 226 O
Age NCT03923790 228 231 B-Age
â¥ NCT03923790 232 233 B-Eq_Comparison
18 NCT03923790 234 236 I-Eq_Comparison
; NCT03923790 237 238 O
presence NCT03923790 239 247 O
of NCT03923790 248 250 O
hypertension NCT03923790 251 263 B-Condition
( NCT03923790 264 265 O
by NCT03923790 266 268 O
clinical NCT03923790 269 277 B-Observation
history NCT03923790 278 285 I-Observation
or NCT03923790 286 288 B-Or
hospital NCT03923790 289 297 O
BP NCT03923790 298 300 B-Observation
â¥ NCT03923790 301 302 B-Eq_Comparison
140 NCT03923790 303 306 I-Eq_Comparison
/ NCT03923790 307 308 I-Eq_Comparison
90 NCT03923790 309 311 I-Eq_Comparison
on NCT03923790 312 314 O
two NCT03923790 315 318 B-Eq_Comparison
occasions NCT03923790 319 328 O
) NCT03923790 329 330 O

- NCT03923790 334 335 O
Plan NCT03923790 337 341 B-Eq_Comparison
to NCT03923790 342 344 O
discharge NCT03923790 345 354 B-Encounter
home NCT03923790 355 359 O
after NCT03923790 360 365 B-Temporal_Connection___Temporal_Connection_Type_Value:after
stroke NCT03923790 366 372 B-Condition

- NCT03923790 375 376 O
Ability NCT03923790 378 385 O
to NCT03923790 386 388 O
provide NCT03923790 389 396 O
consent NCT03923790 397 404 O
( NCT03923790 405 406 O
patient NCT03923790 407 414 O
or NCT03923790 415 417 O
caregiver NCT03923790 418 427 O
) NCT03923790 428 429 O

- NCT03923790 433 434 O
Ability NCT03923790 436 443 O
to NCT03923790 444 446 O
communicate NCT03923790 447 458 O
in NCT03923790 459 461 O
English NCT03923790 462 469 O

Exclusion NCT03923790 470 479 O
Criteria NCT03923790 480 488 O
: NCT03923790 489 490 O

- NCT03923790 494 495 O
modified NCT03923790 497 505 B-Observation
Rankin NCT03923790 506 512 I-Observation
scale NCT03923790 513 518 I-Observation
> NCT03923790 519 520 B-Eq_Comparison
4 NCT03923790 521 522 I-Eq_Comparison
at NCT03923790 523 525 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03923790 526 529 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03923790 530 534 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03923790 535 537 O
enrollment NCT03923790 538 548 B-Study
( NCT03923790 549 550 O
severe NCT03923790 551 557 O
disability NCT03923790 558 568 B-Condition
) NCT03923790 569 570 O

- NCT03923790 574 575 O
life NCT03923790 577 581 B-Observation
expectancy NCT03923790 582 592 I-Observation
< NCT03923790 593 594 B-Eq_Comparison
1 NCT03923790 595 596 I-Eq_Comparison
year NCT03923790 597 601 I-Eq_Comparison
or NCT03923790 602 604 B-Or
terminal NCT03923790 605 613 B-Condition
illness NCT03923790 614 621 I-Condition
, NCT03923790 622 623 O

- NCT03923790 627 628 O
eGFR NCT03923790 630 634 B-Observation
< NCT03923790 635 636 B-Eq_Comparison
30 NCT03923790 637 639 I-Eq_Comparison
at NCT03923790 640 642 B-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03923790 643 647 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03923790 648 650 I-Temporal_Connection___Temporal_Connection_Type_Value:during
discharge NCT03923790 651 660 B-Encounter

- NCT03923790 663 664 O
pregnancy NCT03923790 666 675 B-Condition

- NCT03923790 678 679 O
symptomatic NCT03923790 681 692 B-Condition
flow NCT03923790 693 697 I-Condition
limiting NCT03923790 698 706 O
carotid NCT03923790 707 714 B-Condition
stenosis NCT03923790 715 723 I-Condition
without NCT03923790 724 731 B-Negation
plan NCT03923790 732 736 B-Assertion___Assertion_Type_Value:intention
for NCT03923790 737 740 O
intervention NCT03923790 741 753 B-Procedure

- NCT03923790 756 757 O
urine NCT03923790 759 764 B-Observation
toxicology NCT03923790 765 775 I-Observation
positive NCT03923790 776 784 O
for NCT03923790 785 788 O
cocaine NCT03923790 789 796 B-Drug
or NCT03923790 797 799 B-Or
methamphetamine NCT03923790 800 815 B-Drug
or NCT03923790 816 818 B-Or
recent NCT03923790 819 825 B-Eq_Comparison
use NCT03923790 826 829 O

- NCT03923790 832 833 O
long NCT03923790 835 839 O
- NCT03923790 840 841 O
term NCT03923790 842 846 O
BP NCT03923790 847 849 B-Observation
goal NCT03923790 850 854 B-Assertion___Assertion_Type_Value:hypothetical
â¥ NCT03923790 855 856 B-Eq_Comparison
130 NCT03923790 857 860 I-Eq_Comparison
/ NCT03923790 861 862 I-Eq_Comparison
80 NCT03923790 863 865 I-Eq_Comparison
mmHg NCT03923790 866 870 I-Eq_Comparison
according NCT03923790 871 880 O
to NCT03923790 881 883 O
clinical NCT03923790 884 892 O
team NCT03923790 893 897 O

Patient NCT03869216 0 7 O
Inclusion NCT03869216 8 17 O
Criteria NCT03869216 18 26 O
: NCT03869216 27 28 O

- NCT03869216 32 33 O
Receiving NCT03869216 35 44 B-Eq_Comparison
care NCT03869216 45 49 B-Procedure
at NCT03869216 50 52 O
the NCT03869216 53 56 O
clinical NCT03869216 57 65 O
sites NCT03869216 66 71 O

- NCT03869216 74 75 O
Identify NCT03869216 77 85 O
as NCT03869216 86 88 O
African NCT03869216 89 96 O
American NCT03869216 97 105 O
male NCT03869216 106 110 O

- NCT03869216 113 114 O
Ages NCT03869216 116 120 B-Age
40 NCT03869216 121 123 B-Eq_Comparison
- NCT03869216 124 125 I-Eq_Comparison
69 NCT03869216 126 128 I-Eq_Comparison
years NCT03869216 129 134 I-Eq_Comparison
old NCT03869216 135 138 O

- NCT03869216 141 142 O
Provider NCT03869216 144 152 O
- NCT03869216 153 154 O
estimated NCT03869216 155 164 O
life NCT03869216 165 169 B-Observation
expectancy NCT03869216 170 180 I-Observation
of NCT03869216 181 183 O
at NCT03869216 184 186 B-Eq_Comparison
least NCT03869216 187 192 I-Eq_Comparison
10 NCT03869216 193 195 I-Eq_Comparison
years NCT03869216 196 201 I-Eq_Comparison

Patient NCT03869216 202 209 O
Exclusion NCT03869216 210 219 O
Criteria NCT03869216 220 228 O
: NCT03869216 229 230 O

- NCT03869216 234 235 O
Personal NCT03869216 237 245 O
history NCT03869216 246 253 B-Eq_Comparison
of NCT03869216 254 256 O
prostate NCT03869216 257 265 B-Modifier
cancer NCT03869216 266 272 B-Condition
at NCT03869216 273 275 O
the NCT03869216 276 279 O
time NCT03869216 280 284 O
of NCT03869216 285 287 O
consent NCT03869216 288 295 O

- NCT03869216 298 299 O
Cognitive NCT03869216 301 310 B-Condition
impairment NCT03869216 311 321 I-Condition
that NCT03869216 322 326 O
would NCT03869216 327 332 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03869216 333 342 O
with NCT03869216 343 347 O
participation NCT03869216 348 361 O
in NCT03869216 362 364 O
the NCT03869216 365 368 O
study NCT03869216 369 374 B-Study

- NCT03869216 377 378 O
Unable NCT03869216 380 386 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03869216 387 389 O
complete NCT03869216 390 398 O
any NCT03869216 399 402 O
aspect NCT03869216 403 409 O
of NCT03869216 410 412 O
the NCT03869216 413 416 O
intervention NCT03869216 417 429 B-Study
within NCT03869216 430 436 O
the NCT03869216 437 440 O
specified NCT03869216 441 450 O
time NCT03869216 451 455 O
limit NCT03869216 456 461 O

Inclusion NCT03865797 0 9 O
Criteria NCT03865797 10 18 O
: NCT03865797 19 20 O

- NCT03865797 24 25 O
Rugby NCT03865797 27 32 B-Observation
players NCT03865797 33 40 I-Observation

- NCT03865797 43 44 O
Both NCT03865797 46 50 O
gender NCT03865797 51 57 O

- NCT03865797 60 61 O
From NCT03865797 63 67 B-Eq_Comparison
18 NCT03865797 68 70 I-Eq_Comparison
to NCT03865797 71 73 I-Eq_Comparison
40 NCT03865797 74 76 I-Eq_Comparison
years NCT03865797 77 82 I-Eq_Comparison
old NCT03865797 83 86 B-Age

- NCT03865797 89 90 O
Federated NCT03865797 92 101 O
. NCT03865797 102 103 O

Exclusion NCT03865797 105 114 O
Criteria NCT03865797 115 123 O
: NCT03865797 124 125 O

- NCT03865797 129 130 O
At NCT03865797 132 134 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865797 135 138 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03865797 139 143 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03865797 144 146 O
the NCT03865797 147 150 O
study NCT03865797 151 156 B-Study
, NCT03865797 157 158 O
they NCT03865797 159 163 O
present NCT03865797 164 171 O
an NCT03865797 172 174 O
injury NCT03865797 175 181 B-Condition
that NCT03865797 182 186 O
prevents NCT03865797 187 195 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
them NCT03865797 196 200 O
from NCT03865797 201 205 O
carrying NCT03865797 206 214 O
out NCT03865797 215 218 O
the NCT03865797 219 222 O
proposed NCT03865797 223 231 O
intervention NCT03865797 232 244 B-Procedure

- NCT03865797 247 248 O
Included NCT03865797 250 258 O
in NCT03865797 259 261 O
a NCT03865797 262 263 O
personal NCT03865797 264 272 B-Observation
training NCT03865797 273 281 I-Observation
regime NCT03865797 282 288 I-Observation

- NCT03865797 291 292 O
With NCT03865797 294 298 O
musculoskeletal NCT03865797 299 314 B-Modifier
injuries NCT03865797 315 323 B-Condition
in NCT03865797 324 326 O
the NCT03865797 327 330 O
ankle NCT03865797 331 336 B-Modifier
in NCT03865797 337 339 O
the NCT03865797 340 343 O
last NCT03865797 344 348 B-Eq_Comparison
3 NCT03865797 349 350 I-Eq_Comparison
months NCT03865797 351 357 I-Eq_Comparison

- NCT03865797 360 361 O
Not NCT03865797 363 366 O
sign NCT03865797 367 371 O
the NCT03865797 372 375 O
informed NCT03865797 376 384 O
consent NCT03865797 385 392 O
document NCT03865797 393 401 O
. NCT03865797 402 403 O

Inclusion NCT03864900 0 9 O
Criteria NCT03864900 10 18 O
: NCT03864900 19 20 O

1 NCT03864900 24 25 O
. NCT03864900 25 26 O
â¥ NCT03864900 28 29 B-Eq_Comparison
20 NCT03864900 30 32 I-Eq_Comparison
years NCT03864900 33 38 I-Eq_Comparison
of NCT03864900 39 41 O
age NCT03864900 42 45 B-Age

2 NCT03864900 48 49 O
. NCT03864900 49 50 O
fluent NCT03864900 52 58 O
in NCT03864900 59 61 O
Mandarin NCT03864900 62 70 O
or NCT03864900 71 73 B-Or
Taiwanese NCT03864900 74 83 O

3 NCT03864900 86 87 O
. NCT03864900 87 88 O
diagnosed NCT03864900 90 99 O
with NCT03864900 100 104 O
AF NCT03864900 105 107 B-Condition

4 NCT03864900 110 111 O
. NCT03864900 111 112 O
treated NCT03864900 114 121 B-Procedure
with NCT03864900 122 126 O
warfarin NCT03864900 127 135 B-Drug
or NCT03864900 136 138 B-Or
NOACs NCT03864900 139 144 B-Drug
for NCT03864900 145 148 O
anticoagulation NCT03864900 149 164 B-Procedure
. NCT03864900 165 166 O

Exclusion NCT03864900 168 177 O
Criteria NCT03864900 178 186 O
: NCT03864900 187 188 O

1 NCT03864900 192 193 O
. NCT03864900 193 194 O
diagnosed NCT03864900 196 205 O
with NCT03864900 206 210 O
psychological NCT03864900 211 224 B-Condition
diseases NCT03864900 225 233 I-Condition

2 NCT03864900 236 237 O
. NCT03864900 237 238 O
diagnosed NCT03864900 240 249 O
with NCT03864900 250 254 O
uncontrolled NCT03864900 255 267 B-Modifier
hypertension NCT03864900 268 280 B-Condition

3 NCT03864900 283 284 O
. NCT03864900 284 285 O
diagnosed NCT03864900 287 296 O
with NCT03864900 297 301 O
the NCT03864900 302 305 O
New NCT03864900 306 309 B-Observation
York NCT03864900 310 314 I-Observation
Heart NCT03864900 315 320 I-Observation
Association NCT03864900 321 332 I-Observation
( NCT03864900 333 334 O
NYHA NCT03864900 335 339 B-Observation
) NCT03864900 340 341 O
grade NCT03864900 342 347 B-Eq_Comparison
VI NCT03864900 348 350 I-Eq_Comparison
heart NCT03864900 351 356 B-Condition
failure NCT03864900 357 364 I-Condition

4 NCT03864900 367 368 O
. NCT03864900 368 369 O
implanted NCT03864900 371 380 O
with NCT03864900 381 385 O
a NCT03864900 386 387 O
cardiac NCT03864900 388 395 B-Procedure
pacemaker NCT03864900 396 405 I-Procedure

5 NCT03864900 408 409 O
. NCT03864900 409 410 O
had NCT03864900 412 415 O
a NCT03864900 416 417 O
cardiac NCT03864900 418 425 B-Procedure
surgery NCT03864900 426 433 I-Procedure
in NCT03864900 434 436 O
the NCT03864900 437 440 O
past NCT03864900 441 445 B-Eq_Comparison
three NCT03864900 446 451 I-Eq_Comparison
months NCT03864900 452 458 I-Eq_Comparison

6 NCT03864900 461 462 O
. NCT03864900 462 463 O
hospitalized NCT03864900 465 477 B-Encounter
for NCT03864900 478 481 O
AF NCT03864900 482 484 B-Condition
in NCT03864900 485 487 O
the NCT03864900 488 491 O
past NCT03864900 492 496 B-Eq_Comparison
three NCT03864900 497 502 I-Eq_Comparison
months NCT03864900 503 509 I-Eq_Comparison
. NCT03864900 510 511 O

Inclusion NCT03865966 0 9 O
Criteria NCT03865966 10 18 O
: NCT03865966 19 20 O

- NCT03865966 24 25 O
Patients NCT03865966 27 35 O
with NCT03865966 36 40 O
end NCT03865966 41 44 B-Modifier
- NCT03865966 45 46 I-Modifier
stage NCT03865966 47 52 I-Modifier
liver NCT03865966 53 58 B-Condition
disease NCT03865966 59 66 I-Condition
who NCT03865966 67 70 B-And
require NCT03865966 71 78 B-Assertion___Assertion_Type_Value:hypothetical
liver NCT03865966 79 84 B-Procedure
transplantation NCT03865966 85 100 I-Procedure

Exclusion NCT03865966 101 110 O
Criteria NCT03865966 111 119 O
: NCT03865966 120 121 O

- NCT03865966 125 126 O
Children NCT03865966 128 136 O
without NCT03865966 137 144 B-Negation
liver NCT03865966 145 150 B-Procedure
transplantation NCT03865966 151 166 I-Procedure
refer NCT03865966 167 172 O
to NCT03865966 173 175 O
children NCT03865966 176 184 O
; NCT03865966 184 185 O

- NCT03865966 188 189 O
Children NCT03865966 191 199 O
who NCT03865966 200 203 O
are NCT03865966 204 207 O
unwilling NCT03865966 208 217 O
to NCT03865966 218 220 O
participate NCT03865966 221 232 O
; NCT03865966 232 233 O

Inclusion NCT03920748 0 9 O
Criteria NCT03920748 10 18 O
: NCT03920748 19 20 O

- NCT03920748 24 25 O
Newborn NCT03920748 27 34 O
and NCT03920748 35 38 B-Or
infant NCT03920748 39 45 O
age NCT03920748 46 49 O
group NCT03920748 50 55 O

- NCT03920748 58 59 O
Undergoing NCT03920748 61 71 B-Eq_Comparison
elective NCT03920748 72 80 B-Modifier
surgery NCT03920748 81 88 B-Procedure
requiring NCT03920748 89 98 O
intubation NCT03920748 99 109 B-Procedure
under NCT03920748 110 115 O
general NCT03920748 116 123 B-Procedure
anesthesia NCT03920748 124 134 I-Procedure

Exclusion NCT03920748 135 144 O
Criteria NCT03920748 145 153 O
: NCT03920748 154 155 O

- NCT03920748 159 160 O
History NCT03920748 162 169 B-Eq_Comparison
of NCT03920748 170 172 O
congenital NCT03920748 173 183 B-Modifier
maxillofacial NCT03920748 184 197 B-Condition
defect NCT03920748 198 204 I-Condition
, NCT03920748 205 206 O

- NCT03920748 210 211 O
History NCT03920748 213 220 B-Eq_Comparison
of NCT03920748 221 223 O
upper NCT03920748 224 229 B-Condition
airway NCT03920748 230 236 I-Condition
pathology NCT03920748 237 246 I-Condition
( NCT03920748 247 248 O
tumor NCT03920748 249 254 B-Condition
, NCT03920748 255 256 O
cleft NCT03920748 257 262 B-Condition
palate NCT03920748 263 269 I-Condition
- NCT03920748 270 271 I-Condition
lips NCT03920748 272 276 I-Condition
, NCT03920748 277 278 O
etc NCT03920748 279 282 O
. NCT03920748 283 284 O
) NCT03920748 285 286 O

- NCT03920748 290 291 O
History NCT03920748 293 300 B-Eq_Comparison
of NCT03920748 301 303 O
head NCT03920748 304 308 B-Modifier
and NCT03920748 309 312 B-Or
neck NCT03920748 313 317 B-Modifier
trauma NCT03920748 318 324 B-Condition
( NCT03920748 325 326 O
fracture NCT03920748 327 335 B-Condition
, NCT03920748 336 337 O
swelling NCT03920748 338 346 B-Condition
, NCT03920748 347 348 O
scar NCT03920748 349 353 B-Condition
) NCT03920748 354 355 O

Inclusion NCT03862508 0 9 O
Criteria NCT03862508 10 18 O
: NCT03862508 19 20 O

- NCT03862508 24 25 O
Height NCT03862508 27 33 B-Observation
jumpers NCT03862508 34 41 I-Observation

- NCT03862508 44 45 O
Age NCT03862508 47 50 B-Age
between NCT03862508 51 58 B-Eq_Comparison
18 NCT03862508 59 61 I-Eq_Comparison
and NCT03862508 62 65 I-Eq_Comparison
40 NCT03862508 66 68 I-Eq_Comparison
years NCT03862508 69 74 I-Eq_Comparison

- NCT03862508 77 78 O
Currently NCT03862508 80 89 O
participate NCT03862508 90 101 O
in NCT03862508 102 104 O
the NCT03862508 105 108 O
competitive NCT03862508 109 120 O
field NCT03862508 121 126 O

Exclusion NCT03862508 127 136 O
Criteria NCT03862508 137 145 O
: NCT03862508 146 147 O

- NCT03862508 151 152 O
Present NCT03862508 154 161 O
medical NCT03862508 162 169 O
diagnosis NCT03862508 170 179 O
of NCT03862508 180 182 O
musculoskeletal NCT03862508 183 198 B-Modifier
pathology NCT03862508 199 208 B-Condition

- NCT03862508 211 212 O
Who NCT03862508 214 217 O
have NCT03862508 218 222 O
not NCT03862508 223 226 B-Negation
had NCT03862508 227 230 O
musculoskeletal NCT03862508 231 246 B-Modifier
injuries NCT03862508 247 255 B-Condition
in NCT03862508 256 258 O
the NCT03862508 259 262 O
last NCT03862508 263 267 B-Eq_Comparison
month NCT03862508 268 273 I-Eq_Comparison

- NCT03862508 276 277 O
Not NCT03862508 279 282 O
signed NCT03862508 283 289 O
the NCT03862508 290 293 O
informed NCT03862508 294 302 O
consent NCT03862508 303 310 O
document NCT03862508 311 319 O
. NCT03862508 320 321 O

Inclusion NCT03926949 0 9 O
Criteria NCT03926949 10 18 O
: NCT03926949 19 20 O

1 NCT03926949 24 25 O
. NCT03926949 25 26 O
Patients NCT03926949 28 36 O
18 NCT03926949 37 39 B-Eq_Comparison
years NCT03926949 40 45 I-Eq_Comparison
of NCT03926949 46 48 I-Eq_Comparison
age NCT03926949 49 52 I-Eq_Comparison
or NCT03926949 53 55 I-Eq_Comparison
older NCT03926949 56 61 I-Eq_Comparison

2 NCT03926949 64 65 O
. NCT03926949 65 66 O
Patients NCT03926949 68 76 O
screened NCT03926949 77 85 O
at NCT03926949 86 88 O
risk NCT03926949 89 93 B-Risk
of NCT03926949 94 96 O
malnutrition NCT03926949 97 109 B-Condition
by NCT03926949 110 112 O
Canadian NCT03926949 113 121 B-Observation
Nutrition NCT03926949 122 131 I-Observation
Screening NCT03926949 132 141 I-Observation
Tool NCT03926949 142 146 I-Observation
( NCT03926949 147 148 O
CNST NCT03926949 149 153 B-Observation
) NCT03926949 154 155 O
and NCT03926949 156 159 B-And
identified NCT03926949 160 170 O
as NCT03926949 171 173 O
malnourished NCT03926949 174 186 B-Condition
by NCT03926949 187 189 O
subjective NCT03926949 190 200 B-Procedure
global NCT03926949 201 207 I-Procedure
assessment NCT03926949 208 218 I-Procedure
( NCT03926949 219 220 O
SGA NCT03926949 221 224 B-Procedure
) NCT03926949 225 226 O
B NCT03926949 227 228 B-Modifier
or NCT03926949 229 231 B-Or
C NCT03926949 232 233 B-Modifier

Exclusion NCT03926949 234 243 O
Criteria NCT03926949 244 252 O
: NCT03926949 253 254 O

1 NCT03926949 258 259 O
. NCT03926949 259 260 O
Patients NCT03926949 262 270 O
undergoing NCT03926949 271 281 B-Eq_Comparison
minor NCT03926949 282 287 B-Modifier
or NCT03926949 288 290 B-Or
laparoscopic NCT03926949 291 303 B-Modifier
surgery NCT03926949 304 311 B-Procedure

2 NCT03926949 314 315 O
. NCT03926949 315 316 O
Pregnancy NCT03926949 318 327 B-Condition

3 NCT03926949 330 331 O
. NCT03926949 331 332 O
Patients NCT03926949 334 342 O
with NCT03926949 343 347 O
severe NCT03926949 348 354 O
systemic NCT03926949 355 363 B-Modifier
diseases NCT03926949 364 372 B-Condition
defined NCT03926949 373 380 O
by NCT03926949 381 383 O
American NCT03926949 384 392 B-Observation
Society NCT03926949 393 400 I-Observation
of NCT03926949 401 403 I-Observation
Anesthesiologists NCT03926949 404 421 I-Observation
( NCT03926949 422 423 O
ASA NCT03926949 424 427 B-Observation
) NCT03926949 428 429 O
classification NCT03926949 430 444 B-Eq_Comparison
III NCT03926949 445 448 I-Eq_Comparison
to NCT03926949 449 451 I-Eq_Comparison
V NCT03926949 452 453 I-Eq_Comparison

4 NCT03926949 456 457 O
. NCT03926949 457 458 O
Patients NCT03926949 460 468 O
with NCT03926949 469 473 O
diabetes NCT03926949 474 482 B-Condition
mellitus NCT03926949 483 491 I-Condition

5 NCT03926949 494 495 O
. NCT03926949 495 496 O
Patients NCT03926949 498 506 O
with NCT03926949 507 511 O
planned NCT03926949 512 519 B-Eq_Comparison
palliative NCT03926949 520 530 B-Procedure
treatment NCT03926949 531 540 I-Procedure

Inclusion NCT03862677 0 9 O
Criteria NCT03862677 10 18 O
: NCT03862677 19 20 O

- NCT03862677 24 25 O
Patients NCT03862677 27 35 O
with NCT03862677 36 40 O
( NCT03862677 41 42 O
suspicion NCT03862677 43 52 B-Assertion___Assertion_Type_Value:possible
of NCT03862677 53 55 O
) NCT03862677 56 57 O
primary NCT03862677 58 65 B-Modifier
or NCT03862677 66 68 B-Or
recurrent NCT03862677 69 78 B-Modifier
EOC NCT03862677 79 82 B-Condition
with NCT03862677 83 87 B-And
an NCT03862677 88 90 O
indication NCT03862677 91 101 B-Indication
for NCT03862677 102 105 O
surgery NCT03862677 106 113 B-Procedure
, NCT03862677 114 115 O
chemotherapy NCT03862677 116 128 B-Procedure
and NCT03862677 129 132 B-Or
/ NCT03862677 133 134 I-Or
or NCT03862677 135 137 I-Or
immunotherapy NCT03862677 138 151 B-Procedure
. NCT03862677 152 153 O

- NCT03862677 157 158 O
Age NCT03862677 160 163 B-Age
â¥ NCT03862677 164 165 B-Eq_Comparison
18 NCT03862677 166 168 I-Eq_Comparison
years NCT03862677 169 174 I-Eq_Comparison
. NCT03862677 175 176 O

- NCT03862677 180 181 O
WHO NCT03862677 183 186 B-Observation
performance NCT03862677 187 198 I-Observation
status NCT03862677 199 205 I-Observation
0 NCT03862677 206 207 B-Eq_Comparison
- NCT03862677 208 209 I-Eq_Comparison
2 NCT03862677 210 211 I-Eq_Comparison
. NCT03862677 211 212 O

- NCT03862677 216 217 O
Accessible NCT03862677 219 229 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03862677 230 233 I-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03862677 234 243 B-Procedure
and NCT03862677 244 247 B-And
follow NCT03862677 248 254 B-Encounter
- NCT03862677 255 256 I-Encounter
up NCT03862677 257 259 I-Encounter
. NCT03862677 260 261 O

- NCT03862677 265 266 O
Written NCT03862677 268 275 O
informed NCT03862677 276 284 O
consent NCT03862677 285 292 O
. NCT03862677 293 294 O

Exclusion NCT03862677 296 305 O
Criteria NCT03862677 306 314 O
: NCT03862677 315 316 O

- NCT03862677 320 321 O
Other NCT03862677 323 328 B-Other
active NCT03862677 329 335 B-Eq_Comparison
malignancy NCT03862677 336 346 B-Condition
in NCT03862677 347 349 O
past NCT03862677 350 354 B-Eq_Comparison
5 NCT03862677 355 356 I-Eq_Comparison
years NCT03862677 357 362 I-Eq_Comparison
prior NCT03862677 363 368 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862677 369 371 I-Temporal_Connection___Temporal_Connection_Type_Value:before
entry NCT03862677 372 377 O
into NCT03862677 378 382 O
the NCT03862677 383 386 O
study NCT03862677 387 392 B-Study
, NCT03862677 393 394 O
except NCT03862677 395 401 B-Exception
for NCT03862677 402 405 O
treated NCT03862677 406 413 B-Procedure
non NCT03862677 414 417 B-Negation
- NCT03862677 418 419 O
melanoma NCT03862677 420 428 B-Modifier
skin NCT03862677 429 433 I-Modifier
cancer NCT03862677 434 440 B-Condition
. NCT03862677 441 442 O

- NCT03862677 446 447 O
Any NCT03862677 449 452 O
known NCT03862677 453 458 O
severe NCT03862677 459 465 O
infection NCT03862677 466 475 B-Condition
like NCT03862677 476 480 O
HIV NCT03862677 481 484 B-Condition
, NCT03862677 485 486 O
hepatitis NCT03862677 487 496 B-Condition
A NCT03862677 497 498 B-Modifier
, NCT03862677 499 500 O
B NCT03862677 501 502 B-Modifier
and NCT03862677 503 506 B-Or
C NCT03862677 507 508 B-Modifier
. NCT03862677 509 510 O

- NCT03862677 514 515 O
Receiving NCT03862677 517 526 B-Eq_Comparison
immune NCT03862677 527 533 B-Procedure
suppressive NCT03862677 534 545 I-Procedure
treatment NCT03862677 546 555 I-Procedure
. NCT03862677 556 557 O

- NCT03862677 561 562 O
Medical NCT03862677 564 571 B-Modifier
or NCT03862677 572 574 B-Or
psychological NCT03862677 575 588 B-Modifier
condition NCT03862677 589 598 B-Condition
which NCT03862677 599 604 O
in NCT03862677 605 607 O
the NCT03862677 608 611 O
opinion NCT03862677 612 619 O
of NCT03862677 620 622 O
the NCT03862677 623 626 O
investigator NCT03862677 627 639 O
would NCT03862677 640 645 O
not NCT03862677 646 649 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
permit NCT03862677 650 656 O
the NCT03862677 657 660 O
patient NCT03862677 661 668 O
to NCT03862677 669 671 O
complete NCT03862677 672 680 O
the NCT03862677 681 684 O
study NCT03862677 685 690 B-Study
or NCT03862677 691 693 O
sign NCT03862677 694 698 O
meaningful NCT03862677 699 709 O
informed NCT03862677 710 718 O
consent NCT03862677 719 726 O
. NCT03862677 727 728 O

Inclusion NCT03868514 0 9 O
Criteria NCT03868514 10 18 O
: NCT03868514 19 20 O

Age NCT03868514 22 25 B-Age
[ NCT03868514 26 27 O
â¥ NCT03868514 28 29 B-Eq_Comparison
18 NCT03868514 30 32 I-Eq_Comparison
] NCT03868514 33 34 O

Indications NCT03868514 36 47 B-Indication
of NCT03868514 48 50 O
breast NCT03868514 51 57 B-Procedure
reconstruction NCT03868514 58 72 I-Procedure
: NCT03868514 73 74 O
histologically NCT03868514 75 89 B-Procedure
confirmed NCT03868514 90 99 O
breast NCT03868514 100 106 B-Modifier
cancer NCT03868514 107 113 B-Condition
, NCT03868514 114 115 O
precancerous NCT03868514 116 128 B-Modifier
lesions NCT03868514 129 136 B-Condition
( NCT03868514 137 138 O
DCIS NCT03868514 139 143 B-Condition
, NCT03868514 144 145 O
LCIS NCT03868514 146 150 B-Condition
) NCT03868514 151 152 O
, NCT03868514 153 154 O
mutation NCT03868514 155 163 B-Condition
carrier NCT03868514 164 171 I-Condition
with NCT03868514 172 176 B-And
increased NCT03868514 177 186 O
breast NCT03868514 187 193 B-Condition
cancer NCT03868514 194 200 I-Condition
risk NCT03868514 201 205 B-Risk
, NCT03868514 206 207 O
strong NCT03868514 208 214 O
family NCT03868514 215 221 B-Family_Member
history NCT03868514 222 229 I-Family_Member
( NCT03868514 230 231 O
lifetime NCT03868514 232 240 O
risk NCT03868514 241 245 B-Risk
> NCT03868514 246 247 B-Eq_Comparison
15 NCT03868514 248 250 I-Eq_Comparison
% NCT03868514 251 252 I-Eq_Comparison
) NCT03868514 253 254 O

The NCT03868514 256 259 O
patient NCT03868514 260 267 O
is NCT03868514 268 270 O
capable NCT03868514 271 278 O
to NCT03868514 279 281 O
realise NCT03868514 282 289 O
the NCT03868514 290 293 O
nature NCT03868514 294 300 O
, NCT03868514 301 302 O
aims NCT03868514 303 307 O
and NCT03868514 308 311 O
possible NCT03868514 312 320 O
consequences NCT03868514 321 333 O
of NCT03868514 334 336 O
the NCT03868514 337 340 O
clinical NCT03868514 341 349 O
trial NCT03868514 350 355 O
( NCT03868514 356 357 O
MPG NCT03868514 358 361 O
Â§ NCT03868514 362 363 O
20.2.1 NCT03868514 364 370 O
) NCT03868514 371 372 O

Patient NCT03868514 374 381 O
information NCT03868514 382 393 O
has NCT03868514 394 397 O
been NCT03868514 398 402 O
provided NCT03868514 403 411 O
and NCT03868514 412 415 O
all NCT03868514 416 419 O
written NCT03868514 420 427 O
consents NCT03868514 428 436 O
of NCT03868514 437 439 O
the NCT03868514 440 443 O
patient NCT03868514 444 451 O
are NCT03868514 452 455 O
available NCT03868514 456 465 O

Exclusion NCT03868514 466 475 O
Criteria NCT03868514 476 484 O
: NCT03868514 485 486 O

Metastatic NCT03868514 488 498 B-Modifier
breast NCT03868514 499 505 B-Condition
cancer NCT03868514 506 512 I-Condition

Patient NCT03868514 513 520 O
with NCT03868514 521 525 O
known NCT03868514 526 531 O
contraindications NCT03868514 532 549 B-Contraindication
against NCT03868514 550 557 O
mesh NCT03868514 558 562 B-Modifier
- NCT03868514 563 564 I-Modifier
assisted NCT03868514 565 573 I-Modifier
or NCT03868514 574 576 B-Or
plastic NCT03868514 577 584 B-Modifier
- NCT03868514 585 586 I-Modifier
reconstructive NCT03868514 587 601 I-Modifier
breast NCT03868514 602 608 B-Procedure
surgery NCT03868514 609 616 I-Procedure
according NCT03868514 617 626 O
to NCT03868514 627 629 O
the NCT03868514 630 633 O
instruction NCT03868514 634 645 O
for NCT03868514 646 649 O
use NCT03868514 650 653 O

Patient NCT03868514 654 661 O
is NCT03868514 662 664 O
kept NCT03868514 665 669 O
in NCT03868514 670 672 O
an NCT03868514 673 675 O
institution NCT03868514 676 687 B-Observation
under NCT03868514 688 693 I-Observation
judicial NCT03868514 694 702 I-Observation
or NCT03868514 703 705 O
official NCT03868514 706 714 O
orders NCT03868514 715 721 O
( NCT03868514 722 723 O
MPG NCT03868514 724 727 O
Â§ NCT03868514 728 729 O
20.3 NCT03868514 730 734 O
) NCT03868514 735 736 O

Participate NCT03868514 738 749 O
in NCT03868514 750 752 O
another NCT03868514 753 760 B-Other
operative NCT03868514 761 770 B-Procedure
clinical NCT03868514 771 779 B-Study
trial NCT03868514 780 785 I-Study
, NCT03868514 786 787 O
if NCT03868514 788 790 O
it NCT03868514 791 793 O
relates NCT03868514 794 801 O
to NCT03868514 802 804 O
the NCT03868514 805 808 O
area NCT03868514 809 813 O
of NCT03868514 814 816 O
reconstructive NCT03868514 817 831 B-Procedure
breast NCT03868514 832 838 I-Procedure
surgery NCT03868514 839 846 I-Procedure
and NCT03868514 847 850 B-Or
/ NCT03868514 851 852 I-Or
or NCT03868514 853 855 I-Or
influences NCT03868514 856 866 O
the NCT03868514 867 870 O
primary NCT03868514 871 878 O
endpoint NCT03868514 879 887 O
of NCT03868514 888 890 O
the NCT03868514 891 894 O
clinical NCT03868514 895 903 O
trial NCT03868514 904 909 B-Study


Inclusion NCT03927794 0 9 O
Criteria NCT03927794 10 18 O
: NCT03927794 19 20 O

- NCT03927794 24 25 O
â¥ NCT03927794 27 28 B-Eq_Comparison
1 NCT03927794 29 30 I-Eq_Comparison
Primary NCT03927794 31 38 B-Modifier
Anterior NCT03927794 39 47 I-Modifier
Teeth NCT03927794 48 53 I-Modifier
with NCT03927794 54 58 O
early NCT03927794 59 64 B-Modifier
carious NCT03927794 65 72 B-Condition
lesion NCT03927794 73 79 I-Condition
( NCT03927794 80 81 O
Class NCT03927794 82 87 B-Eq_Comparison
V NCT03927794 88 89 I-Eq_Comparison
) NCT03927794 90 91 O
of NCT03927794 92 94 B-And
ICDAS NCT03927794 95 100 B-Observation
scores NCT03927794 101 107 I-Observation
1 NCT03927794 108 109 B-Eq_Comparison
- NCT03927794 110 111 I-Eq_Comparison
2 NCT03927794 112 113 O
. NCT03927794 113 114 O

- NCT03927794 118 119 O
Subjects NCT03927794 121 129 O
whose NCT03927794 130 135 O
parents NCT03927794 136 143 O
are NCT03927794 144 147 O
willing NCT03927794 148 155 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03927794 156 159 I-Assertion___Assertion_Type_Value:hypothetical
able NCT03927794 160 164 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03927794 165 167 O
maintain NCT03927794 168 176 O
good NCT03927794 177 181 O
oral NCT03927794 182 186 B-Condition
hygiene NCT03927794 187 194 I-Condition
for NCT03927794 195 198 O
their NCT03927794 199 204 O
children NCT03927794 205 213 B-Family_Member___Family_Member_Type:child
and NCT03927794 214 217 B-And
attend NCT03927794 218 224 O
study NCT03927794 225 230 B-Study
visits NCT03927794 231 237 O
. NCT03927794 238 239 O

- NCT03927794 243 244 O
Subjects NCT03927794 246 254 O
with NCT03927794 255 259 O
Saliva NCT03927794 260 266 B-Observation
of NCT03927794 267 269 O
normal NCT03927794 270 276 O
flow NCT03927794 277 281 B-Modifier
rates NCT03927794 282 287 I-Modifier
( NCT03927794 288 289 O
30 NCT03927794 290 292 B-Eq_Comparison
- NCT03927794 293 294 I-Eq_Comparison
60 NCT03927794 295 297 I-Eq_Comparison
sec NCT03927794 298 301 I-Eq_Comparison
) NCT03927794 302 303 O
and NCT03927794 304 307 B-And
with NCT03927794 308 312 O
healthy NCT03927794 313 320 O
saliva NCT03927794 321 327 B-Observation
pH NCT03927794 328 330 I-Observation
6.75 NCT03927794 331 335 B-Eq_Comparison
- NCT03927794 336 337 I-Eq_Comparison
7.25 NCT03927794 338 342 I-Eq_Comparison
. NCT03927794 342 343 O

- NCT03927794 352 353 O
Patients NCT03927794 355 363 O
aged NCT03927794 364 368 B-Age
between NCT03927794 369 376 B-Eq_Comparison
3 NCT03927794 377 378 I-Eq_Comparison
- NCT03927794 379 380 I-Eq_Comparison
5 NCT03927794 381 382 I-Eq_Comparison
years NCT03927794 383 388 I-Eq_Comparison
. NCT03927794 389 390 O

- NCT03927794 394 395 O
Subjects NCT03927794 397 405 O
with NCT03927794 406 410 O
a NCT03927794 411 412 O
minimum NCT03927794 413 420 B-Eq_Comparison
of NCT03927794 421 423 I-Eq_Comparison
1 NCT03927794 424 425 I-Eq_Comparison
and NCT03927794 426 429 O
a NCT03927794 430 431 O
maximum NCT03927794 432 439 B-Eq_Comparison
of NCT03927794 440 442 I-Eq_Comparison
12 NCT03927794 443 445 I-Eq_Comparison
primary NCT03927794 446 453 B-Modifier
anterior NCT03927794 454 462 I-Modifier
teeth NCT03927794 463 468 I-Modifier
with NCT03927794 469 473 O
early NCT03927794 474 479 B-Modifier
carious NCT03927794 480 487 B-Condition
lesions NCT03927794 488 495 I-Condition
Class NCT03927794 496 501 B-Eq_Comparison
V NCT03927794 502 503 I-Eq_Comparison
of NCT03927794 504 506 B-And
ICDAS NCT03927794 507 512 B-Observation
score NCT03927794 513 518 I-Observation
1 NCT03927794 519 520 B-Eq_Comparison
- NCT03927794 521 522 I-Eq_Comparison
2 NCT03927794 523 524 O
. NCT03927794 524 525 O

Exclusion NCT03927794 527 536 O
Criteria NCT03927794 537 545 O
: NCT03927794 546 547 O

- NCT03927794 551 552 O
Primary NCT03927794 554 561 B-Modifier
anterior NCT03927794 562 570 I-Modifier
teeth NCT03927794 571 576 I-Modifier
in NCT03927794 577 579 O
which NCT03927794 580 585 O
carious NCT03927794 586 593 B-Condition
lesions NCT03927794 594 601 I-Condition
are NCT03927794 602 605 O
scored NCT03927794 606 612 O
with NCT03927794 613 617 B-And
ICDAS NCT03927794 618 623 B-Observation
â¥ NCT03927794 624 625 B-Eq_Comparison
3 NCT03927794 626 627 I-Eq_Comparison
. NCT03927794 627 628 O

- NCT03927794 632 633 O
Subjects NCT03927794 635 643 O
on NCT03927794 644 646 B-Eq_Comparison
medication NCT03927794 647 657 B-Drug
that NCT03927794 658 662 O
affects NCT03927794 663 670 O
the NCT03927794 671 674 O
salivary NCT03927794 675 683 B-Observation
flow NCT03927794 684 688 I-Observation
rate NCT03927794 689 693 I-Observation
. NCT03927794 694 695 O

- NCT03927794 699 700 O
Subjects NCT03927794 702 710 O
with NCT03927794 711 715 O
evidence NCT03927794 716 724 O
of NCT03927794 725 727 O
reduced NCT03927794 728 735 O
salivary NCT03927794 736 744 B-Observation
flow NCT03927794 745 749 I-Observation
( NCT03927794 750 751 O
> NCT03927794 752 753 B-Eq_Comparison
60 NCT03927794 754 756 I-Eq_Comparison
sec NCT03927794 757 760 I-Eq_Comparison
) NCT03927794 761 762 O
or NCT03927794 763 765 B-Or
with NCT03927794 766 770 O
acidic NCT03927794 771 777 B-Modifier
saliva NCT03927794 778 784 B-Observation
pH NCT03927794 785 787 I-Observation
< NCT03927794 788 789 B-Eq_Comparison
5.8 NCT03927794 790 793 I-Eq_Comparison
. NCT03927794 793 794 O


Inclusion NCT03862092 0 9 O
Criteria NCT03862092 10 18 O
: NCT03862092 19 20 O

- NCT03862092 24 25 O
Patients NCT03862092 27 35 O
aged NCT03862092 36 40 B-Age
â¥ NCT03862092 41 42 B-Eq_Comparison
18 NCT03862092 43 45 I-Eq_Comparison
, NCT03862092 46 47 O
and NCT03862092 48 51 B-Or
< NCT03862092 52 53 B-Eq_Comparison
80 NCT03862092 54 56 I-Eq_Comparison
years NCT03862092 57 62 I-Eq_Comparison

- NCT03862092 65 66 O
ER NCT03862092 68 70 B-Encounter
- NCT03862092 71 72 I-Encounter
visit NCT03862092 73 78 I-Encounter
patients NCT03862092 79 87 O
with NCT03862092 88 92 B-And
acute NCT03862092 93 98 O
abdominal NCT03862092 99 108 B-Modifier
pain NCT03862092 109 113 B-Condition

- NCT03862092 121 122 O
NRS NCT03862092 124 127 B-Observation
â¥ NCT03862092 128 129 B-Eq_Comparison
6 NCT03862092 130 131 I-Eq_Comparison

- NCT03862092 140 141 O
Unresponsive NCT03862092 143 155 B-Condition
to NCT03862092 156 158 O
gastrointestinal NCT03862092 159 175 B-Drug
motility NCT03862092 176 184 I-Drug
drug NCT03862092 185 189 I-Drug
, NCT03862092 190 191 O
antacid NCT03862092 192 199 B-Drug

Exclusion NCT03862092 200 209 O
Criteria NCT03862092 210 218 O
: NCT03862092 219 220 O

- NCT03862092 224 225 O
Unwilling NCT03862092 227 236 O
or NCT03862092 237 239 O
unable NCT03862092 240 246 O
to NCT03862092 247 249 O
give NCT03862092 250 254 O
informed NCT03862092 255 263 O
consent NCT03862092 264 271 O

- NCT03862092 274 275 O
Patients NCT03862092 277 285 O
who NCT03862092 286 289 O
take NCT03862092 290 294 B-Eq_Comparison
antiviral NCT03862092 295 304 B-Drug
agents NCT03862092 305 311 I-Drug
( NCT03862092 312 313 O
acyclovir NCT03862092 314 323 B-Drug
, NCT03862092 324 325 O
valacyclovir NCT03862092 326 338 B-Drug
, NCT03862092 339 340 O
famciclovir NCT03862092 341 352 B-Drug
, NCT03862092 353 354 O
ganciclovir NCT03862092 355 366 B-Drug
, NCT03862092 367 368 O
valganciclovir NCT03862092 369 383 B-Drug
, NCT03862092 384 385 O
foscarnet NCT03862092 386 395 B-Drug
. NCT03862092 396 397 O
. NCT03862092 398 399 O
. NCT03862092 400 401 O
) NCT03862092 402 403 O

- NCT03862092 407 408 O
Patients NCT03862092 410 418 O
complaining NCT03862092 419 430 O
abdominal NCT03862092 431 440 B-Modifier
pain NCT03862092 441 445 B-Condition
with NCT03862092 446 450 B-And
NRS NCT03862092 451 454 B-Observation
â¤ NCT03862092 455 456 B-Eq_Comparison
5 NCT03862092 457 458 I-Eq_Comparison
or NCT03862092 459 461 B-Or
improved NCT03862092 462 470 O
symptom NCT03862092 471 478 B-Condition
by NCT03862092 479 481 O
gastrointestinal NCT03862092 482 498 B-Drug
motility NCT03862092 499 507 I-Drug
drug NCT03862092 508 512 I-Drug
, NCT03862092 513 514 O
antacid NCT03862092 515 522 B-Drug

Inclusion NCT03927378 0 9 O
Criteria NCT03927378 10 18 O
: NCT03927378 19 20 O

- NCT03927378 24 25 O
Parturients NCT03927378 27 38 O
with NCT03927378 39 43 O
age NCT03927378 44 47 B-Age
â¥ NCT03927378 48 49 B-Eq_Comparison
18 NCT03927378 50 52 I-Eq_Comparison
years NCT03927378 53 58 I-Eq_Comparison
; NCT03927378 58 59 O

- NCT03927378 62 63 O
Presence NCT03927378 65 73 O
of NCT03927378 74 76 O
prenatal NCT03927378 77 85 B-Modifier
depression NCT03927378 86 96 B-Condition
( NCT03927378 97 98 O
EPDS NCT03927378 99 103 B-Observation
score NCT03927378 104 109 I-Observation
â¥ NCT03927378 110 111 B-Eq_Comparison
10 NCT03927378 112 114 I-Eq_Comparison
) NCT03927378 115 116 O
; NCT03927378 117 118 O

- NCT03927378 121 122 O
Provide NCT03927378 124 131 O
written NCT03927378 132 139 O
informed NCT03927378 140 148 O
consents NCT03927378 149 157 O
. NCT03927378 158 159 O

Exclusion NCT03927378 161 170 O
Criteria NCT03927378 171 179 O
: NCT03927378 180 181 O

- NCT03927378 185 186 O
History NCT03927378 188 195 B-Eq_Comparison
of NCT03927378 196 198 O
psychiatric NCT03927378 199 210 B-Condition
disease NCT03927378 211 218 I-Condition
( NCT03927378 219 220 O
schizophrenia NCT03927378 221 234 B-Condition
) NCT03927378 235 236 O
or NCT03927378 237 239 B-Or
communication NCT03927378 240 253 B-Condition
barriers NCT03927378 254 262 I-Condition
that NCT03927378 263 267 O
prevent NCT03927378 268 275 B-Negation
normal NCT03927378 276 282 O
communication NCT03927378 283 296 B-Observation
before NCT03927378 297 303 B-Temporal_Connection___Temporal_Connection_Type_Value:before
childbirth NCT03927378 304 314 B-Procedure
; NCT03927378 314 315 O

- NCT03927378 318 319 O
Severe NCT03927378 321 327 O
complications NCT03927378 328 341 B-Condition
during NCT03927378 342 348 B-Temporal_Connection___Temporal_Connection_Type_Value:during
pregnancy NCT03927378 349 358 B-Condition
( NCT03927378 359 360 O
such NCT03927378 361 365 O
as NCT03927378 366 368 O
severe NCT03927378 369 375 O
preeclampsia NCT03927378 376 388 B-Condition
, NCT03927378 389 390 O
placenta NCT03927378 391 399 B-Condition
accreta NCT03927378 400 407 I-Condition
, NCT03927378 408 409 O
or NCT03927378 410 412 B-Or
HELLP NCT03927378 413 418 B-Condition
[ NCT03927378 419 420 O
Hemolysis NCT03927378 421 430 B-Condition
, NCT03927378 431 432 I-Condition
Elevated NCT03927378 433 441 I-Condition
Liver NCT03927378 442 447 I-Condition
enzymes NCT03927378 448 455 I-Condition
and NCT03927378 456 459 I-Condition
Low NCT03927378 460 463 I-Condition
Platelets NCT03927378 464 473 I-Condition
] NCT03927378 474 475 O
syndrome NCT03927378 476 484 B-Modifier
) NCT03927378 485 486 O
; NCT03927378 487 488 O

- NCT03927378 491 492 O
ASA NCT03927378 494 497 B-Observation
physical NCT03927378 498 506 O
status NCT03927378 507 513 O
classification NCT03927378 514 528 B-Eq_Comparison
â¥ NCT03927378 529 530 I-Eq_Comparison
III NCT03927378 531 534 I-Eq_Comparison
; NCT03927378 534 535 O

- NCT03927378 538 539 O
Presence NCT03927378 541 549 O
of NCT03927378 550 552 O
contraindications NCT03927378 553 570 B-Contraindication
to NCT03927378 571 573 O
ketamine NCT03927378 574 582 B-Drug
, NCT03927378 583 584 O
including NCT03927378 585 594 O
refractory NCT03927378 595 605 B-Modifier
hypertension NCT03927378 606 618 B-Condition
, NCT03927378 619 620 O
severe NCT03927378 621 627 O
cardiovascular NCT03927378 628 642 B-Condition
disease NCT03927378 643 650 I-Condition
( NCT03927378 651 652 O
heart NCT03927378 653 658 B-Condition
function NCT03927378 659 667 I-Condition
classification NCT03927378 668 682 B-Eq_Comparison
â¥ NCT03927378 683 684 I-Eq_Comparison
III NCT03927378 685 688 I-Eq_Comparison
) NCT03927378 689 690 O
, NCT03927378 691 692 O
or NCT03927378 693 695 B-Or
hyperthyroidism NCT03927378 696 711 B-Condition
; NCT03927378 711 712 O

- NCT03927378 715 716 O
Refuse NCT03927378 718 724 O
to NCT03927378 725 727 O
participate NCT03927378 728 739 O
. NCT03927378 740 741 O

Inclusion NCT03926806 0 9 O
Criteria NCT03926806 10 18 O
: NCT03926806 19 20 O

- NCT03926806 24 25 O
BMI NCT03926806 27 30 B-Observation
27 NCT03926806 31 33 B-Eq_Comparison
- NCT03926806 34 35 I-Eq_Comparison
36 NCT03926806 36 38 I-Eq_Comparison

- NCT03926806 42 43 O
HbA NCT03926806 45 48 B-Observation
1C NCT03926806 49 51 I-Observation
< NCT03926806 52 53 B-Eq_Comparison
8.5 NCT03926806 54 57 I-Eq_Comparison
% NCT03926806 58 59 I-Eq_Comparison

- NCT03926806 63 64 O
Constant NCT03926806 66 74 O
body NCT03926806 75 79 B-Observation
weight NCT03926806 80 86 I-Observation
and NCT03926806 87 90 B-And
dietary NCT03926806 91 98 B-Observation
habits NCT03926806 99 105 I-Observation
for NCT03926806 106 109 O
the NCT03926806 110 113 O
last NCT03926806 114 118 B-Eq_Comparison
3 NCT03926806 119 120 I-Eq_Comparison
months NCT03926806 121 127 I-Eq_Comparison

- NCT03926806 130 131 O
Stable NCT03926806 133 139 O
dose NCT03926806 140 144 O
of NCT03926806 145 147 O
oral NCT03926806 148 152 B-Drug
medication NCT03926806 153 163 I-Drug
for NCT03926806 164 167 O
at NCT03926806 168 170 B-Eq_Comparison
least NCT03926806 171 176 I-Eq_Comparison
3 NCT03926806 177 178 I-Eq_Comparison
months NCT03926806 179 185 I-Eq_Comparison

- NCT03926806 188 189 O
Diagnosed NCT03926806 191 200 O
with NCT03926806 201 205 O
T NCT03926806 206 207 B-Condition
2DM NCT03926806 208 211 I-Condition
for NCT03926806 212 215 O
more NCT03926806 216 220 B-Eq_Comparison
than NCT03926806 221 225 I-Eq_Comparison
1 NCT03926806 226 227 I-Eq_Comparison
year NCT03926806 228 232 I-Eq_Comparison

Exclusion NCT03926806 233 242 O
Criteria NCT03926806 243 251 O
: NCT03926806 252 253 O

- NCT03926806 257 258 O
History NCT03926806 260 267 B-Eq_Comparison
of NCT03926806 268 270 O
cardiovascular NCT03926806 271 285 B-Modifier
, NCT03926806 286 287 O
gastrointestinal NCT03926806 288 304 B-Modifier
, NCT03926806 305 306 O
renal NCT03926806 307 312 B-Modifier
and NCT03926806 313 316 B-And
endocrinological NCT03926806 317 333 B-Modifier
diseases NCT03926806 334 342 B-Condition

- NCT03926806 345 346 O
Treatment NCT03926806 348 357 O
for NCT03926806 358 361 O
weight NCT03926806 362 368 B-Condition
reduction NCT03926806 369 378 I-Condition

- NCT03926806 381 382 O
Lactose NCT03926806 384 391 B-Condition
intolerance NCT03926806 392 403 I-Condition

- NCT03926806 406 407 O
Allergies NCT03926806 409 418 B-Allergy
to NCT03926806 419 421 O
milk NCT03926806 422 426 O
and NCT03926806 427 430 B-Or
dairy NCT03926806 431 436 O
products NCT03926806 437 445 O

- NCT03926806 448 449 O
Alcohol NCT03926806 451 458 B-Observation
consumption NCT03926806 459 470 I-Observation
( NCT03926806 471 472 O
> NCT03926806 473 474 B-Eq_Comparison
2 NCT03926806 475 476 I-Eq_Comparison
drinks NCT03926806 477 483 I-Eq_Comparison
per NCT03926806 484 487 I-Eq_Comparison
day NCT03926806 488 491 I-Eq_Comparison
) NCT03926806 492 493 O

- NCT03926806 497 498 O
Intake NCT03926806 500 506 O
of NCT03926806 507 509 O
supplements NCT03926806 510 521 B-Drug

- NCT03926806 524 525 O
Receiving NCT03926806 527 536 B-Eq_Comparison
insulin NCT03926806 537 544 B-Drug

Inclusion NCT03860376 0 9 O
Criteria NCT03860376 10 18 O
: NCT03860376 19 20 O

- NCT03860376 24 25 O
Patients NCT03860376 27 35 O
aged NCT03860376 36 40 B-Age
21 NCT03860376 41 43 B-Eq_Comparison
years NCT03860376 44 49 I-Eq_Comparison
or NCT03860376 50 52 I-Eq_Comparison
younger NCT03860376 53 60 I-Eq_Comparison
at NCT03860376 61 63 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860376 64 67 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03860376 68 72 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03860376 73 75 O
enrollment NCT03860376 76 86 B-Study
on NCT03860376 87 89 O
this NCT03860376 90 94 O
study NCT03860376 95 100 O
of NCT03860376 101 103 O
any NCT03860376 104 107 O
gender NCT03860376 108 114 O
, NCT03860376 115 116 O
race NCT03860376 117 121 O
or NCT03860376 122 124 O
ethnicity NCT03860376 125 134 O
. NCT03860376 135 136 O

- NCT03860376 145 146 O
Subjects NCT03860376 148 156 O
with NCT03860376 157 161 O
suspected NCT03860376 162 171 B-Assertion___Assertion_Type_Value:possible
or NCT03860376 172 174 B-Or
confirmed NCT03860376 175 184 B-Modifier
diagnosis NCT03860376 185 194 O
of NCT03860376 195 197 O
recurrent NCT03860376 198 207 B-Modifier
or NCT03860376 208 210 B-Or
refractory NCT03860376 211 221 B-Modifier
cancer NCT03860376 222 228 B-Condition

- NCT03860376 236 237 O
Subjects NCT03860376 239 247 O
who NCT03860376 248 251 O
are NCT03860376 252 255 O
scheduled NCT03860376 256 265 B-Eq_Comparison
for NCT03860376 266 269 O
or NCT03860376 270 272 B-Or
have NCT03860376 273 277 O
recently NCT03860376 278 286 B-Eq_Comparison
had NCT03860376 287 290 O
biopsy NCT03860376 291 297 B-Procedure
or NCT03860376 298 300 B-Or
tumor NCT03860376 301 306 B-Condition
excised NCT03860376 307 314 B-Procedure
( NCT03860376 315 316 O
solid NCT03860376 317 322 B-Modifier
tumors NCT03860376 323 329 B-Condition
) NCT03860376 330 331 O
or NCT03860376 332 334 B-Or
bone NCT03860376 335 339 B-Modifier
marrow NCT03860376 340 346 I-Modifier
aspirate NCT03860376 347 355 B-Procedure
( NCT03860376 356 357 O
blood NCT03860376 358 363 B-Modifier
cancers NCT03860376 364 371 B-Condition
) NCT03860376 372 373 O

- NCT03860376 382 383 O
Subjects NCT03860376 385 393 O
willing NCT03860376 394 401 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860376 402 404 I-Assertion___Assertion_Type_Value:hypothetical
have NCT03860376 405 409 O
a NCT03860376 410 411 O
blood NCT03860376 412 417 B-Observation
draw NCT03860376 418 422 I-Observation
or NCT03860376 423 425 B-Or
buccal NCT03860376 426 432 B-Procedure
swab NCT03860376 433 437 I-Procedure
done NCT03860376 438 442 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03860376 443 446 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03860376 447 450 O
purposes NCT03860376 451 459 O
of NCT03860376 460 462 O
genetic NCT03860376 463 470 B-Procedure
testing NCT03860376 471 478 I-Procedure

- NCT03860376 486 487 O
Subjects NCT03860376 489 497 O
or NCT03860376 498 500 O
their NCT03860376 501 506 O
parents NCT03860376 507 514 O
or NCT03860376 515 517 O
legal NCT03860376 518 523 O
guardians NCT03860376 524 533 O
willing NCT03860376 534 541 O
to NCT03860376 542 544 O
sign NCT03860376 545 549 O
informed NCT03860376 550 558 O
consent NCT03860376 559 566 O

- NCT03860376 574 575 O
Subjects NCT03860376 577 585 O
aged NCT03860376 586 590 B-Age
7 NCT03860376 591 592 B-Eq_Comparison
to NCT03860376 593 595 I-Eq_Comparison
17 NCT03860376 596 598 I-Eq_Comparison
willing NCT03860376 599 606 O
to NCT03860376 607 609 O
sign NCT03860376 610 614 O
assent NCT03860376 615 621 O

Exclusion NCT03860376 622 631 O
Criteria NCT03860376 632 640 O
: NCT03860376 641 642 O

- NCT03860376 646 647 O
Subjects NCT03860376 649 657 O
who NCT03860376 658 661 O
do NCT03860376 662 664 O
not NCT03860376 665 668 B-Negation
have NCT03860376 669 673 O
malignant NCT03860376 674 683 B-Condition
tissue NCT03860376 684 690 I-Condition
available NCT03860376 691 700 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03860376 701 704 B-Or
accessible NCT03860376 705 715 B-Assertion___Assertion_Type_Value:hypothetical

- NCT03860376 718 719 O
The NCT03860376 721 724 O
amount NCT03860376 725 731 O
of NCT03860376 732 734 O
excised NCT03860376 735 742 B-Procedure
malignant NCT03860376 743 752 B-Condition
tissue NCT03860376 753 759 I-Condition
is NCT03860376 760 762 O
not NCT03860376 763 766 B-Negation
sufficient NCT03860376 767 777 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03860376 778 781 O
the NCT03860376 782 785 O
ex NCT03860376 786 788 B-Modifier
vivo NCT03860376 789 793 I-Modifier
drug NCT03860376 794 798 B-Procedure
testing NCT03860376 799 806 I-Procedure
and NCT03860376 807 810 B-Or
/ NCT03860376 811 812 I-Or
or NCT03860376 813 815 I-Or
genetic NCT03860376 816 823 B-Procedure
profiling NCT03860376 824 833 I-Procedure
. NCT03860376 834 835 O

- NCT03860376 839 840 O
Patients NCT03860376 842 850 O
with NCT03860376 851 855 O
newly NCT03860376 856 861 B-Eq_Comparison
diagnosed NCT03860376 862 871 O
tumors NCT03860376 872 878 B-Condition
and NCT03860376 879 882 B-Or
tumors NCT03860376 883 889 B-Condition
that NCT03860376 890 894 O
have NCT03860376 895 899 O
high NCT03860376 900 904 O
( NCT03860376 905 906 O
> NCT03860376 907 908 B-Eq_Comparison
90 NCT03860376 909 911 I-Eq_Comparison
% NCT03860376 912 913 I-Eq_Comparison
) NCT03860376 914 915 O
cure NCT03860376 916 920 B-Observation
rate NCT03860376 921 925 I-Observation
with NCT03860376 926 930 O
safe NCT03860376 931 935 B-Modifier
standard NCT03860376 936 944 B-Procedure
therapy NCT03860376 945 952 I-Procedure
. NCT03860376 953 954 O

Inclusion NCT03928392 0 9 O
Criteria NCT03928392 10 18 O
: NCT03928392 19 20 O

- NCT03928392 24 25 O
18 NCT03928392 27 29 B-Eq_Comparison
to NCT03928392 30 32 I-Eq_Comparison
95 NCT03928392 33 35 I-Eq_Comparison
years NCT03928392 36 41 I-Eq_Comparison
of NCT03928392 42 44 O
age NCT03928392 45 48 B-Age

- NCT03928392 51 52 O
Participation NCT03928392 54 67 O
in NCT03928392 68 70 O
WAVES NCT03928392 71 76 O
Project NCT03928392 77 84 O
for NCT03928392 85 88 O
at NCT03928392 89 91 B-Eq_Comparison
least NCT03928392 92 97 I-Eq_Comparison
3 NCT03928392 98 99 I-Eq_Comparison
months NCT03928392 100 106 I-Eq_Comparison

- NCT03928392 109 110 O
Completion NCT03928392 112 122 O
of NCT03928392 123 125 O
3 NCT03928392 126 127 B-Eq_Comparison
open NCT03928392 128 132 B-Observation
water NCT03928392 133 138 I-Observation
dives NCT03928392 139 144 I-Observation

- NCT03928392 147 148 O
Proficient NCT03928392 150 160 O
in NCT03928392 161 163 O
written NCT03928392 164 171 O
and NCT03928392 172 175 O
verbal NCT03928392 176 182 O
English NCT03928392 183 190 O

Exclusion NCT03928392 191 200 O
Criteria NCT03928392 201 209 O
: NCT03928392 210 211 O

- NCT03928392 215 216 O
Younger NCT03928392 218 225 B-Eq_Comparison
than NCT03928392 226 230 I-Eq_Comparison
18 NCT03928392 231 233 I-Eq_Comparison
years NCT03928392 234 239 I-Eq_Comparison
of NCT03928392 240 242 O
age NCT03928392 243 246 B-Age
or NCT03928392 247 249 B-Or
older NCT03928392 250 255 B-Eq_Comparison
than NCT03928392 256 260 I-Eq_Comparison
95 NCT03928392 261 263 I-Eq_Comparison
years NCT03928392 264 269 I-Eq_Comparison
of NCT03928392 270 272 O
age NCT03928392 273 276 B-Age

- NCT03928392 279 280 O
Not NCT03928392 282 285 B-Negation
a NCT03928392 286 287 O
member NCT03928392 288 294 O
of NCT03928392 295 297 O
WAVES NCT03928392 298 303 O
Project NCT03928392 304 311 O
within NCT03928392 312 318 B-Eq_Comparison
3 NCT03928392 319 320 I-Eq_Comparison
months NCT03928392 321 327 I-Eq_Comparison
of NCT03928392 328 330 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03928392 331 336 B-Study
recruitment NCT03928392 337 348 O

- NCT03928392 351 352 O
Has NCT03928392 354 357 O
not NCT03928392 358 361 B-Negation
completed NCT03928392 362 371 O
3 NCT03928392 372 373 B-Eq_Comparison
open NCT03928392 374 378 B-Observation
water NCT03928392 379 384 I-Observation
dives NCT03928392 385 390 I-Observation

- NCT03928392 393 394 O
Not NCT03928392 396 399 B-Negation
proficient NCT03928392 400 410 O
in NCT03928392 411 413 O
written NCT03928392 414 421 O
and NCT03928392 422 425 O
verbal NCT03928392 426 432 O
English NCT03928392 433 440 O

Inclusion NCT03924804 0 9 O
Criteria NCT03924804 10 18 O
: NCT03924804 19 20 O

- NCT03924804 24 25 O
1 NCT03924804 27 28 O
. NCT03924804 28 29 O
ethnic NCT03924804 31 37 O
Chinese NCT03924804 38 45 O
; NCT03924804 45 46 O

- NCT03924804 49 50 O
2 NCT03924804 52 53 O
. NCT03924804 53 54 O
age NCT03924804 56 59 B-Age
, NCT03924804 60 61 O
18 NCT03924804 62 64 B-Eq_Comparison
to NCT03924804 65 67 I-Eq_Comparison
65 NCT03924804 68 70 I-Eq_Comparison
years NCT03924804 71 76 I-Eq_Comparison
old NCT03924804 77 80 O
; NCT03924804 80 81 O

- NCT03924804 84 85 O
3 NCT03924804 87 88 O
. NCT03924804 88 89 O
American NCT03924804 91 99 B-Observation
Society NCT03924804 100 107 I-Observation
of NCT03924804 108 110 I-Observation
Anaesthesiologists NCT03924804 111 129 I-Observation
( NCT03924804 130 131 O
ASA NCT03924804 132 135 B-Observation
) NCT03924804 136 137 O
physical NCT03924804 138 146 O
status NCT03924804 147 153 O
I NCT03924804 154 155 B-Eq_Comparison
or NCT03924804 156 158 I-Eq_Comparison
II NCT03924804 159 161 I-Eq_Comparison
; NCT03924804 161 162 O

- NCT03924804 165 166 O
4 NCT03924804 168 169 O
. NCT03924804 169 170 O
Daytime NCT03924804 172 179 O
patients NCT03924804 180 188 O
scheduled NCT03924804 189 198 B-Eq_Comparison
for NCT03924804 199 202 O
general NCT03924804 203 210 B-Procedure
anesthesia NCT03924804 211 221 I-Procedure

Exclusion NCT03924804 222 231 O
Criteria NCT03924804 232 240 O
: NCT03924804 241 242 O

- NCT03924804 246 247 O
Patients NCT03924804 249 257 O
unwilling NCT03924804 258 267 O
to NCT03924804 268 270 O
cooperate NCT03924804 271 280 O
with NCT03924804 281 285 O
the NCT03924804 286 289 O
experiment NCT03924804 290 300 O

- NCT03924804 303 304 O
Body NCT03924804 306 310 B-Observation
mass NCT03924804 311 315 I-Observation
index NCT03924804 316 321 I-Observation
exceeding NCT03924804 322 331 B-Eq_Comparison
30 NCT03924804 332 334 I-Eq_Comparison
kg NCT03924804 335 337 I-Eq_Comparison
/ NCT03924804 338 339 I-Eq_Comparison
m NCT03924804 340 341 I-Eq_Comparison
2 NCT03924804 342 343 I-Eq_Comparison
; NCT03924804 343 344 O

- NCT03924804 347 348 O
Patients NCT03924804 350 358 O
with NCT03924804 359 363 O
a NCT03924804 364 365 O
history NCT03924804 366 373 B-Eq_Comparison
of NCT03924804 374 376 O
heart NCT03924804 377 382 B-Modifier
, NCT03924804 383 384 O
liver NCT03924804 385 390 B-Modifier
and NCT03924804 391 394 B-Or
Renal NCT03924804 395 400 B-Modifier
failure NCT03924804 401 408 B-Condition
, NCT03924804 409 410 O
hypertension NCT03924804 411 423 B-Condition
, NCT03924804 424 425 O
diabetes NCT03924804 426 434 B-Condition
mellitus NCT03924804 435 443 I-Condition
or NCT03924804 444 446 B-Or
arteriosclerosis NCT03924804 447 463 B-Condition
; NCT03924804 463 464 O
and NCT03924804 465 468 B-Or
any NCT03924804 469 472 O
allergy NCT03924804 473 480 B-Allergy
to NCT03924804 481 483 O
drugs NCT03924804 484 489 B-Drug
used NCT03924804 490 494 O
in NCT03924804 495 497 O
the NCT03924804 498 501 O
study NCT03924804 502 507 B-Study
. NCT03924804 508 509 O

- NCT03924804 513 514 O
Patients NCT03924804 516 524 O
with NCT03924804 525 529 O
the NCT03924804 530 533 O
urinary NCT03924804 534 541 B-Condition
diseases NCT03924804 542 550 I-Condition
, NCT03924804 551 552 O
such NCT03924804 553 557 O
as NCT03924804 558 560 O
kidney NCT03924804 561 567 B-Condition
, NCT03924804 568 569 O
ureteral NCT03924804 570 578 B-Condition
calculi NCT03924804 579 586 I-Condition
and NCT03924804 587 590 B-Or
tumors NCT03924804 591 597 B-Condition
, NCT03924804 598 599 O
prostatic NCT03924804 600 609 B-Condition
hypertrophy NCT03924804 610 621 I-Condition
. NCT03924804 622 623 O

Inclusion NCT03930849 0 9 O
Criteria NCT03930849 10 18 O
: NCT03930849 19 20 O

VA NCT03930849 22 24 O
Patient NCT03930849 25 32 O

- NCT03930849 35 36 O
Diagnosed NCT03930849 38 47 O
with NCT03930849 48 52 O
depression NCT03930849 53 63 B-Condition

- NCT03930849 66 67 O
Initiating NCT03930849 69 79 B-Eq_Comparison
or NCT03930849 80 82 B-Or
changing NCT03930849 83 91 O
to NCT03930849 92 94 O
a NCT03930849 95 96 O
new NCT03930849 97 100 O
antidepressant NCT03930849 101 115 B-Drug
medication NCT03930849 116 126 I-Drug

- NCT03930849 129 130 O
Cell NCT03930849 132 136 O
phone NCT03930849 137 142 O
with NCT03930849 143 147 O
text NCT03930849 148 152 O
messaging NCT03930849 153 162 O
capabilities NCT03930849 163 175 O

- NCT03930849 178 179 O
Registered NCT03930849 181 191 O
with NCT03930849 192 196 O
My NCT03930849 197 199 O
HealtheVet NCT03930849 200 210 O

- NCT03930849 213 214 O
Follow NCT03930849 216 222 B-Encounter
- NCT03930849 223 224 I-Encounter
up NCT03930849 225 227 I-Encounter
appointment NCT03930849 228 239 I-Encounter
with NCT03930849 240 244 O
their NCT03930849 245 250 O
provider NCT03930849 251 259 B-Provider
in NCT03930849 260 262 O
the NCT03930849 263 266 O
next NCT03930849 267 271 B-Eq_Comparison
12 NCT03930849 272 274 I-Eq_Comparison
weeks NCT03930849 275 280 I-Eq_Comparison

- NCT03930849 283 284 O
Internet NCT03930849 286 294 O
access NCT03930849 295 301 O

- NCT03930849 304 305 O
English NCT03930849 307 314 O
speaking NCT03930849 315 323 O
VA NCT03930849 324 326 O
Providers NCT03930849 327 336 B-Provider
: NCT03930849 337 338 O
provide NCT03930849 339 346 O
care NCT03930849 347 351 O
to NCT03930849 352 354 O
a NCT03930849 355 356 O
study NCT03930849 357 362 B-Study
participant NCT03930849 363 374 O

Exclusion NCT03930849 375 384 O
Criteria NCT03930849 385 393 O
: NCT03930849 394 395 O

- NCT03930849 399 400 O
Lack NCT03930849 402 406 O
of NCT03930849 407 409 O
cell NCT03930849 410 414 O
phone NCT03930849 415 420 O
access NCT03930849 421 427 O
/ NCT03930849 428 429 O
willingness NCT03930849 430 441 O
to NCT03930849 442 444 O
receive NCT03930849 445 452 O
text NCT03930849 453 457 O
messages NCT03930849 458 466 O

- NCT03930849 469 470 O
Diagnosis NCT03930849 472 481 O
of NCT03930849 482 484 O
cognitive NCT03930849 485 494 B-Condition
disorders NCT03930849 495 504 I-Condition
, NCT03930849 505 506 O
psychotic NCT03930849 507 516 B-Condition
disorders NCT03930849 517 526 I-Condition
, NCT03930849 527 528 O
bipolar NCT03930849 529 536 B-Condition
disorder NCT03930849 537 545 I-Condition
, NCT03930849 546 547 O
or NCT03930849 548 550 B-Or
active NCT03930849 551 557 B-Eq_Comparison
substance NCT03930849 558 567 B-Condition
abuse NCT03930849 568 573 I-Condition
. NCT03930849 574 575 O

Inclusion NCT03929653 0 9 O
Criteria NCT03929653 10 18 O
: NCT03929653 19 20 O

1 NCT03929653 24 25 O
. NCT03929653 25 26 O
Is NCT03929653 28 30 O
equal NCT03929653 31 36 B-Eq_Comparison
to NCT03929653 37 39 I-Eq_Comparison
or NCT03929653 40 42 I-Eq_Comparison
greater NCT03929653 43 50 I-Eq_Comparison
than NCT03929653 51 55 I-Eq_Comparison
18 NCT03929653 56 58 I-Eq_Comparison
years NCT03929653 59 64 I-Eq_Comparison
of NCT03929653 65 67 O
age NCT03929653 68 71 B-Age
. NCT03929653 72 73 O

2 NCT03929653 77 78 O
. NCT03929653 78 79 O
Histologic NCT03929653 81 91 B-Procedure
or NCT03929653 92 94 B-Or
cytologic NCT03929653 95 104 B-Procedure
confirmation NCT03929653 105 117 O
of NCT03929653 118 120 O
advanced NCT03929653 121 129 B-Modifier
refractory NCT03929653 130 140 I-Modifier
solid NCT03929653 141 146 B-Condition
tumors NCT03929653 147 153 I-Condition
with NCT03929653 154 158 O
no NCT03929653 159 161 B-Negation
standard NCT03929653 162 170 O
treatment NCT03929653 171 180 B-Procedure
options NCT03929653 181 188 B-Assertion___Assertion_Type_Value:hypothetical
, NCT03929653 189 190 O
including NCT03929653 191 200 O
some NCT03929653 201 205 O
patients NCT03929653 206 214 O
with NCT03929653 215 219 O
advanced NCT03929653 220 228 O
disease NCT03929653 229 236 O
in NCT03929653 237 239 O
reduced NCT03929653 240 247 B-Condition
general NCT03929653 248 255 I-Condition
condition NCT03929653 256 265 I-Condition
( NCT03929653 266 267 O
Eastern NCT03929653 268 275 B-Observation
Cooperative NCT03929653 276 287 I-Observation
Oncology NCT03929653 288 296 I-Observation
Group NCT03929653 297 302 I-Observation
( NCT03929653 303 304 O
ECOG NCT03929653 305 309 B-Observation
) NCT03929653 310 311 O
3 NCT03929653 312 313 B-Eq_Comparison
and NCT03929653 314 317 I-Eq_Comparison
4 NCT03929653 318 319 I-Eq_Comparison
) NCT03929653 320 321 O
. NCT03929653 322 323 O

3 NCT03929653 327 328 O
. NCT03929653 328 329 O
Patients NCT03929653 331 339 O
with NCT03929653 340 344 O
measurable NCT03929653 345 355 B-Modifier
or NCT03929653 356 358 B-Or
evaluable NCT03929653 359 368 B-Modifier
disease NCT03929653 369 376 B-Condition
per NCT03929653 377 380 O
Response NCT03929653 381 389 O
Evaluation NCT03929653 390 400 O
Criteria NCT03929653 401 409 O
In NCT03929653 410 412 O
Solid NCT03929653 413 418 O
Tumors NCT03929653 419 425 O
( NCT03929653 426 427 O
RECIST NCT03929653 428 434 O
) NCT03929653 435 436 O
version NCT03929653 437 444 O
1.1 NCT03929653 445 448 O
. NCT03929653 448 449 O

4 NCT03929653 453 454 O
. NCT03929653 454 455 O
Patients NCT03929653 457 465 O
must NCT03929653 466 470 O
be NCT03929653 471 473 O
able NCT03929653 474 478 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929653 479 481 I-Assertion___Assertion_Type_Value:hypothetical
provide NCT03929653 482 489 O
blood NCT03929653 490 495 B-Observation
samples NCT03929653 496 503 I-Observation
or NCT03929653 504 506 B-Or
tissue NCT03929653 507 513 B-Observation
samples NCT03929653 514 521 I-Observation
for NCT03929653 522 525 O
NGS NCT03929653 526 529 B-Procedure
( NCT03929653 530 531 O
Next NCT03929653 532 536 B-Procedure
Generation NCT03929653 537 547 I-Procedure
Sequencing NCT03929653 548 558 I-Procedure
) NCT03929653 559 560 O
testing NCT03929653 561 568 O
. NCT03929653 569 570 O
The NCT03929653 572 575 O
amount NCT03929653 576 582 O
of NCT03929653 583 585 O
blood NCT03929653 586 591 B-Observation
and NCT03929653 592 595 B-Or
tissue NCT03929653 596 602 B-Observation
samples NCT03929653 603 610 I-Observation
should NCT03929653 611 617 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03929653 618 620 I-Assertion___Assertion_Type_Value:hypothetical
able NCT03929653 621 625 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03929653 626 628 O
meet NCT03929653 629 633 O
the NCT03929653 634 637 O
requirements NCT03929653 638 650 O
of NCT03929653 651 653 O
DNA NCT03929653 654 657 O
extraction NCT03929653 658 668 O
and NCT03929653 669 672 O
quality NCT03929653 673 680 O
control NCT03929653 681 688 O
. NCT03929653 689 690 O

5 NCT03929653 694 695 O
. NCT03929653 695 696 O
Adequate NCT03929653 698 706 O
baseline NCT03929653 707 715 O
organ NCT03929653 716 721 B-Condition
system NCT03929653 722 728 I-Condition
function NCT03929653 729 737 I-Condition
. NCT03929653 738 739 O

6 NCT03929653 743 744 O
. NCT03929653 744 745 O
Patients NCT03929653 747 755 O
could NCT03929653 756 761 B-Assertion___Assertion_Type_Value:hypothetical
receive NCT03929653 762 769 O
treatment NCT03929653 770 779 B-Procedure
program NCT03929653 780 787 O
from NCT03929653 788 792 O
MTB NCT03929653 793 796 B-Procedure
( NCT03929653 797 798 O
Molecular NCT03929653 799 808 B-Procedure
Tumor NCT03929653 809 814 I-Procedure
Board NCT03929653 815 820 I-Procedure
) NCT03929653 821 822 O
. NCT03929653 823 824 O

7 NCT03929653 828 829 O
. NCT03929653 829 830 O
Ability NCT03929653 832 839 O
to NCT03929653 840 842 O
understand NCT03929653 843 853 O
and NCT03929653 854 857 O
the NCT03929653 858 861 O
willingness NCT03929653 862 873 O
to NCT03929653 874 876 O
provide NCT03929653 877 884 O
a NCT03929653 885 886 O
written NCT03929653 887 894 O
informed NCT03929653 895 903 O
consent NCT03929653 904 911 O
document NCT03929653 912 920 O
. NCT03929653 921 922 O

Exclusion NCT03929653 924 933 O
Criteria NCT03929653 934 942 O
: NCT03929653 943 944 O

1 NCT03929653 947 948 O
. NCT03929653 948 949 O
According NCT03929653 950 959 O
to NCT03929653 960 962 O
the NCT03929653 963 966 O
investigator NCT03929653 967 979 O
' NCT03929653 979 980 O
judgment NCT03929653 981 989 O
, NCT03929653 990 991 O
there NCT03929653 992 997 O
are NCT03929653 998 1001 O
serious NCT03929653 1002 1009 O
, NCT03929653 1010 1011 O
uncontrollable NCT03929653 1012 1026 B-Modifier
risks NCT03929653 1027 1032 B-Risk
to NCT03929653 1033 1035 O
patients NCT03929653 1036 1044 O
' NCT03929653 1044 1045 O
safety NCT03929653 1046 1052 O
, NCT03929653 1053 1054 O
or NCT03929653 1055 1057 B-Or
associated NCT03929653 1058 1068 O
diseases NCT03929653 1069 1077 B-Condition
( NCT03929653 1078 1079 O
such NCT03929653 1080 1084 O
as NCT03929653 1085 1087 O
severe NCT03929653 1088 1094 O
diabetes NCT03929653 1095 1103 B-Condition
, NCT03929653 1104 1105 O
thyroid NCT03929653 1106 1113 B-Condition
disease NCT03929653 1114 1121 I-Condition
, NCT03929653 1122 1123 O
infection NCT03929653 1124 1133 B-Condition
, NCT03929653 1134 1135 O
spinal NCT03929653 1136 1142 B-Condition
cord NCT03929653 1143 1147 I-Condition
compression NCT03929653 1148 1159 I-Condition
, NCT03929653 1160 1161 O
superior NCT03929653 1162 1170 B-Condition
vena NCT03929653 1171 1175 I-Condition
cava NCT03929653 1176 1180 I-Condition
syndrome NCT03929653 1181 1189 I-Condition
, NCT03929653 1190 1191 O
neurological NCT03929653 1192 1204 B-Modifier
or NCT03929653 1205 1207 B-Or
psychiatric NCT03929653 1208 1219 B-Modifier
disorders NCT03929653 1220 1229 B-Condition
and NCT03929653 1230 1233 O
so NCT03929653 1234 1236 O
on NCT03929653 1237 1239 O
) NCT03929653 1240 1241 O
that NCT03929653 1242 1246 O
affect NCT03929653 1247 1253 O
the NCT03929653 1254 1257 O
patients NCT03929653 1258 1266 O
completion NCT03929653 1267 1277 O
of NCT03929653 1278 1280 O
the NCT03929653 1281 1284 O
study NCT03929653 1285 1290 B-Study
. NCT03929653 1291 1292 O


Inclusion NCT03924349 0 9 O
Criteria NCT03924349 10 18 O
: NCT03924349 19 20 O

- NCT03924349 24 25 O
Cases NCT03924349 27 32 O
which NCT03924349 33 38 O
are NCT03924349 39 42 O
deemed NCT03924349 43 49 O
necessary NCT03924349 50 59 O
to NCT03924349 60 62 O
mark NCT03924349 63 67 O
the NCT03924349 68 71 O
location NCT03924349 72 80 O
of NCT03924349 81 83 O
the NCT03924349 84 87 O
colon NCT03924349 88 93 B-Modifier
lesion NCT03924349 94 100 B-Condition
before NCT03924349 101 107 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03924349 108 115 B-Procedure

Exclusion NCT03924349 116 125 O
Criteria NCT03924349 126 134 O
: NCT03924349 135 136 O

- NCT03924349 140 141 O
Pre NCT03924349 143 146 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03924349 147 156 B-Procedure
colonoscopy NCT03924349 157 168 B-Procedure
is NCT03924349 169 171 O
not NCT03924349 172 175 B-Negation
possible NCT03924349 176 184 B-Assertion___Assertion_Type_Value:hypothetical
due NCT03924349 185 188 O
to NCT03924349 189 191 O
intestinal NCT03924349 192 202 B-Condition
obstruction NCT03924349 203 214 I-Condition

- NCT03924349 217 218 O
If NCT03924349 220 222 O
the NCT03924349 223 226 O
lesion NCT03924349 227 233 B-Condition
is NCT03924349 234 236 O
located NCT03924349 237 244 O
in NCT03924349 245 247 O
the NCT03924349 248 251 O
rectal NCT03924349 252 258 B-Modifier
area NCT03924349 259 263 I-Modifier
and NCT03924349 264 267 B-And
the NCT03924349 268 271 O
lesion NCT03924349 272 278 B-Condition
can NCT03924349 279 282 O
be NCT03924349 283 285 O
confirmed NCT03924349 286 295 O
by NCT03924349 296 298 O
digital NCT03924349 299 306 B-Modifier
rectal NCT03924349 307 313 B-Procedure
exam NCT03924349 314 318 I-Procedure

- NCT03924349 321 322 O
disagreement NCT03924349 324 336 O
with NCT03924349 337 341 O
the NCT03924349 342 345 O
study NCT03924349 346 351 B-Study

Inclusion NCT03867890 0 9 O
Criteria NCT03867890 10 18 O
: NCT03867890 19 20 O

- NCT03867890 24 25 O
walk NCT03867890 27 31 B-Observation
or NCT03867890 32 34 B-Or
run NCT03867890 35 38 B-Observation
at NCT03867890 39 41 B-Eq_Comparison
least NCT03867890 42 47 I-Eq_Comparison
10 NCT03867890 48 50 I-Eq_Comparison
kilometres NCT03867890 51 61 I-Eq_Comparison
per NCT03867890 62 65 I-Eq_Comparison
week NCT03867890 66 70 I-Eq_Comparison

- NCT03867890 73 74 O
maintain NCT03867890 76 84 B-Observation
a NCT03867890 85 86 O
minimal NCT03867890 87 94 B-Eq_Comparison
distance NCT03867890 95 103 I-Eq_Comparison
of NCT03867890 104 106 I-Eq_Comparison
ten NCT03867890 107 110 I-Eq_Comparison
kilometres NCT03867890 111 121 I-Eq_Comparison
per NCT03867890 122 125 I-Eq_Comparison
week NCT03867890 126 130 I-Eq_Comparison
, NCT03867890 131 132 O
for NCT03867890 133 136 O
a NCT03867890 137 138 O
period NCT03867890 139 145 O
of NCT03867890 146 148 O
24 NCT03867890 149 151 B-Eq_Comparison
weeks NCT03867890 152 157 I-Eq_Comparison

- NCT03867890 160 161 O
wear NCT03867890 163 167 B-Observation
one NCT03867890 168 171 B-Eq_Comparison
and NCT03867890 172 175 B-And
the NCT03867890 176 179 O
same NCT03867890 180 184 B-Modifier
pair NCT03867890 185 189 I-Modifier
of NCT03867890 190 192 I-Modifier
shoes NCT03867890 193 198 I-Modifier
during NCT03867890 199 205 B-Temporal_Connection___Temporal_Connection_Type_Value:during
walking NCT03867890 206 213 B-Observation
/ NCT03867890 214 215 B-Or
running NCT03867890 216 223 B-Observation
activities NCT03867890 224 234 O
during NCT03867890 235 241 B-Temporal_Connection___Temporal_Connection_Type_Value:during
this NCT03867890 242 246 O
period NCT03867890 247 253 O

Exclusion NCT03867890 254 263 O
Criteria NCT03867890 264 272 O
: NCT03867890 273 274 O

- NCT03867890 278 279 O
systemic NCT03867890 281 289 B-Condition
disease NCT03867890 290 297 I-Condition
, NCT03867890 298 299 O
cardiac NCT03867890 300 307 B-Condition
problems NCT03867890 308 316 I-Condition
or NCT03867890 317 319 B-Or
diabetes NCT03867890 320 328 B-Condition

- NCT03867890 331 332 O
complaints NCT03867890 334 344 B-Condition
at NCT03867890 345 347 O
the NCT03867890 348 351 O
lower NCT03867890 352 357 B-Modifier
extremities NCT03867890 358 369 I-Modifier
in NCT03867890 370 372 O
the NCT03867890 373 376 O
last NCT03867890 377 381 B-Eq_Comparison
two NCT03867890 382 385 I-Eq_Comparison
weeks NCT03867890 386 391 I-Eq_Comparison
, NCT03867890 392 393 O

- NCT03867890 397 398 O
surgery NCT03867890 400 407 B-Procedure
at NCT03867890 408 410 O
the NCT03867890 411 414 O
lower NCT03867890 415 420 B-Modifier
extremities NCT03867890 421 432 I-Modifier
in NCT03867890 433 435 O
the NCT03867890 436 439 O
last NCT03867890 440 444 B-Eq_Comparison
three NCT03867890 445 450 I-Eq_Comparison
years NCT03867890 451 456 I-Eq_Comparison

Inclusion NCT03923738 0 9 O
Criteria NCT03923738 10 18 O
: NCT03923738 19 20 O

- NCT03923738 24 25 O
Diagnosis NCT03923738 27 36 O
of NCT03923738 37 39 O
GCA NCT03923738 40 43 B-Condition
as NCT03923738 44 46 O
classified NCT03923738 47 57 O
according NCT03923738 58 67 O
to NCT03923738 68 70 O
protocol NCT03923738 71 79 O
- NCT03923738 80 81 O
specified NCT03923738 82 91 O
criteria NCT03923738 92 100 O
; NCT03923738 100 101 O

- NCT03923738 104 105 O
Participants NCT03923738 107 119 O
entering NCT03923738 120 128 B-Assertion___Assertion_Type_Value:hypothetical
Period NCT03923738 129 135 O
1 NCT03923738 136 137 O
must NCT03923738 138 142 O
be NCT03923738 143 145 O
receiving NCT03923738 146 155 B-Eq_Comparison
treatment NCT03923738 156 165 B-Procedure
with NCT03923738 166 170 O
TCZ NCT03923738 171 174 B-Drug
8 NCT03923738 175 176 B-Eq_Comparison
mg NCT03923738 177 179 I-Eq_Comparison
/ NCT03923738 180 181 I-Eq_Comparison
kg NCT03923738 182 184 I-Eq_Comparison
IV NCT03923738 185 187 I-Eq_Comparison
Q NCT03923738 188 189 I-Eq_Comparison
4W NCT03923738 190 192 I-Eq_Comparison
. NCT03923738 193 194 O

Exclusion NCT03923738 196 205 O
Criteria NCT03923738 206 214 O
: NCT03923738 215 216 O

- NCT03923738 220 221 O
Treatment NCT03923738 223 232 B-Procedure
with NCT03923738 233 237 O
any NCT03923738 238 241 O
other NCT03923738 242 247 B-Other
investigational NCT03923738 248 263 B-Study
agent NCT03923738 264 269 B-Drug
besides NCT03923738 270 277 B-Exception
TCZ NCT03923738 278 281 B-Drug
within NCT03923738 282 288 B-Eq_Comparison
12 NCT03923738 289 291 I-Eq_Comparison
weeks NCT03923738 292 297 I-Eq_Comparison
( NCT03923738 298 299 O
or NCT03923738 300 302 B-Or
5 NCT03923738 303 304 B-Eq_Comparison
half NCT03923738 305 309 I-Eq_Comparison
- NCT03923738 310 311 I-Eq_Comparison
lives NCT03923738 312 317 I-Eq_Comparison
of NCT03923738 318 320 O
the NCT03923738 321 324 O
investigational NCT03923738 325 340 O
drug NCT03923738 341 345 O
, NCT03923738 346 347 O
whichever NCT03923738 348 357 O
is NCT03923738 358 360 O
longer NCT03923738 361 367 O
) NCT03923738 368 369 O
prior NCT03923738 370 375 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03923738 376 378 O
screening NCT03923738 379 388 B-Study
; NCT03923738 388 389 O

- NCT03923738 392 393 O
Evidence NCT03923738 395 403 O
of NCT03923738 404 406 O
serious NCT03923738 407 414 O
uncontrolled NCT03923738 415 427 B-Modifier
disease NCT03923738 428 435 B-Condition
; NCT03923738 435 436 O

- NCT03923738 439 440 O
Known NCT03923738 442 447 O
active NCT03923738 448 454 B-Eq_Comparison
current NCT03923738 455 462 I-Eq_Comparison
or NCT03923738 463 465 B-Or
history NCT03923738 466 473 B-Eq_Comparison
of NCT03923738 474 476 I-Eq_Comparison
recurrent NCT03923738 477 486 O
bacterial NCT03923738 487 496 B-Modifier
, NCT03923738 497 498 O
viral NCT03923738 499 504 B-Modifier
, NCT03923738 505 506 O
fungal NCT03923738 507 513 B-Modifier
, NCT03923738 514 515 O
mycobacterial NCT03923738 516 529 B-Modifier
, NCT03923738 530 531 O
or NCT03923738 532 534 O
other NCT03923738 535 540 O
infections NCT03923738 541 551 B-Condition
; NCT03923738 551 552 O

- NCT03923738 555 556 O
Active NCT03923738 558 564 B-Eq_Comparison
TB NCT03923738 565 567 B-Condition
requiring NCT03923738 568 577 O
treatment NCT03923738 578 587 B-Drug
within NCT03923738 588 594 B-Eq_Comparison
the NCT03923738 595 598 I-Eq_Comparison
previous NCT03923738 599 607 I-Eq_Comparison
3 NCT03923738 608 609 I-Eq_Comparison
years NCT03923738 610 615 I-Eq_Comparison
. NCT03923738 616 617 O

Inclusion NCT03860194 0 9 O
Criteria NCT03860194 10 18 O
: NCT03860194 19 20 O

- NCT03860194 24 25 O
Older NCT03860194 27 32 O
adults NCT03860194 33 39 O
( NCT03860194 40 41 O
â¥ NCT03860194 42 43 B-Eq_Comparison
65 NCT03860194 44 46 I-Eq_Comparison
years NCT03860194 47 52 I-Eq_Comparison
) NCT03860194 53 54 O

- NCT03860194 58 59 O
Subject NCT03860194 61 68 O
has NCT03860194 69 72 O
lower NCT03860194 73 78 B-Observation
appendicular NCT03860194 79 91 I-Observation
muscle NCT03860194 92 98 I-Observation
mass NCT03860194 99 103 I-Observation
index NCT03860194 104 109 I-Observation
( NCT03860194 110 111 O
AMMI NCT03860194 112 116 B-Observation
) NCT03860194 117 118 O
( NCT03860194 119 120 O
< NCT03860194 121 122 B-Eq_Comparison
7 NCT03860194 123 124 I-Eq_Comparison
kg NCT03860194 125 127 I-Eq_Comparison
/ NCT03860194 128 129 I-Eq_Comparison
m^ NCT03860194 130 132 I-Eq_Comparison
2 NCT03860194 133 134 I-Eq_Comparison
in NCT03860194 135 137 O
men NCT03860194 138 141 O
; NCT03860194 141 142 O
< NCT03860194 143 144 B-Eq_Comparison
5.7 NCT03860194 145 148 I-Eq_Comparison
kg NCT03860194 149 151 I-Eq_Comparison
/ NCT03860194 152 153 I-Eq_Comparison
m^ NCT03860194 154 156 I-Eq_Comparison
2 NCT03860194 157 158 I-Eq_Comparison
in NCT03860194 159 161 O
women NCT03860194 162 167 O
) NCT03860194 168 169 O
using NCT03860194 170 175 O
Bioelectrical NCT03860194 176 189 B-Procedure
impedance NCT03860194 190 199 I-Procedure
analysis NCT03860194 200 208 I-Procedure
( NCT03860194 209 210 O
BIA NCT03860194 211 214 O
, NCT03860194 215 216 O
TANITA NCT03860194 217 223 O
BC NCT03860194 224 226 O
- NCT03860194 227 228 O
418 NCT03860194 229 232 O
Â® NCT03860194 233 234 O
, NCT03860194 235 236 O
Tokyo NCT03860194 237 242 O
, NCT03860194 243 244 O
Japan NCT03860194 245 250 O
) NCT03860194 251 252 O

- NCT03860194 256 257 O
Subject NCT03860194 259 266 O
has NCT03860194 267 270 O
lower NCT03860194 271 276 B-Observation
handgrip NCT03860194 277 285 I-Observation
strength NCT03860194 286 294 I-Observation
( NCT03860194 295 296 O
< NCT03860194 297 298 B-Eq_Comparison
26 NCT03860194 299 301 I-Eq_Comparison
kg NCT03860194 302 304 I-Eq_Comparison
in NCT03860194 305 307 O
men NCT03860194 308 311 O
; NCT03860194 311 312 O
< NCT03860194 313 314 B-Eq_Comparison
18 NCT03860194 315 317 I-Eq_Comparison
kg NCT03860194 318 320 I-Eq_Comparison
in NCT03860194 321 323 O
women NCT03860194 324 329 O
) NCT03860194 330 331 O
using NCT03860194 332 337 O
dynamometer NCT03860194 338 349 B-Procedure
( NCT03860194 350 351 O
CAMRY NCT03860194 352 357 O
Â® NCT03860194 357 358 O
, NCT03860194 359 360 O
Zhongshan NCT03860194 361 370 O
, NCT03860194 371 372 O
Guangdong NCT03860194 373 382 O
) NCT03860194 383 384 O
or NCT03860194 385 387 B-Or
slowly NCT03860194 388 394 O
gait NCT03860194 395 399 B-Observation
speed NCT03860194 400 405 I-Observation
( NCT03860194 406 407 O
< NCT03860194 408 409 B-Eq_Comparison
1 NCT03860194 410 411 I-Eq_Comparison
m NCT03860194 412 413 I-Eq_Comparison
/ NCT03860194 414 415 I-Eq_Comparison
s NCT03860194 416 417 I-Eq_Comparison
) NCT03860194 418 419 O

Exclusion NCT03860194 421 430 O
Criteria NCT03860194 431 439 O
: NCT03860194 440 441 O

- NCT03860194 445 446 O
Subject NCT03860194 448 455 O
's NCT03860194 455 457 O
life NCT03860194 458 462 B-Observation
expectancy NCT03860194 463 473 I-Observation
was NCT03860194 474 477 O
shorter NCT03860194 478 485 B-Eq_Comparison
than NCT03860194 486 490 I-Eq_Comparison
6 NCT03860194 491 492 I-Eq_Comparison
months NCT03860194 493 499 I-Eq_Comparison

- NCT03860194 502 503 O
Nursing NCT03860194 505 512 O
home NCT03860194 513 517 O
resident NCT03860194 518 526 O

- NCT03860194 529 530 O
Subject NCT03860194 532 539 O
has NCT03860194 540 543 O
the NCT03860194 544 547 O
history NCT03860194 548 555 B-Eq_Comparison
of NCT03860194 556 558 O
kidney NCT03860194 559 565 B-Condition
failure NCT03860194 566 573 I-Condition

- NCT03860194 576 577 O
Subject NCT03860194 579 586 O
has NCT03860194 587 590 O
the NCT03860194 591 594 O
history NCT03860194 595 602 B-Eq_Comparison
of NCT03860194 603 605 O
liver NCT03860194 606 611 B-Condition
failure NCT03860194 612 619 I-Condition

- NCT03860194 622 623 O
Subject NCT03860194 625 632 O
has NCT03860194 633 636 O
the NCT03860194 637 640 O
history NCT03860194 641 648 B-Eq_Comparison
of NCT03860194 649 651 O
diabetes NCT03860194 652 660 B-Condition
mellitus NCT03860194 661 669 I-Condition

- NCT03860194 672 673 O
Subject NCT03860194 675 682 O
has NCT03860194 683 686 O
resistance NCT03860194 687 697 B-Observation
exercise NCT03860194 698 706 I-Observation
habit NCT03860194 707 712 O
. NCT03860194 713 714 O

Inclusion NCT03860896 0 9 O
Criteria NCT03860896 10 18 O
: NCT03860896 19 20 O

- NCT03860896 24 25 O
Patients NCT03860896 27 35 O
aged NCT03860896 36 40 B-Age
18 NCT03860896 41 43 B-Eq_Comparison
- NCT03860896 44 45 I-Eq_Comparison
74 NCT03860896 46 48 I-Eq_Comparison
, NCT03860896 49 50 O
receiving NCT03860896 51 60 B-Eq_Comparison
therapy NCT03860896 61 68 B-Procedure
for NCT03860896 69 72 O
active NCT03860896 73 79 B-Eq_Comparison
ulcerative NCT03860896 80 90 B-Condition
colitis NCT03860896 91 98 I-Condition
confirmed NCT03860896 99 108 O
by NCT03860896 109 111 O
Mayo NCT03860896 112 116 B-Observation
Score NCT03860896 117 122 I-Observation
assessment NCT03860896 123 133 I-Observation
, NCT03860896 134 135 O
and NCT03860896 136 139 B-And
evidence NCT03860896 140 148 O
of NCT03860896 149 151 O
colonic NCT03860896 152 159 B-Condition
inflammation NCT03860896 160 172 I-Condition
. NCT03860896 173 174 O

Exclusion NCT03860896 176 185 O
Criteria NCT03860896 186 194 O
: NCT03860896 195 196 O

- NCT03860896 200 201 O
Evidence NCT03860896 203 211 O
of NCT03860896 212 214 O
Crohn NCT03860896 215 220 B-Condition
's NCT03860896 220 222 I-Condition
disease NCT03860896 223 230 I-Condition
, NCT03860896 231 232 O
indeterminate NCT03860896 233 246 B-Condition
colitis NCT03860896 247 254 I-Condition
, NCT03860896 255 256 O
or NCT03860896 257 259 B-Or
presence NCT03860896 260 268 O
of NCT03860896 269 271 O
bacterial NCT03860896 272 281 B-Modifier
or NCT03860896 282 284 B-Or
parasitic NCT03860896 285 294 B-Modifier
infection NCT03860896 295 304 B-Condition
. NCT03860896 305 306 O

- NCT03860896 310 311 O
Patients NCT03860896 313 321 O
receiving NCT03860896 322 331 B-Eq_Comparison
biologic NCT03860896 332 340 B-Drug
agents NCT03860896 341 347 I-Drug
and NCT03860896 348 351 B-Or
experimental NCT03860896 352 364 B-Drug
agents NCT03860896 365 371 I-Drug
are NCT03860896 372 375 O
excluded NCT03860896 376 384 B-Negation
. NCT03860896 385 386 O

Inclusion NCT03865771 0 9 O
Criteria NCT03865771 10 18 O
: NCT03865771 19 20 O

Principal NCT03865771 22 31 O
: NCT03865771 32 33 O

- NCT03865771 37 38 O
normal NCT03865771 40 46 O
psychomotor NCT03865771 47 58 B-Condition
development NCT03865771 59 70 I-Condition

- NCT03865771 73 74 O
informed NCT03865771 76 84 O
consent NCT03865771 85 92 O
signed NCT03865771 93 99 O
by NCT03865771 100 102 O
both NCT03865771 103 107 O
parents NCT03865771 108 115 O
and NCT03865771 116 119 O
subject NCT03865771 120 127 O
if NCT03865771 128 130 O
able NCT03865771 131 135 O

- NCT03865771 138 139 O
affiliated NCT03865771 141 151 O
to NCT03865771 152 154 O
social NCT03865771 155 161 O
security NCT03865771 162 170 O
regimen NCT03865771 171 178 O

Specific NCT03865771 179 187 O

Patients NCT03865771 188 196 O
from NCT03865771 197 201 O
" NCT03865771 202 203 O
severe NCT03865771 203 209 O
" NCT03865771 209 210 O
and NCT03865771 211 214 O
" NCT03865771 215 216 O
benign NCT03865771 216 222 O
" NCT03865771 222 223 O
groups NCT03865771 224 230 O
: NCT03865771 231 232 O

- NCT03865771 236 237 O
focal NCT03865771 239 244 B-Modifier
age NCT03865771 245 248 I-Modifier
related NCT03865771 249 256 I-Modifier
epilepsy NCT03865771 257 265 B-Condition
: NCT03865771 266 267 O
BECTS NCT03865771 268 273 B-Condition
, NCT03865771 274 275 O
ABPE NCT03865771 276 280 B-Condition
, NCT03865771 281 282 O
ECSWS NCT03865771 283 288 B-Condition
( NCT03865771 289 290 O
ILAE NCT03865771 291 295 O
criteria NCT03865771 296 304 O
) NCT03865771 305 306 O

- NCT03865771 310 311 O
children NCT03865771 313 321 O
hospitalized NCT03865771 322 334 B-Encounter
for NCT03865771 335 338 B-Temporal_Connection___Temporal_Connection_Type_Value:during
their NCT03865771 339 344 O
follow NCT03865771 345 351 B-Encounter
- NCT03865771 352 353 I-Encounter
up NCT03865771 354 356 I-Encounter

- NCT03865771 359 360 O
normal NCT03865771 362 368 O
neuroimaging NCT03865771 369 381 B-Procedure

Control NCT03865771 382 389 O
group NCT03865771 390 395 O

- NCT03865771 397 398 O
children NCT03865771 399 407 O
hospitalized NCT03865771 408 420 B-Encounter
for NCT03865771 421 424 O
a NCT03865771 425 426 O
non NCT03865771 427 430 B-Negation
neurologic NCT03865771 431 441 B-Condition
disease NCT03865771 442 449 I-Condition

Exclusion NCT03865771 450 459 O
Criteria NCT03865771 460 468 O
: NCT03865771 469 470 O

Principal NCT03865771 472 481 O
: NCT03865771 482 483 O

Psychiatric NCT03865771 485 496 B-Condition
trouble NCT03865771 497 504 I-Condition
( NCT03865771 505 506 O
DSM NCT03865771 507 510 O
V NCT03865771 511 512 O
) NCT03865771 513 514 O
Sensorial NCT03865771 515 524 B-Condition
trouble NCT03865771 525 532 I-Condition
without NCT03865771 533 540 B-Negation
correction NCT03865771 541 551 B-Modifier
Poor NCT03865771 552 556 B-Negation
command NCT03865771 557 564 I-Negation
of NCT03865771 565 567 O
French NCT03865771 568 574 O
language NCT03865771 575 583 O
Minor NCT03865771 584 589 O
under NCT03865771 590 595 O
care NCT03865771 596 600 O

Specific NCT03865771 601 609 O

Patients NCT03865771 610 618 O
from NCT03865771 619 623 O
" NCT03865771 624 625 O
severe NCT03865771 625 631 O
" NCT03865771 631 632 O
and NCT03865771 633 636 O
" NCT03865771 637 638 O
benign NCT03865771 638 644 O
" NCT03865771 644 645 O
groups NCT03865771 646 652 O
: NCT03865771 653 654 O

- NCT03865771 658 659 O
degenerative NCT03865771 661 673 B-Condition
disease NCT03865771 674 681 I-Condition

- NCT03865771 684 685 O
abnormal NCT03865771 687 695 O
neuroimaging NCT03865771 696 708 B-Procedure

- NCT03865771 711 712 O
mental NCT03865771 714 720 B-Condition
deficiency NCT03865771 721 731 I-Condition

Control NCT03865771 732 739 O
group NCT03865771 740 745 O

- NCT03865771 748 749 O
neurologic NCT03865771 751 761 B-Condition
trouble NCT03865771 762 769 I-Condition

- NCT03865771 772 773 O
abnormal NCT03865771 775 783 O
sleep NCT03865771 784 789 B-Procedure
EEG NCT03865771 790 793 I-Procedure

- NCT03865771 796 797 O
intellectual NCT03865771 799 811 B-Condition
deficiency NCT03865771 812 822 I-Condition


Inclusion NCT03929744 0 9 O
Criteria NCT03929744 10 18 O
: NCT03929744 19 20 O

- NCT03929744 24 25 O
Healthy NCT03929744 27 34 B-Condition
male NCT03929744 35 39 O
or NCT03929744 40 42 B-Or
females NCT03929744 43 50 O
, NCT03929744 51 52 O
as NCT03929744 53 55 O
determined NCT03929744 56 66 O
by NCT03929744 67 69 O
medical NCT03929744 70 77 O
history NCT03929744 78 85 O

- NCT03929744 88 89 O
Have NCT03929744 91 95 O
safety NCT03929744 96 102 B-Modifier
laboratory NCT03929744 103 113 B-Observation
results NCT03929744 114 121 I-Observation
within NCT03929744 122 128 B-Eq_Comparison
normal NCT03929744 129 135 I-Eq_Comparison
reference NCT03929744 136 145 I-Eq_Comparison
ranges NCT03929744 146 152 I-Eq_Comparison

Exclusion NCT03929744 153 162 O
Criteria NCT03929744 163 171 O
: NCT03929744 172 173 O

- NCT03929744 177 178 O
Have NCT03929744 180 184 O
known NCT03929744 185 190 O
allergies NCT03929744 191 200 B-Allergy
to NCT03929744 201 203 O
LY NCT03929744 204 206 B-Drug
3502970 NCT03929744 207 214 I-Drug
, NCT03929744 215 216 O
glucagon NCT03929744 217 225 B-Drug
- NCT03929744 226 227 I-Drug
like NCT03929744 228 232 I-Drug
peptide NCT03929744 233 240 I-Drug
- NCT03929744 241 242 I-Drug
1 NCT03929744 243 244 I-Drug
( NCT03929744 245 246 O
GLP NCT03929744 247 250 B-Drug
- NCT03929744 251 252 I-Drug
1 NCT03929744 253 254 I-Drug
) NCT03929744 255 256 O
analogs NCT03929744 257 264 B-Modifier
, NCT03929744 265 266 O
related NCT03929744 267 274 O
compounds NCT03929744 275 284 O

- NCT03929744 287 288 O
Abnormal NCT03929744 290 298 O
electrocardiogram NCT03929744 299 316 B-Procedure
( NCT03929744 317 318 O
ECG NCT03929744 319 322 B-Procedure
) NCT03929744 323 324 O
at NCT03929744 325 327 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03929744 328 337 B-Study

- NCT03929744 340 341 O
Significant NCT03929744 343 354 O
history NCT03929744 355 362 B-Eq_Comparison
of NCT03929744 363 365 O
or NCT03929744 366 368 B-Or
current NCT03929744 369 376 B-Eq_Comparison
cardiovascular NCT03929744 377 391 B-Modifier
, NCT03929744 392 393 O
respiratory NCT03929744 394 405 B-Modifier
, NCT03929744 406 407 O
hepatic NCT03929744 408 415 B-Modifier
, NCT03929744 416 417 O
renal NCT03929744 418 423 B-Modifier
, NCT03929744 424 425 O
gastrointestinal NCT03929744 426 442 B-Modifier
, NCT03929744 443 444 O
endocrine NCT03929744 445 454 B-Modifier
, NCT03929744 455 456 O
hematological NCT03929744 457 470 B-Modifier
or NCT03929744 471 473 B-Or
neurological NCT03929744 474 486 B-Modifier
disorders NCT03929744 487 496 B-Condition
. NCT03929744 497 498 O

Inclusion NCT03925116 0 9 O
Criteria NCT03925116 10 18 O

- NCT03925116 21 22 O
Women NCT03925116 24 29 O
at NCT03925116 30 32 O
risk NCT03925116 33 37 B-Risk
for NCT03925116 38 41 O
pregnancy NCT03925116 42 51 B-Condition

- NCT03925116 54 55 O
Women NCT03925116 57 62 O
able NCT03925116 63 67 O
to NCT03925116 68 70 O
read NCT03925116 71 75 O
and NCT03925116 76 79 O
write NCT03925116 80 85 O
in NCT03925116 86 88 O
English NCT03925116 89 96 O

Exclusion NCT03925116 97 106 O
Criteria NCT03925116 107 115 O

- NCT03925116 118 119 O
Women NCT03925116 121 126 O
who NCT03925116 127 130 B-And
have NCT03925116 131 135 O
undergone NCT03925116 136 145 B-Eq_Comparison
permanent NCT03925116 146 155 B-Procedure
sterilization NCT03925116 156 169 I-Procedure

- NCT03925116 172 173 O
Women NCT03925116 175 180 O
not NCT03925116 181 184 B-Negation
sexually NCT03925116 185 193 B-Condition
active NCT03925116 194 200 I-Condition
with NCT03925116 201 205 B-And
a NCT03925116 206 207 O
male NCT03925116 208 212 O
partner NCT03925116 213 220 B-Other

- NCT03925116 223 224 O
Women NCT03925116 226 231 O
who NCT03925116 232 235 B-And
intend NCT03925116 236 242 B-Assertion___Assertion_Type_Value:intention
to NCT03925116 243 245 I-Assertion___Assertion_Type_Value:intention
become NCT03925116 246 252 O
pregnant NCT03925116 253 261 B-Condition
in NCT03925116 262 264 O
the NCT03925116 265 268 O
next NCT03925116 269 273 B-Eq_Comparison
12 NCT03925116 274 276 I-Eq_Comparison
months NCT03925116 277 283 I-Eq_Comparison

Inclusion NCT03927846 0 9 O
Criteria NCT03927846 10 18 O
: NCT03927846 19 20 O
- NCT03927846 21 22 O

1 NCT03927846 26 27 O
. NCT03927846 27 28 O
patients NCT03927846 30 38 O
at NCT03927846 39 41 O
the NCT03927846 42 45 O
primary NCT03927846 46 53 O
care NCT03927846 54 58 O
or NCT03927846 59 61 B-Or
rheumatology NCT03927846 62 74 O
clinic NCT03927846 75 81 O
with NCT03927846 82 86 B-And
daily NCT03927846 87 92 B-Eq_Comparison
pain NCT03927846 93 97 B-Condition
for NCT03927846 98 101 O
6 NCT03927846 102 103 B-Eq_Comparison
months NCT03927846 104 110 I-Eq_Comparison
or NCT03927846 111 113 I-Eq_Comparison
longer NCT03927846 114 120 I-Eq_Comparison
affecting NCT03927846 121 130 O
the NCT03927846 131 134 O
low NCT03927846 135 138 B-Modifier
back NCT03927846 139 143 I-Modifier
, NCT03927846 144 145 O
neck NCT03927846 146 150 B-Modifier
, NCT03927846 151 152 O
hip NCT03927846 153 156 B-Modifier
, NCT03927846 157 158 O
knee NCT03927846 159 163 B-Modifier
or NCT03927846 164 166 B-Or
widespread NCT03927846 167 177 B-Condition
pain NCT03927846 178 182 I-Condition
; NCT03927846 182 183 O

2 NCT03927846 186 187 O
. NCT03927846 187 188 O
at NCT03927846 190 192 B-Eq_Comparison
least NCT03927846 193 198 I-Eq_Comparison
moderate NCT03927846 199 207 I-Eq_Comparison
in NCT03927846 208 210 O
average NCT03927846 211 218 O
pain NCT03927846 219 223 B-Condition
severity NCT03927846 224 232 O
, NCT03927846 233 234 O
defined NCT03927846 235 242 O
as NCT03927846 243 245 O
a NCT03927846 246 247 O
weekly NCT03927846 248 254 O
average NCT03927846 255 262 O
pain NCT03927846 263 267 B-Observation
severity NCT03927846 268 276 I-Observation
score NCT03927846 277 282 I-Observation
of NCT03927846 283 285 O
5 NCT03927846 286 287 B-Eq_Comparison
or NCT03927846 288 290 I-Eq_Comparison
greater NCT03927846 291 298 I-Eq_Comparison
24 NCT03927846 299 301 O
; NCT03927846 302 303 O

3 NCT03927846 306 307 O
. NCT03927846 307 308 O
at NCT03927846 310 312 B-Eq_Comparison
least NCT03927846 313 318 I-Eq_Comparison
18 NCT03927846 319 321 I-Eq_Comparison
years NCT03927846 322 327 I-Eq_Comparison
of NCT03927846 328 330 O
age NCT03927846 331 334 B-Age
; NCT03927846 334 335 O

4 NCT03927846 338 339 O
. NCT03927846 339 340 O
reliable NCT03927846 342 350 O
phone NCT03927846 351 356 O
( NCT03927846 357 358 O
landline NCT03927846 359 367 O
or NCT03927846 368 370 O
cell NCT03927846 371 375 O
) NCT03927846 376 377 O
, NCT03927846 378 379 O
and NCT03927846 380 383 O

5 NCT03927846 386 387 O
. NCT03927846 387 388 O
have NCT03927846 390 394 O
home NCT03927846 395 399 O
computer NCT03927846 400 408 O
with NCT03927846 409 413 O
reliable NCT03927846 414 422 O
internet NCT03927846 423 431 O
access NCT03927846 432 438 O
. NCT03927846 439 440 O

Exclusion NCT03927846 442 451 O
Criteria NCT03927846 452 460 O
: NCT03927846 461 462 O

1 NCT03927846 466 467 O
. NCT03927846 467 468 O
planned NCT03927846 470 477 B-Eq_Comparison
elective NCT03927846 478 486 O
surgery NCT03927846 487 494 B-Procedure
during NCT03927846 495 501 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03927846 502 505 O
study NCT03927846 506 511 B-Study
period NCT03927846 512 518 O
; NCT03927846 518 519 O

2 NCT03927846 522 523 O
. NCT03927846 523 524 O
very NCT03927846 526 530 O
severe NCT03927846 531 537 O
symptoms NCT03927846 538 546 B-Assertion___Assertion_Type_Value:possible
of NCT03927846 547 549 O
depression NCT03927846 550 560 B-Condition
( NCT03927846 561 562 O
i NCT03927846 563 564 O
. NCT03927846 565 566 O
e NCT03927846 567 568 O
. NCT03927846 569 570 O
, NCT03927846 571 572 O
PHQ NCT03927846 573 576 B-Observation
8 NCT03927846 577 578 I-Observation
score NCT03927846 579 584 O
of NCT03927846 585 587 O
â¥ NCT03927846 588 589 B-Eq_Comparison
20 NCT03927846 590 592 I-Eq_Comparison
) NCT03927846 593 594 O
; NCT03927846 595 596 O

3 NCT03927846 599 600 O
. NCT03927846 600 601 O
ongoing NCT03927846 603 610 O
unresolved NCT03927846 611 621 O
disability NCT03927846 622 632 O
claims NCT03927846 633 639 O
; NCT03927846 639 640 O

4 NCT03927846 643 644 O
. NCT03927846 644 645 O
inflammatory NCT03927846 647 659 B-Condition
arthritis NCT03927846 660 669 I-Condition
( NCT03927846 670 671 O
e NCT03927846 672 673 O
. NCT03927846 674 675 O
g NCT03927846 676 677 O
. NCT03927846 678 679 O
, NCT03927846 680 681 O
lupus NCT03927846 682 687 B-Condition
, NCT03927846 688 689 O
rheumatoid NCT03927846 690 700 B-Condition
arthritis NCT03927846 701 710 I-Condition
, NCT03927846 711 712 O
ankylosing NCT03927846 713 723 B-Condition
spondylitis NCT03927846 724 735 I-Condition
, NCT03927846 736 737 O
etc NCT03927846 738 741 O
. NCT03927846 742 743 O
) NCT03927846 744 745 O
; NCT03927846 746 747 O

5 NCT03927846 750 751 O
. NCT03927846 751 752 O
cancer NCT03927846 754 760 B-Condition
- NCT03927846 761 762 O
related NCT03927846 763 770 O
musculoskeletal NCT03927846 771 786 B-Modifier
pain NCT03927846 787 791 B-Condition
; NCT03927846 791 792 O

6 NCT03927846 795 796 O
. NCT03927846 796 797 O
history NCT03927846 799 806 B-Eq_Comparison
of NCT03927846 807 809 O
bipolar NCT03927846 810 817 B-Condition
disorder NCT03927846 818 826 I-Condition
or NCT03927846 827 829 B-Or
schizophrenia NCT03927846 830 843 B-Condition
; NCT03927846 843 844 O
and NCT03927846 845 848 O

7 NCT03927846 851 852 O
. NCT03927846 852 853 O
takes NCT03927846 855 860 B-Eq_Comparison
daily NCT03927846 861 866 B-Eq_Comparison
opioid NCT03927846 867 873 B-Drug
for NCT03927846 874 877 O
more NCT03927846 878 882 B-Eq_Comparison
than NCT03927846 883 887 I-Eq_Comparison
one NCT03927846 888 891 I-Eq_Comparison
year NCT03927846 892 896 I-Eq_Comparison
. NCT03927846 897 898 O

Inclusion NCT03925129 0 9 O
Criteria NCT03925129 10 18 O
: NCT03925129 19 20 O

- NCT03925129 24 25 O
Patients NCT03925129 27 35 O
seeking NCT03925129 36 43 B-Assertion___Assertion_Type_Value:intention
medication NCT03925129 44 54 B-Drug
abortion NCT03925129 55 63 B-Procedure
with NCT03925129 64 68 O
a NCT03925129 69 70 O
definite NCT03925129 71 79 B-Modifier
, NCT03925129 80 81 O
singleton NCT03925129 82 91 B-Modifier
, NCT03925129 92 93 O
intrauterine NCT03925129 94 106 B-Modifier
pregnancy NCT03925129 107 116 B-Condition
( NCT03925129 117 118 O
IUP NCT03925129 119 122 B-Condition
) NCT03925129 123 124 O
< NCT03925129 125 126 B-Eq_Comparison
70 NCT03925129 127 129 I-Eq_Comparison
days NCT03925129 130 134 I-Eq_Comparison
' NCT03925129 134 135 O
gestation NCT03925129 136 145 B-Observation
on NCT03925129 146 148 O
ultrasound NCT03925129 149 159 B-Procedure

- NCT03925129 162 163 O
Rapid NCT03925129 165 170 B-Observation
Estimate NCT03925129 171 179 I-Observation
of NCT03925129 180 182 I-Observation
Adult NCT03925129 183 188 I-Observation
Literacy NCT03925129 189 197 I-Observation
in NCT03925129 198 200 I-Observation
Medicine NCT03925129 201 209 I-Observation
- NCT03925129 210 211 I-Observation
Short NCT03925129 212 217 I-Observation
Form NCT03925129 218 222 I-Observation
( NCT03925129 223 224 O
REALM NCT03925129 225 230 B-Observation
- NCT03925129 231 232 I-Observation
SF NCT03925129 233 235 I-Observation
) NCT03925129 236 237 O
22 NCT03925129 238 240 O
score NCT03925129 241 246 B-Eq_Comparison
> NCT03925129 247 248 I-Eq_Comparison
4 NCT03925129 249 250 I-Eq_Comparison

- NCT03925129 254 255 O
Age NCT03925129 257 260 B-Age
equal NCT03925129 261 266 B-Eq_Comparison
to NCT03925129 267 269 I-Eq_Comparison
or NCT03925129 270 272 I-Eq_Comparison
greater NCT03925129 273 280 I-Eq_Comparison
than NCT03925129 281 285 I-Eq_Comparison
18 NCT03925129 286 288 I-Eq_Comparison
years NCT03925129 289 294 I-Eq_Comparison

- NCT03925129 297 298 O
Provide NCT03925129 300 307 O
informed NCT03925129 308 316 O
consent NCT03925129 317 324 O
to NCT03925129 325 327 O
participate NCT03925129 328 339 O

- NCT03925129 342 343 O
Willing NCT03925129 345 352 O
to NCT03925129 353 355 O
adhere NCT03925129 356 362 O
to NCT03925129 363 365 O
study NCT03925129 366 371 O
procedures NCT03925129 372 382 O
, NCT03925129 383 384 O
including NCT03925129 385 394 O
access NCT03925129 395 401 O
to NCT03925129 402 404 O
a NCT03925129 405 406 O
smart NCT03925129 407 412 O
phone NCT03925129 413 418 O
, NCT03925129 419 420 O
ability NCT03925129 421 428 O
to NCT03925129 429 431 O
receive NCT03925129 432 439 O
text NCT03925129 440 444 O
messages NCT03925129 445 453 O
and NCT03925129 454 457 O
answer NCT03925129 458 464 O
online NCT03925129 465 471 O
surveys NCT03925129 472 479 O
on NCT03925129 480 482 O
smart NCT03925129 483 488 O
phone NCT03925129 489 494 O

Exclusion NCT03925129 495 504 O
Criteria NCT03925129 505 513 O
: NCT03925129 514 515 O

- NCT03925129 519 520 O
Contraindication NCT03925129 522 538 B-Contraindication
to NCT03925129 539 541 O
medication NCT03925129 542 552 B-Drug
abortion NCT03925129 553 561 B-Procedure

- NCT03925129 564 565 O
Allergy NCT03925129 567 574 B-Allergy
to NCT03925129 575 577 O
mifepristone NCT03925129 578 590 B-Drug
or NCT03925129 591 593 B-Or
misoprostol NCT03925129 594 605 B-Drug

- NCT03925129 608 609 O
Contraindication NCT03925129 611 627 B-Contraindication
or NCT03925129 628 630 B-Or
allergy NCT03925129 631 638 B-Allergy
to NCT03925129 639 641 O
ibuprofen NCT03925129 642 651 B-Drug

- NCT03925129 654 655 O
History NCT03925129 657 664 B-Eq_Comparison
of NCT03925129 665 667 O
cardiac NCT03925129 668 675 B-Condition
arrhythmia NCT03925129 676 686 I-Condition

- NCT03925129 689 690 O
Presence NCT03925129 692 700 O
of NCT03925129 701 703 O
an NCT03925129 704 706 O
implantable NCT03925129 707 718 B-Procedure
device NCT03925129 719 725 I-Procedure
with NCT03925129 726 730 O
electrical NCT03925129 731 741 B-Modifier
discharge NCT03925129 742 751 I-Modifier
, NCT03925129 752 753 O
i NCT03925129 754 755 O
. NCT03925129 756 757 O
e NCT03925129 758 759 O
. NCT03925129 760 761 O
cardiac NCT03925129 763 770 B-Procedure
pacemaker NCT03925129 771 780 I-Procedure

- NCT03925129 783 784 O
History NCT03925129 786 793 B-Eq_Comparison
of NCT03925129 794 796 O
chronic NCT03925129 797 804 O
pain NCT03925129 805 809 B-Condition
disorder NCT03925129 810 818 I-Condition

- NCT03925129 821 822 O
Any NCT03925129 824 827 O
opioid NCT03925129 828 834 B-Drug
use NCT03925129 835 838 O
during NCT03925129 839 845 B-Temporal_Connection___Temporal_Connection_Type_Value:during
previous NCT03925129 846 854 B-Eq_Comparison
30 NCT03925129 855 857 I-Eq_Comparison
days NCT03925129 858 862 I-Eq_Comparison

- NCT03925129 865 866 O
Current NCT03925129 868 875 B-Eq_Comparison
or NCT03925129 876 878 B-Or
prior NCT03925129 879 884 B-Eq_Comparison
use NCT03925129 885 888 O
of NCT03925129 889 891 O
TENS NCT03925129 892 896 B-Procedure

- NCT03925129 899 900 O
BMI NCT03925129 902 905 B-Observation
> NCT03925129 906 907 B-Eq_Comparison
30 NCT03925129 908 910 I-Eq_Comparison

Inclusion NCT03865108 0 9 O
Criteria NCT03865108 10 18 O
: NCT03865108 19 20 O

- NCT03865108 24 25 O
Singleton NCT03865108 27 36 B-Modifier
gestation NCT03865108 37 46 B-Condition
. NCT03865108 47 48 O

- NCT03865108 57 58 O
Twin NCT03865108 60 64 B-Modifier
gestation NCT03865108 65 74 B-Condition
reduced NCT03865108 75 82 O
to NCT03865108 83 85 O
singleton NCT03865108 86 95 B-Modifier
either NCT03865108 96 102 O
spontaneously NCT03865108 103 116 B-Modifier
or NCT03865108 117 119 B-Or
therapeutically NCT03865108 120 135 B-Procedure
, NCT03865108 136 137 O
is NCT03865108 138 140 O
not NCT03865108 141 144 B-Negation
eligible NCT03865108 145 153 O
unless NCT03865108 154 160 B-Exception
the NCT03865108 161 164 O
reduction NCT03865108 165 174 O
occurred NCT03865108 175 183 O
before NCT03865108 184 190 B-Temporal_Connection___Temporal_Connection_Type_Value:before
13 NCT03865108 191 193 B-Eq_Comparison
weeks NCT03865108 194 199 I-Eq_Comparison
6 NCT03865108 200 201 I-Eq_Comparison
days NCT03865108 202 206 I-Eq_Comparison
project NCT03865108 207 214 O
gestational NCT03865108 215 226 B-Observation
age NCT03865108 227 230 I-Observation
. NCT03865108 231 232 O

- NCT03865108 241 242 O
Higher NCT03865108 244 250 B-Modifier
order NCT03865108 251 256 I-Modifier
multifetal NCT03865108 257 267 I-Modifier
gestations NCT03865108 268 278 B-Condition
reduced NCT03865108 279 286 O
to NCT03865108 287 289 O
singletons NCT03865108 290 300 B-Modifier
are NCT03865108 301 304 O
not NCT03865108 305 308 B-Negation
eligible NCT03865108 309 317 O
. NCT03865108 318 319 O

- NCT03865108 323 324 O
Gestational NCT03865108 326 337 B-Observation
age NCT03865108 338 341 I-Observation
at NCT03865108 342 344 B-Temporal_Connection___Temporal_Connection_Type_Value:during
randomization NCT03865108 345 358 B-Study
between NCT03865108 359 366 B-Eq_Comparison
16 NCT03865108 367 369 I-Eq_Comparison
weeks NCT03865108 370 375 I-Eq_Comparison
0 NCT03865108 376 377 I-Eq_Comparison
days NCT03865108 378 382 I-Eq_Comparison
and NCT03865108 383 386 B-And
23 NCT03865108 387 389 B-Eq_Comparison
weeks NCT03865108 390 395 I-Eq_Comparison
6 NCT03865108 396 397 I-Eq_Comparison
days NCT03865108 398 402 I-Eq_Comparison
based NCT03865108 403 408 O
on NCT03865108 409 411 O
clinical NCT03865108 412 420 O
information NCT03865108 421 432 O
and NCT03865108 433 436 O
evaluation NCT03865108 437 447 O
of NCT03865108 448 450 O
the NCT03865108 451 454 O
earliest NCT03865108 455 463 B-Eq_Comparison
ultrasound NCT03865108 464 474 B-Procedure
as NCT03865108 475 477 O
described NCT03865108 478 487 O
in NCT03865108 488 490 O
Gestational NCT03865108 491 502 B-Observation
Age NCT03865108 503 506 I-Observation
. NCT03865108 507 508 O

- NCT03865108 512 513 O
Cervical NCT03865108 515 523 B-Observation
length NCT03865108 524 530 I-Observation
on NCT03865108 531 533 O
transvaginal NCT03865108 534 546 B-Procedure
examination NCT03865108 547 558 I-Procedure
of NCT03865108 559 561 O
less NCT03865108 562 566 B-Eq_Comparison
than NCT03865108 567 571 I-Eq_Comparison
or NCT03865108 572 574 I-Eq_Comparison
equal NCT03865108 575 580 I-Eq_Comparison
to NCT03865108 581 583 I-Eq_Comparison
20 NCT03865108 584 586 I-Eq_Comparison
mm NCT03865108 587 589 I-Eq_Comparison
within NCT03865108 590 596 B-Eq_Comparison
10 NCT03865108 597 599 I-Eq_Comparison
days NCT03865108 600 604 I-Eq_Comparison
prior NCT03865108 605 610 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865108 611 613 I-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03865108 614 627 O
by NCT03865108 628 630 O
a NCT03865108 631 632 O
study NCT03865108 633 638 B-Study
certified NCT03865108 639 648 O
sonographer NCT03865108 649 660 B-Provider
. NCT03865108 661 662 O
There NCT03865108 664 669 O
is NCT03865108 670 672 O
no NCT03865108 673 675 B-Negation
lower NCT03865108 676 681 O
cervical NCT03865108 682 690 B-Observation
length NCT03865108 691 697 I-Observation
threshold NCT03865108 698 707 O
. NCT03865108 708 709 O

Exclusion NCT03865108 711 720 O
Criteria NCT03865108 721 729 O
: NCT03865108 730 731 O

- NCT03865108 735 736 O
Women NCT03865108 738 743 O
who NCT03865108 744 747 B-And
are NCT03865108 748 751 O
ineligible NCT03865108 752 762 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03865108 763 766 O
the NCT03865108 767 770 O
TOPS NCT03865108 771 775 O
trial NCT03865108 776 781 O
. NCT03865108 782 783 O

Inclusion NCT03926871 0 9 O
Criteria NCT03926871 10 18 O
: NCT03926871 19 20 O

To NCT03926871 22 24 O
Novato NCT03926871 25 31 O
workers NCT03926871 32 39 O

- NCT03926871 42 43 O
1 NCT03926871 45 46 B-Eq_Comparison
to NCT03926871 47 49 I-Eq_Comparison
2 NCT03926871 50 51 I-Eq_Comparison
days NCT03926871 52 56 I-Eq_Comparison
in NCT03926871 57 59 O
the NCT03926871 60 63 O
company NCT03926871 64 71 O

- NCT03926871 74 75 O
Not NCT03926871 77 80 B-Negation
have NCT03926871 81 85 O
previous NCT03926871 86 94 B-Eq_Comparison
experience NCT03926871 95 105 O
in NCT03926871 106 108 O
a NCT03926871 109 110 O
frigorifico NCT03926871 111 122 O
, NCT03926871 123 124 O
or NCT03926871 125 127 O
butcher NCT03926871 128 135 O
's NCT03926871 135 137 O
shop NCT03926871 138 142 O

- NCT03926871 145 146 O
Not NCT03926871 148 151 B-Negation
have NCT03926871 152 156 O
prior NCT03926871 157 162 B-Eq_Comparison
knowledge NCT03926871 163 172 O
of NCT03926871 173 175 O
the NCT03926871 176 179 O
activity NCT03926871 180 188 O
. NCT03926871 189 190 O
To NCT03926871 192 194 O
experienced NCT03926871 195 206 O
workers NCT03926871 207 214 O

- NCT03926871 217 218 O
Work NCT03926871 220 224 B-Observation
on NCT03926871 225 227 O
the NCT03926871 228 231 O
task NCT03926871 232 236 O
for NCT03926871 237 240 O
more NCT03926871 241 245 B-Eq_Comparison
than NCT03926871 246 250 I-Eq_Comparison
six NCT03926871 251 254 I-Eq_Comparison
months NCT03926871 255 261 I-Eq_Comparison

- NCT03926871 264 265 O
Be NCT03926871 267 269 O
present NCT03926871 270 277 O
in NCT03926871 278 280 O
company NCT03926871 281 288 O
during NCT03926871 289 295 O
the NCT03926871 296 299 O
study NCT03926871 300 305 B-Study
period NCT03926871 306 312 O

Exclusion NCT03926871 313 322 O
Criteria NCT03926871 323 331 O
: NCT03926871 332 333 O

For NCT03926871 335 338 O
all NCT03926871 339 342 O
workers NCT03926871 343 350 O

- NCT03926871 353 354 O
Had NCT03926871 356 359 O
already NCT03926871 360 367 B-Eq_Comparison
received NCT03926871 368 376 I-Eq_Comparison
ergonomic NCT03926871 377 386 B-Procedure
training NCT03926871 387 395 I-Procedure
( NCT03926871 396 397 O
general NCT03926871 398 405 O
guidelines NCT03926871 406 416 O
and NCT03926871 417 420 O
postural NCT03926871 421 429 O
adjustments NCT03926871 430 441 O
) NCT03926871 442 443 O

- NCT03926871 447 448 O
Pregnant NCT03926871 450 458 B-Condition
women NCT03926871 459 464 O

- NCT03926871 467 468 O
People NCT03926871 470 476 O
with NCT03926871 477 481 O
disabilities NCT03926871 482 494 B-Condition
. NCT03926871 495 496 O

Inclusion NCT03864471 0 9 O
Criteria NCT03864471 10 18 O
: NCT03864471 19 20 O

- NCT03864471 24 25 O
lived NCT03864471 27 32 O
in NCT03864471 33 35 O
the NCT03864471 36 39 O
community NCT03864471 40 49 O
at NCT03864471 50 52 B-Eq_Comparison
least NCT03864471 53 58 I-Eq_Comparison
three NCT03864471 59 64 I-Eq_Comparison
months NCT03864471 65 71 I-Eq_Comparison

- NCT03864471 74 75 O
over NCT03864471 77 81 B-Eq_Comparison
65 NCT03864471 82 84 I-Eq_Comparison
years NCT03864471 85 90 I-Eq_Comparison
old NCT03864471 91 94 B-Age

- NCT03864471 97 98 O
fluently NCT03864471 100 108 O
communicated NCT03864471 109 121 O
in NCT03864471 122 124 O
Mandarin NCT03864471 125 133 O
or NCT03864471 134 136 B-Or
Taiwanese NCT03864471 137 146 O

- NCT03864471 149 150 O
screened NCT03864471 152 160 O
by NCT03864471 161 163 O
the NCT03864471 164 167 O
High NCT03864471 168 172 B-Observation
- NCT03864471 173 174 I-Observation
need NCT03864471 175 179 I-Observation
Community NCT03864471 180 189 I-Observation
Older NCT03864471 190 195 I-Observation
Adults NCT03864471 196 202 I-Observation
Screening NCT03864471 203 212 I-Observation
Scale NCT03864471 213 218 I-Observation
( NCT03864471 219 220 O
HCOASS NCT03864471 221 227 B-Observation
) NCT03864471 228 229 O
as NCT03864471 230 232 O
high NCT03864471 233 237 B-Condition
- NCT03864471 238 239 I-Condition
need NCT03864471 240 244 I-Condition
older NCT03864471 245 250 O
adults NCT03864471 251 257 O

Exclusion NCT03864471 258 267 O
Criteria NCT03864471 268 276 O
: NCT03864471 277 278 O

- NCT03864471 282 283 O
diagnosed NCT03864471 285 294 O
as NCT03864471 295 297 O
dementia NCT03864471 298 306 B-Condition

Inclusion NCT03921489 0 9 O
Criteria NCT03921489 10 18 O
: NCT03921489 19 20 O

- NCT03921489 24 25 O
BME NCT03921489 27 30 B-Condition
diagnosed NCT03921489 31 40 O
on NCT03921489 41 43 O
MRI NCT03921489 44 47 B-Procedure

- NCT03921489 50 51 O
Pain NCT03921489 53 57 B-Condition
to NCT03921489 58 60 O
that NCT03921489 61 65 O
area NCT03921489 66 70 B-Modifier

- NCT03921489 73 74 O
Failed NCT03921489 76 82 O
3 NCT03921489 83 84 B-Eq_Comparison
months NCT03921489 85 91 I-Eq_Comparison
of NCT03921489 92 94 O
conservative NCT03921489 95 107 B-Procedure
treatment NCT03921489 108 117 I-Procedure

Exclusion NCT03921489 118 127 O
Criteria NCT03921489 128 136 O
: NCT03921489 137 138 O

- NCT03921489 142 143 O
Patient NCT03921489 145 152 O
< NCT03921489 153 154 B-Eq_Comparison
18 NCT03921489 155 157 I-Eq_Comparison
years NCT03921489 158 163 I-Eq_Comparison
of NCT03921489 164 166 O
age NCT03921489 167 170 B-Age

- NCT03921489 173 174 O
Presence NCT03921489 176 184 O
of NCT03921489 185 187 O
osteomyelitis NCT03921489 188 201 B-Condition
of NCT03921489 202 204 O
poor NCT03921489 205 209 O
surgical NCT03921489 210 218 O
candidates NCT03921489 219 229 O
due NCT03921489 230 233 O
to NCT03921489 234 236 O
comorbidities NCT03921489 237 250 B-Condition
such NCT03921489 251 255 O
as NCT03921489 256 258 O
diabetics NCT03921489 259 268 B-Condition
with NCT03921489 269 273 B-And
an NCT03921489 274 276 O
HbA NCT03921489 277 280 B-Observation
1c NCT03921489 281 283 I-Observation
of NCT03921489 284 286 O
> NCT03921489 287 288 B-Eq_Comparison
8 NCT03921489 289 290 I-Eq_Comparison
% NCT03921489 291 292 I-Eq_Comparison

- NCT03921489 296 297 O
Patient NCT03921489 299 306 O
with NCT03921489 307 311 O
previous NCT03921489 312 320 B-Eq_Comparison
foot NCT03921489 321 325 B-Modifier
and NCT03921489 326 329 B-Or
ankle NCT03921489 330 335 B-Modifier
surgeries NCT03921489 336 345 B-Procedure
that NCT03921489 346 350 O
may NCT03921489 351 354 O
interfere NCT03921489 355 364 O
with NCT03921489 365 369 O
future NCT03921489 370 376 O
outcomes NCT03921489 377 385 O

Inclusion NCT03925389 0 9 O
Criteria NCT03925389 10 18 O
: NCT03925389 19 20 O

- NCT03925389 24 25 O
at NCT03925389 27 29 B-Eq_Comparison
least NCT03925389 30 35 I-Eq_Comparison
18 NCT03925389 36 38 I-Eq_Comparison
years NCT03925389 39 44 I-Eq_Comparison
old NCT03925389 45 48 B-Age

- NCT03925389 51 52 O
Patients NCT03925389 54 62 O
eligible NCT03925389 63 71 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03925389 72 75 I-Assertion___Assertion_Type_Value:hypothetical
external NCT03925389 76 84 B-Procedure
septorhinoplasty NCT03925389 85 101 I-Procedure
: NCT03925389 102 103 O
patients NCT03925389 104 112 O
seen NCT03925389 113 117 O
in NCT03925389 118 120 O
consultation NCT03925389 121 133 O
because NCT03925389 134 141 O
of NCT03925389 142 144 O
nasal NCT03925389 145 150 B-Condition
obstruction NCT03925389 151 162 I-Condition
were NCT03925389 163 167 O
evaluated NCT03925389 168 177 B-Assertion___Assertion_Type_Value:possible
. NCT03925389 178 179 O
Patients NCT03925389 181 189 O
who NCT03925389 190 193 O
had NCT03925389 194 197 O
symptoms NCT03925389 198 206 B-Assertion___Assertion_Type_Value:possible
of NCT03925389 207 209 O
nasal NCT03925389 210 215 B-Condition
obstruction NCT03925389 216 227 I-Condition
for NCT03925389 228 231 O
at NCT03925389 232 234 B-Eq_Comparison
least NCT03925389 235 240 I-Eq_Comparison
1 NCT03925389 241 242 I-Eq_Comparison
year NCT03925389 243 247 I-Eq_Comparison
that NCT03925389 248 252 O
were NCT03925389 253 257 O
the NCT03925389 258 261 O
result NCT03925389 262 268 O
of NCT03925389 269 271 O
an NCT03925389 272 274 O
identifiable NCT03925389 275 287 O
anatomical NCT03925389 288 298 B-Condition
cause NCT03925389 299 304 I-Condition
such NCT03925389 305 309 O
as NCT03925389 310 312 O
septal NCT03925389 313 319 B-Condition
deviation NCT03925389 320 329 I-Condition
, NCT03925389 330 331 O
turbinate NCT03925389 332 341 B-Condition
hypertrophy NCT03925389 342 353 I-Condition
, NCT03925389 354 355 O
internal NCT03925389 356 364 B-Condition
valve NCT03925389 365 370 I-Condition
collapse NCT03925389 371 379 I-Condition
, NCT03925389 380 381 O
or NCT03925389 382 384 B-Or
external NCT03925389 385 393 B-Condition
valve NCT03925389 394 399 I-Condition
collapse NCT03925389 400 408 I-Condition
were NCT03925389 409 413 O
included NCT03925389 414 422 O
in NCT03925389 423 425 O
the NCT03925389 426 429 O
study NCT03925389 430 435 O
. NCT03925389 436 437 O

Exclusion NCT03925389 439 448 O
Criteria NCT03925389 449 457 O
: NCT03925389 458 459 O

- NCT03925389 463 464 O
< NCT03925389 466 467 B-Eq_Comparison
18 NCT03925389 468 470 I-Eq_Comparison
years NCT03925389 471 476 I-Eq_Comparison

- NCT03925389 479 480 O
mental NCT03925389 482 488 B-Modifier
or NCT03925389 489 491 B-Or
physical NCT03925389 492 500 B-Modifier
incapacity NCT03925389 501 511 B-Condition
to NCT03925389 512 514 O
answer NCT03925389 515 521 O
the NCT03925389 522 525 O
questionnaires NCT03925389 526 540 O

- NCT03925389 543 544 O
nasal NCT03925389 546 551 B-Condition
fracture NCT03925389 552 560 I-Condition
or NCT03925389 561 563 B-Or
surgery NCT03925389 564 571 B-Procedure
in NCT03925389 572 574 O
the NCT03925389 575 578 O
past NCT03925389 579 583 B-Eq_Comparison
year NCT03925389 584 588 I-Eq_Comparison

- NCT03925389 591 592 O
nasal NCT03925389 594 599 B-Modifier
cocaine NCT03925389 600 607 B-Drug
use NCT03925389 608 611 O
in NCT03925389 612 614 O
the NCT03925389 615 618 O
past NCT03925389 619 623 B-Eq_Comparison
year NCT03925389 624 628 I-Eq_Comparison

Inclusion NCT03867240 0 9 O
Criteria NCT03867240 10 18 O
: NCT03867240 19 20 O

- NCT03867240 24 25 O
Be NCT03867240 27 29 O
aged NCT03867240 30 34 B-Age
10 NCT03867240 35 37 B-Eq_Comparison
- NCT03867240 38 39 I-Eq_Comparison
18 NCT03867240 40 42 I-Eq_Comparison
years NCT03867240 43 48 I-Eq_Comparison
at NCT03867240 49 51 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867240 52 55 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03867240 56 60 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03867240 61 63 O
surgery NCT03867240 64 71 B-Procedure

- NCT03867240 74 75 O
Have NCT03867240 77 81 O
a NCT03867240 82 83 O
diagnosis NCT03867240 84 93 O
of NCT03867240 94 96 O
idiopathic NCT03867240 97 107 B-Condition
scoliosis NCT03867240 108 117 I-Condition
and NCT03867240 118 121 B-Or
/ NCT03867240 122 123 I-Or
or NCT03867240 124 126 I-Or
kyphosis NCT03867240 127 135 B-Condition

- NCT03867240 138 139 O
Be NCT03867240 141 143 O
undergoing NCT03867240 144 154 B-Eq_Comparison
elective NCT03867240 155 163 B-Modifier
posterior NCT03867240 164 173 B-Procedure
spinal NCT03867240 174 180 I-Procedure
fusion NCT03867240 181 187 I-Procedure

- NCT03867240 190 191 O
Have NCT03867240 193 197 O
only NCT03867240 198 202 O
mild NCT03867240 203 207 O
systemic NCT03867240 208 216 B-Condition
disease NCT03867240 217 224 I-Condition

Exclusion NCT03867240 225 234 O
Criteria NCT03867240 235 243 O
: NCT03867240 244 245 O

- NCT03867240 249 250 O
A NCT03867240 252 253 O
diagnosis NCT03867240 254 263 O
of NCT03867240 264 266 O
neuromuscular NCT03867240 267 280 B-Condition
scoliosis NCT03867240 281 290 I-Condition
and NCT03867240 291 294 B-Or
/ NCT03867240 295 296 I-Or
or NCT03867240 297 299 I-Or
kyphosis NCT03867240 300 308 B-Condition

- NCT03867240 311 312 O
A NCT03867240 314 315 O
diagnosis NCT03867240 316 325 O
of NCT03867240 326 328 O
chronic NCT03867240 329 336 O
pain NCT03867240 337 341 B-Condition

- NCT03867240 344 345 O
Used NCT03867240 347 351 B-Eq_Comparison
opioids NCT03867240 352 359 B-Drug
in NCT03867240 360 362 O
the NCT03867240 363 366 O
past NCT03867240 367 371 B-Eq_Comparison
6 NCT03867240 372 373 I-Eq_Comparison
months NCT03867240 374 380 I-Eq_Comparison

- NCT03867240 383 384 O
Developmental NCT03867240 386 399 B-Condition
delay NCT03867240 400 405 I-Condition

- NCT03867240 408 409 O
Liver NCT03867240 411 416 B-Modifier
or NCT03867240 417 419 B-Or
kidney NCT03867240 420 426 B-Modifier
disease NCT03867240 427 434 B-Condition

- NCT03867240 437 438 O
Obstructive NCT03867240 440 451 B-Condition
sleep NCT03867240 452 457 I-Condition
apnea NCT03867240 458 463 I-Condition

- NCT03867240 466 467 O
Body NCT03867240 469 473 B-Observation
mass NCT03867240 474 478 I-Observation
index NCT03867240 479 484 I-Observation
> NCT03867240 485 486 B-Eq_Comparison
40 NCT03867240 487 489 I-Eq_Comparison

- NCT03867240 493 494 O
Be NCT03867240 496 498 O
pregnant NCT03867240 499 507 B-Condition
or NCT03867240 508 510 B-Or
breastfeeding NCT03867240 511 524 B-Condition

Inclusion NCT03862703 0 9 O
Criteria NCT03862703 10 18 O
: NCT03862703 19 20 O

1 NCT03862703 24 25 O
. NCT03862703 25 26 O
must NCT03862703 28 32 O
be NCT03862703 33 35 O
at NCT03862703 36 38 B-Eq_Comparison
least NCT03862703 39 44 I-Eq_Comparison
18 NCT03862703 45 47 I-Eq_Comparison
years NCT03862703 48 53 I-Eq_Comparison
old NCT03862703 54 57 B-Age
. NCT03862703 58 59 O

2 NCT03862703 63 64 O
. NCT03862703 64 65 O
fulfil NCT03862703 67 73 O
the NCT03862703 74 77 O
DSM NCT03862703 78 81 O
- NCT03862703 82 83 O
5 NCT03862703 84 85 O
PTSD NCT03862703 86 90 B-Condition
diagnosis NCT03862703 91 100 O
criteria NCT03862703 101 109 O
. NCT03862703 110 111 O

3 NCT03862703 115 116 O
. NCT03862703 116 117 O
be NCT03862703 119 121 O
referred NCT03862703 122 130 O
to NCT03862703 131 133 O
PTSD NCT03862703 134 138 B-Condition
care NCT03862703 139 143 B-Procedure
package NCT03862703 144 151 I-Procedure
treatment NCT03862703 152 161 I-Procedure
( NCT03862703 162 163 O
Danske NCT03862703 164 170 O
regioner NCT03862703 171 179 O
, NCT03862703 180 181 O
pakkeforlÃ¸b NCT03862703 182 193 O
for NCT03862703 194 197 O
PTSD NCT03862703 198 202 O
, NCT03862703 203 204 O
2017 NCT03862703 205 209 O
) NCT03862703 210 211 O

4 NCT03862703 219 220 O
. NCT03862703 220 221 O
have NCT03862703 223 227 O
access NCT03862703 228 234 O
to NCT03862703 235 237 O
a NCT03862703 238 239 O
smartphone NCT03862703 240 250 O
with NCT03862703 251 255 O
iOS NCT03862703 256 259 O
( NCT03862703 260 261 O
version NCT03862703 262 269 O
10 NCT03862703 270 272 O
or NCT03862703 273 275 O
higher NCT03862703 276 282 O
) NCT03862703 283 284 O
or NCT03862703 285 287 O
Android NCT03862703 288 295 O
( NCT03862703 296 297 O
version NCT03862703 298 305 O
5.0.1 NCT03862703 306 311 O
. NCT03862703 311 312 O
or NCT03862703 314 316 O
higher NCT03862703 317 323 O
) NCT03862703 324 325 O

5 NCT03862703 329 330 O
. NCT03862703 330 331 O
provide NCT03862703 333 340 O
informed NCT03862703 341 349 O
consent NCT03862703 350 357 O
. NCT03862703 358 359 O

Exclusion NCT03862703 361 370 O
Criteria NCT03862703 371 379 O
: NCT03862703 380 381 O

1 NCT03862703 385 386 O
. NCT03862703 386 387 O
suicidal NCT03862703 389 397 B-Condition
risk NCT03862703 398 402 B-Risk

2 NCT03862703 405 406 O
. NCT03862703 406 407 O
ongoing NCT03862703 409 416 B-Eq_Comparison
episode NCT03862703 417 424 O
of NCT03862703 425 427 O
bipolar NCT03862703 428 435 B-Condition
disease NCT03862703 436 443 I-Condition
or NCT03862703 444 446 B-Or
psychotic NCT03862703 447 456 B-Condition
disorder NCT03862703 457 465 I-Condition

3 NCT03862703 468 469 O
. NCT03862703 469 470 O
current NCT03862703 472 479 B-Eq_Comparison
abuse NCT03862703 480 485 B-Condition
of NCT03862703 486 488 O
alcohol NCT03862703 489 496 B-Modifier
or NCT03862703 497 499 B-Or
drugs NCT03862703 500 505 B-Modifier

4 NCT03862703 508 509 O
. NCT03862703 509 510 O
inability NCT03862703 512 521 B-Negation
to NCT03862703 522 524 O
understand NCT03862703 525 535 O
and NCT03862703 536 539 O
/ NCT03862703 540 541 O
or NCT03862703 542 544 O
read NCT03862703 545 549 O
Danish NCT03862703 550 556 O

5 NCT03862703 559 560 O
. NCT03862703 560 561 O
concurrent NCT03862703 563 573 B-Modifier
psychiatric NCT03862703 574 585 I-Modifier
or NCT03862703 586 588 B-Or
psychological NCT03862703 589 602 B-Modifier
treatment NCT03862703 603 612 B-Procedure
of NCT03862703 613 615 O
PTSD NCT03862703 616 620 B-Condition
outside NCT03862703 621 628 B-Exception
of NCT03862703 629 631 I-Exception
MHS NCT03862703 632 635 B-Procedure
- NCT03862703 636 637 I-Procedure
CRD NCT03862703 638 641 I-Procedure
. NCT03862703 642 643 O


Inclusion NCT03864107 0 9 O
Criteria NCT03864107 10 18 O
: NCT03864107 19 20 O

- NCT03864107 24 25 O
Men NCT03864107 27 30 O
and NCT03864107 31 34 B-Or
women NCT03864107 35 40 O
aged NCT03864107 41 45 B-Age
18 NCT03864107 46 48 B-Eq_Comparison
- NCT03864107 49 50 I-Eq_Comparison
70 NCT03864107 51 53 I-Eq_Comparison
years NCT03864107 54 59 I-Eq_Comparison

- NCT03864107 62 63 O
BMI NCT03864107 65 68 B-Observation
18.5 NCT03864107 69 73 B-Eq_Comparison
- NCT03864107 74 75 I-Eq_Comparison
50 NCT03864107 76 78 I-Eq_Comparison
kg NCT03864107 79 81 I-Eq_Comparison
/ NCT03864107 82 83 I-Eq_Comparison
m NCT03864107 84 85 I-Eq_Comparison
2 NCT03864107 86 87 I-Eq_Comparison

- NCT03864107 90 91 O
Not NCT03864107 93 96 B-Negation
taking NCT03864107 97 103 B-Eq_Comparison
antibiotics NCT03864107 104 115 B-Drug
and NCT03864107 116 119 B-Or
antimicrobial NCT03864107 120 133 B-Drug
drugs NCT03864107 134 139 I-Drug
for NCT03864107 140 143 O
at NCT03864107 144 146 B-Eq_Comparison
least NCT03864107 147 152 I-Eq_Comparison
three NCT03864107 153 158 I-Eq_Comparison
months NCT03864107 159 165 I-Eq_Comparison

- NCT03864107 168 169 O
Both NCT03864107 171 175 O
physically NCT03864107 176 186 B-Observation
active NCT03864107 187 193 I-Observation
and NCT03864107 194 197 B-Or
sedentary NCT03864107 198 207 B-Observation
individuals NCT03864107 208 219 O
will NCT03864107 220 224 O
be NCT03864107 225 227 O
eligible NCT03864107 228 236 O
to NCT03864107 237 239 O
take NCT03864107 240 244 O
part NCT03864107 245 249 O
in NCT03864107 250 252 O
the NCT03864107 253 256 O
study NCT03864107 257 262 B-Study

- NCT03864107 265 266 O
Weight NCT03864107 268 274 B-Observation
stable NCT03864107 275 281 O
( NCT03864107 282 283 O
Â± NCT03864107 284 285 B-Eq_Comparison
5 NCT03864107 286 287 I-Eq_Comparison
kg NCT03864107 288 290 I-Eq_Comparison
) NCT03864107 291 292 O
for NCT03864107 293 296 O
at NCT03864107 297 299 B-Eq_Comparison
least NCT03864107 300 305 I-Eq_Comparison
6 NCT03864107 306 307 I-Eq_Comparison
months NCT03864107 308 314 I-Eq_Comparison

Excusion NCT03864107 315 323 O
Criteria NCT03864107 324 332 O
: NCT03864107 333 334 O

- NCT03864107 338 339 O
No NCT03864107 341 343 B-Negation
cardiometabolic NCT03864107 344 359 B-Condition
( NCT03864107 360 361 O
e NCT03864107 362 363 O
. NCT03864107 364 365 O
g NCT03864107 366 367 O
. NCT03864107 368 369 O
heart NCT03864107 371 376 B-Condition
disease NCT03864107 377 384 I-Condition
, NCT03864107 385 386 O
high NCT03864107 387 391 O
blood NCT03864107 392 397 B-Condition
pressure NCT03864107 398 406 I-Condition
) NCT03864107 407 408 O
or NCT03864107 409 411 B-Or
inflammatory NCT03864107 412 424 B-Modifier
illness NCT03864107 425 432 B-Condition

- NCT03864107 435 436 O
Smokers NCT03864107 438 445 B-Condition
( NCT03864107 446 447 O
including NCT03864107 448 457 O
the NCT03864107 458 461 O
use NCT03864107 462 465 O
of NCT03864107 466 468 O
vaporisers NCT03864107 469 479 B-Drug
and NCT03864107 480 483 B-Or
e NCT03864107 484 485 B-Drug
- NCT03864107 486 487 I-Drug
cigarettes NCT03864107 488 498 I-Drug
) NCT03864107 499 500 O

- NCT03864107 504 505 O
Taking NCT03864107 507 513 B-Eq_Comparison
anti NCT03864107 514 518 B-Drug
- NCT03864107 519 520 I-Drug
inflammatory NCT03864107 521 533 I-Drug
drugs NCT03864107 534 539 I-Drug
( NCT03864107 540 541 O
excluding NCT03864107 542 551 B-Exception
aspirin NCT03864107 552 559 B-Drug
) NCT03864107 560 561 O

Inclusion NCT03865784 0 9 O
Criteria NCT03865784 10 18 O
: NCT03865784 19 20 O

- NCT03865784 24 25 O
Federated NCT03865784 27 36 B-Observation
boxers NCT03865784 37 43 I-Observation

- NCT03865784 46 47 O
Over NCT03865784 49 53 B-Eq_Comparison
18 NCT03865784 54 56 I-Eq_Comparison
years NCT03865784 57 62 I-Eq_Comparison

- NCT03865784 65 66 O
Male NCT03865784 68 72 O

- NCT03865784 75 76 O
With NCT03865784 78 82 O
non NCT03865784 83 86 B-Negation
- NCT03865784 87 88 O
specific NCT03865784 89 97 B-Modifier
back NCT03865784 98 102 B-Modifier
pain NCT03865784 103 107 B-Condition
that NCT03865784 108 112 O
does NCT03865784 113 117 O
not NCT03865784 118 121 O
incapacitate NCT03865784 122 134 O
them NCT03865784 135 139 O
for NCT03865784 140 143 O
the NCT03865784 144 147 O
realization NCT03865784 148 159 O
of NCT03865784 160 162 O
their NCT03865784 163 168 O
sport NCT03865784 169 174 O
or NCT03865784 175 177 O
work NCT03865784 178 182 O
activity NCT03865784 183 191 O
. NCT03865784 192 193 O

Exclusion NCT03865784 195 204 O
Criteria NCT03865784 205 213 O
: NCT03865784 214 215 O

- NCT03865784 219 220 O
Federated NCT03865784 222 231 B-Observation
boxers NCT03865784 232 238 I-Observation
with NCT03865784 239 243 B-And
lumbar NCT03865784 244 250 B-Modifier
injury NCT03865784 251 257 B-Condition
with NCT03865784 258 262 O
medical NCT03865784 263 270 O
diagnosis NCT03865784 271 280 O

- NCT03865784 283 284 O
Who NCT03865784 286 289 O
are NCT03865784 290 293 B-Eq_Comparison
or NCT03865784 294 296 B-Or
have NCT03865784 297 301 B-Eq_Comparison
been NCT03865784 302 306 I-Eq_Comparison
treated NCT03865784 307 314 B-Procedure
by NCT03865784 315 317 O
pharmacological NCT03865784 318 333 B-Procedure
or NCT03865784 334 336 B-Or
physiotherapy NCT03865784 337 350 B-Procedure
in NCT03865784 351 353 O
the NCT03865784 354 357 O
last NCT03865784 358 362 B-Eq_Comparison
6 NCT03865784 363 364 I-Eq_Comparison
months NCT03865784 365 371 I-Eq_Comparison

- NCT03865784 374 375 O
Presenting NCT03865784 377 387 O
allergies NCT03865784 388 397 B-Allergy
or NCT03865784 398 400 B-Or
alterations NCT03865784 401 412 B-Condition
of NCT03865784 413 415 O
the NCT03865784 416 419 O
skin NCT03865784 420 424 B-Modifier

- NCT03865784 427 428 O
Not NCT03865784 430 433 O
sign NCT03865784 434 438 O
the NCT03865784 439 442 O
informed NCT03865784 443 451 O
consent NCT03865784 452 459 O
document NCT03865784 460 468 O
. NCT03865784 469 470 O

Inclusion NCT03860415 0 9 O
Criteria NCT03860415 10 18 O
: NCT03860415 19 20 O

- NCT03860415 24 25 O
Chronic NCT03860415 27 34 O
( NCT03860415 35 36 O
more NCT03860415 37 41 B-Eq_Comparison
than NCT03860415 42 46 I-Eq_Comparison
three NCT03860415 47 52 I-Eq_Comparison
months NCT03860415 53 59 I-Eq_Comparison
) NCT03860415 60 61 O
ESBL NCT03860415 62 66 B-Condition
colonization NCT03860415 67 79 I-Condition
of NCT03860415 80 82 O
the NCT03860415 83 86 O
same NCT03860415 87 91 O
strain NCT03860415 92 98 O
as NCT03860415 99 101 O
determined NCT03860415 102 112 O
by NCT03860415 113 115 O

- NCT03860415 118 119 O
species NCT03860415 121 128 B-Observation
, NCT03860415 129 130 O
phenotype NCT03860415 131 140 B-Condition
and NCT03860415 141 144 B-Or
antibiogram NCT03860415 145 156 B-Procedure
. NCT03860415 157 158 O

- NCT03860415 162 163 O
Patients NCT03860415 165 173 O
must NCT03860415 174 178 O
be NCT03860415 179 181 O
able NCT03860415 182 186 O
to NCT03860415 187 189 O
swallow NCT03860415 190 197 O
sachets NCT03860415 198 205 O
. NCT03860415 206 207 O

- NCT03860415 211 212 O
Must NCT03860415 214 218 O
be NCT03860415 219 221 O
able NCT03860415 222 226 O
to NCT03860415 227 229 O
speak NCT03860415 230 235 O
and NCT03860415 236 239 O
understand NCT03860415 240 250 O
Swedish NCT03860415 251 258 O
. NCT03860415 259 260 O

- NCT03860415 264 265 O
Must NCT03860415 267 271 O
have NCT03860415 272 276 O
a NCT03860415 277 278 O
permanent NCT03860415 279 288 O
residence NCT03860415 289 298 O
in NCT03860415 299 301 O
Sweden NCT03860415 302 308 O
. NCT03860415 309 310 O

- NCT03860415 314 315 O
Must NCT03860415 317 321 O
be NCT03860415 322 324 O
able NCT03860415 325 329 O
to NCT03860415 330 332 O
sign NCT03860415 333 337 O
informed NCT03860415 338 346 O
consent NCT03860415 347 354 O
in NCT03860415 355 357 O
Swedish NCT03860415 358 365 O
. NCT03860415 366 367 O

Exclusion NCT03860415 369 378 O
Criteria NCT03860415 379 387 O
: NCT03860415 388 389 O

- NCT03860415 393 394 O
Immunosuppression NCT03860415 396 413 B-Condition
( NCT03860415 414 415 O
i NCT03860415 416 417 O
. NCT03860415 418 419 O
e NCT03860415 420 421 O
. NCT03860415 422 423 O
chemotheraphy NCT03860415 425 438 B-Procedure
, NCT03860415 439 440 O
treatment NCT03860415 441 450 B-Procedure
with NCT03860415 451 455 O
TNF NCT03860415 456 459 B-Drug
- NCT03860415 460 461 I-Drug
alpha NCT03860415 462 467 I-Drug
- NCT03860415 468 469 I-Drug
inhibitors NCT03860415 470 480 I-Drug
) NCT03860415 481 482 O
. NCT03860415 483 484 O

- NCT03860415 488 489 O
In NCT03860415 491 493 O
patient NCT03860415 494 501 O
care NCT03860415 502 506 O
. NCT03860415 507 508 O

- NCT03860415 512 513 O
immunodeficiency NCT03860415 515 531 B-Condition

- NCT03860415 534 535 O
psychiatric NCT03860415 537 548 B-Condition
disorder NCT03860415 549 557 I-Condition

- NCT03860415 560 561 O
alcohol NCT03860415 563 570 B-Modifier
or NCT03860415 571 573 B-Or
substance NCT03860415 574 583 B-Modifier
abuse NCT03860415 584 589 B-Condition

- NCT03860415 592 593 O
dementia NCT03860415 595 603 B-Condition

- NCT03860415 606 607 O
Invasive NCT03860415 609 617 B-Procedure
catheters NCT03860415 618 627 I-Procedure
. NCT03860415 628 629 O

Inclusion NCT03867370 0 9 O
Criteria NCT03867370 10 18 O
: NCT03867370 19 20 O

1 NCT03867370 24 25 O
. NCT03867370 25 26 O
Confirmed NCT03867370 28 37 O
by NCT03867370 38 40 O
histopathological NCT03867370 41 58 B-Procedure
or NCT03867370 59 61 B-Or
cytological NCT03867370 62 73 B-Procedure
examination NCT03867370 74 85 I-Procedure
; NCT03867370 85 86 O

2 NCT03867370 89 90 O
. NCT03867370 90 91 O
The NCT03867370 93 96 O
criteria NCT03867370 97 105 O
for NCT03867370 106 109 O
resectability NCT03867370 110 123 O
is NCT03867370 124 126 O
met NCT03867370 127 130 O

3 NCT03867370 133 134 O
. NCT03867370 134 135 O
Has NCT03867370 137 140 O
at NCT03867370 141 143 B-Eq_Comparison
least NCT03867370 144 149 I-Eq_Comparison
one NCT03867370 150 153 I-Eq_Comparison
evaluable NCT03867370 154 163 B-Modifier
lesion NCT03867370 164 170 B-Condition
according NCT03867370 171 180 O
to NCT03867370 181 183 O
the NCT03867370 184 187 O
RECIST NCT03867370 188 194 O
1.1 NCT03867370 195 198 O
standard NCT03867370 199 207 O
and NCT03867370 208 211 B-And
has NCT03867370 212 215 O
not NCT03867370 216 219 B-Negation
received NCT03867370 220 228 B-Eq_Comparison
local NCT03867370 229 234 B-Modifier
treatment NCT03867370 235 244 B-Procedure

Exclusion NCT03867370 245 254 O
Criteria NCT03867370 255 263 O
: NCT03867370 264 265 O

1 NCT03867370 269 270 O
. NCT03867370 270 271 O
Patients NCT03867370 273 281 O
who NCT03867370 282 285 O
previously NCT03867370 286 296 B-Eq_Comparison
received NCT03867370 297 305 I-Eq_Comparison
anti NCT03867370 306 310 B-Drug
- NCT03867370 311 312 I-Drug
programmed NCT03867370 313 323 I-Drug
death NCT03867370 324 329 I-Drug
receptor NCT03867370 330 338 I-Drug
- NCT03867370 339 340 I-Drug
1 NCT03867370 341 342 I-Drug
( NCT03867370 343 344 O
PD NCT03867370 345 347 B-Drug
- NCT03867370 348 349 I-Drug
1 NCT03867370 350 351 I-Drug
) NCT03867370 352 353 O
antibody NCT03867370 354 362 B-Modifier
, NCT03867370 363 364 O
anti NCT03867370 365 369 B-Drug
- NCT03867370 370 371 I-Drug
programmed NCT03867370 372 382 I-Drug
death NCT03867370 383 388 I-Drug
ligand NCT03867370 389 395 I-Drug
- NCT03867370 396 397 I-Drug
1 NCT03867370 398 399 I-Drug
( NCT03867370 400 401 O
PD NCT03867370 402 404 B-Drug
- NCT03867370 405 406 I-Drug
L NCT03867370 407 408 I-Drug
1 NCT03867370 409 410 I-Drug
) NCT03867370 411 412 O
antibody NCT03867370 413 421 B-Modifier
, NCT03867370 422 423 O
anti NCT03867370 424 428 B-Drug
- NCT03867370 429 430 I-Drug
programmed NCT03867370 431 441 I-Drug
death NCT03867370 442 447 I-Drug
ligand NCT03867370 448 454 I-Drug
- NCT03867370 455 456 I-Drug
2 NCT03867370 457 458 I-Drug
( NCT03867370 459 460 O
PD NCT03867370 461 463 B-Drug
- NCT03867370 464 465 I-Drug
L NCT03867370 466 467 I-Drug
2 NCT03867370 468 469 I-Drug
) NCT03867370 470 471 O
antibody NCT03867370 472 480 B-Modifier
or NCT03867370 481 483 B-Or
anti NCT03867370 484 488 B-Drug
- NCT03867370 489 490 I-Drug
cytotoxic NCT03867370 491 500 I-Drug
T NCT03867370 501 502 I-Drug
lymphocyte NCT03867370 503 513 I-Drug
- NCT03867370 514 515 I-Drug
associated NCT03867370 516 526 I-Drug
antigen NCT03867370 527 534 I-Drug
- NCT03867370 535 536 I-Drug
4 NCT03867370 537 538 I-Drug
( NCT03867370 539 540 O
CTLA NCT03867370 541 545 B-Drug
- NCT03867370 546 547 I-Drug
4 NCT03867370 548 549 I-Drug
) NCT03867370 550 551 O
antibodies NCT03867370 552 562 B-Modifier
, NCT03867370 563 564 O
including NCT03867370 565 574 O
those NCT03867370 575 580 O
who NCT03867370 581 584 O
have NCT03867370 585 589 O
participated NCT03867370 590 602 O
in NCT03867370 603 605 O
a NCT03867370 606 607 O
JS NCT03867370 608 610 O
001 NCT03867370 611 614 O
clinical NCT03867370 615 623 O
study NCT03867370 624 629 B-Study
; NCT03867370 629 630 O

2 NCT03867370 633 634 O
. NCT03867370 634 635 O
Patients NCT03867370 637 645 O
who NCT03867370 646 649 O
previously NCT03867370 650 660 B-Eq_Comparison
received NCT03867370 661 669 I-Eq_Comparison
any NCT03867370 670 673 O
TACE NCT03867370 674 678 B-Procedure
, NCT03867370 679 680 O
radiofrequency NCT03867370 681 695 B-Procedure
ablation NCT03867370 696 704 I-Procedure
and NCT03867370 705 708 B-Or
other NCT03867370 709 714 B-Other
liver NCT03867370 715 720 B-Modifier
cancer NCT03867370 721 727 B-Condition
treatments NCT03867370 728 738 B-Procedure
; NCT03867370 738 739 O

3 NCT03867370 742 743 O
. NCT03867370 743 744 O
Patients NCT03867370 746 754 O
with NCT03867370 755 759 O
a NCT03867370 760 761 O
history NCT03867370 762 769 B-Eq_Comparison
of NCT03867370 770 772 O
gastroesophageal NCT03867370 773 789 B-Condition
varices NCT03867370 790 797 I-Condition
or NCT03867370 798 800 B-Or
active NCT03867370 801 807 B-Eq_Comparison
cardia NCT03867370 808 814 B-Condition
ulcers NCT03867370 815 821 I-Condition
associated NCT03867370 822 832 O
with NCT03867370 833 837 O
a NCT03867370 838 839 O
high NCT03867370 840 844 O
risk NCT03867370 845 849 B-Risk
of NCT03867370 850 852 O
bleeding NCT03867370 853 861 B-Condition
; NCT03867370 861 862 O

4 NCT03867370 865 866 O
. NCT03867370 866 867 O
Patients NCT03867370 869 877 O
who NCT03867370 878 881 O
have NCT03867370 882 886 O
upper NCT03867370 887 892 B-Modifier
gastrointestinal NCT03867370 893 909 I-Modifier
hemorrhage NCT03867370 910 920 B-Condition
within NCT03867370 921 927 B-Eq_Comparison
1 NCT03867370 928 929 I-Eq_Comparison
year NCT03867370 930 934 I-Eq_Comparison
; NCT03867370 934 935 O

5 NCT03867370 938 939 O
. NCT03867370 939 940 O
Patients NCT03867370 942 950 O
known NCT03867370 951 956 O
to NCT03867370 957 959 O
have NCT03867370 960 964 O
fibrous NCT03867370 965 972 B-Modifier
layer NCT03867370 973 978 I-Modifier
HCC NCT03867370 979 982 B-Condition
, NCT03867370 983 984 O
sarcomatoid NCT03867370 985 996 B-Modifier
HCC NCT03867370 997 1000 B-Condition
or NCT03867370 1001 1003 B-Or
mixed NCT03867370 1004 1009 B-Modifier
cholangiocarcinoma NCT03867370 1010 1028 B-Condition
and NCT03867370 1029 1032 B-And
HCC NCT03867370 1033 1036 B-Condition
; NCT03867370 1036 1037 O
Other NCT03867370 1038 1043 O
protocol NCT03867370 1044 1052 O
defined NCT03867370 1053 1060 O
inclusion NCT03867370 1061 1070 O
/ NCT03867370 1071 1072 O
exclusion NCT03867370 1073 1082 O
criteria NCT03867370 1083 1091 O
could NCT03867370 1092 1097 O
apply NCT03867370 1098 1103 O

Inclusion NCT03923062 0 9 O
Criteria NCT03923062 10 18 O
: NCT03923062 19 20 O

- NCT03923062 24 25 O
- NCT03923062 27 28 O
Subjects NCT03923062 29 37 O
presented NCT03923062 38 47 O
with NCT03923062 48 52 O
melasma NCT03923062 53 60 B-Condition
. NCT03923062 61 62 O

- NCT03923062 66 67 O
Age NCT03923062 69 72 B-Age
20 NCT03923062 73 75 B-Eq_Comparison
- NCT03923062 76 77 I-Eq_Comparison
40 NCT03923062 78 80 I-Eq_Comparison
years NCT03923062 81 86 I-Eq_Comparison
old NCT03923062 87 90 O
. NCT03923062 91 92 O

- NCT03923062 96 97 O
Melasma NCT03923062 99 106 B-Condition
persisting NCT03923062 107 117 O
for NCT03923062 118 121 O
more NCT03923062 122 126 B-Eq_Comparison
than NCT03923062 127 131 I-Eq_Comparison
6 NCT03923062 132 133 I-Eq_Comparison
months NCT03923062 134 140 I-Eq_Comparison
that NCT03923062 141 145 O
has NCT03923062 146 149 O
failed NCT03923062 150 156 O
to NCT03923062 157 159 O
respond NCT03923062 160 167 O
to NCT03923062 168 170 O
conventional NCT03923062 171 183 B-Procedure
treatment NCT03923062 184 193 I-Procedure
with NCT03923062 194 198 O
hydroquinone NCT03923062 199 211 B-Drug
or NCT03923062 212 214 B-Or
other NCT03923062 215 220 O
topical NCT03923062 221 228 B-Drug
lightening NCT03923062 229 239 I-Drug
agents NCT03923062 240 246 I-Drug
. NCT03923062 247 248 O

Exclusion NCT03923062 250 259 O
Criteria NCT03923062 260 268 O
: NCT03923062 269 270 O

- NCT03923062 274 275 O
- NCT03923062 277 278 O
History NCT03923062 279 286 B-Eq_Comparison
of NCT03923062 287 289 O
photosensitivity NCT03923062 290 306 B-Condition
, NCT03923062 307 308 O
keloids NCT03923062 309 316 B-Condition
, NCT03923062 317 318 O
hypertrophic NCT03923062 319 331 B-Condition
scarring NCT03923062 332 340 I-Condition
and NCT03923062 341 344 B-Or
post NCT03923062 345 349 B-Condition
- NCT03923062 350 351 I-Condition
inflammatory NCT03923062 352 364 I-Condition
hyperpigmentation NCT03923062 365 382 I-Condition
. NCT03923062 383 384 O

- NCT03923062 388 389 O
Pregnancy NCT03923062 391 400 B-Condition
and NCT03923062 401 404 B-Or
lactation NCT03923062 405 414 B-Condition
. NCT03923062 415 416 O

- NCT03923062 420 421 O
Subjects NCT03923062 423 431 O
with NCT03923062 432 436 O
local NCT03923062 437 442 B-Condition
inflammatory NCT03923062 443 455 I-Condition
skin NCT03923062 456 460 I-Condition
disorder NCT03923062 461 469 I-Condition
or NCT03923062 470 472 B-Or
active NCT03923062 473 479 B-Eq_Comparison
herpes NCT03923062 480 486 B-Condition
infection NCT03923062 487 496 I-Condition
at NCT03923062 497 499 O
the NCT03923062 500 503 O
site NCT03923062 504 508 B-Modifier
of NCT03923062 509 511 O
procedure NCT03923062 512 521 B-Procedure
. NCT03923062 522 523 O

- NCT03923062 527 528 O
Subjects NCT03923062 530 538 O
with NCT03923062 539 543 O
history NCT03923062 544 551 B-Eq_Comparison
of NCT03923062 552 554 O
medical NCT03923062 555 562 B-Condition
diseases NCT03923062 563 571 I-Condition
which NCT03923062 572 577 O
contraindicate NCT03923062 578 592 B-Contraindication
cryosurgery NCT03923062 593 604 B-Procedure
such NCT03923062 605 609 O
as NCT03923062 610 612 O
; NCT03923062 612 613 O
cold NCT03923062 614 618 B-Condition
intolerance NCT03923062 619 630 I-Condition
, NCT03923062 631 632 O
cold NCT03923062 633 637 B-Condition
urticaria NCT03923062 638 647 I-Condition
, NCT03923062 648 649 O
Raynaud`s NCT03923062 650 659 B-Condition
disease NCT03923062 660 667 I-Condition
and NCT03923062 668 671 B-And
history NCT03923062 672 679 B-Eq_Comparison
of NCT03923062 680 682 O
allergic NCT03923062 683 691 B-Allergy
reactions NCT03923062 692 701 O
to NCT03923062 702 704 O
cryosurgery NCT03923062 705 716 B-Procedure
. NCT03923062 717 718 O

Inclusion NCT03868488 0 9 O
Criteria NCT03868488 10 18 O
: NCT03868488 19 20 O

- NCT03868488 24 25 O
The NCT03868488 27 30 O
scores NCT03868488 31 37 O
of NCT03868488 38 40 O
the NCT03868488 41 44 O
9 NCT03868488 45 46 O
items NCT03868488 47 52 O
of NCT03868488 53 55 O
The NCT03868488 56 59 O
Diagnostic NCT03868488 60 70 O
and NCT03868488 71 74 O
Statistical NCT03868488 75 86 O
Manual NCT03868488 87 93 O
of NCT03868488 94 96 O
Mental NCT03868488 97 103 O
Disorders NCT03868488 104 113 O
, NCT03868488 114 115 O
Fifth NCT03868488 116 121 O
Edition NCT03868488 122 129 O
( NCT03868488 130 131 O
DSM NCT03868488 132 135 O
- NCT03868488 136 137 O
5 NCT03868488 138 139 O
) NCT03868488 140 141 O
recommended NCT03868488 142 153 O
diagnosis NCT03868488 154 163 O
for NCT03868488 164 167 O
Internet NCT03868488 168 176 B-Condition
gaming NCT03868488 177 183 I-Condition
disorder NCT03868488 184 192 I-Condition
â¥ NCT03868488 193 194 B-Eq_Comparison
5 NCT03868488 195 196 I-Eq_Comparison
. NCT03868488 196 197 O

- NCT03868488 201 202 O
Engagement NCT03868488 204 214 B-Observation
in NCT03868488 215 217 I-Observation
popular NCT03868488 218 225 I-Observation
Internet NCT03868488 226 234 I-Observation
games NCT03868488 235 240 I-Observation
( NCT03868488 241 242 O
e NCT03868488 243 244 O
. NCT03868488 245 246 O
g NCT03868488 247 248 O
. NCT03868488 249 250 O
Arena NCT03868488 252 257 O
of NCT03868488 258 260 O
Valor NCT03868488 261 266 O
, NCT03868488 267 268 O
League NCT03868488 269 275 O
of NCT03868488 276 278 O
Legends NCT03868488 279 286 O
and NCT03868488 287 290 O
Player NCT03868488 291 297 O
Unknown NCT03868488 298 305 O
's NCT03868488 305 307 O
Battle NCT03868488 308 314 O
Grounds NCT03868488 315 322 O
) NCT03868488 323 324 O
for NCT03868488 325 328 O
over NCT03868488 329 333 B-Eq_Comparison
20 NCT03868488 334 336 I-Eq_Comparison
hours NCT03868488 337 342 I-Eq_Comparison
per NCT03868488 343 346 I-Eq_Comparison
week NCT03868488 347 351 I-Eq_Comparison
for NCT03868488 352 355 O
a NCT03868488 356 357 O
minimum NCT03868488 358 365 B-Eq_Comparison
of NCT03868488 366 368 I-Eq_Comparison
12 NCT03868488 369 371 I-Eq_Comparison
months NCT03868488 372 378 I-Eq_Comparison
. NCT03868488 379 380 O

- NCT03868488 384 385 O
The NCT03868488 387 390 O
scores NCT03868488 391 397 O
of NCT03868488 398 400 O
the NCT03868488 401 404 O
Young NCT03868488 405 410 B-Observation
- NCT03868488 411 412 I-Observation
Internet NCT03868488 413 421 I-Observation
Addiction NCT03868488 422 431 I-Observation
Test NCT03868488 432 436 I-Observation
( NCT03868488 437 438 O
Y NCT03868488 439 440 B-Observation
- NCT03868488 441 442 I-Observation
IAT NCT03868488 443 446 I-Observation
) NCT03868488 447 448 O
â¥ NCT03868488 449 450 B-Eq_Comparison
50 NCT03868488 451 453 I-Eq_Comparison

Exclusion NCT03868488 455 464 O
Criteria NCT03868488 465 473 O
: NCT03868488 474 475 O

- NCT03868488 479 480 O
Current NCT03868488 482 489 B-Eq_Comparison
or NCT03868488 490 492 B-Or
history NCT03868488 493 500 B-Eq_Comparison
of NCT03868488 501 503 O
use NCT03868488 504 507 O
of NCT03868488 508 510 O
illegal NCT03868488 511 518 B-Drug
substances NCT03868488 519 529 I-Drug
and NCT03868488 530 533 B-Or
gambling NCT03868488 534 542 B-Observation
; NCT03868488 542 543 O

- NCT03868488 546 547 O
Current NCT03868488 549 556 B-Eq_Comparison
or NCT03868488 557 559 B-Or
history NCT03868488 560 567 B-Eq_Comparison
of NCT03868488 568 570 O
psychiatric NCT03868488 571 582 B-Modifier
or NCT03868488 583 585 B-Or
neurological NCT03868488 586 598 B-Modifier
illness NCT03868488 599 606 B-Condition
; NCT03868488 606 607 O

- NCT03868488 610 611 O
Current NCT03868488 613 620 B-Eq_Comparison
use NCT03868488 621 624 O
of NCT03868488 625 627 O
psychotropic NCT03868488 628 640 B-Drug
medications NCT03868488 641 652 I-Drug
. NCT03868488 653 654 O


Inclusion NCT03867565 0 9 O
Criteria NCT03867565 10 18 O
: NCT03867565 19 20 O

- NCT03867565 24 25 O
Minor NCT03867565 27 32 B-Condition
burn NCT03867565 33 37 I-Condition
, NCT03867565 38 39 O
TBSA NCT03867565 40 44 B-Observation
< NCT03867565 45 46 B-Eq_Comparison
20 NCT03867565 47 49 I-Eq_Comparison
% NCT03867565 50 51 I-Eq_Comparison

- NCT03867565 55 56 O
Age NCT03867565 58 61 B-Age
â¥ NCT03867565 62 63 B-Eq_Comparison
18 NCT03867565 64 66 I-Eq_Comparison
years NCT03867565 67 72 I-Eq_Comparison
old NCT03867565 73 76 O

- NCT03867565 79 80 O
Understands NCT03867565 82 93 O
Swedish NCT03867565 94 101 O
or NCT03867565 102 104 B-Or
English NCT03867565 105 112 O
verbally NCT03867565 113 121 O
and NCT03867565 122 125 O
in NCT03867565 126 128 O
writing NCT03867565 129 136 O

- NCT03867565 139 140 O
Mentally NCT03867565 142 150 B-Condition
adequate NCT03867565 151 159 I-Condition

- NCT03867565 162 163 O
Oral NCT03867565 165 169 O
and NCT03867565 170 173 O
written NCT03867565 174 181 O
informed NCT03867565 182 190 O
consent NCT03867565 191 198 O
. NCT03867565 199 200 O

Exclusion NCT03867565 202 211 O
Criteria NCT03867565 212 220 O
: NCT03867565 221 222 O

- NCT03867565 226 227 O
Patients NCT03867565 229 237 O
deemed NCT03867565 238 244 O
not NCT03867565 245 248 O
to NCT03867565 249 251 O
be NCT03867565 252 254 O
able NCT03867565 255 259 O
to NCT03867565 260 262 O
complete NCT03867565 263 271 O
study NCT03867565 272 277 O
protocol NCT03867565 278 286 O
. NCT03867565 287 288 O

- NCT03867565 292 293 O
TBSA NCT03867565 295 299 B-Observation
< NCT03867565 300 301 B-Eq_Comparison
2 NCT03867565 302 303 I-Eq_Comparison
% NCT03867565 304 305 I-Eq_Comparison
. NCT03867565 306 307 O

Inclusion NCT03929237 0 9 O
Criteria NCT03929237 10 18 O
: NCT03929237 19 20 O

- NCT03929237 24 25 O
ACL NCT03929237 27 30 B-Procedure
reconstruction NCT03929237 31 45 I-Procedure
surgery NCT03929237 46 53 I-Procedure

- NCT03929237 56 57 O
currently NCT03929237 59 68 B-Eq_Comparison
enrolled NCT03929237 69 77 O
in NCT03929237 78 80 O
middle NCT03929237 81 87 O
or NCT03929237 88 90 O
high NCT03929237 91 95 O
school NCT03929237 96 102 O
( NCT03929237 103 104 O
grades NCT03929237 105 111 O
6 NCT03929237 112 113 O
- NCT03929237 114 115 O
12 NCT03929237 116 118 O
) NCT03929237 119 120 O

- NCT03929237 124 125 O
Surgery NCT03929237 127 134 B-Procedure
occurs NCT03929237 135 141 O
during NCT03929237 142 148 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03929237 149 152 O
school NCT03929237 153 159 B-Observation
year NCT03929237 160 164 I-Observation

- NCT03929237 167 168 O
No NCT03929237 170 172 B-Negation
concomitant NCT03929237 173 184 B-Modifier
additional NCT03929237 185 195 I-Modifier
ligament NCT03929237 196 204 B-Procedure
surgery NCT03929237 205 212 I-Procedure
( NCT03929237 213 214 O
ie NCT03929237 215 217 O
. NCT03929237 218 219 O
PCL NCT03929237 221 224 B-Procedure
, NCT03929237 225 226 O
MCL NCT03929237 227 230 B-Procedure
, NCT03929237 231 232 O
LCL NCT03929237 233 236 B-Procedure
or NCT03929237 237 239 B-Or
MPFL NCT03929237 240 244 B-Procedure
) NCT03929237 245 246 O

Exclusion NCT03929237 248 257 O
Criteria NCT03929237 258 266 O
: NCT03929237 267 268 O

- NCT03929237 272 273 O
patient NCT03929237 275 282 O
is NCT03929237 283 285 O
home NCT03929237 286 290 B-Observation
schooled NCT03929237 291 299 I-Observation
or NCT03929237 300 302 B-Or
in NCT03929237 303 305 O
non NCT03929237 306 309 B-Observation
- NCT03929237 310 311 I-Observation
traditional NCT03929237 312 323 I-Observation
school NCT03929237 324 330 I-Observation
setting NCT03929237 331 338 I-Observation
( NCT03929237 339 340 O
ie NCT03929237 341 343 O
. NCT03929237 344 345 O
school NCT03929237 347 353 B-Observation
for NCT03929237 354 357 I-Observation
special NCT03929237 358 365 I-Observation
needs NCT03929237 366 371 I-Observation
) NCT03929237 372 373 O

- NCT03929237 377 378 O
concomitant NCT03929237 380 391 B-Modifier
additional NCT03929237 392 402 I-Modifier
ligament NCT03929237 403 411 B-Procedure
surgery NCT03929237 412 419 I-Procedure

- NCT03929237 422 423 O
surgery NCT03929237 425 432 B-Procedure
occurs NCT03929237 433 439 B-Temporal_Connection___Temporal_Connection_Type_Value:during
outside NCT03929237 440 447 B-Negation
of NCT03929237 448 450 O
the NCT03929237 451 454 O
school NCT03929237 455 461 B-Observation
year NCT03929237 462 466 I-Observation
or NCT03929237 467 469 O
on NCT03929237 470 472 O
a NCT03929237 473 474 O
scheduled NCT03929237 475 484 O
break NCT03929237 485 490 O
from NCT03929237 491 495 O
school NCT03929237 496 502 O

Inclusion NCT03923439 0 9 O
Criteria NCT03923439 10 18 O
: NCT03923439 19 20 O

- NCT03923439 24 25 O
Patients NCT03923439 27 35 O
older NCT03923439 36 41 B-Eq_Comparison
than NCT03923439 42 46 I-Eq_Comparison
18 NCT03923439 47 49 I-Eq_Comparison
years NCT03923439 50 55 I-Eq_Comparison
old NCT03923439 56 59 B-Age

- NCT03923439 62 63 O
Cerebral NCT03923439 65 73 B-Condition
infarct NCT03923439 74 81 I-Condition
within NCT03923439 82 88 O
the NCT03923439 89 92 O
anterior NCT03923439 93 101 B-Modifier
circulation NCT03923439 102 113 I-Modifier
due NCT03923439 114 117 O
to NCT03923439 118 120 O
occlusion NCT03923439 121 130 B-Condition
of NCT03923439 131 133 I-Condition
intracranial NCT03923439 134 146 I-Condition
carotid NCT03923439 147 154 I-Condition
artery NCT03923439 155 161 I-Condition
or NCT03923439 162 164 O
proximal NCT03923439 165 173 B-Modifier
( NCT03923439 174 175 O
M NCT03923439 176 177 B-Eq_Comparison
1 NCT03923439 178 179 I-Eq_Comparison
) NCT03923439 180 181 O
MCA NCT03923439 182 185 B-Condition
. NCT03923439 186 187 O

- NCT03923439 191 192 O
With NCT03923439 194 198 O
acute NCT03923439 199 204 O
MRI NCT03923439 205 208 B-Procedure
performed NCT03923439 209 218 O
within NCT03923439 219 225 B-Eq_Comparison
the NCT03923439 226 229 I-Eq_Comparison
first NCT03923439 230 235 I-Eq_Comparison
24 NCT03923439 236 238 I-Eq_Comparison
h NCT03923439 239 240 I-Eq_Comparison
and NCT03923439 241 244 B-And
showing NCT03923439 245 252 O
significant NCT03923439 253 264 O
penumbra NCT03923439 265 273 B-Condition
defined NCT03923439 274 281 O
as NCT03923439 282 284 O
ratio NCT03923439 285 290 B-Observation
between NCT03923439 291 298 I-Observation
the NCT03923439 299 302 I-Observation
volumes NCT03923439 303 310 I-Observation
of NCT03923439 311 313 O
critically NCT03923439 314 324 O
hypoperfused NCT03923439 325 337 B-Modifier
tissue NCT03923439 338 344 I-Modifier
( NCT03923439 345 346 O
defined NCT03923439 347 354 O
by NCT03923439 355 357 O
Tmax NCT03923439 358 362 B-Observation
> NCT03923439 363 364 B-Eq_Comparison
6 NCT03923439 365 366 I-Eq_Comparison
s NCT03923439 367 368 I-Eq_Comparison
) NCT03923439 369 370 O
and NCT03923439 371 374 B-And
the NCT03923439 375 378 O
ischemic NCT03923439 379 387 B-Modifier
core NCT03923439 388 392 I-Modifier
( NCT03923439 393 394 O
defined NCT03923439 395 402 O
by NCT03923439 403 405 O
ADC NCT03923439 406 409 B-Observation
< NCT03923439 410 411 B-Eq_Comparison
600 NCT03923439 412 415 I-Eq_Comparison
Ã NCT03923439 416 417 O
10 NCT03923439 418 420 B-Eq_Comparison
- NCT03923439 421 422 I-Eq_Comparison
6 NCT03923439 423 424 I-Eq_Comparison
mm NCT03923439 425 427 I-Eq_Comparison
2 NCT03923439 428 429 I-Eq_Comparison
/ NCT03923439 430 431 I-Eq_Comparison
s NCT03923439 432 433 I-Eq_Comparison
) NCT03923439 434 435 O
of NCT03923439 436 438 O
1.8 NCT03923439 439 442 B-Eq_Comparison
or NCT03923439 443 445 I-Eq_Comparison
more NCT03923439 446 450 I-Eq_Comparison
, NCT03923439 451 452 O
with NCT03923439 453 457 O
an NCT03923439 458 460 O
absolute NCT03923439 461 469 B-Observation
difference NCT03923439 470 480 I-Observation
of NCT03923439 481 483 O
15 NCT03923439 484 486 B-Eq_Comparison
mL NCT03923439 487 489 I-Eq_Comparison
or NCT03923439 490 492 I-Eq_Comparison
more NCT03923439 493 497 I-Eq_Comparison
and NCT03923439 498 501 B-And
ischemic NCT03923439 502 510 B-Observation
core NCT03923439 511 515 I-Observation
volume NCT03923439 516 522 I-Observation
of NCT03923439 523 525 O
less NCT03923439 526 530 B-Eq_Comparison
than NCT03923439 531 535 I-Eq_Comparison
70 NCT03923439 536 538 I-Eq_Comparison
mL NCT03923439 539 541 I-Eq_Comparison
. NCT03923439 542 543 O

- NCT03923439 547 548 O
Successful NCT03923439 550 560 O
recanalization NCT03923439 561 575 B-Procedure
( NCT03923439 576 577 O
TICI NCT03923439 578 582 B-Condition
2 NCT03923439 583 584 B-Eq_Comparison
b NCT03923439 585 586 I-Eq_Comparison
- NCT03923439 587 588 I-Eq_Comparison
3 NCT03923439 589 590 I-Eq_Comparison
) NCT03923439 591 592 O
by NCT03923439 593 595 O
thrombectomy NCT03923439 596 608 B-Procedure
alone NCT03923439 609 614 B-Modifier
or NCT03923439 615 617 B-Or
in NCT03923439 618 620 O
combination NCT03923439 621 632 O
with NCT03923439 633 637 O
IV NCT03923439 638 640 B-Modifier
thrombolysis NCT03923439 641 653 B-Procedure
( NCT03923439 654 655 O
if NCT03923439 656 658 O
within NCT03923439 659 665 B-Eq_Comparison
the NCT03923439 666 669 I-Eq_Comparison
first NCT03923439 670 675 I-Eq_Comparison
4.5 NCT03923439 676 679 I-Eq_Comparison
h NCT03923439 680 681 I-Eq_Comparison
) NCT03923439 682 683 O
. NCT03923439 684 685 O

- NCT03923439 689 690 O
Patient NCT03923439 692 699 O
/ NCT03923439 700 701 O
Legally NCT03923439 702 709 O
Authorized NCT03923439 710 720 O
Representative NCT03923439 721 735 O
has NCT03923439 736 739 O
signed NCT03923439 740 746 O
the NCT03923439 747 750 O
Informed NCT03923439 751 759 O
Consent NCT03923439 760 767 O
form NCT03923439 768 772 O
. NCT03923439 773 774 O

Exclusion NCT03923439 776 785 O
Criteria NCT03923439 786 794 O
: NCT03923439 795 796 O

- NCT03923439 800 801 O
History NCT03923439 803 810 B-Eq_Comparison
of NCT03923439 811 813 O
symptomatic NCT03923439 814 825 B-Assertion___Assertion_Type_Value:possible
cerebral NCT03923439 826 834 B-Condition
infarct NCT03923439 835 842 I-Condition
with NCT03923439 843 847 B-And
functional NCT03923439 848 858 B-Condition
deficit NCT03923439 859 866 I-Condition
( NCT03923439 867 868 O
pre NCT03923439 869 872 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03923439 873 874 O
stroke NCT03923439 875 881 B-Condition
modified NCT03923439 882 890 B-Observation
Rankin NCT03923439 891 897 I-Observation
Scale NCT03923439 898 903 I-Observation
score NCT03923439 904 909 B-Eq_Comparison
â¥ NCT03923439 910 911 I-Eq_Comparison
1 NCT03923439 912 913 I-Eq_Comparison
) NCT03923439 914 915 O
to NCT03923439 916 918 B-Assertion___Assertion_Type_Value:hypothetical
measure NCT03923439 919 926 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03923439 927 930 O
impact NCT03923439 931 937 O
of NCT03923439 938 940 O
the NCT03923439 941 944 O
infarct NCT03923439 945 952 B-Condition
and NCT03923439 953 956 B-And
selective NCT03923439 957 966 B-Condition
neuronal NCT03923439 967 975 I-Condition
loss NCT03923439 976 980 I-Condition
on NCT03923439 981 983 O
long NCT03923439 984 988 O
- NCT03923439 989 990 O
term NCT03923439 991 995 O
outcome NCT03923439 996 1003 O
without NCT03923439 1004 1011 O
being NCT03923439 1012 1017 O
biased NCT03923439 1018 1024 O
by NCT03923439 1025 1027 O
pre NCT03923439 1028 1031 O
- NCT03923439 1032 1033 O
existing NCT03923439 1034 1042 O
deficits NCT03923439 1043 1051 O
. NCT03923439 1052 1053 O

- NCT03923439 1057 1058 O
History NCT03923439 1060 1067 B-Eq_Comparison
of NCT03923439 1068 1070 O
severe NCT03923439 1071 1077 O
cognitive NCT03923439 1078 1087 B-Condition
impairment NCT03923439 1088 1098 I-Condition
( NCT03923439 1099 1100 O
dementia NCT03923439 1101 1109 B-Condition
) NCT03923439 1110 1111 O
or NCT03923439 1112 1114 B-Or
DSMIV NCT03923439 1115 1120 O
axis NCT03923439 1121 1125 O
1 NCT03923439 1126 1127 O
psychiatric NCT03923439 1128 1139 B-Condition
disorders NCT03923439 1140 1149 I-Condition
that NCT03923439 1150 1154 O
would NCT03923439 1155 1160 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03923439 1161 1169 O
the NCT03923439 1170 1173 O
neurological NCT03923439 1174 1186 B-Procedure
evaluations NCT03923439 1187 1198 I-Procedure
. NCT03923439 1199 1200 O

- NCT03923439 1204 1205 O
Pregnant NCT03923439 1207 1215 B-Condition
or NCT03923439 1216 1218 B-Or
breast NCT03923439 1219 1225 B-Condition
- NCT03923439 1226 1227 I-Condition
feeding NCT03923439 1228 1235 I-Condition
women NCT03923439 1236 1241 O
. NCT03923439 1242 1243 O

- NCT03923439 1247 1248 O
Contraindications NCT03923439 1250 1267 B-Contraindication
to NCT03923439 1268 1270 O
MRI NCT03923439 1271 1274 B-Procedure
. NCT03923439 1275 1276 O

Inclusion NCT03924440 0 9 O
Criteria NCT03924440 10 18 O
: NCT03924440 19 20 O

1 NCT03924440 24 25 O
. NCT03924440 25 26 O
Female NCT03924440 28 34 O
( NCT03924440 35 36 O
mandatory NCT03924440 37 46 O
) NCT03924440 47 48 O

2 NCT03924440 52 53 O
. NCT03924440 53 54 O
Not NCT03924440 56 59 B-Negation
currently NCT03924440 60 69 B-Eq_Comparison
pregnant NCT03924440 70 78 B-Condition
or NCT03924440 79 81 B-Or
nursing NCT03924440 82 89 B-Condition
( NCT03924440 90 91 O
pregnancy NCT03924440 92 101 O
affects NCT03924440 102 109 O
PdG NCT03924440 110 113 O
levels NCT03924440 114 120 O
) NCT03924440 121 122 O

3 NCT03924440 126 127 O
. NCT03924440 127 128 O
Aged NCT03924440 130 134 B-Age
18 NCT03924440 135 137 B-Eq_Comparison
- NCT03924440 138 139 I-Eq_Comparison
34 NCT03924440 140 142 I-Eq_Comparison
( NCT03924440 143 144 O
advanced NCT03924440 145 153 O
age NCT03924440 154 157 O
can NCT03924440 158 161 O
hinder NCT03924440 162 168 O
PdG NCT03924440 169 172 O
levels NCT03924440 173 179 O
) NCT03924440 180 181 O

4 NCT03924440 185 186 O
. NCT03924440 186 187 O
Cycle NCT03924440 189 194 B-Observation
length NCT03924440 195 201 I-Observation
of NCT03924440 202 204 O
26 NCT03924440 205 207 B-Eq_Comparison
- NCT03924440 208 209 I-Eq_Comparison
39 NCT03924440 210 212 I-Eq_Comparison
days NCT03924440 213 217 I-Eq_Comparison
( NCT03924440 218 219 O
long NCT03924440 220 224 B-Modifier
or NCT03924440 225 227 B-Or
short NCT03924440 228 233 B-Modifier
cycles NCT03924440 234 240 B-Observation
have NCT03924440 241 245 B-Assertion___Assertion_Type_Value:hypothetical
inconsistent NCT03924440 246 258 O
PdG NCT03924440 259 262 B-Observation
levels NCT03924440 263 269 I-Observation
) NCT03924440 270 271 O

5 NCT03924440 275 276 O
. NCT03924440 276 277 O
Currently NCT03924440 279 288 B-Eq_Comparison
use NCT03924440 289 292 O
other NCT03924440 293 298 O
fertility NCT03924440 299 308 B-Procedure
monitoring NCT03924440 309 319 I-Procedure
tools NCT03924440 320 325 I-Procedure
( NCT03924440 326 327 O
this NCT03924440 328 332 O
allows NCT03924440 333 339 O
us NCT03924440 340 342 O
to NCT03924440 343 345 O
compare NCT03924440 346 353 O
Proov NCT03924440 354 359 O
- NCT03924440 360 361 O
Ovulation NCT03924440 362 371 O
Double NCT03924440 372 378 O
Check NCT03924440 379 384 O
test NCT03924440 385 389 O
results NCT03924440 390 397 O
with NCT03924440 398 402 O
other NCT03924440 403 408 O
fertility NCT03924440 409 418 O
tracking NCT03924440 419 427 O
methods NCT03924440 428 435 O
) NCT03924440 436 437 O

Exclusion NCT03924440 439 448 O
Criteria NCT03924440 449 457 O
: NCT03924440 458 459 O

1 NCT03924440 463 464 O
. NCT03924440 464 465 O
Male NCT03924440 467 471 O

2 NCT03924440 474 475 O
. NCT03924440 475 476 O
Pregnant NCT03924440 478 486 B-Condition

3 NCT03924440 489 490 O
. NCT03924440 490 491 O
Nursing NCT03924440 493 500 B-Condition


Inclusion NCT03862417 0 9 O
Criteria NCT03862417 10 18 O
: NCT03862417 19 20 O

- NCT03862417 24 25 O
Adults NCT03862417 27 33 O
over NCT03862417 34 38 B-Eq_Comparison
50 NCT03862417 39 41 I-Eq_Comparison
years NCT03862417 42 47 I-Eq_Comparison
old NCT03862417 48 51 B-Age
with NCT03862417 52 56 B-And
degenerative NCT03862417 57 69 B-Condition
scoliosis NCT03862417 70 79 I-Condition
( NCT03862417 80 81 O
n NCT03862417 82 83 O
= NCT03862417 84 85 O
20 NCT03862417 86 88 O
) NCT03862417 89 90 O
with NCT03862417 91 95 B-And
pain NCT03862417 96 100 B-Observation
( NCT03862417 101 102 O
> NCT03862417 103 104 B-Eq_Comparison
2 NCT03862417 105 106 I-Eq_Comparison
/ NCT03862417 107 108 I-Eq_Comparison
10 NCT03862417 109 111 I-Eq_Comparison
) NCT03862417 112 113 O
. NCT03862417 114 115 O
Other NCT03862417 117 122 O
inclusion NCT03862417 123 132 O
criteria NCT03862417 133 141 O
are NCT03862417 142 145 O
: NCT03862417 146 147 O
( NCT03862417 148 149 O
1 NCT03862417 150 151 O
) NCT03862417 152 153 O
curves NCT03862417 154 160 B-Observation
15 NCT03862417 161 163 B-Eq_Comparison
Â° NCT03862417 164 165 I-Eq_Comparison
- NCT03862417 166 167 I-Eq_Comparison
45 NCT03862417 168 170 I-Eq_Comparison
Â° NCT03862417 171 172 I-Eq_Comparison
. NCT03862417 173 174 O

Exclusion NCT03862417 176 185 O
Criteria NCT03862417 186 194 O
: NCT03862417 195 196 O

- NCT03862417 200 201 O
Curves NCT03862417 203 209 B-Observation
over NCT03862417 210 214 B-Eq_Comparison
50 NCT03862417 215 217 I-Eq_Comparison
Â° NCT03862417 218 219 I-Eq_Comparison
are NCT03862417 220 223 O
surgical NCT03862417 224 232 B-Procedure
candidates NCT03862417 233 243 B-Assertion___Assertion_Type_Value:hypothetical
, NCT03862417 244 245 O
and NCT03862417 246 249 O
will NCT03862417 250 254 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03862417 255 257 I-Assertion___Assertion_Type_Value:hypothetical
excluded NCT03862417 258 266 B-Negation
. NCT03862417 267 268 O
Patients NCT03862417 270 278 O
who NCT03862417 279 282 O
have NCT03862417 283 287 O
had NCT03862417 288 291 B-Eq_Comparison
cortisone NCT03862417 292 301 B-Drug
or NCT03862417 302 304 B-Or
anesthetic NCT03862417 305 315 B-Drug
injections NCT03862417 316 326 B-Procedure
within NCT03862417 327 333 B-Eq_Comparison
the NCT03862417 334 337 I-Eq_Comparison
last NCT03862417 338 342 I-Eq_Comparison
3 NCT03862417 343 344 I-Eq_Comparison
months NCT03862417 345 351 I-Eq_Comparison
, NCT03862417 352 353 O
surgery NCT03862417 354 361 B-Procedure
or NCT03862417 362 364 B-Or
presenting NCT03862417 365 375 O
contra NCT03862417 376 382 B-Contraindication
- NCT03862417 383 384 I-Contraindication
indications NCT03862417 385 396 I-Contraindication
to NCT03862417 397 399 O
exercises NCT03862417 400 409 B-Observation
( NCT03862417 410 411 O
fractures NCT03862417 412 421 B-Condition
, NCT03862417 422 423 O
cancer NCT03862417 424 430 B-Condition
, NCT03862417 431 432 O
severe NCT03862417 433 439 O
cardio NCT03862417 440 446 B-Condition
- NCT03862417 447 448 I-Condition
vascular NCT03862417 449 457 I-Condition
co NCT03862417 458 460 I-Condition
- NCT03862417 461 462 I-Condition
morbidities NCT03862417 463 474 I-Condition
, NCT03862417 475 476 O
or NCT03862417 477 479 B-Or
osteopenia NCT03862417 480 490 B-Condition
) NCT03862417 491 492 O
will NCT03862417 493 497 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03862417 498 500 I-Assertion___Assertion_Type_Value:hypothetical
excluded NCT03862417 501 509 B-Negation
. NCT03862417 510 511 O

Inclusion NCT03929458 0 9 O
Criteria NCT03929458 10 18 O
: NCT03929458 19 20 O

- NCT03929458 24 25 O
Both NCT03929458 27 31 O
sexes NCT03929458 32 37 O
aged NCT03929458 38 42 B-Age
between NCT03929458 43 50 O
20 NCT03929458 51 53 B-Eq_Comparison
- NCT03929458 54 55 I-Eq_Comparison
90 NCT03929458 56 58 I-Eq_Comparison
years NCT03929458 59 64 I-Eq_Comparison
. NCT03929458 65 66 O

- NCT03929458 70 71 O
Received NCT03929458 73 81 B-Eq_Comparison
stable NCT03929458 82 88 O
hemodialysis NCT03929458 89 101 B-Procedure
at NCT03929458 102 104 B-Eq_Comparison
least NCT03929458 105 110 I-Eq_Comparison
3 NCT03929458 111 112 I-Eq_Comparison
months NCT03929458 113 119 I-Eq_Comparison
. NCT03929458 120 121 O

- NCT03929458 125 126 O
Written NCT03929458 128 135 O
informed NCT03929458 136 144 O
consent NCT03929458 145 152 O
. NCT03929458 153 154 O

Exclusion NCT03929458 156 165 O
Criteria NCT03929458 166 174 O
: NCT03929458 175 176 O

- NCT03929458 180 181 O
patients NCT03929458 183 191 O
with NCT03929458 192 196 O
severe NCT03929458 197 203 O
infections NCT03929458 204 214 B-Condition
, NCT03929458 215 216 O
severe NCT03929458 217 223 O
heart NCT03929458 224 229 B-Condition
disease NCT03929458 230 237 I-Condition
and NCT03929458 238 241 B-Or
liver NCT03929458 242 247 B-Condition
disease NCT03929458 248 255 I-Condition
, NCT03929458 256 257 O
malignancy NCT03929458 258 268 B-Condition
, NCT03929458 269 270 O
autoimmune NCT03929458 271 281 B-Condition
disorders NCT03929458 282 291 I-Condition
, NCT03929458 292 293 O
severe NCT03929458 294 300 B-Condition
malnutrition NCT03929458 301 313 I-Condition
, NCT03929458 314 315 O
or NCT03929458 316 318 O
clinical NCT03929458 319 327 O
conditions NCT03929458 328 338 B-Condition
requiring NCT03929458 339 348 B-Assertion___Assertion_Type_Value:hypothetical
oral NCT03929458 349 353 B-Drug
nutrition NCT03929458 354 363 I-Drug
supplements NCT03929458 364 375 I-Drug
; NCT03929458 375 376 O

- NCT03929458 379 380 O
Inability NCT03929458 382 391 O
to NCT03929458 392 394 O
follow NCT03929458 395 401 O
protocol NCT03929458 402 410 O
. NCT03929458 411 412 O

- NCT03929458 416 417 O
Pregnancy NCT03929458 419 428 B-Condition
or NCT03929458 429 431 B-Or
wishing NCT03929458 432 439 B-Assertion___Assertion_Type_Value:intention
/ NCT03929458 440 441 B-Or
trying NCT03929458 442 448 B-Assertion___Assertion_Type_Value:intention
to NCT03929458 449 451 O
get NCT03929458 452 455 O
pregnant NCT03929458 456 464 B-Condition

Inclusion NCT03861806 0 9 O
Criteria NCT03861806 10 18 O
: NCT03861806 19 20 O

- NCT03861806 24 25 O
Unilateral NCT03861806 27 37 B-Modifier
ischemic NCT03861806 38 46 I-Modifier
stroke NCT03861806 47 53 B-Condition
with NCT03861806 54 58 B-And
residual NCT03861806 59 67 B-Modifier
arm NCT03861806 68 71 I-Modifier
weakness NCT03861806 72 80 B-Condition
( NCT03861806 81 82 O
Fugl NCT03861806 83 87 B-Observation
- NCT03861806 88 89 I-Observation
Meyer NCT03861806 90 95 I-Observation
Upper NCT03861806 96 101 I-Observation
Limb NCT03861806 102 106 I-Observation
< NCT03861806 107 108 B-Eq_Comparison
60 NCT03861806 109 111 I-Eq_Comparison
) NCT03861806 112 113 O
more NCT03861806 114 118 B-Eq_Comparison
than NCT03861806 119 123 I-Eq_Comparison
6 NCT03861806 124 125 I-Eq_Comparison
months NCT03861806 126 132 I-Eq_Comparison
prior NCT03861806 133 138 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03861806 139 141 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03861806 142 152 B-Study
. NCT03861806 153 154 O

- NCT03861806 158 159 O
Ability NCT03861806 161 168 O
to NCT03861806 169 171 O
give NCT03861806 172 176 O
informed NCT03861806 177 185 O
consent NCT03861806 186 193 O
and NCT03861806 194 197 O
understand NCT03861806 198 208 O
the NCT03861806 209 212 O
tasks NCT03861806 213 218 O
involved NCT03861806 219 227 O
. NCT03861806 228 229 O

- NCT03861806 233 234 O
Age NCT03861806 236 239 B-Age
over NCT03861806 240 244 B-Eq_Comparison
18 NCT03861806 245 247 I-Eq_Comparison
years NCT03861806 248 253 I-Eq_Comparison
. NCT03861806 254 255 O

Exclusion NCT03861806 257 266 O
Criteria NCT03861806 267 275 O
: NCT03861806 276 277 O

- NCT03861806 281 282 O
Hemorrhagic NCT03861806 284 295 B-Modifier
Stroke NCT03861806 296 302 B-Condition

- NCT03861806 305 306 O
Contraindications NCT03861806 308 325 B-Contraindication
to NCT03861806 326 328 O
TMS NCT03861806 329 332 B-Drug
: NCT03861806 333 334 O
history NCT03861806 335 342 B-Eq_Comparison
of NCT03861806 343 345 O
seizure NCT03861806 346 353 B-Condition
/ NCT03861806 354 355 B-Or
epilepsy NCT03861806 356 364 B-Condition
, NCT03861806 365 366 O
pacemaker NCT03861806 367 376 B-Procedure
, NCT03861806 377 378 O
other NCT03861806 379 384 B-Other
neurological NCT03861806 385 397 B-Condition
disorders NCT03861806 398 407 I-Condition
, NCT03861806 408 409 O
brain NCT03861806 410 415 B-Procedure
surgery NCT03861806 416 423 I-Procedure
, NCT03861806 424 425 O
metal NCT03861806 426 431 B-Procedure
implant NCT03861806 432 439 B-Modifier
/ NCT03861806 440 441 B-Or
fragment NCT03861806 442 450 B-Modifier
in NCT03861806 451 453 O
the NCT03861806 454 457 O
head NCT03861806 458 462 B-Modifier
, NCT03861806 463 464 O
pregnancy NCT03861806 465 474 B-Condition

- NCT03861806 477 478 O
Taking NCT03861806 480 486 B-Eq_Comparison
medications NCT03861806 487 498 B-Drug
or NCT03861806 499 501 B-Or
substances NCT03861806 502 512 B-Drug
that NCT03861806 513 517 O
are NCT03861806 518 521 O
known NCT03861806 522 527 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861806 528 530 I-Assertion___Assertion_Type_Value:hypothetical
affect NCT03861806 531 537 O
PAS NCT03861806 538 541 B-Modifier
- NCT03861806 542 543 I-Modifier
induced NCT03861806 544 551 I-Modifier
plasticity NCT03861806 552 562 B-Condition
within NCT03861806 563 569 B-Eq_Comparison
the NCT03861806 570 573 I-Eq_Comparison
past NCT03861806 574 578 I-Eq_Comparison
2 NCT03861806 579 580 I-Eq_Comparison
months NCT03861806 581 587 I-Eq_Comparison
: NCT03861806 588 589 O
selective NCT03861806 590 599 O
serotonin NCT03861806 600 609 B-Drug
reuptake NCT03861806 610 618 I-Drug
inhibitors NCT03861806 619 629 I-Drug
, NCT03861806 630 631 O
dopamine NCT03861806 632 640 B-Drug
, NCT03861806 641 642 O
dopamine NCT03861806 643 651 B-Drug
agonists NCT03861806 652 660 I-Drug
, NCT03861806 661 662 O
haloperidol NCT03861806 663 674 B-Drug
, NCT03861806 675 676 O
lithium NCT03861806 677 684 B-Drug
, NCT03861806 685 686 O
acetylcholinesterase NCT03861806 687 707 B-Drug
inhibitors NCT03861806 708 718 I-Drug
, NCT03861806 719 720 O
beta NCT03861806 721 725 B-Drug
- NCT03861806 726 727 I-Drug
blockers NCT03861806 728 736 I-Drug
, NCT03861806 737 738 O
nimodipine NCT03861806 739 749 B-Drug
, NCT03861806 750 751 O
levetiracetam NCT03861806 752 765 B-Drug
, NCT03861806 766 767 O
ethosuximide NCT03861806 768 780 B-Drug
, NCT03861806 781 782 O
benzodiazepines NCT03861806 783 798 B-Drug
, NCT03861806 799 800 O
baclofen NCT03861806 801 809 B-Drug
, NCT03861806 810 811 O
nicotine NCT03861806 812 820 B-Drug

- NCT03861806 823 824 O
Peripheral NCT03861806 826 836 B-Modifier
neuropathy NCT03861806 837 847 B-Condition
or NCT03861806 848 850 B-Or
history NCT03861806 851 858 B-Eq_Comparison
of NCT03861806 859 861 O
nerve NCT03861806 862 867 B-Modifier
injury NCT03861806 868 874 B-Condition
in NCT03861806 875 877 O
the NCT03861806 878 881 O
paretic NCT03861806 882 889 B-Modifier
upper NCT03861806 890 895 I-Modifier
limb NCT03861806 896 900 I-Modifier
. NCT03861806 901 902 O

- NCT03861806 906 907 O
Social NCT03861806 909 915 B-Modifier
and NCT03861806 916 919 B-Or
/ NCT03861806 920 921 I-Or
or NCT03861806 922 924 I-Or
personal NCT03861806 925 933 B-Modifier
circumstances NCT03861806 934 947 B-Condition
that NCT03861806 948 952 O
interfere NCT03861806 953 962 O
with NCT03861806 963 967 O
ability NCT03861806 968 975 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861806 976 978 I-Assertion___Assertion_Type_Value:hypothetical
return NCT03861806 979 985 O
for NCT03861806 986 989 O
all NCT03861806 990 993 O
study NCT03861806 994 999 B-Study
visits NCT03861806 1000 1006 O
. NCT03861806 1007 1008 O

Inclusion NCT03861949 0 9 O
Criteria NCT03861949 10 18 O
: NCT03861949 19 20 O

- NCT03861949 24 25 O
adult NCT03861949 27 32 O
patients NCT03861949 33 41 O
of NCT03861949 42 44 O
ASA NCT03861949 45 48 B-Observation
physical NCT03861949 49 57 O
status NCT03861949 58 64 B-Eq_Comparison
I NCT03861949 65 66 I-Eq_Comparison
and NCT03861949 67 70 I-Eq_Comparison
II NCT03861949 71 73 I-Eq_Comparison
undergoing NCT03861949 74 84 B-Eq_Comparison
surgery NCT03861949 85 92 B-Procedure
under NCT03861949 93 98 O
general NCT03861949 99 106 B-Procedure
anaesthesia NCT03861949 107 118 I-Procedure

Exclusion NCT03861949 119 128 O
Criteria NCT03861949 129 137 O
: NCT03861949 138 139 O

- NCT03861949 143 144 O
anticipated NCT03861949 146 157 B-Assertion___Assertion_Type_Value:hypothetical
difficult NCT03861949 158 167 B-Modifier
mask NCT03861949 168 172 B-Procedure
ventilation NCT03861949 173 184 I-Procedure
/ NCT03861949 185 186 B-Or
intubation NCT03861949 187 197 B-Procedure

- NCT03861949 200 201 O
individuals NCT03861949 203 214 O
with NCT03861949 215 219 O
significant NCT03861949 220 231 O
cardiorespiratory NCT03861949 232 249 B-Modifier
or NCT03861949 250 252 B-Or
cerebrovascular NCT03861949 253 268 B-Modifier
disease NCT03861949 269 276 B-Condition

- NCT03861949 279 280 O
pregnant NCT03861949 282 290 B-Condition
ladies NCT03861949 291 297 O

- NCT03861949 300 301 O
patient NCT03861949 303 310 O
with NCT03861949 311 315 O
history NCT03861949 316 323 B-Eq_Comparison
of NCT03861949 324 326 O
epilepsy NCT03861949 327 335 B-Condition

- NCT03861949 338 339 O
body NCT03861949 341 345 B-Observation
mass NCT03861949 346 350 I-Observation
index NCT03861949 351 356 I-Observation
> NCT03861949 357 358 B-Eq_Comparison
25 NCT03861949 359 361 I-Eq_Comparison
kg NCT03861949 362 364 I-Eq_Comparison
/ NCT03861949 365 366 I-Eq_Comparison
m NCT03861949 367 368 I-Eq_Comparison
2 NCT03861949 369 370 I-Eq_Comparison

- NCT03861949 373 374 O
hemoglobin NCT03861949 376 386 B-Observation
< NCT03861949 387 388 B-Eq_Comparison
8 NCT03861949 389 390 I-Eq_Comparison
gm NCT03861949 391 393 I-Eq_Comparison
/ NCT03861949 394 395 I-Eq_Comparison
dL NCT03861949 396 398 I-Eq_Comparison

- NCT03861949 401 402 O
patients NCT03861949 404 412 O
who NCT03861949 413 416 O
were NCT03861949 417 421 B-Eq_Comparison
non NCT03861949 422 425 B-Negation
- NCT03861949 426 427 O
ambulant NCT03861949 428 436 B-Condition
for NCT03861949 437 440 O
> NCT03861949 441 442 B-Eq_Comparison
24 NCT03861949 443 445 I-Eq_Comparison
h NCT03861949 446 447 I-Eq_Comparison
, NCT03861949 448 449 O
having NCT03861949 450 456 B-And
SpO NCT03861949 457 460 B-Observation
2 NCT03861949 461 462 I-Observation
< NCT03861949 463 464 B-Eq_Comparison
97 NCT03861949 465 467 I-Eq_Comparison
% NCT03861949 468 469 I-Eq_Comparison
while NCT03861949 470 475 B-Temporal_Connection___Temporal_Connection_Type_Value:during
breathing NCT03861949 476 485 B-Observation
in NCT03861949 486 488 O
room NCT03861949 489 493 B-Modifier
air NCT03861949 494 497 I-Modifier

- NCT03861949 500 501 O
phobia NCT03861949 503 509 B-Condition
to NCT03861949 510 512 O
facemask NCT03861949 513 521 B-Modifier
. NCT03861949 522 523 O

Inclusion NCT03864172 0 9 O
Criteria NCT03864172 10 18 O

- NCT03864172 21 22 O
Screened NCT03864172 24 32 O
to NCT03864172 33 35 O
be NCT03864172 36 38 O
generally NCT03864172 39 48 O
healthy NCT03864172 49 56 B-Condition
as NCT03864172 57 59 O
determined NCT03864172 60 70 O
by NCT03864172 71 73 O
standard NCT03864172 74 82 B-Procedure
medical NCT03864172 83 90 I-Procedure
assessment NCT03864172 91 101 I-Procedure
on NCT03864172 102 104 O
physical NCT03864172 105 113 B-Modifier
and NCT03864172 114 117 B-Or
mental NCT03864172 118 124 B-Modifier
health NCT03864172 125 131 I-Modifier

- NCT03864172 134 135 O
Tanner NCT03864172 137 143 B-Condition
stage NCT03864172 144 149 B-Eq_Comparison
2 NCT03864172 150 151 I-Eq_Comparison
based NCT03864172 152 157 O
on NCT03864172 158 160 O
breast NCT03864172 161 167 B-Condition
development NCT03864172 168 179 I-Condition
for NCT03864172 180 183 O
girls NCT03864172 184 189 O
, NCT03864172 190 191 O
and NCT03864172 192 195 B-Or
pubic NCT03864172 196 201 B-Condition
hair NCT03864172 202 206 I-Condition
in NCT03864172 207 209 O
boys NCT03864172 210 214 O
. NCT03864172 215 216 O
Girls NCT03864172 218 223 O
will NCT03864172 224 228 O
have NCT03864172 229 233 O
to NCT03864172 234 236 O
be NCT03864172 237 239 O
premenarcheal NCT03864172 240 253 B-Condition

- NCT03864172 256 257 O
Having NCT03864172 259 265 O
obtained NCT03864172 266 274 O
his NCT03864172 275 278 O
/ NCT03864172 279 280 O
her NCT03864172 281 284 O
informed NCT03864172 285 293 O
consent NCT03864172 294 301 O
and NCT03864172 302 305 O
parents NCT03864172 306 313 O
or NCT03864172 314 316 O
legal NCT03864172 317 322 O
guardians NCT03864172 323 332 O
consent NCT03864172 333 340 O

Exclusion NCT03864172 341 350 O
Criteria NCT03864172 351 359 O
: NCT03864172 360 361 O

- NCT03864172 365 366 O
History NCT03864172 368 375 B-Eq_Comparison
of NCT03864172 376 378 O
serious NCT03864172 379 386 O
medical NCT03864172 387 394 B-Condition
conditions NCT03864172 395 405 I-Condition
such NCT03864172 406 410 O
as NCT03864172 411 413 O
intestinal NCT03864172 414 424 B-Modifier
or NCT03864172 425 427 B-Or
severe NCT03864172 428 434 O
metabolic NCT03864172 435 444 B-Condition
diseases NCT03864172 445 453 I-Condition
, NCT03864172 454 455 O
disorders NCT03864172 456 465 B-Condition
such NCT03864172 466 470 O
as NCT03864172 471 473 O
diabetes NCT03864172 474 482 B-Condition
, NCT03864172 483 484 O
renal NCT03864172 485 490 B-Modifier
, NCT03864172 491 492 O
hepatic NCT03864172 493 500 B-Modifier
or NCT03864172 501 503 B-Or
pancreatic NCT03864172 504 514 B-Modifier
diseases NCT03864172 515 523 B-Condition
, NCT03864172 524 525 O
disorders NCT03864172 526 535 B-Condition
, NCT03864172 536 537 O
ulcer NCT03864172 538 543 B-Condition
, NCT03864172 544 545 O
hyperthyroidism NCT03864172 546 561 B-Condition
, NCT03864172 562 563 O
malignance NCT03864172 564 574 B-Condition
, NCT03864172 575 576 O
chronic NCT03864172 577 584 O
malnutrition NCT03864172 585 597 B-Condition
, NCT03864172 598 599 O
anaemia NCT03864172 600 607 B-Condition

- NCT03864172 610 611 O
History NCT03864172 613 620 B-Eq_Comparison
or NCT03864172 621 623 B-Or
on NCT03864172 624 626 B-Eq_Comparison
therapy NCT03864172 627 634 B-Procedure
with NCT03864172 635 639 O
medication NCT03864172 640 650 B-Drug
known NCT03864172 651 656 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864172 657 659 I-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03864172 660 669 O
with NCT03864172 670 674 O
bone NCT03864172 675 679 B-Condition
metabolism NCT03864172 680 690 I-Condition
such NCT03864172 691 695 O
as NCT03864172 696 698 O
steroids NCT03864172 699 707 B-Drug
, NCT03864172 708 709 O
hormones NCT03864172 710 718 B-Drug
, NCT03864172 719 720 O
diuretics NCT03864172 721 730 B-Drug
, NCT03864172 731 732 O
cortisone NCT03864172 733 742 B-Drug
or NCT03864172 743 745 B-Or
anti NCT03864172 746 750 O
- NCT03864172 751 752 O
seizure NCT03864172 753 760 B-Condition
medication NCT03864172 761 771 B-Drug

- NCT03864172 774 775 O
Taking NCT03864172 777 783 B-Eq_Comparison
regularly NCT03864172 784 793 O
any NCT03864172 794 797 O
nutritional NCT03864172 798 809 B-Drug
supplements NCT03864172 810 821 I-Drug
and NCT03864172 822 825 B-And
unwilling NCT03864172 826 835 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864172 836 838 O
stop NCT03864172 839 843 B-Negation
for NCT03864172 844 847 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864172 848 851 I-Temporal_Connection___Temporal_Connection_Type_Value:during
study NCT03864172 852 857 B-Study

Inclusion NCT03860090 0 9 O
Criteria NCT03860090 10 18 O
: NCT03860090 19 20 O

- NCT03860090 24 25 O
Patients NCT03860090 27 35 O
with NCT03860090 36 40 O
a NCT03860090 41 42 O
endovenous NCT03860090 43 53 B-Procedure
pacemaker NCT03860090 54 63 I-Procedure
or NCT03860090 64 66 B-Or
defibrillator NCT03860090 67 80 B-Procedure
indication NCT03860090 81 91 B-Indication
. NCT03860090 92 93 O

Exclusion NCT03860090 95 104 O
Criteria NCT03860090 105 113 O
: NCT03860090 114 115 O

- NCT03860090 119 120 O
Pre NCT03860090 122 125 B-Eq_Comparison
- NCT03860090 126 127 I-Eq_Comparison
existing NCT03860090 128 136 I-Eq_Comparison
ipsilateral NCT03860090 137 148 B-Procedure
pacing NCT03860090 149 155 I-Procedure
electrode NCT03860090 156 165 I-Procedure
. NCT03860090 166 167 O

- NCT03860090 171 172 O
Previous NCT03860090 174 182 B-Eq_Comparison
ipsilateral NCT03860090 183 194 B-Condition
lymphadenectomy NCT03860090 195 210 I-Condition
. NCT03860090 211 212 O

- NCT03860090 216 217 O
Indication NCT03860090 219 229 B-Indication
of NCT03860090 230 232 O
cardiac NCT03860090 233 240 B-Procedure
resynchronization NCT03860090 241 258 I-Procedure
therapy NCT03860090 259 266 I-Procedure
. NCT03860090 267 268 O

Inclusion NCT03925844 0 9 O
Criteria NCT03925844 10 18 O
: NCT03925844 19 20 O

- NCT03925844 24 25 O
population NCT03925844 27 37 O
aged NCT03925844 38 42 B-Age
55 NCT03925844 43 45 B-Eq_Comparison
to NCT03925844 46 48 I-Eq_Comparison
74 NCT03925844 49 51 I-Eq_Comparison
years NCT03925844 52 57 I-Eq_Comparison
from NCT03925844 58 62 O
NEDICES NCT03925844 63 70 O
2 NCT03925844 71 72 O
study NCT03925844 73 78 B-Study

- NCT03925844 81 82 O
to NCT03925844 84 86 O
have NCT03925844 87 91 O
signed NCT03925844 92 98 O
informed NCT03925844 99 107 O
consent NCT03925844 108 115 O

- NCT03925844 118 119 O
to NCT03925844 121 123 O
have NCT03925844 124 128 O
done NCT03925844 129 133 B-Eq_Comparison
the NCT03925844 134 137 O
neuropsicological NCT03925844 138 155 B-Procedure
assessment NCT03925844 156 166 I-Procedure

Exclusion NCT03925844 167 176 O
Criteria NCT03925844 177 185 O
: NCT03925844 186 187 O

- NCT03925844 191 192 O
to NCT03925844 194 196 O
have NCT03925844 197 201 O
a NCT03925844 202 203 O
dementia NCT03925844 204 212 B-Condition
diagnosis NCT03925844 213 222 O
at NCT03925844 223 225 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03925844 226 234 B-Study
. NCT03925844 235 236 O

Inclusion NCT03866460 0 9 O
Criteria NCT03866460 10 18 O
: NCT03866460 19 20 O

- NCT03866460 24 25 O
Signed NCT03866460 27 33 O
informed NCT03866460 34 42 O
consent NCT03866460 43 50 O
indicating NCT03866460 51 61 O
awareness NCT03866460 62 71 O
of NCT03866460 72 74 O
the NCT03866460 75 78 O
investigational NCT03866460 79 94 O
nature NCT03866460 95 101 O
of NCT03866460 102 104 O
the NCT03866460 105 108 O
protocol NCT03866460 109 117 O
. NCT03866460 118 119 O

- NCT03866460 123 124 O
Children NCT03866460 126 134 O
with NCT03866460 135 139 B-And
RB NCT03866460 140 142 B-Condition
aged NCT03866460 143 147 B-Age
3 NCT03866460 148 149 B-Eq_Comparison
months NCT03866460 150 156 I-Eq_Comparison
and NCT03866460 157 160 I-Eq_Comparison
older NCT03866460 161 166 I-Eq_Comparison
who NCT03866460 167 170 B-And
are NCT03866460 171 174 O
scheduled NCT03866460 175 184 B-Eq_Comparison
to NCT03866460 185 187 O
receive NCT03866460 188 195 O
their NCT03866460 196 201 O
first NCT03866460 202 207 B-Eq_Comparison
dose NCT03866460 208 212 O
of NCT03866460 213 215 O
IA NCT03866460 216 218 B-Drug
carboplatin NCT03866460 219 230 I-Drug
chemotherapy NCT03866460 231 243 B-Procedure
. NCT03866460 244 245 O

- NCT03866460 254 255 O
Retinoblastoma NCT03866460 257 271 B-Condition
is NCT03866460 272 274 O
rarely NCT03866460 275 281 O
seen NCT03866460 282 286 O
in NCT03866460 287 289 O
children NCT03866460 290 298 O
over NCT03866460 299 303 B-Eq_Comparison
8 NCT03866460 304 305 I-Eq_Comparison
years NCT03866460 306 311 I-Eq_Comparison
old NCT03866460 312 315 I-Eq_Comparison
, NCT03866460 316 317 O
however NCT03866460 318 325 O
we NCT03866460 326 328 O
will NCT03866460 329 333 O
not NCT03866460 334 337 O
include NCT03866460 338 345 O
an NCT03866460 346 348 O
upper NCT03866460 349 354 O
age NCT03866460 355 358 O
range NCT03866460 359 364 O
so NCT03866460 365 367 O
as NCT03866460 368 370 O
not NCT03866460 371 374 O
to NCT03866460 375 377 O
exclude NCT03866460 378 385 O
any NCT03866460 386 389 O
possible NCT03866460 390 398 O
participants NCT03866460 399 411 O

Exclusion NCT03866460 412 421 O
Criteria NCT03866460 422 430 O
: NCT03866460 431 432 O

- NCT03866460 436 437 O
Children NCT03866460 439 447 O
with NCT03866460 448 452 B-And
known NCT03866460 453 458 O
and NCT03866460 459 462 O
documented NCT03866460 463 473 O
preexisting NCT03866460 474 485 B-Eq_Comparison
hearing NCT03866460 486 493 B-Condition
loss NCT03866460 494 498 I-Condition
. NCT03866460 499 500 O

Inclusion NCT03865810 0 9 O
Criteria NCT03865810 10 18 O
: NCT03865810 19 20 O

- NCT03865810 24 25 O
All NCT03865810 27 30 O
patients NCT03865810 31 39 O
over NCT03865810 40 44 B-Eq_Comparison
18 NCT03865810 45 47 I-Eq_Comparison
years NCT03865810 48 53 I-Eq_Comparison
of NCT03865810 54 56 O
age NCT03865810 57 60 B-Age
undergoing NCT03865810 61 71 B-Eq_Comparison
gastric NCT03865810 72 79 B-Procedure
resection NCT03865810 80 89 I-Procedure
surgery NCT03865810 90 97 I-Procedure
due NCT03865810 98 101 O
to NCT03865810 102 104 O
cancer NCT03865810 105 111 B-Condition
within NCT03865810 112 118 B-And
or NCT03865810 119 121 B-Or
not NCT03865810 122 125 B-Negation
of NCT03865810 126 128 O
an NCT03865810 129 131 O
intensified NCT03865810 132 143 B-Modifier
recovery NCT03865810 144 152 B-Procedure
program NCT03865810 153 160 I-Procedure
( NCT03865810 161 162 O
ERAS NCT03865810 163 167 B-Procedure
) NCT03865810 168 169 O
with NCT03865810 170 174 O
any NCT03865810 175 178 O
level NCT03865810 179 184 O
of NCT03865810 185 187 O
compliance NCT03865810 188 198 O
with NCT03865810 199 203 O
the NCT03865810 204 207 O
protocol NCT03865810 208 216 O
( NCT03865810 217 218 O
from NCT03865810 219 223 O
0 NCT03865810 224 225 B-Eq_Comparison
- NCT03865810 226 227 I-Eq_Comparison
100 NCT03865810 228 231 I-Eq_Comparison
% NCT03865810 232 233 I-Eq_Comparison
) NCT03865810 234 235 O
. NCT03865810 236 237 O

Exclusion NCT03865810 239 248 O
Criteria NCT03865810 249 257 O
: NCT03865810 258 259 O

- NCT03865810 263 264 O
Patients NCT03865810 266 274 O
undergoing NCT03865810 275 285 B-Eq_Comparison
emergency NCT03865810 286 295 B-Modifier
surgery NCT03865810 296 303 B-Procedure

- NCT03865810 311 312 O
Endoscopic NCT03865810 314 324 B-Procedure
procedures NCT03865810 325 335 I-Procedure

- NCT03865810 343 344 O
Non NCT03865810 346 349 B-Negation
- NCT03865810 350 351 O
oncological NCT03865810 352 363 B-Procedure
gastric NCT03865810 364 371 I-Procedure
surgery NCT03865810 372 379 I-Procedure

- NCT03865810 387 388 O
Patients NCT03865810 390 398 O
who NCT03865810 399 402 O
refuse NCT03865810 403 409 O
to NCT03865810 410 412 O
participate NCT03865810 413 424 O

Inclusion NCT03922178 0 9 O
Criteria NCT03922178 10 18 O
: NCT03922178 19 20 O

- NCT03922178 24 25 O
Patient NCT03922178 27 34 O
of NCT03922178 35 37 O
the NCT03922178 38 41 O
CHU NCT03922178 42 45 O
Brugmann NCT03922178 46 54 O
Hospital NCT03922178 55 63 O
receiving NCT03922178 64 73 B-Eq_Comparison
elective NCT03922178 74 82 B-Modifier
coronary NCT03922178 83 91 B-Procedure
surgery NCT03922178 92 99 I-Procedure
. NCT03922178 100 101 O

- NCT03922178 105 106 O
Patient NCT03922178 108 115 O
in NCT03922178 116 118 O
sinusal NCT03922178 119 126 B-Condition
rhythm NCT03922178 127 133 I-Condition
before NCT03922178 134 140 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03922178 141 144 O
operation NCT03922178 145 154 O
and NCT03922178 155 158 O
during NCT03922178 159 165 O
the NCT03922178 166 169 O
collection NCT03922178 170 180 O
of NCT03922178 181 183 O
hemodynamic NCT03922178 184 195 O
data NCT03922178 196 200 O
. NCT03922178 201 202 O

- NCT03922178 206 207 O
Patients NCT03922178 209 217 O
with NCT03922178 218 222 O
conserved NCT03922178 223 232 B-Condition
left NCT03922178 233 237 I-Condition
ventricular NCT03922178 238 249 I-Condition
function NCT03922178 250 258 I-Condition
( NCT03922178 259 260 O
based NCT03922178 261 266 O
on NCT03922178 267 269 O
left NCT03922178 270 274 B-Observation
ventricular NCT03922178 275 286 I-Observation
ejection NCT03922178 287 295 I-Observation
fraction NCT03922178 296 304 I-Observation
assessed NCT03922178 305 313 O
by NCT03922178 314 316 O
pre NCT03922178 317 320 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03922178 321 330 B-Procedure
echocardiography NCT03922178 331 347 B-Procedure
and NCT03922178 348 351 O
superior NCT03922178 352 360 B-Eq_Comparison
to NCT03922178 361 363 I-Eq_Comparison
50 NCT03922178 364 366 I-Eq_Comparison
% NCT03922178 367 368 I-Eq_Comparison
) NCT03922178 369 370 O

Exclusion NCT03922178 372 381 O
Criteria NCT03922178 382 390 O
: NCT03922178 391 392 O

- NCT03922178 396 397 O
Hypertrophic NCT03922178 399 411 B-Condition
cardiomyopathy NCT03922178 412 426 I-Condition
( NCT03922178 427 428 O
diastolic NCT03922178 429 438 B-Observation
septal NCT03922178 439 445 I-Observation
thickness NCT03922178 446 455 I-Observation
> NCT03922178 456 457 B-Eq_Comparison
15 NCT03922178 458 460 I-Eq_Comparison
mm NCT03922178 461 463 I-Eq_Comparison
) NCT03922178 464 465 O

- NCT03922178 469 470 O
Heart NCT03922178 472 477 B-Condition
failure NCT03922178 478 485 I-Condition
with NCT03922178 486 490 B-And
left NCT03922178 491 495 B-Observation
ventricular NCT03922178 496 507 I-Observation
ejection NCT03922178 508 516 I-Observation
fraction NCT03922178 517 525 I-Observation
< NCT03922178 526 527 B-Eq_Comparison
50 NCT03922178 528 530 I-Eq_Comparison
% NCT03922178 531 532 I-Eq_Comparison

- NCT03922178 536 537 O
Presence NCT03922178 539 547 O
of NCT03922178 548 550 O
cardiac NCT03922178 551 558 B-Condition
valvulopathy NCT03922178 559 571 I-Condition
, NCT03922178 572 573 O
concerning NCT03922178 574 584 O
both NCT03922178 585 589 O
right NCT03922178 590 595 B-Modifier
and NCT03922178 596 599 B-And
left NCT03922178 600 604 B-Modifier
atrio NCT03922178 605 610 B-Modifier
- NCT03922178 611 612 I-Modifier
ventricular NCT03922178 613 624 I-Modifier
and NCT03922178 625 628 B-And
ventriculo NCT03922178 629 639 B-Modifier
- NCT03922178 640 641 I-Modifier
arterial NCT03922178 642 650 I-Modifier
valves NCT03922178 651 657 I-Modifier

- NCT03922178 660 661 O
Presence NCT03922178 663 671 O
of NCT03922178 672 674 O
valvular NCT03922178 675 683 B-Procedure
prosthesis NCT03922178 684 694 I-Procedure

- NCT03922178 697 698 O
Congenital NCT03922178 700 710 B-Condition
heart NCT03922178 711 716 I-Condition
disease NCT03922178 717 724 I-Condition

- NCT03922178 727 728 O
Pregnancy NCT03922178 730 739 B-Condition

- NCT03922178 742 743 O
Participation NCT03922178 745 758 O
to NCT03922178 759 761 O
another NCT03922178 762 769 B-Other
clinical NCT03922178 770 778 O
study NCT03922178 779 784 B-Study
